{"text": "Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. The vast majority of women with advanced ovarian cancer will ultimately relapse and develop a drug-resistant disease with an overall 5-year survival of <50%. Unfortunately, the mechanisms of drug resistance actually operating in patients are still unknown. To address this issue, in 41 patients affected by advanced ovarian cancer the three main mechanisms of paclitaxel resistance were investigated: overexpression of MDR-1 gene, point mutations at prominently expressed alpha-tubulin and beta-tubulin genes and selective alterations in the expression of beta-tubulin isotypes. MDR-1 and the beta-tubulin isotypes expression were evaluated by semiquantitative and real-time PCR. On the same specimens, quantitative immunohistochemistry was also done in the tumor area. No statistically significant changes of MDR-1 expression were noticed between the sensitive and resistant patients either at the mRNA or protein level. The tubulin mutations for the ubiquitous alpha-tubulin and beta-tubulin genes were evaluated by automated DNA sequencing, and in all patients, no mutations were detected in both resistant and sensitive cases. With regard to the expression of tubulin isoforms, a statistically significant up-regulation of class III beta-tubulin was found in the resistant subset. It is worth noting that this statistically significant increase of the expression of class III beta-tubulin was detectable at the mRNA and protein level. By a direct comparison of the three main known mechanisms of paclitaxel resistance, this study indicates that overexpression of class III beta-tubulin is the most prominent mechanism of paclitaxel resistance in ovarian cancer.", "title": {"charStart": 0, "charEnd": 114}, "docId": "15671559", "entity": [{"duid": "PU:6jre", "entityType": "Gene", "charEnd": 21, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Class III beta-tubulin"}, {"duid": "PU:DzyM", "entityType": "Gene", "charEnd": 600, "source": "PUBTATOR", "charStart": 588, "entityId": [{"idString": "10376", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "alpha-tubulin"}, {"duid": "PU:B7CH", "entityType": "Chemical", "charEnd": 75, "source": "PUBTATOR", "charStart": 66, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "paclitaxel"}, {"duid": "PU:moBW", "entityType": "Gene", "charEnd": 699, "source": "PUBTATOR", "charStart": 695, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MDR-1"}, {"duid": "PU:FzmP", "entityType": "Species", "charEnd": 1178, "source": "PUBTATOR", "charStart": 1171, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:fcxQ", "entityType": "Species", "charEnd": 999, "source": "PUBTATOR", "charStart": 992, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:6WUC", "entityType": "Species", "charEnd": 141, "source": "PUBTATOR", "charStart": 137, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "women"}, {"duid": "PU:KByw", "entityType": "Chemical", "charEnd": 485, "source": "PUBTATOR", "charStart": 476, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 3, "entityText": "paclitaxel"}, {"duid": "PU:HgaP", "entityType": "Chemical", "charEnd": 1750, "source": "PUBTATOR", "charStart": 1741, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 10, "entityText": "paclitaxel"}, {"duid": "PU:MBCY", "entityType": "Disease", "charEnd": 231, "source": "PUBTATOR", "charStart": 210, "entityId": [{"idString": "D060467", "source": "MESH"}], "sentenceIndex": 1, "entityText": "drug-resistant disease"}, {"duid": "PU:EqTz", "entityType": "Chemical", "charEnd": 1625, "source": "PUBTATOR", "charStart": 1616, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 10, "entityText": "paclitaxel"}, {"duid": "PU:a5Eo", "entityType": "Disease", "charEnd": 878, "source": "PUBTATOR", "charStart": 874, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumor"}, {"duid": "PU:jzK9", "entityType": "Gene", "charEnd": 539, "source": "PUBTATOR", "charStart": 535, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MDR-1"}, {"duid": "PU:tFKH", "entityType": "Species", "charEnd": 409, "source": "PUBTATOR", "charStart": 402, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:c9dU", "entityType": "Gene", "charEnd": 1704, "source": "PUBTATOR", "charStart": 1683, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "class III beta-tubulin"}, {"duid": "PU:EsCx", "entityType": "Gene", "charEnd": 1091, "source": "PUBTATOR", "charStart": 1079, "entityId": [{"idString": "10376", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "alpha-tubulin"}, {"duid": "PU:VuQ9", "entityType": "Disease", "charEnd": 104, "source": "PUBTATOR", "charStart": 91, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 0, "entityText": "ovarian cancer"}, {"duid": "PU:qUkP", "entityType": "Disease", "charEnd": 170, "source": "PUBTATOR", "charStart": 157, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 1, "entityText": "ovarian cancer"}, {"duid": "PU:GRsH", "entityType": "Disease", "charEnd": 1779, "source": "PUBTATOR", "charStart": 1766, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 10, "entityText": "ovarian cancer"}, {"duid": "PU:MucE", "entityType": "Gene", "charEnd": 1364, "source": "PUBTATOR", "charStart": 1343, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "class III beta-tubulin"}, {"duid": "PU:fLzf", "entityType": "Gene", "charEnd": 930, "source": "PUBTATOR", "charStart": 926, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "MDR-1"}, {"duid": "PU:PwJD", "entityType": "Disease", "charEnd": 445, "source": "PUBTATOR", "charStart": 432, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 3, "entityText": "ovarian cancer"}, {"duid": "PU:kwTh", "entityType": "Species", "charEnd": 113, "source": "PUBTATOR", "charStart": 106, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:my6e", "entityType": "Gene", "charEnd": 1507, "source": "PUBTATOR", "charStart": 1486, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "class III beta-tubulin"}, {"duid": "PU:M2XN", "entityType": "Species", "charEnd": 352, "source": "PUBTATOR", "charStart": 345, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}]}
{"text": "Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. The vast majority of women with advanced ovarian cancer will ultimately relapse and develop a drug-resistant disease with an overall 5-year survival of <50%. Unfortunately, the mechanisms of drug resistance actually operating in patients are still unknown. To address this issue, in 41 patients affected by advanced ovarian cancer the three main mechanisms of paclitaxel resistance were investigated: overexpression of MDR-1 gene, point mutations at prominently expressed alpha-tubulin and beta-tubulin genes and selective alterations in the expression of beta-tubulin isotypes. MDR-1 and the beta-tubulin isotypes expression were evaluated by semiquantitative and real-time PCR. On the same specimens, quantitative immunohistochemistry was also done in the tumor area. No statistically significant changes of MDR-1 expression were noticed between the sensitive and resistant patients either at the mRNA or protein level. The tubulin mutations for the ubiquitous alpha-tubulin and beta-tubulin genes were evaluated by automated DNA sequencing, and in all patients, no mutations were detected in both resistant and sensitive cases. With regard to the expression of tubulin isoforms, a statistically significant up-regulation of class III beta-tubulin was found in the resistant subset. It is worth noting that this statistically significant increase of the expression of class III beta-tubulin was detectable at the mRNA and protein level. By a direct comparison of the three main known mechanisms of paclitaxel resistance, this study indicates that overexpression of class III beta-tubulin is the most prominent mechanism of paclitaxel resistance in ovarian cancer.", "title": {"charStart": 0, "charEnd": 114}, "docId": "15671559", "entity": [{"duid": "PU:6jre", "entityType": "Gene", "charEnd": 21, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Class III beta-tubulin"}, {"duid": "PU:DzyM", "entityType": "Gene", "charEnd": 600, "source": "PUBTATOR", "charStart": 588, "entityId": [{"idString": "10376", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "alpha-tubulin"}, {"duid": "PU:B7CH", "entityType": "Chemical", "charEnd": 75, "source": "PUBTATOR", "charStart": 66, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "paclitaxel"}, {"duid": "PU:moBW", "entityType": "Gene", "charEnd": 699, "source": "PUBTATOR", "charStart": 695, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MDR-1"}, {"duid": "PU:FzmP", "entityType": "Species", "charEnd": 1178, "source": "PUBTATOR", "charStart": 1171, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:fcxQ", "entityType": "Species", "charEnd": 999, "source": "PUBTATOR", "charStart": 992, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:6WUC", "entityType": "Species", "charEnd": 141, "source": "PUBTATOR", "charStart": 137, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "women"}, {"duid": "PU:KByw", "entityType": "Chemical", "charEnd": 485, "source": "PUBTATOR", "charStart": 476, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 3, "entityText": "paclitaxel"}, {"duid": "PU:HgaP", "entityType": "Chemical", "charEnd": 1750, "source": "PUBTATOR", "charStart": 1741, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 10, "entityText": "paclitaxel"}, {"duid": "PU:MBCY", "entityType": "Disease", "charEnd": 231, "source": "PUBTATOR", "charStart": 210, "entityId": [{"idString": "D060467", "source": "MESH"}], "sentenceIndex": 1, "entityText": "drug-resistant disease"}, {"duid": "PU:EqTz", "entityType": "Chemical", "charEnd": 1625, "source": "PUBTATOR", "charStart": 1616, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 10, "entityText": "paclitaxel"}, {"duid": "PU:a5Eo", "entityType": "Disease", "charEnd": 878, "source": "PUBTATOR", "charStart": 874, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumor"}, {"duid": "PU:jzK9", "entityType": "Gene", "charEnd": 539, "source": "PUBTATOR", "charStart": 535, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MDR-1"}, {"duid": "PU:tFKH", "entityType": "Species", "charEnd": 409, "source": "PUBTATOR", "charStart": 402, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:c9dU", "entityType": "Gene", "charEnd": 1704, "source": "PUBTATOR", "charStart": 1683, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "class III beta-tubulin"}, {"duid": "PU:EsCx", "entityType": "Gene", "charEnd": 1091, "source": "PUBTATOR", "charStart": 1079, "entityId": [{"idString": "10376", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "alpha-tubulin"}, {"duid": "PU:VuQ9", "entityType": "Disease", "charEnd": 104, "source": "PUBTATOR", "charStart": 91, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 0, "entityText": "ovarian cancer"}, {"duid": "PU:qUkP", "entityType": "Disease", "charEnd": 170, "source": "PUBTATOR", "charStart": 157, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 1, "entityText": "ovarian cancer"}, {"duid": "PU:GRsH", "entityType": "Disease", "charEnd": 1779, "source": "PUBTATOR", "charStart": 1766, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 10, "entityText": "ovarian cancer"}, {"duid": "PU:MucE", "entityType": "Gene", "charEnd": 1364, "source": "PUBTATOR", "charStart": 1343, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "class III beta-tubulin"}, {"duid": "PU:fLzf", "entityType": "Gene", "charEnd": 930, "source": "PUBTATOR", "charStart": 926, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "MDR-1"}, {"duid": "PU:PwJD", "entityType": "Disease", "charEnd": 445, "source": "PUBTATOR", "charStart": 432, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 3, "entityText": "ovarian cancer"}, {"duid": "PU:kwTh", "entityType": "Species", "charEnd": 113, "source": "PUBTATOR", "charStart": 106, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:my6e", "entityType": "Gene", "charEnd": 1507, "source": "PUBTATOR", "charStart": 1486, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "class III beta-tubulin"}, {"duid": "PU:M2XN", "entityType": "Species", "charEnd": 352, "source": "PUBTATOR", "charStart": 345, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}]}
{"text": "Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery. PURPOSE: The first suggestions of a relationship between gene mRNA expression and differential sensitivity to gemcitabine/cisplatin are now emerging. ERCC1, RRM1, and XPD are involved in the nucleotide excision repair pathways, and tumor up-regulation of these genes leads to chemotherapy failure. In the present study, we have examined the potential correlation and predictive value of ERCC1, RRM1, and XPD mRNA expression in resected specimens from 67 stage IIB, IIIA, and IIIB non-small cell lung cancer patients treated with neoadjuvant gemcitabine/platinum followed by surgery. EXPERIMENTAL DESIGN: ERCC1, RRM1, and XPD expression was quantified using real-time quantitative reverse transcription-PCR. RESULTS: A good correlation was found between mRNA expression levels of the three genes. For RRM1 levels, patients in the bottom quartile had a decreased risk of death compared with those in the top quartile (risk ratio = 0.30; P = 0.033). Median survival for the 17 patients in the bottom quartile was 52 months, whereas for the 15 in the top quartile, it was 26 months (P = 0.018). When the characteristics of these 17 patients were compared with all of the other 50 patients, no differences in initial staging were observed. However, the 17 patients in the bottom quartile had better outcomes, including more radiographic responses (65% versus 54%; P = 0.24), complete resections (94% versus 72%; P = 0.03), lobectomies (71% versus 34%; P = 0.004), and pathological complete responses (29% versus 0%; P = 0.00001). CONCLUSIONS: Patients with RRM1 levels in the bottom quartile benefited significantly from gemcitabine/cisplatin neoadjuvant chemotherapy, leading us to conclude that RRM1 mRNA levels should be additionally validated to proceed with tailored chemotherapy.", "title": {"charStart": 0, "charEnd": 178}, "docId": "15217961", "entity": [{"duid": "PU:NwK4", "entityType": "Disease", "charEnd": 1053, "source": "PUBTATOR", "charStart": 1049, "entityId": [{"idString": "D003643", "source": "MESH"}], "sentenceIndex": 6, "entityText": "death"}, {"duid": "PU:vcqF", "entityType": "Species", "charEnd": 1000, "source": "PUBTATOR", "charStart": 993, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:DR5A", "entityType": "Gene", "charEnd": 340, "source": "PUBTATOR", "charStart": 337, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "RRM1"}, {"duid": "PU:KgnL", "entityType": "Chemical", "charEnd": 310, "source": "PUBTATOR", "charStart": 302, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:PJFd", "entityType": "Gene", "charEnd": 794, "source": "PUBTATOR", "charStart": 791, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RRM1"}, {"duid": "PU:XnPY", "entityType": "Disease", "charEnd": 98, "source": "PUBTATOR", "charStart": 73, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:Krwo", "entityType": "Gene", "charEnd": 577, "source": "PUBTATOR", "charStart": 574, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "RRM1"}, {"duid": "PU:TTcz", "entityType": "Chemical", "charEnd": 300, "source": "PUBTATOR", "charStart": 290, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gemcitabine"}, {"duid": "PU:AGcL", "entityType": "Gene", "charEnd": 1875, "source": "PUBTATOR", "charStart": 1872, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "RRM1"}, {"duid": "PU:mUzE", "entityType": "Gene", "charEnd": 983, "source": "PUBTATOR", "charStart": 980, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "RRM1"}, {"duid": "PU:6Je9", "entityType": "Chemical", "charEnd": 1806, "source": "PUBTATOR", "charStart": 1796, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 10, "entityText": "gemcitabine"}, {"duid": "PU:g2mp", "entityType": "Gene", "charEnd": 586, "source": "PUBTATOR", "charStart": 584, "entityId": [{"idString": "2068", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "XPD"}, {"duid": "PU:wXky", "entityType": "Gene", "charEnd": 334, "source": "PUBTATOR", "charStart": 330, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:aVUP", "entityType": "Chemical", "charEnd": 740, "source": "PUBTATOR", "charStart": 733, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 3, "entityText": "platinum"}, {"duid": "PU:jMQT", "entityType": "Disease", "charEnd": 416, "source": "PUBTATOR", "charStart": 412, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:FSUy", "entityType": "Species", "charEnd": 1315, "source": "PUBTATOR", "charStart": 1308, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:fw7Z", "entityType": "Chemical", "charEnd": 731, "source": "PUBTATOR", "charStart": 721, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gemcitabine"}, {"duid": "PU:4bvm", "entityType": "Species", "charEnd": 1363, "source": "PUBTATOR", "charStart": 1356, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:VUZm", "entityType": "Gene", "charEnd": 349, "source": "PUBTATOR", "charStart": 347, "entityId": [{"idString": "2068", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "XPD"}, {"duid": "PU:C3yd", "entityType": "Gene", "charEnd": 571, "source": "PUBTATOR", "charStart": 567, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:3wL2", "entityType": "Species", "charEnd": 1438, "source": "PUBTATOR", "charStart": 1431, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:Hdp5", "entityType": "Chemical", "charEnd": 1816, "source": "PUBTATOR", "charStart": 1808, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 10, "entityText": "cisplatin"}, {"duid": "PU:a2Up", "entityType": "Disease", "charEnd": 685, "source": "PUBTATOR", "charStart": 660, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "non-small cell lung cancer"}, {"duid": "PU:ecnM", "entityType": "Species", "charEnd": 1725, "source": "PUBTATOR", "charStart": 1718, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "Patients"}, {"duid": "PU:hX98", "entityType": "Species", "charEnd": 694, "source": "PUBTATOR", "charStart": 687, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:pGgz", "entityType": "Gene", "charEnd": 803, "source": "PUBTATOR", "charStart": 801, "entityId": [{"idString": "2068", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "XPD"}, {"duid": "PU:Ryx6", "entityType": "Chemical", "charEnd": 126, "source": "PUBTATOR", "charStart": 116, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gemcitabine"}, {"duid": "PU:H75u", "entityType": "Gene", "charEnd": 788, "source": "PUBTATOR", "charStart": 784, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:8Fgc", "entityType": "Gene", "charEnd": 1735, "source": "PUBTATOR", "charStart": 1732, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "RRM1"}, {"duid": "PU:Bc8t", "entityType": "Species", "charEnd": 1161, "source": "PUBTATOR", "charStart": 1154, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}]}
{"text": "Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma. The identification of molecular markers, useful for therapeutic decisions in pancreatic cancer patients, is crucial for advances in disease management. Gemcitabine, although a cornerstone of current therapy, has limited efficacy. RRM1 is a key molecule for gemcitabine efficacy and is also involved in tumor progression. We determined in situ RRM1 and excision repair cross complementation group 1 (ERCC1) protein levels in 68 pancreatic cancer patients. All had R0 resections without preoperative therapy. Protein levels were determined by automated quantitative analysis (AQUA), a fluorescence-based immunohistochemical method. The relationship between protein expressions and clinical outcomes, including response to gemcitabine at the time of disease recurrence, was determined. Patients with high RRM1 showed significantly better overall survival than patients with low expression (P=0.0196). There was a trend toward better overall survival for patient with high ERCC1 (P=0.0552). When both markers were considered together, patients with both high RRM1 and ERCC1 faired the best in terms of overall and disease-free survival (P=0.0066, P=0.0127). In addition, treatment benefit from gemcitabine in patients with disease recurrence was observed only in patients with low RRM1. The combination of RRM1 and ERCC1 expression is prognostic in pancreatic cancer patients after a complete resection. On disease recurrence, only patients with low RRM1 derive benefit from gemcitabine.", "title": {"charStart": 0, "charEnd": 81}, "docId": "19543324", "entity": [{"duid": "PU:YCwk", "entityType": "Disease", "charEnd": 526, "source": "PUBTATOR", "charStart": 510, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 4, "entityText": "pancreatic cancer"}, {"duid": "PU:MHhT", "entityType": "Gene", "charEnd": 888, "source": "PUBTATOR", "charStart": 885, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "RRM1"}, {"duid": "PU:NSvb", "entityType": "Chemical", "charEnd": 1283, "source": "PUBTATOR", "charStart": 1273, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gemcitabine"}, {"duid": "PU:PVvx", "entityType": "Species", "charEnd": 1349, "source": "PUBTATOR", "charStart": 1342, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:u3DB", "entityType": "Gene", "charEnd": 19, "source": "PUBTATOR", "charStart": 16, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "RRM1"}, {"duid": "PU:K9oQ", "entityType": "Chemical", "charEnd": 1564, "source": "PUBTATOR", "charStart": 1554, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 13, "entityText": "gemcitabine"}, {"duid": "PU:7ywc", "entityType": "Disease", "charEnd": 80, "source": "PUBTATOR", "charStart": 56, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 0, "entityText": "pancreatic adenocarcinoma"}, {"duid": "PU:agT4", "entityType": "Gene", "charEnd": 1363, "source": "PUBTATOR", "charStart": 1360, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "RRM1"}, {"duid": "PU:WxLC", "entityType": "Gene", "charEnd": 429, "source": "PUBTATOR", "charStart": 426, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RRM1"}, {"duid": "PU:iES4", "entityType": "Disease", "charEnd": 176, "source": "PUBTATOR", "charStart": 160, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 1, "entityText": "pancreatic cancer"}, {"duid": "PU:e2PB", "entityType": "Disease", "charEnd": 1444, "source": "PUBTATOR", "charStart": 1428, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 12, "entityText": "pancreatic cancer"}, {"duid": "PU:ZHBN", "entityType": "Gene", "charEnd": 1398, "source": "PUBTATOR", "charStart": 1394, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "ERCC1"}, {"duid": "PU:3YWW", "entityType": "Chemical", "charEnd": 245, "source": "PUBTATOR", "charStart": 235, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 2, "entityText": "Gemcitabine"}, {"duid": "PU:Xq2J", "entityType": "Gene", "charEnd": 486, "source": "PUBTATOR", "charStart": 482, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:NAXu", "entityType": "Chemical", "charEnd": 813, "source": "PUBTATOR", "charStart": 803, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 7, "entityText": "gemcitabine"}, {"duid": "PU:9o3v", "entityType": "Gene", "charEnd": 479, "source": "PUBTATOR", "charStart": 435, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "excision repair cross complementation group 1"}, {"duid": "PU:cjPz", "entityType": "Gene", "charEnd": 1141, "source": "PUBTATOR", "charStart": 1138, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "RRM1"}, {"duid": "PU:vAFY", "entityType": "Gene", "charEnd": 29, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:Smwk", "entityType": "Species", "charEnd": 1453, "source": "PUBTATOR", "charStart": 1446, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 12, "entityText": "patients"}, {"duid": "PU:poGM", "entityType": "Species", "charEnd": 1295, "source": "PUBTATOR", "charStart": 1288, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:VEFy", "entityType": "Gene", "charEnd": 316, "source": "PUBTATOR", "charStart": 313, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "RRM1"}, {"duid": "PU:zw3Y", "entityType": "Species", "charEnd": 535, "source": "PUBTATOR", "charStart": 528, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:4GsU", "entityType": "Disease", "charEnd": 389, "source": "PUBTATOR", "charStart": 385, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:eXVo", "entityType": "Species", "charEnd": 947, "source": "PUBTATOR", "charStart": 940, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:Nte8", "entityType": "Species", "charEnd": 1518, "source": "PUBTATOR", "charStart": 1511, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 13, "entityText": "patients"}, {"duid": "PU:64cQ", "entityType": "Species", "charEnd": 873, "source": "PUBTATOR", "charStart": 866, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "Patients"}, {"duid": "PU:ZyGn", "entityType": "Species", "charEnd": 1040, "source": "PUBTATOR", "charStart": 1034, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patient"}, {"duid": "PU:cRWY", "entityType": "Gene", "charEnd": 1388, "source": "PUBTATOR", "charStart": 1385, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "RRM1"}, {"duid": "PU:gwbt", "entityType": "Species", "charEnd": 185, "source": "PUBTATOR", "charStart": 178, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:ow4K", "entityType": "Species", "charEnd": 1121, "source": "PUBTATOR", "charStart": 1114, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:nCYm", "entityType": "Gene", "charEnd": 1532, "source": "PUBTATOR", "charStart": 1529, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "RRM1"}, {"duid": "PU:Fhe3", "entityType": "Gene", "charEnd": 1056, "source": "PUBTATOR", "charStart": 1052, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:J47Y", "entityType": "Chemical", "charEnd": 350, "source": "PUBTATOR", "charStart": 340, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gemcitabine"}, {"duid": "PU:uvbv", "entityType": "Gene", "charEnd": 1151, "source": "PUBTATOR", "charStart": 1147, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}]}
{"text": "Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma. The identification of molecular markers, useful for therapeutic decisions in pancreatic cancer patients, is crucial for advances in disease management. Gemcitabine, although a cornerstone of current therapy, has limited efficacy. RRM1 is a key molecule for gemcitabine efficacy and is also involved in tumor progression. We determined in situ RRM1 and excision repair cross complementation group 1 (ERCC1) protein levels in 68 pancreatic cancer patients. All had R0 resections without preoperative therapy. Protein levels were determined by automated quantitative analysis (AQUA), a fluorescence-based immunohistochemical method. The relationship between protein expressions and clinical outcomes, including response to gemcitabine at the time of disease recurrence, was determined. Patients with high RRM1 showed significantly better overall survival than patients with low expression (P=0.0196). There was a trend toward better overall survival for patient with high ERCC1 (P=0.0552). When both markers were considered together, patients with both high RRM1 and ERCC1 faired the best in terms of overall and disease-free survival (P=0.0066, P=0.0127). In addition, treatment benefit from gemcitabine in patients with disease recurrence was observed only in patients with low RRM1. The combination of RRM1 and ERCC1 expression is prognostic in pancreatic cancer patients after a complete resection. On disease recurrence, only patients with low RRM1 derive benefit from gemcitabine.", "title": {"charStart": 0, "charEnd": 81}, "docId": "19543324", "entity": [{"duid": "PU:YCwk", "entityType": "Disease", "charEnd": 526, "source": "PUBTATOR", "charStart": 510, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 4, "entityText": "pancreatic cancer"}, {"duid": "PU:MHhT", "entityType": "Gene", "charEnd": 888, "source": "PUBTATOR", "charStart": 885, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "RRM1"}, {"duid": "PU:NSvb", "entityType": "Chemical", "charEnd": 1283, "source": "PUBTATOR", "charStart": 1273, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gemcitabine"}, {"duid": "PU:PVvx", "entityType": "Species", "charEnd": 1349, "source": "PUBTATOR", "charStart": 1342, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:u3DB", "entityType": "Gene", "charEnd": 19, "source": "PUBTATOR", "charStart": 16, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "RRM1"}, {"duid": "PU:K9oQ", "entityType": "Chemical", "charEnd": 1564, "source": "PUBTATOR", "charStart": 1554, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 13, "entityText": "gemcitabine"}, {"duid": "PU:7ywc", "entityType": "Disease", "charEnd": 80, "source": "PUBTATOR", "charStart": 56, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 0, "entityText": "pancreatic adenocarcinoma"}, {"duid": "PU:agT4", "entityType": "Gene", "charEnd": 1363, "source": "PUBTATOR", "charStart": 1360, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "RRM1"}, {"duid": "PU:WxLC", "entityType": "Gene", "charEnd": 429, "source": "PUBTATOR", "charStart": 426, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RRM1"}, {"duid": "PU:iES4", "entityType": "Disease", "charEnd": 176, "source": "PUBTATOR", "charStart": 160, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 1, "entityText": "pancreatic cancer"}, {"duid": "PU:e2PB", "entityType": "Disease", "charEnd": 1444, "source": "PUBTATOR", "charStart": 1428, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 12, "entityText": "pancreatic cancer"}, {"duid": "PU:ZHBN", "entityType": "Gene", "charEnd": 1398, "source": "PUBTATOR", "charStart": 1394, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "ERCC1"}, {"duid": "PU:3YWW", "entityType": "Chemical", "charEnd": 245, "source": "PUBTATOR", "charStart": 235, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 2, "entityText": "Gemcitabine"}, {"duid": "PU:Xq2J", "entityType": "Gene", "charEnd": 486, "source": "PUBTATOR", "charStart": 482, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:NAXu", "entityType": "Chemical", "charEnd": 813, "source": "PUBTATOR", "charStart": 803, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 7, "entityText": "gemcitabine"}, {"duid": "PU:9o3v", "entityType": "Gene", "charEnd": 479, "source": "PUBTATOR", "charStart": 435, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "excision repair cross complementation group 1"}, {"duid": "PU:cjPz", "entityType": "Gene", "charEnd": 1141, "source": "PUBTATOR", "charStart": 1138, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "RRM1"}, {"duid": "PU:vAFY", "entityType": "Gene", "charEnd": 29, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:Smwk", "entityType": "Species", "charEnd": 1453, "source": "PUBTATOR", "charStart": 1446, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 12, "entityText": "patients"}, {"duid": "PU:poGM", "entityType": "Species", "charEnd": 1295, "source": "PUBTATOR", "charStart": 1288, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:VEFy", "entityType": "Gene", "charEnd": 316, "source": "PUBTATOR", "charStart": 313, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "RRM1"}, {"duid": "PU:zw3Y", "entityType": "Species", "charEnd": 535, "source": "PUBTATOR", "charStart": 528, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:4GsU", "entityType": "Disease", "charEnd": 389, "source": "PUBTATOR", "charStart": 385, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:eXVo", "entityType": "Species", "charEnd": 947, "source": "PUBTATOR", "charStart": 940, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:Nte8", "entityType": "Species", "charEnd": 1518, "source": "PUBTATOR", "charStart": 1511, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 13, "entityText": "patients"}, {"duid": "PU:64cQ", "entityType": "Species", "charEnd": 873, "source": "PUBTATOR", "charStart": 866, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "Patients"}, {"duid": "PU:ZyGn", "entityType": "Species", "charEnd": 1040, "source": "PUBTATOR", "charStart": 1034, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patient"}, {"duid": "PU:cRWY", "entityType": "Gene", "charEnd": 1388, "source": "PUBTATOR", "charStart": 1385, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "RRM1"}, {"duid": "PU:gwbt", "entityType": "Species", "charEnd": 185, "source": "PUBTATOR", "charStart": 178, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:ow4K", "entityType": "Species", "charEnd": 1121, "source": "PUBTATOR", "charStart": 1114, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:nCYm", "entityType": "Gene", "charEnd": 1532, "source": "PUBTATOR", "charStart": 1529, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "RRM1"}, {"duid": "PU:Fhe3", "entityType": "Gene", "charEnd": 1056, "source": "PUBTATOR", "charStart": 1052, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:J47Y", "entityType": "Chemical", "charEnd": 350, "source": "PUBTATOR", "charStart": 340, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gemcitabine"}, {"duid": "PU:uvbv", "entityType": "Gene", "charEnd": 1151, "source": "PUBTATOR", "charStart": 1147, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}]}
{"text": "Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy. BACKGROUND: Thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), thymidine phosphorylase (TP) and orotate phosphoribosyltransferase (OPRT) have been reported to be predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy. Therapy guided by chemotherapy sensitivity and resistance assays may lead to rational treatment decisions. MATERIALS AND METHODS: mRNA expression of TS, DPD, TP, and OPRT were quantified by reverse-transcriptase polymerase chain reaction (RT-PCR) after harvesting from paraffin embedded specimens through microdissection. In vitro chemosensitivity testing by histoculture drug response assay (HDRA) was performed with fresh specimens of the primary tumor from 49 patients with colorectal cancer. Correlations between the results of a chemosensitivity test (the T/C ratio; the percentage of optical density of a tumor treated with anticancer drugs in relation to the optical density of the tumor cultured in RPMI 1640 medium only) and the gene expression were assessed. RESULTS: The gene expression of TS, TP, and OPRT had no correlation with clinicopathological factors, survival, and T/C ratio. The DPD mRNA levels (0.295 vs. 0.381, p = 0.2460) and OPRT/DPD ratio (5.535 vs. 4.394. p = 0.226) had a weak correlation with the T/C ratio. Of the eleven patients who were actually treated with chemotherapy, the responders had higher OPRT/DPD ratios (8.065 vs. 4.081, p = 0.090). CONCLUSION: The DPD mRNA level and OPRT/DPD ratio evaluated from paraffin embedded specimens are candidates for further evaluation as predictors of response against 5-fluorouracil-based chemotherapy in colorectal cancer.", "title": {"charStart": 0, "charEnd": 172}, "docId": "17465211", "entity": [{"duid": "PU:YGXS", "entityType": "Gene", "charEnd": 1564, "source": "PUBTATOR", "charStart": 1561, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "OPRT"}, {"duid": "PU:uQAA", "entityType": "Gene", "charEnd": 205, "source": "PUBTATOR", "charStart": 186, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "Thymidylate synthase"}, {"duid": "PU:yQ8W", "entityType": "Gene", "charEnd": 585, "source": "PUBTATOR", "charStart": 583, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "DPD"}, {"duid": "PU:bf7z", "entityType": "Gene", "charEnd": 1568, "source": "PUBTATOR", "charStart": 1566, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "DPD"}, {"duid": "PU:W3gF", "entityType": "Gene", "charEnd": 1387, "source": "PUBTATOR", "charStart": 1385, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "DPD"}, {"duid": "PU:NSPo", "entityType": "Chemical", "charEnd": 260, "source": "PUBTATOR", "charStart": 252, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}, {"duid": "PU:CxgP", "entityType": "Species", "charEnd": 1488, "source": "PUBTATOR", "charStart": 1481, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:Nw29", "entityType": "Disease", "charEnd": 1825, "source": "PUBTATOR", "charStart": 1809, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 10, "entityText": "colorectal cancer"}, {"duid": "PU:GDSv", "entityType": "Gene", "charEnd": 1645, "source": "PUBTATOR", "charStart": 1642, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "OPRT"}, {"duid": "PU:8wXL", "entityType": "Gene", "charEnd": 1649, "source": "PUBTATOR", "charStart": 1647, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "DPD"}, {"duid": "PU:D7Pu", "entityType": "Gene", "charEnd": 1246, "source": "PUBTATOR", "charStart": 1243, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "OPRT"}, {"duid": "PU:UT6s", "entityType": "Chemical", "charEnd": 229, "source": "PUBTATOR", "charStart": 213, "entityId": [], "sentenceIndex": 1, "entityText": "dihydropyrimidine"}, {"duid": "PU:CS9Q", "entityType": "Gene", "charEnd": 248, "source": "PUBTATOR", "charStart": 246, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "DPD"}, {"duid": "PU:9ubs", "entityType": "Gene", "charEnd": 1383, "source": "PUBTATOR", "charStart": 1380, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "OPRT"}, {"duid": "PU:ScdF", "entityType": "Disease", "charEnd": 883, "source": "PUBTATOR", "charStart": 879, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumor"}, {"duid": "PU:ZMft", "entityType": "Disease", "charEnd": 1232, "source": "PUBTATOR", "charStart": 1231, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:okS4", "entityType": "Chemical", "charEnd": 408, "source": "PUBTATOR", "charStart": 393, "entityId": [], "sentenceIndex": 1, "entityText": "fluoropyrimidine"}, {"duid": "PU:yGZQ", "entityType": "Disease", "charEnd": 209, "source": "PUBTATOR", "charStart": 208, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:2Csa", "entityType": "Disease", "charEnd": 580, "source": "PUBTATOR", "charStart": 579, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 3, "entityText": "TS"}, {"duid": "PU:354n", "entityType": "Gene", "charEnd": 1625, "source": "PUBTATOR", "charStart": 1623, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "DPD"}, {"duid": "PU:AEiF", "entityType": "Chemical", "charEnd": 291, "source": "PUBTATOR", "charStart": 285, "entityId": [{"idString": "30839", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "orotate"}, {"duid": "PU:MGvJ", "entityType": "Gene", "charEnd": 1332, "source": "PUBTATOR", "charStart": 1330, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "DPD"}, {"duid": "PU:eqXb", "entityType": "Gene", "charEnd": 599, "source": "PUBTATOR", "charStart": 596, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "OPRT"}, {"duid": "PU:27g5", "entityType": "Chemical", "charEnd": 152, "source": "PUBTATOR", "charStart": 141, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "fluorouracil"}, {"duid": "PU:UEhV", "entityType": "Disease", "charEnd": 1123, "source": "PUBTATOR", "charStart": 1119, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumor"}, {"duid": "PU:LCUK", "entityType": "Chemical", "charEnd": 1785, "source": "PUBTATOR", "charStart": 1772, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 10, "entityText": "5-fluorouracil"}, {"duid": "PU:UesA", "entityType": "Species", "charEnd": 900, "source": "PUBTATOR", "charStart": 893, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:eYtu", "entityType": "Gene", "charEnd": 317, "source": "PUBTATOR", "charStart": 285, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "orotate phosphoribosyltransferase"}, {"duid": "PU:5rL2", "entityType": "Chemical", "charEnd": 40, "source": "PUBTATOR", "charStart": 27, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-fluorouracil"}, {"duid": "PU:MwH4", "entityType": "Gene", "charEnd": 323, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "OPRT"}, {"duid": "PU:PNVn", "entityType": "Disease", "charEnd": 1045, "source": "PUBTATOR", "charStart": 1041, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumor"}, {"duid": "PU:qbZt", "entityType": "Disease", "charEnd": 923, "source": "PUBTATOR", "charStart": 907, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 4, "entityText": "colorectal cancer"}, {"duid": "PU:mQbu", "entityType": "Gene", "charEnd": 243, "source": "PUBTATOR", "charStart": 213, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "dihydropyrimidine dehydrogenase"}, {"duid": "PU:SmT4", "entityType": "Disease", "charEnd": 87, "source": "PUBTATOR", "charStart": 71, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 0, "entityText": "colorectal cancer"}]}
{"text": "Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy. BACKGROUND: Thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), thymidine phosphorylase (TP) and orotate phosphoribosyltransferase (OPRT) have been reported to be predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy. Therapy guided by chemotherapy sensitivity and resistance assays may lead to rational treatment decisions. MATERIALS AND METHODS: mRNA expression of TS, DPD, TP, and OPRT were quantified by reverse-transcriptase polymerase chain reaction (RT-PCR) after harvesting from paraffin embedded specimens through microdissection. In vitro chemosensitivity testing by histoculture drug response assay (HDRA) was performed with fresh specimens of the primary tumor from 49 patients with colorectal cancer. Correlations between the results of a chemosensitivity test (the T/C ratio; the percentage of optical density of a tumor treated with anticancer drugs in relation to the optical density of the tumor cultured in RPMI 1640 medium only) and the gene expression were assessed. RESULTS: The gene expression of TS, TP, and OPRT had no correlation with clinicopathological factors, survival, and T/C ratio. The DPD mRNA levels (0.295 vs. 0.381, p = 0.2460) and OPRT/DPD ratio (5.535 vs. 4.394. p = 0.226) had a weak correlation with the T/C ratio. Of the eleven patients who were actually treated with chemotherapy, the responders had higher OPRT/DPD ratios (8.065 vs. 4.081, p = 0.090). CONCLUSION: The DPD mRNA level and OPRT/DPD ratio evaluated from paraffin embedded specimens are candidates for further evaluation as predictors of response against 5-fluorouracil-based chemotherapy in colorectal cancer.", "title": {"charStart": 0, "charEnd": 172}, "docId": "17465211", "entity": [{"duid": "PU:YGXS", "entityType": "Gene", "charEnd": 1564, "source": "PUBTATOR", "charStart": 1561, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "OPRT"}, {"duid": "PU:uQAA", "entityType": "Gene", "charEnd": 205, "source": "PUBTATOR", "charStart": 186, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "Thymidylate synthase"}, {"duid": "PU:yQ8W", "entityType": "Gene", "charEnd": 585, "source": "PUBTATOR", "charStart": 583, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "DPD"}, {"duid": "PU:bf7z", "entityType": "Gene", "charEnd": 1568, "source": "PUBTATOR", "charStart": 1566, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "DPD"}, {"duid": "PU:W3gF", "entityType": "Gene", "charEnd": 1387, "source": "PUBTATOR", "charStart": 1385, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "DPD"}, {"duid": "PU:NSPo", "entityType": "Chemical", "charEnd": 260, "source": "PUBTATOR", "charStart": 252, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}, {"duid": "PU:CxgP", "entityType": "Species", "charEnd": 1488, "source": "PUBTATOR", "charStart": 1481, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:Nw29", "entityType": "Disease", "charEnd": 1825, "source": "PUBTATOR", "charStart": 1809, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 10, "entityText": "colorectal cancer"}, {"duid": "PU:GDSv", "entityType": "Gene", "charEnd": 1645, "source": "PUBTATOR", "charStart": 1642, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "OPRT"}, {"duid": "PU:8wXL", "entityType": "Gene", "charEnd": 1649, "source": "PUBTATOR", "charStart": 1647, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "DPD"}, {"duid": "PU:D7Pu", "entityType": "Gene", "charEnd": 1246, "source": "PUBTATOR", "charStart": 1243, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "OPRT"}, {"duid": "PU:UT6s", "entityType": "Chemical", "charEnd": 229, "source": "PUBTATOR", "charStart": 213, "entityId": [], "sentenceIndex": 1, "entityText": "dihydropyrimidine"}, {"duid": "PU:CS9Q", "entityType": "Gene", "charEnd": 248, "source": "PUBTATOR", "charStart": 246, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "DPD"}, {"duid": "PU:9ubs", "entityType": "Gene", "charEnd": 1383, "source": "PUBTATOR", "charStart": 1380, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "OPRT"}, {"duid": "PU:ScdF", "entityType": "Disease", "charEnd": 883, "source": "PUBTATOR", "charStart": 879, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumor"}, {"duid": "PU:ZMft", "entityType": "Disease", "charEnd": 1232, "source": "PUBTATOR", "charStart": 1231, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:okS4", "entityType": "Chemical", "charEnd": 408, "source": "PUBTATOR", "charStart": 393, "entityId": [], "sentenceIndex": 1, "entityText": "fluoropyrimidine"}, {"duid": "PU:yGZQ", "entityType": "Disease", "charEnd": 209, "source": "PUBTATOR", "charStart": 208, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:2Csa", "entityType": "Disease", "charEnd": 580, "source": "PUBTATOR", "charStart": 579, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 3, "entityText": "TS"}, {"duid": "PU:354n", "entityType": "Gene", "charEnd": 1625, "source": "PUBTATOR", "charStart": 1623, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "DPD"}, {"duid": "PU:AEiF", "entityType": "Chemical", "charEnd": 291, "source": "PUBTATOR", "charStart": 285, "entityId": [{"idString": "30839", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "orotate"}, {"duid": "PU:MGvJ", "entityType": "Gene", "charEnd": 1332, "source": "PUBTATOR", "charStart": 1330, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "DPD"}, {"duid": "PU:eqXb", "entityType": "Gene", "charEnd": 599, "source": "PUBTATOR", "charStart": 596, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "OPRT"}, {"duid": "PU:27g5", "entityType": "Chemical", "charEnd": 152, "source": "PUBTATOR", "charStart": 141, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "fluorouracil"}, {"duid": "PU:UEhV", "entityType": "Disease", "charEnd": 1123, "source": "PUBTATOR", "charStart": 1119, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumor"}, {"duid": "PU:LCUK", "entityType": "Chemical", "charEnd": 1785, "source": "PUBTATOR", "charStart": 1772, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 10, "entityText": "5-fluorouracil"}, {"duid": "PU:UesA", "entityType": "Species", "charEnd": 900, "source": "PUBTATOR", "charStart": 893, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:eYtu", "entityType": "Gene", "charEnd": 317, "source": "PUBTATOR", "charStart": 285, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "orotate phosphoribosyltransferase"}, {"duid": "PU:5rL2", "entityType": "Chemical", "charEnd": 40, "source": "PUBTATOR", "charStart": 27, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-fluorouracil"}, {"duid": "PU:MwH4", "entityType": "Gene", "charEnd": 323, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "7372", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "OPRT"}, {"duid": "PU:PNVn", "entityType": "Disease", "charEnd": 1045, "source": "PUBTATOR", "charStart": 1041, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumor"}, {"duid": "PU:qbZt", "entityType": "Disease", "charEnd": 923, "source": "PUBTATOR", "charStart": 907, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 4, "entityText": "colorectal cancer"}, {"duid": "PU:mQbu", "entityType": "Gene", "charEnd": 243, "source": "PUBTATOR", "charStart": 213, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "dihydropyrimidine dehydrogenase"}, {"duid": "PU:SmT4", "entityType": "Disease", "charEnd": 87, "source": "PUBTATOR", "charStart": 71, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 0, "entityText": "colorectal cancer"}]}
{"text": "Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy. Therapeutic progress in adrenocortical carcinoma (ACC) is severely hampered by its low incidence. Platinum-based chemotherapies are the most effective cytotoxic treatment regimens in ACC but response rates remain <50%. In other tumor entities, expression of excision repair cross complementing group 1 (ERCC1) predicts resistance to platinum compounds. Therefore, we correlated ERCC1 protein expression and clinical outcome. We have retrolectively established adrenal tissue microarrays and analyzed prospectively samples from 163 ACCs, 15 benign adrenal adenomas, and 8 normal adrenal glands by immunohistochemistry for ERCC1 protein expression. Detailed clinical data were available by the German ACC Registry. ERCC1 protein was highly expressed in all normal adrenal glands, 14 benign tumors (93%) and in 75 ACCs (47%). In ACC, no differences in baseline parameters were found between patients with and without ERCC1 expression. Detection of ERCC1 was not correlated with survival in patients who never received platinum-based chemotherapy. In platinum-treated patients (n=45), objective response to platinum compounds was observed in 3/21 patients (14.3%) with high ERCC1 expression and in 7/24 patients (29.2%) with low ERCC1 expression (P=0.23). ERCC1 expression was strongly correlated with overall survival after platinum treatment (median: eight months in patients with high ERCC1 versus 24 months in low ERCC1 expression, hazard ratio (HR) 2.95 (95% confidence interval (CI) 1.4-6.2), P=0.004). Multivariate analysis confirmed that high ERCC1 expression was a predictive factor for poor prognosis in platinum treated patients (HR 2.2, 95% CI 1.0-4.5, P=0.038). Our findings suggest that ERCC1 expression is the first factor for predicting survival in ACC patients treated with platinum-based chemotherapy.", "title": {"charStart": 0, "charEnd": 149}, "docId": "19240185", "entity": [{"duid": "PU:T7gK", "entityType": "Disease", "charEnd": 198, "source": "PUBTATOR", "charStart": 175, "entityId": [{"idString": "D018268", "source": "MESH"}], "sentenceIndex": 1, "entityText": "adrenocortical carcinoma"}, {"duid": "PU:CnBk", "entityType": "Gene", "charEnd": 868, "source": "PUBTATOR", "charStart": 864, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:96fN", "entityType": "Species", "charEnd": 1145, "source": "PUBTATOR", "charStart": 1138, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:ZUvA", "entityType": "Gene", "charEnd": 1325, "source": "PUBTATOR", "charStart": 1321, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:gKFz", "entityType": "Chemical", "charEnd": 1261, "source": "PUBTATOR", "charStart": 1254, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 10, "entityText": "platinum"}, {"duid": "PU:Qffb", "entityType": "Chemical", "charEnd": 1173, "source": "PUBTATOR", "charStart": 1166, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 9, "entityText": "platinum"}, {"duid": "PU:LRKn", "entityType": "Disease", "charEnd": 944, "source": "PUBTATOR", "charStart": 932, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "benign tumors"}, {"duid": "PU:SKmX", "entityType": "Gene", "charEnd": 1069, "source": "PUBTATOR", "charStart": 1065, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:eiD7", "entityType": "Species", "charEnd": 1222, "source": "PUBTATOR", "charStart": 1215, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:8whH", "entityType": "Gene", "charEnd": 56, "source": "PUBTATOR", "charStart": 14, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "excision repair cross complementing group 1"}, {"duid": "PU:XDJd", "entityType": "Chemical", "charEnd": 1479, "source": "PUBTATOR", "charStart": 1472, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 11, "entityText": "platinum"}, {"duid": "PU:PgVU", "entityType": "Species", "charEnd": 1785, "source": "PUBTATOR", "charStart": 1778, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 12, "entityText": "patients"}, {"duid": "PU:rM7w", "entityType": "Disease", "charEnd": 336, "source": "PUBTATOR", "charStart": 334, "entityId": [{"idString": "D018268", "source": "MESH"}], "sentenceIndex": 2, "entityText": "ACC"}, {"duid": "PU:EMbn", "entityType": "Gene", "charEnd": 451, "source": "PUBTATOR", "charStart": 409, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "excision repair cross complementing group 1"}, {"duid": "PU:bLXh", "entityType": "Gene", "charEnd": 1380, "source": "PUBTATOR", "charStart": 1376, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:3HTA", "entityType": "Gene", "charEnd": 1100, "source": "PUBTATOR", "charStart": 1096, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:29M5", "entityType": "Species", "charEnd": 1357, "source": "PUBTATOR", "charStart": 1350, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:MsKS", "entityType": "Gene", "charEnd": 458, "source": "PUBTATOR", "charStart": 454, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:zKUu", "entityType": "Gene", "charEnd": 1702, "source": "PUBTATOR", "charStart": 1698, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "ERCC1"}, {"duid": "PU:YQfi", "entityType": "Species", "charEnd": 1523, "source": "PUBTATOR", "charStart": 1516, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:3SX4", "entityType": "Chemical", "charEnd": 1945, "source": "PUBTATOR", "charStart": 1938, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 13, "entityText": "platinum"}, {"duid": "PU:Y2iv", "entityType": "Disease", "charEnd": 852, "source": "PUBTATOR", "charStart": 850, "entityId": [{"idString": "D018268", "source": "MESH"}], "sentenceIndex": 6, "entityText": "ACC"}, {"duid": "PU:Hotu", "entityType": "Disease", "charEnd": 203, "source": "PUBTATOR", "charStart": 201, "entityId": [{"idString": "D018268", "source": "MESH"}], "sentenceIndex": 1, "entityText": "ACC"}, {"duid": "PU:ByBq", "entityType": "Disease", "charEnd": 383, "source": "PUBTATOR", "charStart": 379, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:RKE4", "entityType": "Chemical", "charEnd": 491, "source": "PUBTATOR", "charStart": 484, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 3, "entityText": "platinum"}, {"duid": "PU:EyLd", "entityType": "Gene", "charEnd": 1539, "source": "PUBTATOR", "charStart": 1535, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ERCC1"}, {"duid": "PU:dy34", "entityType": "Disease", "charEnd": 713, "source": "PUBTATOR", "charStart": 691, "entityId": [{"idString": "D000236", "source": "MESH"}], "sentenceIndex": 5, "entityText": "benign adrenal adenomas"}, {"duid": "PU:RwRb", "entityType": "Species", "charEnd": 1923, "source": "PUBTATOR", "charStart": 1916, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 13, "entityText": "patients"}, {"duid": "PU:wCFV", "entityType": "Chemical", "charEnd": 129, "source": "PUBTATOR", "charStart": 122, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 0, "entityText": "platinum"}, {"duid": "PU:FDyC", "entityType": "Species", "charEnd": 107, "source": "PUBTATOR", "charStart": 100, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:LZcn", "entityType": "Gene", "charEnd": 776, "source": "PUBTATOR", "charStart": 772, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:Nbon", "entityType": "Species", "charEnd": 1301, "source": "PUBTATOR", "charStart": 1294, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:RX95", "entityType": "Gene", "charEnd": 1569, "source": "PUBTATOR", "charStart": 1565, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ERCC1"}, {"duid": "PU:vyyE", "entityType": "Disease", "charEnd": 979, "source": "PUBTATOR", "charStart": 977, "entityId": [{"idString": "D018268", "source": "MESH"}], "sentenceIndex": 8, "entityText": "ACC"}, {"duid": "PU:RHpq", "entityType": "Gene", "charEnd": 1407, "source": "PUBTATOR", "charStart": 1403, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ERCC1"}, {"duid": "PU:GvE9", "entityType": "Disease", "charEnd": 98, "source": "PUBTATOR", "charStart": 75, "entityId": [{"idString": "D018268", "source": "MESH"}], "sentenceIndex": 0, "entityText": "adrenocortical carcinoma"}, {"duid": "PU:txBu", "entityType": "Gene", "charEnd": 1852, "source": "PUBTATOR", "charStart": 1848, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "ERCC1"}, {"duid": "PU:MeAe", "entityType": "Chemical", "charEnd": 1768, "source": "PUBTATOR", "charStart": 1761, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 12, "entityText": "platinum"}, {"duid": "PU:ycRo", "entityType": "Chemical", "charEnd": 256, "source": "PUBTATOR", "charStart": 249, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 2, "entityText": "Platinum"}, {"duid": "PU:GGrH", "entityType": "Gene", "charEnd": 533, "source": "PUBTATOR", "charStart": 529, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:k7vk", "entityType": "Disease", "charEnd": 1914, "source": "PUBTATOR", "charStart": 1912, "entityId": [{"idString": "D018268", "source": "MESH"}], "sentenceIndex": 13, "entityText": "ACC"}, {"duid": "PU:csvr", "entityType": "Chemical", "charEnd": 1205, "source": "PUBTATOR", "charStart": 1198, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 10, "entityText": "platinum"}, {"duid": "PU:vkAK", "entityType": "Species", "charEnd": 1046, "source": "PUBTATOR", "charStart": 1039, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}]}
{"text": "DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. BACKGROUND: Adjuvant cisplatin-based chemotherapy improves survival among patients with completely resected non-small-cell lung cancer, but there is no validated clinical or biologic predictor of the benefit of chemotherapy. METHODS: We used immunohistochemical analysis to determine the expression of the excision repair cross-complementation group 1 (ERCC1) protein in operative specimens of non-small-cell lung cancer. The patients had been enrolled in the International Adjuvant Lung Cancer Trial, thereby allowing a comparison of the effect of adjuvant cisplatin-based chemotherapy on survival, according to ERCC1 expression. Overall survival was analyzed with a Cox model adjusted for clinical and pathological factors. RESULTS: Among 761 tumors, ERCC1 expression was positive in 335 (44%) and negative in 426 (56%). A benefit from cisplatin-based adjuvant chemotherapy was associated with the absence of ERCC1 (test for interaction, P=0.009). Adjuvant chemotherapy, as compared with observation, significantly prolonged survival among patients with ERCC1-negative tumors (adjusted hazard ratio for death, 0.65; 95% confidence interval [CI], 0.50 to 0.86; P=0.002) but not among patients with ERCC1-positive tumors (adjusted hazard ratio for death, 1.14; 95% CI, 0.84 to 1.55; P=0.40). Among patients who did not receive adjuvant chemotherapy, those with ERCC1-positive tumors survived longer than those with ERCC1-negative tumors (adjusted hazard ratio for death, 0.66; 95% CI, 0.49 to 0.90; P=0.009). CONCLUSIONS: Patients with completely resected non-small-cell lung cancer and ERCC1-negative tumors appear to benefit from adjuvant cisplatin-based chemotherapy, whereas patients with ERCC1-positive tumors do not.", "title": {"charStart": 0, "charEnd": 91}, "docId": "16957145", "entity": [{"duid": "PU:r97F", "entityType": "Disease", "charEnd": 226, "source": "PUBTATOR", "charStart": 201, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:5yGV", "entityType": "Disease", "charEnd": 1674, "source": "PUBTATOR", "charStart": 1649, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 9, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:SHqp", "entityType": "Gene", "charEnd": 1684, "source": "PUBTATOR", "charStart": 1680, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:6W74", "entityType": "Disease", "charEnd": 1169, "source": "PUBTATOR", "charStart": 1164, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumors"}, {"duid": "PU:Gr9i", "entityType": "Species", "charEnd": 526, "source": "PUBTATOR", "charStart": 519, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:EzCw", "entityType": "Gene", "charEnd": 1153, "source": "PUBTATOR", "charStart": 1149, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:6Cmf", "entityType": "Gene", "charEnd": 1008, "source": "PUBTATOR", "charStart": 1004, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:QLiX", "entityType": "Chemical", "charEnd": 122, "source": "PUBTATOR", "charStart": 114, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:jBQa", "entityType": "Chemical", "charEnd": 659, "source": "PUBTATOR", "charStart": 651, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cisplatin"}, {"duid": "PU:oxiz", "entityType": "Chemical", "charEnd": 939, "source": "PUBTATOR", "charStart": 931, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 6, "entityText": "cisplatin"}, {"duid": "PU:qiCA", "entityType": "Disease", "charEnd": 1700, "source": "PUBTATOR", "charStart": 1695, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:gKFp", "entityType": "Gene", "charEnd": 1790, "source": "PUBTATOR", "charStart": 1786, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:x9ne", "entityType": "Disease", "charEnd": 1202, "source": "PUBTATOR", "charStart": 1198, "entityId": [{"idString": "D003643", "source": "MESH"}], "sentenceIndex": 7, "entityText": "death"}, {"duid": "PU:pzsG", "entityType": "Disease", "charEnd": 1806, "source": "PUBTATOR", "charStart": 1801, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:6hYc", "entityType": "Gene", "charEnd": 1512, "source": "PUBTATOR", "charStart": 1508, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:Mt5T", "entityType": "Disease", "charEnd": 1345, "source": "PUBTATOR", "charStart": 1341, "entityId": [{"idString": "D003643", "source": "MESH"}], "sentenceIndex": 7, "entityText": "death"}, {"duid": "PU:psUD", "entityType": "Chemical", "charEnd": 62, "source": "PUBTATOR", "charStart": 54, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "cisplatin"}, {"duid": "PU:WepB", "entityType": "Disease", "charEnd": 1561, "source": "PUBTATOR", "charStart": 1557, "entityId": [{"idString": "D003643", "source": "MESH"}], "sentenceIndex": 8, "entityText": "death"}, {"duid": "PU:k6pz", "entityType": "Species", "charEnd": 1142, "source": "PUBTATOR", "charStart": 1135, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:xmjx", "entityType": "Species", "charEnd": 1398, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:79jV", "entityType": "Disease", "charEnd": 1474, "source": "PUBTATOR", "charStart": 1469, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "tumors"}, {"duid": "PU:x7pD", "entityType": "Species", "charEnd": 1285, "source": "PUBTATOR", "charStart": 1278, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:33LW", "entityType": "Gene", "charEnd": 18, "source": "PUBTATOR", "charStart": 14, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:sP6p", "entityType": "Disease", "charEnd": 512, "source": "PUBTATOR", "charStart": 487, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:vdh3", "entityType": "Gene", "charEnd": 710, "source": "PUBTATOR", "charStart": 706, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:9pyW", "entityType": "Gene", "charEnd": 1296, "source": "PUBTATOR", "charStart": 1292, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:ijhz", "entityType": "Disease", "charEnd": 1312, "source": "PUBTATOR", "charStart": 1307, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumors"}, {"duid": "PU:8eym", "entityType": "Chemical", "charEnd": 1742, "source": "PUBTATOR", "charStart": 1734, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 9, "entityText": "cisplatin"}, {"duid": "PU:zC3T", "entityType": "Gene", "charEnd": 1458, "source": "PUBTATOR", "charStart": 1454, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:zQEM", "entityType": "Gene", "charEnd": 443, "source": "PUBTATOR", "charStart": 399, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "excision repair cross-complementation group 1"}, {"duid": "PU:YK5E", "entityType": "Disease", "charEnd": 843, "source": "PUBTATOR", "charStart": 838, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumors"}, {"duid": "PU:prqg", "entityType": "Species", "charEnd": 1622, "source": "PUBTATOR", "charStart": 1615, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "Patients"}, {"duid": "PU:AABz", "entityType": "Species", "charEnd": 174, "source": "PUBTATOR", "charStart": 167, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:LomM", "entityType": "Gene", "charEnd": 850, "source": "PUBTATOR", "charStart": 846, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:J23p", "entityType": "Disease", "charEnd": 48, "source": "PUBTATOR", "charStart": 23, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:huVm", "entityType": "Gene", "charEnd": 450, "source": "PUBTATOR", "charStart": 446, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:w85D", "entityType": "Disease", "charEnd": 1528, "source": "PUBTATOR", "charStart": 1523, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "tumors"}, {"duid": "PU:rAgR", "entityType": "Species", "charEnd": 1779, "source": "PUBTATOR", "charStart": 1772, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}]}
{"text": "Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins. The antineoplastic effect of paclitaxel is mainly related to its ability to bind the beta subunit of tubulin, thus preventing tubulin chain depolarization and inducing apoptosis. The relevance of the Class I beta-tubulin characteristics have also been confirmed in the clinical setting where mutations of paclitaxel-binding site of beta-tubulin Class I have been related to paclitaxel resistance in non small cell lung and ovarian cancers. In the present study, we verified the hypothesis of a relationship between molecular alterations of beta-tubulin Class I and paclitaxel sensitivity in a panel of breast cell lines with different drug IC(50). The Class I beta-tubulin gene cDNA has been sequenced detecting heterozygous missense mutations (exon 1 and 4) only in MCF-7 and SK-BR-3 lines. Furthermore, the expression (at both mRNA and protein level) of the different isotypes have been analyzed demonstrating an association between low cell sensitivity to paclitaxel and Class III beta-tubulin expression increasing. Antisense oligonucleotide (ODN) experiments confirmed that the inhibition of Class III beta-tubulin could at least partially increase paclitaxel-chemosensitivity. The hypothesis of a relationship between beta-tubulin tumor expression and paclitaxel clinical response has been finally verified in a series of 92 advanced breast cancer patients treated with a first line paclitaxel-based chemotherapy. Thirty-five percent (95% CI: 45-31) of patients with high Class III beta-tubulin expression showed a disease progression vs. only 7% of patients with low expression (35% vs. 7%, p < 0.002). Our study suggests that Class III beta-tubulin tumor expression could be considered a predictive biomarker of paclitaxel-clinical resistance for breast cancer patients.", "title": {"charStart": 0, "charEnd": 83}, "docId": "17285590", "entity": [{"duid": "PU:BeDS", "entityType": "Species", "charEnd": 1446, "source": "PUBTATOR", "charStart": 1439, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:s8j6", "entityType": "Chemical", "charEnd": 659, "source": "PUBTATOR", "charStart": 650, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 3, "entityText": "paclitaxel"}, {"duid": "PU:7Qss", "entityType": "Disease", "charEnd": 1746, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Class III beta-tubulin tumor"}, {"duid": "PU:ZcmQ", "entityType": "Disease", "charEnd": 522, "source": "PUBTATOR", "charStart": 508, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 2, "entityText": "ovarian cancers"}, {"duid": "PU:5uM3", "entityType": "Gene", "charEnd": 1584, "source": "PUBTATOR", "charStart": 1563, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "Class III beta-tubulin"}, {"duid": "PU:Moey", "entityType": "Chemical", "charEnd": 399, "source": "PUBTATOR", "charStart": 390, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 2, "entityText": "paclitaxel"}, {"duid": "PU:Bu7B", "entityType": "Chemical", "charEnd": 1814, "source": "PUBTATOR", "charStart": 1805, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 9, "entityText": "paclitaxel"}, {"duid": "PU:ZJzo", "entityType": "Chemical", "charEnd": 1352, "source": "PUBTATOR", "charStart": 1343, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 7, "entityText": "paclitaxel"}, {"duid": "PU:us2A", "entityType": "Species", "charEnd": 1648, "source": "PUBTATOR", "charStart": 1641, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:LSds", "entityType": "Gene", "charEnd": 1080, "source": "PUBTATOR", "charStart": 1059, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "Class III beta-tubulin"}, {"duid": "PU:TjiX", "entityType": "Species", "charEnd": 1861, "source": "PUBTATOR", "charStart": 1854, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:3ibe", "entityType": "Chemical", "charEnd": 123, "source": "PUBTATOR", "charStart": 114, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 1, "entityText": "paclitaxel"}, {"duid": "PU:J24m", "entityType": "Chemical", "charEnd": 1053, "source": "PUBTATOR", "charStart": 1044, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 5, "entityText": "paclitaxel"}, {"duid": "PU:6oio", "entityType": "Species", "charEnd": 1551, "source": "PUBTATOR", "charStart": 1544, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:VpTM", "entityType": "Disease", "charEnd": 1852, "source": "PUBTATOR", "charStart": 1840, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 9, "entityText": "breast cancer"}, {"duid": "PU:5XaF", "entityType": "Chemical", "charEnd": 26, "source": "PUBTATOR", "charStart": 17, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "paclitaxel"}, {"duid": "PU:Hkaz", "entityType": "Gene", "charEnd": 1740, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "Class III beta-tubulin"}, {"duid": "PU:h3MW", "entityType": "Chemical", "charEnd": 1248, "source": "PUBTATOR", "charStart": 1239, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 6, "entityText": "paclitaxel"}, {"duid": "PU:GC7D", "entityType": "Gene", "charEnd": 1203, "source": "PUBTATOR", "charStart": 1182, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "Class III beta-tubulin"}, {"duid": "PU:o2nW", "entityType": "Chemical", "charEnd": 1483, "source": "PUBTATOR", "charStart": 1474, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 7, "entityText": "paclitaxel"}, {"duid": "PU:98ZU", "entityType": "Chemical", "charEnd": 468, "source": "PUBTATOR", "charStart": 459, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 2, "entityText": "paclitaxel"}, {"duid": "PU:uRdz", "entityType": "Disease", "charEnd": 1437, "source": "PUBTATOR", "charStart": 1425, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 7, "entityText": "breast cancer"}, {"duid": "PU:Bvwe", "entityType": "Disease", "charEnd": 55, "source": "PUBTATOR", "charStart": 43, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast cancer"}]}
{"text": "Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine. BACKGROUND: Over-expression of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) in tumor tissue is associated with insensitivity to 5-fluorouracil (5-FU). Over-expression of ERCC1 correlates with insensitivity to oxaliplatin (OX) therapy, while high thymidine phosphorylase (TP) levels predict for increased sensitivity to capecitabine (Xel). METHODS: Biopsies of metastatic tumor were taken before OX (130 mg/m2 day 1) given with Xel (1200-3000 mg/m2 in two divided doses days 1-5 and 8-12) every 3-weeks. Micro-dissected metastatic and primary tumors were analyzed for relative gene expression by real-time quantitative polymerase chain reaction. The clinical protocol prospectively identified the molecular targets of interest that would be tested. Endpoints for the molecular analyses were correlation of median, first and third quartiles for relative gene expression of each target with response, time to treatment failure (TTF), and survival. RESULTS: Among 91 patients participating in this trial; 97% had colorectal cancer. The median number of prior chemotherapy regimens was 2, and most had prior 5-FU and irinotecan. In paired samples, median mRNA levels were significantly higher in metastatic versus primary tumor (-fold): TS (1.9), DPD (3.8), ERCC1 (2.1) and TP (1.6). A strong positive correlation was noted between DPD and TP mRNA levels in both primary (r = 0.693, p < 0.0005) and metastatic tissue (r = 0.697, p < 0.00001). There was an association between TS gene expression and responsive and stable disease: patients whose intratumoral TS mRNA levels were above the median value had significantly greater risk of early disease progression (43% vs 17%), but this did not translate into a significant difference in TTF. ERCC1 gene expression above the third quartile was associated with a shorter TTF (median 85 vs 162 days, p = 0.046). Patients whose TS mRNA levels in metastatic tumor tissue were below the median had a longer overall survival (median 417 vs 294 days, p = 0.042). CONCLUSION: Target gene expression in primary tumor was significantly lower than that in paired metastatic tissue. High ERCC1 mRNA levels in metastatic tumor was associated with a shorter TTF. Lower expression of TS mRNA correlated with a lower chance of early PD with XelOX therapy and improved overall survival.", "title": {"charStart": 0, "charEnd": 241}, "docId": "19105824", "entity": [{"duid": "PU:NJeL", "entityType": "Gene", "charEnd": 334, "source": "PUBTATOR", "charStart": 304, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "dihydropyrimidine dehydrogenase"}, {"duid": "PU:cKqE", "entityType": "Chemical", "charEnd": 485, "source": "PUBTATOR", "charStart": 475, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 2, "entityText": "oxaliplatin"}, {"duid": "PU:oj7k", "entityType": "Gene", "charEnd": 297, "source": "PUBTATOR", "charStart": 296, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:wu4V", "entityType": "Chemical", "charEnd": 10, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "17013", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "Thymidylate"}, {"duid": "PU:hXxA", "entityType": "Gene", "charEnd": 1820, "source": "PUBTATOR", "charStart": 1819, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "TS"}, {"duid": "PU:vV69", "entityType": "Disease", "charEnd": 162, "source": "PUBTATOR", "charStart": 132, "entityId": [{"idString": "D005767", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastrointestinal adenocarcinoma"}, {"duid": "PU:DB8t", "entityType": "Gene", "charEnd": 534, "source": "PUBTATOR", "charStart": 512, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "thymidine phosphorylase"}, {"duid": "PU:exeJ", "entityType": "Species", "charEnd": 181, "source": "PUBTATOR", "charStart": 174, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:HttE", "entityType": "Gene", "charEnd": 2478, "source": "PUBTATOR", "charStart": 2477, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 16, "entityText": "TS"}, {"duid": "PU:VVbu", "entityType": "Disease", "charEnd": 2166, "source": "PUBTATOR", "charStart": 2151, "entityId": [{"idString": "D009362", "source": "MESH"}], "sentenceIndex": 13, "entityText": "metastatic tumor"}, {"duid": "PU:Hqw9", "entityType": "Chemical", "charEnd": 38, "source": "PUBTATOR", "charStart": 22, "entityId": [], "sentenceIndex": 0, "entityText": "dihydropyrimidine"}, {"duid": "PU:f3Zq", "entityType": "Species", "charEnd": 1798, "source": "PUBTATOR", "charStart": 1791, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:TMdf", "entityType": "Gene", "charEnd": 19, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Thymidylate synthase"}, {"duid": "PU:UPWa", "entityType": "Gene", "charEnd": 2388, "source": "PUBTATOR", "charStart": 2384, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 15, "entityText": "ERCC1"}, {"duid": "PU:6zW3", "entityType": "Chemical", "charEnd": 1387, "source": "PUBTATOR", "charStart": 1378, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 8, "entityText": "irinotecan"}, {"duid": "PU:fukX", "entityType": "Chemical", "charEnd": 407, "source": "PUBTATOR", "charStart": 394, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-fluorouracil"}, {"duid": "PU:Wivf", "entityType": "Chemical", "charEnd": 74, "source": "PUBTATOR", "charStart": 66, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "thymidine"}, {"duid": "PU:pDP6", "entityType": "Species", "charEnd": 2125, "source": "PUBTATOR", "charStart": 2118, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 13, "entityText": "Patients"}, {"duid": "PU:wGJ3", "entityType": "Disease", "charEnd": 2314, "source": "PUBTATOR", "charStart": 2302, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 14, "entityText": "primary tumor"}, {"duid": "PU:ypK2", "entityType": "Disease", "charEnd": 641, "source": "PUBTATOR", "charStart": 626, "entityId": [{"idString": "D009362", "source": "MESH"}], "sentenceIndex": 3, "entityText": "metastatic tumor"}, {"duid": "PU:3c6Z", "entityType": "Gene", "charEnd": 2134, "source": "PUBTATOR", "charStart": 2133, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "TS"}, {"duid": "PU:ASPs", "entityType": "Chemical", "charEnd": 596, "source": "PUBTATOR", "charStart": 585, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 2, "entityText": "capecitabine"}, {"duid": "PU:D9sp", "entityType": "Chemical", "charEnd": 223, "source": "PUBTATOR", "charStart": 213, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 0, "entityText": "oxaliplatin"}, {"duid": "PU:3Fq9", "entityType": "Disease", "charEnd": 349, "source": "PUBTATOR", "charStart": 345, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumor"}, {"duid": "PU:eYyN", "entityType": "Gene", "charEnd": 2005, "source": "PUBTATOR", "charStart": 2001, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "ERCC1"}, {"duid": "PU:uDZE", "entityType": "Gene", "charEnd": 88, "source": "PUBTATOR", "charStart": 66, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidine phosphorylase"}, {"duid": "PU:MkyX", "entityType": "Disease", "charEnd": 2420, "source": "PUBTATOR", "charStart": 2405, "entityId": [{"idString": "D009362", "source": "MESH"}], "sentenceIndex": 15, "entityText": "metastatic tumor"}, {"duid": "PU:8FVK", "entityType": "Gene", "charEnd": 59, "source": "PUBTATOR", "charStart": 55, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:PNhg", "entityType": "Chemical", "charEnd": 1372, "source": "PUBTATOR", "charStart": 1369, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 8, "entityText": "5-FU"}, {"duid": "PU:ujKJ", "entityType": "Chemical", "charEnd": 520, "source": "PUBTATOR", "charStart": 512, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 2, "entityText": "thymidine"}, {"duid": "PU:gg9V", "entityType": "Gene", "charEnd": 440, "source": "PUBTATOR", "charStart": 436, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:bASd", "entityType": "Gene", "charEnd": 293, "source": "PUBTATOR", "charStart": 274, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:vhBN", "entityType": "Chemical", "charEnd": 413, "source": "PUBTATOR", "charStart": 410, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:usLF", "entityType": "Species", "charEnd": 1236, "source": "PUBTATOR", "charStart": 1229, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:sD9n", "entityType": "Chemical", "charEnd": 601, "source": "PUBTATOR", "charStart": 599, "entityId": [], "sentenceIndex": 2, "entityText": "Xel"}, {"duid": "PU:37jY", "entityType": "Gene", "charEnd": 1523, "source": "PUBTATOR", "charStart": 1519, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:sw9m", "entityType": "Gene", "charEnd": 52, "source": "PUBTATOR", "charStart": 22, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "dihydropyrimidine dehydrogenase"}, {"duid": "PU:3Wmp", "entityType": "Chemical", "charEnd": 240, "source": "PUBTATOR", "charStart": 229, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 0, "entityText": "capecitabine"}, {"duid": "PU:eib2", "entityType": "Disease", "charEnd": 1291, "source": "PUBTATOR", "charStart": 1275, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 7, "entityText": "colorectal cancer"}, {"duid": "PU:fgWV", "entityType": "Disease", "charEnd": 1487, "source": "PUBTATOR", "charStart": 1475, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "primary tumor"}, {"duid": "PU:V88g", "entityType": "Chemical", "charEnd": 320, "source": "PUBTATOR", "charStart": 304, "entityId": [], "sentenceIndex": 1, "entityText": "dihydropyrimidine"}, {"duid": "PU:aSbm", "entityType": "Gene", "charEnd": 1499, "source": "PUBTATOR", "charStart": 1498, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:MfBF", "entityType": "Gene", "charEnd": 1738, "source": "PUBTATOR", "charStart": 1737, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "TS"}, {"duid": "PU:8WBS", "entityType": "Disease", "charEnd": 813, "source": "PUBTATOR", "charStart": 808, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumors"}]}
{"text": "Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine. BACKGROUND: Over-expression of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) in tumor tissue is associated with insensitivity to 5-fluorouracil (5-FU). Over-expression of ERCC1 correlates with insensitivity to oxaliplatin (OX) therapy, while high thymidine phosphorylase (TP) levels predict for increased sensitivity to capecitabine (Xel). METHODS: Biopsies of metastatic tumor were taken before OX (130 mg/m2 day 1) given with Xel (1200-3000 mg/m2 in two divided doses days 1-5 and 8-12) every 3-weeks. Micro-dissected metastatic and primary tumors were analyzed for relative gene expression by real-time quantitative polymerase chain reaction. The clinical protocol prospectively identified the molecular targets of interest that would be tested. Endpoints for the molecular analyses were correlation of median, first and third quartiles for relative gene expression of each target with response, time to treatment failure (TTF), and survival. RESULTS: Among 91 patients participating in this trial; 97% had colorectal cancer. The median number of prior chemotherapy regimens was 2, and most had prior 5-FU and irinotecan. In paired samples, median mRNA levels were significantly higher in metastatic versus primary tumor (-fold): TS (1.9), DPD (3.8), ERCC1 (2.1) and TP (1.6). A strong positive correlation was noted between DPD and TP mRNA levels in both primary (r = 0.693, p < 0.0005) and metastatic tissue (r = 0.697, p < 0.00001). There was an association between TS gene expression and responsive and stable disease: patients whose intratumoral TS mRNA levels were above the median value had significantly greater risk of early disease progression (43% vs 17%), but this did not translate into a significant difference in TTF. ERCC1 gene expression above the third quartile was associated with a shorter TTF (median 85 vs 162 days, p = 0.046). Patients whose TS mRNA levels in metastatic tumor tissue were below the median had a longer overall survival (median 417 vs 294 days, p = 0.042). CONCLUSION: Target gene expression in primary tumor was significantly lower than that in paired metastatic tissue. High ERCC1 mRNA levels in metastatic tumor was associated with a shorter TTF. Lower expression of TS mRNA correlated with a lower chance of early PD with XelOX therapy and improved overall survival.", "title": {"charStart": 0, "charEnd": 241}, "docId": "19105824", "entity": [{"duid": "PU:NJeL", "entityType": "Gene", "charEnd": 334, "source": "PUBTATOR", "charStart": 304, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "dihydropyrimidine dehydrogenase"}, {"duid": "PU:cKqE", "entityType": "Chemical", "charEnd": 485, "source": "PUBTATOR", "charStart": 475, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 2, "entityText": "oxaliplatin"}, {"duid": "PU:oj7k", "entityType": "Gene", "charEnd": 297, "source": "PUBTATOR", "charStart": 296, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:wu4V", "entityType": "Chemical", "charEnd": 10, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "17013", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "Thymidylate"}, {"duid": "PU:hXxA", "entityType": "Gene", "charEnd": 1820, "source": "PUBTATOR", "charStart": 1819, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "TS"}, {"duid": "PU:vV69", "entityType": "Disease", "charEnd": 162, "source": "PUBTATOR", "charStart": 132, "entityId": [{"idString": "D005767", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastrointestinal adenocarcinoma"}, {"duid": "PU:DB8t", "entityType": "Gene", "charEnd": 534, "source": "PUBTATOR", "charStart": 512, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "thymidine phosphorylase"}, {"duid": "PU:exeJ", "entityType": "Species", "charEnd": 181, "source": "PUBTATOR", "charStart": 174, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:HttE", "entityType": "Gene", "charEnd": 2478, "source": "PUBTATOR", "charStart": 2477, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 16, "entityText": "TS"}, {"duid": "PU:VVbu", "entityType": "Disease", "charEnd": 2166, "source": "PUBTATOR", "charStart": 2151, "entityId": [{"idString": "D009362", "source": "MESH"}], "sentenceIndex": 13, "entityText": "metastatic tumor"}, {"duid": "PU:Hqw9", "entityType": "Chemical", "charEnd": 38, "source": "PUBTATOR", "charStart": 22, "entityId": [], "sentenceIndex": 0, "entityText": "dihydropyrimidine"}, {"duid": "PU:f3Zq", "entityType": "Species", "charEnd": 1798, "source": "PUBTATOR", "charStart": 1791, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:TMdf", "entityType": "Gene", "charEnd": 19, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Thymidylate synthase"}, {"duid": "PU:UPWa", "entityType": "Gene", "charEnd": 2388, "source": "PUBTATOR", "charStart": 2384, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 15, "entityText": "ERCC1"}, {"duid": "PU:6zW3", "entityType": "Chemical", "charEnd": 1387, "source": "PUBTATOR", "charStart": 1378, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 8, "entityText": "irinotecan"}, {"duid": "PU:fukX", "entityType": "Chemical", "charEnd": 407, "source": "PUBTATOR", "charStart": 394, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-fluorouracil"}, {"duid": "PU:Wivf", "entityType": "Chemical", "charEnd": 74, "source": "PUBTATOR", "charStart": 66, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "thymidine"}, {"duid": "PU:pDP6", "entityType": "Species", "charEnd": 2125, "source": "PUBTATOR", "charStart": 2118, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 13, "entityText": "Patients"}, {"duid": "PU:wGJ3", "entityType": "Disease", "charEnd": 2314, "source": "PUBTATOR", "charStart": 2302, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 14, "entityText": "primary tumor"}, {"duid": "PU:ypK2", "entityType": "Disease", "charEnd": 641, "source": "PUBTATOR", "charStart": 626, "entityId": [{"idString": "D009362", "source": "MESH"}], "sentenceIndex": 3, "entityText": "metastatic tumor"}, {"duid": "PU:3c6Z", "entityType": "Gene", "charEnd": 2134, "source": "PUBTATOR", "charStart": 2133, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "TS"}, {"duid": "PU:ASPs", "entityType": "Chemical", "charEnd": 596, "source": "PUBTATOR", "charStart": 585, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 2, "entityText": "capecitabine"}, {"duid": "PU:D9sp", "entityType": "Chemical", "charEnd": 223, "source": "PUBTATOR", "charStart": 213, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 0, "entityText": "oxaliplatin"}, {"duid": "PU:3Fq9", "entityType": "Disease", "charEnd": 349, "source": "PUBTATOR", "charStart": 345, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumor"}, {"duid": "PU:eYyN", "entityType": "Gene", "charEnd": 2005, "source": "PUBTATOR", "charStart": 2001, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "ERCC1"}, {"duid": "PU:uDZE", "entityType": "Gene", "charEnd": 88, "source": "PUBTATOR", "charStart": 66, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidine phosphorylase"}, {"duid": "PU:MkyX", "entityType": "Disease", "charEnd": 2420, "source": "PUBTATOR", "charStart": 2405, "entityId": [{"idString": "D009362", "source": "MESH"}], "sentenceIndex": 15, "entityText": "metastatic tumor"}, {"duid": "PU:8FVK", "entityType": "Gene", "charEnd": 59, "source": "PUBTATOR", "charStart": 55, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:PNhg", "entityType": "Chemical", "charEnd": 1372, "source": "PUBTATOR", "charStart": 1369, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 8, "entityText": "5-FU"}, {"duid": "PU:ujKJ", "entityType": "Chemical", "charEnd": 520, "source": "PUBTATOR", "charStart": 512, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 2, "entityText": "thymidine"}, {"duid": "PU:gg9V", "entityType": "Gene", "charEnd": 440, "source": "PUBTATOR", "charStart": 436, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:bASd", "entityType": "Gene", "charEnd": 293, "source": "PUBTATOR", "charStart": 274, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:vhBN", "entityType": "Chemical", "charEnd": 413, "source": "PUBTATOR", "charStart": 410, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:usLF", "entityType": "Species", "charEnd": 1236, "source": "PUBTATOR", "charStart": 1229, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:sD9n", "entityType": "Chemical", "charEnd": 601, "source": "PUBTATOR", "charStart": 599, "entityId": [], "sentenceIndex": 2, "entityText": "Xel"}, {"duid": "PU:37jY", "entityType": "Gene", "charEnd": 1523, "source": "PUBTATOR", "charStart": 1519, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:sw9m", "entityType": "Gene", "charEnd": 52, "source": "PUBTATOR", "charStart": 22, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "dihydropyrimidine dehydrogenase"}, {"duid": "PU:3Wmp", "entityType": "Chemical", "charEnd": 240, "source": "PUBTATOR", "charStart": 229, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 0, "entityText": "capecitabine"}, {"duid": "PU:eib2", "entityType": "Disease", "charEnd": 1291, "source": "PUBTATOR", "charStart": 1275, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 7, "entityText": "colorectal cancer"}, {"duid": "PU:fgWV", "entityType": "Disease", "charEnd": 1487, "source": "PUBTATOR", "charStart": 1475, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "primary tumor"}, {"duid": "PU:V88g", "entityType": "Chemical", "charEnd": 320, "source": "PUBTATOR", "charStart": 304, "entityId": [], "sentenceIndex": 1, "entityText": "dihydropyrimidine"}, {"duid": "PU:aSbm", "entityType": "Gene", "charEnd": 1499, "source": "PUBTATOR", "charStart": 1498, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:MfBF", "entityType": "Gene", "charEnd": 1738, "source": "PUBTATOR", "charStart": 1737, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "TS"}, {"duid": "PU:8WBS", "entityType": "Disease", "charEnd": 813, "source": "PUBTATOR", "charStart": 808, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumors"}]}
{"text": "ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy. BACKGROUND: ERCC1 is considered as a promising molecular marker that may predict platinum based chemotherapy response in non small cell lung cancer patients. We therefore investigated whether its expression is indeed associated with clinical outcomes in advanced stage NSCLC patients. MATERIALS AND METHODS: Pretreatment tumor biopsy samples of 83 stage 3B and 4 non-small cell lung cancer patients treated with platinum based chemotherapy were retrospectively analyzed for immunohistochemical ERCC1 expression. None of the patients received curative surgery or radiotherapy. RESULTS: By calculating H- scores regarding the extent and intensity of immunohistochemical staining of tumor biopsy samples, ERCC1 expression was found to be positive in 50 patients (60.2%). ERCC1 positive and negative groups had no statistically significant differences regarding treatment response, progression free survival and overall survival (respectively p=0.161; p=0.412; p=0.823). CONCLUSIONS: In our study we found no association between ERCC1 expression and survival or treatment response. The study has some limitations, such as small sample size and retrospective analysis method. There is need of more knowledge for use of ERCC1 guided chemotherapy regimens in advanced stage NSCLC.", "title": {"charStart": 0, "charEnd": 157}, "docId": "24083725", "entity": [{"duid": "PU:ERqK", "entityType": "Disease", "charEnd": 484, "source": "PUBTATOR", "charStart": 480, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:jBun", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:gKCp", "entityType": "Disease", "charEnd": 305, "source": "PUBTATOR", "charStart": 280, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non small cell lung cancer"}, {"duid": "PU:G62u", "entityType": "Chemical", "charEnd": 137, "source": "PUBTATOR", "charStart": 130, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 0, "entityText": "platinum"}, {"duid": "PU:5Qwb", "entityType": "Species", "charEnd": 556, "source": "PUBTATOR", "charStart": 549, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:oumM", "entityType": "Species", "charEnd": 314, "source": "PUBTATOR", "charStart": 307, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:YWaa", "entityType": "Gene", "charEnd": 1377, "source": "PUBTATOR", "charStart": 1373, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:ZbW8", "entityType": "Chemical", "charEnd": 247, "source": "PUBTATOR", "charStart": 240, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:4Xk6", "entityType": "Species", "charEnd": 441, "source": "PUBTATOR", "charStart": 434, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:WaKU", "entityType": "Gene", "charEnd": 865, "source": "PUBTATOR", "charStart": 861, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:A3QM", "entityType": "Disease", "charEnd": 547, "source": "PUBTATOR", "charStart": 522, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "non-small cell lung cancer"}, {"duid": "PU:A2Jo", "entityType": "Chemical", "charEnd": 578, "source": "PUBTATOR", "charStart": 571, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 3, "entityText": "platinum"}, {"duid": "PU:HsA8", "entityType": "Disease", "charEnd": 109, "source": "PUBTATOR", "charStart": 84, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:msNs", "entityType": "Species", "charEnd": 690, "source": "PUBTATOR", "charStart": 683, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:rs25", "entityType": "Species", "charEnd": 916, "source": "PUBTATOR", "charStart": 909, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:zTEw", "entityType": "Gene", "charEnd": 1188, "source": "PUBTATOR", "charStart": 1184, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:u36o", "entityType": "Gene", "charEnd": 175, "source": "PUBTATOR", "charStart": 171, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:TRcf", "entityType": "Disease", "charEnd": 843, "source": "PUBTATOR", "charStart": 839, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumor"}, {"duid": "PU:Vn7g", "entityType": "Gene", "charEnd": 657, "source": "PUBTATOR", "charStart": 653, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:drX8", "entityType": "Gene", "charEnd": 931, "source": "PUBTATOR", "charStart": 927, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}]}
{"text": "Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation. INTRODUCTION: The expression of excision repair cross-complementation group 1 (ERCC1) is reported to be correlated with resistance to platinum-based drugs. Class III beta-tubulin is reported to be correlated with resistance to taxanes. METHODS: In the present study, we evaluated whether ERCC1 and class III beta-tubulin expression could be used to predict progression-free and/or overall survival in 34 patients with locally advanced non-small cell lung cancer (NSCLC) receiving concurrent chemoradiation therapy with cisplatin and docetaxel, and immunohistochemistry was used to examine the expression of these two proteins in tumor samples obtained from the patients. RESULTS: Immunostaining for ERCC1 and class III beta-tubulin was positive in 16 and 12 patients, respectively. A significant correlation was observed between ERCC1 expression and response to chemotherapy (P = 0.012), and between class III beta-tubulin expression and histology (P = 0.029). Patients negative for ERCC1 had a significantly longer median progression-free (62.5 vs. 36 weeks, P = 0.009), but not overall (171 vs. 50.5 weeks, P = 0.208), survival than those positive for ERCC1. Expression of class III beta-tubulin was not correlated with progression-free or overall survival (P = 0.563 and P = 0.265, respectively). Multivariate analysis adjusting for possible confounding factors showed that negative ERCC1 expression (hazard ratio = 3.972, P = 0.009) was a significantly favorable factor for progression-free survival. CONCLUSIONS: This retrospective study indicates that immunostaining for ERCC1 may be useful for predicting survival in NSCLC patients receiving concurrent chemoradiotherapy with cisplatin and docetaxel, and can provide information critical for planning personalized chemotherapy.", "title": {"charStart": 0, "charEnd": 171}, "docId": "19123003", "entity": [{"duid": "PU:VkyZ", "entityType": "Disease", "charEnd": 640, "source": "PUBTATOR", "charStart": 636, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "NSCLC"}, {"duid": "PU:7Sqv", "entityType": "Gene", "charEnd": 350, "source": "PUBTATOR", "charStart": 329, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "Class III beta-tubulin"}, {"duid": "PU:rjyV", "entityType": "Species", "charEnd": 1810, "source": "PUBTATOR", "charStart": 1803, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:t394", "entityType": "Gene", "charEnd": 256, "source": "PUBTATOR", "charStart": 252, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:xkmb", "entityType": "Chemical", "charEnd": 406, "source": "PUBTATOR", "charStart": 400, "entityId": [{"idString": "D043823", "source": "MESH"}], "sentenceIndex": 2, "entityText": "taxanes"}, {"duid": "PU:kku6", "entityType": "Gene", "charEnd": 465, "source": "PUBTATOR", "charStart": 461, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:ySGM", "entityType": "Gene", "charEnd": 1160, "source": "PUBTATOR", "charStart": 1156, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:7bsw", "entityType": "Chemical", "charEnd": 314, "source": "PUBTATOR", "charStart": 307, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:YTF4", "entityType": "Chemical", "charEnd": 700, "source": "PUBTATOR", "charStart": 692, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cisplatin"}, {"duid": "PU:Bckr", "entityType": "Species", "charEnd": 841, "source": "PUBTATOR", "charStart": 834, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:WAN6", "entityType": "Gene", "charEnd": 1006, "source": "PUBTATOR", "charStart": 1002, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:5Abs", "entityType": "Chemical", "charEnd": 1864, "source": "PUBTATOR", "charStart": 1856, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 9, "entityText": "cisplatin"}, {"duid": "PU:wDsE", "entityType": "Disease", "charEnd": 1801, "source": "PUBTATOR", "charStart": 1797, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 9, "entityText": "NSCLC"}, {"duid": "PU:kPuj", "entityType": "Gene", "charEnd": 1094, "source": "PUBTATOR", "charStart": 1073, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "class III beta-tubulin"}, {"duid": "PU:uZoo", "entityType": "Chemical", "charEnd": 124, "source": "PUBTATOR", "charStart": 116, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "cisplatin"}, {"duid": "PU:azdH", "entityType": "Gene", "charEnd": 18, "source": "PUBTATOR", "charStart": 14, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:fW23", "entityType": "Disease", "charEnd": 75, "source": "PUBTATOR", "charStart": 50, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:fFnU", "entityType": "Gene", "charEnd": 1563, "source": "PUBTATOR", "charStart": 1559, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:YDNt", "entityType": "Gene", "charEnd": 876, "source": "PUBTATOR", "charStart": 872, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:3dqY", "entityType": "Chemical", "charEnd": 714, "source": "PUBTATOR", "charStart": 706, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 3, "entityText": "docetaxel"}, {"duid": "PU:sY9c", "entityType": "Gene", "charEnd": 1754, "source": "PUBTATOR", "charStart": 1750, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:2vHN", "entityType": "Species", "charEnd": 84, "source": "PUBTATOR", "charStart": 77, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:V2V4", "entityType": "Gene", "charEnd": 249, "source": "PUBTATOR", "charStart": 205, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementation group 1"}, {"duid": "PU:FeWf", "entityType": "Gene", "charEnd": 45, "source": "PUBTATOR", "charStart": 24, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "class III beta-tubulin"}, {"duid": "PU:wtxu", "entityType": "Gene", "charEnd": 1369, "source": "PUBTATOR", "charStart": 1348, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "class III beta-tubulin"}, {"duid": "PU:ajh5", "entityType": "Species", "charEnd": 584, "source": "PUBTATOR", "charStart": 577, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:eeXk", "entityType": "Disease", "charEnd": 806, "source": "PUBTATOR", "charStart": 802, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:WyGW", "entityType": "Chemical", "charEnd": 134, "source": "PUBTATOR", "charStart": 126, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 0, "entityText": "docetaxel"}, {"duid": "PU:DFkK", "entityType": "Chemical", "charEnd": 1878, "source": "PUBTATOR", "charStart": 1870, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 9, "entityText": "docetaxel"}, {"duid": "PU:PayW", "entityType": "Gene", "charEnd": 492, "source": "PUBTATOR", "charStart": 471, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "class III beta-tubulin"}, {"duid": "PU:6BUz", "entityType": "Gene", "charEnd": 903, "source": "PUBTATOR", "charStart": 882, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "class III beta-tubulin"}, {"duid": "PU:oneW", "entityType": "Species", "charEnd": 1141, "source": "PUBTATOR", "charStart": 1134, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "Patients"}, {"duid": "PU:u2QM", "entityType": "Species", "charEnd": 938, "source": "PUBTATOR", "charStart": 931, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:yuAc", "entityType": "Disease", "charEnd": 633, "source": "PUBTATOR", "charStart": 608, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "non-small cell lung cancer"}, {"duid": "PU:Ndaw", "entityType": "Gene", "charEnd": 1331, "source": "PUBTATOR", "charStart": 1327, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}]}
{"text": "Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation. INTRODUCTION: The expression of excision repair cross-complementation group 1 (ERCC1) is reported to be correlated with resistance to platinum-based drugs. Class III beta-tubulin is reported to be correlated with resistance to taxanes. METHODS: In the present study, we evaluated whether ERCC1 and class III beta-tubulin expression could be used to predict progression-free and/or overall survival in 34 patients with locally advanced non-small cell lung cancer (NSCLC) receiving concurrent chemoradiation therapy with cisplatin and docetaxel, and immunohistochemistry was used to examine the expression of these two proteins in tumor samples obtained from the patients. RESULTS: Immunostaining for ERCC1 and class III beta-tubulin was positive in 16 and 12 patients, respectively. A significant correlation was observed between ERCC1 expression and response to chemotherapy (P = 0.012), and between class III beta-tubulin expression and histology (P = 0.029). Patients negative for ERCC1 had a significantly longer median progression-free (62.5 vs. 36 weeks, P = 0.009), but not overall (171 vs. 50.5 weeks, P = 0.208), survival than those positive for ERCC1. Expression of class III beta-tubulin was not correlated with progression-free or overall survival (P = 0.563 and P = 0.265, respectively). Multivariate analysis adjusting for possible confounding factors showed that negative ERCC1 expression (hazard ratio = 3.972, P = 0.009) was a significantly favorable factor for progression-free survival. CONCLUSIONS: This retrospective study indicates that immunostaining for ERCC1 may be useful for predicting survival in NSCLC patients receiving concurrent chemoradiotherapy with cisplatin and docetaxel, and can provide information critical for planning personalized chemotherapy.", "title": {"charStart": 0, "charEnd": 171}, "docId": "19123003", "entity": [{"duid": "PU:VkyZ", "entityType": "Disease", "charEnd": 640, "source": "PUBTATOR", "charStart": 636, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "NSCLC"}, {"duid": "PU:7Sqv", "entityType": "Gene", "charEnd": 350, "source": "PUBTATOR", "charStart": 329, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "Class III beta-tubulin"}, {"duid": "PU:rjyV", "entityType": "Species", "charEnd": 1810, "source": "PUBTATOR", "charStart": 1803, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:t394", "entityType": "Gene", "charEnd": 256, "source": "PUBTATOR", "charStart": 252, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:xkmb", "entityType": "Chemical", "charEnd": 406, "source": "PUBTATOR", "charStart": 400, "entityId": [{"idString": "D043823", "source": "MESH"}], "sentenceIndex": 2, "entityText": "taxanes"}, {"duid": "PU:kku6", "entityType": "Gene", "charEnd": 465, "source": "PUBTATOR", "charStart": 461, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:ySGM", "entityType": "Gene", "charEnd": 1160, "source": "PUBTATOR", "charStart": 1156, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:7bsw", "entityType": "Chemical", "charEnd": 314, "source": "PUBTATOR", "charStart": 307, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:YTF4", "entityType": "Chemical", "charEnd": 700, "source": "PUBTATOR", "charStart": 692, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cisplatin"}, {"duid": "PU:Bckr", "entityType": "Species", "charEnd": 841, "source": "PUBTATOR", "charStart": 834, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:WAN6", "entityType": "Gene", "charEnd": 1006, "source": "PUBTATOR", "charStart": 1002, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:5Abs", "entityType": "Chemical", "charEnd": 1864, "source": "PUBTATOR", "charStart": 1856, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 9, "entityText": "cisplatin"}, {"duid": "PU:wDsE", "entityType": "Disease", "charEnd": 1801, "source": "PUBTATOR", "charStart": 1797, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 9, "entityText": "NSCLC"}, {"duid": "PU:kPuj", "entityType": "Gene", "charEnd": 1094, "source": "PUBTATOR", "charStart": 1073, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "class III beta-tubulin"}, {"duid": "PU:uZoo", "entityType": "Chemical", "charEnd": 124, "source": "PUBTATOR", "charStart": 116, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "cisplatin"}, {"duid": "PU:azdH", "entityType": "Gene", "charEnd": 18, "source": "PUBTATOR", "charStart": 14, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:fW23", "entityType": "Disease", "charEnd": 75, "source": "PUBTATOR", "charStart": 50, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:fFnU", "entityType": "Gene", "charEnd": 1563, "source": "PUBTATOR", "charStart": 1559, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:YDNt", "entityType": "Gene", "charEnd": 876, "source": "PUBTATOR", "charStart": 872, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:3dqY", "entityType": "Chemical", "charEnd": 714, "source": "PUBTATOR", "charStart": 706, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 3, "entityText": "docetaxel"}, {"duid": "PU:sY9c", "entityType": "Gene", "charEnd": 1754, "source": "PUBTATOR", "charStart": 1750, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:2vHN", "entityType": "Species", "charEnd": 84, "source": "PUBTATOR", "charStart": 77, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:V2V4", "entityType": "Gene", "charEnd": 249, "source": "PUBTATOR", "charStart": 205, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementation group 1"}, {"duid": "PU:FeWf", "entityType": "Gene", "charEnd": 45, "source": "PUBTATOR", "charStart": 24, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "class III beta-tubulin"}, {"duid": "PU:wtxu", "entityType": "Gene", "charEnd": 1369, "source": "PUBTATOR", "charStart": 1348, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "class III beta-tubulin"}, {"duid": "PU:ajh5", "entityType": "Species", "charEnd": 584, "source": "PUBTATOR", "charStart": 577, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:eeXk", "entityType": "Disease", "charEnd": 806, "source": "PUBTATOR", "charStart": 802, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:WyGW", "entityType": "Chemical", "charEnd": 134, "source": "PUBTATOR", "charStart": 126, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 0, "entityText": "docetaxel"}, {"duid": "PU:DFkK", "entityType": "Chemical", "charEnd": 1878, "source": "PUBTATOR", "charStart": 1870, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 9, "entityText": "docetaxel"}, {"duid": "PU:PayW", "entityType": "Gene", "charEnd": 492, "source": "PUBTATOR", "charStart": 471, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "class III beta-tubulin"}, {"duid": "PU:6BUz", "entityType": "Gene", "charEnd": 903, "source": "PUBTATOR", "charStart": 882, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "class III beta-tubulin"}, {"duid": "PU:oneW", "entityType": "Species", "charEnd": 1141, "source": "PUBTATOR", "charStart": 1134, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "Patients"}, {"duid": "PU:u2QM", "entityType": "Species", "charEnd": 938, "source": "PUBTATOR", "charStart": 931, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:yuAc", "entityType": "Disease", "charEnd": 633, "source": "PUBTATOR", "charStart": 608, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "non-small cell lung cancer"}, {"duid": "PU:Ndaw", "entityType": "Gene", "charEnd": 1331, "source": "PUBTATOR", "charStart": 1327, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}]}
{"text": "High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy. BACKGROUND: In the past 4 years, the weekly 24-hour infusion of high dose 5-fluorouracil (5-FU) and leucovorin in the treatment of patients with advanced gastric carcinoma has been prospectively studied at the authors' institution. This has enabled them to explore the possibility that the level of expression of thymidylate synthase (TS), the target enzyme of 5-FU, is related to the drug sensitivity of gastric carcinoma to 5-FU-based chemotherapy. METHODS: To be eligible for this study, patients were required to have received high dose 5-FU and leucovorin chemotherapy (weekly 24-hour infusions of 5-FU, 2,600 mg/m2, and leucovorin, 300 mg/m2) and to have had adequate prechemotherapy gastric carcinoma tissues for immunohistochemical study. TS106 monoclonal antibody was used to detect the expression of TS. A visual scoring system, which ranged from 0 to 3+, was adopted by 2 independent pathologists to semiquantitate the intensity of TS expression. RESULTS: Between 1993 and 1996, a total of 30 patients, 18 men and 12 women, with a median age of 61.5 years, were enrolled. Of these patients, 16 (53.3%) and 14 (46.7%) had high and low expression of TS, respectively. Two of the 16 patients (12.5%) with high expression of TS and 13 of the 14 patients (92.9%) with low expression of TS responded to chemotherapy (P < 0.001, chi-square test). The median overall survival was 10 months for patients with low TS expression and 4 months for patients with high TS expression (P < 0.01, log rank test). CONCLUSIONS: The data from this study suggest that the expression of TS, as determined by immunohistochemistry, is a relatively reliable indicator of whether 5-FU should be used in the treatment of patients with gastric carcinoma.", "title": {"charStart": 0, "charEnd": 155}, "docId": "9576280", "entity": [{"duid": "PU:xCmJ", "entityType": "Chemical", "charEnd": 266, "source": "PUBTATOR", "charStart": 257, "entityId": [{"idString": "D002955", "source": "MESH"}], "sentenceIndex": 1, "entityText": "leucovorin"}, {"duid": "PU:NwAC", "entityType": "Disease", "charEnd": 327, "source": "PUBTATOR", "charStart": 311, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gastric carcinoma"}, {"duid": "PU:tBYA", "entityType": "Chemical", "charEnd": 586, "source": "PUBTATOR", "charStart": 583, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-FU"}, {"duid": "PU:8DUY", "entityType": "Chemical", "charEnd": 1824, "source": "PUBTATOR", "charStart": 1821, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 10, "entityText": "5-FU"}, {"duid": "PU:TA9f", "entityType": "Disease", "charEnd": 1891, "source": "PUBTATOR", "charStart": 1875, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 10, "entityText": "gastric carcinoma"}, {"duid": "PU:dpjP", "entityType": "Species", "charEnd": 1176, "source": "PUBTATOR", "charStart": 1174, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "men"}, {"duid": "PU:sPeF", "entityType": "Species", "charEnd": 1189, "source": "PUBTATOR", "charStart": 1185, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "women"}, {"duid": "PU:AWZC", "entityType": "Chemical", "charEnd": 701, "source": "PUBTATOR", "charStart": 698, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 3, "entityText": "5-FU"}, {"duid": "PU:PGwj", "entityType": "Chemical", "charEnd": 126, "source": "PUBTATOR", "charStart": 113, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-fluorouracil"}, {"duid": "PU:Sowr", "entityType": "Gene", "charEnd": 1733, "source": "PUBTATOR", "charStart": 1732, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "TS"}, {"duid": "PU:AfxZ", "entityType": "Species", "charEnd": 1561, "source": "PUBTATOR", "charStart": 1554, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:zATY", "entityType": "Species", "charEnd": 1868, "source": "PUBTATOR", "charStart": 1861, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:SdS4", "entityType": "Gene", "charEnd": 1101, "source": "PUBTATOR", "charStart": 1100, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:csF2", "entityType": "Chemical", "charEnd": 763, "source": "PUBTATOR", "charStart": 760, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 3, "entityText": "5-FU"}, {"duid": "PU:C9PL", "entityType": "Species", "charEnd": 1416, "source": "PUBTATOR", "charStart": 1409, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:M8ZF", "entityType": "Gene", "charEnd": 1450, "source": "PUBTATOR", "charStart": 1449, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:Y8r7", "entityType": "Gene", "charEnd": 38, "source": "PUBTATOR", "charStart": 19, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidylate synthase"}, {"duid": "PU:pW79", "entityType": "Gene", "charEnd": 493, "source": "PUBTATOR", "charStart": 492, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:iUwg", "entityType": "Species", "charEnd": 295, "source": "PUBTATOR", "charStart": 288, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:GHx7", "entityType": "Gene", "charEnd": 1623, "source": "PUBTATOR", "charStart": 1622, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:ZNhZ", "entityType": "Chemical", "charEnd": 250, "source": "PUBTATOR", "charStart": 247, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:c5Fm", "entityType": "Chemical", "charEnd": 716, "source": "PUBTATOR", "charStart": 707, "entityId": [{"idString": "D002955", "source": "MESH"}], "sentenceIndex": 3, "entityText": "leucovorin"}, {"duid": "PU:oPr7", "entityType": "Gene", "charEnd": 1390, "source": "PUBTATOR", "charStart": 1389, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:DpwJ", "entityType": "Species", "charEnd": 655, "source": "PUBTATOR", "charStart": 648, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:bvox", "entityType": "Chemical", "charEnd": 244, "source": "PUBTATOR", "charStart": 231, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-fluorouracil"}, {"duid": "PU:4X4z", "entityType": "Disease", "charEnd": 98, "source": "PUBTATOR", "charStart": 82, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric carcinoma"}, {"duid": "PU:8uco", "entityType": "Gene", "charEnd": 1317, "source": "PUBTATOR", "charStart": 1316, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TS"}, {"duid": "PU:HpAX", "entityType": "Species", "charEnd": 1256, "source": "PUBTATOR", "charStart": 1249, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:8x48", "entityType": "Chemical", "charEnd": 792, "source": "PUBTATOR", "charStart": 783, "entityId": [{"idString": "D002955", "source": "MESH"}], "sentenceIndex": 3, "entityText": "leucovorin"}, {"duid": "PU:RqP9", "entityType": "Chemical", "charEnd": 521, "source": "PUBTATOR", "charStart": 518, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-FU"}, {"duid": "PU:yzre", "entityType": "Species", "charEnd": 1355, "source": "PUBTATOR", "charStart": 1348, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:be6K", "entityType": "Gene", "charEnd": 1573, "source": "PUBTATOR", "charStart": 1572, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:qwz2", "entityType": "Disease", "charEnd": 578, "source": "PUBTATOR", "charStart": 562, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric carcinoma"}, {"duid": "PU:owKn", "entityType": "Disease", "charEnd": 863, "source": "PUBTATOR", "charStart": 847, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gastric carcinoma"}, {"duid": "PU:Thas", "entityType": "Gene", "charEnd": 968, "source": "PUBTATOR", "charStart": 967, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:jqEv", "entityType": "Gene", "charEnd": 489, "source": "PUBTATOR", "charStart": 470, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "thymidylate synthase"}, {"duid": "PU:PStp", "entityType": "Species", "charEnd": 1168, "source": "PUBTATOR", "charStart": 1161, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:Nhuu", "entityType": "Species", "charEnd": 1610, "source": "PUBTATOR", "charStart": 1603, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}]}
{"text": "ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen. Molecular markers involved in DNA repair can help to predict survival in gastric cancer patients treated with 5-FU plus platinum chemotherapy. Excision repair cross-complementing 1 (ERCC1) and thymidylate synthase (TS) mRNA expression levels were assessed in advanced gastric cancer tumour samples using real-time quantitative PCR in 76 patients treated with a modified FOLFOX (biweekly oxaliplatin plus 5-FU and folinic acid) regimen. Median survival time in patients with low ERCC1 levels was significantly longer than in those with high levels (15.8 vs 6.2 months; P<0.0001). Patients with high TS levels had longer survival than those with low levels (12.2 vs 10.1 months; P=0.01). Forty-eight patients with low ERCC1 and high TS levels had a median survival of 16.1 months (P<0.0001). The hazard ratio for patients with high ERCC1 expression was 9.4 (P<0.0001). In patients with high mRNA levels of ERCC1, alternative chemotherapy regimens should be considered.", "title": {"charStart": 0, "charEnd": 105}, "docId": "18362936", "entity": [{"duid": "PU:h3Ep", "entityType": "Gene", "charEnd": 293, "source": "PUBTATOR", "charStart": 289, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:okMV", "entityType": "Gene", "charEnd": 319, "source": "PUBTATOR", "charStart": 300, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "thymidylate synthase"}, {"duid": "PU:Mbvs", "entityType": "Species", "charEnd": 925, "source": "PUBTATOR", "charStart": 918, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:YaQt", "entityType": "Gene", "charEnd": 286, "source": "PUBTATOR", "charStart": 250, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "Excision repair cross-complementing 1"}, {"duid": "PU:KF48", "entityType": "Gene", "charEnd": 589, "source": "PUBTATOR", "charStart": 585, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:C2wp", "entityType": "Species", "charEnd": 574, "source": "PUBTATOR", "charStart": 567, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:573C", "entityType": "Gene", "charEnd": 323, "source": "PUBTATOR", "charStart": 322, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:o2aW", "entityType": "Chemical", "charEnd": 234, "source": "PUBTATOR", "charStart": 227, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:nKdL", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:uXpP", "entityType": "Species", "charEnd": 202, "source": "PUBTATOR", "charStart": 195, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:Zf6w", "entityType": "Species", "charEnd": 451, "source": "PUBTATOR", "charStart": 444, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:kEUG", "entityType": "Species", "charEnd": 693, "source": "PUBTATOR", "charStart": 686, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "Patients"}, {"duid": "PU:3KUt", "entityType": "Species", "charEnd": 984, "source": "PUBTATOR", "charStart": 977, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:BxPN", "entityType": "Chemical", "charEnd": 531, "source": "PUBTATOR", "charStart": 520, "entityId": [{"idString": "D002955", "source": "MESH"}], "sentenceIndex": 2, "entityText": "folinic acid"}, {"duid": "PU:KUnQ", "entityType": "Species", "charEnd": 65, "source": "PUBTATOR", "charStart": 58, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:SD9c", "entityType": "Disease", "charEnd": 56, "source": "PUBTATOR", "charStart": 43, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric cancer"}, {"duid": "PU:EP67", "entityType": "Chemical", "charEnd": 514, "source": "PUBTATOR", "charStart": 511, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-FU"}, {"duid": "PU:tUzo", "entityType": "Gene", "charEnd": 941, "source": "PUBTATOR", "charStart": 937, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:oMvX", "entityType": "Gene", "charEnd": 706, "source": "PUBTATOR", "charStart": 705, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:sRLS", "entityType": "Disease", "charEnd": 395, "source": "PUBTATOR", "charStart": 375, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer tumour"}, {"duid": "PU:h79o", "entityType": "Gene", "charEnd": 1015, "source": "PUBTATOR", "charStart": 1011, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:FSw8", "entityType": "Chemical", "charEnd": 504, "source": "PUBTATOR", "charStart": 494, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 2, "entityText": "oxaliplatin"}, {"duid": "PU:fTJi", "entityType": "Chemical", "charEnd": 220, "source": "PUBTATOR", "charStart": 217, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:jHwC", "entityType": "Gene", "charEnd": 839, "source": "PUBTATOR", "charStart": 838, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:rz6W", "entityType": "Disease", "charEnd": 193, "source": "PUBTATOR", "charStart": 180, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gastric cancer"}, {"duid": "PU:5V33", "entityType": "Species", "charEnd": 812, "source": "PUBTATOR", "charStart": 805, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:Hngc", "entityType": "Gene", "charEnd": 827, "source": "PUBTATOR", "charStart": 823, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}]}
{"text": "ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen. Molecular markers involved in DNA repair can help to predict survival in gastric cancer patients treated with 5-FU plus platinum chemotherapy. Excision repair cross-complementing 1 (ERCC1) and thymidylate synthase (TS) mRNA expression levels were assessed in advanced gastric cancer tumour samples using real-time quantitative PCR in 76 patients treated with a modified FOLFOX (biweekly oxaliplatin plus 5-FU and folinic acid) regimen. Median survival time in patients with low ERCC1 levels was significantly longer than in those with high levels (15.8 vs 6.2 months; P<0.0001). Patients with high TS levels had longer survival than those with low levels (12.2 vs 10.1 months; P=0.01). Forty-eight patients with low ERCC1 and high TS levels had a median survival of 16.1 months (P<0.0001). The hazard ratio for patients with high ERCC1 expression was 9.4 (P<0.0001). In patients with high mRNA levels of ERCC1, alternative chemotherapy regimens should be considered.", "title": {"charStart": 0, "charEnd": 105}, "docId": "18362936", "entity": [{"duid": "PU:h3Ep", "entityType": "Gene", "charEnd": 293, "source": "PUBTATOR", "charStart": 289, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:okMV", "entityType": "Gene", "charEnd": 319, "source": "PUBTATOR", "charStart": 300, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "thymidylate synthase"}, {"duid": "PU:Mbvs", "entityType": "Species", "charEnd": 925, "source": "PUBTATOR", "charStart": 918, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:YaQt", "entityType": "Gene", "charEnd": 286, "source": "PUBTATOR", "charStart": 250, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "Excision repair cross-complementing 1"}, {"duid": "PU:KF48", "entityType": "Gene", "charEnd": 589, "source": "PUBTATOR", "charStart": 585, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:C2wp", "entityType": "Species", "charEnd": 574, "source": "PUBTATOR", "charStart": 567, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:573C", "entityType": "Gene", "charEnd": 323, "source": "PUBTATOR", "charStart": 322, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:o2aW", "entityType": "Chemical", "charEnd": 234, "source": "PUBTATOR", "charStart": 227, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:nKdL", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:uXpP", "entityType": "Species", "charEnd": 202, "source": "PUBTATOR", "charStart": 195, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:Zf6w", "entityType": "Species", "charEnd": 451, "source": "PUBTATOR", "charStart": 444, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:kEUG", "entityType": "Species", "charEnd": 693, "source": "PUBTATOR", "charStart": 686, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "Patients"}, {"duid": "PU:3KUt", "entityType": "Species", "charEnd": 984, "source": "PUBTATOR", "charStart": 977, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:BxPN", "entityType": "Chemical", "charEnd": 531, "source": "PUBTATOR", "charStart": 520, "entityId": [{"idString": "D002955", "source": "MESH"}], "sentenceIndex": 2, "entityText": "folinic acid"}, {"duid": "PU:KUnQ", "entityType": "Species", "charEnd": 65, "source": "PUBTATOR", "charStart": 58, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:SD9c", "entityType": "Disease", "charEnd": 56, "source": "PUBTATOR", "charStart": 43, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric cancer"}, {"duid": "PU:EP67", "entityType": "Chemical", "charEnd": 514, "source": "PUBTATOR", "charStart": 511, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-FU"}, {"duid": "PU:tUzo", "entityType": "Gene", "charEnd": 941, "source": "PUBTATOR", "charStart": 937, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:oMvX", "entityType": "Gene", "charEnd": 706, "source": "PUBTATOR", "charStart": 705, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:sRLS", "entityType": "Disease", "charEnd": 395, "source": "PUBTATOR", "charStart": 375, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer tumour"}, {"duid": "PU:h79o", "entityType": "Gene", "charEnd": 1015, "source": "PUBTATOR", "charStart": 1011, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:FSw8", "entityType": "Chemical", "charEnd": 504, "source": "PUBTATOR", "charStart": 494, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 2, "entityText": "oxaliplatin"}, {"duid": "PU:fTJi", "entityType": "Chemical", "charEnd": 220, "source": "PUBTATOR", "charStart": 217, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:jHwC", "entityType": "Gene", "charEnd": 839, "source": "PUBTATOR", "charStart": 838, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:rz6W", "entityType": "Disease", "charEnd": 193, "source": "PUBTATOR", "charStart": 180, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gastric cancer"}, {"duid": "PU:5V33", "entityType": "Species", "charEnd": 812, "source": "PUBTATOR", "charStart": 805, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:Hngc", "entityType": "Gene", "charEnd": 827, "source": "PUBTATOR", "charStart": 823, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}]}
{"text": "Promoter methylation and expression analysis of MGMT in advanced pediatric brain tumors. Insufficient response to oral temozolomide (TMZ) in children with brain tumor may depend on the repair-action of inducible O6-methylguanine-DNA methyltransferase (MGMT). To investigate the clinical relevance of MGMT expression, we analyzed MGMT levels by qRT-PCR and immunohistochemistry, and the methylation of gene promoter in patients with relapsed or refractory brain tumor, enrolled in an off-label trial with oral temozolomide. The drug was administered at the dose of 200 mg/m(2)/day in patients with no prior cranio-spinal irradiation, and 180 mg/m(2)/day in those with previous radiotherapy and/or high-dose chemotherapy followed by autologous hematopoietic stem cell rescue. Nine patients with recurrent ependymoma (n=3), low grade glioma (n=3), glioblastoma (n=1), relapsed medulloblastoma (n=2) were enrolled in the study. Median absolute MGMT mRNA expression level standardized for GAPDH was 1.06 (range -0.453 to 3.932). The median relative expression level (RQ=2(-ddC)) was 4.29 (range 1.585 to 12.228). By immunohistochemistry, the score was 2+ in 6 of the 9 tumor samples, and 1+ in 3, while none was MGMT negative. Methylation of MGMT promoter was detected in only one ependymoma sample. The heterogeneous PFS in our patients treated with second line TMZ, indicates that MGMT expression alone is insufficient to predict the response to TMZ, presumably because of the DNA repair mechanisms involved.", "title": {"charStart": 0, "charEnd": 87}, "docId": "19724855", "entity": [{"duid": "PU:AD6g", "entityType": "Gene", "charEnd": 303, "source": "PUBTATOR", "charStart": 300, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "MGMT"}, {"duid": "PU:mQBd", "entityType": "Gene", "charEnd": 249, "source": "PUBTATOR", "charStart": 212, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "O6-methylguanine-DNA methyltransferase"}, {"duid": "PU:ja26", "entityType": "Disease", "charEnd": 1285, "source": "PUBTATOR", "charStart": 1276, "entityId": [{"idString": "D004806", "source": "MESH"}], "sentenceIndex": 8, "entityText": "ependymoma"}, {"duid": "PU:FB6k", "entityType": "Chemical", "charEnd": 1360, "source": "PUBTATOR", "charStart": 1358, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 9, "entityText": "TMZ"}, {"duid": "PU:7iVX", "entityType": "Disease", "charEnd": 856, "source": "PUBTATOR", "charStart": 845, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 4, "entityText": "glioblastoma"}, {"duid": "PU:4DEo", "entityType": "Gene", "charEnd": 1210, "source": "PUBTATOR", "charStart": 1207, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MGMT"}, {"duid": "PU:hedU", "entityType": "Chemical", "charEnd": 227, "source": "PUBTATOR", "charStart": 212, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 1, "entityText": "O6-methylguanine"}, {"duid": "PU:z7D2", "entityType": "Chemical", "charEnd": 135, "source": "PUBTATOR", "charStart": 133, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "TMZ"}, {"duid": "PU:L7Cr", "entityType": "Chemical", "charEnd": 130, "source": "PUBTATOR", "charStart": 119, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "temozolomide"}, {"duid": "PU:29KE", "entityType": "Disease", "charEnd": 888, "source": "PUBTATOR", "charStart": 874, "entityId": [{"idString": "D008527", "source": "MESH"}], "sentenceIndex": 4, "entityText": "medulloblastoma"}, {"duid": "PU:Uwvs", "entityType": "Species", "charEnd": 786, "source": "PUBTATOR", "charStart": 779, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:EhoM", "entityType": "Gene", "charEnd": 1381, "source": "PUBTATOR", "charStart": 1378, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "MGMT"}, {"duid": "PU:Y5CD", "entityType": "Disease", "charEnd": 812, "source": "PUBTATOR", "charStart": 803, "entityId": [{"idString": "D004806", "source": "MESH"}], "sentenceIndex": 4, "entityText": "ependymoma"}, {"duid": "PU:DXFv", "entityType": "Gene", "charEnd": 51, "source": "PUBTATOR", "charStart": 48, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "MGMT"}, {"duid": "PU:3uwA", "entityType": "Species", "charEnd": 590, "source": "PUBTATOR", "charStart": 583, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:foCG", "entityType": "Disease", "charEnd": 86, "source": "PUBTATOR", "charStart": 75, "entityId": [{"idString": "D001932", "source": "MESH"}], "sentenceIndex": 0, "entityText": "brain tumors"}, {"duid": "PU:ZGuo", "entityType": "Gene", "charEnd": 255, "source": "PUBTATOR", "charStart": 252, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "MGMT"}, {"duid": "PU:3duJ", "entityType": "Disease", "charEnd": 1168, "source": "PUBTATOR", "charStart": 1164, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumor"}, {"duid": "PU:Rntq", "entityType": "Disease", "charEnd": 465, "source": "PUBTATOR", "charStart": 444, "entityId": [{"idString": "D001932", "source": "MESH"}], "sentenceIndex": 2, "entityText": "refractory brain tumor"}, {"duid": "PU:hEcq", "entityType": "Disease", "charEnd": 165, "source": "PUBTATOR", "charStart": 155, "entityId": [{"idString": "D001932", "source": "MESH"}], "sentenceIndex": 1, "entityText": "brain tumor"}, {"duid": "PU:AS8o", "entityType": "Chemical", "charEnd": 1445, "source": "PUBTATOR", "charStart": 1443, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 9, "entityText": "TMZ"}, {"duid": "PU:Kk8k", "entityType": "Gene", "charEnd": 1240, "source": "PUBTATOR", "charStart": 1237, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MGMT"}, {"duid": "PU:R7Vs", "entityType": "Disease", "charEnd": 836, "source": "PUBTATOR", "charStart": 831, "entityId": [{"idString": "D005910", "source": "MESH"}], "sentenceIndex": 4, "entityText": "glioma"}, {"duid": "PU:8Wtv", "entityType": "Species", "charEnd": 148, "source": "PUBTATOR", "charStart": 141, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "children"}, {"duid": "PU:Bc6h", "entityType": "Chemical", "charEnd": 520, "source": "PUBTATOR", "charStart": 509, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 2, "entityText": "temozolomide"}, {"duid": "PU:mS3e", "entityType": "Gene", "charEnd": 332, "source": "PUBTATOR", "charStart": 329, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "MGMT"}, {"duid": "PU:Xdw2", "entityType": "Species", "charEnd": 425, "source": "PUBTATOR", "charStart": 418, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:DmRn", "entityType": "Gene", "charEnd": 943, "source": "PUBTATOR", "charStart": 940, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "MGMT"}, {"duid": "PU:hpdM", "entityType": "Species", "charEnd": 1331, "source": "PUBTATOR", "charStart": 1324, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}]}
{"text": "Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy. BACKGROUND: Aim was to explore the association of ERCC1 and TS mRNA levels with the disease free survival (DFS) in Chinese colorectal cancer (CRC) patients receiving oxaliplatin and 5-FU based adjuvant chemotherapy. METHODS: Total 112 Chinese stage II-III CRC patients were respectively treated by four different chemotherapy regimens after curative operation. The TS and ERCC1 mRNA levels in primary tumor were measured by real-time RT-PCR. Kaplan-Meier curves and log-rank tests were used for DFS analysis. The Cox proportional hazards model was used for prognostic analysis. RESULTS: In univariate analysis, the hazard ratio (HR) for the mRNA expression levels of TS and ERCC1 (logTS: HR = 0.820, 95% CI = 0.600 - 1.117, P = 0.210; logERCC1: HR = 1.054, 95% CI = 0.852 - 1.304, P = 0.638) indicated no significant association of DFS with the TS and ERCC1 mRNA levels. In multivariate analyses, tumor stage (IIIc: reference, P = 0.083; IIb: HR = 0.240, 95% CI = 0.080 - 0.724, P = 0.011; IIc: HR < 0.0001, P = 0.977; IIIa: HR = 0.179, 95% CI = 0.012 - 2.593, P = 0.207) was confirmed to be the independent prognostic factor for DFS. Moreover, the Kaplan-Meier DFS curves showed that TS and ERCC1 mRNA levels were not significantly associated with the DFS (TS: P = 0.264; ERCC1: P = 0.484). CONCLUSION: The mRNA expression of ERCC1 and TS were not applicable to predict the DFS of Chinese stage II-III CRC patients receiving 5-FU and oxaliplatin based adjuvant chemotherapy.", "title": {"charStart": 0, "charEnd": 168}, "docId": "25175730", "entity": [{"duid": "PU:KPcT", "entityType": "Gene", "charEnd": 1366, "source": "PUBTATOR", "charStart": 1362, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:2Qmb", "entityType": "Chemical", "charEnd": 1599, "source": "PUBTATOR", "charStart": 1596, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 9, "entityText": "5-FU"}, {"duid": "PU:iW7S", "entityType": "Gene", "charEnd": 848, "source": "PUBTATOR", "charStart": 844, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:58Hg", "entityType": "Disease", "charEnd": 428, "source": "PUBTATOR", "charStart": 405, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 2, "entityText": "Chinese stage II-III CRC"}, {"duid": "PU:dLVU", "entityType": "Disease", "charEnd": 1429, "source": "PUBTATOR", "charStart": 1428, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:bvhu", "entityType": "Disease", "charEnd": 314, "source": "PUBTATOR", "charStart": 312, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 1, "entityText": "CRC"}, {"duid": "PU:5M5y", "entityType": "Disease", "charEnd": 1575, "source": "PUBTATOR", "charStart": 1552, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Chinese stage II-III CRC"}, {"duid": "PU:Cw8H", "entityType": "Disease", "charEnd": 536, "source": "PUBTATOR", "charStart": 535, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 3, "entityText": "TS"}, {"duid": "PU:MUMU", "entityType": "Species", "charEnd": 324, "source": "PUBTATOR", "charStart": 317, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:bDMy", "entityType": "Gene", "charEnd": 24, "source": "PUBTATOR", "charStart": 20, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:ctYK", "entityType": "Chemical", "charEnd": 138, "source": "PUBTATOR", "charStart": 127, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "fluorouracil"}, {"duid": "PU:tAxe", "entityType": "Gene", "charEnd": 1026, "source": "PUBTATOR", "charStart": 1022, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:fqWd", "entityType": "Gene", "charEnd": 546, "source": "PUBTATOR", "charStart": 542, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:Jwa8", "entityType": "Disease", "charEnd": 838, "source": "PUBTATOR", "charStart": 837, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:XwGq", "entityType": "Disease", "charEnd": 90, "source": "PUBTATOR", "charStart": 74, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 0, "entityText": "colorectal cancer"}, {"duid": "PU:KniM", "entityType": "Disease", "charEnd": 31, "source": "PUBTATOR", "charStart": 30, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 0, "entityText": "TS"}, {"duid": "PU:v5wH", "entityType": "Chemical", "charEnd": 346, "source": "PUBTATOR", "charStart": 336, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 1, "entityText": "oxaliplatin"}, {"duid": "PU:Huj2", "entityType": "Disease", "charEnd": 1071, "source": "PUBTATOR", "charStart": 1067, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumor"}, {"duid": "PU:bDWp", "entityType": "Gene", "charEnd": 1447, "source": "PUBTATOR", "charStart": 1443, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:dqXP", "entityType": "Species", "charEnd": 99, "source": "PUBTATOR", "charStart": 92, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:ZPPB", "entityType": "Disease", "charEnd": 231, "source": "PUBTATOR", "charStart": 230, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:X7mC", "entityType": "Chemical", "charEnd": 355, "source": "PUBTATOR", "charStart": 352, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:bfz4", "entityType": "Species", "charEnd": 1584, "source": "PUBTATOR", "charStart": 1577, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:hGax", "entityType": "Gene", "charEnd": 1501, "source": "PUBTATOR", "charStart": 1497, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:3nQa", "entityType": "Disease", "charEnd": 1016, "source": "PUBTATOR", "charStart": 1015, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:4L6v", "entityType": "Disease", "charEnd": 575, "source": "PUBTATOR", "charStart": 571, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:WDGP", "entityType": "Chemical", "charEnd": 144, "source": "PUBTATOR", "charStart": 141, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-FU"}, {"duid": "PU:nCvz", "entityType": "Disease", "charEnd": 1356, "source": "PUBTATOR", "charStart": 1355, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:NRuj", "entityType": "Chemical", "charEnd": 121, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 0, "entityText": "oxaliplatin"}, {"duid": "PU:3WDt", "entityType": "Chemical", "charEnd": 1615, "source": "PUBTATOR", "charStart": 1605, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 9, "entityText": "oxaliplatin"}, {"duid": "PU:TkpG", "entityType": "Disease", "charEnd": 309, "source": "PUBTATOR", "charStart": 293, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 1, "entityText": "colorectal cancer"}, {"duid": "PU:xXmr", "entityType": "Gene", "charEnd": 224, "source": "PUBTATOR", "charStart": 220, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:EeLM", "entityType": "Species", "charEnd": 437, "source": "PUBTATOR", "charStart": 430, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:E4Kw", "entityType": "Disease", "charEnd": 1508, "source": "PUBTATOR", "charStart": 1507, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TS"}]}
{"text": "Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy. BACKGROUND: Aim was to explore the association of ERCC1 and TS mRNA levels with the disease free survival (DFS) in Chinese colorectal cancer (CRC) patients receiving oxaliplatin and 5-FU based adjuvant chemotherapy. METHODS: Total 112 Chinese stage II-III CRC patients were respectively treated by four different chemotherapy regimens after curative operation. The TS and ERCC1 mRNA levels in primary tumor were measured by real-time RT-PCR. Kaplan-Meier curves and log-rank tests were used for DFS analysis. The Cox proportional hazards model was used for prognostic analysis. RESULTS: In univariate analysis, the hazard ratio (HR) for the mRNA expression levels of TS and ERCC1 (logTS: HR = 0.820, 95% CI = 0.600 - 1.117, P = 0.210; logERCC1: HR = 1.054, 95% CI = 0.852 - 1.304, P = 0.638) indicated no significant association of DFS with the TS and ERCC1 mRNA levels. In multivariate analyses, tumor stage (IIIc: reference, P = 0.083; IIb: HR = 0.240, 95% CI = 0.080 - 0.724, P = 0.011; IIc: HR < 0.0001, P = 0.977; IIIa: HR = 0.179, 95% CI = 0.012 - 2.593, P = 0.207) was confirmed to be the independent prognostic factor for DFS. Moreover, the Kaplan-Meier DFS curves showed that TS and ERCC1 mRNA levels were not significantly associated with the DFS (TS: P = 0.264; ERCC1: P = 0.484). CONCLUSION: The mRNA expression of ERCC1 and TS were not applicable to predict the DFS of Chinese stage II-III CRC patients receiving 5-FU and oxaliplatin based adjuvant chemotherapy.", "title": {"charStart": 0, "charEnd": 168}, "docId": "25175730", "entity": [{"duid": "PU:KPcT", "entityType": "Gene", "charEnd": 1366, "source": "PUBTATOR", "charStart": 1362, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:2Qmb", "entityType": "Chemical", "charEnd": 1599, "source": "PUBTATOR", "charStart": 1596, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 9, "entityText": "5-FU"}, {"duid": "PU:iW7S", "entityType": "Gene", "charEnd": 848, "source": "PUBTATOR", "charStart": 844, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:58Hg", "entityType": "Disease", "charEnd": 428, "source": "PUBTATOR", "charStart": 405, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 2, "entityText": "Chinese stage II-III CRC"}, {"duid": "PU:dLVU", "entityType": "Disease", "charEnd": 1429, "source": "PUBTATOR", "charStart": 1428, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:bvhu", "entityType": "Disease", "charEnd": 314, "source": "PUBTATOR", "charStart": 312, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 1, "entityText": "CRC"}, {"duid": "PU:5M5y", "entityType": "Disease", "charEnd": 1575, "source": "PUBTATOR", "charStart": 1552, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Chinese stage II-III CRC"}, {"duid": "PU:Cw8H", "entityType": "Disease", "charEnd": 536, "source": "PUBTATOR", "charStart": 535, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 3, "entityText": "TS"}, {"duid": "PU:MUMU", "entityType": "Species", "charEnd": 324, "source": "PUBTATOR", "charStart": 317, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:bDMy", "entityType": "Gene", "charEnd": 24, "source": "PUBTATOR", "charStart": 20, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:ctYK", "entityType": "Chemical", "charEnd": 138, "source": "PUBTATOR", "charStart": 127, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "fluorouracil"}, {"duid": "PU:tAxe", "entityType": "Gene", "charEnd": 1026, "source": "PUBTATOR", "charStart": 1022, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:fqWd", "entityType": "Gene", "charEnd": 546, "source": "PUBTATOR", "charStart": 542, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:Jwa8", "entityType": "Disease", "charEnd": 838, "source": "PUBTATOR", "charStart": 837, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:XwGq", "entityType": "Disease", "charEnd": 90, "source": "PUBTATOR", "charStart": 74, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 0, "entityText": "colorectal cancer"}, {"duid": "PU:KniM", "entityType": "Disease", "charEnd": 31, "source": "PUBTATOR", "charStart": 30, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 0, "entityText": "TS"}, {"duid": "PU:v5wH", "entityType": "Chemical", "charEnd": 346, "source": "PUBTATOR", "charStart": 336, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 1, "entityText": "oxaliplatin"}, {"duid": "PU:Huj2", "entityType": "Disease", "charEnd": 1071, "source": "PUBTATOR", "charStart": 1067, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumor"}, {"duid": "PU:bDWp", "entityType": "Gene", "charEnd": 1447, "source": "PUBTATOR", "charStart": 1443, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:dqXP", "entityType": "Species", "charEnd": 99, "source": "PUBTATOR", "charStart": 92, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:ZPPB", "entityType": "Disease", "charEnd": 231, "source": "PUBTATOR", "charStart": 230, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:X7mC", "entityType": "Chemical", "charEnd": 355, "source": "PUBTATOR", "charStart": 352, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:bfz4", "entityType": "Species", "charEnd": 1584, "source": "PUBTATOR", "charStart": 1577, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:hGax", "entityType": "Gene", "charEnd": 1501, "source": "PUBTATOR", "charStart": 1497, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:3nQa", "entityType": "Disease", "charEnd": 1016, "source": "PUBTATOR", "charStart": 1015, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:4L6v", "entityType": "Disease", "charEnd": 575, "source": "PUBTATOR", "charStart": 571, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:WDGP", "entityType": "Chemical", "charEnd": 144, "source": "PUBTATOR", "charStart": 141, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-FU"}, {"duid": "PU:nCvz", "entityType": "Disease", "charEnd": 1356, "source": "PUBTATOR", "charStart": 1355, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:NRuj", "entityType": "Chemical", "charEnd": 121, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 0, "entityText": "oxaliplatin"}, {"duid": "PU:3WDt", "entityType": "Chemical", "charEnd": 1615, "source": "PUBTATOR", "charStart": 1605, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 9, "entityText": "oxaliplatin"}, {"duid": "PU:TkpG", "entityType": "Disease", "charEnd": 309, "source": "PUBTATOR", "charStart": 293, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 1, "entityText": "colorectal cancer"}, {"duid": "PU:xXmr", "entityType": "Gene", "charEnd": 224, "source": "PUBTATOR", "charStart": 220, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:EeLM", "entityType": "Species", "charEnd": 437, "source": "PUBTATOR", "charStart": 430, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:E4Kw", "entityType": "Disease", "charEnd": 1508, "source": "PUBTATOR", "charStart": 1507, "entityId": [{"idString": "C536962", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TS"}]}
{"text": "Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells. O6-methylguanine DNA methyltransferase (MGMT) can remove DNA alkylation adducts, thereby repairing damaged DNA and contributing to the drug resistance of gliomas to alkylating agents. In addition, glioma stem-like cells (GSCs) have been demonstrated to be involved in the recurrence and treatment resistance of gliomas. In this study, we aimed to investigate MGMT expression and regulatory mechanisms in GSCs and the association of MGMT with temozolomide (TMZ) sensitivity. GSCs were enriched from one MGMT-positive cell line (SF-767) and 7 MGMT-negative cell lines (U251, SKMG-4, SKMG-1, SF295, U87, MGR1, and MGR2) through serum-free clone culture. GSCs from the U251G, SKMG-4G, SF295G, and SKMG-1G cell lines became MGMT-positive, but those from the U87G, MGR1G, and MGR2G cell lines remained MGMT-negative. However, all the GSCs and their parental glioma cell lines were positive for nuclear factor-\u03baB (NF-\u03baB). In addition, GSCs were more resistant to TMZ than their parental glioma cell lines (P < 0.05). However, there was no significant difference in the 50% inhibition concentration (IC50) of TMZ between MGMT-positive and MGMT-negative GSCs (P > 0.05). When we treated the MGMT-positive GSCs with TMZ plus MG-132 (an NF-\u03baB inhibitor), the antitumor activity was significantly enhanced compared to that of GSCs treated with TMZ alone (P <0.05). Furthermore, we found that MGMT expression decreased through the down-regulation of NF-\u03baB expression by MG-132. Our results show that MG-132 may inhibit NF-\u03baB expression and further decrease MGMT expression, resulting in a synergistic effect on MGMT-positive GSCs. These results indicate that enhanced MGMT expression contributes to TMZ resistance in MGMT-positive GSCs.", "title": {"charStart": 0, "charEnd": 89}, "docId": "23958055", "entity": [{"duid": "PU:gm3T", "entityType": "Gene", "charEnd": 128, "source": "PUBTATOR", "charStart": 91, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "O6-methylguanine DNA methyltransferase"}, {"duid": "PU:eMBo", "entityType": "Gene", "charEnd": 890, "source": "PUBTATOR", "charStart": 887, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "MGMT"}, {"duid": "PU:Doeq", "entityType": "Disease", "charEnd": 948, "source": "PUBTATOR", "charStart": 943, "entityId": [{"idString": "D005910", "source": "MESH"}], "sentenceIndex": 6, "entityText": "glioma"}, {"duid": "PU:TkSX", "entityType": "Gene", "charEnd": 1638, "source": "PUBTATOR", "charStart": 1635, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "MGMT"}, {"duid": "PU:4XH6", "entityType": "Disease", "charEnd": 293, "source": "PUBTATOR", "charStart": 288, "entityId": [{"idString": "D005910", "source": "MESH"}], "sentenceIndex": 2, "entityText": "glioma"}, {"duid": "PU:zFtR", "entityType": "Gene", "charEnd": 12, "source": "PUBTATOR", "charStart": 9, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "MGMT"}, {"duid": "PU:yiU7", "entityType": "Chemical", "charEnd": 106, "source": "PUBTATOR", "charStart": 91, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 1, "entityText": "O6-methylguanine"}, {"duid": "PU:y4Zb", "entityType": "Gene", "charEnd": 1749, "source": "PUBTATOR", "charStart": 1746, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "MGMT"}, {"duid": "PU:AmBr", "entityType": "Gene", "charEnd": 1276, "source": "PUBTATOR", "charStart": 1273, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "MGMT"}, {"duid": "PU:TxRN", "entityType": "Gene", "charEnd": 526, "source": "PUBTATOR", "charStart": 523, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MGMT"}, {"duid": "PU:jPy8", "entityType": "Chemical", "charEnd": 1049, "source": "PUBTATOR", "charStart": 1047, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 7, "entityText": "TMZ"}, {"duid": "PU:5sYy", "entityType": "Gene", "charEnd": 695, "source": "PUBTATOR", "charStart": 692, "entityId": [{"idString": "192115", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MGR1"}, {"duid": "PU:dyq7", "entityType": "Gene", "charEnd": 1692, "source": "PUBTATOR", "charStart": 1689, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "MGMT"}, {"duid": "PU:Avaf", "entityType": "Gene", "charEnd": 1553, "source": "PUBTATOR", "charStart": 1548, "entityId": [{"idString": "875581", "source": "Entrez"}, {"idString": "243273", "source": "Tax"}], "sentenceIndex": 10, "entityText": "MG-132"}, {"duid": "PU:U2Ue", "entityType": "Chemical", "charEnd": 1194, "source": "PUBTATOR", "charStart": 1192, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 8, "entityText": "TMZ"}, {"duid": "PU:w4mE", "entityType": "Chemical", "charEnd": 1425, "source": "PUBTATOR", "charStart": 1423, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 9, "entityText": "TMZ"}, {"duid": "PU:ebgT", "entityType": "Gene", "charEnd": 1583, "source": "PUBTATOR", "charStart": 1578, "entityId": [{"idString": "875581", "source": "Entrez"}, {"idString": "243273", "source": "Tax"}], "sentenceIndex": 11, "entityText": "MG-132"}, {"duid": "PU:FoV5", "entityType": "Gene", "charEnd": 1474, "source": "PUBTATOR", "charStart": 1471, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "MGMT"}, {"duid": "PU:YJhz", "entityType": "Gene", "charEnd": 1798, "source": "PUBTATOR", "charStart": 1795, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "MGMT"}, {"duid": "PU:e7Yn", "entityType": "Gene", "charEnd": 705, "source": "PUBTATOR", "charStart": 702, "entityId": [{"idString": "8249", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MGR2"}, {"duid": "PU:EGCi", "entityType": "Disease", "charEnd": 251, "source": "PUBTATOR", "charStart": 245, "entityId": [{"idString": "D005910", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gliomas"}, {"duid": "PU:X4ER", "entityType": "Gene", "charEnd": 1311, "source": "PUBTATOR", "charStart": 1306, "entityId": [{"idString": "875581", "source": "Entrez"}, {"idString": "243273", "source": "Tax"}], "sentenceIndex": 9, "entityText": "MG-132"}, {"duid": "PU:J9f2", "entityType": "Chemical", "charEnd": 544, "source": "PUBTATOR", "charStart": 533, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 3, "entityText": "temozolomide"}, {"duid": "PU:rnkY", "entityType": "Gene", "charEnd": 689, "source": "PUBTATOR", "charStart": 687, "entityId": [{"idString": "641648", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "U87"}, {"duid": "PU:YzkL", "entityType": "Chemical", "charEnd": 51, "source": "PUBTATOR", "charStart": 40, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "temozolomide"}, {"duid": "PU:jULE", "entityType": "Chemical", "charEnd": 549, "source": "PUBTATOR", "charStart": 547, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 3, "entityText": "TMZ"}, {"duid": "PU:sVi4", "entityType": "Chemical", "charEnd": 1779, "source": "PUBTATOR", "charStart": 1777, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 12, "entityText": "TMZ"}, {"duid": "PU:WQFf", "entityType": "Disease", "charEnd": 408, "source": "PUBTATOR", "charStart": 402, "entityId": [{"idString": "D005910", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gliomas"}, {"duid": "PU:5ngu", "entityType": "Gene", "charEnd": 453, "source": "PUBTATOR", "charStart": 450, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MGMT"}, {"duid": "PU:aZqL", "entityType": "Disease", "charEnd": 72, "source": "PUBTATOR", "charStart": 67, "entityId": [{"idString": "D005910", "source": "MESH"}], "sentenceIndex": 0, "entityText": "glioma"}, {"duid": "PU:xtGv", "entityType": "Gene", "charEnd": 1225, "source": "PUBTATOR", "charStart": 1222, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MGMT"}, {"duid": "PU:zzT8", "entityType": "Gene", "charEnd": 596, "source": "PUBTATOR", "charStart": 593, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MGMT"}, {"duid": "PU:9gWz", "entityType": "Gene", "charEnd": 1207, "source": "PUBTATOR", "charStart": 1204, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MGMT"}, {"duid": "PU:XBCS", "entityType": "Chemical", "charEnd": 1299, "source": "PUBTATOR", "charStart": 1297, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 9, "entityText": "TMZ"}, {"duid": "PU:S5pF", "entityType": "Gene", "charEnd": 134, "source": "PUBTATOR", "charStart": 131, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "MGMT"}, {"duid": "PU:KrZY", "entityType": "Gene", "charEnd": 635, "source": "PUBTATOR", "charStart": 632, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MGMT"}, {"duid": "PU:EBxk", "entityType": "Disease", "charEnd": 1076, "source": "PUBTATOR", "charStart": 1071, "entityId": [{"idString": "D005910", "source": "MESH"}], "sentenceIndex": 7, "entityText": "glioma"}, {"duid": "PU:YCV2", "entityType": "Gene", "charEnd": 813, "source": "PUBTATOR", "charStart": 810, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "MGMT"}]}
{"text": "Expressions of Thymidylate Synthase,Thymidine Phosphorylase, Class III \u03b2-tubulin, and Excision Repair Cross-complementing Group 1predict Response in Advanced Gastric Cancer Patients Receiving Capecitabine Plus Paclitaxel or Cisplatin. OBJECTIVE: Toevaluate the role of class III \u03b2-tubulin (TUBB3), thymidylate synthase (TS), thymidine phosphorylase (TP), and excision repair cross-complementing group 1 (ERCC1) in clinical outcome of advanced gastric cancer patients receiving capecitabine plus paclitaxel or cisplatin. METHODS: The clinical data and tumor specimens from 57 advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel (cohort 1, n=36) and capecitabine plus cisplatin (cohort 2, n=21) were retrospectively collected, and TUBB3, TS, TP, and ERCC1 expressions were detected by real-time quantitative PCR. The associations between expressions of biomarkers and response or survival were analyzed statistically. RESULTS: The median age of 57 patients was 57 years (range: 27-75 years) with 38 males and 19 females. Of all patients, the response rates of patients with high TP, low TP and high TS, low TS expressions were 57.1%, 27.6% (P=0.024), and 55.2%, 28.6% (P=0.042), respectively. Among cohort 1, the response rates and median overall survivals of patients with low and high TUBB3 expressions were 61.1% vs. 33.3% (P=0.095) and 13.8 months vs. 6.6 months (P=0.019), respectively; the response rate (87.5%) of patients with low TUBB3 and high TP expressions was higher than that (14.3%) of patients with high TUBB3 and low TP expressions (P=0.01). Among cohort 2, the response rates of patients with low ERCC1 and high ERCC1 expressions were 45.5% and 20.0% respectively (P=0.361). CONCLUSION: TUBB3, TS and TP expressions could predict the response of advanced gastric cancer patients receiving capecitabine-based and paclitaxel-based chemotherapy. These results will be further confirmed in future large samples.", "title": {"charStart": 0, "charEnd": 233}, "docId": "23358102", "entity": [{"duid": "PU:c2Mz", "entityType": "Gene", "charEnd": 1553, "source": "PUBTATOR", "charStart": 1549, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:zgj2", "entityType": "Gene", "charEnd": 1472, "source": "PUBTATOR", "charStart": 1468, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:Quot", "entityType": "Chemical", "charEnd": 44, "source": "PUBTATOR", "charStart": 36, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Thymidine"}, {"duid": "PU:fjrs", "entityType": "Gene", "charEnd": 401, "source": "PUBTATOR", "charStart": 359, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementing group 1"}, {"duid": "PU:FiGh", "entityType": "Chemical", "charEnd": 656, "source": "PUBTATOR", "charStart": 647, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 2, "entityText": "paclitaxel"}, {"duid": "PU:fpW9", "entityType": "Gene", "charEnd": 783, "source": "PUBTATOR", "charStart": 779, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:LNuz", "entityType": "Species", "charEnd": 1096, "source": "PUBTATOR", "charStart": 1089, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:dFjX", "entityType": "Gene", "charEnd": 1129, "source": "PUBTATOR", "charStart": 1128, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:B54E", "entityType": "Disease", "charEnd": 597, "source": "PUBTATOR", "charStart": 584, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:36du", "entityType": "Chemical", "charEnd": 690, "source": "PUBTATOR", "charStart": 679, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 2, "entityText": "capecitabine"}, {"duid": "PU:KjeM", "entityType": "Gene", "charEnd": 317, "source": "PUBTATOR", "charStart": 298, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:g83M", "entityType": "Gene", "charEnd": 1137, "source": "PUBTATOR", "charStart": 1136, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:h9Ds", "entityType": "Disease", "charEnd": 555, "source": "PUBTATOR", "charStart": 551, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:ZXDC", "entityType": "Species", "charEnd": 1457, "source": "PUBTATOR", "charStart": 1450, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:sRez", "entityType": "Species", "charEnd": 1296, "source": "PUBTATOR", "charStart": 1289, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:2LF8", "entityType": "Gene", "charEnd": 768, "source": "PUBTATOR", "charStart": 767, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:csRY", "entityType": "Species", "charEnd": 984, "source": "PUBTATOR", "charStart": 977, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:NAvj", "entityType": "Chemical", "charEnd": 232, "source": "PUBTATOR", "charStart": 224, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Cisplatin"}, {"duid": "PU:wDDG", "entityType": "Chemical", "charEnd": 1868, "source": "PUBTATOR", "charStart": 1859, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 8, "entityText": "paclitaxel"}, {"duid": "PU:SNcA", "entityType": "Species", "charEnd": 1824, "source": "PUBTATOR", "charStart": 1817, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:7YtP", "entityType": "Gene", "charEnd": 1663, "source": "PUBTATOR", "charStart": 1659, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:px3W", "entityType": "Chemical", "charEnd": 333, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}, {"duid": "PU:2LwP", "entityType": "Disease", "charEnd": 1815, "source": "PUBTATOR", "charStart": 1802, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gastric cancer"}, {"duid": "PU:XDLb", "entityType": "Chemical", "charEnd": 504, "source": "PUBTATOR", "charStart": 495, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 1, "entityText": "paclitaxel"}, {"duid": "PU:t6JW", "entityType": "Chemical", "charEnd": 640, "source": "PUBTATOR", "charStart": 629, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 2, "entityText": "capecitabine"}, {"duid": "PU:iDyF", "entityType": "Chemical", "charEnd": 25, "source": "PUBTATOR", "charStart": 15, "entityId": [{"idString": "17013", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "Thymidylate"}, {"duid": "PU:eY7P", "entityType": "Chemical", "charEnd": 488, "source": "PUBTATOR", "charStart": 477, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 1, "entityText": "capecitabine"}, {"duid": "PU:JTHx", "entityType": "Disease", "charEnd": 171, "source": "PUBTATOR", "charStart": 158, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Gastric Cancer"}, {"duid": "PU:nFb5", "entityType": "Species", "charEnd": 1537, "source": "PUBTATOR", "charStart": 1530, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:DHC8", "entityType": "Disease", "charEnd": 456, "source": "PUBTATOR", "charStart": 443, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gastric cancer"}, {"duid": "PU:WKQW", "entityType": "Gene", "charEnd": 408, "source": "PUBTATOR", "charStart": 404, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:TQC5", "entityType": "Gene", "charEnd": 1648, "source": "PUBTATOR", "charStart": 1644, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:ApVT", "entityType": "Species", "charEnd": 180, "source": "PUBTATOR", "charStart": 173, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "Patients"}, {"duid": "PU:Xd3H", "entityType": "Chemical", "charEnd": 203, "source": "PUBTATOR", "charStart": 192, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Capecitabine"}, {"duid": "PU:wU7g", "entityType": "Gene", "charEnd": 58, "source": "PUBTATOR", "charStart": 36, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Thymidine Phosphorylase"}, {"duid": "PU:y7WW", "entityType": "Species", "charEnd": 606, "source": "PUBTATOR", "charStart": 599, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:k7eY", "entityType": "Chemical", "charEnd": 219, "source": "PUBTATOR", "charStart": 210, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Paclitaxel"}, {"duid": "PU:tnvo", "entityType": "Gene", "charEnd": 764, "source": "PUBTATOR", "charStart": 760, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TUBB3"}, {"duid": "PU:brV4", "entityType": "Chemical", "charEnd": 705, "source": "PUBTATOR", "charStart": 697, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cisplatin"}, {"duid": "PU:5D64", "entityType": "Species", "charEnd": 1633, "source": "PUBTATOR", "charStart": 1626, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:GHDw", "entityType": "Species", "charEnd": 465, "source": "PUBTATOR", "charStart": 458, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:3rem", "entityType": "Gene", "charEnd": 347, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidine phosphorylase"}, {"duid": "PU:mgvX", "entityType": "Species", "charEnd": 1064, "source": "PUBTATOR", "charStart": 1057, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:R6uP", "entityType": "Gene", "charEnd": 1742, "source": "PUBTATOR", "charStart": 1741, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:LFKi", "entityType": "Gene", "charEnd": 294, "source": "PUBTATOR", "charStart": 290, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TUBB3"}, {"duid": "PU:y8ZF", "entityType": "Gene", "charEnd": 1738, "source": "PUBTATOR", "charStart": 1734, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TUBB3"}, {"duid": "PU:w6ED", "entityType": "Chemical", "charEnd": 517, "source": "PUBTATOR", "charStart": 509, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:UwBC", "entityType": "Gene", "charEnd": 1320, "source": "PUBTATOR", "charStart": 1316, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:cCSB", "entityType": "Chemical", "charEnd": 1847, "source": "PUBTATOR", "charStart": 1836, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 8, "entityText": "capecitabine"}, {"duid": "PU:YawT", "entityType": "Gene", "charEnd": 34, "source": "PUBTATOR", "charStart": 15, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Thymidylate Synthase"}, {"duid": "PU:5TtE", "entityType": "Gene", "charEnd": 321, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TS"}]}
{"text": "Expressions of Thymidylate Synthase,Thymidine Phosphorylase, Class III \u03b2-tubulin, and Excision Repair Cross-complementing Group 1predict Response in Advanced Gastric Cancer Patients Receiving Capecitabine Plus Paclitaxel or Cisplatin. OBJECTIVE: Toevaluate the role of class III \u03b2-tubulin (TUBB3), thymidylate synthase (TS), thymidine phosphorylase (TP), and excision repair cross-complementing group 1 (ERCC1) in clinical outcome of advanced gastric cancer patients receiving capecitabine plus paclitaxel or cisplatin. METHODS: The clinical data and tumor specimens from 57 advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel (cohort 1, n=36) and capecitabine plus cisplatin (cohort 2, n=21) were retrospectively collected, and TUBB3, TS, TP, and ERCC1 expressions were detected by real-time quantitative PCR. The associations between expressions of biomarkers and response or survival were analyzed statistically. RESULTS: The median age of 57 patients was 57 years (range: 27-75 years) with 38 males and 19 females. Of all patients, the response rates of patients with high TP, low TP and high TS, low TS expressions were 57.1%, 27.6% (P=0.024), and 55.2%, 28.6% (P=0.042), respectively. Among cohort 1, the response rates and median overall survivals of patients with low and high TUBB3 expressions were 61.1% vs. 33.3% (P=0.095) and 13.8 months vs. 6.6 months (P=0.019), respectively; the response rate (87.5%) of patients with low TUBB3 and high TP expressions was higher than that (14.3%) of patients with high TUBB3 and low TP expressions (P=0.01). Among cohort 2, the response rates of patients with low ERCC1 and high ERCC1 expressions were 45.5% and 20.0% respectively (P=0.361). CONCLUSION: TUBB3, TS and TP expressions could predict the response of advanced gastric cancer patients receiving capecitabine-based and paclitaxel-based chemotherapy. These results will be further confirmed in future large samples.", "title": {"charStart": 0, "charEnd": 233}, "docId": "23358102", "entity": [{"duid": "PU:c2Mz", "entityType": "Gene", "charEnd": 1553, "source": "PUBTATOR", "charStart": 1549, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:zgj2", "entityType": "Gene", "charEnd": 1472, "source": "PUBTATOR", "charStart": 1468, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:Quot", "entityType": "Chemical", "charEnd": 44, "source": "PUBTATOR", "charStart": 36, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Thymidine"}, {"duid": "PU:fjrs", "entityType": "Gene", "charEnd": 401, "source": "PUBTATOR", "charStart": 359, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementing group 1"}, {"duid": "PU:FiGh", "entityType": "Chemical", "charEnd": 656, "source": "PUBTATOR", "charStart": 647, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 2, "entityText": "paclitaxel"}, {"duid": "PU:fpW9", "entityType": "Gene", "charEnd": 783, "source": "PUBTATOR", "charStart": 779, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:LNuz", "entityType": "Species", "charEnd": 1096, "source": "PUBTATOR", "charStart": 1089, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:dFjX", "entityType": "Gene", "charEnd": 1129, "source": "PUBTATOR", "charStart": 1128, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:B54E", "entityType": "Disease", "charEnd": 597, "source": "PUBTATOR", "charStart": 584, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:36du", "entityType": "Chemical", "charEnd": 690, "source": "PUBTATOR", "charStart": 679, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 2, "entityText": "capecitabine"}, {"duid": "PU:KjeM", "entityType": "Gene", "charEnd": 317, "source": "PUBTATOR", "charStart": 298, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:g83M", "entityType": "Gene", "charEnd": 1137, "source": "PUBTATOR", "charStart": 1136, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:h9Ds", "entityType": "Disease", "charEnd": 555, "source": "PUBTATOR", "charStart": 551, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:ZXDC", "entityType": "Species", "charEnd": 1457, "source": "PUBTATOR", "charStart": 1450, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:sRez", "entityType": "Species", "charEnd": 1296, "source": "PUBTATOR", "charStart": 1289, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:2LF8", "entityType": "Gene", "charEnd": 768, "source": "PUBTATOR", "charStart": 767, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:csRY", "entityType": "Species", "charEnd": 984, "source": "PUBTATOR", "charStart": 977, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:NAvj", "entityType": "Chemical", "charEnd": 232, "source": "PUBTATOR", "charStart": 224, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Cisplatin"}, {"duid": "PU:wDDG", "entityType": "Chemical", "charEnd": 1868, "source": "PUBTATOR", "charStart": 1859, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 8, "entityText": "paclitaxel"}, {"duid": "PU:SNcA", "entityType": "Species", "charEnd": 1824, "source": "PUBTATOR", "charStart": 1817, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:7YtP", "entityType": "Gene", "charEnd": 1663, "source": "PUBTATOR", "charStart": 1659, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:px3W", "entityType": "Chemical", "charEnd": 333, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}, {"duid": "PU:2LwP", "entityType": "Disease", "charEnd": 1815, "source": "PUBTATOR", "charStart": 1802, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gastric cancer"}, {"duid": "PU:XDLb", "entityType": "Chemical", "charEnd": 504, "source": "PUBTATOR", "charStart": 495, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 1, "entityText": "paclitaxel"}, {"duid": "PU:t6JW", "entityType": "Chemical", "charEnd": 640, "source": "PUBTATOR", "charStart": 629, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 2, "entityText": "capecitabine"}, {"duid": "PU:iDyF", "entityType": "Chemical", "charEnd": 25, "source": "PUBTATOR", "charStart": 15, "entityId": [{"idString": "17013", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "Thymidylate"}, {"duid": "PU:eY7P", "entityType": "Chemical", "charEnd": 488, "source": "PUBTATOR", "charStart": 477, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 1, "entityText": "capecitabine"}, {"duid": "PU:JTHx", "entityType": "Disease", "charEnd": 171, "source": "PUBTATOR", "charStart": 158, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Gastric Cancer"}, {"duid": "PU:nFb5", "entityType": "Species", "charEnd": 1537, "source": "PUBTATOR", "charStart": 1530, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:DHC8", "entityType": "Disease", "charEnd": 456, "source": "PUBTATOR", "charStart": 443, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gastric cancer"}, {"duid": "PU:WKQW", "entityType": "Gene", "charEnd": 408, "source": "PUBTATOR", "charStart": 404, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:TQC5", "entityType": "Gene", "charEnd": 1648, "source": "PUBTATOR", "charStart": 1644, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:ApVT", "entityType": "Species", "charEnd": 180, "source": "PUBTATOR", "charStart": 173, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "Patients"}, {"duid": "PU:Xd3H", "entityType": "Chemical", "charEnd": 203, "source": "PUBTATOR", "charStart": 192, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Capecitabine"}, {"duid": "PU:wU7g", "entityType": "Gene", "charEnd": 58, "source": "PUBTATOR", "charStart": 36, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Thymidine Phosphorylase"}, {"duid": "PU:y7WW", "entityType": "Species", "charEnd": 606, "source": "PUBTATOR", "charStart": 599, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:k7eY", "entityType": "Chemical", "charEnd": 219, "source": "PUBTATOR", "charStart": 210, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Paclitaxel"}, {"duid": "PU:tnvo", "entityType": "Gene", "charEnd": 764, "source": "PUBTATOR", "charStart": 760, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TUBB3"}, {"duid": "PU:brV4", "entityType": "Chemical", "charEnd": 705, "source": "PUBTATOR", "charStart": 697, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cisplatin"}, {"duid": "PU:5D64", "entityType": "Species", "charEnd": 1633, "source": "PUBTATOR", "charStart": 1626, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:GHDw", "entityType": "Species", "charEnd": 465, "source": "PUBTATOR", "charStart": 458, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:3rem", "entityType": "Gene", "charEnd": 347, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidine phosphorylase"}, {"duid": "PU:mgvX", "entityType": "Species", "charEnd": 1064, "source": "PUBTATOR", "charStart": 1057, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:R6uP", "entityType": "Gene", "charEnd": 1742, "source": "PUBTATOR", "charStart": 1741, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:LFKi", "entityType": "Gene", "charEnd": 294, "source": "PUBTATOR", "charStart": 290, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TUBB3"}, {"duid": "PU:y8ZF", "entityType": "Gene", "charEnd": 1738, "source": "PUBTATOR", "charStart": 1734, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TUBB3"}, {"duid": "PU:w6ED", "entityType": "Chemical", "charEnd": 517, "source": "PUBTATOR", "charStart": 509, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:UwBC", "entityType": "Gene", "charEnd": 1320, "source": "PUBTATOR", "charStart": 1316, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:cCSB", "entityType": "Chemical", "charEnd": 1847, "source": "PUBTATOR", "charStart": 1836, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 8, "entityText": "capecitabine"}, {"duid": "PU:YawT", "entityType": "Gene", "charEnd": 34, "source": "PUBTATOR", "charStart": 15, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Thymidylate Synthase"}, {"duid": "PU:5TtE", "entityType": "Gene", "charEnd": 321, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TS"}]}
{"text": "Expressions of Thymidylate Synthase,Thymidine Phosphorylase, Class III \u03b2-tubulin, and Excision Repair Cross-complementing Group 1predict Response in Advanced Gastric Cancer Patients Receiving Capecitabine Plus Paclitaxel or Cisplatin. OBJECTIVE: Toevaluate the role of class III \u03b2-tubulin (TUBB3), thymidylate synthase (TS), thymidine phosphorylase (TP), and excision repair cross-complementing group 1 (ERCC1) in clinical outcome of advanced gastric cancer patients receiving capecitabine plus paclitaxel or cisplatin. METHODS: The clinical data and tumor specimens from 57 advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel (cohort 1, n=36) and capecitabine plus cisplatin (cohort 2, n=21) were retrospectively collected, and TUBB3, TS, TP, and ERCC1 expressions were detected by real-time quantitative PCR. The associations between expressions of biomarkers and response or survival were analyzed statistically. RESULTS: The median age of 57 patients was 57 years (range: 27-75 years) with 38 males and 19 females. Of all patients, the response rates of patients with high TP, low TP and high TS, low TS expressions were 57.1%, 27.6% (P=0.024), and 55.2%, 28.6% (P=0.042), respectively. Among cohort 1, the response rates and median overall survivals of patients with low and high TUBB3 expressions were 61.1% vs. 33.3% (P=0.095) and 13.8 months vs. 6.6 months (P=0.019), respectively; the response rate (87.5%) of patients with low TUBB3 and high TP expressions was higher than that (14.3%) of patients with high TUBB3 and low TP expressions (P=0.01). Among cohort 2, the response rates of patients with low ERCC1 and high ERCC1 expressions were 45.5% and 20.0% respectively (P=0.361). CONCLUSION: TUBB3, TS and TP expressions could predict the response of advanced gastric cancer patients receiving capecitabine-based and paclitaxel-based chemotherapy. These results will be further confirmed in future large samples.", "title": {"charStart": 0, "charEnd": 233}, "docId": "23358102", "entity": [{"duid": "PU:c2Mz", "entityType": "Gene", "charEnd": 1553, "source": "PUBTATOR", "charStart": 1549, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:zgj2", "entityType": "Gene", "charEnd": 1472, "source": "PUBTATOR", "charStart": 1468, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:Quot", "entityType": "Chemical", "charEnd": 44, "source": "PUBTATOR", "charStart": 36, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Thymidine"}, {"duid": "PU:fjrs", "entityType": "Gene", "charEnd": 401, "source": "PUBTATOR", "charStart": 359, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementing group 1"}, {"duid": "PU:FiGh", "entityType": "Chemical", "charEnd": 656, "source": "PUBTATOR", "charStart": 647, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 2, "entityText": "paclitaxel"}, {"duid": "PU:fpW9", "entityType": "Gene", "charEnd": 783, "source": "PUBTATOR", "charStart": 779, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:LNuz", "entityType": "Species", "charEnd": 1096, "source": "PUBTATOR", "charStart": 1089, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:dFjX", "entityType": "Gene", "charEnd": 1129, "source": "PUBTATOR", "charStart": 1128, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:B54E", "entityType": "Disease", "charEnd": 597, "source": "PUBTATOR", "charStart": 584, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:36du", "entityType": "Chemical", "charEnd": 690, "source": "PUBTATOR", "charStart": 679, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 2, "entityText": "capecitabine"}, {"duid": "PU:KjeM", "entityType": "Gene", "charEnd": 317, "source": "PUBTATOR", "charStart": 298, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:g83M", "entityType": "Gene", "charEnd": 1137, "source": "PUBTATOR", "charStart": 1136, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:h9Ds", "entityType": "Disease", "charEnd": 555, "source": "PUBTATOR", "charStart": 551, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:ZXDC", "entityType": "Species", "charEnd": 1457, "source": "PUBTATOR", "charStart": 1450, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:sRez", "entityType": "Species", "charEnd": 1296, "source": "PUBTATOR", "charStart": 1289, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:2LF8", "entityType": "Gene", "charEnd": 768, "source": "PUBTATOR", "charStart": 767, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:csRY", "entityType": "Species", "charEnd": 984, "source": "PUBTATOR", "charStart": 977, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:NAvj", "entityType": "Chemical", "charEnd": 232, "source": "PUBTATOR", "charStart": 224, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Cisplatin"}, {"duid": "PU:wDDG", "entityType": "Chemical", "charEnd": 1868, "source": "PUBTATOR", "charStart": 1859, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 8, "entityText": "paclitaxel"}, {"duid": "PU:SNcA", "entityType": "Species", "charEnd": 1824, "source": "PUBTATOR", "charStart": 1817, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:7YtP", "entityType": "Gene", "charEnd": 1663, "source": "PUBTATOR", "charStart": 1659, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:px3W", "entityType": "Chemical", "charEnd": 333, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}, {"duid": "PU:2LwP", "entityType": "Disease", "charEnd": 1815, "source": "PUBTATOR", "charStart": 1802, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gastric cancer"}, {"duid": "PU:XDLb", "entityType": "Chemical", "charEnd": 504, "source": "PUBTATOR", "charStart": 495, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 1, "entityText": "paclitaxel"}, {"duid": "PU:t6JW", "entityType": "Chemical", "charEnd": 640, "source": "PUBTATOR", "charStart": 629, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 2, "entityText": "capecitabine"}, {"duid": "PU:iDyF", "entityType": "Chemical", "charEnd": 25, "source": "PUBTATOR", "charStart": 15, "entityId": [{"idString": "17013", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "Thymidylate"}, {"duid": "PU:eY7P", "entityType": "Chemical", "charEnd": 488, "source": "PUBTATOR", "charStart": 477, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 1, "entityText": "capecitabine"}, {"duid": "PU:JTHx", "entityType": "Disease", "charEnd": 171, "source": "PUBTATOR", "charStart": 158, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Gastric Cancer"}, {"duid": "PU:nFb5", "entityType": "Species", "charEnd": 1537, "source": "PUBTATOR", "charStart": 1530, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:DHC8", "entityType": "Disease", "charEnd": 456, "source": "PUBTATOR", "charStart": 443, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gastric cancer"}, {"duid": "PU:WKQW", "entityType": "Gene", "charEnd": 408, "source": "PUBTATOR", "charStart": 404, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:TQC5", "entityType": "Gene", "charEnd": 1648, "source": "PUBTATOR", "charStart": 1644, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:ApVT", "entityType": "Species", "charEnd": 180, "source": "PUBTATOR", "charStart": 173, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "Patients"}, {"duid": "PU:Xd3H", "entityType": "Chemical", "charEnd": 203, "source": "PUBTATOR", "charStart": 192, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Capecitabine"}, {"duid": "PU:wU7g", "entityType": "Gene", "charEnd": 58, "source": "PUBTATOR", "charStart": 36, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Thymidine Phosphorylase"}, {"duid": "PU:y7WW", "entityType": "Species", "charEnd": 606, "source": "PUBTATOR", "charStart": 599, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:k7eY", "entityType": "Chemical", "charEnd": 219, "source": "PUBTATOR", "charStart": 210, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Paclitaxel"}, {"duid": "PU:tnvo", "entityType": "Gene", "charEnd": 764, "source": "PUBTATOR", "charStart": 760, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TUBB3"}, {"duid": "PU:brV4", "entityType": "Chemical", "charEnd": 705, "source": "PUBTATOR", "charStart": 697, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cisplatin"}, {"duid": "PU:5D64", "entityType": "Species", "charEnd": 1633, "source": "PUBTATOR", "charStart": 1626, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:GHDw", "entityType": "Species", "charEnd": 465, "source": "PUBTATOR", "charStart": 458, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:3rem", "entityType": "Gene", "charEnd": 347, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidine phosphorylase"}, {"duid": "PU:mgvX", "entityType": "Species", "charEnd": 1064, "source": "PUBTATOR", "charStart": 1057, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:R6uP", "entityType": "Gene", "charEnd": 1742, "source": "PUBTATOR", "charStart": 1741, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:LFKi", "entityType": "Gene", "charEnd": 294, "source": "PUBTATOR", "charStart": 290, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TUBB3"}, {"duid": "PU:y8ZF", "entityType": "Gene", "charEnd": 1738, "source": "PUBTATOR", "charStart": 1734, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TUBB3"}, {"duid": "PU:w6ED", "entityType": "Chemical", "charEnd": 517, "source": "PUBTATOR", "charStart": 509, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:UwBC", "entityType": "Gene", "charEnd": 1320, "source": "PUBTATOR", "charStart": 1316, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:cCSB", "entityType": "Chemical", "charEnd": 1847, "source": "PUBTATOR", "charStart": 1836, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 8, "entityText": "capecitabine"}, {"duid": "PU:YawT", "entityType": "Gene", "charEnd": 34, "source": "PUBTATOR", "charStart": 15, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Thymidylate Synthase"}, {"duid": "PU:5TtE", "entityType": "Gene", "charEnd": 321, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TS"}]}
{"text": "Expressions of Thymidylate Synthase,Thymidine Phosphorylase, Class III \u03b2-tubulin, and Excision Repair Cross-complementing Group 1predict Response in Advanced Gastric Cancer Patients Receiving Capecitabine Plus Paclitaxel or Cisplatin. OBJECTIVE: Toevaluate the role of class III \u03b2-tubulin (TUBB3), thymidylate synthase (TS), thymidine phosphorylase (TP), and excision repair cross-complementing group 1 (ERCC1) in clinical outcome of advanced gastric cancer patients receiving capecitabine plus paclitaxel or cisplatin. METHODS: The clinical data and tumor specimens from 57 advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel (cohort 1, n=36) and capecitabine plus cisplatin (cohort 2, n=21) were retrospectively collected, and TUBB3, TS, TP, and ERCC1 expressions were detected by real-time quantitative PCR. The associations between expressions of biomarkers and response or survival were analyzed statistically. RESULTS: The median age of 57 patients was 57 years (range: 27-75 years) with 38 males and 19 females. Of all patients, the response rates of patients with high TP, low TP and high TS, low TS expressions were 57.1%, 27.6% (P=0.024), and 55.2%, 28.6% (P=0.042), respectively. Among cohort 1, the response rates and median overall survivals of patients with low and high TUBB3 expressions were 61.1% vs. 33.3% (P=0.095) and 13.8 months vs. 6.6 months (P=0.019), respectively; the response rate (87.5%) of patients with low TUBB3 and high TP expressions was higher than that (14.3%) of patients with high TUBB3 and low TP expressions (P=0.01). Among cohort 2, the response rates of patients with low ERCC1 and high ERCC1 expressions were 45.5% and 20.0% respectively (P=0.361). CONCLUSION: TUBB3, TS and TP expressions could predict the response of advanced gastric cancer patients receiving capecitabine-based and paclitaxel-based chemotherapy. These results will be further confirmed in future large samples.", "title": {"charStart": 0, "charEnd": 233}, "docId": "23358102", "entity": [{"duid": "PU:c2Mz", "entityType": "Gene", "charEnd": 1553, "source": "PUBTATOR", "charStart": 1549, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:zgj2", "entityType": "Gene", "charEnd": 1472, "source": "PUBTATOR", "charStart": 1468, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:Quot", "entityType": "Chemical", "charEnd": 44, "source": "PUBTATOR", "charStart": 36, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Thymidine"}, {"duid": "PU:fjrs", "entityType": "Gene", "charEnd": 401, "source": "PUBTATOR", "charStart": 359, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementing group 1"}, {"duid": "PU:FiGh", "entityType": "Chemical", "charEnd": 656, "source": "PUBTATOR", "charStart": 647, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 2, "entityText": "paclitaxel"}, {"duid": "PU:fpW9", "entityType": "Gene", "charEnd": 783, "source": "PUBTATOR", "charStart": 779, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:LNuz", "entityType": "Species", "charEnd": 1096, "source": "PUBTATOR", "charStart": 1089, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:dFjX", "entityType": "Gene", "charEnd": 1129, "source": "PUBTATOR", "charStart": 1128, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:B54E", "entityType": "Disease", "charEnd": 597, "source": "PUBTATOR", "charStart": 584, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:36du", "entityType": "Chemical", "charEnd": 690, "source": "PUBTATOR", "charStart": 679, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 2, "entityText": "capecitabine"}, {"duid": "PU:KjeM", "entityType": "Gene", "charEnd": 317, "source": "PUBTATOR", "charStart": 298, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:g83M", "entityType": "Gene", "charEnd": 1137, "source": "PUBTATOR", "charStart": 1136, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:h9Ds", "entityType": "Disease", "charEnd": 555, "source": "PUBTATOR", "charStart": 551, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:ZXDC", "entityType": "Species", "charEnd": 1457, "source": "PUBTATOR", "charStart": 1450, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:sRez", "entityType": "Species", "charEnd": 1296, "source": "PUBTATOR", "charStart": 1289, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:2LF8", "entityType": "Gene", "charEnd": 768, "source": "PUBTATOR", "charStart": 767, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:csRY", "entityType": "Species", "charEnd": 984, "source": "PUBTATOR", "charStart": 977, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:NAvj", "entityType": "Chemical", "charEnd": 232, "source": "PUBTATOR", "charStart": 224, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Cisplatin"}, {"duid": "PU:wDDG", "entityType": "Chemical", "charEnd": 1868, "source": "PUBTATOR", "charStart": 1859, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 8, "entityText": "paclitaxel"}, {"duid": "PU:SNcA", "entityType": "Species", "charEnd": 1824, "source": "PUBTATOR", "charStart": 1817, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:7YtP", "entityType": "Gene", "charEnd": 1663, "source": "PUBTATOR", "charStart": 1659, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:px3W", "entityType": "Chemical", "charEnd": 333, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}, {"duid": "PU:2LwP", "entityType": "Disease", "charEnd": 1815, "source": "PUBTATOR", "charStart": 1802, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gastric cancer"}, {"duid": "PU:XDLb", "entityType": "Chemical", "charEnd": 504, "source": "PUBTATOR", "charStart": 495, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 1, "entityText": "paclitaxel"}, {"duid": "PU:t6JW", "entityType": "Chemical", "charEnd": 640, "source": "PUBTATOR", "charStart": 629, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 2, "entityText": "capecitabine"}, {"duid": "PU:iDyF", "entityType": "Chemical", "charEnd": 25, "source": "PUBTATOR", "charStart": 15, "entityId": [{"idString": "17013", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "Thymidylate"}, {"duid": "PU:eY7P", "entityType": "Chemical", "charEnd": 488, "source": "PUBTATOR", "charStart": 477, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 1, "entityText": "capecitabine"}, {"duid": "PU:JTHx", "entityType": "Disease", "charEnd": 171, "source": "PUBTATOR", "charStart": 158, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Gastric Cancer"}, {"duid": "PU:nFb5", "entityType": "Species", "charEnd": 1537, "source": "PUBTATOR", "charStart": 1530, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:DHC8", "entityType": "Disease", "charEnd": 456, "source": "PUBTATOR", "charStart": 443, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gastric cancer"}, {"duid": "PU:WKQW", "entityType": "Gene", "charEnd": 408, "source": "PUBTATOR", "charStart": 404, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:TQC5", "entityType": "Gene", "charEnd": 1648, "source": "PUBTATOR", "charStart": 1644, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:ApVT", "entityType": "Species", "charEnd": 180, "source": "PUBTATOR", "charStart": 173, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "Patients"}, {"duid": "PU:Xd3H", "entityType": "Chemical", "charEnd": 203, "source": "PUBTATOR", "charStart": 192, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Capecitabine"}, {"duid": "PU:wU7g", "entityType": "Gene", "charEnd": 58, "source": "PUBTATOR", "charStart": 36, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Thymidine Phosphorylase"}, {"duid": "PU:y7WW", "entityType": "Species", "charEnd": 606, "source": "PUBTATOR", "charStart": 599, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:k7eY", "entityType": "Chemical", "charEnd": 219, "source": "PUBTATOR", "charStart": 210, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Paclitaxel"}, {"duid": "PU:tnvo", "entityType": "Gene", "charEnd": 764, "source": "PUBTATOR", "charStart": 760, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TUBB3"}, {"duid": "PU:brV4", "entityType": "Chemical", "charEnd": 705, "source": "PUBTATOR", "charStart": 697, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cisplatin"}, {"duid": "PU:5D64", "entityType": "Species", "charEnd": 1633, "source": "PUBTATOR", "charStart": 1626, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:GHDw", "entityType": "Species", "charEnd": 465, "source": "PUBTATOR", "charStart": 458, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:3rem", "entityType": "Gene", "charEnd": 347, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidine phosphorylase"}, {"duid": "PU:mgvX", "entityType": "Species", "charEnd": 1064, "source": "PUBTATOR", "charStart": 1057, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:R6uP", "entityType": "Gene", "charEnd": 1742, "source": "PUBTATOR", "charStart": 1741, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:LFKi", "entityType": "Gene", "charEnd": 294, "source": "PUBTATOR", "charStart": 290, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TUBB3"}, {"duid": "PU:y8ZF", "entityType": "Gene", "charEnd": 1738, "source": "PUBTATOR", "charStart": 1734, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TUBB3"}, {"duid": "PU:w6ED", "entityType": "Chemical", "charEnd": 517, "source": "PUBTATOR", "charStart": 509, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:UwBC", "entityType": "Gene", "charEnd": 1320, "source": "PUBTATOR", "charStart": 1316, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:cCSB", "entityType": "Chemical", "charEnd": 1847, "source": "PUBTATOR", "charStart": 1836, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 8, "entityText": "capecitabine"}, {"duid": "PU:YawT", "entityType": "Gene", "charEnd": 34, "source": "PUBTATOR", "charStart": 15, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Thymidylate Synthase"}, {"duid": "PU:5TtE", "entityType": "Gene", "charEnd": 321, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TS"}]}
{"text": "Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer. AIMS AND BACKGROUND: The aims of this study were to investigate the correlation between topoisomerase II alpha (TOP2A), microtubule-associated protein-tau (MAP-tau) and other prognostic factors in breast cancer and to evaluate the predictive value of TOP2A and MAP-tau in breast cancer patients who received anthracycline and taxane-containing adjuvant chemotherapy. METHODS AND STUDY DESIGN: Seventy patients with axillary lymph node positive breast cancer who underwent curative surgery between January 2000 and December 2005 were evaluated retrospectively. The levels of protein expression of TOP2A and MAP-tau were assessed using immunohistochemistry. RESULTS: Among the 70 patients, 43 (61.4%) showed TOP2A overexpression and 30 (42.9%) showed MAP-tau positivity. TOP2A overexpression was associated with p53 positivity and high histological grade. MAP-tau positivity was associated with a lower positive lymph node ratio, lower proliferative activity, and hormone receptor positivity. Based on the TOP2A and MAP-tau expression, there was no significant difference in disease-free survival in the breast cancer patients who received anthracycline and taxane-containing adjuvant chemotherapy. CONCLUSIONS: We conclude that immunohistochemical analysis of TOP2A and MAP-tau protein expression may not predict the benefits of adjuvant anthracycline and taxane chemotherapy in axillary node positive breast cancer.", "title": {"charStart": 0, "charEnd": 130}, "docId": "24675496", "entity": [{"duid": "PU:rTLy", "entityType": "Gene", "charEnd": 1407, "source": "PUBTATOR", "charStart": 1401, "entityId": [{"idString": "4137", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MAP-tau"}, {"duid": "PU:9Kqk", "entityType": "Gene", "charEnd": 1395, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TOP2A"}, {"duid": "PU:MtPa", "entityType": "Species", "charEnd": 1255, "source": "PUBTATOR", "charStart": 1248, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:yy8i", "entityType": "Disease", "charEnd": 416, "source": "PUBTATOR", "charStart": 404, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast cancer"}, {"duid": "PU:Y9iW", "entityType": "Gene", "charEnd": 248, "source": "PUBTATOR", "charStart": 244, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TOP2A"}, {"duid": "PU:AW2S", "entityType": "Gene", "charEnd": 905, "source": "PUBTATOR", "charStart": 901, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TOP2A"}, {"duid": "PU:oxoo", "entityType": "Gene", "charEnd": 60, "source": "PUBTATOR", "charStart": 27, "entityId": [{"idString": "4137", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "microtubule-associated protein-tau"}, {"duid": "PU:LEBV", "entityType": "Disease", "charEnd": 129, "source": "PUBTATOR", "charStart": 117, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast cancer"}, {"duid": "PU:kpKS", "entityType": "Gene", "charEnd": 387, "source": "PUBTATOR", "charStart": 383, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TOP2A"}, {"duid": "PU:fSpr", "entityType": "Species", "charEnd": 540, "source": "PUBTATOR", "charStart": 533, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:HcBU", "entityType": "Gene", "charEnd": 992, "source": "PUBTATOR", "charStart": 986, "entityId": [{"idString": "4137", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "MAP-tau"}, {"duid": "PU:miPD", "entityType": "Chemical", "charEnd": 1481, "source": "PUBTATOR", "charStart": 1469, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 8, "entityText": "anthracycline"}, {"duid": "PU:qpLd", "entityType": "Gene", "charEnd": 399, "source": "PUBTATOR", "charStart": 393, "entityId": [{"idString": "4137", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "MAP-tau"}, {"duid": "PU:zQUF", "entityType": "Disease", "charEnd": 341, "source": "PUBTATOR", "charStart": 329, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast cancer"}, {"duid": "PU:33Sj", "entityType": "Chemical", "charEnd": 452, "source": "PUBTATOR", "charStart": 440, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "anthracycline"}, {"duid": "PU:RJqx", "entityType": "Disease", "charEnd": 1246, "source": "PUBTATOR", "charStart": 1234, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 7, "entityText": "breast cancer"}, {"duid": "PU:GbCS", "entityType": "Chemical", "charEnd": 1293, "source": "PUBTATOR", "charStart": 1288, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 7, "entityText": "taxane"}, {"duid": "PU:m3jm", "entityType": "Gene", "charEnd": 285, "source": "PUBTATOR", "charStart": 252, "entityId": [{"idString": "4137", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "microtubule-associated protein-tau"}, {"duid": "PU:mAXz", "entityType": "Gene", "charEnd": 1152, "source": "PUBTATOR", "charStart": 1146, "entityId": [{"idString": "4137", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MAP-tau"}, {"duid": "PU:3Wxt", "entityType": "Disease", "charEnd": 588, "source": "PUBTATOR", "charStart": 576, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 2, "entityText": "breast cancer"}, {"duid": "PU:Y2vq", "entityType": "Species", "charEnd": 817, "source": "PUBTATOR", "charStart": 810, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:5E8E", "entityType": "Gene", "charEnd": 1140, "source": "PUBTATOR", "charStart": 1136, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TOP2A"}, {"duid": "PU:JVBT", "entityType": "Chemical", "charEnd": 1492, "source": "PUBTATOR", "charStart": 1487, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 8, "entityText": "taxane"}, {"duid": "PU:Rrvf", "entityType": "Species", "charEnd": 425, "source": "PUBTATOR", "charStart": 418, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:RGz5", "entityType": "Gene", "charEnd": 294, "source": "PUBTATOR", "charStart": 288, "entityId": [{"idString": "4137", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "MAP-tau"}, {"duid": "PU:RVGz", "entityType": "Gene", "charEnd": 744, "source": "PUBTATOR", "charStart": 738, "entityId": [{"idString": "4137", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MAP-tau"}, {"duid": "PU:LWKo", "entityType": "Gene", "charEnd": 732, "source": "PUBTATOR", "charStart": 728, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "TOP2A"}, {"duid": "PU:Ybnq", "entityType": "Chemical", "charEnd": 1282, "source": "PUBTATOR", "charStart": 1270, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 7, "entityText": "anthracycline"}, {"duid": "PU:CxRK", "entityType": "Gene", "charEnd": 887, "source": "PUBTATOR", "charStart": 881, "entityId": [{"idString": "4137", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MAP-tau"}, {"duid": "PU:cGZW", "entityType": "Gene", "charEnd": 944, "source": "PUBTATOR", "charStart": 942, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p53"}, {"duid": "PU:QxhG", "entityType": "Chemical", "charEnd": 463, "source": "PUBTATOR", "charStart": 458, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 1, "entityText": "taxane"}, {"duid": "PU:dUUw", "entityType": "Gene", "charEnd": 842, "source": "PUBTATOR", "charStart": 838, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TOP2A"}, {"duid": "PU:ReqH", "entityType": "Disease", "charEnd": 1545, "source": "PUBTATOR", "charStart": 1533, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 8, "entityText": "breast cancer"}]}
{"text": "MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. PURPOSE: The role of adjuvant chemotherapy in patients with locally advanced bladder cancer still remains to be defined. We hypothesized that assessing the gene expression of the chemotherapy response modifiers multidrug resistance gene 1 (MDR1) and excision repair cross-complementing 1 (ERCC1) may help identify the group of patients benefiting from cisplatin-based adjuvant chemotherapy. EXPERIMENTAL DESIGN: Formalin-fixed paraffin-embedded tumor samples from 108 patients with locally advanced bladder cancer, who had been enrolled in AUO-AB05/95, a phase 3 trial randomizing a maximum of three courses of adjuvant cisplatin and methotrexate (CM) versus methotrexate, vinblastine, epirubicin, and cisplatin (M-VEC), were included in the study. Tumor cells were retrieved by laser-captured microdissection and analyzed for MDR1 and ERCC1 expression using a quantitative real-time reverse transcription-polymerase chain reaction assay. Gene expression levels were correlated with clinical outcomes by multivariate Cox proportional hazards regression analysis. RESULTS: Expressions of MDR1 and ERCC1 were independently associated with overall progression-free survival (P = .001, relative risk = 2.9 and P = .01, relative risk = 2.24, respectively). The correlation of high MDR1 expression with inferior outcome was stronger in patients receiving M-VEC, whereas ERCC1 analysis performed equally in the CM and M-VEC groups. CONCLUSIONS: High MDR1 and ERCC1 gene expressions are associated with inferior outcome after cisplatin-based adjuvant chemotherapy for locally advanced bladder cancer. Prospective studies are warranted to define a role for MDR1 and ERCC1 analysis in individualizing multimodality treatment in locally advanced bladder cancer.", "title": {"charStart": 0, "charEnd": 122}, "docId": "20689757", "entity": [{"duid": "PU:Kciz", "entityType": "Gene", "charEnd": 964, "source": "PUBTATOR", "charStart": 960, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:fe58", "entityType": "Gene", "charEnd": 1214, "source": "PUBTATOR", "charStart": 1211, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "MDR1"}, {"duid": "PU:yPMo", "entityType": "Disease", "charEnd": 214, "source": "PUBTATOR", "charStart": 201, "entityId": [{"idString": "D001749", "source": "MESH"}], "sentenceIndex": 1, "entityText": "bladder cancer"}, {"duid": "PU:7LJk", "entityType": "Chemical", "charEnd": 1650, "source": "PUBTATOR", "charStart": 1642, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 8, "entityText": "cisplatin"}, {"duid": "PU:n3jW", "entityType": "Disease", "charEnd": 1872, "source": "PUBTATOR", "charStart": 1859, "entityId": [{"idString": "D001749", "source": "MESH"}], "sentenceIndex": 9, "entityText": "bladder cancer"}, {"duid": "PU:e7Hw", "entityType": "Chemical", "charEnd": 819, "source": "PUBTATOR", "charStart": 810, "entityId": [{"idString": "D015251", "source": "MESH"}], "sentenceIndex": 3, "entityText": "epirubicin"}, {"duid": "PU:umct", "entityType": "Disease", "charEnd": 1714, "source": "PUBTATOR", "charStart": 1701, "entityId": [{"idString": "D001749", "source": "MESH"}], "sentenceIndex": 8, "entityText": "bladder cancer"}, {"duid": "PU:iw8V", "entityType": "Gene", "charEnd": 417, "source": "PUBTATOR", "charStart": 413, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:jdHj", "entityType": "Gene", "charEnd": 1403, "source": "PUBTATOR", "charStart": 1400, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MDR1"}, {"duid": "PU:iaHC", "entityType": "Gene", "charEnd": 13, "source": "PUBTATOR", "charStart": 9, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:kYwg", "entityType": "Gene", "charEnd": 1570, "source": "PUBTATOR", "charStart": 1567, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MDR1"}, {"duid": "PU:Pf25", "entityType": "Chemical", "charEnd": 769, "source": "PUBTATOR", "charStart": 758, "entityId": [{"idString": "D008727", "source": "MESH"}], "sentenceIndex": 3, "entityText": "methotrexate"}, {"duid": "PU:v35N", "entityType": "Gene", "charEnd": 954, "source": "PUBTATOR", "charStart": 951, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MDR1"}, {"duid": "PU:cVgU", "entityType": "Chemical", "charEnd": 752, "source": "PUBTATOR", "charStart": 744, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cisplatin"}, {"duid": "PU:xmZb", "entityType": "Gene", "charEnd": 1785, "source": "PUBTATOR", "charStart": 1781, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:Q53W", "entityType": "Chemical", "charEnd": 807, "source": "PUBTATOR", "charStart": 797, "entityId": [{"idString": "D014747", "source": "MESH"}], "sentenceIndex": 3, "entityText": "vinblastine"}, {"duid": "PU:cTrj", "entityType": "Species", "charEnd": 52, "source": "PUBTATOR", "charStart": 45, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:994d", "entityType": "Species", "charEnd": 177, "source": "PUBTATOR", "charStart": 170, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:YgPw", "entityType": "Species", "charEnd": 458, "source": "PUBTATOR", "charStart": 451, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:DSvu", "entityType": "Gene", "charEnd": 1580, "source": "PUBTATOR", "charStart": 1576, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:8ygm", "entityType": "Chemical", "charEnd": 484, "source": "PUBTATOR", "charStart": 476, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cisplatin"}, {"duid": "PU:xgq6", "entityType": "Species", "charEnd": 599, "source": "PUBTATOR", "charStart": 592, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:odT2", "entityType": "Disease", "charEnd": 89, "source": "PUBTATOR", "charStart": 76, "entityId": [{"idString": "D001749", "source": "MESH"}], "sentenceIndex": 0, "entityText": "bladder cancer"}, {"duid": "PU:kCnp", "entityType": "Chemical", "charEnd": 543, "source": "PUBTATOR", "charStart": 536, "entityId": [{"idString": "D005557", "source": "MESH"}], "sentenceIndex": 3, "entityText": "Formalin"}, {"duid": "PU:c4sq", "entityType": "Gene", "charEnd": 410, "source": "PUBTATOR", "charStart": 374, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "excision repair cross-complementing 1"}, {"duid": "PU:SBBb", "entityType": "Disease", "charEnd": 573, "source": "PUBTATOR", "charStart": 569, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:f5Ak", "entityType": "Gene", "charEnd": 3, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "MDR1"}, {"duid": "PU:gpvB", "entityType": "Species", "charEnd": 1461, "source": "PUBTATOR", "charStart": 1454, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:iMWH", "entityType": "Gene", "charEnd": 1224, "source": "PUBTATOR", "charStart": 1220, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:vvv2", "entityType": "Gene", "charEnd": 1775, "source": "PUBTATOR", "charStart": 1772, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "MDR1"}, {"duid": "PU:66ux", "entityType": "Gene", "charEnd": 1492, "source": "PUBTATOR", "charStart": 1488, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:YYdF", "entityType": "Chemical", "charEnd": 794, "source": "PUBTATOR", "charStart": 783, "entityId": [{"idString": "D008727", "source": "MESH"}], "sentenceIndex": 3, "entityText": "methotrexate"}, {"duid": "PU:Mz3R", "entityType": "Disease", "charEnd": 636, "source": "PUBTATOR", "charStart": 623, "entityId": [{"idString": "D001749", "source": "MESH"}], "sentenceIndex": 3, "entityText": "bladder cancer"}, {"duid": "PU:QXav", "entityType": "Chemical", "charEnd": 834, "source": "PUBTATOR", "charStart": 826, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cisplatin"}, {"duid": "PU:nwya", "entityType": "Gene", "charEnd": 367, "source": "PUBTATOR", "charStart": 364, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "MDR1"}, {"duid": "PU:8EJU", "entityType": "Disease", "charEnd": 877, "source": "PUBTATOR", "charStart": 873, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "Tumor"}]}
{"text": "MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. PURPOSE: The role of adjuvant chemotherapy in patients with locally advanced bladder cancer still remains to be defined. We hypothesized that assessing the gene expression of the chemotherapy response modifiers multidrug resistance gene 1 (MDR1) and excision repair cross-complementing 1 (ERCC1) may help identify the group of patients benefiting from cisplatin-based adjuvant chemotherapy. EXPERIMENTAL DESIGN: Formalin-fixed paraffin-embedded tumor samples from 108 patients with locally advanced bladder cancer, who had been enrolled in AUO-AB05/95, a phase 3 trial randomizing a maximum of three courses of adjuvant cisplatin and methotrexate (CM) versus methotrexate, vinblastine, epirubicin, and cisplatin (M-VEC), were included in the study. Tumor cells were retrieved by laser-captured microdissection and analyzed for MDR1 and ERCC1 expression using a quantitative real-time reverse transcription-polymerase chain reaction assay. Gene expression levels were correlated with clinical outcomes by multivariate Cox proportional hazards regression analysis. RESULTS: Expressions of MDR1 and ERCC1 were independently associated with overall progression-free survival (P = .001, relative risk = 2.9 and P = .01, relative risk = 2.24, respectively). The correlation of high MDR1 expression with inferior outcome was stronger in patients receiving M-VEC, whereas ERCC1 analysis performed equally in the CM and M-VEC groups. CONCLUSIONS: High MDR1 and ERCC1 gene expressions are associated with inferior outcome after cisplatin-based adjuvant chemotherapy for locally advanced bladder cancer. Prospective studies are warranted to define a role for MDR1 and ERCC1 analysis in individualizing multimodality treatment in locally advanced bladder cancer.", "title": {"charStart": 0, "charEnd": 122}, "docId": "20689757", "entity": [{"duid": "PU:Kciz", "entityType": "Gene", "charEnd": 964, "source": "PUBTATOR", "charStart": 960, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:fe58", "entityType": "Gene", "charEnd": 1214, "source": "PUBTATOR", "charStart": 1211, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "MDR1"}, {"duid": "PU:yPMo", "entityType": "Disease", "charEnd": 214, "source": "PUBTATOR", "charStart": 201, "entityId": [{"idString": "D001749", "source": "MESH"}], "sentenceIndex": 1, "entityText": "bladder cancer"}, {"duid": "PU:7LJk", "entityType": "Chemical", "charEnd": 1650, "source": "PUBTATOR", "charStart": 1642, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 8, "entityText": "cisplatin"}, {"duid": "PU:n3jW", "entityType": "Disease", "charEnd": 1872, "source": "PUBTATOR", "charStart": 1859, "entityId": [{"idString": "D001749", "source": "MESH"}], "sentenceIndex": 9, "entityText": "bladder cancer"}, {"duid": "PU:e7Hw", "entityType": "Chemical", "charEnd": 819, "source": "PUBTATOR", "charStart": 810, "entityId": [{"idString": "D015251", "source": "MESH"}], "sentenceIndex": 3, "entityText": "epirubicin"}, {"duid": "PU:umct", "entityType": "Disease", "charEnd": 1714, "source": "PUBTATOR", "charStart": 1701, "entityId": [{"idString": "D001749", "source": "MESH"}], "sentenceIndex": 8, "entityText": "bladder cancer"}, {"duid": "PU:iw8V", "entityType": "Gene", "charEnd": 417, "source": "PUBTATOR", "charStart": 413, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:jdHj", "entityType": "Gene", "charEnd": 1403, "source": "PUBTATOR", "charStart": 1400, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MDR1"}, {"duid": "PU:iaHC", "entityType": "Gene", "charEnd": 13, "source": "PUBTATOR", "charStart": 9, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:kYwg", "entityType": "Gene", "charEnd": 1570, "source": "PUBTATOR", "charStart": 1567, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MDR1"}, {"duid": "PU:Pf25", "entityType": "Chemical", "charEnd": 769, "source": "PUBTATOR", "charStart": 758, "entityId": [{"idString": "D008727", "source": "MESH"}], "sentenceIndex": 3, "entityText": "methotrexate"}, {"duid": "PU:v35N", "entityType": "Gene", "charEnd": 954, "source": "PUBTATOR", "charStart": 951, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MDR1"}, {"duid": "PU:cVgU", "entityType": "Chemical", "charEnd": 752, "source": "PUBTATOR", "charStart": 744, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cisplatin"}, {"duid": "PU:xmZb", "entityType": "Gene", "charEnd": 1785, "source": "PUBTATOR", "charStart": 1781, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:Q53W", "entityType": "Chemical", "charEnd": 807, "source": "PUBTATOR", "charStart": 797, "entityId": [{"idString": "D014747", "source": "MESH"}], "sentenceIndex": 3, "entityText": "vinblastine"}, {"duid": "PU:cTrj", "entityType": "Species", "charEnd": 52, "source": "PUBTATOR", "charStart": 45, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:994d", "entityType": "Species", "charEnd": 177, "source": "PUBTATOR", "charStart": 170, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:YgPw", "entityType": "Species", "charEnd": 458, "source": "PUBTATOR", "charStart": 451, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:DSvu", "entityType": "Gene", "charEnd": 1580, "source": "PUBTATOR", "charStart": 1576, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:8ygm", "entityType": "Chemical", "charEnd": 484, "source": "PUBTATOR", "charStart": 476, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cisplatin"}, {"duid": "PU:xgq6", "entityType": "Species", "charEnd": 599, "source": "PUBTATOR", "charStart": 592, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:odT2", "entityType": "Disease", "charEnd": 89, "source": "PUBTATOR", "charStart": 76, "entityId": [{"idString": "D001749", "source": "MESH"}], "sentenceIndex": 0, "entityText": "bladder cancer"}, {"duid": "PU:kCnp", "entityType": "Chemical", "charEnd": 543, "source": "PUBTATOR", "charStart": 536, "entityId": [{"idString": "D005557", "source": "MESH"}], "sentenceIndex": 3, "entityText": "Formalin"}, {"duid": "PU:c4sq", "entityType": "Gene", "charEnd": 410, "source": "PUBTATOR", "charStart": 374, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "excision repair cross-complementing 1"}, {"duid": "PU:SBBb", "entityType": "Disease", "charEnd": 573, "source": "PUBTATOR", "charStart": 569, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:f5Ak", "entityType": "Gene", "charEnd": 3, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "MDR1"}, {"duid": "PU:gpvB", "entityType": "Species", "charEnd": 1461, "source": "PUBTATOR", "charStart": 1454, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:iMWH", "entityType": "Gene", "charEnd": 1224, "source": "PUBTATOR", "charStart": 1220, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:vvv2", "entityType": "Gene", "charEnd": 1775, "source": "PUBTATOR", "charStart": 1772, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "MDR1"}, {"duid": "PU:66ux", "entityType": "Gene", "charEnd": 1492, "source": "PUBTATOR", "charStart": 1488, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:YYdF", "entityType": "Chemical", "charEnd": 794, "source": "PUBTATOR", "charStart": 783, "entityId": [{"idString": "D008727", "source": "MESH"}], "sentenceIndex": 3, "entityText": "methotrexate"}, {"duid": "PU:Mz3R", "entityType": "Disease", "charEnd": 636, "source": "PUBTATOR", "charStart": 623, "entityId": [{"idString": "D001749", "source": "MESH"}], "sentenceIndex": 3, "entityText": "bladder cancer"}, {"duid": "PU:QXav", "entityType": "Chemical", "charEnd": 834, "source": "PUBTATOR", "charStart": 826, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cisplatin"}, {"duid": "PU:nwya", "entityType": "Gene", "charEnd": 367, "source": "PUBTATOR", "charStart": 364, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "MDR1"}, {"duid": "PU:8EJU", "entityType": "Disease", "charEnd": 877, "source": "PUBTATOR", "charStart": 873, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "Tumor"}]}
{"text": "Genomic and molecular profiling predicts response to temozolomide in melanoma. PURPOSE: Despite objective response rates of only approximately 13%, temozolomide remains one of the most effective single chemotherapy agents against metastatic melanoma, second only to dacarbazine, the current standard of care for systemic treatment of melanoma. The goal of this study was to identify molecular and/or genetic markers that correlate with, and could be used to predict, response to temozolomide-based treatment regimens and that reflect the intrinsic properties of a patient's tumor. EXPERIMENTAL DESIGN: Using a panel of 26 human melanoma-derived cell lines, we determined in vitro temozolomide sensitivity, O(6)-methylguanine-DNA methyltransferase (MGMT) activity, MGMT protein expression and promoter methylation status, and mismatch repair proficiency, as well as the expression profile of 38,000 genes using an oligonucleotide-based microarray platform. RESULTS: The results showed a broad spectrum of temozolomide sensitivity across the panel of cell lines, with IC(50) values ranging from 100 micromol/L to 1 mmol/L. There was a significant correlation between measured temozolomide sensitivity and a gene expression signature-derived prediction of temozolomide sensitivity (P < 0.005). Notably, MGMT alone showed a significant correlation with temozolomide sensitivity (MGMT activity, P < 0.0001; MGMT expression, P <or= 0.0001). The promoter methylation status of the MGMT gene, however, was not consistent with MGMT gene expression or temozolomide sensitivity. CONCLUSIONS: These results show that melanoma resistance to temozolomide is conferred predominantly by MGMT activity and suggest that MGMT expression could potentially be a useful tool for predicting the response of melanoma patients to temozolomide therapy.", "title": {"charStart": 0, "charEnd": 77}, "docId": "19147755", "entity": [{"duid": "PU:sP48", "entityType": "Disease", "charEnd": 578, "source": "PUBTATOR", "charStart": 574, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:BViQ", "entityType": "Chemical", "charEnd": 159, "source": "PUBTATOR", "charStart": 148, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "temozolomide"}, {"duid": "PU:RAjf", "entityType": "Gene", "charEnd": 751, "source": "PUBTATOR", "charStart": 748, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MGMT"}, {"duid": "PU:5R2U", "entityType": "Species", "charEnd": 570, "source": "PUBTATOR", "charStart": 564, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patient"}, {"duid": "PU:Ebqi", "entityType": "Gene", "charEnd": 1405, "source": "PUBTATOR", "charStart": 1402, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "MGMT"}, {"duid": "PU:ymob", "entityType": "Chemical", "charEnd": 723, "source": "PUBTATOR", "charStart": 706, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 3, "entityText": "O(6)-methylguanine"}, {"duid": "PU:Mvk2", "entityType": "Gene", "charEnd": 1705, "source": "PUBTATOR", "charStart": 1702, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MGMT"}, {"duid": "PU:8caY", "entityType": "Gene", "charEnd": 1477, "source": "PUBTATOR", "charStart": 1474, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MGMT"}, {"duid": "PU:cZha", "entityType": "Chemical", "charEnd": 1639, "source": "PUBTATOR", "charStart": 1628, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 8, "entityText": "temozolomide"}, {"duid": "PU:tcmv", "entityType": "Gene", "charEnd": 745, "source": "PUBTATOR", "charStart": 706, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "O(6)-methylguanine-DNA methyltransferase"}, {"duid": "PU:ZTvq", "entityType": "Species", "charEnd": 1800, "source": "PUBTATOR", "charStart": 1793, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:PyXa", "entityType": "Disease", "charEnd": 635, "source": "PUBTATOR", "charStart": 628, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 3, "entityText": "melanoma"}, {"duid": "PU:y7ta", "entityType": "Gene", "charEnd": 1674, "source": "PUBTATOR", "charStart": 1671, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MGMT"}, {"duid": "PU:PJLh", "entityType": "Chemical", "charEnd": 1185, "source": "PUBTATOR", "charStart": 1174, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 5, "entityText": "temozolomide"}, {"duid": "PU:WRX7", "entityType": "Chemical", "charEnd": 691, "source": "PUBTATOR", "charStart": 680, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 3, "entityText": "temozolomide"}, {"duid": "PU:fw7M", "entityType": "Chemical", "charEnd": 64, "source": "PUBTATOR", "charStart": 53, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "temozolomide"}, {"duid": "PU:Me9M", "entityType": "Disease", "charEnd": 76, "source": "PUBTATOR", "charStart": 69, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 0, "entityText": "melanoma"}, {"duid": "PU:WcPJ", "entityType": "Chemical", "charEnd": 1816, "source": "PUBTATOR", "charStart": 1805, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 8, "entityText": "temozolomide"}, {"duid": "PU:p7TZ", "entityType": "Chemical", "charEnd": 1360, "source": "PUBTATOR", "charStart": 1349, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 6, "entityText": "temozolomide"}, {"duid": "PU:uwig", "entityType": "Species", "charEnd": 626, "source": "PUBTATOR", "charStart": 622, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "human"}, {"duid": "PU:KbX8", "entityType": "Disease", "charEnd": 1791, "source": "PUBTATOR", "charStart": 1784, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 8, "entityText": "melanoma"}, {"duid": "PU:3UgG", "entityType": "Gene", "charEnd": 1378, "source": "PUBTATOR", "charStart": 1375, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "MGMT"}, {"duid": "PU:jGNU", "entityType": "Gene", "charEnd": 767, "source": "PUBTATOR", "charStart": 764, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MGMT"}, {"duid": "PU:gX6v", "entityType": "Disease", "charEnd": 341, "source": "PUBTATOR", "charStart": 334, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 1, "entityText": "melanoma"}, {"duid": "PU:ptXZ", "entityType": "Chemical", "charEnd": 1015, "source": "PUBTATOR", "charStart": 1004, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 4, "entityText": "temozolomide"}, {"duid": "PU:yddp", "entityType": "Gene", "charEnd": 1521, "source": "PUBTATOR", "charStart": 1518, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MGMT"}, {"duid": "PU:e9ZP", "entityType": "Chemical", "charEnd": 1553, "source": "PUBTATOR", "charStart": 1542, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 7, "entityText": "temozolomide"}, {"duid": "PU:mi5B", "entityType": "Chemical", "charEnd": 490, "source": "PUBTATOR", "charStart": 479, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 2, "entityText": "temozolomide"}, {"duid": "PU:588i", "entityType": "Disease", "charEnd": 248, "source": "PUBTATOR", "charStart": 230, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 1, "entityText": "metastatic melanoma"}, {"duid": "PU:5PmA", "entityType": "Gene", "charEnd": 1303, "source": "PUBTATOR", "charStart": 1300, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "MGMT"}, {"duid": "PU:EZq5", "entityType": "Disease", "charEnd": 1612, "source": "PUBTATOR", "charStart": 1605, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 8, "entityText": "melanoma"}, {"duid": "PU:jRCw", "entityType": "Chemical", "charEnd": 276, "source": "PUBTATOR", "charStart": 266, "entityId": [{"idString": "D003606", "source": "MESH"}], "sentenceIndex": 1, "entityText": "dacarbazine"}, {"duid": "PU:XES3", "entityType": "Chemical", "charEnd": 1264, "source": "PUBTATOR", "charStart": 1253, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 5, "entityText": "temozolomide"}]}
{"text": "Loss of class III beta-tubulin induced by histone deacetylation is associated with chemosensitivity to paclitaxel in malignant melanoma cells. Overexpression of class III beta-tubulin (TUBB3) is an important mechanism of taxane resistance. Using 7 melanoma cell lines, 2 normal neonatal human epidermal melanocyte (NHEM) cultures, and 49 primary melanomas, we investigated TUBB3 expression, its relationship to chemosensitivity to taxane derivatives, and the epigenetic mechanism controlling TUBB3 gene expression. Normal melanocytes in vitro and in vivo strongly expressed TUBB3 protein. NHEMs exhibited marked chemoresistance to paclitaxel-induced apoptosis. A subset (10 of 49, 20%) of primary malignant melanomas was TUBB3 negative. The incidence of TUBB3-negative melanomas increased with stage of progression. TUBB3 protein expression varied among cell lines; one (HMV-I) of the seven cell lines exhibited an extremely low endogenous level. TUBB3 protein expression correlated well with chemosensitivity to paclitaxel-induced apoptosis (P<0.05). Treatment with a histone deacetylase (HDAC) inhibitor restored TUBB3 expression in HMV-I. Chromatin immunoprecipitation assays revealed that histones H3 and H4 were hypoacetylated at the TUBB3 gene in HMV-I as compared with a TUBB3-overexpressing cell type (HMV-II). Treatment with the HDAC inhibitor induced gain of histone acetylation only in HMV-I. These results suggest that loss of TUBB3 protein may be induced by histone deacetylation in a subset of malignant melanomas, and may be associated with chemosensitivity to taxane.", "title": {"charStart": 0, "charEnd": 141}, "docId": "19122647", "entity": [{"duid": "PU:ypAp", "entityType": "Gene", "charEnd": 496, "source": "PUBTATOR", "charStart": 492, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TUBB3"}, {"duid": "PU:nyXS", "entityType": "Gene", "charEnd": 820, "source": "PUBTATOR", "charStart": 816, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TUBB3"}, {"duid": "PU:Ne4B", "entityType": "Disease", "charEnd": 134, "source": "PUBTATOR", "charStart": 117, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 0, "entityText": "malignant melanoma"}, {"duid": "PU:4Tec", "entityType": "Gene", "charEnd": 725, "source": "PUBTATOR", "charStart": 721, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TUBB3"}, {"duid": "PU:ASNV", "entityType": "Gene", "charEnd": 1282, "source": "PUBTATOR", "charStart": 1278, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "TUBB3"}, {"duid": "PU:7jt3", "entityType": "Gene", "charEnd": 758, "source": "PUBTATOR", "charStart": 754, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:tpUc", "entityType": "Gene", "charEnd": 29, "source": "PUBTATOR", "charStart": 8, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "class III beta-tubulin"}, {"duid": "PU:MKxU", "entityType": "Species", "charEnd": 291, "source": "PUBTATOR", "charStart": 287, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "human"}, {"duid": "PU:AhD2", "entityType": "Chemical", "charEnd": 436, "source": "PUBTATOR", "charStart": 431, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 2, "entityText": "taxane"}, {"duid": "PU:5rJJ", "entityType": "Gene", "charEnd": 1443, "source": "PUBTATOR", "charStart": 1439, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "TUBB3"}, {"duid": "PU:No9R", "entityType": "Disease", "charEnd": 255, "source": "PUBTATOR", "charStart": 248, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 2, "entityText": "melanoma"}, {"duid": "PU:GUur", "entityType": "Chemical", "charEnd": 1022, "source": "PUBTATOR", "charStart": 1013, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 8, "entityText": "paclitaxel"}, {"duid": "PU:vhvr", "entityType": "Gene", "charEnd": 578, "source": "PUBTATOR", "charStart": 574, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "TUBB3"}, {"duid": "PU:yJ3J", "entityType": "Gene", "charEnd": 377, "source": "PUBTATOR", "charStart": 373, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TUBB3"}, {"duid": "PU:T3Up", "entityType": "Chemical", "charEnd": 640, "source": "PUBTATOR", "charStart": 631, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 4, "entityText": "paclitaxel"}, {"duid": "PU:gRgu", "entityType": "Disease", "charEnd": 354, "source": "PUBTATOR", "charStart": 346, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 2, "entityText": "melanomas"}, {"duid": "PU:s62E", "entityType": "Disease", "charEnd": 715, "source": "PUBTATOR", "charStart": 697, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 5, "entityText": "malignant melanomas"}, {"duid": "PU:62HN", "entityType": "Gene", "charEnd": 182, "source": "PUBTATOR", "charStart": 161, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "class III beta-tubulin"}, {"duid": "PU:y9KC", "entityType": "Chemical", "charEnd": 112, "source": "PUBTATOR", "charStart": 103, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "paclitaxel"}, {"duid": "PU:gjHV", "entityType": "Gene", "charEnd": 951, "source": "PUBTATOR", "charStart": 947, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TUBB3"}, {"duid": "PU:dj9r", "entityType": "Chemical", "charEnd": 1581, "source": "PUBTATOR", "charStart": 1576, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 12, "entityText": "taxane"}, {"duid": "PU:njaJ", "entityType": "Disease", "charEnd": 1526, "source": "PUBTATOR", "charStart": 1508, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 12, "entityText": "malignant melanomas"}, {"duid": "PU:SmjJ", "entityType": "Gene", "charEnd": 189, "source": "PUBTATOR", "charStart": 185, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TUBB3"}, {"duid": "PU:sE44", "entityType": "Chemical", "charEnd": 226, "source": "PUBTATOR", "charStart": 221, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 1, "entityText": "taxane"}, {"duid": "PU:iw9N", "entityType": "Gene", "charEnd": 1119, "source": "PUBTATOR", "charStart": 1115, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TUBB3"}, {"duid": "PU:MkBe", "entityType": "Gene", "charEnd": 1243, "source": "PUBTATOR", "charStart": 1239, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "TUBB3"}, {"duid": "PU:iHok", "entityType": "Disease", "charEnd": 777, "source": "PUBTATOR", "charStart": 769, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 6, "entityText": "melanomas"}]}
{"text": "Response prediction in metastasised colorectal cancer using intratumoural thymidylate synthase: results of a randomised multicentre trial. BACKGROUND: Molecular markers to predict response to 5-fluorouracil (FU)-based treatment of recurrent or metastasised colorectal cancer (mCRC) are not established. The aim of this trial was to determine the value of thymidylate synthase (TS), a key enzyme of DNA synthesis and target of 5-FU, to predict response to chemotherapy of mCRC. METHODS: Tumour tissue was obtained from 168 patients with mCRC for relative thymidylate synthase (TS) mRNA quantitation. Patients were randomised to receive either 5-FU/folinic acid (FA, FUFA) alone or in combination with irinotecan 5-fluorouracil/folinic acid and irinotecan (FOLFIRI) stratified by TS (low versus high). Primary end-point was overall response to first-line treatment among TS high patients. All parties, except for the randomisation centre, were blinded for TS status. RESULTS: Biopsies (n=168) were taken without complications. TS levels were available for 147 patients (87.5%). Analysing response to FUFA and FOLFIRI in the per protocol set (n=119) after un-blinding TS in the data base revealed a trend to better overall response to FOLFIRI (9/19, 47%) in TS high compared to FUFA (5/23, 22%, p=0.077). In patients with biopsies taken from liver lesions (n=91) overall response to FOLFIRI and FUFA in TS high was 53% (9/17) and 18% (3/17), respectively (p=0.035). In patients with low TS, no remarkable difference in overall response to FOLFIRI and FUFA was observed. CONCLUSIONS: Taking a pre-treatment biopsy is a safe and feasible procedure in mCRC. After validation of our data in a larger group TS determination may have the potential to better help direct systemic treatment in patients with primarily non-resectable mCRC.", "title": {"charStart": 0, "charEnd": 137}, "docId": "22133572", "entity": [{"duid": "PU:u8cS", "entityType": "Chemical", "charEnd": 1101, "source": "PUBTATOR", "charStart": 1098, "entityId": [], "sentenceIndex": 9, "entityText": "FUFA"}, {"duid": "PU:Ud8v", "entityType": "Gene", "charEnd": 870, "source": "PUBTATOR", "charStart": 869, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:pe5T", "entityType": "Chemical", "charEnd": 737, "source": "PUBTATOR", "charStart": 726, "entityId": [{"idString": "D002955", "source": "MESH"}], "sentenceIndex": 4, "entityText": "folinic acid"}, {"duid": "PU:hXzW", "entityType": "Gene", "charEnd": 1401, "source": "PUBTATOR", "charStart": 1400, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "TS"}, {"duid": "PU:bNqm", "entityType": "Species", "charEnd": 1473, "source": "PUBTATOR", "charStart": 1466, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:QdyA", "entityType": "Gene", "charEnd": 1700, "source": "PUBTATOR", "charStart": 1699, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "TS"}, {"duid": "PU:JEVn", "entityType": "Gene", "charEnd": 1166, "source": "PUBTATOR", "charStart": 1165, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:kLQa", "entityType": "Species", "charEnd": 529, "source": "PUBTATOR", "charStart": 522, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:uhYQ", "entityType": "Gene", "charEnd": 378, "source": "PUBTATOR", "charStart": 377, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:FKMj", "entityType": "Gene", "charEnd": 93, "source": "PUBTATOR", "charStart": 74, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidylate synthase"}, {"duid": "PU:eNtt", "entityType": "Chemical", "charEnd": 658, "source": "PUBTATOR", "charStart": 642, "entityId": [], "sentenceIndex": 4, "entityText": "5-FU/folinic acid"}, {"duid": "PU:q4rM", "entityType": "Chemical", "charEnd": 429, "source": "PUBTATOR", "charStart": 426, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-FU"}, {"duid": "PU:Lva4", "entityType": "Gene", "charEnd": 573, "source": "PUBTATOR", "charStart": 554, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "thymidylate synthase"}, {"duid": "PU:RC5T", "entityType": "Chemical", "charEnd": 205, "source": "PUBTATOR", "charStart": 192, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-fluorouracil"}, {"duid": "PU:5AST", "entityType": "Gene", "charEnd": 779, "source": "PUBTATOR", "charStart": 778, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:9Haw", "entityType": "Gene", "charEnd": 577, "source": "PUBTATOR", "charStart": 576, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "TS"}, {"duid": "PU:FiXY", "entityType": "Species", "charEnd": 1065, "source": "PUBTATOR", "charStart": 1058, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:From", "entityType": "Species", "charEnd": 606, "source": "PUBTATOR", "charStart": 599, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "Patients"}, {"duid": "PU:V6Bc", "entityType": "Chemical", "charEnd": 1551, "source": "PUBTATOR", "charStart": 1548, "entityId": [], "sentenceIndex": 11, "entityText": "FUFA"}, {"duid": "PU:ZU8T", "entityType": "Species", "charEnd": 884, "source": "PUBTATOR", "charStart": 877, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:Sced", "entityType": "Gene", "charEnd": 1026, "source": "PUBTATOR", "charStart": 1025, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:iCoW", "entityType": "Species", "charEnd": 1790, "source": "PUBTATOR", "charStart": 1783, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 13, "entityText": "patients"}, {"duid": "PU:WVjG", "entityType": "Chemical", "charEnd": 752, "source": "PUBTATOR", "charStart": 743, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 4, "entityText": "irinotecan"}, {"duid": "PU:xAQa", "entityType": "Disease", "charEnd": 52, "source": "PUBTATOR", "charStart": 36, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 0, "entityText": "colorectal cancer"}, {"duid": "PU:rbMg", "entityType": "Gene", "charEnd": 955, "source": "PUBTATOR", "charStart": 954, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:uoL2", "entityType": "Disease", "charEnd": 273, "source": "PUBTATOR", "charStart": 257, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 1, "entityText": "colorectal cancer"}, {"duid": "PU:dqj2", "entityType": "Chemical", "charEnd": 724, "source": "PUBTATOR", "charStart": 700, "entityId": [], "sentenceIndex": 4, "entityText": "irinotecan 5-fluorouracil"}, {"duid": "PU:xNfM", "entityType": "Chemical", "charEnd": 1395, "source": "PUBTATOR", "charStart": 1392, "entityId": [], "sentenceIndex": 10, "entityText": "FUFA"}, {"duid": "PU:bsYh", "entityType": "Gene", "charEnd": 374, "source": "PUBTATOR", "charStart": 355, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "thymidylate synthase"}, {"duid": "PU:nWZW", "entityType": "Chemical", "charEnd": 668, "source": "PUBTATOR", "charStart": 665, "entityId": [], "sentenceIndex": 4, "entityText": "FUFA"}, {"duid": "PU:xR47", "entityType": "Gene", "charEnd": 1256, "source": "PUBTATOR", "charStart": 1255, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:B3c2", "entityType": "Species", "charEnd": 1312, "source": "PUBTATOR", "charStart": 1305, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:TJBW", "entityType": "Gene", "charEnd": 1485, "source": "PUBTATOR", "charStart": 1484, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "TS"}, {"duid": "PU:G9jv", "entityType": "Disease", "charEnd": 491, "source": "PUBTATOR", "charStart": 486, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "Tumour"}, {"duid": "PU:ubio", "entityType": "Chemical", "charEnd": 1278, "source": "PUBTATOR", "charStart": 1275, "entityId": [], "sentenceIndex": 9, "entityText": "FUFA"}]}
{"text": "Sensitivity to temozolomide in brain tumor initiating cells. Molecular alterations in glioblastoma have the potential to guide treatment. Here, we explore the relationship between temozolomide (TMZ) response and O(6)-methylguanine DNA methyltransferase (MGMT) status in brain tumor initiating cells (BTICs). Methylation, expression, and sensitivity were assessed in 20 lines; associations were evaluated by Fisher's exact test. Some BTICs were sensitive. Sensitivity to TMZ was only associated with protein expression (P = .001). There were atypical BTICs including TMZ-resistant lines in which the methylation-specific PCR reaction revealed both methylated and unmethylated bands. BTICs are not uniformly resistant to TMZ; some are sensitive. MGMT status does not predict TMZ response with high precision.", "title": {"charStart": 0, "charEnd": 59}, "docId": "20388697", "entity": [{"duid": "PU:X6Kq", "entityType": "Chemical", "charEnd": 775, "source": "PUBTATOR", "charStart": 773, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 8, "entityText": "TMZ"}, {"duid": "PU:XW45", "entityType": "Chemical", "charEnd": 472, "source": "PUBTATOR", "charStart": 470, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 5, "entityText": "TMZ"}, {"duid": "PU:gArz", "entityType": "Disease", "charEnd": 41, "source": "PUBTATOR", "charStart": 31, "entityId": [{"idString": "D001932", "source": "MESH"}], "sentenceIndex": 0, "entityText": "brain tumor"}, {"duid": "PU:TAit", "entityType": "Chemical", "charEnd": 26, "source": "PUBTATOR", "charStart": 15, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "temozolomide"}, {"duid": "PU:3QSN", "entityType": "Chemical", "charEnd": 229, "source": "PUBTATOR", "charStart": 212, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 2, "entityText": "O(6)-methylguanine"}, {"duid": "PU:jVnU", "entityType": "Disease", "charEnd": 97, "source": "PUBTATOR", "charStart": 86, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 1, "entityText": "glioblastoma"}, {"duid": "PU:uxXi", "entityType": "Disease", "charEnd": 280, "source": "PUBTATOR", "charStart": 270, "entityId": [{"idString": "D001932", "source": "MESH"}], "sentenceIndex": 2, "entityText": "brain tumor"}, {"duid": "PU:bdiC", "entityType": "Chemical", "charEnd": 568, "source": "PUBTATOR", "charStart": 566, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 6, "entityText": "TMZ"}, {"duid": "PU:vCba", "entityType": "Chemical", "charEnd": 191, "source": "PUBTATOR", "charStart": 180, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 2, "entityText": "temozolomide"}, {"duid": "PU:JWws", "entityType": "Chemical", "charEnd": 721, "source": "PUBTATOR", "charStart": 719, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 7, "entityText": "TMZ"}, {"duid": "PU:aPzV", "entityType": "Chemical", "charEnd": 196, "source": "PUBTATOR", "charStart": 194, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 2, "entityText": "TMZ"}, {"duid": "PU:ft86", "entityType": "Species", "charEnd": 412, "source": "PUBTATOR", "charStart": 407, "entityId": [{"idString": "76720", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "Fisher"}]}
{"text": "Predictive role of midtreatment changes in survivin, GSTP1, and topoisomerase 2\u03b1 expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. INTRODUCTION: The primary aim of this study is to investigate the effect of change in the expression levels of survivin, glutathione-S-transferase P1 (GSTP1), and topoisomerase 2\u03b1 (TOP2A) on the response to antracyclin-based and taxane-based neoadjuvant chemotherapy. METHODS: This study included 32 locally advanced breast cancer patients. Tumoral expressions of survivin, TOP2A, and GSTP1 in serial biopsy specimens obtained before treatment, after sequential 4 cycles of doxorubicin+cyclophosphomide, and 4 cycles of docetaxel were analyzed by real-time polymerase chain reaction. Survivin expressions were additionally analyzed in serial blood samples. RESULTS: The pathologic complete response (pCR) rate and the overall response rate (clinical complete and partial) were 28% (n=9) and 91% (n=29), respectively. There were no statistically significant correlations between serial TOP2A expression levels and response. There was a nonsignificant trend toward an improved response rate with decreased survivin expression. A significant decrease in the GSTP1 expression level throughout treatment (P=0.014), which was also shown to be significantly correlated with a pCR (P=0.0001), was seen. Downregulation of GSTP1 after 4 cycles of anthracycline-based combination was independently associated with improved progression-free survival (P=0.01). CONCLUSIONS: Downregulation of GSTP1 is a significant predictor of pCR and improved progression-free survival during anthracycline-based and taxane-based neoadjuvant chemotherapy in patients with locally advanced breast cancer.", "title": {"charStart": 0, "charEnd": 201}, "docId": "22441341", "entity": [{"duid": "PU:Ddtf", "entityType": "Chemical", "charEnd": 1697, "source": "PUBTATOR", "charStart": 1692, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 10, "entityText": "taxane"}, {"duid": "PU:gt5A", "entityType": "Chemical", "charEnd": 1452, "source": "PUBTATOR", "charStart": 1440, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 9, "entityText": "anthracycline"}, {"duid": "PU:pY8f", "entityType": "Chemical", "charEnd": 437, "source": "PUBTATOR", "charStart": 432, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 1, "entityText": "taxane"}, {"duid": "PU:CS5V", "entityType": "Gene", "charEnd": 351, "source": "PUBTATOR", "charStart": 324, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "glutathione-S-transferase P1"}, {"duid": "PU:vkPR", "entityType": "Chemical", "charEnd": 704, "source": "PUBTATOR", "charStart": 689, "entityId": [], "sentenceIndex": 3, "entityText": "cyclophosphomide"}, {"duid": "PU:3mff", "entityType": "Gene", "charEnd": 57, "source": "PUBTATOR", "charStart": 53, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "GSTP1"}, {"duid": "PU:km2S", "entityType": "Species", "charEnd": 1740, "source": "PUBTATOR", "charStart": 1733, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:k2uF", "entityType": "Gene", "charEnd": 581, "source": "PUBTATOR", "charStart": 577, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "TOP2A"}, {"duid": "PU:a4s6", "entityType": "Chemical", "charEnd": 1680, "source": "PUBTATOR", "charStart": 1668, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 10, "entityText": "anthracycline"}, {"duid": "PU:yrLe", "entityType": "Chemical", "charEnd": 687, "source": "PUBTATOR", "charStart": 677, "entityId": [{"idString": "D004317", "source": "MESH"}], "sentenceIndex": 3, "entityText": "doxorubicin"}, {"duid": "PU:42M3", "entityType": "Disease", "charEnd": 200, "source": "PUBTATOR", "charStart": 188, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast cancer"}, {"duid": "PU:yhFU", "entityType": "Species", "charEnd": 164, "source": "PUBTATOR", "charStart": 157, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:ECqK", "entityType": "Gene", "charEnd": 592, "source": "PUBTATOR", "charStart": 588, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "GSTP1"}, {"duid": "PU:2zfd", "entityType": "Species", "charEnd": 541, "source": "PUBTATOR", "charStart": 534, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:J4MQ", "entityType": "Gene", "charEnd": 358, "source": "PUBTATOR", "charStart": 354, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "GSTP1"}, {"duid": "PU:Gtdd", "entityType": "Gene", "charEnd": 1586, "source": "PUBTATOR", "charStart": 1582, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "GSTP1"}, {"duid": "PU:qT6X", "entityType": "Disease", "charEnd": 1776, "source": "PUBTATOR", "charStart": 1764, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 10, "entityText": "breast cancer"}, {"duid": "PU:CirW", "entityType": "Chemical", "charEnd": 420, "source": "PUBTATOR", "charStart": 410, "entityId": [], "sentenceIndex": 1, "entityText": "antracyclin"}, {"duid": "PU:oS92", "entityType": "Gene", "charEnd": 1262, "source": "PUBTATOR", "charStart": 1258, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "GSTP1"}, {"duid": "PU:Y2S7", "entityType": "Gene", "charEnd": 1092, "source": "PUBTATOR", "charStart": 1088, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TOP2A"}, {"duid": "PU:uRbF", "entityType": "Disease", "charEnd": 532, "source": "PUBTATOR", "charStart": 520, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 2, "entityText": "breast cancer"}, {"duid": "PU:NVVV", "entityType": "Chemical", "charEnd": 334, "source": "PUBTATOR", "charStart": 324, "entityId": [{"idString": "D005978", "source": "MESH"}], "sentenceIndex": 1, "entityText": "glutathione"}, {"duid": "PU:Gzj9", "entityType": "Chemical", "charEnd": 336, "source": "PUBTATOR", "charStart": 336, "entityId": [], "sentenceIndex": 1, "entityText": "S"}, {"duid": "PU:DVyK", "entityType": "Gene", "charEnd": 1420, "source": "PUBTATOR", "charStart": 1416, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "GSTP1"}, {"duid": "PU:Uc2S", "entityType": "Gene", "charEnd": 388, "source": "PUBTATOR", "charStart": 384, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TOP2A"}, {"duid": "PU:YZjN", "entityType": "Chemical", "charEnd": 731, "source": "PUBTATOR", "charStart": 723, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 3, "entityText": "docetaxel"}]}
{"text": "Predictive role of midtreatment changes in survivin, GSTP1, and topoisomerase 2\u03b1 expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. INTRODUCTION: The primary aim of this study is to investigate the effect of change in the expression levels of survivin, glutathione-S-transferase P1 (GSTP1), and topoisomerase 2\u03b1 (TOP2A) on the response to antracyclin-based and taxane-based neoadjuvant chemotherapy. METHODS: This study included 32 locally advanced breast cancer patients. Tumoral expressions of survivin, TOP2A, and GSTP1 in serial biopsy specimens obtained before treatment, after sequential 4 cycles of doxorubicin+cyclophosphomide, and 4 cycles of docetaxel were analyzed by real-time polymerase chain reaction. Survivin expressions were additionally analyzed in serial blood samples. RESULTS: The pathologic complete response (pCR) rate and the overall response rate (clinical complete and partial) were 28% (n=9) and 91% (n=29), respectively. There were no statistically significant correlations between serial TOP2A expression levels and response. There was a nonsignificant trend toward an improved response rate with decreased survivin expression. A significant decrease in the GSTP1 expression level throughout treatment (P=0.014), which was also shown to be significantly correlated with a pCR (P=0.0001), was seen. Downregulation of GSTP1 after 4 cycles of anthracycline-based combination was independently associated with improved progression-free survival (P=0.01). CONCLUSIONS: Downregulation of GSTP1 is a significant predictor of pCR and improved progression-free survival during anthracycline-based and taxane-based neoadjuvant chemotherapy in patients with locally advanced breast cancer.", "title": {"charStart": 0, "charEnd": 201}, "docId": "22441341", "entity": [{"duid": "PU:Ddtf", "entityType": "Chemical", "charEnd": 1697, "source": "PUBTATOR", "charStart": 1692, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 10, "entityText": "taxane"}, {"duid": "PU:gt5A", "entityType": "Chemical", "charEnd": 1452, "source": "PUBTATOR", "charStart": 1440, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 9, "entityText": "anthracycline"}, {"duid": "PU:pY8f", "entityType": "Chemical", "charEnd": 437, "source": "PUBTATOR", "charStart": 432, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 1, "entityText": "taxane"}, {"duid": "PU:CS5V", "entityType": "Gene", "charEnd": 351, "source": "PUBTATOR", "charStart": 324, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "glutathione-S-transferase P1"}, {"duid": "PU:vkPR", "entityType": "Chemical", "charEnd": 704, "source": "PUBTATOR", "charStart": 689, "entityId": [], "sentenceIndex": 3, "entityText": "cyclophosphomide"}, {"duid": "PU:3mff", "entityType": "Gene", "charEnd": 57, "source": "PUBTATOR", "charStart": 53, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "GSTP1"}, {"duid": "PU:km2S", "entityType": "Species", "charEnd": 1740, "source": "PUBTATOR", "charStart": 1733, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:k2uF", "entityType": "Gene", "charEnd": 581, "source": "PUBTATOR", "charStart": 577, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "TOP2A"}, {"duid": "PU:a4s6", "entityType": "Chemical", "charEnd": 1680, "source": "PUBTATOR", "charStart": 1668, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 10, "entityText": "anthracycline"}, {"duid": "PU:yrLe", "entityType": "Chemical", "charEnd": 687, "source": "PUBTATOR", "charStart": 677, "entityId": [{"idString": "D004317", "source": "MESH"}], "sentenceIndex": 3, "entityText": "doxorubicin"}, {"duid": "PU:42M3", "entityType": "Disease", "charEnd": 200, "source": "PUBTATOR", "charStart": 188, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast cancer"}, {"duid": "PU:yhFU", "entityType": "Species", "charEnd": 164, "source": "PUBTATOR", "charStart": 157, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:ECqK", "entityType": "Gene", "charEnd": 592, "source": "PUBTATOR", "charStart": 588, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "GSTP1"}, {"duid": "PU:2zfd", "entityType": "Species", "charEnd": 541, "source": "PUBTATOR", "charStart": 534, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:J4MQ", "entityType": "Gene", "charEnd": 358, "source": "PUBTATOR", "charStart": 354, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "GSTP1"}, {"duid": "PU:Gtdd", "entityType": "Gene", "charEnd": 1586, "source": "PUBTATOR", "charStart": 1582, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "GSTP1"}, {"duid": "PU:qT6X", "entityType": "Disease", "charEnd": 1776, "source": "PUBTATOR", "charStart": 1764, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 10, "entityText": "breast cancer"}, {"duid": "PU:CirW", "entityType": "Chemical", "charEnd": 420, "source": "PUBTATOR", "charStart": 410, "entityId": [], "sentenceIndex": 1, "entityText": "antracyclin"}, {"duid": "PU:oS92", "entityType": "Gene", "charEnd": 1262, "source": "PUBTATOR", "charStart": 1258, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "GSTP1"}, {"duid": "PU:Y2S7", "entityType": "Gene", "charEnd": 1092, "source": "PUBTATOR", "charStart": 1088, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TOP2A"}, {"duid": "PU:uRbF", "entityType": "Disease", "charEnd": 532, "source": "PUBTATOR", "charStart": 520, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 2, "entityText": "breast cancer"}, {"duid": "PU:NVVV", "entityType": "Chemical", "charEnd": 334, "source": "PUBTATOR", "charStart": 324, "entityId": [{"idString": "D005978", "source": "MESH"}], "sentenceIndex": 1, "entityText": "glutathione"}, {"duid": "PU:Gzj9", "entityType": "Chemical", "charEnd": 336, "source": "PUBTATOR", "charStart": 336, "entityId": [], "sentenceIndex": 1, "entityText": "S"}, {"duid": "PU:DVyK", "entityType": "Gene", "charEnd": 1420, "source": "PUBTATOR", "charStart": 1416, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "GSTP1"}, {"duid": "PU:Uc2S", "entityType": "Gene", "charEnd": 388, "source": "PUBTATOR", "charStart": 384, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TOP2A"}, {"duid": "PU:YZjN", "entityType": "Chemical", "charEnd": 731, "source": "PUBTATOR", "charStart": 723, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 3, "entityText": "docetaxel"}]}
{"text": "Predictive role of midtreatment changes in survivin, GSTP1, and topoisomerase 2\u03b1 expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. INTRODUCTION: The primary aim of this study is to investigate the effect of change in the expression levels of survivin, glutathione-S-transferase P1 (GSTP1), and topoisomerase 2\u03b1 (TOP2A) on the response to antracyclin-based and taxane-based neoadjuvant chemotherapy. METHODS: This study included 32 locally advanced breast cancer patients. Tumoral expressions of survivin, TOP2A, and GSTP1 in serial biopsy specimens obtained before treatment, after sequential 4 cycles of doxorubicin+cyclophosphomide, and 4 cycles of docetaxel were analyzed by real-time polymerase chain reaction. Survivin expressions were additionally analyzed in serial blood samples. RESULTS: The pathologic complete response (pCR) rate and the overall response rate (clinical complete and partial) were 28% (n=9) and 91% (n=29), respectively. There were no statistically significant correlations between serial TOP2A expression levels and response. There was a nonsignificant trend toward an improved response rate with decreased survivin expression. A significant decrease in the GSTP1 expression level throughout treatment (P=0.014), which was also shown to be significantly correlated with a pCR (P=0.0001), was seen. Downregulation of GSTP1 after 4 cycles of anthracycline-based combination was independently associated with improved progression-free survival (P=0.01). CONCLUSIONS: Downregulation of GSTP1 is a significant predictor of pCR and improved progression-free survival during anthracycline-based and taxane-based neoadjuvant chemotherapy in patients with locally advanced breast cancer.", "title": {"charStart": 0, "charEnd": 201}, "docId": "22441341", "entity": [{"duid": "PU:Ddtf", "entityType": "Chemical", "charEnd": 1697, "source": "PUBTATOR", "charStart": 1692, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 10, "entityText": "taxane"}, {"duid": "PU:gt5A", "entityType": "Chemical", "charEnd": 1452, "source": "PUBTATOR", "charStart": 1440, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 9, "entityText": "anthracycline"}, {"duid": "PU:pY8f", "entityType": "Chemical", "charEnd": 437, "source": "PUBTATOR", "charStart": 432, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 1, "entityText": "taxane"}, {"duid": "PU:CS5V", "entityType": "Gene", "charEnd": 351, "source": "PUBTATOR", "charStart": 324, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "glutathione-S-transferase P1"}, {"duid": "PU:vkPR", "entityType": "Chemical", "charEnd": 704, "source": "PUBTATOR", "charStart": 689, "entityId": [], "sentenceIndex": 3, "entityText": "cyclophosphomide"}, {"duid": "PU:3mff", "entityType": "Gene", "charEnd": 57, "source": "PUBTATOR", "charStart": 53, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "GSTP1"}, {"duid": "PU:km2S", "entityType": "Species", "charEnd": 1740, "source": "PUBTATOR", "charStart": 1733, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:k2uF", "entityType": "Gene", "charEnd": 581, "source": "PUBTATOR", "charStart": 577, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "TOP2A"}, {"duid": "PU:a4s6", "entityType": "Chemical", "charEnd": 1680, "source": "PUBTATOR", "charStart": 1668, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 10, "entityText": "anthracycline"}, {"duid": "PU:yrLe", "entityType": "Chemical", "charEnd": 687, "source": "PUBTATOR", "charStart": 677, "entityId": [{"idString": "D004317", "source": "MESH"}], "sentenceIndex": 3, "entityText": "doxorubicin"}, {"duid": "PU:42M3", "entityType": "Disease", "charEnd": 200, "source": "PUBTATOR", "charStart": 188, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast cancer"}, {"duid": "PU:yhFU", "entityType": "Species", "charEnd": 164, "source": "PUBTATOR", "charStart": 157, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:ECqK", "entityType": "Gene", "charEnd": 592, "source": "PUBTATOR", "charStart": 588, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "GSTP1"}, {"duid": "PU:2zfd", "entityType": "Species", "charEnd": 541, "source": "PUBTATOR", "charStart": 534, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:J4MQ", "entityType": "Gene", "charEnd": 358, "source": "PUBTATOR", "charStart": 354, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "GSTP1"}, {"duid": "PU:Gtdd", "entityType": "Gene", "charEnd": 1586, "source": "PUBTATOR", "charStart": 1582, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "GSTP1"}, {"duid": "PU:qT6X", "entityType": "Disease", "charEnd": 1776, "source": "PUBTATOR", "charStart": 1764, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 10, "entityText": "breast cancer"}, {"duid": "PU:CirW", "entityType": "Chemical", "charEnd": 420, "source": "PUBTATOR", "charStart": 410, "entityId": [], "sentenceIndex": 1, "entityText": "antracyclin"}, {"duid": "PU:oS92", "entityType": "Gene", "charEnd": 1262, "source": "PUBTATOR", "charStart": 1258, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "GSTP1"}, {"duid": "PU:Y2S7", "entityType": "Gene", "charEnd": 1092, "source": "PUBTATOR", "charStart": 1088, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TOP2A"}, {"duid": "PU:uRbF", "entityType": "Disease", "charEnd": 532, "source": "PUBTATOR", "charStart": 520, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 2, "entityText": "breast cancer"}, {"duid": "PU:NVVV", "entityType": "Chemical", "charEnd": 334, "source": "PUBTATOR", "charStart": 324, "entityId": [{"idString": "D005978", "source": "MESH"}], "sentenceIndex": 1, "entityText": "glutathione"}, {"duid": "PU:Gzj9", "entityType": "Chemical", "charEnd": 336, "source": "PUBTATOR", "charStart": 336, "entityId": [], "sentenceIndex": 1, "entityText": "S"}, {"duid": "PU:DVyK", "entityType": "Gene", "charEnd": 1420, "source": "PUBTATOR", "charStart": 1416, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "GSTP1"}, {"duid": "PU:Uc2S", "entityType": "Gene", "charEnd": 388, "source": "PUBTATOR", "charStart": 384, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TOP2A"}, {"duid": "PU:YZjN", "entityType": "Chemical", "charEnd": 731, "source": "PUBTATOR", "charStart": 723, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 3, "entityText": "docetaxel"}]}
{"text": "Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines. PURPOSE: Paclitaxel (PACL) plus gemcitabine (GEM) is an effective regimen for advanced breast cancer patients pretreated with anthracyclines. A prolonged GEM infusion at a fixed dose rate (FDR) of 10 mg/m\u00b2/min produces higher levels of intracellular active metabolites of GEM when compared with a standard 30-min infusion. In the present phase I/II trial, we investigated the association of FDR GEM plus PACL. METHODS: 1,200 mg/m\u00b2 was the dose of GEM recommended for the phase II study, in which patients received PACL at 150 mg/m\u00b2, followed by FDR GEM at 1,200 mg/m\u00b2 (total GEM infusion time = 120 min), both drugs administered biweekly. RESULTS: Forty-two anthracycline-pretreated advanced breast cancer patients with disease recurrence following at least one line of chemotherapy were enrolled. Two (4.8%) and 12 (33.3%) patients experienced a complete and partial response, respectively, for an overall response rate of 38.1% (95% CI 23.4-52.8%). Median progression free survival and overall survival were 5 and 19.9 months, respectively. No statistically significant association was noted between in situ protein expression of RRM1 and BRCA1 (as assessed by immunofluorescence combined with automated quantitative analysis) and response to treatment in 15 patients with tissue available for analysis. Toxicity was mostly mild to moderate, mainly consisting of G3-G4 neutropenia (9.6%) and hypertransaminasemia (9.5%). CONCLUSIONS: Biweekly FDR GEM in combination with PACL is an active and safe regimen for advanced breast cancer patients pretreated with anthracyclines. A prolonged infusion regimen of GEM does not seem to improve the efficacy of a standard 30-min infusion.", "title": {"charStart": 0, "charEnd": 156}, "docId": "20512334", "entity": [{"duid": "PU:DZNm", "entityType": "Chemical", "charEnd": 200, "source": "PUBTATOR", "charStart": 190, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gemcitabine"}, {"duid": "PU:pMBm", "entityType": "Disease", "charEnd": 862, "source": "PUBTATOR", "charStart": 841, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 5, "entityText": "advanced breast cancer"}, {"duid": "PU:PFtv", "entityType": "Chemical", "charEnd": 155, "source": "PUBTATOR", "charStart": 142, "entityId": [{"idString": "D018943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "anthracyclines"}, {"duid": "PU:uXer", "entityType": "Disease", "charEnd": 1691, "source": "PUBTATOR", "charStart": 1670, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 10, "entityText": "advanced breast cancer"}, {"duid": "PU:uhQH", "entityType": "Chemical", "charEnd": 1634, "source": "PUBTATOR", "charStart": 1631, "entityId": [], "sentenceIndex": 10, "entityText": "PACL"}, {"duid": "PU:P8vk", "entityType": "Gene", "charEnd": 1293, "source": "PUBTATOR", "charStart": 1290, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "RRM1"}, {"duid": "PU:N2pg", "entityType": "Disease", "charEnd": 1471, "source": "PUBTATOR", "charStart": 1464, "entityId": [{"idString": "D064420", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Toxicity"}, {"duid": "PU:D5ir", "entityType": "Chemical", "charEnd": 1731, "source": "PUBTATOR", "charStart": 1718, "entityId": [{"idString": "D018943", "source": "MESH"}], "sentenceIndex": 10, "entityText": "anthracyclines"}, {"duid": "PU:2V3G", "entityType": "Species", "charEnd": 871, "source": "PUBTATOR", "charStart": 864, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:4nLL", "entityType": "Species", "charEnd": 266, "source": "PUBTATOR", "charStart": 259, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:JDWz", "entityType": "Species", "charEnd": 1700, "source": "PUBTATOR", "charStart": 1693, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:mzkZ", "entityType": "Chemical", "charEnd": 297, "source": "PUBTATOR", "charStart": 284, "entityId": [{"idString": "D018943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "anthracyclines"}, {"duid": "PU:tR5w", "entityType": "Chemical", "charEnd": 65, "source": "PUBTATOR", "charStart": 56, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "paclitaxel"}, {"duid": "PU:LoBc", "entityType": "Gene", "charEnd": 1303, "source": "PUBTATOR", "charStart": 1299, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "BRCA1"}, {"duid": "PU:AkYr", "entityType": "Disease", "charEnd": 257, "source": "PUBTATOR", "charStart": 236, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "advanced breast cancer"}, {"duid": "PU:d6T4", "entityType": "Disease", "charEnd": 115, "source": "PUBTATOR", "charStart": 94, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "advanced breast cancer"}, {"duid": "PU:6adH", "entityType": "Chemical", "charEnd": 182, "source": "PUBTATOR", "charStart": 179, "entityId": [], "sentenceIndex": 1, "entityText": "PACL"}, {"duid": "PU:sC94", "entityType": "Chemical", "charEnd": 40, "source": "PUBTATOR", "charStart": 30, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gemcitabine"}, {"duid": "PU:VQXo", "entityType": "Species", "charEnd": 124, "source": "PUBTATOR", "charStart": 117, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:racH", "entityType": "Disease", "charEnd": 1539, "source": "PUBTATOR", "charStart": 1529, "entityId": [{"idString": "D009503", "source": "MESH"}], "sentenceIndex": 9, "entityText": "neutropenia"}, {"duid": "PU:AWZ4", "entityType": "Species", "charEnd": 1426, "source": "PUBTATOR", "charStart": 1419, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:NurV", "entityType": "Chemical", "charEnd": 675, "source": "PUBTATOR", "charStart": 672, "entityId": [], "sentenceIndex": 4, "entityText": "PACL"}, {"duid": "PU:bHUs", "entityType": "Chemical", "charEnd": 205, "source": "PUBTATOR", "charStart": 203, "entityId": [], "sentenceIndex": 1, "entityText": "GEM"}, {"duid": "PU:tQzL", "entityType": "Species", "charEnd": 661, "source": "PUBTATOR", "charStart": 654, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:q6Vy", "entityType": "Chemical", "charEnd": 565, "source": "PUBTATOR", "charStart": 562, "entityId": [], "sentenceIndex": 3, "entityText": "PACL"}, {"duid": "PU:qQUR", "entityType": "Chemical", "charEnd": 828, "source": "PUBTATOR", "charStart": 816, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 5, "entityText": "anthracycline"}, {"duid": "PU:yLic", "entityType": "Species", "charEnd": 989, "source": "PUBTATOR", "charStart": 982, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:HNdV", "entityType": "Chemical", "charEnd": 176, "source": "PUBTATOR", "charStart": 167, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Paclitaxel"}]}
{"text": "ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial. BACKGROUND: Customized chemotherapy is likely to improve outcome in patients with advanced non-small-cell lung cancer (NSCLC). Excision repair cross-complementation group 1 (ERCC1) is a promising biomarker; however, current evidence is inadequate. Impact of ERCC1 status was evaluated among patients participating in a large randomized chemotherapy trial. PATIENTS AND METHODS: Four hundred and forty-three patients with advanced NSCLC were enrolled in a phase III trial and were randomly allocated to triplet chemotherapy or standard doublet regimen. Immunohistochemical evaluation for ERCC1 status was mainly carried out on bioptic material. RESULTS: Two hundred and sixty-four (59.5%) patients had representative tissue samples for ERCC1 evaluation. Median overall survival (OS) in the ERCC1-negative and ERCC1-positive population was 11.8 and 9.8 months, respectively (P = 0.028). The median OS among patients with adenocarcinomas (n = 122) was 15.2 and 8.3 months, respectively (P = 0.007). Interaction analysis between ERCC1-negative status and adenocarcinomas yielded a hazard ratio of 0.64 for death (P = 0.002). CONCLUSIONS: Clinically applicable evaluation of ERCC1 status predicted cisplatin sensitivity in the largest randomized patient population with advanced NSCLC reported to date. The predictive value can be ascribed to the adenocarcinomas emphasizing the relevance of ERCC1 expression in this subgroup.", "title": {"charStart": 0, "charEnd": 101}, "docId": "20332140", "entity": [{"duid": "PU:tYwZ", "entityType": "Gene", "charEnd": 281, "source": "PUBTATOR", "charStart": 277, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:pMvD", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:cioN", "entityType": "Gene", "charEnd": 915, "source": "PUBTATOR", "charStart": 911, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:itnm", "entityType": "Species", "charEnd": 178, "source": "PUBTATOR", "charStart": 171, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:kVxE", "entityType": "Gene", "charEnd": 842, "source": "PUBTATOR", "charStart": 838, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:G2Cq", "entityType": "Gene", "charEnd": 694, "source": "PUBTATOR", "charStart": 690, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:Y4LK", "entityType": "Disease", "charEnd": 1168, "source": "PUBTATOR", "charStart": 1154, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 9, "entityText": "adenocarcinomas"}, {"duid": "PU:7Fpn", "entityType": "Species", "charEnd": 798, "source": "PUBTATOR", "charStart": 791, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:ujBF", "entityType": "Species", "charEnd": 1015, "source": "PUBTATOR", "charStart": 1008, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:Gic8", "entityType": "Gene", "charEnd": 1277, "source": "PUBTATOR", "charStart": 1273, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:9E76", "entityType": "Species", "charEnd": 1350, "source": "PUBTATOR", "charStart": 1344, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patient"}, {"duid": "PU:bLfJ", "entityType": "Gene", "charEnd": 365, "source": "PUBTATOR", "charStart": 361, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:DpVL", "entityType": "Chemical", "charEnd": 1304, "source": "PUBTATOR", "charStart": 1296, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 10, "entityText": "cisplatin"}, {"duid": "PU:HdPE", "entityType": "Disease", "charEnd": 537, "source": "PUBTATOR", "charStart": 533, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 4, "entityText": "NSCLC"}, {"duid": "PU:pgXi", "entityType": "Gene", "charEnd": 896, "source": "PUBTATOR", "charStart": 892, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:YCAq", "entityType": "Species", "charEnd": 50, "source": "PUBTATOR", "charStart": 43, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:Zchb", "entityType": "Species", "charEnd": 401, "source": "PUBTATOR", "charStart": 394, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:RJNz", "entityType": "Disease", "charEnd": 41, "source": "PUBTATOR", "charStart": 37, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "NSCLC"}, {"duid": "PU:eKMQ", "entityType": "Gene", "charEnd": 1494, "source": "PUBTATOR", "charStart": 1490, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ERCC1"}, {"duid": "PU:itBs", "entityType": "Disease", "charEnd": 219, "source": "PUBTATOR", "charStart": 194, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:mbQ9", "entityType": "Gene", "charEnd": 274, "source": "PUBTATOR", "charStart": 230, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "Excision repair cross-complementation group 1"}, {"duid": "PU:Yuq4", "entityType": "Disease", "charEnd": 1036, "source": "PUBTATOR", "charStart": 1022, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 8, "entityText": "adenocarcinomas"}, {"duid": "PU:dGWX", "entityType": "Disease", "charEnd": 1381, "source": "PUBTATOR", "charStart": 1377, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 10, "entityText": "NSCLC"}, {"duid": "PU:j787", "entityType": "Disease", "charEnd": 1209, "source": "PUBTATOR", "charStart": 1205, "entityId": [{"idString": "D003643", "source": "MESH"}], "sentenceIndex": 9, "entityText": "death"}, {"duid": "PU:7Ben", "entityType": "Species", "charEnd": 466, "source": "PUBTATOR", "charStart": 459, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "PATIENTS"}, {"duid": "PU:cX4D", "entityType": "Disease", "charEnd": 226, "source": "PUBTATOR", "charStart": 222, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:8B6f", "entityType": "Species", "charEnd": 517, "source": "PUBTATOR", "charStart": 510, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:nHi6", "entityType": "Gene", "charEnd": 1132, "source": "PUBTATOR", "charStart": 1128, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:YZhM", "entityType": "Disease", "charEnd": 1459, "source": "PUBTATOR", "charStart": 1445, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 11, "entityText": "adenocarcinomas"}]}
{"text": "mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines. BACKGROUND AND OBJECTIVE: Expression of genes involved in DNA repair and/or DNA synthesis, including ribonucleotide reductase M1 (RRM1) and excision repair cross-complementation 1 (ERCC1) has been reported to be associated with chemosensitivity to platinum agents and gemcitabine. The aim of this study was to test whether similar associations would be seen between mRNA expression for the RRM1, ERCC1 and ERCC2 genes and in vitro chemosensitivity in lung cancer. METHODS: Using a panel of 20 lung cancer cell lines, including 15 NSCLC and 5 small cell lung cancers (SCLC), the mRNA expression levels for the RRM1, ERCC1 and ERCC2 genes were examined by quantitative real-time reverse transcription PCR. The in vitro cytotoxicity of cisplatin, carboplatin and gemcitabine was assessed using a tetrazolium-based colorimetric assay (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide (MTT) assay). RESULTS: Significantly, higher RRM1 mRNA expression was found in SCLC compared with NSCLC. However, there were no correlations between mRNA expression of the ERCC1, ERCC2 and RRM1 genes and chemosensitivity to cisplatin, carboplatin or gemcitabine. CONCLUSIONS: These in vitro results suggest that further studies are needed to evaluate the expression of the RRM1, ERCC1 and ERCC2 genes as predictive biomarkers for sensitivity to platinum agents and gemcitabine.", "title": {"charStart": 0, "charEnd": 154}, "docId": "18494946", "entity": [{"duid": "PU:zL3j", "entityType": "Chemical", "charEnd": 121, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gemcitabine"}, {"duid": "PU:eefC", "entityType": "Chemical", "charEnd": 1045, "source": "PUBTATOR", "charStart": 987, "entityId": [{"idString": "C022616", "source": "MESH"}], "sentenceIndex": 4, "entityText": "3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide"}, {"duid": "PU:WhWu", "entityType": "Disease", "charEnd": 884, "source": "PUBTATOR", "charStart": 873, "entityId": [{"idString": "D064420", "source": "MESH"}], "sentenceIndex": 4, "entityText": "cytotoxicity"}, {"duid": "PU:k52t", "entityType": "Species", "charEnd": 130, "source": "PUBTATOR", "charStart": 126, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "human"}, {"duid": "PU:jTvh", "entityType": "Chemical", "charEnd": 1522, "source": "PUBTATOR", "charStart": 1512, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 7, "entityText": "gemcitabine"}, {"duid": "PU:8nPh", "entityType": "Chemical", "charEnd": 1050, "source": "PUBTATOR", "charStart": 1048, "entityId": [{"idString": "53233", "source": "CHEBI"}], "sentenceIndex": 4, "entityText": "MTT"}, {"duid": "PU:dbNM", "entityType": "Chemical", "charEnd": 92, "source": "PUBTATOR", "charStart": 84, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "cisplatin"}, {"duid": "PU:CXr5", "entityType": "Disease", "charEnd": 659, "source": "PUBTATOR", "charStart": 649, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 3, "entityText": "lung cancer"}, {"duid": "PU:S8tV", "entityType": "Chemical", "charEnd": 434, "source": "PUBTATOR", "charStart": 424, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gemcitabine"}, {"duid": "PU:hRfj", "entityType": "Gene", "charEnd": 1239, "source": "PUBTATOR", "charStart": 1236, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "RRM1"}, {"duid": "PU:uhLb", "entityType": "Chemical", "charEnd": 1499, "source": "PUBTATOR", "charStart": 1492, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 7, "entityText": "platinum"}, {"duid": "PU:D8BQ", "entityType": "Chemical", "charEnd": 1279, "source": "PUBTATOR", "charStart": 1271, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 6, "entityText": "cisplatin"}, {"duid": "PU:QmrL", "entityType": "Disease", "charEnd": 1129, "source": "PUBTATOR", "charStart": 1126, "entityId": [{"idString": "D055752", "source": "MESH"}], "sentenceIndex": 5, "entityText": "SCLC"}, {"duid": "PU:nnf7", "entityType": "Gene", "charEnd": 39, "source": "PUBTATOR", "charStart": 35, "entityId": [{"idString": "2068", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC2"}, {"duid": "PU:XkCi", "entityType": "Gene", "charEnd": 29, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:Y8MX", "entityType": "Gene", "charEnd": 1440, "source": "PUBTATOR", "charStart": 1436, "entityId": [{"idString": "2068", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC2"}, {"duid": "PU:JY97", "entityType": "Gene", "charEnd": 1230, "source": "PUBTATOR", "charStart": 1226, "entityId": [{"idString": "2068", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC2"}, {"duid": "PU:W6tv", "entityType": "Gene", "charEnd": 549, "source": "PUBTATOR", "charStart": 546, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "RRM1"}, {"duid": "PU:ugku", "entityType": "Gene", "charEnd": 22, "source": "PUBTATOR", "charStart": 19, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "RRM1"}, {"duid": "PU:oxgr", "entityType": "Gene", "charEnd": 785, "source": "PUBTATOR", "charStart": 781, "entityId": [{"idString": "2068", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC2"}, {"duid": "PU:uequ", "entityType": "Gene", "charEnd": 341, "source": "PUBTATOR", "charStart": 337, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:zE4J", "entityType": "Chemical", "charEnd": 105, "source": "PUBTATOR", "charStart": 95, "entityId": [{"idString": "D016190", "source": "MESH"}], "sentenceIndex": 0, "entityText": "carboplatin"}, {"duid": "PU:T6TK", "entityType": "Gene", "charEnd": 1430, "source": "PUBTATOR", "charStart": 1426, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:awxE", "entityType": "Gene", "charEnd": 775, "source": "PUBTATOR", "charStart": 771, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:34Ho", "entityType": "Chemical", "charEnd": 411, "source": "PUBTATOR", "charStart": 404, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:FXDQ", "entityType": "Chemical", "charEnd": 897, "source": "PUBTATOR", "charStart": 889, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 4, "entityText": "cisplatin"}, {"duid": "PU:zQJs", "entityType": "Gene", "charEnd": 566, "source": "PUBTATOR", "charStart": 562, "entityId": [{"idString": "2068", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC2"}, {"duid": "PU:p9aY", "entityType": "Chemical", "charEnd": 1292, "source": "PUBTATOR", "charStart": 1282, "entityId": [{"idString": "D016190", "source": "MESH"}], "sentenceIndex": 6, "entityText": "carboplatin"}, {"duid": "PU:nmPR", "entityType": "Chemical", "charEnd": 926, "source": "PUBTATOR", "charStart": 916, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 4, "entityText": "gemcitabine"}, {"duid": "PU:FiUs", "entityType": "Gene", "charEnd": 289, "source": "PUBTATOR", "charStart": 286, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "RRM1"}, {"duid": "PU:y7qL", "entityType": "Disease", "charEnd": 142, "source": "PUBTATOR", "charStart": 132, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 0, "entityText": "lung cancer"}, {"duid": "PU:m4ZA", "entityType": "Disease", "charEnd": 726, "source": "PUBTATOR", "charStart": 723, "entityId": [{"idString": "D055752", "source": "MESH"}], "sentenceIndex": 3, "entityText": "SCLC"}, {"duid": "PU:qCyZ", "entityType": "Gene", "charEnd": 1423, "source": "PUBTATOR", "charStart": 1420, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM1"}, {"duid": "PU:8iLp", "entityType": "Gene", "charEnd": 283, "source": "PUBTATOR", "charStart": 257, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ribonucleotide reductase M1"}, {"duid": "PU:WuF4", "entityType": "Chemical", "charEnd": 270, "source": "PUBTATOR", "charStart": 257, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "ribonucleotide"}, {"duid": "PU:MZdo", "entityType": "Disease", "charEnd": 617, "source": "PUBTATOR", "charStart": 607, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 2, "entityText": "lung cancer"}, {"duid": "PU:joPK", "entityType": "Gene", "charEnd": 1223, "source": "PUBTATOR", "charStart": 1219, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:dBs4", "entityType": "Chemical", "charEnd": 1307, "source": "PUBTATOR", "charStart": 1297, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gemcitabine"}, {"duid": "PU:Xhyb", "entityType": "Gene", "charEnd": 1095, "source": "PUBTATOR", "charStart": 1092, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "RRM1"}, {"duid": "PU:YmAb", "entityType": "Chemical", "charEnd": 959, "source": "PUBTATOR", "charStart": 949, "entityId": [], "sentenceIndex": 4, "entityText": "tetrazolium"}, {"duid": "PU:LJbc", "entityType": "Gene", "charEnd": 768, "source": "PUBTATOR", "charStart": 765, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "RRM1"}, {"duid": "PU:UoGm", "entityType": "Chemical", "charEnd": 910, "source": "PUBTATOR", "charStart": 900, "entityId": [{"idString": "D016190", "source": "MESH"}], "sentenceIndex": 4, "entityText": "carboplatin"}, {"duid": "PU:7q5V", "entityType": "Gene", "charEnd": 556, "source": "PUBTATOR", "charStart": 552, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:3A73", "entityType": "Disease", "charEnd": 720, "source": "PUBTATOR", "charStart": 698, "entityId": [{"idString": "D055752", "source": "MESH"}], "sentenceIndex": 3, "entityText": "small cell lung cancers"}]}
{"text": "Clinical significance of the thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase mRNA expressions in hepatocellular carcinoma patients receiving 5-fluorouracil-based transarterial chemoembolization treatment. PURPOSE: To determine whether 5-fluorouracil (5-FU) sensitivity is associated with the mRNA expressions of thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), and thymidine phosphorylase (TP) in patients with hepatocellular carcinoma (HCC) treated with 5-FU-based transarterial chemoembolization (TACE). METHODS: Formalin-fixed, paraffin-embedded tumor specimens from 40 patients treated with 5-FU-based TACE were selected for the examination of TS, DPD, and TP expression level by a quantitative real-time reverse transcription- polymerase chain reaction (PCR) technique. Patients were categorized into high and low expression groups according to the median expression level of each enzyme. Associations between the mRNA expression levels of TS, DPD, and TP and clinical parameters including treatment efficacies, clinicopathological factors, and prognosis were assessed. RESULTS: High DPD expression was associated with worse treatment outcome, including intrahepatic disease progression rate (hazard ratio [HR] for high DPD versus low DPD, 2.212; 95% confidence interval [CI], 1.030-4.753; P = 0.042), extrahepatic disease progression rate (HR for high versus low DPD, 3.171; 95% CI, 1.003-10.023; P = 0.049), and progression-free survival (HR for high versus low DPD, 2.308; 95% CI, 1.102-4.836; P = 0.027). No correlation was found between the mRNA expression of TS/TP and treatment outcome. CONCLUSION: DPD mRNA expression level was negatively correlated with the clinical outcomes of HCC patients treated with 5-FU-based TACE. These results provide indirect evidence that high DPD mRNA expression is a predictive marker of treatment resistance for 5-FU.", "title": {"charStart": 0, "charEnd": 238}, "docId": "23861589", "entity": [{"duid": "PU:Rkeg", "entityType": "Gene", "charEnd": 48, "source": "PUBTATOR", "charStart": 29, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidylate synthase"}, {"duid": "PU:oRtt", "entityType": "Species", "charEnd": 632, "source": "PUBTATOR", "charStart": 625, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:evAq", "entityType": "Gene", "charEnd": 1143, "source": "PUBTATOR", "charStart": 1141, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "DPD"}, {"duid": "PU:SmVP", "entityType": "Disease", "charEnd": 491, "source": "PUBTATOR", "charStart": 489, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 1, "entityText": "HCC"}, {"duid": "PU:Ye4F", "entityType": "Species", "charEnd": 164, "source": "PUBTATOR", "charStart": 157, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:GqWP", "entityType": "Chemical", "charEnd": 425, "source": "PUBTATOR", "charStart": 417, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}, {"duid": "PU:2fje", "entityType": "Chemical", "charEnd": 67, "source": "PUBTATOR", "charStart": 51, "entityId": [], "sentenceIndex": 0, "entityText": "dihydropyrimidine"}, {"duid": "PU:uCFi", "entityType": "Gene", "charEnd": 1665, "source": "PUBTATOR", "charStart": 1663, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "DPD"}, {"duid": "PU:WVfc", "entityType": "Chemical", "charEnd": 289, "source": "PUBTATOR", "charStart": 286, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:vgUA", "entityType": "Chemical", "charEnd": 96, "source": "PUBTATOR", "charStart": 88, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "thymidine"}, {"duid": "PU:Xb7z", "entityType": "Gene", "charEnd": 1840, "source": "PUBTATOR", "charStart": 1838, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "DPD"}, {"duid": "PU:yPdU", "entityType": "Gene", "charEnd": 439, "source": "PUBTATOR", "charStart": 417, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidine phosphorylase"}, {"duid": "PU:uv82", "entityType": "Gene", "charEnd": 110, "source": "PUBTATOR", "charStart": 88, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidine phosphorylase"}, {"duid": "PU:RN7u", "entityType": "Gene", "charEnd": 443, "source": "PUBTATOR", "charStart": 442, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TP"}, {"duid": "PU:qYUT", "entityType": "Gene", "charEnd": 1423, "source": "PUBTATOR", "charStart": 1421, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "DPD"}, {"duid": "PU:Q6SM", "entityType": "Gene", "charEnd": 1003, "source": "PUBTATOR", "charStart": 1001, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "DPD"}, {"duid": "PU:va5V", "entityType": "Species", "charEnd": 834, "source": "PUBTATOR", "charStart": 827, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "Patients"}, {"duid": "PU:KfuT", "entityType": "Disease", "charEnd": 370, "source": "PUBTATOR", "charStart": 369, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:pFZU", "entityType": "Gene", "charEnd": 409, "source": "PUBTATOR", "charStart": 407, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "DPD"}, {"duid": "PU:roN3", "entityType": "Chemical", "charEnd": 189, "source": "PUBTATOR", "charStart": 176, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-fluorouracil"}, {"duid": "PU:tWQY", "entityType": "Disease", "charEnd": 605, "source": "PUBTATOR", "charStart": 601, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:Gq4r", "entityType": "Chemical", "charEnd": 510, "source": "PUBTATOR", "charStart": 507, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:qpcK", "entityType": "Disease", "charEnd": 701, "source": "PUBTATOR", "charStart": 700, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:HdED", "entityType": "Gene", "charEnd": 714, "source": "PUBTATOR", "charStart": 713, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TP"}, {"duid": "PU:YjDq", "entityType": "Gene", "charEnd": 1523, "source": "PUBTATOR", "charStart": 1521, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "DPD"}, {"duid": "PU:o9en", "entityType": "Species", "charEnd": 456, "source": "PUBTATOR", "charStart": 449, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:xUbt", "entityType": "Chemical", "charEnd": 283, "source": "PUBTATOR", "charStart": 270, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-fluorouracil"}, {"duid": "PU:eVkx", "entityType": "Disease", "charEnd": 486, "source": "PUBTATOR", "charStart": 463, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 1, "entityText": "hepatocellular carcinoma"}, {"duid": "PU:xwbo", "entityType": "Gene", "charEnd": 1626, "source": "PUBTATOR", "charStart": 1625, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TP"}, {"duid": "PU:o8JT", "entityType": "Disease", "charEnd": 998, "source": "PUBTATOR", "charStart": 997, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:7zHm", "entityType": "Chemical", "charEnd": 1912, "source": "PUBTATOR", "charStart": 1909, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 8, "entityText": "5-FU"}, {"duid": "PU:LZbV", "entityType": "Disease", "charEnd": 1747, "source": "PUBTATOR", "charStart": 1745, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 7, "entityText": "HCC"}, {"duid": "PU:SbAz", "entityType": "Gene", "charEnd": 706, "source": "PUBTATOR", "charStart": 704, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "DPD"}, {"duid": "PU:BFAY", "entityType": "Chemical", "charEnd": 650, "source": "PUBTATOR", "charStart": 647, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-FU"}, {"duid": "PU:j2ME", "entityType": "Species", "charEnd": 1756, "source": "PUBTATOR", "charStart": 1749, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:Phqw", "entityType": "Gene", "charEnd": 1294, "source": "PUBTATOR", "charStart": 1292, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "DPD"}, {"duid": "PU:dKut", "entityType": "Chemical", "charEnd": 1774, "source": "PUBTATOR", "charStart": 1771, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 7, "entityText": "5-FU"}, {"duid": "PU:ihxy", "entityType": "Disease", "charEnd": 155, "source": "PUBTATOR", "charStart": 132, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 0, "entityText": "hepatocellular carcinoma"}, {"duid": "PU:VcVo", "entityType": "Chemical", "charEnd": 390, "source": "PUBTATOR", "charStart": 374, "entityId": [], "sentenceIndex": 1, "entityText": "dihydropyrimidine"}, {"duid": "PU:S5X5", "entityType": "Gene", "charEnd": 81, "source": "PUBTATOR", "charStart": 51, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "dihydropyrimidine dehydrogenase"}, {"duid": "PU:jxBz", "entityType": "Disease", "charEnd": 1623, "source": "PUBTATOR", "charStart": 1622, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:yh4p", "entityType": "Gene", "charEnd": 366, "source": "PUBTATOR", "charStart": 347, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:Prx2", "entityType": "Chemical", "charEnd": 590, "source": "PUBTATOR", "charStart": 583, "entityId": [{"idString": "D010232", "source": "MESH"}], "sentenceIndex": 2, "entityText": "paraffin"}, {"duid": "PU:VELY", "entityType": "Gene", "charEnd": 1011, "source": "PUBTATOR", "charStart": 1010, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TP"}, {"duid": "PU:ozFd", "entityType": "Gene", "charEnd": 404, "source": "PUBTATOR", "charStart": 374, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "dihydropyrimidine dehydrogenase"}, {"duid": "PU:qAkF", "entityType": "Gene", "charEnd": 1279, "source": "PUBTATOR", "charStart": 1277, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "DPD"}]}
{"text": "Clinical significance of the thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase mRNA expressions in hepatocellular carcinoma patients receiving 5-fluorouracil-based transarterial chemoembolization treatment. PURPOSE: To determine whether 5-fluorouracil (5-FU) sensitivity is associated with the mRNA expressions of thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), and thymidine phosphorylase (TP) in patients with hepatocellular carcinoma (HCC) treated with 5-FU-based transarterial chemoembolization (TACE). METHODS: Formalin-fixed, paraffin-embedded tumor specimens from 40 patients treated with 5-FU-based TACE were selected for the examination of TS, DPD, and TP expression level by a quantitative real-time reverse transcription- polymerase chain reaction (PCR) technique. Patients were categorized into high and low expression groups according to the median expression level of each enzyme. Associations between the mRNA expression levels of TS, DPD, and TP and clinical parameters including treatment efficacies, clinicopathological factors, and prognosis were assessed. RESULTS: High DPD expression was associated with worse treatment outcome, including intrahepatic disease progression rate (hazard ratio [HR] for high DPD versus low DPD, 2.212; 95% confidence interval [CI], 1.030-4.753; P = 0.042), extrahepatic disease progression rate (HR for high versus low DPD, 3.171; 95% CI, 1.003-10.023; P = 0.049), and progression-free survival (HR for high versus low DPD, 2.308; 95% CI, 1.102-4.836; P = 0.027). No correlation was found between the mRNA expression of TS/TP and treatment outcome. CONCLUSION: DPD mRNA expression level was negatively correlated with the clinical outcomes of HCC patients treated with 5-FU-based TACE. These results provide indirect evidence that high DPD mRNA expression is a predictive marker of treatment resistance for 5-FU.", "title": {"charStart": 0, "charEnd": 238}, "docId": "23861589", "entity": [{"duid": "PU:Rkeg", "entityType": "Gene", "charEnd": 48, "source": "PUBTATOR", "charStart": 29, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidylate synthase"}, {"duid": "PU:oRtt", "entityType": "Species", "charEnd": 632, "source": "PUBTATOR", "charStart": 625, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:evAq", "entityType": "Gene", "charEnd": 1143, "source": "PUBTATOR", "charStart": 1141, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "DPD"}, {"duid": "PU:SmVP", "entityType": "Disease", "charEnd": 491, "source": "PUBTATOR", "charStart": 489, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 1, "entityText": "HCC"}, {"duid": "PU:Ye4F", "entityType": "Species", "charEnd": 164, "source": "PUBTATOR", "charStart": 157, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:GqWP", "entityType": "Chemical", "charEnd": 425, "source": "PUBTATOR", "charStart": 417, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}, {"duid": "PU:2fje", "entityType": "Chemical", "charEnd": 67, "source": "PUBTATOR", "charStart": 51, "entityId": [], "sentenceIndex": 0, "entityText": "dihydropyrimidine"}, {"duid": "PU:uCFi", "entityType": "Gene", "charEnd": 1665, "source": "PUBTATOR", "charStart": 1663, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "DPD"}, {"duid": "PU:WVfc", "entityType": "Chemical", "charEnd": 289, "source": "PUBTATOR", "charStart": 286, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:vgUA", "entityType": "Chemical", "charEnd": 96, "source": "PUBTATOR", "charStart": 88, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "thymidine"}, {"duid": "PU:Xb7z", "entityType": "Gene", "charEnd": 1840, "source": "PUBTATOR", "charStart": 1838, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "DPD"}, {"duid": "PU:yPdU", "entityType": "Gene", "charEnd": 439, "source": "PUBTATOR", "charStart": 417, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidine phosphorylase"}, {"duid": "PU:uv82", "entityType": "Gene", "charEnd": 110, "source": "PUBTATOR", "charStart": 88, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidine phosphorylase"}, {"duid": "PU:RN7u", "entityType": "Gene", "charEnd": 443, "source": "PUBTATOR", "charStart": 442, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TP"}, {"duid": "PU:qYUT", "entityType": "Gene", "charEnd": 1423, "source": "PUBTATOR", "charStart": 1421, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "DPD"}, {"duid": "PU:Q6SM", "entityType": "Gene", "charEnd": 1003, "source": "PUBTATOR", "charStart": 1001, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "DPD"}, {"duid": "PU:va5V", "entityType": "Species", "charEnd": 834, "source": "PUBTATOR", "charStart": 827, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "Patients"}, {"duid": "PU:KfuT", "entityType": "Disease", "charEnd": 370, "source": "PUBTATOR", "charStart": 369, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:pFZU", "entityType": "Gene", "charEnd": 409, "source": "PUBTATOR", "charStart": 407, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "DPD"}, {"duid": "PU:roN3", "entityType": "Chemical", "charEnd": 189, "source": "PUBTATOR", "charStart": 176, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-fluorouracil"}, {"duid": "PU:tWQY", "entityType": "Disease", "charEnd": 605, "source": "PUBTATOR", "charStart": 601, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:Gq4r", "entityType": "Chemical", "charEnd": 510, "source": "PUBTATOR", "charStart": 507, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:qpcK", "entityType": "Disease", "charEnd": 701, "source": "PUBTATOR", "charStart": 700, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:HdED", "entityType": "Gene", "charEnd": 714, "source": "PUBTATOR", "charStart": 713, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TP"}, {"duid": "PU:YjDq", "entityType": "Gene", "charEnd": 1523, "source": "PUBTATOR", "charStart": 1521, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "DPD"}, {"duid": "PU:o9en", "entityType": "Species", "charEnd": 456, "source": "PUBTATOR", "charStart": 449, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:xUbt", "entityType": "Chemical", "charEnd": 283, "source": "PUBTATOR", "charStart": 270, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-fluorouracil"}, {"duid": "PU:eVkx", "entityType": "Disease", "charEnd": 486, "source": "PUBTATOR", "charStart": 463, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 1, "entityText": "hepatocellular carcinoma"}, {"duid": "PU:xwbo", "entityType": "Gene", "charEnd": 1626, "source": "PUBTATOR", "charStart": 1625, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TP"}, {"duid": "PU:o8JT", "entityType": "Disease", "charEnd": 998, "source": "PUBTATOR", "charStart": 997, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:7zHm", "entityType": "Chemical", "charEnd": 1912, "source": "PUBTATOR", "charStart": 1909, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 8, "entityText": "5-FU"}, {"duid": "PU:LZbV", "entityType": "Disease", "charEnd": 1747, "source": "PUBTATOR", "charStart": 1745, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 7, "entityText": "HCC"}, {"duid": "PU:SbAz", "entityType": "Gene", "charEnd": 706, "source": "PUBTATOR", "charStart": 704, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "DPD"}, {"duid": "PU:BFAY", "entityType": "Chemical", "charEnd": 650, "source": "PUBTATOR", "charStart": 647, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-FU"}, {"duid": "PU:j2ME", "entityType": "Species", "charEnd": 1756, "source": "PUBTATOR", "charStart": 1749, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:Phqw", "entityType": "Gene", "charEnd": 1294, "source": "PUBTATOR", "charStart": 1292, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "DPD"}, {"duid": "PU:dKut", "entityType": "Chemical", "charEnd": 1774, "source": "PUBTATOR", "charStart": 1771, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 7, "entityText": "5-FU"}, {"duid": "PU:ihxy", "entityType": "Disease", "charEnd": 155, "source": "PUBTATOR", "charStart": 132, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 0, "entityText": "hepatocellular carcinoma"}, {"duid": "PU:VcVo", "entityType": "Chemical", "charEnd": 390, "source": "PUBTATOR", "charStart": 374, "entityId": [], "sentenceIndex": 1, "entityText": "dihydropyrimidine"}, {"duid": "PU:S5X5", "entityType": "Gene", "charEnd": 81, "source": "PUBTATOR", "charStart": 51, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "dihydropyrimidine dehydrogenase"}, {"duid": "PU:jxBz", "entityType": "Disease", "charEnd": 1623, "source": "PUBTATOR", "charStart": 1622, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:yh4p", "entityType": "Gene", "charEnd": 366, "source": "PUBTATOR", "charStart": 347, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:Prx2", "entityType": "Chemical", "charEnd": 590, "source": "PUBTATOR", "charStart": 583, "entityId": [{"idString": "D010232", "source": "MESH"}], "sentenceIndex": 2, "entityText": "paraffin"}, {"duid": "PU:VELY", "entityType": "Gene", "charEnd": 1011, "source": "PUBTATOR", "charStart": 1010, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TP"}, {"duid": "PU:ozFd", "entityType": "Gene", "charEnd": 404, "source": "PUBTATOR", "charStart": 374, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "dihydropyrimidine dehydrogenase"}, {"duid": "PU:qAkF", "entityType": "Gene", "charEnd": 1279, "source": "PUBTATOR", "charStart": 1277, "entityId": [{"idString": "1806", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "DPD"}]}
{"text": "Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma? BACKGROUND: RRM1 and ERCC1 overexpression has been extensively investigated as potential predictive markers of tumor sensitivity to conventional chemotherapy agents, most thoroughly in lung cancer. However, data in pancreatic cancer are scarce. METHODS: We investigated the mRNA and protein expression of ERCC1 and RRM1 by RT-PCR and immunohistochemistry (IHC) in formalin-fixed, paraffin-embedded pancreatic ductal carcinoma (PDA) tissues. The primary outcome investigated was the association between RRM1 and ERCC1 expression and overall survival (OS) or disease-free survival (DFS). RESULTS: A total of 94 patients with resected PDA were included in this study. Most of them (87%) received gemcitabine based chemotherapy. Data for OS analysis was available in all cases but only 68% had enough information to estimate DFS. IHC analysis revealed information for 99% (93/94) and 100% of the cases for RRM1 and ERCC1 expression respectively. However, PCR data interpretation was possible in only 49 (52%) and 79 (84%) cases respectively. There was no significant association between high or low expression of either RRM1 or ERCC1, detected by IHC and OS (14.4 vs. 19.9 months; P = 0.5 and 17.1 vs. 19.9; P = 0.83 respectively) or PCR and OS (48.0 vs. 24.1 months; P = 0.21 and 22.0 vs. 16.0 months; P = 0.39 respectively). Similar results were obtained for DFS. CONCLUSIONS: RRM1 and ERCC1 expression does not seem to have a clear predictive or prognostic value in pancreatic cancer. Our data raise some questions regarding the real clinical and practical significance of analyzing these molecules as predictors of outcomes.", "title": {"charStart": 0, "charEnd": 103}, "docId": "22436573", "entity": [{"duid": "PU:MXM3", "entityType": "Gene", "charEnd": 1224, "source": "PUBTATOR", "charStart": 1221, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "RRM1"}, {"duid": "PU:wEE3", "entityType": "Disease", "charEnd": 1586, "source": "PUBTATOR", "charStart": 1570, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 12, "entityText": "pancreatic cancer"}, {"duid": "PU:Mo97", "entityType": "Chemical", "charEnd": 808, "source": "PUBTATOR", "charStart": 798, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gemcitabine"}, {"duid": "PU:PSQm", "entityType": "Gene", "charEnd": 1010, "source": "PUBTATOR", "charStart": 1007, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "RRM1"}, {"duid": "PU:8fow", "entityType": "Disease", "charEnd": 1257, "source": "PUBTATOR", "charStart": 1256, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 10, "entityText": "OS"}, {"duid": "PU:CizS", "entityType": "Gene", "charEnd": 1020, "source": "PUBTATOR", "charStart": 1016, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:jzbV", "entityType": "Gene", "charEnd": 1233, "source": "PUBTATOR", "charStart": 1229, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:YZ6z", "entityType": "Gene", "charEnd": 414, "source": "PUBTATOR", "charStart": 410, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:gbbK", "entityType": "Gene", "charEnd": 610, "source": "PUBTATOR", "charStart": 607, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RRM1"}, {"duid": "PU:a4qj", "entityType": "Gene", "charEnd": 620, "source": "PUBTATOR", "charStart": 616, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:aF7H", "entityType": "Gene", "charEnd": 130, "source": "PUBTATOR", "charStart": 126, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:st6r", "entityType": "Gene", "charEnd": 55, "source": "PUBTATOR", "charStart": 51, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:AdhM", "entityType": "Gene", "charEnd": 423, "source": "PUBTATOR", "charStart": 420, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "RRM1"}, {"duid": "PU:ekHY", "entityType": "Gene", "charEnd": 45, "source": "PUBTATOR", "charStart": 42, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "RRM1"}, {"duid": "PU:g9ag", "entityType": "Gene", "charEnd": 1483, "source": "PUBTATOR", "charStart": 1480, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "RRM1"}, {"duid": "PU:6BR2", "entityType": "Disease", "charEnd": 529, "source": "PUBTATOR", "charStart": 503, "entityId": [{"idString": "D021441", "source": "MESH"}], "sentenceIndex": 3, "entityText": "pancreatic ductal carcinoma"}, {"duid": "PU:PJs5", "entityType": "Disease", "charEnd": 220, "source": "PUBTATOR", "charStart": 216, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumor"}, {"duid": "PU:Q5uV", "entityType": "Gene", "charEnd": 1493, "source": "PUBTATOR", "charStart": 1489, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "ERCC1"}, {"duid": "PU:RJ2i", "entityType": "Disease", "charEnd": 656, "source": "PUBTATOR", "charStart": 655, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 4, "entityText": "OS"}, {"duid": "PU:6xkT", "entityType": "Chemical", "charEnd": 476, "source": "PUBTATOR", "charStart": 469, "entityId": [{"idString": "D005557", "source": "MESH"}], "sentenceIndex": 3, "entityText": "formalin"}, {"duid": "PU:BSXA", "entityType": "Disease", "charEnd": 652, "source": "PUBTATOR", "charStart": 637, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 4, "entityText": "overall survival"}, {"duid": "PU:WjYp", "entityType": "Disease", "charEnd": 336, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 2, "entityText": "pancreatic cancer"}, {"duid": "PU:oV2X", "entityType": "Species", "charEnd": 721, "source": "PUBTATOR", "charStart": 714, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:4vRg", "entityType": "Disease", "charEnd": 739, "source": "PUBTATOR", "charStart": 737, "entityId": [{"idString": "D021441", "source": "MESH"}], "sentenceIndex": 5, "entityText": "PDA"}, {"duid": "PU:AhfQ", "entityType": "Disease", "charEnd": 534, "source": "PUBTATOR", "charStart": 532, "entityId": [{"idString": "D021441", "source": "MESH"}], "sentenceIndex": 3, "entityText": "PDA"}, {"duid": "PU:bQS4", "entityType": "Disease", "charEnd": 102, "source": "PUBTATOR", "charStart": 71, "entityId": [{"idString": "D021441", "source": "MESH"}], "sentenceIndex": 0, "entityText": "pancreatic ductal adenocarcinoma"}, {"duid": "PU:EQUJ", "entityType": "Disease", "charEnd": 840, "source": "PUBTATOR", "charStart": 839, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 7, "entityText": "OS"}, {"duid": "PU:SXz7", "entityType": "Gene", "charEnd": 120, "source": "PUBTATOR", "charStart": 117, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "RRM1"}, {"duid": "PU:3SKs", "entityType": "Disease", "charEnd": 300, "source": "PUBTATOR", "charStart": 290, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 1, "entityText": "lung cancer"}, {"duid": "PU:RtYR", "entityType": "Disease", "charEnd": 1344, "source": "PUBTATOR", "charStart": 1343, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 10, "entityText": "OS"}]}
{"text": "Temozolomide in advanced and recurrent uterine leiomyosarcoma and correlation with o6-methylguanine DNA methyltransferase expression: a case series. INTRODUCTION: Our objective was to retrospectively review temozolomide in advanced and recurrent uterine leiomyosarcoma and to determine if tumor O-methylguanine DNA methyltransferase (MGMT) expression correlated with clinical response. METHODS: All patients with advanced or recurrent uterine leiomyosarcoma who received temozolomide during treatment were retrospectively identified. Relevant clinical and pathologic data were collected and compared. O-Methylguanine DNA methyltransferase expression was assessed by immunohistochemistry and scored by a gynecologic pathologist blinded to clinical outcomes. RESULTS: From 1999 to 2008, 9 cases of leiomyosarcoma were diagnosed; 6 patients received temozolomide. Median follow-up was 54 months (range, 4-114 months). There was 1 patient with complete response, 1 durable partial response (27+ months), 3 stable disease (range, 3-10 months), and 1 progressive disease. Overall, 5 out of 6 patients derived clinical benefit. The patient with a complete response recurred 18 months after her last cycle. Median progression free interval was 15.4 months (95% confidence interval, 9.4-21.4). Two patients died of disease. Temozolomide was well tolerated with no dose-limiting toxicities, and no dose adjustments were required in 64 prescribed cycles. The MGMT expression was inversely correlated with response to temozolomide. Patients with tumors negative for MGMT expression had a median progression free interval of 18.5 months compared with 3 months for those whose tumors were positive, although not statistically significant. CONCLUSIONS: Temozolomide is an easily administered, well-tolerated chemotherapeutic option in advanced or recurrent uterine leiomyosarcomas with a reasonable response rate. Assessment of MGMT expression may identify a subset of patients that will respond optimally to this therapy.", "title": {"charStart": 0, "charEnd": 147}, "docId": "20130512", "entity": [{"duid": "PU:WzDG", "entityType": "Chemical", "charEnd": 615, "source": "PUBTATOR", "charStart": 601, "entityId": [], "sentenceIndex": 4, "entityText": "O-Methylguanine"}, {"duid": "PU:NCSb", "entityType": "Species", "charEnd": 1527, "source": "PUBTATOR", "charStart": 1520, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 14, "entityText": "Patients"}, {"duid": "PU:k57W", "entityType": "Disease", "charEnd": 267, "source": "PUBTATOR", "charStart": 246, "entityId": [{"idString": "D007890", "source": "MESH"}], "sentenceIndex": 1, "entityText": "uterine leiomyosarcoma"}, {"duid": "PU:TWWV", "entityType": "Chemical", "charEnd": 1749, "source": "PUBTATOR", "charStart": 1738, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 15, "entityText": "Temozolomide"}, {"duid": "PU:qLFL", "entityType": "Disease", "charEnd": 809, "source": "PUBTATOR", "charStart": 796, "entityId": [{"idString": "D007890", "source": "MESH"}], "sentenceIndex": 5, "entityText": "leiomyosarcoma"}, {"duid": "PU:R3ao", "entityType": "Chemical", "charEnd": 1517, "source": "PUBTATOR", "charStart": 1506, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 13, "entityText": "temozolomide"}, {"duid": "PU:stfb", "entityType": "Gene", "charEnd": 637, "source": "PUBTATOR", "charStart": 603, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "Methylguanine DNA methyltransferase"}, {"duid": "PU:tcpM", "entityType": "Disease", "charEnd": 1668, "source": "PUBTATOR", "charStart": 1663, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 14, "entityText": "tumors"}, {"duid": "PU:haua", "entityType": "Chemical", "charEnd": 1326, "source": "PUBTATOR", "charStart": 1315, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 12, "entityText": "Temozolomide"}, {"duid": "PU:tiXi", "entityType": "Chemical", "charEnd": 858, "source": "PUBTATOR", "charStart": 847, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 5, "entityText": "temozolomide"}, {"duid": "PU:RivA", "entityType": "Disease", "charEnd": 60, "source": "PUBTATOR", "charStart": 39, "entityId": [{"idString": "D007890", "source": "MESH"}], "sentenceIndex": 0, "entityText": "uterine leiomyosarcoma"}, {"duid": "PU:Zr6W", "entityType": "Chemical", "charEnd": 309, "source": "PUBTATOR", "charStart": 295, "entityId": [], "sentenceIndex": 1, "entityText": "O-methylguanine"}, {"duid": "PU:5rzH", "entityType": "Disease", "charEnd": 1539, "source": "PUBTATOR", "charStart": 1534, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 14, "entityText": "tumors"}, {"duid": "PU:UxdS", "entityType": "Gene", "charEnd": 120, "source": "PUBTATOR", "charStart": 83, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "o6-methylguanine DNA methyltransferase"}, {"duid": "PU:8HKd", "entityType": "Chemical", "charEnd": 11, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Temozolomide"}, {"duid": "PU:onhm", "entityType": "Chemical", "charEnd": 482, "source": "PUBTATOR", "charStart": 471, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 2, "entityText": "temozolomide"}, {"duid": "PU:Zfkj", "entityType": "Species", "charEnd": 1296, "source": "PUBTATOR", "charStart": 1289, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:J5PX", "entityType": "Disease", "charEnd": 293, "source": "PUBTATOR", "charStart": 289, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumor"}, {"duid": "PU:UyHT", "entityType": "Gene", "charEnd": 331, "source": "PUBTATOR", "charStart": 295, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "O-methylguanine DNA methyltransferase"}, {"duid": "PU:RLuv", "entityType": "Gene", "charEnd": 1916, "source": "PUBTATOR", "charStart": 1913, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 16, "entityText": "MGMT"}, {"duid": "PU:6Jfv", "entityType": "Species", "charEnd": 836, "source": "PUBTATOR", "charStart": 829, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:wsaj", "entityType": "Species", "charEnd": 933, "source": "PUBTATOR", "charStart": 927, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patient"}, {"duid": "PU:Rip9", "entityType": "Gene", "charEnd": 1557, "source": "PUBTATOR", "charStart": 1554, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "MGMT"}, {"duid": "PU:vUAR", "entityType": "Species", "charEnd": 1093, "source": "PUBTATOR", "charStart": 1086, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:rkFv", "entityType": "Species", "charEnd": 1131, "source": "PUBTATOR", "charStart": 1125, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patient"}, {"duid": "PU:qhTm", "entityType": "Species", "charEnd": 406, "source": "PUBTATOR", "charStart": 399, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:QVQU", "entityType": "Species", "charEnd": 1961, "source": "PUBTATOR", "charStart": 1954, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 16, "entityText": "patients"}, {"duid": "PU:GqnM", "entityType": "Gene", "charEnd": 337, "source": "PUBTATOR", "charStart": 334, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "MGMT"}, {"duid": "PU:Bpgy", "entityType": "Chemical", "charEnd": 98, "source": "PUBTATOR", "charStart": 83, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 0, "entityText": "o6-methylguanine"}, {"duid": "PU:nmo4", "entityType": "Disease", "charEnd": 456, "source": "PUBTATOR", "charStart": 435, "entityId": [{"idString": "D007890", "source": "MESH"}], "sentenceIndex": 2, "entityText": "uterine leiomyosarcoma"}, {"duid": "PU:LuyA", "entityType": "Disease", "charEnd": 1378, "source": "PUBTATOR", "charStart": 1369, "entityId": [{"idString": "D064420", "source": "MESH"}], "sentenceIndex": 12, "entityText": "toxicities"}, {"duid": "PU:eV3B", "entityType": "Gene", "charEnd": 1451, "source": "PUBTATOR", "charStart": 1448, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "MGMT"}, {"duid": "PU:ABNa", "entityType": "Disease", "charEnd": 1864, "source": "PUBTATOR", "charStart": 1842, "entityId": [{"idString": "D007890", "source": "MESH"}], "sentenceIndex": 15, "entityText": "uterine leiomyosarcomas"}, {"duid": "PU:oZtL", "entityType": "Chemical", "charEnd": 218, "source": "PUBTATOR", "charStart": 207, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "temozolomide"}]}
{"text": "Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines. Five-year survival rate for lung cancer is limited to 10% to 15%. Therefore, the identification of novel therapeutic prognostic factors is an urgent requirement. The aim of this study is thus to highlight specific biomarkers in chemoresistant non-small cell lung cancer cell lines. Therefore, we checked-in the control condition as well as after short-term pharmacological treatment with either docetaxel or gemcitabine-the expression of genes such as tumor suppressor genes (CDKN2A, DAPK, FHIT, GSTP1, MGMT, RAR\u03b22, RASSF1A, and TIMP3), genes associated with drug resistance (BRCA1, COX2, ERCC1, IGFBP3, RRM1, and TUBB3), and stemness-related genes (CD133, OCT4, and SLUG) in two cellular models of squamous carcinoma (CAEP) and adenocarcinoma (RAL) of the lung originally established. Their promoter methylation profile was also evaluated. Drug-related genes were upregulated. Cisplatin resistance matched with high levels of BRCA1 and ERCC1 in both cell lines; docetaxel sensitivity of CAEP cells was associated to levels of TUBB3 lower than RAL cells. Although CAEP cells were more sensitive to gemcitabine, both cell lines showed high levels of RRM1. Stemness-related genes were downregulated in the control condition but became upregulated in docetaxel-resistant cells, indicating the selection of a population with stemness features. We did not find an unequivocal correspondence between gene expression and respective DNA promoter methylation status, suggesting the involvement of additional mechanisms of gene expression regulation. These results highlight specific biomarkers consistent with the different responses of the two cell lines to standard pharmacological treatments and indicate specific molecular traits for their chemoresistance.", "title": {"charStart": 0, "charEnd": 91}, "docId": "23397475", "entity": [{"duid": "PU:QMQL", "entityType": "Gene", "charEnd": 615, "source": "PUBTATOR", "charStart": 609, "entityId": [{"idString": "11186", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RASSF1A"}, {"duid": "PU:Sim3", "entityType": "Chemical", "charEnd": 63, "source": "PUBTATOR", "charStart": 53, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Gemcitabine"}, {"duid": "PU:JgW6", "entityType": "Gene", "charEnd": 574, "source": "PUBTATOR", "charStart": 569, "entityId": [{"idString": "1029", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "CDKN2A"}, {"duid": "PU:M2Lv", "entityType": "Gene", "charEnd": 753, "source": "PUBTATOR", "charStart": 750, "entityId": [{"idString": "5460", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "OCT4"}, {"duid": "PU:bJhi", "entityType": "Gene", "charEnd": 679, "source": "PUBTATOR", "charStart": 676, "entityId": [{"idString": "4513", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "COX2"}, {"duid": "PU:sNHp", "entityType": "Gene", "charEnd": 711, "source": "PUBTATOR", "charStart": 707, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TUBB3"}, {"duid": "PU:SY4w", "entityType": "Gene", "charEnd": 686, "source": "PUBTATOR", "charStart": 682, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:Yht3", "entityType": "Disease", "charEnd": 361, "source": "PUBTATOR", "charStart": 336, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "non-small cell lung cancer"}, {"duid": "PU:pS68", "entityType": "Disease", "charEnd": 131, "source": "PUBTATOR", "charStart": 121, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 1, "entityText": "lung cancer"}, {"duid": "PU:qkqM", "entityType": "Gene", "charEnd": 1024, "source": "PUBTATOR", "charStart": 1020, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "BRCA1"}, {"duid": "PU:ufcx", "entityType": "Chemical", "charEnd": 1201, "source": "PUBTATOR", "charStart": 1191, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gemcitabine"}, {"duid": "PU:FJsh", "entityType": "Disease", "charEnd": 549, "source": "PUBTATOR", "charStart": 545, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumor"}, {"duid": "PU:2U7A", "entityType": "Chemical", "charEnd": 1349, "source": "PUBTATOR", "charStart": 1341, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 9, "entityText": "docetaxel"}, {"duid": "PU:4Uwk", "entityType": "Gene", "charEnd": 673, "source": "PUBTATOR", "charStart": 669, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "BRCA1"}, {"duid": "PU:RbcQ", "entityType": "Gene", "charEnd": 747, "source": "PUBTATOR", "charStart": 743, "entityId": [{"idString": "8842", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "CD133"}, {"duid": "PU:T72B", "entityType": "Gene", "charEnd": 593, "source": "PUBTATOR", "charStart": 589, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "GSTP1"}, {"duid": "PU:x66b", "entityType": "Gene", "charEnd": 1124, "source": "PUBTATOR", "charStart": 1120, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TUBB3"}, {"duid": "PU:dGfk", "entityType": "Gene", "charEnd": 626, "source": "PUBTATOR", "charStart": 622, "entityId": [{"idString": "7078", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TIMP3"}, {"duid": "PU:Xm74", "entityType": "Chemical", "charEnd": 1064, "source": "PUBTATOR", "charStart": 1056, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 7, "entityText": "docetaxel"}, {"duid": "PU:TcQ3", "entityType": "Gene", "charEnd": 580, "source": "PUBTATOR", "charStart": 577, "entityId": [{"idString": "1612", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "DAPK"}, {"duid": "PU:gPG8", "entityType": "Disease", "charEnd": 835, "source": "PUBTATOR", "charStart": 822, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 4, "entityText": "adenocarcinoma"}, {"duid": "PU:BP9p", "entityType": "Gene", "charEnd": 586, "source": "PUBTATOR", "charStart": 583, "entityId": [{"idString": "2272", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "FHIT"}, {"duid": "PU:MS9r", "entityType": "Gene", "charEnd": 700, "source": "PUBTATOR", "charStart": 697, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RRM1"}, {"duid": "PU:QqmM", "entityType": "Gene", "charEnd": 763, "source": "PUBTATOR", "charStart": 760, "entityId": [{"idString": "6591", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "SLUG"}, {"duid": "PU:fSEJ", "entityType": "Chemical", "charEnd": 496, "source": "PUBTATOR", "charStart": 488, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 4, "entityText": "docetaxel"}, {"duid": "PU:HTgq", "entityType": "Disease", "charEnd": 809, "source": "PUBTATOR", "charStart": 792, "entityId": [{"idString": "D002294", "source": "MESH"}], "sentenceIndex": 4, "entityText": "squamous carcinoma"}, {"duid": "PU:C2Hb", "entityType": "Gene", "charEnd": 599, "source": "PUBTATOR", "charStart": 596, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MGMT"}, {"duid": "PU:GYFW", "entityType": "Chemical", "charEnd": 979, "source": "PUBTATOR", "charStart": 971, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 7, "entityText": "Cisplatin"}, {"duid": "PU:og6m", "entityType": "Gene", "charEnd": 1034, "source": "PUBTATOR", "charStart": 1030, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:qiXA", "entityType": "Gene", "charEnd": 1245, "source": "PUBTATOR", "charStart": 1242, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "RRM1"}, {"duid": "PU:Uge5", "entityType": "Chemical", "charEnd": 511, "source": "PUBTATOR", "charStart": 501, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 4, "entityText": "gemcitabine"}, {"duid": "PU:qzE2", "entityType": "Gene", "charEnd": 694, "source": "PUBTATOR", "charStart": 689, "entityId": [{"idString": "3486", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "IGFBP3"}]}
{"text": "Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines. Five-year survival rate for lung cancer is limited to 10% to 15%. Therefore, the identification of novel therapeutic prognostic factors is an urgent requirement. The aim of this study is thus to highlight specific biomarkers in chemoresistant non-small cell lung cancer cell lines. Therefore, we checked-in the control condition as well as after short-term pharmacological treatment with either docetaxel or gemcitabine-the expression of genes such as tumor suppressor genes (CDKN2A, DAPK, FHIT, GSTP1, MGMT, RAR\u03b22, RASSF1A, and TIMP3), genes associated with drug resistance (BRCA1, COX2, ERCC1, IGFBP3, RRM1, and TUBB3), and stemness-related genes (CD133, OCT4, and SLUG) in two cellular models of squamous carcinoma (CAEP) and adenocarcinoma (RAL) of the lung originally established. Their promoter methylation profile was also evaluated. Drug-related genes were upregulated. Cisplatin resistance matched with high levels of BRCA1 and ERCC1 in both cell lines; docetaxel sensitivity of CAEP cells was associated to levels of TUBB3 lower than RAL cells. Although CAEP cells were more sensitive to gemcitabine, both cell lines showed high levels of RRM1. Stemness-related genes were downregulated in the control condition but became upregulated in docetaxel-resistant cells, indicating the selection of a population with stemness features. We did not find an unequivocal correspondence between gene expression and respective DNA promoter methylation status, suggesting the involvement of additional mechanisms of gene expression regulation. These results highlight specific biomarkers consistent with the different responses of the two cell lines to standard pharmacological treatments and indicate specific molecular traits for their chemoresistance.", "title": {"charStart": 0, "charEnd": 91}, "docId": "23397475", "entity": [{"duid": "PU:QMQL", "entityType": "Gene", "charEnd": 615, "source": "PUBTATOR", "charStart": 609, "entityId": [{"idString": "11186", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RASSF1A"}, {"duid": "PU:Sim3", "entityType": "Chemical", "charEnd": 63, "source": "PUBTATOR", "charStart": 53, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Gemcitabine"}, {"duid": "PU:JgW6", "entityType": "Gene", "charEnd": 574, "source": "PUBTATOR", "charStart": 569, "entityId": [{"idString": "1029", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "CDKN2A"}, {"duid": "PU:M2Lv", "entityType": "Gene", "charEnd": 753, "source": "PUBTATOR", "charStart": 750, "entityId": [{"idString": "5460", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "OCT4"}, {"duid": "PU:bJhi", "entityType": "Gene", "charEnd": 679, "source": "PUBTATOR", "charStart": 676, "entityId": [{"idString": "4513", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "COX2"}, {"duid": "PU:sNHp", "entityType": "Gene", "charEnd": 711, "source": "PUBTATOR", "charStart": 707, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TUBB3"}, {"duid": "PU:SY4w", "entityType": "Gene", "charEnd": 686, "source": "PUBTATOR", "charStart": 682, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:Yht3", "entityType": "Disease", "charEnd": 361, "source": "PUBTATOR", "charStart": 336, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "non-small cell lung cancer"}, {"duid": "PU:pS68", "entityType": "Disease", "charEnd": 131, "source": "PUBTATOR", "charStart": 121, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 1, "entityText": "lung cancer"}, {"duid": "PU:qkqM", "entityType": "Gene", "charEnd": 1024, "source": "PUBTATOR", "charStart": 1020, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "BRCA1"}, {"duid": "PU:ufcx", "entityType": "Chemical", "charEnd": 1201, "source": "PUBTATOR", "charStart": 1191, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gemcitabine"}, {"duid": "PU:FJsh", "entityType": "Disease", "charEnd": 549, "source": "PUBTATOR", "charStart": 545, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumor"}, {"duid": "PU:2U7A", "entityType": "Chemical", "charEnd": 1349, "source": "PUBTATOR", "charStart": 1341, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 9, "entityText": "docetaxel"}, {"duid": "PU:4Uwk", "entityType": "Gene", "charEnd": 673, "source": "PUBTATOR", "charStart": 669, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "BRCA1"}, {"duid": "PU:RbcQ", "entityType": "Gene", "charEnd": 747, "source": "PUBTATOR", "charStart": 743, "entityId": [{"idString": "8842", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "CD133"}, {"duid": "PU:T72B", "entityType": "Gene", "charEnd": 593, "source": "PUBTATOR", "charStart": 589, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "GSTP1"}, {"duid": "PU:x66b", "entityType": "Gene", "charEnd": 1124, "source": "PUBTATOR", "charStart": 1120, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TUBB3"}, {"duid": "PU:dGfk", "entityType": "Gene", "charEnd": 626, "source": "PUBTATOR", "charStart": 622, "entityId": [{"idString": "7078", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TIMP3"}, {"duid": "PU:Xm74", "entityType": "Chemical", "charEnd": 1064, "source": "PUBTATOR", "charStart": 1056, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 7, "entityText": "docetaxel"}, {"duid": "PU:TcQ3", "entityType": "Gene", "charEnd": 580, "source": "PUBTATOR", "charStart": 577, "entityId": [{"idString": "1612", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "DAPK"}, {"duid": "PU:gPG8", "entityType": "Disease", "charEnd": 835, "source": "PUBTATOR", "charStart": 822, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 4, "entityText": "adenocarcinoma"}, {"duid": "PU:BP9p", "entityType": "Gene", "charEnd": 586, "source": "PUBTATOR", "charStart": 583, "entityId": [{"idString": "2272", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "FHIT"}, {"duid": "PU:MS9r", "entityType": "Gene", "charEnd": 700, "source": "PUBTATOR", "charStart": 697, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RRM1"}, {"duid": "PU:QqmM", "entityType": "Gene", "charEnd": 763, "source": "PUBTATOR", "charStart": 760, "entityId": [{"idString": "6591", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "SLUG"}, {"duid": "PU:fSEJ", "entityType": "Chemical", "charEnd": 496, "source": "PUBTATOR", "charStart": 488, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 4, "entityText": "docetaxel"}, {"duid": "PU:HTgq", "entityType": "Disease", "charEnd": 809, "source": "PUBTATOR", "charStart": 792, "entityId": [{"idString": "D002294", "source": "MESH"}], "sentenceIndex": 4, "entityText": "squamous carcinoma"}, {"duid": "PU:C2Hb", "entityType": "Gene", "charEnd": 599, "source": "PUBTATOR", "charStart": 596, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MGMT"}, {"duid": "PU:GYFW", "entityType": "Chemical", "charEnd": 979, "source": "PUBTATOR", "charStart": 971, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 7, "entityText": "Cisplatin"}, {"duid": "PU:og6m", "entityType": "Gene", "charEnd": 1034, "source": "PUBTATOR", "charStart": 1030, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:qiXA", "entityType": "Gene", "charEnd": 1245, "source": "PUBTATOR", "charStart": 1242, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "RRM1"}, {"duid": "PU:Uge5", "entityType": "Chemical", "charEnd": 511, "source": "PUBTATOR", "charStart": 501, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 4, "entityText": "gemcitabine"}, {"duid": "PU:qzE2", "entityType": "Gene", "charEnd": 694, "source": "PUBTATOR", "charStart": 689, "entityId": [{"idString": "3486", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "IGFBP3"}]}
{"text": "Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines. Five-year survival rate for lung cancer is limited to 10% to 15%. Therefore, the identification of novel therapeutic prognostic factors is an urgent requirement. The aim of this study is thus to highlight specific biomarkers in chemoresistant non-small cell lung cancer cell lines. Therefore, we checked-in the control condition as well as after short-term pharmacological treatment with either docetaxel or gemcitabine-the expression of genes such as tumor suppressor genes (CDKN2A, DAPK, FHIT, GSTP1, MGMT, RAR\u03b22, RASSF1A, and TIMP3), genes associated with drug resistance (BRCA1, COX2, ERCC1, IGFBP3, RRM1, and TUBB3), and stemness-related genes (CD133, OCT4, and SLUG) in two cellular models of squamous carcinoma (CAEP) and adenocarcinoma (RAL) of the lung originally established. Their promoter methylation profile was also evaluated. Drug-related genes were upregulated. Cisplatin resistance matched with high levels of BRCA1 and ERCC1 in both cell lines; docetaxel sensitivity of CAEP cells was associated to levels of TUBB3 lower than RAL cells. Although CAEP cells were more sensitive to gemcitabine, both cell lines showed high levels of RRM1. Stemness-related genes were downregulated in the control condition but became upregulated in docetaxel-resistant cells, indicating the selection of a population with stemness features. We did not find an unequivocal correspondence between gene expression and respective DNA promoter methylation status, suggesting the involvement of additional mechanisms of gene expression regulation. These results highlight specific biomarkers consistent with the different responses of the two cell lines to standard pharmacological treatments and indicate specific molecular traits for their chemoresistance.", "title": {"charStart": 0, "charEnd": 91}, "docId": "23397475", "entity": [{"duid": "PU:QMQL", "entityType": "Gene", "charEnd": 615, "source": "PUBTATOR", "charStart": 609, "entityId": [{"idString": "11186", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RASSF1A"}, {"duid": "PU:Sim3", "entityType": "Chemical", "charEnd": 63, "source": "PUBTATOR", "charStart": 53, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Gemcitabine"}, {"duid": "PU:JgW6", "entityType": "Gene", "charEnd": 574, "source": "PUBTATOR", "charStart": 569, "entityId": [{"idString": "1029", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "CDKN2A"}, {"duid": "PU:M2Lv", "entityType": "Gene", "charEnd": 753, "source": "PUBTATOR", "charStart": 750, "entityId": [{"idString": "5460", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "OCT4"}, {"duid": "PU:bJhi", "entityType": "Gene", "charEnd": 679, "source": "PUBTATOR", "charStart": 676, "entityId": [{"idString": "4513", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "COX2"}, {"duid": "PU:sNHp", "entityType": "Gene", "charEnd": 711, "source": "PUBTATOR", "charStart": 707, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TUBB3"}, {"duid": "PU:SY4w", "entityType": "Gene", "charEnd": 686, "source": "PUBTATOR", "charStart": 682, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:Yht3", "entityType": "Disease", "charEnd": 361, "source": "PUBTATOR", "charStart": 336, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "non-small cell lung cancer"}, {"duid": "PU:pS68", "entityType": "Disease", "charEnd": 131, "source": "PUBTATOR", "charStart": 121, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 1, "entityText": "lung cancer"}, {"duid": "PU:qkqM", "entityType": "Gene", "charEnd": 1024, "source": "PUBTATOR", "charStart": 1020, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "BRCA1"}, {"duid": "PU:ufcx", "entityType": "Chemical", "charEnd": 1201, "source": "PUBTATOR", "charStart": 1191, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gemcitabine"}, {"duid": "PU:FJsh", "entityType": "Disease", "charEnd": 549, "source": "PUBTATOR", "charStart": 545, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumor"}, {"duid": "PU:2U7A", "entityType": "Chemical", "charEnd": 1349, "source": "PUBTATOR", "charStart": 1341, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 9, "entityText": "docetaxel"}, {"duid": "PU:4Uwk", "entityType": "Gene", "charEnd": 673, "source": "PUBTATOR", "charStart": 669, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "BRCA1"}, {"duid": "PU:RbcQ", "entityType": "Gene", "charEnd": 747, "source": "PUBTATOR", "charStart": 743, "entityId": [{"idString": "8842", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "CD133"}, {"duid": "PU:T72B", "entityType": "Gene", "charEnd": 593, "source": "PUBTATOR", "charStart": 589, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "GSTP1"}, {"duid": "PU:x66b", "entityType": "Gene", "charEnd": 1124, "source": "PUBTATOR", "charStart": 1120, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TUBB3"}, {"duid": "PU:dGfk", "entityType": "Gene", "charEnd": 626, "source": "PUBTATOR", "charStart": 622, "entityId": [{"idString": "7078", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TIMP3"}, {"duid": "PU:Xm74", "entityType": "Chemical", "charEnd": 1064, "source": "PUBTATOR", "charStart": 1056, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 7, "entityText": "docetaxel"}, {"duid": "PU:TcQ3", "entityType": "Gene", "charEnd": 580, "source": "PUBTATOR", "charStart": 577, "entityId": [{"idString": "1612", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "DAPK"}, {"duid": "PU:gPG8", "entityType": "Disease", "charEnd": 835, "source": "PUBTATOR", "charStart": 822, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 4, "entityText": "adenocarcinoma"}, {"duid": "PU:BP9p", "entityType": "Gene", "charEnd": 586, "source": "PUBTATOR", "charStart": 583, "entityId": [{"idString": "2272", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "FHIT"}, {"duid": "PU:MS9r", "entityType": "Gene", "charEnd": 700, "source": "PUBTATOR", "charStart": 697, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RRM1"}, {"duid": "PU:QqmM", "entityType": "Gene", "charEnd": 763, "source": "PUBTATOR", "charStart": 760, "entityId": [{"idString": "6591", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "SLUG"}, {"duid": "PU:fSEJ", "entityType": "Chemical", "charEnd": 496, "source": "PUBTATOR", "charStart": 488, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 4, "entityText": "docetaxel"}, {"duid": "PU:HTgq", "entityType": "Disease", "charEnd": 809, "source": "PUBTATOR", "charStart": 792, "entityId": [{"idString": "D002294", "source": "MESH"}], "sentenceIndex": 4, "entityText": "squamous carcinoma"}, {"duid": "PU:C2Hb", "entityType": "Gene", "charEnd": 599, "source": "PUBTATOR", "charStart": 596, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MGMT"}, {"duid": "PU:GYFW", "entityType": "Chemical", "charEnd": 979, "source": "PUBTATOR", "charStart": 971, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 7, "entityText": "Cisplatin"}, {"duid": "PU:og6m", "entityType": "Gene", "charEnd": 1034, "source": "PUBTATOR", "charStart": 1030, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:qiXA", "entityType": "Gene", "charEnd": 1245, "source": "PUBTATOR", "charStart": 1242, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "RRM1"}, {"duid": "PU:Uge5", "entityType": "Chemical", "charEnd": 511, "source": "PUBTATOR", "charStart": 501, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 4, "entityText": "gemcitabine"}, {"duid": "PU:qzE2", "entityType": "Gene", "charEnd": 694, "source": "PUBTATOR", "charStart": 689, "entityId": [{"idString": "3486", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "IGFBP3"}]}
{"text": "Topoisomerase levels determine chemotherapy response in vitro and in vivo. Topoisomerase poisons are chemotherapeutic agents that are used extensively for treating human malignancies. These drugs can be highly effective, yet tumors are frequently refractory to treatment or become resistant upon tumor relapse. Using a pool-based RNAi screening approach and a well characterized mouse model of lymphoma, we explored the genetic basis for heterogeneous responses to topoisomerase poisons in vitro and in vivo. These experiments identified Top2A expression levels as major determinants of response to the topoisomerase 2 poison doxorubicin and showed that suppression of Top2A produces resistance to doxorubicin in vitro and in vivo. Analogously, using a targeted RNAi approach, we demonstrated that suppression of Top1 produces resistance to the topoisomerase 1 poison camptothecin yet hypersensitizes cancer cells to doxorubicin. Importantly, lymphomas relapsing after treatment display spontaneous changes in topoisomerase levels as predicted by in vitro gene knockdown studies. These results highlight the utility of pooled shRNA screens for identifying genetic determinants of chemotherapy response and suggest strategies for improving the effectiveness of topoisomerase poisons in the clinic.", "title": {"charStart": 0, "charEnd": 73}, "docId": "18574145", "entity": [{"duid": "PU:BnYS", "entityType": "Chemical", "charEnd": 927, "source": "PUBTATOR", "charStart": 917, "entityId": [{"idString": "D004317", "source": "MESH"}], "sentenceIndex": 5, "entityText": "doxorubicin"}, {"duid": "PU:yNH7", "entityType": "Chemical", "charEnd": 708, "source": "PUBTATOR", "charStart": 698, "entityId": [{"idString": "D004317", "source": "MESH"}], "sentenceIndex": 4, "entityText": "doxorubicin"}, {"duid": "PU:MdKu", "entityType": "Species", "charEnd": 383, "source": "PUBTATOR", "charStart": 379, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "mouse"}, {"duid": "PU:icpx", "entityType": "Disease", "charEnd": 300, "source": "PUBTATOR", "charStart": 296, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:oHjH", "entityType": "Chemical", "charEnd": 879, "source": "PUBTATOR", "charStart": 868, "entityId": [{"idString": "D002166", "source": "MESH"}], "sentenceIndex": 5, "entityText": "camptothecin"}, {"duid": "PU:aHAh", "entityType": "Disease", "charEnd": 401, "source": "PUBTATOR", "charStart": 394, "entityId": [{"idString": "D008223", "source": "MESH"}], "sentenceIndex": 3, "entityText": "lymphoma"}, {"duid": "PU:hCa2", "entityType": "Chemical", "charEnd": 636, "source": "PUBTATOR", "charStart": 626, "entityId": [{"idString": "D004317", "source": "MESH"}], "sentenceIndex": 4, "entityText": "doxorubicin"}, {"duid": "PU:7aof", "entityType": "Disease", "charEnd": 951, "source": "PUBTATOR", "charStart": 943, "entityId": [{"idString": "D008223", "source": "MESH"}], "sentenceIndex": 6, "entityText": "lymphomas"}, {"duid": "PU:cVpk", "entityType": "Gene", "charEnd": 673, "source": "PUBTATOR", "charStart": 669, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "Top2A"}, {"duid": "PU:QDF3", "entityType": "Disease", "charEnd": 230, "source": "PUBTATOR", "charStart": 225, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumors"}, {"duid": "PU:Mdhe", "entityType": "Disease", "charEnd": 181, "source": "PUBTATOR", "charStart": 170, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "malignancies"}, {"duid": "PU:KwSj", "entityType": "Species", "charEnd": 168, "source": "PUBTATOR", "charStart": 164, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "human"}, {"duid": "PU:empS", "entityType": "Disease", "charEnd": 906, "source": "PUBTATOR", "charStart": 901, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "cancer"}, {"duid": "PU:fVYr", "entityType": "Gene", "charEnd": 542, "source": "PUBTATOR", "charStart": 538, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "Top2A"}]}
{"text": "Topoisomerase levels determine chemotherapy response in vitro and in vivo. Topoisomerase poisons are chemotherapeutic agents that are used extensively for treating human malignancies. These drugs can be highly effective, yet tumors are frequently refractory to treatment or become resistant upon tumor relapse. Using a pool-based RNAi screening approach and a well characterized mouse model of lymphoma, we explored the genetic basis for heterogeneous responses to topoisomerase poisons in vitro and in vivo. These experiments identified Top2A expression levels as major determinants of response to the topoisomerase 2 poison doxorubicin and showed that suppression of Top2A produces resistance to doxorubicin in vitro and in vivo. Analogously, using a targeted RNAi approach, we demonstrated that suppression of Top1 produces resistance to the topoisomerase 1 poison camptothecin yet hypersensitizes cancer cells to doxorubicin. Importantly, lymphomas relapsing after treatment display spontaneous changes in topoisomerase levels as predicted by in vitro gene knockdown studies. These results highlight the utility of pooled shRNA screens for identifying genetic determinants of chemotherapy response and suggest strategies for improving the effectiveness of topoisomerase poisons in the clinic.", "title": {"charStart": 0, "charEnd": 73}, "docId": "18574145", "entity": [{"duid": "PU:BnYS", "entityType": "Chemical", "charEnd": 927, "source": "PUBTATOR", "charStart": 917, "entityId": [{"idString": "D004317", "source": "MESH"}], "sentenceIndex": 5, "entityText": "doxorubicin"}, {"duid": "PU:yNH7", "entityType": "Chemical", "charEnd": 708, "source": "PUBTATOR", "charStart": 698, "entityId": [{"idString": "D004317", "source": "MESH"}], "sentenceIndex": 4, "entityText": "doxorubicin"}, {"duid": "PU:MdKu", "entityType": "Species", "charEnd": 383, "source": "PUBTATOR", "charStart": 379, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "mouse"}, {"duid": "PU:icpx", "entityType": "Disease", "charEnd": 300, "source": "PUBTATOR", "charStart": 296, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:oHjH", "entityType": "Chemical", "charEnd": 879, "source": "PUBTATOR", "charStart": 868, "entityId": [{"idString": "D002166", "source": "MESH"}], "sentenceIndex": 5, "entityText": "camptothecin"}, {"duid": "PU:aHAh", "entityType": "Disease", "charEnd": 401, "source": "PUBTATOR", "charStart": 394, "entityId": [{"idString": "D008223", "source": "MESH"}], "sentenceIndex": 3, "entityText": "lymphoma"}, {"duid": "PU:hCa2", "entityType": "Chemical", "charEnd": 636, "source": "PUBTATOR", "charStart": 626, "entityId": [{"idString": "D004317", "source": "MESH"}], "sentenceIndex": 4, "entityText": "doxorubicin"}, {"duid": "PU:7aof", "entityType": "Disease", "charEnd": 951, "source": "PUBTATOR", "charStart": 943, "entityId": [{"idString": "D008223", "source": "MESH"}], "sentenceIndex": 6, "entityText": "lymphomas"}, {"duid": "PU:cVpk", "entityType": "Gene", "charEnd": 673, "source": "PUBTATOR", "charStart": 669, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "Top2A"}, {"duid": "PU:QDF3", "entityType": "Disease", "charEnd": 230, "source": "PUBTATOR", "charStart": 225, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumors"}, {"duid": "PU:Mdhe", "entityType": "Disease", "charEnd": 181, "source": "PUBTATOR", "charStart": 170, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "malignancies"}, {"duid": "PU:KwSj", "entityType": "Species", "charEnd": 168, "source": "PUBTATOR", "charStart": 164, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "human"}, {"duid": "PU:empS", "entityType": "Disease", "charEnd": 906, "source": "PUBTATOR", "charStart": 901, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "cancer"}, {"duid": "PU:fVYr", "entityType": "Gene", "charEnd": 542, "source": "PUBTATOR", "charStart": 538, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "Top2A"}]}
{"text": "Topoisomerase levels determine chemotherapy response in vitro and in vivo. Topoisomerase poisons are chemotherapeutic agents that are used extensively for treating human malignancies. These drugs can be highly effective, yet tumors are frequently refractory to treatment or become resistant upon tumor relapse. Using a pool-based RNAi screening approach and a well characterized mouse model of lymphoma, we explored the genetic basis for heterogeneous responses to topoisomerase poisons in vitro and in vivo. These experiments identified Top2A expression levels as major determinants of response to the topoisomerase 2 poison doxorubicin and showed that suppression of Top2A produces resistance to doxorubicin in vitro and in vivo. Analogously, using a targeted RNAi approach, we demonstrated that suppression of Top1 produces resistance to the topoisomerase 1 poison camptothecin yet hypersensitizes cancer cells to doxorubicin. Importantly, lymphomas relapsing after treatment display spontaneous changes in topoisomerase levels as predicted by in vitro gene knockdown studies. These results highlight the utility of pooled shRNA screens for identifying genetic determinants of chemotherapy response and suggest strategies for improving the effectiveness of topoisomerase poisons in the clinic.", "title": {"charStart": 0, "charEnd": 73}, "docId": "18574145", "entity": [{"duid": "PU:BnYS", "entityType": "Chemical", "charEnd": 927, "source": "PUBTATOR", "charStart": 917, "entityId": [{"idString": "D004317", "source": "MESH"}], "sentenceIndex": 5, "entityText": "doxorubicin"}, {"duid": "PU:yNH7", "entityType": "Chemical", "charEnd": 708, "source": "PUBTATOR", "charStart": 698, "entityId": [{"idString": "D004317", "source": "MESH"}], "sentenceIndex": 4, "entityText": "doxorubicin"}, {"duid": "PU:MdKu", "entityType": "Species", "charEnd": 383, "source": "PUBTATOR", "charStart": 379, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "mouse"}, {"duid": "PU:icpx", "entityType": "Disease", "charEnd": 300, "source": "PUBTATOR", "charStart": 296, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:oHjH", "entityType": "Chemical", "charEnd": 879, "source": "PUBTATOR", "charStart": 868, "entityId": [{"idString": "D002166", "source": "MESH"}], "sentenceIndex": 5, "entityText": "camptothecin"}, {"duid": "PU:aHAh", "entityType": "Disease", "charEnd": 401, "source": "PUBTATOR", "charStart": 394, "entityId": [{"idString": "D008223", "source": "MESH"}], "sentenceIndex": 3, "entityText": "lymphoma"}, {"duid": "PU:hCa2", "entityType": "Chemical", "charEnd": 636, "source": "PUBTATOR", "charStart": 626, "entityId": [{"idString": "D004317", "source": "MESH"}], "sentenceIndex": 4, "entityText": "doxorubicin"}, {"duid": "PU:7aof", "entityType": "Disease", "charEnd": 951, "source": "PUBTATOR", "charStart": 943, "entityId": [{"idString": "D008223", "source": "MESH"}], "sentenceIndex": 6, "entityText": "lymphomas"}, {"duid": "PU:cVpk", "entityType": "Gene", "charEnd": 673, "source": "PUBTATOR", "charStart": 669, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "Top2A"}, {"duid": "PU:QDF3", "entityType": "Disease", "charEnd": 230, "source": "PUBTATOR", "charStart": 225, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumors"}, {"duid": "PU:Mdhe", "entityType": "Disease", "charEnd": 181, "source": "PUBTATOR", "charStart": 170, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "malignancies"}, {"duid": "PU:KwSj", "entityType": "Species", "charEnd": 168, "source": "PUBTATOR", "charStart": 164, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "human"}, {"duid": "PU:empS", "entityType": "Disease", "charEnd": 906, "source": "PUBTATOR", "charStart": 901, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "cancer"}, {"duid": "PU:fVYr", "entityType": "Gene", "charEnd": 542, "source": "PUBTATOR", "charStart": 538, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "Top2A"}]}
{"text": "Class III \u03b2-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial. PURPOSE: Platinum-based doublets are the cornerstone of treatment in advanced non-small-cell lung cancer (NSCLC) and often include vinorelbine or taxanes. A predictive biomarker is greatly needed to select chemotherapy-sensitive patients for these microtubule-interfering agents. Class III \u03b2-tubulin (TUBB3) has been shown of value in NSCLC, but evidence is not uniform. Accordingly, we explored the predictive role of TUBB3 in advanced NSCLC. EXPERIMENTAL DESIGN: Four hundred forty-three patients with advanced NSCLC were enrolled in a phase III trial and randomized to vinorelbine- or paclitaxel-containing chemotherapy. Immunohistochemical evaluation of TUBB3 status was mainly done on bioptic material and correlated to response rates, progression-free survival (PFS), overall survival (OS), quality of life (QOL), and toxicity. RESULTS: Two hundred sixty-one (58.9%) patients had representative tissue samples for TUBB3 evaluation. Patients with TUBB3-negative adenocarcinomas had a significantly prolonged PFS and OS when compared with the opposite subgroup (7.87 vs. 6.83 months, P = 0.035 and 14.17 vs. 11.17 months, P = 0.018, respectively). Multivariate analyses revealed an HR of 1.55 (95% CI, 1.04-2.31, P = 0.032) for TUBB3-positive adenocarcinoma patients. TUBB3-negative adenocarcinoma patients showed a mean QOL decline of -18.25 points (95% CI, -4.28 to -32.22, P = 0.013) as compared with -3.86 (95% CI, -7.0 to 15.52, P = 0.5). CONCLUSION: TUBB3 was of predictive value in adenocarcinoma patients in the largest, randomized advanced NSCLC population published to date. It may be clinically useful in conjunction with other biomarkers, but QOL information should be recorded during validation, as prophylactic intervention may be needed in specific subgroups at risk of toxicity.", "title": {"charStart": 0, "charEnd": 111}, "docId": "21690572", "entity": [{"duid": "PU:8rdv", "entityType": "Chemical", "charEnd": 129, "source": "PUBTATOR", "charStart": 122, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Platinum"}, {"duid": "PU:ccw6", "entityType": "Species", "charEnd": 610, "source": "PUBTATOR", "charStart": 603, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:zuqQ", "entityType": "Gene", "charEnd": 418, "source": "PUBTATOR", "charStart": 414, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "TUBB3"}, {"duid": "PU:nHZJ", "entityType": "Disease", "charEnd": 554, "source": "PUBTATOR", "charStart": 550, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 4, "entityText": "NSCLC"}, {"duid": "PU:d58i", "entityType": "Disease", "charEnd": 36, "source": "PUBTATOR", "charStart": 32, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "NSCLC"}, {"duid": "PU:SZAB", "entityType": "Disease", "charEnd": 1619, "source": "PUBTATOR", "charStart": 1606, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 11, "entityText": "adenocarcinoma"}, {"duid": "PU:Dpf2", "entityType": "Species", "charEnd": 993, "source": "PUBTATOR", "charStart": 986, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:TJtd", "entityType": "Gene", "charEnd": 1389, "source": "PUBTATOR", "charStart": 1385, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "TUBB3"}, {"duid": "PU:DeDu", "entityType": "Gene", "charEnd": 536, "source": "PUBTATOR", "charStart": 532, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TUBB3"}, {"duid": "PU:rtSf", "entityType": "Disease", "charEnd": 630, "source": "PUBTATOR", "charStart": 626, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 5, "entityText": "NSCLC"}, {"duid": "PU:SC5D", "entityType": "Disease", "charEnd": 216, "source": "PUBTATOR", "charStart": 191, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:GBFH", "entityType": "Species", "charEnd": 1422, "source": "PUBTATOR", "charStart": 1415, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:LNGh", "entityType": "Disease", "charEnd": 906, "source": "PUBTATOR", "charStart": 905, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 6, "entityText": "OS"}, {"duid": "PU:ACeA", "entityType": "Species", "charEnd": 1058, "source": "PUBTATOR", "charStart": 1051, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "Patients"}, {"duid": "PU:6di3", "entityType": "Disease", "charEnd": 1413, "source": "PUBTATOR", "charStart": 1400, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 10, "entityText": "adenocarcinoma"}, {"duid": "PU:WqNK", "entityType": "Chemical", "charEnd": 710, "source": "PUBTATOR", "charStart": 701, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 5, "entityText": "paclitaxel"}, {"duid": "PU:oUMT", "entityType": "Gene", "charEnd": 1069, "source": "PUBTATOR", "charStart": 1065, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TUBB3"}, {"duid": "PU:Rr29", "entityType": "Gene", "charEnd": 1037, "source": "PUBTATOR", "charStart": 1033, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TUBB3"}, {"duid": "PU:aVsw", "entityType": "Disease", "charEnd": 1373, "source": "PUBTATOR", "charStart": 1360, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 9, "entityText": "adenocarcinoma"}, {"duid": "PU:4W4A", "entityType": "Disease", "charEnd": 1909, "source": "PUBTATOR", "charStart": 1902, "entityId": [{"idString": "D064420", "source": "MESH"}], "sentenceIndex": 12, "entityText": "toxicity"}, {"duid": "PU:Eg7F", "entityType": "Gene", "charEnd": 1349, "source": "PUBTATOR", "charStart": 1345, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TUBB3"}, {"duid": "PU:zAHg", "entityType": "Disease", "charEnd": 902, "source": "PUBTATOR", "charStart": 887, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 6, "entityText": "overall survival"}, {"duid": "PU:5mwE", "entityType": "Disease", "charEnd": 1094, "source": "PUBTATOR", "charStart": 1080, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 8, "entityText": "adenocarcinomas"}, {"duid": "PU:hiLU", "entityType": "Gene", "charEnd": 1577, "source": "PUBTATOR", "charStart": 1573, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "TUBB3"}, {"duid": "PU:oxqo", "entityType": "Chemical", "charEnd": 695, "source": "PUBTATOR", "charStart": 685, "entityId": [{"idString": "C030852", "source": "MESH"}], "sentenceIndex": 5, "entityText": "vinorelbine"}, {"duid": "PU:ZLsp", "entityType": "Disease", "charEnd": 452, "source": "PUBTATOR", "charStart": 448, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "NSCLC"}, {"duid": "PU:3shY", "entityType": "Disease", "charEnd": 944, "source": "PUBTATOR", "charStart": 937, "entityId": [{"idString": "D064420", "source": "MESH"}], "sentenceIndex": 6, "entityText": "toxicity"}, {"duid": "PU:22Et", "entityType": "Chemical", "charEnd": 265, "source": "PUBTATOR", "charStart": 259, "entityId": [{"idString": "D043823", "source": "MESH"}], "sentenceIndex": 1, "entityText": "taxanes"}, {"duid": "PU:Z2J3", "entityType": "Chemical", "charEnd": 254, "source": "PUBTATOR", "charStart": 244, "entityId": [{"idString": "C030852", "source": "MESH"}], "sentenceIndex": 1, "entityText": "vinorelbine"}, {"duid": "PU:nP75", "entityType": "Disease", "charEnd": 223, "source": "PUBTATOR", "charStart": 219, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:vSXU", "entityType": "Species", "charEnd": 1382, "source": "PUBTATOR", "charStart": 1375, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:iFfJ", "entityType": "Species", "charEnd": 349, "source": "PUBTATOR", "charStart": 342, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:RNYu", "entityType": "Disease", "charEnd": 1135, "source": "PUBTATOR", "charStart": 1134, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 8, "entityText": "OS"}, {"duid": "PU:Xc4S", "entityType": "Species", "charEnd": 1628, "source": "PUBTATOR", "charStart": 1621, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:6Wg6", "entityType": "Gene", "charEnd": 775, "source": "PUBTATOR", "charStart": 771, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:965p", "entityType": "Disease", "charEnd": 1670, "source": "PUBTATOR", "charStart": 1666, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 11, "entityText": "NSCLC"}, {"duid": "PU:wLes", "entityType": "Disease", "charEnd": 54, "source": "PUBTATOR", "charStart": 41, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 0, "entityText": "adenocarcinoma"}]}
{"text": "Exclusion of histiocytes/endothelial cells and using endothelial cells as internal reference are crucial for interpretation of MGMT immunohistochemistry in glioblastoma. We evaluated the predictive value of O6-methylguanine-DNA methyltransferase (MGMT) protein expression and MGMT promoter methylation status in glioblastomas (GBM) treated with temozolomide (TMZ) in a Taiwan medical center. Protein expression by immunohistochemical analysis (IHC) and MGMT promoter methylation detected by methylation-specific polymerase chain reaction (MSP) were performed in a series of 107 newly diagnosed GBMs. We used endothelial cells as an internal reference for IHC staining because the staining intensities of the MGMT-expressing cells in different specimens varied considerably; a positive result was defined as the staining intensity of the majority of tumor cells similar to that of the adjacent endothelial cells. Immunostainings for microglial/endothelial markers were included as part of the MGMT IHC evaluation, and in cases that were difficult to interpret, double-labeling helped to clarify the nature of reactive cells. The MGMT protein expression was reversely associated with MGMT promoter methylation status in 83.7% of cases (MSP/IHC and MSP/IHC; Pearson r=-0.644, P<0.001). Twenty-two of 24 (91.7%) IHC tumors did not respond to TMZ treatment. Combining MSP and IHC results, all the 15 MSP/IHC GBMs were TMZ resistant. The MGMT status detected by either IHC or MSP was significantly correlated with the TMZ treatment response (both P<0.001) and survival of GBM patients (both P<0.05).", "title": {"charStart": 0, "charEnd": 168}, "docId": "23282970", "entity": [{"duid": "PU:SYzA", "entityType": "Gene", "charEnd": 456, "source": "PUBTATOR", "charStart": 453, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "MGMT"}, {"duid": "PU:ksCf", "entityType": "Gene", "charEnd": 1401, "source": "PUBTATOR", "charStart": 1395, "entityId": [{"idString": "4477", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MSP/IHC"}, {"duid": "PU:pWTn", "entityType": "Chemical", "charEnd": 222, "source": "PUBTATOR", "charStart": 207, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 1, "entityText": "O6-methylguanine"}, {"duid": "PU:vQVL", "entityType": "Gene", "charEnd": 711, "source": "PUBTATOR", "charStart": 708, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MGMT"}, {"duid": "PU:voiA", "entityType": "Chemical", "charEnd": 657, "source": "PUBTATOR", "charStart": 655, "entityId": [], "sentenceIndex": 3, "entityText": "IHC"}, {"duid": "PU:URFX", "entityType": "Gene", "charEnd": 1435, "source": "PUBTATOR", "charStart": 1432, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MGMT"}, {"duid": "PU:Qq8F", "entityType": "Gene", "charEnd": 995, "source": "PUBTATOR", "charStart": 992, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MGMT"}, {"duid": "PU:27Us", "entityType": "Chemical", "charEnd": 356, "source": "PUBTATOR", "charStart": 345, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "temozolomide"}, {"duid": "PU:dx3B", "entityType": "Gene", "charEnd": 1252, "source": "PUBTATOR", "charStart": 1246, "entityId": [{"idString": "4477", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "MSP/IHC"}, {"duid": "PU:72Hz", "entityType": "Gene", "charEnd": 250, "source": "PUBTATOR", "charStart": 247, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "MGMT"}, {"duid": "PU:ALzm", "entityType": "Species", "charEnd": 1577, "source": "PUBTATOR", "charStart": 1570, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:dUMm", "entityType": "Gene", "charEnd": 1185, "source": "PUBTATOR", "charStart": 1182, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "MGMT"}, {"duid": "PU:Qfse", "entityType": "Gene", "charEnd": 1365, "source": "PUBTATOR", "charStart": 1363, "entityId": [{"idString": "4477", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MSP"}, {"duid": "PU:BHy3", "entityType": "Gene", "charEnd": 541, "source": "PUBTATOR", "charStart": 539, "entityId": [{"idString": "4477", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "MSP"}, {"duid": "PU:zaFZ", "entityType": "Disease", "charEnd": 1568, "source": "PUBTATOR", "charStart": 1566, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 8, "entityText": "GBM"}, {"duid": "PU:zrpn", "entityType": "Gene", "charEnd": 244, "source": "PUBTATOR", "charStart": 207, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "O6-methylguanine-DNA methyltransferase"}, {"duid": "PU:ZFAo", "entityType": "Chemical", "charEnd": 1415, "source": "PUBTATOR", "charStart": 1413, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 7, "entityText": "TMZ"}, {"duid": "PU:HVJ7", "entityType": "Gene", "charEnd": 1131, "source": "PUBTATOR", "charStart": 1128, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "MGMT"}, {"duid": "PU:xQsn", "entityType": "Gene", "charEnd": 130, "source": "PUBTATOR", "charStart": 127, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "MGMT"}, {"duid": "PU:VQhR", "entityType": "Gene", "charEnd": 1472, "source": "PUBTATOR", "charStart": 1470, "entityId": [{"idString": "4477", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MSP"}, {"duid": "PU:h4j5", "entityType": "Chemical", "charEnd": 1340, "source": "PUBTATOR", "charStart": 1338, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 6, "entityText": "TMZ"}, {"duid": "PU:Edhy", "entityType": "Disease", "charEnd": 167, "source": "PUBTATOR", "charStart": 156, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 0, "entityText": "glioblastoma"}, {"duid": "PU:eEQu", "entityType": "Chemical", "charEnd": 361, "source": "PUBTATOR", "charStart": 359, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "TMZ"}, {"duid": "PU:xKpE", "entityType": "Chemical", "charEnd": 1514, "source": "PUBTATOR", "charStart": 1512, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 8, "entityText": "TMZ"}, {"duid": "PU:3gAq", "entityType": "Disease", "charEnd": 329, "source": "PUBTATOR", "charStart": 327, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 1, "entityText": "GBM"}, {"duid": "PU:aAN5", "entityType": "Disease", "charEnd": 324, "source": "PUBTATOR", "charStart": 312, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 1, "entityText": "glioblastomas"}, {"duid": "PU:mXtM", "entityType": "Gene", "charEnd": 279, "source": "PUBTATOR", "charStart": 276, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "MGMT"}, {"duid": "PU:jxMf", "entityType": "Disease", "charEnd": 853, "source": "PUBTATOR", "charStart": 849, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:f5kN", "entityType": "Gene", "charEnd": 1240, "source": "PUBTATOR", "charStart": 1234, "entityId": [{"idString": "4477", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "MSP/IHC"}, {"duid": "PU:SbYy", "entityType": "Disease", "charEnd": 1317, "source": "PUBTATOR", "charStart": 1312, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumors"}]}
{"text": "[Correlation between expression of ERCC1 and the treatment of cisplatin-based chemotherapy in local advanced nasopharyngeal carcinoma]. OBJECTIVE: To study the expression of excision repair cross-complementing 1 (ERCC1) and the treatment of cisplatin-based chemotherapy in local advanced nasopharyngeal carcinoma (NPC). METHOD: The expression of ERCC1 protein in 107 cases with NPC and in 48 normal nasopharyngeal tissues adjacent to the cancer was detected by immunohistochemical method. RESULT: High expression of ERCC1 was observed in 52 cases with NPC, and 18 cases normal nasopharyngeal tissues, there was no statistically significant differences between them. The expression of ERCC1 protein was significant correlated with patient total TNM stage, but not significantly correlated with age, gender, histological type, T stage and N stage. The recent treatment efficiency in Low ER-CCl expression cases was higher than high expression cases. There was statistically significant difference between them. In 97 follow-up cases, 2 cases died, 5 cases with liver and lung metastasis, there was no statistically significant difference between them. CONCLUSION: ERCC1 expression maybe regarded as indicator platinum based chemotherapy sensitivity prediction in nasopharyngeal carcinoma, and also helpful for formulating individualized treatment. The immunohistochemical detection is also simple and effective detection method for ERCC1 expression.", "title": {"charStart": 0, "charEnd": 134}, "docId": "25989663", "entity": [{"duid": "PU:wnYv", "entityType": "Gene", "charEnd": 688, "source": "PUBTATOR", "charStart": 684, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:9eyQ", "entityType": "Chemical", "charEnd": 249, "source": "PUBTATOR", "charStart": 241, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:EvyW", "entityType": "Gene", "charEnd": 350, "source": "PUBTATOR", "charStart": 346, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:5DRW", "entityType": "Disease", "charEnd": 443, "source": "PUBTATOR", "charStart": 438, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cancer"}, {"duid": "PU:eEeL", "entityType": "Disease", "charEnd": 316, "source": "PUBTATOR", "charStart": 314, "entityId": [{"idString": "D002277", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NPC"}, {"duid": "PU:imHB", "entityType": "Gene", "charEnd": 39, "source": "PUBTATOR", "charStart": 35, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:nZNV", "entityType": "Gene", "charEnd": 520, "source": "PUBTATOR", "charStart": 516, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:Zm82", "entityType": "Gene", "charEnd": 210, "source": "PUBTATOR", "charStart": 174, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementing 1"}, {"duid": "PU:25ci", "entityType": "Species", "charEnd": 736, "source": "PUBTATOR", "charStart": 730, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patient"}, {"duid": "PU:m46D", "entityType": "Disease", "charEnd": 311, "source": "PUBTATOR", "charStart": 288, "entityId": [{"idString": "D002277", "source": "MESH"}], "sentenceIndex": 1, "entityText": "nasopharyngeal carcinoma"}, {"duid": "PU:bWMu", "entityType": "Chemical", "charEnd": 70, "source": "PUBTATOR", "charStart": 62, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "cisplatin"}, {"duid": "PU:yAXR", "entityType": "Chemical", "charEnd": 1214, "source": "PUBTATOR", "charStart": 1207, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 8, "entityText": "platinum"}, {"duid": "PU:KCSN", "entityType": "Disease", "charEnd": 380, "source": "PUBTATOR", "charStart": 378, "entityId": [{"idString": "D002277", "source": "MESH"}], "sentenceIndex": 2, "entityText": "NPC"}, {"duid": "PU:Cate", "entityType": "Disease", "charEnd": 554, "source": "PUBTATOR", "charStart": 552, "entityId": [{"idString": "D002277", "source": "MESH"}], "sentenceIndex": 3, "entityText": "NPC"}, {"duid": "PU:w4qc", "entityType": "Disease", "charEnd": 1284, "source": "PUBTATOR", "charStart": 1261, "entityId": [{"idString": "D002277", "source": "MESH"}], "sentenceIndex": 8, "entityText": "nasopharyngeal carcinoma"}, {"duid": "PU:nWkN", "entityType": "Gene", "charEnd": 217, "source": "PUBTATOR", "charStart": 213, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:UuZL", "entityType": "Disease", "charEnd": 132, "source": "PUBTATOR", "charStart": 109, "entityId": [{"idString": "D002277", "source": "MESH"}], "sentenceIndex": 0, "entityText": "nasopharyngeal carcinoma"}, {"duid": "PU:3yVZ", "entityType": "Gene", "charEnd": 1434, "source": "PUBTATOR", "charStart": 1430, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:QoHM", "entityType": "Gene", "charEnd": 1166, "source": "PUBTATOR", "charStart": 1162, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}]}
{"text": "A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer. OBJECTIVE: Personalized chemotherapy based on molecular biomarkers can maximize anticancer efficiency. We aim to investigate predictive biomarkers capable of predicting response to irinotecan-based treatment in gastric cancer. METHODS: We examined gene expression of APTX, BRCA1, ERCC1, ISG15, Topo1 and methylation of SULF2 in formalin-fixed paraffin-embedded gastric cancer tissues from 175 patients and evaluated the association between gene expression levels or methylation status and in vitro sensitivity to irinotecan. We used multiple linear regression analysis to develop a gene-expression model to predict irinotecan sensitivity in gastric cancer and validated this model in vitro and vivo. RESULTS: Gene expression levels of APTX, BRCA1 and ERCC1 were significantly lower in irinotecan-sensitive gastric cancer samples than those irinotecan-resistant samples (P<0.001 for all genes), while ISG15 (P=0.047) and Topo1 (P=0.002) were significantly higher. Based on those genes, a three-gene signature were established, which was calculated as follows: Index =0.488 - 0.020\u00d7 expression level of APTX\u2009+\u20090.015\u00d7 expression level of Topo1 - 0.011 \u00d7 expression level of BRCA1. The three-gene signature was significantly associated with irinotecan sensitivity (rho=0.71, P<0.001). The sensitivity and specificity for the prediction of irinotecan sensitivity based on the three-gene signature reached 73% and 86%, respectively. In another independent testing set, the irinotecan inhibition rates in gastric samples with sensitive-signature were much higher than those with resistant-signature (65% vs. 22%, P<0.001). Irinotecan therapy with 20 mg/kg per week to immunodeficient mice carrying xenografts with sensitive-signature dramatically arrested the growth of tumors (P<0.001), but had no effect on mice carrying xenografts with resistant-signature. CONCLUSIONS: The three-gene signature established herein is a potential predictive biomarker for irinotecan sensitivity in gastric cancer.", "title": {"charStart": 0, "charEnd": 101}, "docId": "23517622", "entity": [{"duid": "PU:zKw7", "entityType": "Disease", "charEnd": 922, "source": "PUBTATOR", "charStart": 888, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan-sensitive gastric cancer"}, {"duid": "PU:NhWw", "entityType": "Chemical", "charEnd": 70, "source": "PUBTATOR", "charStart": 61, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 0, "entityText": "irinotecan"}, {"duid": "PU:tFVi", "entityType": "Gene", "charEnd": 858, "source": "PUBTATOR", "charStart": 854, "entityId": [{"idString": "13870", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:cRZV", "entityType": "Gene", "charEnd": 380, "source": "PUBTATOR", "charStart": 376, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "BRCA1"}, {"duid": "PU:J9Z4", "entityType": "Disease", "charEnd": 100, "source": "PUBTATOR", "charStart": 87, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric cancer"}, {"duid": "PU:Dbm5", "entityType": "Chemical", "charEnd": 727, "source": "PUBTATOR", "charStart": 718, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 4, "entityText": "irinotecan"}, {"duid": "PU:ffc8", "entityType": "Chemical", "charEnd": 1579, "source": "PUBTATOR", "charStart": 1570, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 9, "entityText": "irinotecan"}, {"duid": "PU:xGrQ", "entityType": "Gene", "charEnd": 426, "source": "PUBTATOR", "charStart": 422, "entityId": [{"idString": "55959", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "SULF2"}, {"duid": "PU:55XP", "entityType": "Chemical", "charEnd": 952, "source": "PUBTATOR", "charStart": 943, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan"}, {"duid": "PU:j9w2", "entityType": "Chemical", "charEnd": 897, "source": "PUBTATOR", "charStart": 888, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan"}, {"duid": "PU:PsBH", "entityType": "Gene", "charEnd": 841, "source": "PUBTATOR", "charStart": 838, "entityId": [{"idString": "66408", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "APTX"}, {"duid": "PU:ysuY", "entityType": "Chemical", "charEnd": 293, "source": "PUBTATOR", "charStart": 284, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 2, "entityText": "irinotecan"}, {"duid": "PU:vwM6", "entityType": "Gene", "charEnd": 1278, "source": "PUBTATOR", "charStart": 1274, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 6, "entityText": "BRCA1"}, {"duid": "PU:YvXV", "entityType": "Chemical", "charEnd": 438, "source": "PUBTATOR", "charStart": 431, "entityId": [{"idString": "D005557", "source": "MESH"}], "sentenceIndex": 3, "entityText": "formalin"}, {"duid": "PU:JTJi", "entityType": "Gene", "charEnd": 387, "source": "PUBTATOR", "charStart": 383, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:t7VK", "entityType": "Disease", "charEnd": 1871, "source": "PUBTATOR", "charStart": 1866, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}, {"duid": "PU:mDEL", "entityType": "Gene", "charEnd": 1007, "source": "PUBTATOR", "charStart": 1003, "entityId": [{"idString": "100038882", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "ISG15"}, {"duid": "PU:c7Zm", "entityType": "Chemical", "charEnd": 1447, "source": "PUBTATOR", "charStart": 1438, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 8, "entityText": "irinotecan"}, {"duid": "PU:5Kdp", "entityType": "Chemical", "charEnd": 625, "source": "PUBTATOR", "charStart": 616, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 3, "entityText": "irinotecan"}, {"duid": "PU:TvnY", "entityType": "Species", "charEnd": 1908, "source": "PUBTATOR", "charStart": 1905, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "mice"}, {"duid": "PU:pjky", "entityType": "Gene", "charEnd": 848, "source": "PUBTATOR", "charStart": 844, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "BRCA1"}, {"duid": "PU:LLY9", "entityType": "Chemical", "charEnd": 2062, "source": "PUBTATOR", "charStart": 2053, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 11, "entityText": "irinotecan"}, {"duid": "PU:jNUZ", "entityType": "Disease", "charEnd": 477, "source": "PUBTATOR", "charStart": 464, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gastric cancer"}, {"duid": "PU:MEzY", "entityType": "Gene", "charEnd": 1207, "source": "PUBTATOR", "charStart": 1204, "entityId": [{"idString": "66408", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 6, "entityText": "APTX"}, {"duid": "PU:m3nz", "entityType": "Chemical", "charEnd": 1728, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 10, "entityText": "Irinotecan"}, {"duid": "PU:Wx4y", "entityType": "Chemical", "charEnd": 1349, "source": "PUBTATOR", "charStart": 1340, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 7, "entityText": "irinotecan"}, {"duid": "PU:zzHa", "entityType": "Species", "charEnd": 503, "source": "PUBTATOR", "charStart": 496, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:Rmcu", "entityType": "Gene", "charEnd": 394, "source": "PUBTATOR", "charStart": 390, "entityId": [{"idString": "9636", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ISG15"}, {"duid": "PU:bTmM", "entityType": "Disease", "charEnd": 327, "source": "PUBTATOR", "charStart": 314, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:7P2x", "entityType": "Disease", "charEnd": 2092, "source": "PUBTATOR", "charStart": 2079, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gastric cancer"}, {"duid": "PU:cUEy", "entityType": "Gene", "charEnd": 373, "source": "PUBTATOR", "charStart": 370, "entityId": [{"idString": "54840", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "APTX"}, {"duid": "PU:uYPr", "entityType": "Species", "charEnd": 1783, "source": "PUBTATOR", "charStart": 1780, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "mice"}, {"duid": "PU:4ErJ", "entityType": "Disease", "charEnd": 757, "source": "PUBTATOR", "charStart": 744, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 4, "entityText": "gastric cancer"}]}
{"text": "A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer. OBJECTIVE: Personalized chemotherapy based on molecular biomarkers can maximize anticancer efficiency. We aim to investigate predictive biomarkers capable of predicting response to irinotecan-based treatment in gastric cancer. METHODS: We examined gene expression of APTX, BRCA1, ERCC1, ISG15, Topo1 and methylation of SULF2 in formalin-fixed paraffin-embedded gastric cancer tissues from 175 patients and evaluated the association between gene expression levels or methylation status and in vitro sensitivity to irinotecan. We used multiple linear regression analysis to develop a gene-expression model to predict irinotecan sensitivity in gastric cancer and validated this model in vitro and vivo. RESULTS: Gene expression levels of APTX, BRCA1 and ERCC1 were significantly lower in irinotecan-sensitive gastric cancer samples than those irinotecan-resistant samples (P<0.001 for all genes), while ISG15 (P=0.047) and Topo1 (P=0.002) were significantly higher. Based on those genes, a three-gene signature were established, which was calculated as follows: Index =0.488 - 0.020\u00d7 expression level of APTX\u2009+\u20090.015\u00d7 expression level of Topo1 - 0.011 \u00d7 expression level of BRCA1. The three-gene signature was significantly associated with irinotecan sensitivity (rho=0.71, P<0.001). The sensitivity and specificity for the prediction of irinotecan sensitivity based on the three-gene signature reached 73% and 86%, respectively. In another independent testing set, the irinotecan inhibition rates in gastric samples with sensitive-signature were much higher than those with resistant-signature (65% vs. 22%, P<0.001). Irinotecan therapy with 20 mg/kg per week to immunodeficient mice carrying xenografts with sensitive-signature dramatically arrested the growth of tumors (P<0.001), but had no effect on mice carrying xenografts with resistant-signature. CONCLUSIONS: The three-gene signature established herein is a potential predictive biomarker for irinotecan sensitivity in gastric cancer.", "title": {"charStart": 0, "charEnd": 101}, "docId": "23517622", "entity": [{"duid": "PU:zKw7", "entityType": "Disease", "charEnd": 922, "source": "PUBTATOR", "charStart": 888, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan-sensitive gastric cancer"}, {"duid": "PU:NhWw", "entityType": "Chemical", "charEnd": 70, "source": "PUBTATOR", "charStart": 61, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 0, "entityText": "irinotecan"}, {"duid": "PU:tFVi", "entityType": "Gene", "charEnd": 858, "source": "PUBTATOR", "charStart": 854, "entityId": [{"idString": "13870", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:cRZV", "entityType": "Gene", "charEnd": 380, "source": "PUBTATOR", "charStart": 376, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "BRCA1"}, {"duid": "PU:J9Z4", "entityType": "Disease", "charEnd": 100, "source": "PUBTATOR", "charStart": 87, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric cancer"}, {"duid": "PU:Dbm5", "entityType": "Chemical", "charEnd": 727, "source": "PUBTATOR", "charStart": 718, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 4, "entityText": "irinotecan"}, {"duid": "PU:ffc8", "entityType": "Chemical", "charEnd": 1579, "source": "PUBTATOR", "charStart": 1570, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 9, "entityText": "irinotecan"}, {"duid": "PU:xGrQ", "entityType": "Gene", "charEnd": 426, "source": "PUBTATOR", "charStart": 422, "entityId": [{"idString": "55959", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "SULF2"}, {"duid": "PU:55XP", "entityType": "Chemical", "charEnd": 952, "source": "PUBTATOR", "charStart": 943, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan"}, {"duid": "PU:j9w2", "entityType": "Chemical", "charEnd": 897, "source": "PUBTATOR", "charStart": 888, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan"}, {"duid": "PU:PsBH", "entityType": "Gene", "charEnd": 841, "source": "PUBTATOR", "charStart": 838, "entityId": [{"idString": "66408", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "APTX"}, {"duid": "PU:ysuY", "entityType": "Chemical", "charEnd": 293, "source": "PUBTATOR", "charStart": 284, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 2, "entityText": "irinotecan"}, {"duid": "PU:vwM6", "entityType": "Gene", "charEnd": 1278, "source": "PUBTATOR", "charStart": 1274, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 6, "entityText": "BRCA1"}, {"duid": "PU:YvXV", "entityType": "Chemical", "charEnd": 438, "source": "PUBTATOR", "charStart": 431, "entityId": [{"idString": "D005557", "source": "MESH"}], "sentenceIndex": 3, "entityText": "formalin"}, {"duid": "PU:JTJi", "entityType": "Gene", "charEnd": 387, "source": "PUBTATOR", "charStart": 383, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:t7VK", "entityType": "Disease", "charEnd": 1871, "source": "PUBTATOR", "charStart": 1866, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}, {"duid": "PU:mDEL", "entityType": "Gene", "charEnd": 1007, "source": "PUBTATOR", "charStart": 1003, "entityId": [{"idString": "100038882", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "ISG15"}, {"duid": "PU:c7Zm", "entityType": "Chemical", "charEnd": 1447, "source": "PUBTATOR", "charStart": 1438, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 8, "entityText": "irinotecan"}, {"duid": "PU:5Kdp", "entityType": "Chemical", "charEnd": 625, "source": "PUBTATOR", "charStart": 616, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 3, "entityText": "irinotecan"}, {"duid": "PU:TvnY", "entityType": "Species", "charEnd": 1908, "source": "PUBTATOR", "charStart": 1905, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "mice"}, {"duid": "PU:pjky", "entityType": "Gene", "charEnd": 848, "source": "PUBTATOR", "charStart": 844, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "BRCA1"}, {"duid": "PU:LLY9", "entityType": "Chemical", "charEnd": 2062, "source": "PUBTATOR", "charStart": 2053, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 11, "entityText": "irinotecan"}, {"duid": "PU:jNUZ", "entityType": "Disease", "charEnd": 477, "source": "PUBTATOR", "charStart": 464, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gastric cancer"}, {"duid": "PU:MEzY", "entityType": "Gene", "charEnd": 1207, "source": "PUBTATOR", "charStart": 1204, "entityId": [{"idString": "66408", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 6, "entityText": "APTX"}, {"duid": "PU:m3nz", "entityType": "Chemical", "charEnd": 1728, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 10, "entityText": "Irinotecan"}, {"duid": "PU:Wx4y", "entityType": "Chemical", "charEnd": 1349, "source": "PUBTATOR", "charStart": 1340, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 7, "entityText": "irinotecan"}, {"duid": "PU:zzHa", "entityType": "Species", "charEnd": 503, "source": "PUBTATOR", "charStart": 496, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:Rmcu", "entityType": "Gene", "charEnd": 394, "source": "PUBTATOR", "charStart": 390, "entityId": [{"idString": "9636", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ISG15"}, {"duid": "PU:bTmM", "entityType": "Disease", "charEnd": 327, "source": "PUBTATOR", "charStart": 314, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:7P2x", "entityType": "Disease", "charEnd": 2092, "source": "PUBTATOR", "charStart": 2079, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gastric cancer"}, {"duid": "PU:cUEy", "entityType": "Gene", "charEnd": 373, "source": "PUBTATOR", "charStart": 370, "entityId": [{"idString": "54840", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "APTX"}, {"duid": "PU:uYPr", "entityType": "Species", "charEnd": 1783, "source": "PUBTATOR", "charStart": 1780, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "mice"}, {"duid": "PU:4ErJ", "entityType": "Disease", "charEnd": 757, "source": "PUBTATOR", "charStart": 744, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 4, "entityText": "gastric cancer"}]}
{"text": "A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer. OBJECTIVE: Personalized chemotherapy based on molecular biomarkers can maximize anticancer efficiency. We aim to investigate predictive biomarkers capable of predicting response to irinotecan-based treatment in gastric cancer. METHODS: We examined gene expression of APTX, BRCA1, ERCC1, ISG15, Topo1 and methylation of SULF2 in formalin-fixed paraffin-embedded gastric cancer tissues from 175 patients and evaluated the association between gene expression levels or methylation status and in vitro sensitivity to irinotecan. We used multiple linear regression analysis to develop a gene-expression model to predict irinotecan sensitivity in gastric cancer and validated this model in vitro and vivo. RESULTS: Gene expression levels of APTX, BRCA1 and ERCC1 were significantly lower in irinotecan-sensitive gastric cancer samples than those irinotecan-resistant samples (P<0.001 for all genes), while ISG15 (P=0.047) and Topo1 (P=0.002) were significantly higher. Based on those genes, a three-gene signature were established, which was calculated as follows: Index =0.488 - 0.020\u00d7 expression level of APTX\u2009+\u20090.015\u00d7 expression level of Topo1 - 0.011 \u00d7 expression level of BRCA1. The three-gene signature was significantly associated with irinotecan sensitivity (rho=0.71, P<0.001). The sensitivity and specificity for the prediction of irinotecan sensitivity based on the three-gene signature reached 73% and 86%, respectively. In another independent testing set, the irinotecan inhibition rates in gastric samples with sensitive-signature were much higher than those with resistant-signature (65% vs. 22%, P<0.001). Irinotecan therapy with 20 mg/kg per week to immunodeficient mice carrying xenografts with sensitive-signature dramatically arrested the growth of tumors (P<0.001), but had no effect on mice carrying xenografts with resistant-signature. CONCLUSIONS: The three-gene signature established herein is a potential predictive biomarker for irinotecan sensitivity in gastric cancer.", "title": {"charStart": 0, "charEnd": 101}, "docId": "23517622", "entity": [{"duid": "PU:zKw7", "entityType": "Disease", "charEnd": 922, "source": "PUBTATOR", "charStart": 888, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan-sensitive gastric cancer"}, {"duid": "PU:NhWw", "entityType": "Chemical", "charEnd": 70, "source": "PUBTATOR", "charStart": 61, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 0, "entityText": "irinotecan"}, {"duid": "PU:tFVi", "entityType": "Gene", "charEnd": 858, "source": "PUBTATOR", "charStart": 854, "entityId": [{"idString": "13870", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:cRZV", "entityType": "Gene", "charEnd": 380, "source": "PUBTATOR", "charStart": 376, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "BRCA1"}, {"duid": "PU:J9Z4", "entityType": "Disease", "charEnd": 100, "source": "PUBTATOR", "charStart": 87, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric cancer"}, {"duid": "PU:Dbm5", "entityType": "Chemical", "charEnd": 727, "source": "PUBTATOR", "charStart": 718, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 4, "entityText": "irinotecan"}, {"duid": "PU:ffc8", "entityType": "Chemical", "charEnd": 1579, "source": "PUBTATOR", "charStart": 1570, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 9, "entityText": "irinotecan"}, {"duid": "PU:xGrQ", "entityType": "Gene", "charEnd": 426, "source": "PUBTATOR", "charStart": 422, "entityId": [{"idString": "55959", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "SULF2"}, {"duid": "PU:55XP", "entityType": "Chemical", "charEnd": 952, "source": "PUBTATOR", "charStart": 943, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan"}, {"duid": "PU:j9w2", "entityType": "Chemical", "charEnd": 897, "source": "PUBTATOR", "charStart": 888, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan"}, {"duid": "PU:PsBH", "entityType": "Gene", "charEnd": 841, "source": "PUBTATOR", "charStart": 838, "entityId": [{"idString": "66408", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "APTX"}, {"duid": "PU:ysuY", "entityType": "Chemical", "charEnd": 293, "source": "PUBTATOR", "charStart": 284, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 2, "entityText": "irinotecan"}, {"duid": "PU:vwM6", "entityType": "Gene", "charEnd": 1278, "source": "PUBTATOR", "charStart": 1274, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 6, "entityText": "BRCA1"}, {"duid": "PU:YvXV", "entityType": "Chemical", "charEnd": 438, "source": "PUBTATOR", "charStart": 431, "entityId": [{"idString": "D005557", "source": "MESH"}], "sentenceIndex": 3, "entityText": "formalin"}, {"duid": "PU:JTJi", "entityType": "Gene", "charEnd": 387, "source": "PUBTATOR", "charStart": 383, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:t7VK", "entityType": "Disease", "charEnd": 1871, "source": "PUBTATOR", "charStart": 1866, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}, {"duid": "PU:mDEL", "entityType": "Gene", "charEnd": 1007, "source": "PUBTATOR", "charStart": 1003, "entityId": [{"idString": "100038882", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "ISG15"}, {"duid": "PU:c7Zm", "entityType": "Chemical", "charEnd": 1447, "source": "PUBTATOR", "charStart": 1438, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 8, "entityText": "irinotecan"}, {"duid": "PU:5Kdp", "entityType": "Chemical", "charEnd": 625, "source": "PUBTATOR", "charStart": 616, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 3, "entityText": "irinotecan"}, {"duid": "PU:TvnY", "entityType": "Species", "charEnd": 1908, "source": "PUBTATOR", "charStart": 1905, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "mice"}, {"duid": "PU:pjky", "entityType": "Gene", "charEnd": 848, "source": "PUBTATOR", "charStart": 844, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "BRCA1"}, {"duid": "PU:LLY9", "entityType": "Chemical", "charEnd": 2062, "source": "PUBTATOR", "charStart": 2053, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 11, "entityText": "irinotecan"}, {"duid": "PU:jNUZ", "entityType": "Disease", "charEnd": 477, "source": "PUBTATOR", "charStart": 464, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gastric cancer"}, {"duid": "PU:MEzY", "entityType": "Gene", "charEnd": 1207, "source": "PUBTATOR", "charStart": 1204, "entityId": [{"idString": "66408", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 6, "entityText": "APTX"}, {"duid": "PU:m3nz", "entityType": "Chemical", "charEnd": 1728, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 10, "entityText": "Irinotecan"}, {"duid": "PU:Wx4y", "entityType": "Chemical", "charEnd": 1349, "source": "PUBTATOR", "charStart": 1340, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 7, "entityText": "irinotecan"}, {"duid": "PU:zzHa", "entityType": "Species", "charEnd": 503, "source": "PUBTATOR", "charStart": 496, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:Rmcu", "entityType": "Gene", "charEnd": 394, "source": "PUBTATOR", "charStart": 390, "entityId": [{"idString": "9636", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ISG15"}, {"duid": "PU:bTmM", "entityType": "Disease", "charEnd": 327, "source": "PUBTATOR", "charStart": 314, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:7P2x", "entityType": "Disease", "charEnd": 2092, "source": "PUBTATOR", "charStart": 2079, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gastric cancer"}, {"duid": "PU:cUEy", "entityType": "Gene", "charEnd": 373, "source": "PUBTATOR", "charStart": 370, "entityId": [{"idString": "54840", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "APTX"}, {"duid": "PU:uYPr", "entityType": "Species", "charEnd": 1783, "source": "PUBTATOR", "charStart": 1780, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "mice"}, {"duid": "PU:4ErJ", "entityType": "Disease", "charEnd": 757, "source": "PUBTATOR", "charStart": 744, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 4, "entityText": "gastric cancer"}]}
{"text": "A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer. OBJECTIVE: Personalized chemotherapy based on molecular biomarkers can maximize anticancer efficiency. We aim to investigate predictive biomarkers capable of predicting response to irinotecan-based treatment in gastric cancer. METHODS: We examined gene expression of APTX, BRCA1, ERCC1, ISG15, Topo1 and methylation of SULF2 in formalin-fixed paraffin-embedded gastric cancer tissues from 175 patients and evaluated the association between gene expression levels or methylation status and in vitro sensitivity to irinotecan. We used multiple linear regression analysis to develop a gene-expression model to predict irinotecan sensitivity in gastric cancer and validated this model in vitro and vivo. RESULTS: Gene expression levels of APTX, BRCA1 and ERCC1 were significantly lower in irinotecan-sensitive gastric cancer samples than those irinotecan-resistant samples (P<0.001 for all genes), while ISG15 (P=0.047) and Topo1 (P=0.002) were significantly higher. Based on those genes, a three-gene signature were established, which was calculated as follows: Index =0.488 - 0.020\u00d7 expression level of APTX\u2009+\u20090.015\u00d7 expression level of Topo1 - 0.011 \u00d7 expression level of BRCA1. The three-gene signature was significantly associated with irinotecan sensitivity (rho=0.71, P<0.001). The sensitivity and specificity for the prediction of irinotecan sensitivity based on the three-gene signature reached 73% and 86%, respectively. In another independent testing set, the irinotecan inhibition rates in gastric samples with sensitive-signature were much higher than those with resistant-signature (65% vs. 22%, P<0.001). Irinotecan therapy with 20 mg/kg per week to immunodeficient mice carrying xenografts with sensitive-signature dramatically arrested the growth of tumors (P<0.001), but had no effect on mice carrying xenografts with resistant-signature. CONCLUSIONS: The three-gene signature established herein is a potential predictive biomarker for irinotecan sensitivity in gastric cancer.", "title": {"charStart": 0, "charEnd": 101}, "docId": "23517622", "entity": [{"duid": "PU:zKw7", "entityType": "Disease", "charEnd": 922, "source": "PUBTATOR", "charStart": 888, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan-sensitive gastric cancer"}, {"duid": "PU:NhWw", "entityType": "Chemical", "charEnd": 70, "source": "PUBTATOR", "charStart": 61, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 0, "entityText": "irinotecan"}, {"duid": "PU:tFVi", "entityType": "Gene", "charEnd": 858, "source": "PUBTATOR", "charStart": 854, "entityId": [{"idString": "13870", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:cRZV", "entityType": "Gene", "charEnd": 380, "source": "PUBTATOR", "charStart": 376, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "BRCA1"}, {"duid": "PU:J9Z4", "entityType": "Disease", "charEnd": 100, "source": "PUBTATOR", "charStart": 87, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric cancer"}, {"duid": "PU:Dbm5", "entityType": "Chemical", "charEnd": 727, "source": "PUBTATOR", "charStart": 718, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 4, "entityText": "irinotecan"}, {"duid": "PU:ffc8", "entityType": "Chemical", "charEnd": 1579, "source": "PUBTATOR", "charStart": 1570, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 9, "entityText": "irinotecan"}, {"duid": "PU:xGrQ", "entityType": "Gene", "charEnd": 426, "source": "PUBTATOR", "charStart": 422, "entityId": [{"idString": "55959", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "SULF2"}, {"duid": "PU:55XP", "entityType": "Chemical", "charEnd": 952, "source": "PUBTATOR", "charStart": 943, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan"}, {"duid": "PU:j9w2", "entityType": "Chemical", "charEnd": 897, "source": "PUBTATOR", "charStart": 888, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan"}, {"duid": "PU:PsBH", "entityType": "Gene", "charEnd": 841, "source": "PUBTATOR", "charStart": 838, "entityId": [{"idString": "66408", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "APTX"}, {"duid": "PU:ysuY", "entityType": "Chemical", "charEnd": 293, "source": "PUBTATOR", "charStart": 284, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 2, "entityText": "irinotecan"}, {"duid": "PU:vwM6", "entityType": "Gene", "charEnd": 1278, "source": "PUBTATOR", "charStart": 1274, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 6, "entityText": "BRCA1"}, {"duid": "PU:YvXV", "entityType": "Chemical", "charEnd": 438, "source": "PUBTATOR", "charStart": 431, "entityId": [{"idString": "D005557", "source": "MESH"}], "sentenceIndex": 3, "entityText": "formalin"}, {"duid": "PU:JTJi", "entityType": "Gene", "charEnd": 387, "source": "PUBTATOR", "charStart": 383, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:t7VK", "entityType": "Disease", "charEnd": 1871, "source": "PUBTATOR", "charStart": 1866, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}, {"duid": "PU:mDEL", "entityType": "Gene", "charEnd": 1007, "source": "PUBTATOR", "charStart": 1003, "entityId": [{"idString": "100038882", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "ISG15"}, {"duid": "PU:c7Zm", "entityType": "Chemical", "charEnd": 1447, "source": "PUBTATOR", "charStart": 1438, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 8, "entityText": "irinotecan"}, {"duid": "PU:5Kdp", "entityType": "Chemical", "charEnd": 625, "source": "PUBTATOR", "charStart": 616, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 3, "entityText": "irinotecan"}, {"duid": "PU:TvnY", "entityType": "Species", "charEnd": 1908, "source": "PUBTATOR", "charStart": 1905, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "mice"}, {"duid": "PU:pjky", "entityType": "Gene", "charEnd": 848, "source": "PUBTATOR", "charStart": 844, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "BRCA1"}, {"duid": "PU:LLY9", "entityType": "Chemical", "charEnd": 2062, "source": "PUBTATOR", "charStart": 2053, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 11, "entityText": "irinotecan"}, {"duid": "PU:jNUZ", "entityType": "Disease", "charEnd": 477, "source": "PUBTATOR", "charStart": 464, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gastric cancer"}, {"duid": "PU:MEzY", "entityType": "Gene", "charEnd": 1207, "source": "PUBTATOR", "charStart": 1204, "entityId": [{"idString": "66408", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 6, "entityText": "APTX"}, {"duid": "PU:m3nz", "entityType": "Chemical", "charEnd": 1728, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 10, "entityText": "Irinotecan"}, {"duid": "PU:Wx4y", "entityType": "Chemical", "charEnd": 1349, "source": "PUBTATOR", "charStart": 1340, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 7, "entityText": "irinotecan"}, {"duid": "PU:zzHa", "entityType": "Species", "charEnd": 503, "source": "PUBTATOR", "charStart": 496, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:Rmcu", "entityType": "Gene", "charEnd": 394, "source": "PUBTATOR", "charStart": 390, "entityId": [{"idString": "9636", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ISG15"}, {"duid": "PU:bTmM", "entityType": "Disease", "charEnd": 327, "source": "PUBTATOR", "charStart": 314, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:7P2x", "entityType": "Disease", "charEnd": 2092, "source": "PUBTATOR", "charStart": 2079, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gastric cancer"}, {"duid": "PU:cUEy", "entityType": "Gene", "charEnd": 373, "source": "PUBTATOR", "charStart": 370, "entityId": [{"idString": "54840", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "APTX"}, {"duid": "PU:uYPr", "entityType": "Species", "charEnd": 1783, "source": "PUBTATOR", "charStart": 1780, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "mice"}, {"duid": "PU:4ErJ", "entityType": "Disease", "charEnd": 757, "source": "PUBTATOR", "charStart": 744, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 4, "entityText": "gastric cancer"}]}
{"text": "A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer. OBJECTIVE: Personalized chemotherapy based on molecular biomarkers can maximize anticancer efficiency. We aim to investigate predictive biomarkers capable of predicting response to irinotecan-based treatment in gastric cancer. METHODS: We examined gene expression of APTX, BRCA1, ERCC1, ISG15, Topo1 and methylation of SULF2 in formalin-fixed paraffin-embedded gastric cancer tissues from 175 patients and evaluated the association between gene expression levels or methylation status and in vitro sensitivity to irinotecan. We used multiple linear regression analysis to develop a gene-expression model to predict irinotecan sensitivity in gastric cancer and validated this model in vitro and vivo. RESULTS: Gene expression levels of APTX, BRCA1 and ERCC1 were significantly lower in irinotecan-sensitive gastric cancer samples than those irinotecan-resistant samples (P<0.001 for all genes), while ISG15 (P=0.047) and Topo1 (P=0.002) were significantly higher. Based on those genes, a three-gene signature were established, which was calculated as follows: Index =0.488 - 0.020\u00d7 expression level of APTX\u2009+\u20090.015\u00d7 expression level of Topo1 - 0.011 \u00d7 expression level of BRCA1. The three-gene signature was significantly associated with irinotecan sensitivity (rho=0.71, P<0.001). The sensitivity and specificity for the prediction of irinotecan sensitivity based on the three-gene signature reached 73% and 86%, respectively. In another independent testing set, the irinotecan inhibition rates in gastric samples with sensitive-signature were much higher than those with resistant-signature (65% vs. 22%, P<0.001). Irinotecan therapy with 20 mg/kg per week to immunodeficient mice carrying xenografts with sensitive-signature dramatically arrested the growth of tumors (P<0.001), but had no effect on mice carrying xenografts with resistant-signature. CONCLUSIONS: The three-gene signature established herein is a potential predictive biomarker for irinotecan sensitivity in gastric cancer.", "title": {"charStart": 0, "charEnd": 101}, "docId": "23517622", "entity": [{"duid": "PU:zKw7", "entityType": "Disease", "charEnd": 922, "source": "PUBTATOR", "charStart": 888, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan-sensitive gastric cancer"}, {"duid": "PU:NhWw", "entityType": "Chemical", "charEnd": 70, "source": "PUBTATOR", "charStart": 61, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 0, "entityText": "irinotecan"}, {"duid": "PU:tFVi", "entityType": "Gene", "charEnd": 858, "source": "PUBTATOR", "charStart": 854, "entityId": [{"idString": "13870", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:cRZV", "entityType": "Gene", "charEnd": 380, "source": "PUBTATOR", "charStart": 376, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "BRCA1"}, {"duid": "PU:J9Z4", "entityType": "Disease", "charEnd": 100, "source": "PUBTATOR", "charStart": 87, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric cancer"}, {"duid": "PU:Dbm5", "entityType": "Chemical", "charEnd": 727, "source": "PUBTATOR", "charStart": 718, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 4, "entityText": "irinotecan"}, {"duid": "PU:ffc8", "entityType": "Chemical", "charEnd": 1579, "source": "PUBTATOR", "charStart": 1570, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 9, "entityText": "irinotecan"}, {"duid": "PU:xGrQ", "entityType": "Gene", "charEnd": 426, "source": "PUBTATOR", "charStart": 422, "entityId": [{"idString": "55959", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "SULF2"}, {"duid": "PU:55XP", "entityType": "Chemical", "charEnd": 952, "source": "PUBTATOR", "charStart": 943, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan"}, {"duid": "PU:j9w2", "entityType": "Chemical", "charEnd": 897, "source": "PUBTATOR", "charStart": 888, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 5, "entityText": "irinotecan"}, {"duid": "PU:PsBH", "entityType": "Gene", "charEnd": 841, "source": "PUBTATOR", "charStart": 838, "entityId": [{"idString": "66408", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "APTX"}, {"duid": "PU:ysuY", "entityType": "Chemical", "charEnd": 293, "source": "PUBTATOR", "charStart": 284, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 2, "entityText": "irinotecan"}, {"duid": "PU:vwM6", "entityType": "Gene", "charEnd": 1278, "source": "PUBTATOR", "charStart": 1274, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 6, "entityText": "BRCA1"}, {"duid": "PU:YvXV", "entityType": "Chemical", "charEnd": 438, "source": "PUBTATOR", "charStart": 431, "entityId": [{"idString": "D005557", "source": "MESH"}], "sentenceIndex": 3, "entityText": "formalin"}, {"duid": "PU:JTJi", "entityType": "Gene", "charEnd": 387, "source": "PUBTATOR", "charStart": 383, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:t7VK", "entityType": "Disease", "charEnd": 1871, "source": "PUBTATOR", "charStart": 1866, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}, {"duid": "PU:mDEL", "entityType": "Gene", "charEnd": 1007, "source": "PUBTATOR", "charStart": 1003, "entityId": [{"idString": "100038882", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "ISG15"}, {"duid": "PU:c7Zm", "entityType": "Chemical", "charEnd": 1447, "source": "PUBTATOR", "charStart": 1438, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 8, "entityText": "irinotecan"}, {"duid": "PU:5Kdp", "entityType": "Chemical", "charEnd": 625, "source": "PUBTATOR", "charStart": 616, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 3, "entityText": "irinotecan"}, {"duid": "PU:TvnY", "entityType": "Species", "charEnd": 1908, "source": "PUBTATOR", "charStart": 1905, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "mice"}, {"duid": "PU:pjky", "entityType": "Gene", "charEnd": 848, "source": "PUBTATOR", "charStart": 844, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "BRCA1"}, {"duid": "PU:LLY9", "entityType": "Chemical", "charEnd": 2062, "source": "PUBTATOR", "charStart": 2053, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 11, "entityText": "irinotecan"}, {"duid": "PU:jNUZ", "entityType": "Disease", "charEnd": 477, "source": "PUBTATOR", "charStart": 464, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gastric cancer"}, {"duid": "PU:MEzY", "entityType": "Gene", "charEnd": 1207, "source": "PUBTATOR", "charStart": 1204, "entityId": [{"idString": "66408", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 6, "entityText": "APTX"}, {"duid": "PU:m3nz", "entityType": "Chemical", "charEnd": 1728, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 10, "entityText": "Irinotecan"}, {"duid": "PU:Wx4y", "entityType": "Chemical", "charEnd": 1349, "source": "PUBTATOR", "charStart": 1340, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 7, "entityText": "irinotecan"}, {"duid": "PU:zzHa", "entityType": "Species", "charEnd": 503, "source": "PUBTATOR", "charStart": 496, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:Rmcu", "entityType": "Gene", "charEnd": 394, "source": "PUBTATOR", "charStart": 390, "entityId": [{"idString": "9636", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ISG15"}, {"duid": "PU:bTmM", "entityType": "Disease", "charEnd": 327, "source": "PUBTATOR", "charStart": 314, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:7P2x", "entityType": "Disease", "charEnd": 2092, "source": "PUBTATOR", "charStart": 2079, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gastric cancer"}, {"duid": "PU:cUEy", "entityType": "Gene", "charEnd": 373, "source": "PUBTATOR", "charStart": 370, "entityId": [{"idString": "54840", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "APTX"}, {"duid": "PU:uYPr", "entityType": "Species", "charEnd": 1783, "source": "PUBTATOR", "charStart": 1780, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "mice"}, {"duid": "PU:4ErJ", "entityType": "Disease", "charEnd": 757, "source": "PUBTATOR", "charStart": 744, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 4, "entityText": "gastric cancer"}]}
{"text": "Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. The purpose of this work was to analyse the ability of p53 and thymidilate synthase (TS) primary tumour expression to retrospectively predict clinical response to chemotherapy and long-term prognosis in patients with advanced colorectal cancers homogeneously treated by methotrexate (MTX)-modulated-5-fluorouracil (5-FU-FA). A total of 108 advanced colorectal cancer patients entered the present retrospective study. Immunohistochemical p53 (pAb 1801 mAb) and TS (TS106 mAb) expression on formalin-fixed paraffin-embedded primary tumour specimens was related to probability of clinical response to chemotherapy, time to progression and overall survival. p53 was expressed in 53/108 (49%) tumours, while 54/108 (50%) showed TS immunostaining. No relationship was demonstrated between p53 positivity and clinical response to chemotherapy (objective response (OR): 20% vs 23%, in p53+ and p53- cases respectively) or overall survival. Percent of OR was significantly higher in TS-negative with respect to TS-positive tumours (30% vs 15% respectively; P < 0.04); simultaneous analysis of TS and p53 indicated 7% OR for p53-positive/TS-positive tumours vs 46% for p53-positive/TS-negative tumours (P < 0.03). Logistic regression analysis confirmed a significant association between TS tumour status and clinical response to chemotherapy (hazard ratio (HR): 2.91; 95% confidence interval (CI) 8.34-1.01; two-sided P < 0.05). A multivariate analysis of overall survival showed that only a small number of metastatic sites was statistically relevant (HR 1.89; 95% CI 2.85-1.26; two-sided P < 0.03). Our study suggests that immunohistochemical expression of p53 and TS could assist the clinician in predicting response of colorectal cancer patients to modulated MTX-5-FU therapy.", "title": {"charStart": 0, "charEnd": 116}, "docId": "10682666", "entity": [{"duid": "PU:Pfad", "entityType": "Gene", "charEnd": 1279, "source": "PUBTATOR", "charStart": 1277, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "p53"}, {"duid": "PU:w8Fq", "entityType": "Chemical", "charEnd": 404, "source": "PUBTATOR", "charStart": 402, "entityId": [{"idString": "44185", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "MTX"}, {"duid": "PU:iaGH", "entityType": "Disease", "charEnd": 1847, "source": "PUBTATOR", "charStart": 1831, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 9, "entityText": "colorectal cancer"}, {"duid": "PU:psry", "entityType": "Species", "charEnd": 328, "source": "PUBTATOR", "charStart": 321, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:C4xe", "entityType": "Gene", "charEnd": 1006, "source": "PUBTATOR", "charStart": 1004, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p53"}, {"duid": "PU:Fpxh", "entityType": "Species", "charEnd": 1856, "source": "PUBTATOR", "charStart": 1849, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:UPJQ", "entityType": "Disease", "charEnd": 1138, "source": "PUBTATOR", "charStart": 1120, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS-positive tumours"}, {"duid": "PU:HuHs", "entityType": "Gene", "charEnd": 1235, "source": "PUBTATOR", "charStart": 1233, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "p53"}, {"duid": "PU:BSWk", "entityType": "Disease", "charEnd": 1308, "source": "PUBTATOR", "charStart": 1302, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumours"}, {"duid": "PU:VeNY", "entityType": "Gene", "charEnd": 1769, "source": "PUBTATOR", "charStart": 1767, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "p53"}, {"duid": "PU:fGb6", "entityType": "Gene", "charEnd": 175, "source": "PUBTATOR", "charStart": 173, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "p53"}, {"duid": "PU:ucnh", "entityType": "Chemical", "charEnd": 439, "source": "PUBTATOR", "charStart": 433, "entityId": [], "sentenceIndex": 1, "entityText": "5-FU-FA"}, {"duid": "PU:FLjp", "entityType": "Disease", "charEnd": 483, "source": "PUBTATOR", "charStart": 467, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 2, "entityText": "colorectal cancer"}, {"duid": "PU:MYgu", "entityType": "Gene", "charEnd": 1211, "source": "PUBTATOR", "charStart": 1209, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "p53"}, {"duid": "PU:MBsP", "entityType": "Chemical", "charEnd": 1878, "source": "PUBTATOR", "charStart": 1871, "entityId": [], "sentenceIndex": 9, "entityText": "MTX-5-FU"}, {"duid": "PU:Y36c", "entityType": "Disease", "charEnd": 361, "source": "PUBTATOR", "charStart": 344, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 1, "entityText": "colorectal cancers"}, {"duid": "PU:2Dwa", "entityType": "Disease", "charEnd": 812, "source": "PUBTATOR", "charStart": 806, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumours"}, {"duid": "PU:mgnn", "entityType": "Disease", "charEnd": 42, "source": "PUBTATOR", "charStart": 37, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 0, "entityText": "tumour"}, {"duid": "PU:uR5t", "entityType": "Gene", "charEnd": 27, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "p53"}, {"duid": "PU:xXNu", "entityType": "Gene", "charEnd": 997, "source": "PUBTATOR", "charStart": 995, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p53"}, {"duid": "PU:TWad", "entityType": "Disease", "charEnd": 220, "source": "PUBTATOR", "charStart": 215, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumour"}, {"duid": "PU:dpgG", "entityType": "Disease", "charEnd": 106, "source": "PUBTATOR", "charStart": 90, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 0, "entityText": "colorectal cancer"}, {"duid": "PU:TuQo", "entityType": "Gene", "charEnd": 557, "source": "PUBTATOR", "charStart": 555, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "p53"}, {"duid": "PU:nwm5", "entityType": "Gene", "charEnd": 774, "source": "PUBTATOR", "charStart": 772, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "p53"}, {"duid": "PU:9Dkj", "entityType": "Disease", "charEnd": 653, "source": "PUBTATOR", "charStart": 648, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumour"}, {"duid": "PU:mJ84", "entityType": "Chemical", "charEnd": 399, "source": "PUBTATOR", "charStart": 388, "entityId": [{"idString": "D008727", "source": "MESH"}], "sentenceIndex": 1, "entityText": "methotrexate"}, {"duid": "PU:9NFk", "entityType": "Gene", "charEnd": 903, "source": "PUBTATOR", "charStart": 901, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p53"}, {"duid": "PU:MxZa", "entityType": "Species", "charEnd": 115, "source": "PUBTATOR", "charStart": 108, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:XfRf", "entityType": "Disease", "charEnd": 1264, "source": "PUBTATOR", "charStart": 1246, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS-positive tumours"}, {"duid": "PU:S9p7", "entityType": "Species", "charEnd": 492, "source": "PUBTATOR", "charStart": 485, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:ENiu", "entityType": "Disease", "charEnd": 1403, "source": "PUBTATOR", "charStart": 1395, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "TS tumour"}, {"duid": "PU:VA4c", "entityType": "Chemical", "charEnd": 430, "source": "PUBTATOR", "charStart": 407, "entityId": [], "sentenceIndex": 1, "entityText": "modulated-5-fluorouracil"}, {"duid": "PU:qRTD", "entityType": "Chemical", "charEnd": 614, "source": "PUBTATOR", "charStart": 607, "entityId": [{"idString": "D005557", "source": "MESH"}], "sentenceIndex": 3, "entityText": "formalin"}]}
{"text": "Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. The purpose of this work was to analyse the ability of p53 and thymidilate synthase (TS) primary tumour expression to retrospectively predict clinical response to chemotherapy and long-term prognosis in patients with advanced colorectal cancers homogeneously treated by methotrexate (MTX)-modulated-5-fluorouracil (5-FU-FA). A total of 108 advanced colorectal cancer patients entered the present retrospective study. Immunohistochemical p53 (pAb 1801 mAb) and TS (TS106 mAb) expression on formalin-fixed paraffin-embedded primary tumour specimens was related to probability of clinical response to chemotherapy, time to progression and overall survival. p53 was expressed in 53/108 (49%) tumours, while 54/108 (50%) showed TS immunostaining. No relationship was demonstrated between p53 positivity and clinical response to chemotherapy (objective response (OR): 20% vs 23%, in p53+ and p53- cases respectively) or overall survival. Percent of OR was significantly higher in TS-negative with respect to TS-positive tumours (30% vs 15% respectively; P < 0.04); simultaneous analysis of TS and p53 indicated 7% OR for p53-positive/TS-positive tumours vs 46% for p53-positive/TS-negative tumours (P < 0.03). Logistic regression analysis confirmed a significant association between TS tumour status and clinical response to chemotherapy (hazard ratio (HR): 2.91; 95% confidence interval (CI) 8.34-1.01; two-sided P < 0.05). A multivariate analysis of overall survival showed that only a small number of metastatic sites was statistically relevant (HR 1.89; 95% CI 2.85-1.26; two-sided P < 0.03). Our study suggests that immunohistochemical expression of p53 and TS could assist the clinician in predicting response of colorectal cancer patients to modulated MTX-5-FU therapy.", "title": {"charStart": 0, "charEnd": 116}, "docId": "10682666", "entity": [{"duid": "PU:Pfad", "entityType": "Gene", "charEnd": 1279, "source": "PUBTATOR", "charStart": 1277, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "p53"}, {"duid": "PU:w8Fq", "entityType": "Chemical", "charEnd": 404, "source": "PUBTATOR", "charStart": 402, "entityId": [{"idString": "44185", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "MTX"}, {"duid": "PU:iaGH", "entityType": "Disease", "charEnd": 1847, "source": "PUBTATOR", "charStart": 1831, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 9, "entityText": "colorectal cancer"}, {"duid": "PU:psry", "entityType": "Species", "charEnd": 328, "source": "PUBTATOR", "charStart": 321, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:C4xe", "entityType": "Gene", "charEnd": 1006, "source": "PUBTATOR", "charStart": 1004, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p53"}, {"duid": "PU:Fpxh", "entityType": "Species", "charEnd": 1856, "source": "PUBTATOR", "charStart": 1849, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:UPJQ", "entityType": "Disease", "charEnd": 1138, "source": "PUBTATOR", "charStart": 1120, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS-positive tumours"}, {"duid": "PU:HuHs", "entityType": "Gene", "charEnd": 1235, "source": "PUBTATOR", "charStart": 1233, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "p53"}, {"duid": "PU:BSWk", "entityType": "Disease", "charEnd": 1308, "source": "PUBTATOR", "charStart": 1302, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumours"}, {"duid": "PU:VeNY", "entityType": "Gene", "charEnd": 1769, "source": "PUBTATOR", "charStart": 1767, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "p53"}, {"duid": "PU:fGb6", "entityType": "Gene", "charEnd": 175, "source": "PUBTATOR", "charStart": 173, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "p53"}, {"duid": "PU:ucnh", "entityType": "Chemical", "charEnd": 439, "source": "PUBTATOR", "charStart": 433, "entityId": [], "sentenceIndex": 1, "entityText": "5-FU-FA"}, {"duid": "PU:FLjp", "entityType": "Disease", "charEnd": 483, "source": "PUBTATOR", "charStart": 467, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 2, "entityText": "colorectal cancer"}, {"duid": "PU:MYgu", "entityType": "Gene", "charEnd": 1211, "source": "PUBTATOR", "charStart": 1209, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "p53"}, {"duid": "PU:MBsP", "entityType": "Chemical", "charEnd": 1878, "source": "PUBTATOR", "charStart": 1871, "entityId": [], "sentenceIndex": 9, "entityText": "MTX-5-FU"}, {"duid": "PU:Y36c", "entityType": "Disease", "charEnd": 361, "source": "PUBTATOR", "charStart": 344, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 1, "entityText": "colorectal cancers"}, {"duid": "PU:2Dwa", "entityType": "Disease", "charEnd": 812, "source": "PUBTATOR", "charStart": 806, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumours"}, {"duid": "PU:mgnn", "entityType": "Disease", "charEnd": 42, "source": "PUBTATOR", "charStart": 37, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 0, "entityText": "tumour"}, {"duid": "PU:uR5t", "entityType": "Gene", "charEnd": 27, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "p53"}, {"duid": "PU:xXNu", "entityType": "Gene", "charEnd": 997, "source": "PUBTATOR", "charStart": 995, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p53"}, {"duid": "PU:TWad", "entityType": "Disease", "charEnd": 220, "source": "PUBTATOR", "charStart": 215, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumour"}, {"duid": "PU:dpgG", "entityType": "Disease", "charEnd": 106, "source": "PUBTATOR", "charStart": 90, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 0, "entityText": "colorectal cancer"}, {"duid": "PU:TuQo", "entityType": "Gene", "charEnd": 557, "source": "PUBTATOR", "charStart": 555, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "p53"}, {"duid": "PU:nwm5", "entityType": "Gene", "charEnd": 774, "source": "PUBTATOR", "charStart": 772, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "p53"}, {"duid": "PU:9Dkj", "entityType": "Disease", "charEnd": 653, "source": "PUBTATOR", "charStart": 648, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumour"}, {"duid": "PU:mJ84", "entityType": "Chemical", "charEnd": 399, "source": "PUBTATOR", "charStart": 388, "entityId": [{"idString": "D008727", "source": "MESH"}], "sentenceIndex": 1, "entityText": "methotrexate"}, {"duid": "PU:9NFk", "entityType": "Gene", "charEnd": 903, "source": "PUBTATOR", "charStart": 901, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p53"}, {"duid": "PU:MxZa", "entityType": "Species", "charEnd": 115, "source": "PUBTATOR", "charStart": 108, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:XfRf", "entityType": "Disease", "charEnd": 1264, "source": "PUBTATOR", "charStart": 1246, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS-positive tumours"}, {"duid": "PU:S9p7", "entityType": "Species", "charEnd": 492, "source": "PUBTATOR", "charStart": 485, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:ENiu", "entityType": "Disease", "charEnd": 1403, "source": "PUBTATOR", "charStart": 1395, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "TS tumour"}, {"duid": "PU:VA4c", "entityType": "Chemical", "charEnd": 430, "source": "PUBTATOR", "charStart": 407, "entityId": [], "sentenceIndex": 1, "entityText": "modulated-5-fluorouracil"}, {"duid": "PU:qRTD", "entityType": "Chemical", "charEnd": 614, "source": "PUBTATOR", "charStart": 607, "entityId": [{"idString": "D005557", "source": "MESH"}], "sentenceIndex": 3, "entityText": "formalin"}]}
{"text": "Excision-repair cross-complementing 1 predicts response to cisplatin-based neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma. Low excision repair cross-complementing 1 (ERCC1) has been associated with a favorable response to cisplatin (CDDP) in several types of malignancies. The present study aimed to investigate whether ERCC1 predicts the response to CDDP-based chemoradiotherapy (CRT) in patients with esophageal squamous cell carcinoma (ESCC) and to evaluate the association between ERCC1 and platinum drug sensitivity in ESCC cell lines. ERCC1 mRNA levels in pre- and post-treatment tumoral and normal biopsies of 16 ESCC patients receiving CDDP-based CRT and in 4 ESCC cell lines were examined using real-time reverse transcription polymerase chain reaction. Pre-treatment tumoral ERCC1 was compared with clinicopathological variables and response to CRT. Responses to CDDP and oxaliplatin (OXA) in ESCC cell lines were evaluated using the WST-8 colorimetric assay by comparing ERCC1 levels. ERCC1 was significantly higher in cancer tissue compared to normal tissue (p<0.01). Tumoral ERCC1 significantly decreased after CRT to normal levels (p<0.05). ERCC1 levels in patients with a partial response were significantly lower than levels in patients who did not respond to CRT (p<0.05). ESCC cell lines with lower ERCC1 showed significantly greater sensitivity to clinically relevant concentrations of CDDP and OXA compared to lines with higher ERCC1 (p<0.01). In conclusion, low ERCC1 levels were associated with platinum drug sensitivity in ESCC cell lines. Pre-treatment tumoral ERCC1 may be used as a predictive marker for identifying patients who respond to CRT.", "title": {"charStart": 0, "charEnd": 156}, "docId": "21475919", "entity": [{"duid": "PU:2CfY", "entityType": "Gene", "charEnd": 205, "source": "PUBTATOR", "charStart": 201, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:aYUS", "entityType": "Gene", "charEnd": 580, "source": "PUBTATOR", "charStart": 576, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:bMUT", "entityType": "Gene", "charEnd": 1035, "source": "PUBTATOR", "charStart": 1031, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:dcB8", "entityType": "Gene", "charEnd": 198, "source": "PUBTATOR", "charStart": 162, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementing 1"}, {"duid": "PU:EsxL", "entityType": "Disease", "charEnd": 155, "source": "PUBTATOR", "charStart": 122, "entityId": [{"idString": "C562729", "source": "MESH"}], "sentenceIndex": 0, "entityText": "esophageal squamous cell carcinoma"}, {"duid": "PU:FJSP", "entityType": "Chemical", "charEnd": 265, "source": "PUBTATOR", "charStart": 257, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:YNcJ", "entityType": "Disease", "charEnd": 477, "source": "PUBTATOR", "charStart": 474, "entityId": [{"idString": "C562729", "source": "MESH"}], "sentenceIndex": 2, "entityText": "ESCC"}, {"duid": "PU:tMW7", "entityType": "Chemical", "charEnd": 932, "source": "PUBTATOR", "charStart": 930, "entityId": [{"idString": "C015692", "source": "MESH"}], "sentenceIndex": 5, "entityText": "OXA"}, {"duid": "PU:fR48", "entityType": "Species", "charEnd": 1286, "source": "PUBTATOR", "charStart": 1279, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:7PAC", "entityType": "Species", "charEnd": 431, "source": "PUBTATOR", "charStart": 424, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:wDbu", "entityType": "Chemical", "charEnd": 1559, "source": "PUBTATOR", "charStart": 1552, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 10, "entityText": "platinum"}, {"duid": "PU:kZFJ", "entityType": "Chemical", "charEnd": 911, "source": "PUBTATOR", "charStart": 908, "entityId": [], "sentenceIndex": 5, "entityText": "CDDP"}, {"duid": "PU:MWyj", "entityType": "Gene", "charEnd": 824, "source": "PUBTATOR", "charStart": 820, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:UzbX", "entityType": "Gene", "charEnd": 1487, "source": "PUBTATOR", "charStart": 1483, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:d2f4", "entityType": "Disease", "charEnd": 706, "source": "PUBTATOR", "charStart": 703, "entityId": [{"idString": "C562729", "source": "MESH"}], "sentenceIndex": 3, "entityText": "ESCC"}, {"duid": "PU:QJ6D", "entityType": "Species", "charEnd": 1684, "source": "PUBTATOR", "charStart": 1677, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:TYMk", "entityType": "Disease", "charEnd": 1070, "source": "PUBTATOR", "charStart": 1065, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "cancer"}, {"duid": "PU:5DXh", "entityType": "Gene", "charEnd": 359, "source": "PUBTATOR", "charStart": 355, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:8agG", "entityType": "Chemical", "charEnd": 67, "source": "PUBTATOR", "charStart": 59, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "cisplatin"}, {"duid": "PU:ErB7", "entityType": "Disease", "charEnd": 471, "source": "PUBTATOR", "charStart": 438, "entityId": [{"idString": "C562729", "source": "MESH"}], "sentenceIndex": 2, "entityText": "esophageal squamous cell carcinoma"}, {"duid": "PU:ENjj", "entityType": "Species", "charEnd": 1213, "source": "PUBTATOR", "charStart": 1206, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:Z9jK", "entityType": "Chemical", "charEnd": 927, "source": "PUBTATOR", "charStart": 917, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 5, "entityText": "oxaliplatin"}, {"duid": "PU:EpbZ", "entityType": "Gene", "charEnd": 1127, "source": "PUBTATOR", "charStart": 1123, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:Ktaw", "entityType": "Disease", "charEnd": 941, "source": "PUBTATOR", "charStart": 938, "entityId": [{"idString": "C562729", "source": "MESH"}], "sentenceIndex": 5, "entityText": "ESCC"}, {"duid": "PU:zjku", "entityType": "Species", "charEnd": 667, "source": "PUBTATOR", "charStart": 660, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:bKsM", "entityType": "Disease", "charEnd": 1584, "source": "PUBTATOR", "charStart": 1581, "entityId": [{"idString": "C562729", "source": "MESH"}], "sentenceIndex": 10, "entityText": "ESCC"}, {"duid": "PU:A2oc", "entityType": "Disease", "charEnd": 1328, "source": "PUBTATOR", "charStart": 1325, "entityId": [{"idString": "C562729", "source": "MESH"}], "sentenceIndex": 9, "entityText": "ESCC"}, {"duid": "PU:EoS5", "entityType": "Disease", "charEnd": 658, "source": "PUBTATOR", "charStart": 655, "entityId": [{"idString": "C562729", "source": "MESH"}], "sentenceIndex": 3, "entityText": "ESCC"}, {"duid": "PU:dMr8", "entityType": "Gene", "charEnd": 1522, "source": "PUBTATOR", "charStart": 1518, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:hMhF", "entityType": "Species", "charEnd": 115, "source": "PUBTATOR", "charStart": 108, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:hkiz", "entityType": "Gene", "charEnd": 1194, "source": "PUBTATOR", "charStart": 1190, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:GRBT", "entityType": "Disease", "charEnd": 169, "source": "PUBTATOR", "charStart": 158, "entityId": [{"idString": "D009800", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Low excision"}, {"duid": "PU:5PNq", "entityType": "Gene", "charEnd": 1021, "source": "PUBTATOR", "charStart": 1017, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:36HZ", "entityType": "Disease", "charEnd": 305, "source": "PUBTATOR", "charStart": 294, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "malignancies"}, {"duid": "PU:2erg", "entityType": "Gene", "charEnd": 1356, "source": "PUBTATOR", "charStart": 1352, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:Hgso", "entityType": "Gene", "charEnd": 1624, "source": "PUBTATOR", "charStart": 1620, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ERCC1"}, {"duid": "PU:fvxR", "entityType": "Disease", "charEnd": 562, "source": "PUBTATOR", "charStart": 559, "entityId": [{"idString": "C562729", "source": "MESH"}], "sentenceIndex": 2, "entityText": "ESCC"}, {"duid": "PU:Rcuv", "entityType": "Chemical", "charEnd": 537, "source": "PUBTATOR", "charStart": 530, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 2, "entityText": "platinum"}, {"duid": "PU:KFqF", "entityType": "Gene", "charEnd": 524, "source": "PUBTATOR", "charStart": 520, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}]}
{"text": "Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Paclitaxel (PTX), the diterpene alkaloid, is a potent anti-cancer drug and is routinely used for the treatment of breast and ovarian cancers. The cellular targets of PTX are microtubules, which are composed of alpha- and beta-tubulin. Development of PTX resistance in patients has been a major problem associated with cancer chemotherapy. In an effort to get insight into this phenomenon of drug resistance, a PTX-resistant cell line from MCF-7 breast cancer cells has been generated. Western analysis of the cell extracts revealed that the resistant cells contain 2-fold higher amount of tyrosinated alpha-tubulin than those of the wild-type MCF-7 cells. Similar analyses of beta-tubulin with the isotype-specific monoclonal antibodies demonstrated that the PTX-resistant cells contain 2.5-fold higher amounts of beta(III) and 1.5-fold higher amount of beta(IV)-tubulin, while no difference was observed in the level of beta(I) isotype. These results demonstrate for the first time that PTX resistance is associated with an increase in the level of tyrosinated alpha-tubulin.", "title": {"charStart": 0, "charEnd": 131}, "docId": "12054644", "entity": [{"duid": "PU:yCUU", "entityType": "Disease", "charEnd": 197, "source": "PUBTATOR", "charStart": 192, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cancer"}, {"duid": "PU:9C57", "entityType": "Chemical", "charEnd": 301, "source": "PUBTATOR", "charStart": 299, "entityId": [], "sentenceIndex": 2, "entityText": "PTX"}, {"duid": "PU:a57j", "entityType": "Chemical", "charEnd": 94, "source": "PUBTATOR", "charStart": 85, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "paclitaxel"}, {"duid": "PU:wXXj", "entityType": "Chemical", "charEnd": 63, "source": "PUBTATOR", "charStart": 40, "entityId": [], "sentenceIndex": 0, "entityText": "beta(III)-, and beta(IV)"}, {"duid": "PU:DDGi", "entityType": "Species", "charEnd": 408, "source": "PUBTATOR", "charStart": 401, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:vUsk", "entityType": "Chemical", "charEnd": 385, "source": "PUBTATOR", "charStart": 383, "entityId": [], "sentenceIndex": 3, "entityText": "PTX"}, {"duid": "PU:W3NB", "entityType": "Chemical", "charEnd": 163, "source": "PUBTATOR", "charStart": 155, "entityId": [{"idString": "35190", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "diterpene"}, {"duid": "PU:Hfsu", "entityType": "Disease", "charEnd": 590, "source": "PUBTATOR", "charStart": 578, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 4, "entityText": "breast cancer"}, {"duid": "PU:ZTQo", "entityType": "Disease", "charEnd": 272, "source": "PUBTATOR", "charStart": 247, "entityId": [{"idString": "D061325", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast and ovarian cancers"}, {"duid": "PU:JDKz", "entityType": "Chemical", "charEnd": 1123, "source": "PUBTATOR", "charStart": 1121, "entityId": [], "sentenceIndex": 7, "entityText": "PTX"}, {"duid": "PU:3QoC", "entityType": "Chemical", "charEnd": 142, "source": "PUBTATOR", "charStart": 133, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Paclitaxel"}, {"duid": "PU:rFoT", "entityType": "Chemical", "charEnd": 147, "source": "PUBTATOR", "charStart": 145, "entityId": [], "sentenceIndex": 1, "entityText": "PTX"}, {"duid": "PU:7sqM", "entityType": "Disease", "charEnd": 124, "source": "PUBTATOR", "charStart": 112, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast cancer"}, {"duid": "PU:5Atc", "entityType": "Chemical", "charEnd": 545, "source": "PUBTATOR", "charStart": 543, "entityId": [], "sentenceIndex": 4, "entityText": "PTX"}, {"duid": "PU:JXZ6", "entityType": "Disease", "charEnd": 456, "source": "PUBTATOR", "charStart": 451, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cancer"}, {"duid": "PU:2oLf", "entityType": "Chemical", "charEnd": 894, "source": "PUBTATOR", "charStart": 892, "entityId": [], "sentenceIndex": 6, "entityText": "PTX"}, {"duid": "PU:bzkf", "entityType": "Gene", "charEnd": 365, "source": "PUBTATOR", "charStart": 343, "entityId": [{"idString": "10376", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "alpha- and beta-tubulin"}]}
{"text": "Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Paclitaxel (PTX), the diterpene alkaloid, is a potent anti-cancer drug and is routinely used for the treatment of breast and ovarian cancers. The cellular targets of PTX are microtubules, which are composed of alpha- and beta-tubulin. Development of PTX resistance in patients has been a major problem associated with cancer chemotherapy. In an effort to get insight into this phenomenon of drug resistance, a PTX-resistant cell line from MCF-7 breast cancer cells has been generated. Western analysis of the cell extracts revealed that the resistant cells contain 2-fold higher amount of tyrosinated alpha-tubulin than those of the wild-type MCF-7 cells. Similar analyses of beta-tubulin with the isotype-specific monoclonal antibodies demonstrated that the PTX-resistant cells contain 2.5-fold higher amounts of beta(III) and 1.5-fold higher amount of beta(IV)-tubulin, while no difference was observed in the level of beta(I) isotype. These results demonstrate for the first time that PTX resistance is associated with an increase in the level of tyrosinated alpha-tubulin.", "title": {"charStart": 0, "charEnd": 131}, "docId": "12054644", "entity": [{"duid": "PU:yCUU", "entityType": "Disease", "charEnd": 197, "source": "PUBTATOR", "charStart": 192, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cancer"}, {"duid": "PU:9C57", "entityType": "Chemical", "charEnd": 301, "source": "PUBTATOR", "charStart": 299, "entityId": [], "sentenceIndex": 2, "entityText": "PTX"}, {"duid": "PU:a57j", "entityType": "Chemical", "charEnd": 94, "source": "PUBTATOR", "charStart": 85, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "paclitaxel"}, {"duid": "PU:wXXj", "entityType": "Chemical", "charEnd": 63, "source": "PUBTATOR", "charStart": 40, "entityId": [], "sentenceIndex": 0, "entityText": "beta(III)-, and beta(IV)"}, {"duid": "PU:DDGi", "entityType": "Species", "charEnd": 408, "source": "PUBTATOR", "charStart": 401, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:vUsk", "entityType": "Chemical", "charEnd": 385, "source": "PUBTATOR", "charStart": 383, "entityId": [], "sentenceIndex": 3, "entityText": "PTX"}, {"duid": "PU:W3NB", "entityType": "Chemical", "charEnd": 163, "source": "PUBTATOR", "charStart": 155, "entityId": [{"idString": "35190", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "diterpene"}, {"duid": "PU:Hfsu", "entityType": "Disease", "charEnd": 590, "source": "PUBTATOR", "charStart": 578, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 4, "entityText": "breast cancer"}, {"duid": "PU:ZTQo", "entityType": "Disease", "charEnd": 272, "source": "PUBTATOR", "charStart": 247, "entityId": [{"idString": "D061325", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast and ovarian cancers"}, {"duid": "PU:JDKz", "entityType": "Chemical", "charEnd": 1123, "source": "PUBTATOR", "charStart": 1121, "entityId": [], "sentenceIndex": 7, "entityText": "PTX"}, {"duid": "PU:3QoC", "entityType": "Chemical", "charEnd": 142, "source": "PUBTATOR", "charStart": 133, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Paclitaxel"}, {"duid": "PU:rFoT", "entityType": "Chemical", "charEnd": 147, "source": "PUBTATOR", "charStart": 145, "entityId": [], "sentenceIndex": 1, "entityText": "PTX"}, {"duid": "PU:7sqM", "entityType": "Disease", "charEnd": 124, "source": "PUBTATOR", "charStart": 112, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast cancer"}, {"duid": "PU:5Atc", "entityType": "Chemical", "charEnd": 545, "source": "PUBTATOR", "charStart": 543, "entityId": [], "sentenceIndex": 4, "entityText": "PTX"}, {"duid": "PU:JXZ6", "entityType": "Disease", "charEnd": 456, "source": "PUBTATOR", "charStart": 451, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cancer"}, {"duid": "PU:2oLf", "entityType": "Chemical", "charEnd": 894, "source": "PUBTATOR", "charStart": 892, "entityId": [], "sentenceIndex": 6, "entityText": "PTX"}, {"duid": "PU:bzkf", "entityType": "Gene", "charEnd": 365, "source": "PUBTATOR", "charStart": 343, "entityId": [{"idString": "10376", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "alpha- and beta-tubulin"}]}
{"text": "Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Paclitaxel (PTX), the diterpene alkaloid, is a potent anti-cancer drug and is routinely used for the treatment of breast and ovarian cancers. The cellular targets of PTX are microtubules, which are composed of alpha- and beta-tubulin. Development of PTX resistance in patients has been a major problem associated with cancer chemotherapy. In an effort to get insight into this phenomenon of drug resistance, a PTX-resistant cell line from MCF-7 breast cancer cells has been generated. Western analysis of the cell extracts revealed that the resistant cells contain 2-fold higher amount of tyrosinated alpha-tubulin than those of the wild-type MCF-7 cells. Similar analyses of beta-tubulin with the isotype-specific monoclonal antibodies demonstrated that the PTX-resistant cells contain 2.5-fold higher amounts of beta(III) and 1.5-fold higher amount of beta(IV)-tubulin, while no difference was observed in the level of beta(I) isotype. These results demonstrate for the first time that PTX resistance is associated with an increase in the level of tyrosinated alpha-tubulin.", "title": {"charStart": 0, "charEnd": 131}, "docId": "12054644", "entity": [{"duid": "PU:yCUU", "entityType": "Disease", "charEnd": 197, "source": "PUBTATOR", "charStart": 192, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cancer"}, {"duid": "PU:9C57", "entityType": "Chemical", "charEnd": 301, "source": "PUBTATOR", "charStart": 299, "entityId": [], "sentenceIndex": 2, "entityText": "PTX"}, {"duid": "PU:a57j", "entityType": "Chemical", "charEnd": 94, "source": "PUBTATOR", "charStart": 85, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "paclitaxel"}, {"duid": "PU:wXXj", "entityType": "Chemical", "charEnd": 63, "source": "PUBTATOR", "charStart": 40, "entityId": [], "sentenceIndex": 0, "entityText": "beta(III)-, and beta(IV)"}, {"duid": "PU:DDGi", "entityType": "Species", "charEnd": 408, "source": "PUBTATOR", "charStart": 401, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:vUsk", "entityType": "Chemical", "charEnd": 385, "source": "PUBTATOR", "charStart": 383, "entityId": [], "sentenceIndex": 3, "entityText": "PTX"}, {"duid": "PU:W3NB", "entityType": "Chemical", "charEnd": 163, "source": "PUBTATOR", "charStart": 155, "entityId": [{"idString": "35190", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "diterpene"}, {"duid": "PU:Hfsu", "entityType": "Disease", "charEnd": 590, "source": "PUBTATOR", "charStart": 578, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 4, "entityText": "breast cancer"}, {"duid": "PU:ZTQo", "entityType": "Disease", "charEnd": 272, "source": "PUBTATOR", "charStart": 247, "entityId": [{"idString": "D061325", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast and ovarian cancers"}, {"duid": "PU:JDKz", "entityType": "Chemical", "charEnd": 1123, "source": "PUBTATOR", "charStart": 1121, "entityId": [], "sentenceIndex": 7, "entityText": "PTX"}, {"duid": "PU:3QoC", "entityType": "Chemical", "charEnd": 142, "source": "PUBTATOR", "charStart": 133, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Paclitaxel"}, {"duid": "PU:rFoT", "entityType": "Chemical", "charEnd": 147, "source": "PUBTATOR", "charStart": 145, "entityId": [], "sentenceIndex": 1, "entityText": "PTX"}, {"duid": "PU:7sqM", "entityType": "Disease", "charEnd": 124, "source": "PUBTATOR", "charStart": 112, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast cancer"}, {"duid": "PU:5Atc", "entityType": "Chemical", "charEnd": 545, "source": "PUBTATOR", "charStart": 543, "entityId": [], "sentenceIndex": 4, "entityText": "PTX"}, {"duid": "PU:JXZ6", "entityType": "Disease", "charEnd": 456, "source": "PUBTATOR", "charStart": 451, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cancer"}, {"duid": "PU:2oLf", "entityType": "Chemical", "charEnd": 894, "source": "PUBTATOR", "charStart": 892, "entityId": [], "sentenceIndex": 6, "entityText": "PTX"}, {"duid": "PU:bzkf", "entityType": "Gene", "charEnd": 365, "source": "PUBTATOR", "charStart": 343, "entityId": [{"idString": "10376", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "alpha- and beta-tubulin"}]}
{"text": "ERCC1, RRM1 and TUBB3 mRNA expression on the tumor response and overall survival of non-small cell lung cancer treated with platinum-based chemotherapy. OBJECTIVE: We aimed to analyze the expression of ERCC1, RRM1 and TUBB3 in 305 patients with advanced non-small cell lung cancer (NSCLC) and investigate whether these genes can be used as biomarkers for predicting tumor response and clinical outcome. METHODS: Total 305 patients with unresectable and locally advanced NSCLC were collected between January 2007 and December 2008. cDNA of ERCC1, RRM1 and TUBB3 was isolated by a fluorescence-based real-time detection method. RESULTS: All the patients were followed up until December 2012. One hundred seventy five patients showed good response and 130 patients showed poor response to chemotherapy. 126 patients died and 166 patients showed progressive disease during the follow-up period. The median levels of ERCC1, RRM1 and TUBB3 mRNA were 0.53\u00b10.13, 0.31\u00b10.15 and 0.18\u00b10.16, respectively. We found that patients with low ERCC1 expression showed a significantly higher rate of good tumor response, and the adjusted OR (95% CI) was 2.16(1.32-3.45). By Cox regression analysis. We also found that low ERCC1 expression level were correlated with longer overall survival of NSCLC patients, with the adjusted HR (95% CI) was 2.15 (1.26-3.35). CONCLUSION: This study showed that ERCC1 mRNA expression can not affect the response to chemotherapy and clinical outcome of advanced non-small cell lung cancer (NSCLC) patients.", "title": {"charStart": 0, "charEnd": 151}, "docId": "25674147", "entity": [{"duid": "PU:ZBuQ", "entityType": "Disease", "charEnd": 370, "source": "PUBTATOR", "charStart": 366, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumor"}, {"duid": "PU:qspt", "entityType": "Disease", "charEnd": 1508, "source": "PUBTATOR", "charStart": 1504, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 11, "entityText": "NSCLC"}, {"duid": "PU:mvT3", "entityType": "Species", "charEnd": 1518, "source": "PUBTATOR", "charStart": 1511, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:swfJ", "entityType": "Gene", "charEnd": 559, "source": "PUBTATOR", "charStart": 555, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "TUBB3"}, {"duid": "PU:Ds9b", "entityType": "Gene", "charEnd": 916, "source": "PUBTATOR", "charStart": 912, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:Be7V", "entityType": "Species", "charEnd": 833, "source": "PUBTATOR", "charStart": 826, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:TJdf", "entityType": "Gene", "charEnd": 212, "source": "PUBTATOR", "charStart": 209, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "RRM1"}, {"duid": "PU:D2Et", "entityType": "Disease", "charEnd": 49, "source": "PUBTATOR", "charStart": 45, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 0, "entityText": "tumor"}, {"duid": "PU:sy59", "entityType": "Gene", "charEnd": 222, "source": "PUBTATOR", "charStart": 218, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TUBB3"}, {"duid": "PU:FFhP", "entityType": "Disease", "charEnd": 1090, "source": "PUBTATOR", "charStart": 1086, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "tumor"}, {"duid": "PU:X2fC", "entityType": "Gene", "charEnd": 922, "source": "PUBTATOR", "charStart": 919, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM1"}, {"duid": "PU:rnVA", "entityType": "Gene", "charEnd": 549, "source": "PUBTATOR", "charStart": 546, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "RRM1"}, {"duid": "PU:L2MF", "entityType": "Species", "charEnd": 1015, "source": "PUBTATOR", "charStart": 1008, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:NwDX", "entityType": "Gene", "charEnd": 206, "source": "PUBTATOR", "charStart": 202, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:kVPg", "entityType": "Gene", "charEnd": 10, "source": "PUBTATOR", "charStart": 7, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "RRM1"}, {"duid": "PU:X7oR", "entityType": "Disease", "charEnd": 286, "source": "PUBTATOR", "charStart": 282, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:FpoR", "entityType": "Gene", "charEnd": 543, "source": "PUBTATOR", "charStart": 539, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:ez8X", "entityType": "Disease", "charEnd": 279, "source": "PUBTATOR", "charStart": 254, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small cell lung cancer"}, {"duid": "PU:GrmX", "entityType": "Disease", "charEnd": 1278, "source": "PUBTATOR", "charStart": 1274, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 10, "entityText": "NSCLC"}, {"duid": "PU:ZFgj", "entityType": "Disease", "charEnd": 1501, "source": "PUBTATOR", "charStart": 1476, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 11, "entityText": "non-small cell lung cancer"}, {"duid": "PU:iCzQ", "entityType": "Gene", "charEnd": 1030, "source": "PUBTATOR", "charStart": 1026, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:yzSM", "entityType": "Gene", "charEnd": 932, "source": "PUBTATOR", "charStart": 928, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TUBB3"}, {"duid": "PU:4yv9", "entityType": "Disease", "charEnd": 109, "source": "PUBTATOR", "charStart": 84, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:zs8d", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:M7J5", "entityType": "Disease", "charEnd": 474, "source": "PUBTATOR", "charStart": 470, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "NSCLC"}, {"duid": "PU:dfBA", "entityType": "Species", "charEnd": 1287, "source": "PUBTATOR", "charStart": 1280, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:uWEV", "entityType": "Species", "charEnd": 650, "source": "PUBTATOR", "charStart": 643, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:hAmi", "entityType": "Species", "charEnd": 722, "source": "PUBTATOR", "charStart": 715, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:ocgS", "entityType": "Gene", "charEnd": 1381, "source": "PUBTATOR", "charStart": 1377, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ERCC1"}, {"duid": "PU:KkHS", "entityType": "Species", "charEnd": 811, "source": "PUBTATOR", "charStart": 804, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:a6wm", "entityType": "Gene", "charEnd": 1207, "source": "PUBTATOR", "charStart": 1203, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:RFKx", "entityType": "Species", "charEnd": 429, "source": "PUBTATOR", "charStart": 422, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:NUrL", "entityType": "Gene", "charEnd": 20, "source": "PUBTATOR", "charStart": 16, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "TUBB3"}, {"duid": "PU:Pg5J", "entityType": "Species", "charEnd": 238, "source": "PUBTATOR", "charStart": 231, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:sCMW", "entityType": "Species", "charEnd": 760, "source": "PUBTATOR", "charStart": 753, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}]}
{"text": "Resistance to first line platinum paclitaxel chemotherapy in serous epithelial ovarian cancer: the prediction value of ERCC1 and Tau expression. In oncology, a rational approach to identify patients who are likely to benefit from therapy, already before initiation of treatment, is urgently required. Excision repair cross-complementation group 1 enzyme (ERCC1) has been proposed as a molecular predictor of clinical resistance to platinum-based chemotherapy. Other data suggest Tau protein expression as a predictor of clinical outcome in cancer patients treated with paclitaxel-based chemotherapy as low tau expression may render microtubules more vulnerable to paclitaxel. Therefore, the combination of ERCC1 and Tau may be a valuable predictor of sensitivity to platinum/paclitaxel treatment. The primary aim of the study was to investigate whether ERCC1 and Tau protein expression correlates with patient outcome in newly diagnosed epithelial ovarian cancer (EOC) patients. Formalin-fixed, paraffin-embedded tissue sections from 227 newly diagnosed EOC patients were used for immunohistochemical staining for ERCC1 and Tau proteins. All patients received standard first-line combination platinum and paclitaxel chemotherapy. The patients were divided in a training set of 84 patients and an independent validation cohort of 143 patients. Neither ERCC1 nor Tau expression was associated with clinical response or platinum resistance in both the training and validation sets. Patients with ERCC1-positive tumors had significantly shortened progression-free and overall survival compared to patients with ERCC1-negative tumors, p<0.00001 and p=0.0006. In multivariate analysis ERCC1 also proved as an independent predictor of PFS and OS with HR of 3.86 and 1.98, respectively but the data could not be confirmed in the validation set. Tau expression was not associated with PFS or OS in this study. ERCC1 and Tau might serve as biomarkers of DNA repair and for paclitaxel sensitivity but the present study could not validate ERCC1 or Tau protein expression in tumors as pre-treatment tools to predict sensitivity to first-line platinum/paclitaxel chemotherapy.", "title": {"charStart": 0, "charEnd": 143}, "docId": "24585004", "entity": [{"duid": "PU:kVHd", "entityType": "Disease", "charEnd": 92, "source": "PUBTATOR", "charStart": 61, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 0, "entityText": "serous epithelial ovarian cancer"}, {"duid": "PU:FAUE", "entityType": "Chemical", "charEnd": 43, "source": "PUBTATOR", "charStart": 34, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "paclitaxel"}, {"duid": "PU:Q7rM", "entityType": "Chemical", "charEnd": 2136, "source": "PUBTATOR", "charStart": 2129, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 13, "entityText": "platinum"}, {"duid": "PU:jnQg", "entityType": "Disease", "charEnd": 2067, "source": "PUBTATOR", "charStart": 2062, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 13, "entityText": "tumors"}, {"duid": "PU:Ernn", "entityType": "Species", "charEnd": 1065, "source": "PUBTATOR", "charStart": 1058, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:pn7v", "entityType": "Gene", "charEnd": 1683, "source": "PUBTATOR", "charStart": 1679, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ERCC1"}, {"duid": "PU:CKfF", "entityType": "Species", "charEnd": 1340, "source": "PUBTATOR", "charStart": 1333, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:oQfK", "entityType": "Chemical", "charEnd": 673, "source": "PUBTATOR", "charStart": 664, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 3, "entityText": "paclitaxel"}, {"duid": "PU:eMbR", "entityType": "Gene", "charEnd": 1355, "source": "PUBTATOR", "charStart": 1351, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:YYYZ", "entityType": "Disease", "charEnd": 545, "source": "PUBTATOR", "charStart": 540, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cancer"}, {"duid": "PU:a3X7", "entityType": "Chemical", "charEnd": 578, "source": "PUBTATOR", "charStart": 569, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 3, "entityText": "paclitaxel"}, {"duid": "PU:sXGG", "entityType": "Gene", "charEnd": 857, "source": "PUBTATOR", "charStart": 853, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:wZET", "entityType": "Chemical", "charEnd": 784, "source": "PUBTATOR", "charStart": 775, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 4, "entityText": "paclitaxel"}, {"duid": "PU:WYox", "entityType": "Chemical", "charEnd": 438, "source": "PUBTATOR", "charStart": 431, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 2, "entityText": "platinum"}, {"duid": "PU:C98G", "entityType": "Chemical", "charEnd": 1424, "source": "PUBTATOR", "charStart": 1417, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 9, "entityText": "platinum"}, {"duid": "PU:29cM", "entityType": "Disease", "charEnd": 1513, "source": "PUBTATOR", "charStart": 1508, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}, {"duid": "PU:cCBc", "entityType": "Species", "charEnd": 1149, "source": "PUBTATOR", "charStart": 1142, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:5voE", "entityType": "Species", "charEnd": 1287, "source": "PUBTATOR", "charStart": 1280, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:5AME", "entityType": "Chemical", "charEnd": 773, "source": "PUBTATOR", "charStart": 766, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 4, "entityText": "platinum"}, {"duid": "PU:qTUx", "entityType": "Chemical", "charEnd": 32, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 0, "entityText": "platinum"}, {"duid": "PU:SN4x", "entityType": "Disease", "charEnd": 1056, "source": "PUBTATOR", "charStart": 1054, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 6, "entityText": "EOC"}, {"duid": "PU:LmdT", "entityType": "Gene", "charEnd": 123, "source": "PUBTATOR", "charStart": 119, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:adrm", "entityType": "Chemical", "charEnd": 1002, "source": "PUBTATOR", "charStart": 995, "entityId": [{"idString": "D010232", "source": "MESH"}], "sentenceIndex": 6, "entityText": "paraffin"}, {"duid": "PU:fLst", "entityType": "Species", "charEnd": 554, "source": "PUBTATOR", "charStart": 547, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:ZFKT", "entityType": "Chemical", "charEnd": 1214, "source": "PUBTATOR", "charStart": 1205, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 7, "entityText": "paclitaxel"}, {"duid": "PU:rnUh", "entityType": "Disease", "charEnd": 961, "source": "PUBTATOR", "charStart": 937, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 5, "entityText": "epithelial ovarian cancer"}, {"duid": "PU:Cwax", "entityType": "Disease", "charEnd": 966, "source": "PUBTATOR", "charStart": 964, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 5, "entityText": "EOC"}, {"duid": "PU:qpAf", "entityType": "Gene", "charEnd": 1905, "source": "PUBTATOR", "charStart": 1901, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "ERCC1"}, {"duid": "PU:89Vp", "entityType": "Chemical", "charEnd": 1199, "source": "PUBTATOR", "charStart": 1192, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 7, "entityText": "platinum"}, {"duid": "PU:2wzL", "entityType": "Disease", "charEnd": 1884, "source": "PUBTATOR", "charStart": 1883, "entityId": [{"idString": "C567932", "source": "MESH"}], "sentenceIndex": 12, "entityText": "OS"}, {"duid": "PU:Qb2N", "entityType": "Gene", "charEnd": 2031, "source": "PUBTATOR", "charStart": 2027, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "ERCC1"}, {"duid": "PU:J8bX", "entityType": "Species", "charEnd": 1600, "source": "PUBTATOR", "charStart": 1593, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:SpuF", "entityType": "Species", "charEnd": 197, "source": "PUBTATOR", "charStart": 190, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:2SXJ", "entityType": "Disease", "charEnd": 1737, "source": "PUBTATOR", "charStart": 1736, "entityId": [{"idString": "C567932", "source": "MESH"}], "sentenceIndex": 11, "entityText": "OS"}, {"duid": "PU:FmeC", "entityType": "Species", "charEnd": 976, "source": "PUBTATOR", "charStart": 969, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:YvsY", "entityType": "Species", "charEnd": 1486, "source": "PUBTATOR", "charStart": 1479, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "Patients"}, {"duid": "PU:33Hp", "entityType": "Chemical", "charEnd": 2147, "source": "PUBTATOR", "charStart": 2138, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 13, "entityText": "paclitaxel"}, {"duid": "PU:uWFk", "entityType": "Gene", "charEnd": 359, "source": "PUBTATOR", "charStart": 355, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:NeV7", "entityType": "Species", "charEnd": 1241, "source": "PUBTATOR", "charStart": 1234, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:WaZD", "entityType": "Chemical", "charEnd": 1972, "source": "PUBTATOR", "charStart": 1963, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 13, "entityText": "paclitaxel"}, {"duid": "PU:gFLE", "entityType": "Gene", "charEnd": 1118, "source": "PUBTATOR", "charStart": 1114, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:JJwm", "entityType": "Gene", "charEnd": 710, "source": "PUBTATOR", "charStart": 706, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:9UJi", "entityType": "Gene", "charEnd": 1497, "source": "PUBTATOR", "charStart": 1493, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:LNTB", "entityType": "Gene", "charEnd": 1611, "source": "PUBTATOR", "charStart": 1607, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:xbuM", "entityType": "Species", "charEnd": 908, "source": "PUBTATOR", "charStart": 902, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patient"}, {"duid": "PU:QJxT", "entityType": "Disease", "charEnd": 1627, "source": "PUBTATOR", "charStart": 1622, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}]}
{"text": "Resistance to first line platinum paclitaxel chemotherapy in serous epithelial ovarian cancer: the prediction value of ERCC1 and Tau expression. In oncology, a rational approach to identify patients who are likely to benefit from therapy, already before initiation of treatment, is urgently required. Excision repair cross-complementation group 1 enzyme (ERCC1) has been proposed as a molecular predictor of clinical resistance to platinum-based chemotherapy. Other data suggest Tau protein expression as a predictor of clinical outcome in cancer patients treated with paclitaxel-based chemotherapy as low tau expression may render microtubules more vulnerable to paclitaxel. Therefore, the combination of ERCC1 and Tau may be a valuable predictor of sensitivity to platinum/paclitaxel treatment. The primary aim of the study was to investigate whether ERCC1 and Tau protein expression correlates with patient outcome in newly diagnosed epithelial ovarian cancer (EOC) patients. Formalin-fixed, paraffin-embedded tissue sections from 227 newly diagnosed EOC patients were used for immunohistochemical staining for ERCC1 and Tau proteins. All patients received standard first-line combination platinum and paclitaxel chemotherapy. The patients were divided in a training set of 84 patients and an independent validation cohort of 143 patients. Neither ERCC1 nor Tau expression was associated with clinical response or platinum resistance in both the training and validation sets. Patients with ERCC1-positive tumors had significantly shortened progression-free and overall survival compared to patients with ERCC1-negative tumors, p<0.00001 and p=0.0006. In multivariate analysis ERCC1 also proved as an independent predictor of PFS and OS with HR of 3.86 and 1.98, respectively but the data could not be confirmed in the validation set. Tau expression was not associated with PFS or OS in this study. ERCC1 and Tau might serve as biomarkers of DNA repair and for paclitaxel sensitivity but the present study could not validate ERCC1 or Tau protein expression in tumors as pre-treatment tools to predict sensitivity to first-line platinum/paclitaxel chemotherapy.", "title": {"charStart": 0, "charEnd": 143}, "docId": "24585004", "entity": [{"duid": "PU:kVHd", "entityType": "Disease", "charEnd": 92, "source": "PUBTATOR", "charStart": 61, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 0, "entityText": "serous epithelial ovarian cancer"}, {"duid": "PU:FAUE", "entityType": "Chemical", "charEnd": 43, "source": "PUBTATOR", "charStart": 34, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "paclitaxel"}, {"duid": "PU:Q7rM", "entityType": "Chemical", "charEnd": 2136, "source": "PUBTATOR", "charStart": 2129, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 13, "entityText": "platinum"}, {"duid": "PU:jnQg", "entityType": "Disease", "charEnd": 2067, "source": "PUBTATOR", "charStart": 2062, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 13, "entityText": "tumors"}, {"duid": "PU:Ernn", "entityType": "Species", "charEnd": 1065, "source": "PUBTATOR", "charStart": 1058, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:pn7v", "entityType": "Gene", "charEnd": 1683, "source": "PUBTATOR", "charStart": 1679, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ERCC1"}, {"duid": "PU:CKfF", "entityType": "Species", "charEnd": 1340, "source": "PUBTATOR", "charStart": 1333, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:oQfK", "entityType": "Chemical", "charEnd": 673, "source": "PUBTATOR", "charStart": 664, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 3, "entityText": "paclitaxel"}, {"duid": "PU:eMbR", "entityType": "Gene", "charEnd": 1355, "source": "PUBTATOR", "charStart": 1351, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:YYYZ", "entityType": "Disease", "charEnd": 545, "source": "PUBTATOR", "charStart": 540, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cancer"}, {"duid": "PU:a3X7", "entityType": "Chemical", "charEnd": 578, "source": "PUBTATOR", "charStart": 569, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 3, "entityText": "paclitaxel"}, {"duid": "PU:sXGG", "entityType": "Gene", "charEnd": 857, "source": "PUBTATOR", "charStart": 853, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:wZET", "entityType": "Chemical", "charEnd": 784, "source": "PUBTATOR", "charStart": 775, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 4, "entityText": "paclitaxel"}, {"duid": "PU:WYox", "entityType": "Chemical", "charEnd": 438, "source": "PUBTATOR", "charStart": 431, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 2, "entityText": "platinum"}, {"duid": "PU:C98G", "entityType": "Chemical", "charEnd": 1424, "source": "PUBTATOR", "charStart": 1417, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 9, "entityText": "platinum"}, {"duid": "PU:29cM", "entityType": "Disease", "charEnd": 1513, "source": "PUBTATOR", "charStart": 1508, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}, {"duid": "PU:cCBc", "entityType": "Species", "charEnd": 1149, "source": "PUBTATOR", "charStart": 1142, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:5voE", "entityType": "Species", "charEnd": 1287, "source": "PUBTATOR", "charStart": 1280, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:5AME", "entityType": "Chemical", "charEnd": 773, "source": "PUBTATOR", "charStart": 766, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 4, "entityText": "platinum"}, {"duid": "PU:qTUx", "entityType": "Chemical", "charEnd": 32, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 0, "entityText": "platinum"}, {"duid": "PU:SN4x", "entityType": "Disease", "charEnd": 1056, "source": "PUBTATOR", "charStart": 1054, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 6, "entityText": "EOC"}, {"duid": "PU:LmdT", "entityType": "Gene", "charEnd": 123, "source": "PUBTATOR", "charStart": 119, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:adrm", "entityType": "Chemical", "charEnd": 1002, "source": "PUBTATOR", "charStart": 995, "entityId": [{"idString": "D010232", "source": "MESH"}], "sentenceIndex": 6, "entityText": "paraffin"}, {"duid": "PU:fLst", "entityType": "Species", "charEnd": 554, "source": "PUBTATOR", "charStart": 547, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:ZFKT", "entityType": "Chemical", "charEnd": 1214, "source": "PUBTATOR", "charStart": 1205, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 7, "entityText": "paclitaxel"}, {"duid": "PU:rnUh", "entityType": "Disease", "charEnd": 961, "source": "PUBTATOR", "charStart": 937, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 5, "entityText": "epithelial ovarian cancer"}, {"duid": "PU:Cwax", "entityType": "Disease", "charEnd": 966, "source": "PUBTATOR", "charStart": 964, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 5, "entityText": "EOC"}, {"duid": "PU:qpAf", "entityType": "Gene", "charEnd": 1905, "source": "PUBTATOR", "charStart": 1901, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "ERCC1"}, {"duid": "PU:89Vp", "entityType": "Chemical", "charEnd": 1199, "source": "PUBTATOR", "charStart": 1192, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 7, "entityText": "platinum"}, {"duid": "PU:2wzL", "entityType": "Disease", "charEnd": 1884, "source": "PUBTATOR", "charStart": 1883, "entityId": [{"idString": "C567932", "source": "MESH"}], "sentenceIndex": 12, "entityText": "OS"}, {"duid": "PU:Qb2N", "entityType": "Gene", "charEnd": 2031, "source": "PUBTATOR", "charStart": 2027, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "ERCC1"}, {"duid": "PU:J8bX", "entityType": "Species", "charEnd": 1600, "source": "PUBTATOR", "charStart": 1593, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:SpuF", "entityType": "Species", "charEnd": 197, "source": "PUBTATOR", "charStart": 190, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:2SXJ", "entityType": "Disease", "charEnd": 1737, "source": "PUBTATOR", "charStart": 1736, "entityId": [{"idString": "C567932", "source": "MESH"}], "sentenceIndex": 11, "entityText": "OS"}, {"duid": "PU:FmeC", "entityType": "Species", "charEnd": 976, "source": "PUBTATOR", "charStart": 969, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:YvsY", "entityType": "Species", "charEnd": 1486, "source": "PUBTATOR", "charStart": 1479, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "Patients"}, {"duid": "PU:33Hp", "entityType": "Chemical", "charEnd": 2147, "source": "PUBTATOR", "charStart": 2138, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 13, "entityText": "paclitaxel"}, {"duid": "PU:uWFk", "entityType": "Gene", "charEnd": 359, "source": "PUBTATOR", "charStart": 355, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:NeV7", "entityType": "Species", "charEnd": 1241, "source": "PUBTATOR", "charStart": 1234, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:WaZD", "entityType": "Chemical", "charEnd": 1972, "source": "PUBTATOR", "charStart": 1963, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 13, "entityText": "paclitaxel"}, {"duid": "PU:gFLE", "entityType": "Gene", "charEnd": 1118, "source": "PUBTATOR", "charStart": 1114, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:JJwm", "entityType": "Gene", "charEnd": 710, "source": "PUBTATOR", "charStart": 706, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:9UJi", "entityType": "Gene", "charEnd": 1497, "source": "PUBTATOR", "charStart": 1493, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:LNTB", "entityType": "Gene", "charEnd": 1611, "source": "PUBTATOR", "charStart": 1607, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:xbuM", "entityType": "Species", "charEnd": 908, "source": "PUBTATOR", "charStart": 902, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patient"}, {"duid": "PU:QJxT", "entityType": "Disease", "charEnd": 1627, "source": "PUBTATOR", "charStart": 1622, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}]}
{"text": "Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expression. CONTEXT: The typically indolent behavior of pituitary tumors is juxtaposed with high rates of tumor cell invasion into adjacent dural structures, and occasional aggressive behavior. Although clinically significant invasion and malignant transformation remain uncommon, there are limited treatment options available for the management of these aggressive tumors. Recently, case reports have described efficacy of temozolomide for the treatment of aggressive pituitary tumors. DESIGN: Seven patients with aggressive pituitary tumors have been treated with temozolomide. We compared O(6)-methylguanine methyltransferase (MGMT) promoter methylation and MGMT expression in 14 surgical specimens from these seven patients and correlated these molecular features with the clinical response to temozolomide. RESULTS: Significant tumor regression was seen in two patients (29%), a 20% reduction in tumor volume with subsequent stable tumor size was noted in one patient, arrest of tumor growth occurred in three patients, and progressive metastatic disease developed during treatment in one patient. The DNA promoter site for MGMT was unmethylated in all 14 adequate specimens, and variable MGMT expression was seen in all 14 cases. There was no correlation between MGMT expression and clinical outcomes. CONCLUSIONS: We conclude that medical therapy with temozolomide can be helpful in the management of life-threatening pituitary tumors that have failed to respond to conventional treatments. The optimal duration of treatment in patients with stabilization or reduction of tumor size has not been established, and long-term follow up studies are needed.", "title": {"charStart": 0, "charEnd": 172}, "docId": "20668043", "entity": [{"duid": "PU:maW4", "entityType": "Chemical", "charEnd": 597, "source": "PUBTATOR", "charStart": 586, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 3, "entityText": "temozolomide"}, {"duid": "PU:nJDC", "entityType": "Chemical", "charEnd": 971, "source": "PUBTATOR", "charStart": 960, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 5, "entityText": "temozolomide"}, {"duid": "PU:hbvA", "entityType": "Disease", "charEnd": 533, "source": "PUBTATOR", "charStart": 528, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumors"}, {"duid": "PU:vEb6", "entityType": "Disease", "charEnd": 53, "source": "PUBTATOR", "charStart": 38, "entityId": [{"idString": "D010911", "source": "MESH"}], "sentenceIndex": 0, "entityText": "pituitary tumors"}, {"duid": "PU:63dH", "entityType": "Chemical", "charEnd": 11, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Temozolomide"}, {"duid": "PU:n6KV", "entityType": "Disease", "charEnd": 424, "source": "PUBTATOR", "charStart": 401, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "malignant transformation"}, {"duid": "PU:4kFT", "entityType": "Disease", "charEnd": 272, "source": "PUBTATOR", "charStart": 268, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumor"}, {"duid": "PU:VL3c", "entityType": "Disease", "charEnd": 1745, "source": "PUBTATOR", "charStart": 1741, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumor"}, {"duid": "PU:rCPq", "entityType": "Disease", "charEnd": 646, "source": "PUBTATOR", "charStart": 631, "entityId": [{"idString": "D010911", "source": "MESH"}], "sentenceIndex": 3, "entityText": "pituitary tumors"}, {"duid": "PU:ciCP", "entityType": "Disease", "charEnd": 353, "source": "PUBTATOR", "charStart": 335, "entityId": [{"idString": "D001523", "source": "MESH"}], "sentenceIndex": 1, "entityText": "aggressive behavior"}, {"duid": "PU:4dYS", "entityType": "Disease", "charEnd": 999, "source": "PUBTATOR", "charStart": 995, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumor"}, {"duid": "PU:JVar", "entityType": "Disease", "charEnd": 1220, "source": "PUBTATOR", "charStart": 1203, "entityId": [{"idString": "D009362", "source": "MESH"}], "sentenceIndex": 6, "entityText": "metastatic disease"}, {"duid": "PU:HcDb", "entityType": "Chemical", "charEnd": 771, "source": "PUBTATOR", "charStart": 754, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 5, "entityText": "O(6)-methylguanine"}, {"duid": "PU:cubh", "entityType": "Chemical", "charEnd": 110, "source": "PUBTATOR", "charStart": 93, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 0, "entityText": "O(6)-methylguanine"}, {"duid": "PU:F93f", "entityType": "Disease", "charEnd": 1067, "source": "PUBTATOR", "charStart": 1063, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumor"}, {"duid": "PU:hGNp", "entityType": "Disease", "charEnd": 1602, "source": "PUBTATOR", "charStart": 1587, "entityId": [{"idString": "D010911", "source": "MESH"}], "sentenceIndex": 9, "entityText": "pituitary tumors"}, {"duid": "PU:v2EL", "entityType": "Disease", "charEnd": 1150, "source": "PUBTATOR", "charStart": 1146, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumor"}, {"duid": "PU:bupq", "entityType": "Disease", "charEnd": 233, "source": "PUBTATOR", "charStart": 218, "entityId": [{"idString": "D010911", "source": "MESH"}], "sentenceIndex": 1, "entityText": "pituitary tumors"}, {"duid": "PU:QKnu", "entityType": "Disease", "charEnd": 703, "source": "PUBTATOR", "charStart": 688, "entityId": [{"idString": "D010911", "source": "MESH"}], "sentenceIndex": 4, "entityText": "pituitary tumors"}, {"duid": "PU:shHt", "entityType": "Disease", "charEnd": 1103, "source": "PUBTATOR", "charStart": 1099, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumor"}, {"duid": "PU:SMGi", "entityType": "Chemical", "charEnd": 1532, "source": "PUBTATOR", "charStart": 1521, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 9, "entityText": "temozolomide"}, {"duid": "PU:AgtU", "entityType": "Chemical", "charEnd": 739, "source": "PUBTATOR", "charStart": 728, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 4, "entityText": "temozolomide"}]}
{"text": "Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer. The response of tumor cells to platinum-based chemotherapy involves DNA repair mechanisms. Excision repair cross-complementation group 1 (ercc1) is one of the leading genes involved in DNA repair, and several studies have linked ercc1 to platinum resistance in cell lines and in human cancers. A common single nucleotide polymorphism (SNP) of ercc1 at codon 118 has been proposed to impair ercc1 translation and reduce ERCC1 protein expression and consequently influence the response to platinum-based chemotherapy. The primary aim of the present study was to evaluate ERCC1 expression and ercc1 codon 118 polymorphism in epithelial ovarian cancer (EOC) and their possible predictive value in patients treated with platinum-based chemotherapy. Formalin-fixed, paraffin-embedded tissue sections from 159 patients with advanced EOC were used for immunohistochemistry. Ercc1 codon 118 SNP genotyping was performed by real-time polymerase chain reaction. ERCC1 protein overexpression was found in 37.7% of the tumors. The CA-125 response rate was 94.5% (52/55) in patients with ERCC1-negative tumors compared to 80% (36/45) in patients with ERCC1-positive tumors (P = 0.026, chi(2)). The T/T genotype (44%) signalized a better response to chemotherapy than C/C (15%) + C/T (41%) variants (P = 0.045, trend test). Patients with ERCC1-negative tumors appear to have significantly better response to platinum-based chemotherapy compared to patients with ERCC1-positive tumors, but the differences in response rates did not translate into differences in survival. In addition, the TT genotype seems to be favorable toward better response to platinum-based chemotherapy.", "title": {"charStart": 0, "charEnd": 109}, "docId": "17961161", "entity": [{"duid": "PU:u44U", "entityType": "Chemical", "charEnd": 1511, "source": "PUBTATOR", "charStart": 1504, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 10, "entityText": "platinum"}, {"duid": "PU:9pYh", "entityType": "Species", "charEnd": 394, "source": "PUBTATOR", "charStart": 390, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "human"}, {"duid": "PU:j4LC", "entityType": "Gene", "charEnd": 1066, "source": "PUBTATOR", "charStart": 1062, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:7ycP", "entityType": "Disease", "charEnd": 1454, "source": "PUBTATOR", "charStart": 1449, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}, {"duid": "PU:7Yay", "entityType": "Gene", "charEnd": 1438, "source": "PUBTATOR", "charStart": 1434, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:Fu3e", "entityType": "Disease", "charEnd": 1268, "source": "PUBTATOR", "charStart": 1248, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "ERCC1-positive tumors"}, {"duid": "PU:yxBh", "entityType": "Chemical", "charEnd": 356, "source": "PUBTATOR", "charStart": 349, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 2, "entityText": "platinum"}, {"duid": "PU:MKwG", "entityType": "Species", "charEnd": 921, "source": "PUBTATOR", "charStart": 914, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:Ce2e", "entityType": "Gene", "charEnd": 1189, "source": "PUBTATOR", "charStart": 1185, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:WQMB", "entityType": "Disease", "charEnd": 1122, "source": "PUBTATOR", "charStart": 1117, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumors"}, {"duid": "PU:RBNj", "entityType": "Species", "charEnd": 1427, "source": "PUBTATOR", "charStart": 1420, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "Patients"}, {"duid": "PU:kzvD", "entityType": "Species", "charEnd": 1178, "source": "PUBTATOR", "charStart": 1171, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:dgBS", "entityType": "Gene", "charEnd": 253, "source": "PUBTATOR", "charStart": 249, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ercc1"}, {"duid": "PU:g6bx", "entityType": "Gene", "charEnd": 505, "source": "PUBTATOR", "charStart": 501, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ercc1"}, {"duid": "PU:nnSs", "entityType": "Disease", "charEnd": 131, "source": "PUBTATOR", "charStart": 127, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumor"}, {"duid": "PU:6qWF", "entityType": "Disease", "charEnd": 1578, "source": "PUBTATOR", "charStart": 1558, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "ERCC1-positive tumors"}, {"duid": "PU:2hh7", "entityType": "Chemical", "charEnd": 1376, "source": "PUBTATOR", "charStart": 1376, "entityId": [], "sentenceIndex": 9, "entityText": "C"}, {"duid": "PU:smNx", "entityType": "Gene", "charEnd": 344, "source": "PUBTATOR", "charStart": 340, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ercc1"}, {"duid": "PU:y5wX", "entityType": "Gene", "charEnd": 1562, "source": "PUBTATOR", "charStart": 1558, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:qMnT", "entityType": "Gene", "charEnd": 246, "source": "PUBTATOR", "charStart": 202, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "Excision repair cross-complementation group 1"}, {"duid": "PU:XocC", "entityType": "Gene", "charEnd": 77, "source": "PUBTATOR", "charStart": 73, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:4ah7", "entityType": "Disease", "charEnd": 108, "source": "PUBTATOR", "charStart": 95, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 0, "entityText": "ovarian cancer"}, {"duid": "PU:MhFz", "entityType": "Chemical", "charEnd": 1751, "source": "PUBTATOR", "charStart": 1744, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 11, "entityText": "platinum"}, {"duid": "PU:936s", "entityType": "Species", "charEnd": 1241, "source": "PUBTATOR", "charStart": 1234, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:GRzC", "entityType": "Chemical", "charEnd": 878, "source": "PUBTATOR", "charStart": 871, "entityId": [{"idString": "D010232", "source": "MESH"}], "sentenceIndex": 5, "entityText": "paraffin"}, {"duid": "PU:PT7f", "entityType": "Chemical", "charEnd": 149, "source": "PUBTATOR", "charStart": 142, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:CoQQ", "entityType": "Disease", "charEnd": 1205, "source": "PUBTATOR", "charStart": 1200, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "tumors"}, {"duid": "PU:VkHw", "entityType": "Chemical", "charEnd": 833, "source": "PUBTATOR", "charStart": 826, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 4, "entityText": "platinum"}, {"duid": "PU:C56B", "entityType": "Gene", "charEnd": 534, "source": "PUBTATOR", "charStart": 530, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:ABPr", "entityType": "Gene", "charEnd": 981, "source": "PUBTATOR", "charStart": 977, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "Ercc1"}, {"duid": "PU:idvj", "entityType": "Gene", "charEnd": 1252, "source": "PUBTATOR", "charStart": 1248, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:xoaH", "entityType": "Gene", "charEnd": 458, "source": "PUBTATOR", "charStart": 454, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ercc1"}, {"duid": "PU:p8vv", "entityType": "Gene", "charEnd": 684, "source": "PUBTATOR", "charStart": 680, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:beRd", "entityType": "Disease", "charEnd": 402, "source": "PUBTATOR", "charStart": 396, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cancers"}, {"duid": "PU:R2Ez", "entityType": "Gene", "charEnd": 46, "source": "PUBTATOR", "charStart": 42, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:va5n", "entityType": "Chemical", "charEnd": 605, "source": "PUBTATOR", "charStart": 598, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 3, "entityText": "platinum"}, {"duid": "PU:PBaX", "entityType": "Species", "charEnd": 811, "source": "PUBTATOR", "charStart": 804, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:BuXa", "entityType": "Gene", "charEnd": 705, "source": "PUBTATOR", "charStart": 701, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ercc1"}, {"duid": "PU:rEHp", "entityType": "Species", "charEnd": 1551, "source": "PUBTATOR", "charStart": 1544, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:WPTV", "entityType": "Disease", "charEnd": 757, "source": "PUBTATOR", "charStart": 744, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 4, "entityText": "ovarian cancer"}]}
{"text": "Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer. The response of tumor cells to platinum-based chemotherapy involves DNA repair mechanisms. Excision repair cross-complementation group 1 (ercc1) is one of the leading genes involved in DNA repair, and several studies have linked ercc1 to platinum resistance in cell lines and in human cancers. A common single nucleotide polymorphism (SNP) of ercc1 at codon 118 has been proposed to impair ercc1 translation and reduce ERCC1 protein expression and consequently influence the response to platinum-based chemotherapy. The primary aim of the present study was to evaluate ERCC1 expression and ercc1 codon 118 polymorphism in epithelial ovarian cancer (EOC) and their possible predictive value in patients treated with platinum-based chemotherapy. Formalin-fixed, paraffin-embedded tissue sections from 159 patients with advanced EOC were used for immunohistochemistry. Ercc1 codon 118 SNP genotyping was performed by real-time polymerase chain reaction. ERCC1 protein overexpression was found in 37.7% of the tumors. The CA-125 response rate was 94.5% (52/55) in patients with ERCC1-negative tumors compared to 80% (36/45) in patients with ERCC1-positive tumors (P = 0.026, chi(2)). The T/T genotype (44%) signalized a better response to chemotherapy than C/C (15%) + C/T (41%) variants (P = 0.045, trend test). Patients with ERCC1-negative tumors appear to have significantly better response to platinum-based chemotherapy compared to patients with ERCC1-positive tumors, but the differences in response rates did not translate into differences in survival. In addition, the TT genotype seems to be favorable toward better response to platinum-based chemotherapy.", "title": {"charStart": 0, "charEnd": 109}, "docId": "17961161", "entity": [{"duid": "PU:u44U", "entityType": "Chemical", "charEnd": 1511, "source": "PUBTATOR", "charStart": 1504, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 10, "entityText": "platinum"}, {"duid": "PU:9pYh", "entityType": "Species", "charEnd": 394, "source": "PUBTATOR", "charStart": 390, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "human"}, {"duid": "PU:j4LC", "entityType": "Gene", "charEnd": 1066, "source": "PUBTATOR", "charStart": 1062, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:7ycP", "entityType": "Disease", "charEnd": 1454, "source": "PUBTATOR", "charStart": 1449, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}, {"duid": "PU:7Yay", "entityType": "Gene", "charEnd": 1438, "source": "PUBTATOR", "charStart": 1434, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:Fu3e", "entityType": "Disease", "charEnd": 1268, "source": "PUBTATOR", "charStart": 1248, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "ERCC1-positive tumors"}, {"duid": "PU:yxBh", "entityType": "Chemical", "charEnd": 356, "source": "PUBTATOR", "charStart": 349, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 2, "entityText": "platinum"}, {"duid": "PU:MKwG", "entityType": "Species", "charEnd": 921, "source": "PUBTATOR", "charStart": 914, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:Ce2e", "entityType": "Gene", "charEnd": 1189, "source": "PUBTATOR", "charStart": 1185, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:WQMB", "entityType": "Disease", "charEnd": 1122, "source": "PUBTATOR", "charStart": 1117, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumors"}, {"duid": "PU:RBNj", "entityType": "Species", "charEnd": 1427, "source": "PUBTATOR", "charStart": 1420, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "Patients"}, {"duid": "PU:kzvD", "entityType": "Species", "charEnd": 1178, "source": "PUBTATOR", "charStart": 1171, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:dgBS", "entityType": "Gene", "charEnd": 253, "source": "PUBTATOR", "charStart": 249, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ercc1"}, {"duid": "PU:g6bx", "entityType": "Gene", "charEnd": 505, "source": "PUBTATOR", "charStart": 501, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ercc1"}, {"duid": "PU:nnSs", "entityType": "Disease", "charEnd": 131, "source": "PUBTATOR", "charStart": 127, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumor"}, {"duid": "PU:6qWF", "entityType": "Disease", "charEnd": 1578, "source": "PUBTATOR", "charStart": 1558, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "ERCC1-positive tumors"}, {"duid": "PU:2hh7", "entityType": "Chemical", "charEnd": 1376, "source": "PUBTATOR", "charStart": 1376, "entityId": [], "sentenceIndex": 9, "entityText": "C"}, {"duid": "PU:smNx", "entityType": "Gene", "charEnd": 344, "source": "PUBTATOR", "charStart": 340, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ercc1"}, {"duid": "PU:y5wX", "entityType": "Gene", "charEnd": 1562, "source": "PUBTATOR", "charStart": 1558, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:qMnT", "entityType": "Gene", "charEnd": 246, "source": "PUBTATOR", "charStart": 202, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "Excision repair cross-complementation group 1"}, {"duid": "PU:XocC", "entityType": "Gene", "charEnd": 77, "source": "PUBTATOR", "charStart": 73, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:4ah7", "entityType": "Disease", "charEnd": 108, "source": "PUBTATOR", "charStart": 95, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 0, "entityText": "ovarian cancer"}, {"duid": "PU:MhFz", "entityType": "Chemical", "charEnd": 1751, "source": "PUBTATOR", "charStart": 1744, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 11, "entityText": "platinum"}, {"duid": "PU:936s", "entityType": "Species", "charEnd": 1241, "source": "PUBTATOR", "charStart": 1234, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:GRzC", "entityType": "Chemical", "charEnd": 878, "source": "PUBTATOR", "charStart": 871, "entityId": [{"idString": "D010232", "source": "MESH"}], "sentenceIndex": 5, "entityText": "paraffin"}, {"duid": "PU:PT7f", "entityType": "Chemical", "charEnd": 149, "source": "PUBTATOR", "charStart": 142, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:CoQQ", "entityType": "Disease", "charEnd": 1205, "source": "PUBTATOR", "charStart": 1200, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "tumors"}, {"duid": "PU:VkHw", "entityType": "Chemical", "charEnd": 833, "source": "PUBTATOR", "charStart": 826, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 4, "entityText": "platinum"}, {"duid": "PU:C56B", "entityType": "Gene", "charEnd": 534, "source": "PUBTATOR", "charStart": 530, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:ABPr", "entityType": "Gene", "charEnd": 981, "source": "PUBTATOR", "charStart": 977, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "Ercc1"}, {"duid": "PU:idvj", "entityType": "Gene", "charEnd": 1252, "source": "PUBTATOR", "charStart": 1248, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:xoaH", "entityType": "Gene", "charEnd": 458, "source": "PUBTATOR", "charStart": 454, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ercc1"}, {"duid": "PU:p8vv", "entityType": "Gene", "charEnd": 684, "source": "PUBTATOR", "charStart": 680, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:beRd", "entityType": "Disease", "charEnd": 402, "source": "PUBTATOR", "charStart": 396, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cancers"}, {"duid": "PU:R2Ez", "entityType": "Gene", "charEnd": 46, "source": "PUBTATOR", "charStart": 42, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:va5n", "entityType": "Chemical", "charEnd": 605, "source": "PUBTATOR", "charStart": 598, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 3, "entityText": "platinum"}, {"duid": "PU:PBaX", "entityType": "Species", "charEnd": 811, "source": "PUBTATOR", "charStart": 804, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:BuXa", "entityType": "Gene", "charEnd": 705, "source": "PUBTATOR", "charStart": 701, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ercc1"}, {"duid": "PU:rEHp", "entityType": "Species", "charEnd": 1551, "source": "PUBTATOR", "charStart": 1544, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:WPTV", "entityType": "Disease", "charEnd": 757, "source": "PUBTATOR", "charStart": 744, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 4, "entityText": "ovarian cancer"}]}
{"text": "Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer. AIM: To investigate the prognostic role of thymidylate synthase (TS) and thymidine phosphorylase (TP) mRNA levels in T3 or T4 gastric cancer treated with 5-fluorouracil-based adjuvant chemotherapy. METHODS: Fifty-one patients with T3 or T4 gastric cancer received systemic 5-fluorouracil-based adjuvant chemotherapy, and intratumoral expression of TS and TP in 51 gastric cancer tissue samples was tested by real-time quantitative PCR. RESULTS: The median disease-free survival (DFS) time was 10.2 mo in the patients. There were no significant differences in DFS between the groups with high and low levels of TP. However, the group with low level of TS had a longer DFS (14.4 mo vs 8.3 mo, P = 0.017). The median overall survival (OS) time was 18.5 mo, and there were significant differences in OS between the groups with high and low levels of TS or TP (for TS, 17.0 mo vs 21.3 mo, P = 0.010; for TP, 16.6 mo vs 22.5 mo, P = 0.009). Moreover, the coupled low expression of these two genes was strongly associated with a longer survival time of patients as compared with that of a single gene. CONCLUSION: Expression of TS and TP mRNA is a useful predictive parameter for the survival of postoperative gastric cancer patients after 5-fluorouracil-based adjuvant chemotherapy.", "title": {"charStart": 0, "charEnd": 171}, "docId": "17854149", "entity": [{"duid": "PU:W2HD", "entityType": "Chemical", "charEnd": 254, "source": "PUBTATOR", "charStart": 246, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}, {"duid": "PU:9bum", "entityType": "Disease", "charEnd": 312, "source": "PUBTATOR", "charStart": 299, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gastric cancer"}, {"duid": "PU:Vyx2", "entityType": "Gene", "charEnd": 19, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Thymidylate synthase"}, {"duid": "PU:3c9S", "entityType": "Gene", "charEnd": 529, "source": "PUBTATOR", "charStart": 528, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TP"}, {"duid": "PU:ehEp", "entityType": "Gene", "charEnd": 522, "source": "PUBTATOR", "charStart": 521, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:NM85", "entityType": "Chemical", "charEnd": 340, "source": "PUBTATOR", "charStart": 327, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-fluorouracil"}, {"duid": "PU:peys", "entityType": "Gene", "charEnd": 47, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidine phosphorylase"}, {"duid": "PU:6GzT", "entityType": "Gene", "charEnd": 1073, "source": "PUBTATOR", "charStart": 1072, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TP"}, {"duid": "PU:XGrw", "entityType": "Disease", "charEnd": 1389, "source": "PUBTATOR", "charStart": 1376, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gastric cancer"}, {"duid": "PU:cqCp", "entityType": "Disease", "charEnd": 550, "source": "PUBTATOR", "charStart": 537, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:a9r7", "entityType": "Chemical", "charEnd": 459, "source": "PUBTATOR", "charStart": 446, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-fluorouracil"}, {"duid": "PU:HMno", "entityType": "Gene", "charEnd": 1020, "source": "PUBTATOR", "charStart": 1019, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:kmqs", "entityType": "Species", "charEnd": 1226, "source": "PUBTATOR", "charStart": 1219, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:qLrh", "entityType": "Gene", "charEnd": 268, "source": "PUBTATOR", "charStart": 246, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidine phosphorylase"}, {"duid": "PU:UFXe", "entityType": "Species", "charEnd": 397, "source": "PUBTATOR", "charStart": 390, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:bmow", "entityType": "Disease", "charEnd": 170, "source": "PUBTATOR", "charStart": 157, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric cancer"}, {"duid": "PU:7ebN", "entityType": "Gene", "charEnd": 272, "source": "PUBTATOR", "charStart": 271, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TP"}, {"duid": "PU:3GQT", "entityType": "Gene", "charEnd": 235, "source": "PUBTATOR", "charStart": 216, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:ivN5", "entityType": "Gene", "charEnd": 239, "source": "PUBTATOR", "charStart": 238, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:qvBC", "entityType": "Species", "charEnd": 1398, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:tFCD", "entityType": "Chemical", "charEnd": 1419, "source": "PUBTATOR", "charStart": 1406, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 8, "entityText": "5-fluorouracil"}, {"duid": "PU:cVea", "entityType": "Gene", "charEnd": 1026, "source": "PUBTATOR", "charStart": 1025, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TP"}, {"duid": "PU:hSTY", "entityType": "Gene", "charEnd": 1034, "source": "PUBTATOR", "charStart": 1033, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:9c8b", "entityType": "Gene", "charEnd": 1295, "source": "PUBTATOR", "charStart": 1294, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:EtwJ", "entityType": "Species", "charEnd": 688, "source": "PUBTATOR", "charStart": 681, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:fmKJ", "entityType": "Disease", "charEnd": 426, "source": "PUBTATOR", "charStart": 413, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:9HYk", "entityType": "Gene", "charEnd": 825, "source": "PUBTATOR", "charStart": 824, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:ozY8", "entityType": "Gene", "charEnd": 784, "source": "PUBTATOR", "charStart": 783, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TP"}, {"duid": "PU:VNwT", "entityType": "Chemical", "charEnd": 123, "source": "PUBTATOR", "charStart": 110, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-fluorouracil"}, {"duid": "PU:Ko7y", "entityType": "Chemical", "charEnd": 33, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "thymidine"}, {"duid": "PU:o3J6", "entityType": "Gene", "charEnd": 1302, "source": "PUBTATOR", "charStart": 1301, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TP"}, {"duid": "PU:V9ML", "entityType": "Chemical", "charEnd": 10, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "17013", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "Thymidylate"}]}
{"text": "Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer. AIM: To investigate the prognostic role of thymidylate synthase (TS) and thymidine phosphorylase (TP) mRNA levels in T3 or T4 gastric cancer treated with 5-fluorouracil-based adjuvant chemotherapy. METHODS: Fifty-one patients with T3 or T4 gastric cancer received systemic 5-fluorouracil-based adjuvant chemotherapy, and intratumoral expression of TS and TP in 51 gastric cancer tissue samples was tested by real-time quantitative PCR. RESULTS: The median disease-free survival (DFS) time was 10.2 mo in the patients. There were no significant differences in DFS between the groups with high and low levels of TP. However, the group with low level of TS had a longer DFS (14.4 mo vs 8.3 mo, P = 0.017). The median overall survival (OS) time was 18.5 mo, and there were significant differences in OS between the groups with high and low levels of TS or TP (for TS, 17.0 mo vs 21.3 mo, P = 0.010; for TP, 16.6 mo vs 22.5 mo, P = 0.009). Moreover, the coupled low expression of these two genes was strongly associated with a longer survival time of patients as compared with that of a single gene. CONCLUSION: Expression of TS and TP mRNA is a useful predictive parameter for the survival of postoperative gastric cancer patients after 5-fluorouracil-based adjuvant chemotherapy.", "title": {"charStart": 0, "charEnd": 171}, "docId": "17854149", "entity": [{"duid": "PU:W2HD", "entityType": "Chemical", "charEnd": 254, "source": "PUBTATOR", "charStart": 246, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}, {"duid": "PU:9bum", "entityType": "Disease", "charEnd": 312, "source": "PUBTATOR", "charStart": 299, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gastric cancer"}, {"duid": "PU:Vyx2", "entityType": "Gene", "charEnd": 19, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Thymidylate synthase"}, {"duid": "PU:3c9S", "entityType": "Gene", "charEnd": 529, "source": "PUBTATOR", "charStart": 528, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TP"}, {"duid": "PU:ehEp", "entityType": "Gene", "charEnd": 522, "source": "PUBTATOR", "charStart": 521, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:NM85", "entityType": "Chemical", "charEnd": 340, "source": "PUBTATOR", "charStart": 327, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-fluorouracil"}, {"duid": "PU:peys", "entityType": "Gene", "charEnd": 47, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidine phosphorylase"}, {"duid": "PU:6GzT", "entityType": "Gene", "charEnd": 1073, "source": "PUBTATOR", "charStart": 1072, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TP"}, {"duid": "PU:XGrw", "entityType": "Disease", "charEnd": 1389, "source": "PUBTATOR", "charStart": 1376, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gastric cancer"}, {"duid": "PU:cqCp", "entityType": "Disease", "charEnd": 550, "source": "PUBTATOR", "charStart": 537, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:a9r7", "entityType": "Chemical", "charEnd": 459, "source": "PUBTATOR", "charStart": 446, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-fluorouracil"}, {"duid": "PU:HMno", "entityType": "Gene", "charEnd": 1020, "source": "PUBTATOR", "charStart": 1019, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:kmqs", "entityType": "Species", "charEnd": 1226, "source": "PUBTATOR", "charStart": 1219, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:qLrh", "entityType": "Gene", "charEnd": 268, "source": "PUBTATOR", "charStart": 246, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidine phosphorylase"}, {"duid": "PU:UFXe", "entityType": "Species", "charEnd": 397, "source": "PUBTATOR", "charStart": 390, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:bmow", "entityType": "Disease", "charEnd": 170, "source": "PUBTATOR", "charStart": 157, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric cancer"}, {"duid": "PU:7ebN", "entityType": "Gene", "charEnd": 272, "source": "PUBTATOR", "charStart": 271, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TP"}, {"duid": "PU:3GQT", "entityType": "Gene", "charEnd": 235, "source": "PUBTATOR", "charStart": 216, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:ivN5", "entityType": "Gene", "charEnd": 239, "source": "PUBTATOR", "charStart": 238, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:qvBC", "entityType": "Species", "charEnd": 1398, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:tFCD", "entityType": "Chemical", "charEnd": 1419, "source": "PUBTATOR", "charStart": 1406, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 8, "entityText": "5-fluorouracil"}, {"duid": "PU:cVea", "entityType": "Gene", "charEnd": 1026, "source": "PUBTATOR", "charStart": 1025, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TP"}, {"duid": "PU:hSTY", "entityType": "Gene", "charEnd": 1034, "source": "PUBTATOR", "charStart": 1033, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:9c8b", "entityType": "Gene", "charEnd": 1295, "source": "PUBTATOR", "charStart": 1294, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:EtwJ", "entityType": "Species", "charEnd": 688, "source": "PUBTATOR", "charStart": 681, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:fmKJ", "entityType": "Disease", "charEnd": 426, "source": "PUBTATOR", "charStart": 413, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:9HYk", "entityType": "Gene", "charEnd": 825, "source": "PUBTATOR", "charStart": 824, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:ozY8", "entityType": "Gene", "charEnd": 784, "source": "PUBTATOR", "charStart": 783, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TP"}, {"duid": "PU:VNwT", "entityType": "Chemical", "charEnd": 123, "source": "PUBTATOR", "charStart": 110, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-fluorouracil"}, {"duid": "PU:Ko7y", "entityType": "Chemical", "charEnd": 33, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "thymidine"}, {"duid": "PU:o3J6", "entityType": "Gene", "charEnd": 1302, "source": "PUBTATOR", "charStart": 1301, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TP"}, {"duid": "PU:V9ML", "entityType": "Chemical", "charEnd": 10, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "17013", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "Thymidylate"}]}
{"text": "High pretherapeutic thymidylate synthetase and MRP-1 protein levels are associated with nonresponse to neoadjuvant chemotherapy in oesophageal adenocarcinoma patients. BACKGROUND: The aim of this study was to determine whether pretherapeutic protein expression levels of the excision repair cross-complementing (ERCC1) enzyme, thymidylate synthetase (TS), multidrug-resistance protein 1 (MRP-1) and P-glycoprotein (P-gp) are associated with tumour response to cisplatin and fluorouracil (5-FU)-based neoadjuvant chemotherapy in oesophageal adenocarcinomas. METHODS: The expression levels of ERCC1, TS, MDR-1 and P-gp were determined immunohistochemically in pretherapeutic tumour biopsies from 40 oesophageal adenocarcinoma patients and were correlated with histopathological tumour regression and with patient survival. Protein expression was compared to mRNA data, which was previously published for ERCC1, TS and MRP-1 and newly determined for the purpose of this study for MDR-1/P-gp. RESULTS: High-TS and -MRP-1 protein expression was correlated with tumour non-response to chemotherapy (P\u2009=\u20090.001 and P\u2009=\u20090.036, respectively). For ERCC-1 and P-gp, no association between pretherapeutic protein expression and response was found. There was no correlation between mRNA levels and protein expression for all investigated markers. Survival analysis revealed a trend towards increased survival for low-ERCC-1 expression (P\u2009=\u20090.079). CONCLUSIONS: The pattern of pretherapeutic expression of TS and MRP-1 is related to chemotherapy response in oesophageal adenocarcinoma patients. Immunohistochemical assessment of these markers may be helpful for response prediction.", "title": {"charStart": 0, "charEnd": 166}, "docId": "20589706", "entity": [{"duid": "PU:Bohg", "entityType": "Gene", "charEnd": 41, "source": "PUBTATOR", "charStart": 20, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidylate synthetase"}, {"duid": "PU:Vg4g", "entityType": "Gene", "charEnd": 348, "source": "PUBTATOR", "charStart": 327, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthetase"}, {"duid": "PU:K2Fe", "entityType": "Chemical", "charEnd": 30, "source": "PUBTATOR", "charStart": 20, "entityId": [{"idString": "17013", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "thymidylate"}, {"duid": "PU:Fhch", "entityType": "Disease", "charEnd": 1492, "source": "PUBTATOR", "charStart": 1491, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:baHj", "entityType": "Chemical", "charEnd": 468, "source": "PUBTATOR", "charStart": 460, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:X3ds", "entityType": "Gene", "charEnd": 392, "source": "PUBTATOR", "charStart": 388, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "MRP-1"}, {"duid": "PU:VXxc", "entityType": "Disease", "charEnd": 156, "source": "PUBTATOR", "charStart": 131, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 0, "entityText": "oesophageal adenocarcinoma"}, {"duid": "PU:feMN", "entityType": "Gene", "charEnd": 418, "source": "PUBTATOR", "charStart": 415, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "P-gp"}, {"duid": "PU:fSHZ", "entityType": "Gene", "charEnd": 906, "source": "PUBTATOR", "charStart": 902, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:3MMA", "entityType": "Disease", "charEnd": 1004, "source": "PUBTATOR", "charStart": 1003, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:ymyM", "entityType": "Gene", "charEnd": 1142, "source": "PUBTATOR", "charStart": 1137, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC-1"}, {"duid": "PU:d8bj", "entityType": "Chemical", "charEnd": 491, "source": "PUBTATOR", "charStart": 488, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:7wvZ", "entityType": "Disease", "charEnd": 678, "source": "PUBTATOR", "charStart": 673, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumour"}, {"duid": "PU:SRPA", "entityType": "Chemical", "charEnd": 485, "source": "PUBTATOR", "charStart": 474, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "fluorouracil"}, {"duid": "PU:GYCD", "entityType": "Species", "charEnd": 731, "source": "PUBTATOR", "charStart": 724, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:Zh94", "entityType": "Disease", "charEnd": 1061, "source": "PUBTATOR", "charStart": 1056, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumour"}, {"duid": "PU:hB6Z", "entityType": "Gene", "charEnd": 595, "source": "PUBTATOR", "charStart": 591, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:RDa4", "entityType": "Disease", "charEnd": 722, "source": "PUBTATOR", "charStart": 697, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 2, "entityText": "oesophageal adenocarcinoma"}, {"duid": "PU:fd8f", "entityType": "Gene", "charEnd": 920, "source": "PUBTATOR", "charStart": 916, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MRP-1"}, {"duid": "PU:Q5CH", "entityType": "Gene", "charEnd": 599, "source": "PUBTATOR", "charStart": 598, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:e9JK", "entityType": "Gene", "charEnd": 1151, "source": "PUBTATOR", "charStart": 1148, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "P-gp"}, {"duid": "PU:CTmb", "entityType": "Disease", "charEnd": 910, "source": "PUBTATOR", "charStart": 909, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 3, "entityText": "TS"}, {"duid": "PU:Ueju", "entityType": "Gene", "charEnd": 385, "source": "PUBTATOR", "charStart": 356, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "multidrug-resistance protein 1"}, {"duid": "PU:MMUj", "entityType": "Gene", "charEnd": 1502, "source": "PUBTATOR", "charStart": 1498, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MRP-1"}, {"duid": "PU:jSnr", "entityType": "Disease", "charEnd": 554, "source": "PUBTATOR", "charStart": 540, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 1, "entityText": "adenocarcinomas"}, {"duid": "PU:Xjsm", "entityType": "Gene", "charEnd": 1015, "source": "PUBTATOR", "charStart": 1011, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MRP-1"}, {"duid": "PU:Nrx7", "entityType": "Gene", "charEnd": 615, "source": "PUBTATOR", "charStart": 612, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "P-gp"}, {"duid": "PU:JjzK", "entityType": "Gene", "charEnd": 412, "source": "PUBTATOR", "charStart": 399, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "P-glycoprotein"}, {"duid": "PU:hhDk", "entityType": "Disease", "charEnd": 1568, "source": "PUBTATOR", "charStart": 1543, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 8, "entityText": "oesophageal adenocarcinoma"}, {"duid": "PU:7mvZ", "entityType": "Disease", "charEnd": 446, "source": "PUBTATOR", "charStart": 441, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumour"}, {"duid": "PU:d9BB", "entityType": "Disease", "charEnd": 781, "source": "PUBTATOR", "charStart": 776, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumour"}, {"duid": "PU:Mt6Z", "entityType": "Gene", "charEnd": 981, "source": "PUBTATOR", "charStart": 977, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MDR-1"}, {"duid": "PU:nKGe", "entityType": "Gene", "charEnd": 316, "source": "PUBTATOR", "charStart": 312, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:n3E8", "entityType": "Gene", "charEnd": 1408, "source": "PUBTATOR", "charStart": 1403, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC-1"}, {"duid": "PU:3CbQ", "entityType": "Gene", "charEnd": 986, "source": "PUBTATOR", "charStart": 983, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "P-gp"}, {"duid": "PU:K2f7", "entityType": "Species", "charEnd": 165, "source": "PUBTATOR", "charStart": 158, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:Wxm3", "entityType": "Disease", "charEnd": 352, "source": "PUBTATOR", "charStart": 351, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:JCbS", "entityType": "Species", "charEnd": 809, "source": "PUBTATOR", "charStart": 803, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patient"}, {"duid": "PU:rUWs", "entityType": "Gene", "charEnd": 51, "source": "PUBTATOR", "charStart": 47, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "MRP-1"}, {"duid": "PU:8Fgf", "entityType": "Gene", "charEnd": 606, "source": "PUBTATOR", "charStart": 602, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "MDR-1"}, {"duid": "PU:BXf8", "entityType": "Species", "charEnd": 1577, "source": "PUBTATOR", "charStart": 1570, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}]}
{"text": "High pretherapeutic thymidylate synthetase and MRP-1 protein levels are associated with nonresponse to neoadjuvant chemotherapy in oesophageal adenocarcinoma patients. BACKGROUND: The aim of this study was to determine whether pretherapeutic protein expression levels of the excision repair cross-complementing (ERCC1) enzyme, thymidylate synthetase (TS), multidrug-resistance protein 1 (MRP-1) and P-glycoprotein (P-gp) are associated with tumour response to cisplatin and fluorouracil (5-FU)-based neoadjuvant chemotherapy in oesophageal adenocarcinomas. METHODS: The expression levels of ERCC1, TS, MDR-1 and P-gp were determined immunohistochemically in pretherapeutic tumour biopsies from 40 oesophageal adenocarcinoma patients and were correlated with histopathological tumour regression and with patient survival. Protein expression was compared to mRNA data, which was previously published for ERCC1, TS and MRP-1 and newly determined for the purpose of this study for MDR-1/P-gp. RESULTS: High-TS and -MRP-1 protein expression was correlated with tumour non-response to chemotherapy (P\u2009=\u20090.001 and P\u2009=\u20090.036, respectively). For ERCC-1 and P-gp, no association between pretherapeutic protein expression and response was found. There was no correlation between mRNA levels and protein expression for all investigated markers. Survival analysis revealed a trend towards increased survival for low-ERCC-1 expression (P\u2009=\u20090.079). CONCLUSIONS: The pattern of pretherapeutic expression of TS and MRP-1 is related to chemotherapy response in oesophageal adenocarcinoma patients. Immunohistochemical assessment of these markers may be helpful for response prediction.", "title": {"charStart": 0, "charEnd": 166}, "docId": "20589706", "entity": [{"duid": "PU:Bohg", "entityType": "Gene", "charEnd": 41, "source": "PUBTATOR", "charStart": 20, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidylate synthetase"}, {"duid": "PU:Vg4g", "entityType": "Gene", "charEnd": 348, "source": "PUBTATOR", "charStart": 327, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthetase"}, {"duid": "PU:K2Fe", "entityType": "Chemical", "charEnd": 30, "source": "PUBTATOR", "charStart": 20, "entityId": [{"idString": "17013", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "thymidylate"}, {"duid": "PU:Fhch", "entityType": "Disease", "charEnd": 1492, "source": "PUBTATOR", "charStart": 1491, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:baHj", "entityType": "Chemical", "charEnd": 468, "source": "PUBTATOR", "charStart": 460, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:X3ds", "entityType": "Gene", "charEnd": 392, "source": "PUBTATOR", "charStart": 388, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "MRP-1"}, {"duid": "PU:VXxc", "entityType": "Disease", "charEnd": 156, "source": "PUBTATOR", "charStart": 131, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 0, "entityText": "oesophageal adenocarcinoma"}, {"duid": "PU:feMN", "entityType": "Gene", "charEnd": 418, "source": "PUBTATOR", "charStart": 415, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "P-gp"}, {"duid": "PU:fSHZ", "entityType": "Gene", "charEnd": 906, "source": "PUBTATOR", "charStart": 902, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:3MMA", "entityType": "Disease", "charEnd": 1004, "source": "PUBTATOR", "charStart": 1003, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:ymyM", "entityType": "Gene", "charEnd": 1142, "source": "PUBTATOR", "charStart": 1137, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC-1"}, {"duid": "PU:d8bj", "entityType": "Chemical", "charEnd": 491, "source": "PUBTATOR", "charStart": 488, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:7wvZ", "entityType": "Disease", "charEnd": 678, "source": "PUBTATOR", "charStart": 673, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumour"}, {"duid": "PU:SRPA", "entityType": "Chemical", "charEnd": 485, "source": "PUBTATOR", "charStart": 474, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "fluorouracil"}, {"duid": "PU:GYCD", "entityType": "Species", "charEnd": 731, "source": "PUBTATOR", "charStart": 724, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:Zh94", "entityType": "Disease", "charEnd": 1061, "source": "PUBTATOR", "charStart": 1056, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumour"}, {"duid": "PU:hB6Z", "entityType": "Gene", "charEnd": 595, "source": "PUBTATOR", "charStart": 591, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:RDa4", "entityType": "Disease", "charEnd": 722, "source": "PUBTATOR", "charStart": 697, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 2, "entityText": "oesophageal adenocarcinoma"}, {"duid": "PU:fd8f", "entityType": "Gene", "charEnd": 920, "source": "PUBTATOR", "charStart": 916, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MRP-1"}, {"duid": "PU:Q5CH", "entityType": "Gene", "charEnd": 599, "source": "PUBTATOR", "charStart": 598, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:e9JK", "entityType": "Gene", "charEnd": 1151, "source": "PUBTATOR", "charStart": 1148, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "P-gp"}, {"duid": "PU:CTmb", "entityType": "Disease", "charEnd": 910, "source": "PUBTATOR", "charStart": 909, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 3, "entityText": "TS"}, {"duid": "PU:Ueju", "entityType": "Gene", "charEnd": 385, "source": "PUBTATOR", "charStart": 356, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "multidrug-resistance protein 1"}, {"duid": "PU:MMUj", "entityType": "Gene", "charEnd": 1502, "source": "PUBTATOR", "charStart": 1498, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MRP-1"}, {"duid": "PU:jSnr", "entityType": "Disease", "charEnd": 554, "source": "PUBTATOR", "charStart": 540, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 1, "entityText": "adenocarcinomas"}, {"duid": "PU:Xjsm", "entityType": "Gene", "charEnd": 1015, "source": "PUBTATOR", "charStart": 1011, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MRP-1"}, {"duid": "PU:Nrx7", "entityType": "Gene", "charEnd": 615, "source": "PUBTATOR", "charStart": 612, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "P-gp"}, {"duid": "PU:JjzK", "entityType": "Gene", "charEnd": 412, "source": "PUBTATOR", "charStart": 399, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "P-glycoprotein"}, {"duid": "PU:hhDk", "entityType": "Disease", "charEnd": 1568, "source": "PUBTATOR", "charStart": 1543, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 8, "entityText": "oesophageal adenocarcinoma"}, {"duid": "PU:7mvZ", "entityType": "Disease", "charEnd": 446, "source": "PUBTATOR", "charStart": 441, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumour"}, {"duid": "PU:d9BB", "entityType": "Disease", "charEnd": 781, "source": "PUBTATOR", "charStart": 776, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumour"}, {"duid": "PU:Mt6Z", "entityType": "Gene", "charEnd": 981, "source": "PUBTATOR", "charStart": 977, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MDR-1"}, {"duid": "PU:nKGe", "entityType": "Gene", "charEnd": 316, "source": "PUBTATOR", "charStart": 312, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:n3E8", "entityType": "Gene", "charEnd": 1408, "source": "PUBTATOR", "charStart": 1403, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC-1"}, {"duid": "PU:3CbQ", "entityType": "Gene", "charEnd": 986, "source": "PUBTATOR", "charStart": 983, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "P-gp"}, {"duid": "PU:K2f7", "entityType": "Species", "charEnd": 165, "source": "PUBTATOR", "charStart": 158, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:Wxm3", "entityType": "Disease", "charEnd": 352, "source": "PUBTATOR", "charStart": 351, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:JCbS", "entityType": "Species", "charEnd": 809, "source": "PUBTATOR", "charStart": 803, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patient"}, {"duid": "PU:rUWs", "entityType": "Gene", "charEnd": 51, "source": "PUBTATOR", "charStart": 47, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "MRP-1"}, {"duid": "PU:8Fgf", "entityType": "Gene", "charEnd": 606, "source": "PUBTATOR", "charStart": 602, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "MDR-1"}, {"duid": "PU:BXf8", "entityType": "Species", "charEnd": 1577, "source": "PUBTATOR", "charStart": 1570, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}]}
{"text": "The relationship of platinum resistance and ERCC1 protein expression in epithelial ovarian cancer. OBJECTIVE: Although platinum-based chemotherapy remains the cornerstone for treatment of ovarian cancer, some patients are resistant to the treatment and will therefore not benefit from the standard platinum-based chemotherapy. Preclinical and clinical data have suggested a potential use of excision repair cross-complementation group 1 enzyme (ERCC1) as a molecular predictor of clinical resistance to platinum-based chemotherapy. Excision repair cross-complementation group 1 enzyme is a key enzyme in the nucleotide excision repair pathway which is involved in the DNA repair mechanisms in tumor cells damaged by treatment with platinum agents. The primary aim of the present study was to investigate if immunohistochemical expression of ERCC1 protein was associated with resistance to standard combination carboplatin and paclitaxel chemotherapy in newly diagnosed ovarian cancer patients. METHODS: Formalin-fixed, paraffin-embedded tissue sections from 101 patients with newly diagnosed ovarian cancer were used for immunohistochemical staining for the ERCC1 protein. All patients received carboplatin-paclitaxel combination chemotherapy. RESULTS: Excision repair cross-complementation group 1 enzyme protein overexpression was found in 13.9% of the tumors. Platinum resistance was found in 75% of the tumors with positive ERCC1 protein expression compared with 27% among the patients with negative tumor staining for ERCC1 (P = 0.0013). These findings translated into a significant difference in progression-free survival in both univariate (P = 0.0012) and in multivariate analysis (P = 0.006). CONCLUSIONS: The data presented suggest a positive association between positive ERCC1 protein expression and clinical resistance to platinum-based chemotherapy.", "title": {"charStart": 0, "charEnd": 97}, "docId": "19574766", "entity": [{"duid": "PU:KHXj", "entityType": "Chemical", "charEnd": 1216, "source": "PUBTATOR", "charStart": 1207, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 6, "entityText": "paclitaxel"}, {"duid": "PU:CynK", "entityType": "Chemical", "charEnd": 1205, "source": "PUBTATOR", "charStart": 1195, "entityId": [{"idString": "D016190", "source": "MESH"}], "sentenceIndex": 6, "entityText": "carboplatin"}, {"duid": "PU:ZdDe", "entityType": "Gene", "charEnd": 1432, "source": "PUBTATOR", "charStart": 1428, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:RCXj", "entityType": "Chemical", "charEnd": 1841, "source": "PUBTATOR", "charStart": 1834, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 10, "entityText": "platinum"}, {"duid": "PU:JDEi", "entityType": "Gene", "charEnd": 48, "source": "PUBTATOR", "charStart": 44, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:FXJm", "entityType": "Disease", "charEnd": 697, "source": "PUBTATOR", "charStart": 693, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:BAo4", "entityType": "Gene", "charEnd": 449, "source": "PUBTATOR", "charStart": 445, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:2ppN", "entityType": "Gene", "charEnd": 1527, "source": "PUBTATOR", "charStart": 1523, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:2Rh8", "entityType": "Chemical", "charEnd": 738, "source": "PUBTATOR", "charStart": 731, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 3, "entityText": "platinum"}, {"duid": "PU:tvCp", "entityType": "Disease", "charEnd": 1412, "source": "PUBTATOR", "charStart": 1407, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "tumors"}, {"duid": "PU:kg2B", "entityType": "Disease", "charEnd": 982, "source": "PUBTATOR", "charStart": 969, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 4, "entityText": "ovarian cancer"}, {"duid": "PU:3eYf", "entityType": "Chemical", "charEnd": 935, "source": "PUBTATOR", "charStart": 926, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 4, "entityText": "paclitaxel"}, {"duid": "PU:W9uU", "entityType": "Gene", "charEnd": 845, "source": "PUBTATOR", "charStart": 841, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:GU8P", "entityType": "Chemical", "charEnd": 920, "source": "PUBTATOR", "charStart": 910, "entityId": [{"idString": "D016190", "source": "MESH"}], "sentenceIndex": 4, "entityText": "carboplatin"}, {"duid": "PU:oZzw", "entityType": "Chemical", "charEnd": 1370, "source": "PUBTATOR", "charStart": 1363, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 8, "entityText": "Platinum"}, {"duid": "PU:u7JW", "entityType": "Disease", "charEnd": 201, "source": "PUBTATOR", "charStart": 188, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 1, "entityText": "ovarian cancer"}, {"duid": "PU:BvSV", "entityType": "Disease", "charEnd": 1508, "source": "PUBTATOR", "charStart": 1504, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "tumor"}, {"duid": "PU:J3Hk", "entityType": "Species", "charEnd": 1184, "source": "PUBTATOR", "charStart": 1177, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:iSY7", "entityType": "Disease", "charEnd": 96, "source": "PUBTATOR", "charStart": 72, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 0, "entityText": "epithelial ovarian cancer"}, {"duid": "PU:N7kB", "entityType": "Species", "charEnd": 1488, "source": "PUBTATOR", "charStart": 1481, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:jafa", "entityType": "Disease", "charEnd": 1105, "source": "PUBTATOR", "charStart": 1092, "entityId": [{"idString": "D010051", "source": "MESH"}], "sentenceIndex": 5, "entityText": "ovarian cancer"}, {"duid": "PU:tSvp", "entityType": "Chemical", "charEnd": 126, "source": "PUBTATOR", "charStart": 119, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:7p5x", "entityType": "Species", "charEnd": 991, "source": "PUBTATOR", "charStart": 984, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:mNAe", "entityType": "Chemical", "charEnd": 1026, "source": "PUBTATOR", "charStart": 1019, "entityId": [{"idString": "D010232", "source": "MESH"}], "sentenceIndex": 5, "entityText": "paraffin"}, {"duid": "PU:ELNc", "entityType": "Chemical", "charEnd": 27, "source": "PUBTATOR", "charStart": 20, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 0, "entityText": "platinum"}, {"duid": "PU:xxVN", "entityType": "Gene", "charEnd": 1786, "source": "PUBTATOR", "charStart": 1782, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:rxfi", "entityType": "Disease", "charEnd": 1360, "source": "PUBTATOR", "charStart": 1355, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumors"}, {"duid": "PU:KZ4T", "entityType": "Species", "charEnd": 216, "source": "PUBTATOR", "charStart": 209, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:Lmqe", "entityType": "Chemical", "charEnd": 510, "source": "PUBTATOR", "charStart": 503, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 2, "entityText": "platinum"}, {"duid": "PU:hmfh", "entityType": "Chemical", "charEnd": 305, "source": "PUBTATOR", "charStart": 298, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:nwsL", "entityType": "Gene", "charEnd": 1162, "source": "PUBTATOR", "charStart": 1158, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:rH6A", "entityType": "Chemical", "charEnd": 617, "source": "PUBTATOR", "charStart": 608, "entityId": [{"idString": "36976", "source": "CHEBI"}], "sentenceIndex": 3, "entityText": "nucleotide"}, {"duid": "PU:oEuF", "entityType": "Species", "charEnd": 1069, "source": "PUBTATOR", "charStart": 1062, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}]}
{"text": "Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma. BACKGROUND: Our purpose was to evaluate thymidine synthase (TS), thymidine phosphorylase (TP), and excision repair cross-complementation group 1 (ERCC1) expression as biomarkers for capecitabine and cisplatin (XP) combination chemotherapy in patients with metastatic oesophageal squamous cell cancer. METHOD: A total of 113 patients with metastatic oesophageal squamous cell cancer were treated with XP chemotherapy at the Samsung Medical Center between 2003 and 2007, of whom 72 had available clinical data and paraffin blocks for immunohistochemistry of TS, TP, and ERCC1. RESULTS: The median age of the 72 patients was 62 years. The overall response rate (RR) was 51.4%. The median progression-free survival (PFS) and overall survival (OS) were 4.2 and 12.0 months, respectively. High expression of TS and TP was associated with a higher RR than was low expression of TS and TP (54.1 vs 40.5%, P=0.022). Strong ERCC1 expression and a low TS score were identified as unfavourable independent risk factors for PFS (HR 10.71, 95% confidence interval (CI) 2.1-54.7, P=0.004 for strong ERCC1 expression; and HR 2.9, 95% CI 1.0-7.9, P=0.044 for low TS score). Strong ERCC1 expression was identified as an unfavourable independent risk factor for OS (HR 3.73, 95% CI 1.39-10.0, P=0.009). CONCLUSION: These data indicate that expression of TS, TP, and ERCC1 may be predictive markers for response and survival in patients with metastatic oesophageal squamous cell cancer receiving XP chemotherapy.", "title": {"charStart": 0, "charEnd": 258}, "docId": "20700125", "entity": [{"duid": "PU:xJei", "entityType": "Disease", "charEnd": 257, "source": "PUBTATOR", "charStart": 223, "entityId": [{"idString": "D002294", "source": "MESH"}], "sentenceIndex": 0, "entityText": "oesophageal squamous cell carcinoma"}, {"duid": "PU:may4", "entityType": "Chemical", "charEnd": 453, "source": "PUBTATOR", "charStart": 442, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 1, "entityText": "capecitabine"}, {"duid": "PU:6DrB", "entityType": "Species", "charEnd": 509, "source": "PUBTATOR", "charStart": 502, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:pxcX", "entityType": "Chemical", "charEnd": 157, "source": "PUBTATOR", "charStart": 149, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "cisplatin"}, {"duid": "PU:xTJP", "entityType": "Species", "charEnd": 207, "source": "PUBTATOR", "charStart": 200, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:MJKU", "entityType": "Gene", "charEnd": 1348, "source": "PUBTATOR", "charStart": 1344, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:mWG3", "entityType": "Gene", "charEnd": 1428, "source": "PUBTATOR", "charStart": 1424, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:RYkC", "entityType": "Species", "charEnd": 591, "source": "PUBTATOR", "charStart": 584, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:aZay", "entityType": "Disease", "charEnd": 1504, "source": "PUBTATOR", "charStart": 1503, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 8, "entityText": "OS"}, {"duid": "PU:oQXi", "entityType": "Gene", "charEnd": 410, "source": "PUBTATOR", "charStart": 406, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:uem2", "entityType": "Disease", "charEnd": 1132, "source": "PUBTATOR", "charStart": 1131, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:hGdF", "entityType": "Gene", "charEnd": 403, "source": "PUBTATOR", "charStart": 359, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementation group 1"}, {"duid": "PU:ULe6", "entityType": "Chemical", "charEnd": 333, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}, {"duid": "PU:fxKX", "entityType": "Species", "charEnd": 876, "source": "PUBTATOR", "charStart": 869, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:7F3V", "entityType": "Disease", "charEnd": 1407, "source": "PUBTATOR", "charStart": 1406, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 7, "entityText": "TS"}, {"duid": "PU:24Hx", "entityType": "Disease", "charEnd": 996, "source": "PUBTATOR", "charStart": 981, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 5, "entityText": "overall survival"}, {"duid": "PU:gPsX", "entityType": "Disease", "charEnd": 1724, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "cancer"}, {"duid": "PU:LBei", "entityType": "Gene", "charEnd": 42, "source": "PUBTATOR", "charStart": 20, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidine phosphorylase"}, {"duid": "PU:kkgR", "entityType": "Chemical", "charEnd": 8, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Thymidine"}, {"duid": "PU:9cqU", "entityType": "Disease", "charEnd": 817, "source": "PUBTATOR", "charStart": 816, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:329N", "entityType": "Gene", "charEnd": 832, "source": "PUBTATOR", "charStart": 828, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:WFpe", "entityType": "Chemical", "charEnd": 142, "source": "PUBTATOR", "charStart": 131, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 0, "entityText": "capecitabine"}, {"duid": "PU:eUuh", "entityType": "Gene", "charEnd": 93, "source": "PUBTATOR", "charStart": 49, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "excision repair cross-complementation group 1"}, {"duid": "PU:ouQX", "entityType": "Species", "charEnd": 1675, "source": "PUBTATOR", "charStart": 1668, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:DGij", "entityType": "Chemical", "charEnd": 467, "source": "PUBTATOR", "charStart": 459, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:hRo7", "entityType": "Disease", "charEnd": 558, "source": "PUBTATOR", "charStart": 553, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cancer"}, {"duid": "PU:zCQL", "entityType": "Disease", "charEnd": 1202, "source": "PUBTATOR", "charStart": 1201, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 7, "entityText": "TS"}, {"duid": "PU:Nz9T", "entityType": "Disease", "charEnd": 1000, "source": "PUBTATOR", "charStart": 999, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 5, "entityText": "OS"}, {"duid": "PU:oVTm", "entityType": "Disease", "charEnd": 317, "source": "PUBTATOR", "charStart": 300, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine synthase"}, {"duid": "PU:wUB2", "entityType": "Chemical", "charEnd": 28, "source": "PUBTATOR", "charStart": 20, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "thymidine"}, {"duid": "PU:gLs5", "entityType": "Disease", "charEnd": 640, "source": "PUBTATOR", "charStart": 635, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cancer"}, {"duid": "PU:WhjT", "entityType": "Gene", "charEnd": 1611, "source": "PUBTATOR", "charStart": 1607, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:5FUN", "entityType": "Gene", "charEnd": 347, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidine phosphorylase"}, {"duid": "PU:fgjR", "entityType": "Gene", "charEnd": 1178, "source": "PUBTATOR", "charStart": 1174, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:Loj9", "entityType": "Disease", "charEnd": 321, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:VShx", "entityType": "Chemical", "charEnd": 779, "source": "PUBTATOR", "charStart": 772, "entityId": [{"idString": "D010232", "source": "MESH"}], "sentenceIndex": 2, "entityText": "paraffin"}, {"duid": "PU:bPFP", "entityType": "Disease", "charEnd": 1063, "source": "PUBTATOR", "charStart": 1062, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:TDau", "entityType": "Disease", "charEnd": 1596, "source": "PUBTATOR", "charStart": 1595, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:oKNE", "entityType": "Chemical", "charEnd": 308, "source": "PUBTATOR", "charStart": 300, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}]}
{"text": "Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma. BACKGROUND: Our purpose was to evaluate thymidine synthase (TS), thymidine phosphorylase (TP), and excision repair cross-complementation group 1 (ERCC1) expression as biomarkers for capecitabine and cisplatin (XP) combination chemotherapy in patients with metastatic oesophageal squamous cell cancer. METHOD: A total of 113 patients with metastatic oesophageal squamous cell cancer were treated with XP chemotherapy at the Samsung Medical Center between 2003 and 2007, of whom 72 had available clinical data and paraffin blocks for immunohistochemistry of TS, TP, and ERCC1. RESULTS: The median age of the 72 patients was 62 years. The overall response rate (RR) was 51.4%. The median progression-free survival (PFS) and overall survival (OS) were 4.2 and 12.0 months, respectively. High expression of TS and TP was associated with a higher RR than was low expression of TS and TP (54.1 vs 40.5%, P=0.022). Strong ERCC1 expression and a low TS score were identified as unfavourable independent risk factors for PFS (HR 10.71, 95% confidence interval (CI) 2.1-54.7, P=0.004 for strong ERCC1 expression; and HR 2.9, 95% CI 1.0-7.9, P=0.044 for low TS score). Strong ERCC1 expression was identified as an unfavourable independent risk factor for OS (HR 3.73, 95% CI 1.39-10.0, P=0.009). CONCLUSION: These data indicate that expression of TS, TP, and ERCC1 may be predictive markers for response and survival in patients with metastatic oesophageal squamous cell cancer receiving XP chemotherapy.", "title": {"charStart": 0, "charEnd": 258}, "docId": "20700125", "entity": [{"duid": "PU:xJei", "entityType": "Disease", "charEnd": 257, "source": "PUBTATOR", "charStart": 223, "entityId": [{"idString": "D002294", "source": "MESH"}], "sentenceIndex": 0, "entityText": "oesophageal squamous cell carcinoma"}, {"duid": "PU:may4", "entityType": "Chemical", "charEnd": 453, "source": "PUBTATOR", "charStart": 442, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 1, "entityText": "capecitabine"}, {"duid": "PU:6DrB", "entityType": "Species", "charEnd": 509, "source": "PUBTATOR", "charStart": 502, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:pxcX", "entityType": "Chemical", "charEnd": 157, "source": "PUBTATOR", "charStart": 149, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "cisplatin"}, {"duid": "PU:xTJP", "entityType": "Species", "charEnd": 207, "source": "PUBTATOR", "charStart": 200, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:MJKU", "entityType": "Gene", "charEnd": 1348, "source": "PUBTATOR", "charStart": 1344, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:mWG3", "entityType": "Gene", "charEnd": 1428, "source": "PUBTATOR", "charStart": 1424, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:RYkC", "entityType": "Species", "charEnd": 591, "source": "PUBTATOR", "charStart": 584, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:aZay", "entityType": "Disease", "charEnd": 1504, "source": "PUBTATOR", "charStart": 1503, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 8, "entityText": "OS"}, {"duid": "PU:oQXi", "entityType": "Gene", "charEnd": 410, "source": "PUBTATOR", "charStart": 406, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:uem2", "entityType": "Disease", "charEnd": 1132, "source": "PUBTATOR", "charStart": 1131, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:hGdF", "entityType": "Gene", "charEnd": 403, "source": "PUBTATOR", "charStart": 359, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementation group 1"}, {"duid": "PU:ULe6", "entityType": "Chemical", "charEnd": 333, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}, {"duid": "PU:fxKX", "entityType": "Species", "charEnd": 876, "source": "PUBTATOR", "charStart": 869, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:7F3V", "entityType": "Disease", "charEnd": 1407, "source": "PUBTATOR", "charStart": 1406, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 7, "entityText": "TS"}, {"duid": "PU:24Hx", "entityType": "Disease", "charEnd": 996, "source": "PUBTATOR", "charStart": 981, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 5, "entityText": "overall survival"}, {"duid": "PU:gPsX", "entityType": "Disease", "charEnd": 1724, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "cancer"}, {"duid": "PU:LBei", "entityType": "Gene", "charEnd": 42, "source": "PUBTATOR", "charStart": 20, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidine phosphorylase"}, {"duid": "PU:kkgR", "entityType": "Chemical", "charEnd": 8, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Thymidine"}, {"duid": "PU:9cqU", "entityType": "Disease", "charEnd": 817, "source": "PUBTATOR", "charStart": 816, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:329N", "entityType": "Gene", "charEnd": 832, "source": "PUBTATOR", "charStart": 828, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:WFpe", "entityType": "Chemical", "charEnd": 142, "source": "PUBTATOR", "charStart": 131, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 0, "entityText": "capecitabine"}, {"duid": "PU:eUuh", "entityType": "Gene", "charEnd": 93, "source": "PUBTATOR", "charStart": 49, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "excision repair cross-complementation group 1"}, {"duid": "PU:ouQX", "entityType": "Species", "charEnd": 1675, "source": "PUBTATOR", "charStart": 1668, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:DGij", "entityType": "Chemical", "charEnd": 467, "source": "PUBTATOR", "charStart": 459, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:hRo7", "entityType": "Disease", "charEnd": 558, "source": "PUBTATOR", "charStart": 553, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cancer"}, {"duid": "PU:zCQL", "entityType": "Disease", "charEnd": 1202, "source": "PUBTATOR", "charStart": 1201, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 7, "entityText": "TS"}, {"duid": "PU:Nz9T", "entityType": "Disease", "charEnd": 1000, "source": "PUBTATOR", "charStart": 999, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 5, "entityText": "OS"}, {"duid": "PU:oVTm", "entityType": "Disease", "charEnd": 317, "source": "PUBTATOR", "charStart": 300, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine synthase"}, {"duid": "PU:wUB2", "entityType": "Chemical", "charEnd": 28, "source": "PUBTATOR", "charStart": 20, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 0, "entityText": "thymidine"}, {"duid": "PU:gLs5", "entityType": "Disease", "charEnd": 640, "source": "PUBTATOR", "charStart": 635, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cancer"}, {"duid": "PU:WhjT", "entityType": "Gene", "charEnd": 1611, "source": "PUBTATOR", "charStart": 1607, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:5FUN", "entityType": "Gene", "charEnd": 347, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "1890", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidine phosphorylase"}, {"duid": "PU:fgjR", "entityType": "Gene", "charEnd": 1178, "source": "PUBTATOR", "charStart": 1174, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:Loj9", "entityType": "Disease", "charEnd": 321, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:VShx", "entityType": "Chemical", "charEnd": 779, "source": "PUBTATOR", "charStart": 772, "entityId": [{"idString": "D010232", "source": "MESH"}], "sentenceIndex": 2, "entityText": "paraffin"}, {"duid": "PU:bPFP", "entityType": "Disease", "charEnd": 1063, "source": "PUBTATOR", "charStart": 1062, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:TDau", "entityType": "Disease", "charEnd": 1596, "source": "PUBTATOR", "charStart": 1595, "entityId": [{"idString": "C537477", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:oKNE", "entityType": "Chemical", "charEnd": 308, "source": "PUBTATOR", "charStart": 300, "entityId": [{"idString": "D013936", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thymidine"}]}
{"text": "Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high-risk myelodysplastic syndrome patients pre-screened for low O(6) -methylguanine DNA methyltransferase expression. Resistance to temozolomide is largely mediated by the DNA repair enzyme O(6) -methylguanine DNA methyltransferase (MGMT). We conducted a prospective multicentre study of patients with previously untreated acute myeloid leukaemia (AML) or high-risk myelodysplastic syndrome (MDS) who were not candidates for intensive therapy. Patient selection was based on MGMT expression by Western blot. Patients with MGMT:ACTB (\u03b2-actin) ratio <0\u00b72 were eligible to receive temozolomide 200\u00a0mg/m(2) /d \u00d77\u00a0d. Patients achieving a complete response (CR) could receive up to 12 monthly cycles of temozolomide \u00d75/28\u00a0d. Of 166 patients screened, 81 (49%) demonstrated low MGMT expression; 45 of these were treated with temozolomide. The overall response rate was 53%; 36% achieved complete clearance of blasts, with 27% achieving a CR/CR with incomplete platelet recovery (CRp). Factors associated with a trend toward a higher response rate included MDS, methylated MGMT promoter and standard cytogenetic risk group. Induction and post-remission cycles were well-tolerated and most patients were treated on an outpatient basis. Patient who achieved CR/CRp had a superior overall survival compared to partial or non-responders. In conclusion, targeted therapy based on pre-selection for low MGMT expression was associated with a higher response rate to temozolomide compared to previous reports of unselected patients.", "title": {"charStart": 0, "charEnd": 201}, "docId": "25160658", "entity": [{"duid": "PU:33W3", "entityType": "Gene", "charEnd": 615, "source": "PUBTATOR", "charStart": 612, "entityId": [{"idString": "60", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ACTB"}, {"duid": "PU:3tLe", "entityType": "Chemical", "charEnd": 228, "source": "PUBTATOR", "charStart": 217, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "temozolomide"}, {"duid": "PU:TL5y", "entityType": "Chemical", "charEnd": 278, "source": "PUBTATOR", "charStart": 275, "entityId": [], "sentenceIndex": 1, "entityText": "O(6)"}, {"duid": "PU:GqJW", "entityType": "Gene", "charEnd": 859, "source": "PUBTATOR", "charStart": 856, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MGMT"}, {"duid": "PU:r9x7", "entityType": "Disease", "charEnd": 435, "source": "PUBTATOR", "charStart": 433, "entityId": [{"idString": "D015470", "source": "MESH"}], "sentenceIndex": 2, "entityText": "AML"}, {"duid": "PU:3sKt", "entityType": "Species", "charEnd": 1318, "source": "PUBTATOR", "charStart": 1312, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "Patient"}, {"duid": "PU:U7kK", "entityType": "Chemical", "charEnd": 51, "source": "PUBTATOR", "charStart": 40, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "temozolomide"}, {"duid": "PU:qNju", "entityType": "Chemical", "charEnd": 152, "source": "PUBTATOR", "charStart": 149, "entityId": [], "sentenceIndex": 0, "entityText": "O(6)"}, {"duid": "PU:xJqd", "entityType": "Species", "charEnd": 1599, "source": "PUBTATOR", "charStart": 1592, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:SfGM", "entityType": "Species", "charEnd": 535, "source": "PUBTATOR", "charStart": 529, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "Patient"}, {"duid": "PU:vqAH", "entityType": "Species", "charEnd": 126, "source": "PUBTATOR", "charStart": 119, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:wq5Y", "entityType": "Species", "charEnd": 818, "source": "PUBTATOR", "charStart": 811, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:nt6U", "entityType": "Gene", "charEnd": 563, "source": "PUBTATOR", "charStart": 560, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MGMT"}, {"duid": "PU:q99z", "entityType": "Gene", "charEnd": 315, "source": "PUBTATOR", "charStart": 275, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "O(6) -methylguanine DNA methyltransferase"}, {"duid": "PU:HnXS", "entityType": "Species", "charEnd": 1273, "source": "PUBTATOR", "charStart": 1266, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:hN3q", "entityType": "Gene", "charEnd": 189, "source": "PUBTATOR", "charStart": 149, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "O(6) -methylguanine DNA methyltransferase"}, {"duid": "PU:Azek", "entityType": "Gene", "charEnd": 1153, "source": "PUBTATOR", "charStart": 1150, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "MGMT"}, {"duid": "PU:5bnC", "entityType": "Chemical", "charEnd": 914, "source": "PUBTATOR", "charStart": 903, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 4, "entityText": "temozolomide"}, {"duid": "PU:gHoA", "entityType": "Species", "charEnd": 380, "source": "PUBTATOR", "charStart": 373, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:B3f5", "entityType": "Gene", "charEnd": 321, "source": "PUBTATOR", "charStart": 318, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "MGMT"}, {"duid": "PU:7xhR", "entityType": "Chemical", "charEnd": 1547, "source": "PUBTATOR", "charStart": 1536, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 9, "entityText": "temozolomide"}, {"duid": "PU:uDym", "entityType": "Gene", "charEnd": 610, "source": "PUBTATOR", "charStart": 607, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MGMT"}, {"duid": "PU:ibZJ", "entityType": "Chemical", "charEnd": 674, "source": "PUBTATOR", "charStart": 663, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 4, "entityText": "temozolomide"}, {"duid": "PU:GKrA", "entityType": "Gene", "charEnd": 1477, "source": "PUBTATOR", "charStart": 1474, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "MGMT"}, {"duid": "PU:AsyD", "entityType": "Disease", "charEnd": 1136, "source": "PUBTATOR", "charStart": 1134, "entityId": [{"idString": "D009190", "source": "MESH"}], "sentenceIndex": 6, "entityText": "MDS"}, {"duid": "PU:Dnm7", "entityType": "Disease", "charEnd": 430, "source": "PUBTATOR", "charStart": 408, "entityId": [{"idString": "D015470", "source": "MESH"}], "sentenceIndex": 2, "entityText": "acute myeloid leukaemia"}, {"duid": "PU:PXdu", "entityType": "Species", "charEnd": 600, "source": "PUBTATOR", "charStart": 593, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "Patients"}, {"duid": "PU:EBLz", "entityType": "Disease", "charEnd": 117, "source": "PUBTATOR", "charStart": 94, "entityId": [{"idString": "D009190", "source": "MESH"}], "sentenceIndex": 0, "entityText": "myelodysplastic syndrome"}, {"duid": "PU:vFDY", "entityType": "Chemical", "charEnd": 293, "source": "PUBTATOR", "charStart": 281, "entityId": [{"idString": "25305", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "methylguanine"}, {"duid": "PU:8owd", "entityType": "Chemical", "charEnd": 167, "source": "PUBTATOR", "charStart": 155, "entityId": [{"idString": "25305", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "methylguanine"}, {"duid": "PU:yLHL", "entityType": "Species", "charEnd": 704, "source": "PUBTATOR", "charStart": 697, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "Patients"}, {"duid": "PU:FhqQ", "entityType": "Chemical", "charEnd": 793, "source": "PUBTATOR", "charStart": 782, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 4, "entityText": "temozolomide"}, {"duid": "PU:Gnfc", "entityType": "Disease", "charEnd": 78, "source": "PUBTATOR", "charStart": 56, "entityId": [{"idString": "D015470", "source": "MESH"}], "sentenceIndex": 0, "entityText": "acute myeloid leukaemia"}, {"duid": "PU:GHDU", "entityType": "Disease", "charEnd": 479, "source": "PUBTATOR", "charStart": 477, "entityId": [{"idString": "D009190", "source": "MESH"}], "sentenceIndex": 2, "entityText": "MDS"}, {"duid": "PU:t5ce", "entityType": "Disease", "charEnd": 474, "source": "PUBTATOR", "charStart": 451, "entityId": [{"idString": "D009190", "source": "MESH"}], "sentenceIndex": 2, "entityText": "myelodysplastic syndrome"}]}
{"text": "In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant. Gemcitabine is a deoxycytidine (dCyd) analogue with activity against several solid cancers. Gemcitabine is activated by dCyd kinase (dCK) and interferes, as its triphosphate dFdCTP, with tumor growth through incorporation into DNA. Alternatively, the metabolite gemcitabine diphosphate (dFdCDP) can interfere with DNA synthesis and thus tumor growth through inhibition of ribonucleotide reductase. Gemcitabine can be inactivated by the enzyme dCyd deaminase (dCDA). In most in vitro models, resistance to gemcitabine was associated with a decreased dCK activity. In all these models, resistance was established using continuous exposure to gemcitabine with increasing concentrations; however, these in vitro models have limited clinical relevance. To develop in vivo resistance to gemcitabine, we treated mice bearing a moderately sensitive tumor Colon 26-A (T/C = 0.25) with a clinically relevant schedule (120 mg/kg every 3 days). By repeated transplant of the most resistant tumor and continuation of gemcitabine treatment for >1 year, the completely resistant tumor Colon 26-G (T/C = 0.96) was created. Initial studies focused on resistance mechanisms known from in vitro studies. In Colon 26-G, dCK activity was 1.7-fold decreased; dCDA and DNA polymerase were not changed; and Colon 26-G accumulated 1.5-fold less dFdCTP, 6 hours after a gemcitabine injection, than the parental tumor. Based on in vitro studies, these relative minor changes were considered insufficient to explain the completely resistant phenotype. Therefore, an expression microarray was done with Colon 26-A versus Colon 26-G. Using independently grown nonresistant and resistant tumors, a striking increase in expression of the RRM1 subunit gene was found in Colon 26-G. The expression of RRM1 mRNA was 25-fold increased in the resistant tumor, as measured by real-time PCR, which was confirmed by Western blotting. In contrast, RRM2 mRNA was 2-fold decreased. However, ribonucleotide reductase enzyme activity was only moderately increased in Colon 26-G. In conclusion, this is the first model with in vivo induced resistance to gemcitabine. In contrast to most in vitro studies, dCK activity was not the most important determinant of gemcitabine resistance. Expression microarray identified RRM1 as the gene with the highest increase in expression in the Colon 26-G, which might clarify its complete gemcitabine-resistant phenotype. This study is the first in vivo evidence for a key role for RRM1 in acquired gemcitabine resistance.", "title": {"charStart": 0, "charEnd": 142}, "docId": "16230416", "entity": [{"duid": "PU:FZxF", "entityType": "Chemical", "charEnd": 323, "source": "PUBTATOR", "charStart": 318, "entityId": [], "sentenceIndex": 2, "entityText": "dFdCTP"}, {"duid": "PU:Zu27", "entityType": "Chemical", "charEnd": 1469, "source": "PUBTATOR", "charStart": 1464, "entityId": [], "sentenceIndex": 10, "entityText": "dFdCTP"}, {"duid": "PU:baaH", "entityType": "Chemical", "charEnd": 552, "source": "PUBTATOR", "charStart": 542, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 4, "entityText": "Gemcitabine"}, {"duid": "PU:Hu5B", "entityType": "Gene", "charEnd": 279, "source": "PUBTATOR", "charStart": 277, "entityId": [{"idString": "43828", "source": "Entrez"}, {"idString": "7227", "source": "Tax"}], "sentenceIndex": 2, "entityText": "dCK"}, {"duid": "PU:cCuE", "entityType": "Chemical", "charEnd": 95, "source": "PUBTATOR", "charStart": 82, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "ribonucleotide"}, {"duid": "PU:3gNA", "entityType": "Gene", "charEnd": 2305, "source": "PUBTATOR", "charStart": 2303, "entityId": [{"idString": "43828", "source": "Entrez"}, {"idString": "7227", "source": "Tax"}], "sentenceIndex": 18, "entityText": "dCK"}, {"duid": "PU:4TkM", "entityType": "Chemical", "charEnd": 45, "source": "PUBTATOR", "charStart": 35, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gemcitabine"}, {"duid": "PU:LLxK", "entityType": "Chemical", "charEnd": 316, "source": "PUBTATOR", "charStart": 305, "entityId": [{"idString": "C005692", "source": "MESH"}], "sentenceIndex": 2, "entityText": "triphosphate"}, {"duid": "PU:Zgpd", "entityType": "Gene", "charEnd": 2418, "source": "PUBTATOR", "charStart": 2415, "entityId": [{"idString": "20133", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 19, "entityText": "RRM1"}, {"duid": "PU:xXCw", "entityType": "Chemical", "charEnd": 2644, "source": "PUBTATOR", "charStart": 2634, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 20, "entityText": "gemcitabine"}, {"duid": "PU:Howb", "entityType": "Chemical", "charEnd": 935, "source": "PUBTATOR", "charStart": 925, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 7, "entityText": "gemcitabine"}, {"duid": "PU:yCEz", "entityType": "Gene", "charEnd": 1914, "source": "PUBTATOR", "charStart": 1911, "entityId": [{"idString": "20133", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 14, "entityText": "RRM1"}, {"duid": "PU:iozS", "entityType": "Disease", "charEnd": 1533, "source": "PUBTATOR", "charStart": 1529, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumor"}, {"duid": "PU:pK6m", "entityType": "Disease", "charEnd": 485, "source": "PUBTATOR", "charStart": 481, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:7DoQ", "entityType": "Disease", "charEnd": 233, "source": "PUBTATOR", "charStart": 227, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cancers"}, {"duid": "PU:92tS", "entityType": "Disease", "charEnd": 989, "source": "PUBTATOR", "charStart": 985, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumor"}, {"duid": "PU:J3L5", "entityType": "Chemical", "charEnd": 659, "source": "PUBTATOR", "charStart": 649, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gemcitabine"}, {"duid": "PU:ZZHp", "entityType": "Gene", "charEnd": 1346, "source": "PUBTATOR", "charStart": 1344, "entityId": [{"idString": "43828", "source": "Entrez"}, {"idString": "7227", "source": "Tax"}], "sentenceIndex": 10, "entityText": "dCK"}, {"duid": "PU:bBZX", "entityType": "Chemical", "charEnd": 246, "source": "PUBTATOR", "charStart": 236, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 2, "entityText": "Gemcitabine"}, {"duid": "PU:fad8", "entityType": "Chemical", "charEnd": 428, "source": "PUBTATOR", "charStart": 406, "entityId": [], "sentenceIndex": 3, "entityText": "gemcitabine diphosphate"}, {"duid": "PU:vzb6", "entityType": "Chemical", "charEnd": 436, "source": "PUBTATOR", "charStart": 431, "entityId": [], "sentenceIndex": 3, "entityText": "dFdCDP"}, {"duid": "PU:p4oX", "entityType": "Chemical", "charEnd": 2534, "source": "PUBTATOR", "charStart": 2524, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 19, "entityText": "gemcitabine"}, {"duid": "PU:yxu9", "entityType": "Chemical", "charEnd": 2262, "source": "PUBTATOR", "charStart": 2252, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 17, "entityText": "gemcitabine"}, {"duid": "PU:Z6Mj", "entityType": "Disease", "charEnd": 335, "source": "PUBTATOR", "charStart": 331, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:KCxk", "entityType": "Chemical", "charEnd": 794, "source": "PUBTATOR", "charStart": 784, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gemcitabine"}, {"duid": "PU:imv3", "entityType": "Chemical", "charEnd": 2368, "source": "PUBTATOR", "charStart": 2358, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 18, "entityText": "gemcitabine"}, {"duid": "PU:hrvy", "entityType": "Chemical", "charEnd": 154, "source": "PUBTATOR", "charStart": 144, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Gemcitabine"}, {"duid": "PU:4Vq7", "entityType": "Gene", "charEnd": 2054, "source": "PUBTATOR", "charStart": 2051, "entityId": [{"idString": "20135", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 15, "entityText": "RRM2"}, {"duid": "PU:jEcs", "entityType": "Disease", "charEnd": 1126, "source": "PUBTATOR", "charStart": 1122, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "tumor"}, {"duid": "PU:QYTT", "entityType": "Disease", "charEnd": 1964, "source": "PUBTATOR", "charStart": 1960, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 14, "entityText": "tumor"}, {"duid": "PU:WMRF", "entityType": "Gene", "charEnd": 2620, "source": "PUBTATOR", "charStart": 2617, "entityId": [{"idString": "20133", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 20, "entityText": "RRM1"}, {"duid": "PU:KnPH", "entityType": "Disease", "charEnd": 1806, "source": "PUBTATOR", "charStart": 1801, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 13, "entityText": "tumors"}, {"duid": "PU:qjJF", "entityType": "Chemical", "charEnd": 1498, "source": "PUBTATOR", "charStart": 1488, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 10, "entityText": "gemcitabine"}, {"duid": "PU:HrJK", "entityType": "Species", "charEnd": 952, "source": "PUBTATOR", "charStart": 949, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "mice"}, {"duid": "PU:m3Q8", "entityType": "Chemical", "charEnd": 2105, "source": "PUBTATOR", "charStart": 2092, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 16, "entityText": "ribonucleotide"}, {"duid": "PU:TQaR", "entityType": "Chemical", "charEnd": 173, "source": "PUBTATOR", "charStart": 161, "entityId": [{"idString": "D003841", "source": "MESH"}], "sentenceIndex": 1, "entityText": "deoxycytidine"}, {"duid": "PU:Ay83", "entityType": "Gene", "charEnd": 1853, "source": "PUBTATOR", "charStart": 1850, "entityId": [{"idString": "20133", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 13, "entityText": "RRM1"}, {"duid": "PU:sRfN", "entityType": "Disease", "charEnd": 1212, "source": "PUBTATOR", "charStart": 1208, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "tumor"}, {"duid": "PU:hCsK", "entityType": "Chemical", "charEnd": 529, "source": "PUBTATOR", "charStart": 516, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 3, "entityText": "ribonucleotide"}, {"duid": "PU:3B5b", "entityType": "Gene", "charEnd": 695, "source": "PUBTATOR", "charStart": 693, "entityId": [{"idString": "43828", "source": "Entrez"}, {"idString": "7227", "source": "Tax"}], "sentenceIndex": 5, "entityText": "dCK"}, {"duid": "PU:aYD3", "entityType": "Chemical", "charEnd": 1158, "source": "PUBTATOR", "charStart": 1148, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gemcitabine"}]}
{"text": "Prognostic significance of BRCA1, ERCC1, RRM1, and RRM2 in patients with advanced non-small cell lung cancer receiving chemotherapy. The aim of this study was to examine the prognostic value of breast cancer susceptibility gene 1 (BRCA1), excision repair cross-complementation 1 (ERCC1), ribonucleotide reductase subunit M1 (RRM1), and ribonucleotide reductase subunit M2 (RRM2) in patients with advanced non-small cell lung cancer (NSCLC) who received platinum-based chemotherapy. A total of 214 patients with histologically or cytologically confirmed advanced NSCLC were enrolled in this study. The relative complementary DNA (cDNA) quantification for BRCA1, ERCC1, RRM1, and RRM2 was conducted using a fluorescence-based, real-time detection method, and \u03b2-actin was used as a reference gene. A strong correlation was observed between ERCC1 and RRM1 messenger RNA (mRNA) levels (P\u2009=\u20090.0385). There were inverse significant correlations between BRCA1 and ERCC1 (P\u2009<\u20090.0001) or RRM1 (P\u2009<\u20090.0001) mRNA levels. As BRCA1 levels increased, the probability of response increased (odds ratio [OR]\u2009=\u20090.49; P\u2009<\u20090.001) and the risk of progression (hazard ratio [HR]\u2009=\u20091.52; P\u2009=\u20090.034) and death (HR\u2009=\u20091.45; P\u2009=\u20090.024) decreased. As ERCC1, RRM1, and RRM2 levels increased, the probability of response decreased (ERCC1, OR\u2009=\u20090.42, P\u2009<\u20090.001; RRM1, OR\u2009=\u20090.85, P\u2009=\u20090.083; RRM2, OR\u2009=\u20090.42, P\u2009=\u20090.005) and the risk of progression (ERCC1, HR\u2009=\u20091.59, P\u2009=\u20090.002; RRM1, HR\u2009=\u20091.48, P\u2009=\u20090.039; RRM2, HR\u2009=\u20091.49, P\u2009=\u20090.041) and death (ERCC1, HR\u2009=\u20091.62, P\u2009=\u20090.008; RRM1, HR\u2009=\u20091.52, P\u2009=\u20090.023; RRM2, HR\u2009=\u20091.48, P\u2009=\u20090.017) increased. At multivariate analysis, low expression of ERCC1 was shown to be an independent predictive factor for response to chemotherapy (P\u2009=\u20090.018), time to progression (P\u2009=\u20090.025), and overall survival (P\u2009=\u20090.038). Furthermore, concomitant low expression levels of ERCC1, RRM1, and RRM2 and the high expression level of BRCA1 were predictive of a better outcome (P\u2009=\u20090.014). This study suggests that the efficacy of platinum-based chemotherapy can be improved when customized according to the mRNA expression of BRCA1, ERCC1, RRM1, and RRM2.", "title": {"charStart": 0, "charEnd": 131}, "docId": "25227663", "entity": [{"duid": "PU:quzr", "entityType": "Gene", "charEnd": 1572, "source": "PUBTATOR", "charStart": 1569, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM2"}, {"duid": "PU:TdrS", "entityType": "Disease", "charEnd": 206, "source": "PUBTATOR", "charStart": 194, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast cancer"}, {"duid": "PU:ebDK", "entityType": "Species", "charEnd": 66, "source": "PUBTATOR", "charStart": 59, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:kFkX", "entityType": "Disease", "charEnd": 1509, "source": "PUBTATOR", "charStart": 1505, "entityId": [{"idString": "D003643", "source": "MESH"}], "sentenceIndex": 7, "entityText": "death"}, {"duid": "PU:M2yk", "entityType": "Gene", "charEnd": 1227, "source": "PUBTATOR", "charStart": 1223, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:3XHi", "entityType": "Gene", "charEnd": 981, "source": "PUBTATOR", "charStart": 978, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "RRM1"}, {"duid": "PU:PgKE", "entityType": "Gene", "charEnd": 681, "source": "PUBTATOR", "charStart": 678, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "RRM2"}, {"duid": "PU:n8Yq", "entityType": "Gene", "charEnd": 31, "source": "PUBTATOR", "charStart": 27, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "BRCA1"}, {"duid": "PU:Jgfr", "entityType": "Gene", "charEnd": 54, "source": "PUBTATOR", "charStart": 51, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "RRM2"}, {"duid": "PU:bLAq", "entityType": "Gene", "charEnd": 658, "source": "PUBTATOR", "charStart": 654, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "BRCA1"}, {"duid": "PU:vdau", "entityType": "Disease", "charEnd": 1184, "source": "PUBTATOR", "charStart": 1180, "entityId": [{"idString": "D003643", "source": "MESH"}], "sentenceIndex": 6, "entityText": "death"}, {"duid": "PU:LcMG", "entityType": "Gene", "charEnd": 1656, "source": "PUBTATOR", "charStart": 1652, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:b7mM", "entityType": "Gene", "charEnd": 284, "source": "PUBTATOR", "charStart": 280, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:AB8F", "entityType": "Gene", "charEnd": 850, "source": "PUBTATOR", "charStart": 847, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RRM1"}, {"duid": "PU:8GRY", "entityType": "Gene", "charEnd": 1870, "source": "PUBTATOR", "charStart": 1866, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:KpWM", "entityType": "Gene", "charEnd": 1362, "source": "PUBTATOR", "charStart": 1359, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM2"}, {"duid": "PU:myYo", "entityType": "Disease", "charEnd": 107, "source": "PUBTATOR", "charStart": 82, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:ZJm4", "entityType": "Gene", "charEnd": 2140, "source": "PUBTATOR", "charStart": 2137, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "RRM2"}, {"duid": "PU:5PfU", "entityType": "Gene", "charEnd": 2124, "source": "PUBTATOR", "charStart": 2120, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:sxnQ", "entityType": "Gene", "charEnd": 376, "source": "PUBTATOR", "charStart": 373, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "RRM2"}, {"duid": "PU:xGSR", "entityType": "Species", "charEnd": 389, "source": "PUBTATOR", "charStart": 382, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:3kJr", "entityType": "Gene", "charEnd": 1476, "source": "PUBTATOR", "charStart": 1473, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM2"}, {"duid": "PU:EUWt", "entityType": "Species", "charEnd": 504, "source": "PUBTATOR", "charStart": 497, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:d2Mi", "entityType": "Gene", "charEnd": 1886, "source": "PUBTATOR", "charStart": 1883, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "RRM2"}, {"duid": "PU:ikLf", "entityType": "Gene", "charEnd": 1448, "source": "PUBTATOR", "charStart": 1445, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM1"}, {"duid": "PU:th4L", "entityType": "Gene", "charEnd": 665, "source": "PUBTATOR", "charStart": 661, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:vxXS", "entityType": "Chemical", "charEnd": 301, "source": "PUBTATOR", "charStart": 288, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "ribonucleotide"}, {"duid": "PU:LkQY", "entityType": "Gene", "charEnd": 841, "source": "PUBTATOR", "charStart": 837, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:YLbB", "entityType": "Gene", "charEnd": 960, "source": "PUBTATOR", "charStart": 956, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:RcwX", "entityType": "Gene", "charEnd": 328, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "RRM1"}, {"duid": "PU:RYdm", "entityType": "Gene", "charEnd": 1544, "source": "PUBTATOR", "charStart": 1541, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM1"}, {"duid": "PU:BtKP", "entityType": "Disease", "charEnd": 430, "source": "PUBTATOR", "charStart": 405, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small cell lung cancer"}, {"duid": "PU:PASp", "entityType": "Gene", "charEnd": 1233, "source": "PUBTATOR", "charStart": 1230, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM1"}, {"duid": "PU:B4j8", "entityType": "Gene", "charEnd": 1334, "source": "PUBTATOR", "charStart": 1331, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM1"}, {"duid": "PU:KEF7", "entityType": "Gene", "charEnd": 1016, "source": "PUBTATOR", "charStart": 1012, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "BRCA1"}, {"duid": "PU:z6H6", "entityType": "Gene", "charEnd": 1306, "source": "PUBTATOR", "charStart": 1302, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:x3Zf", "entityType": "Gene", "charEnd": 235, "source": "PUBTATOR", "charStart": 231, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "BRCA1"}, {"duid": "PU:Wn3H", "entityType": "Disease", "charEnd": 566, "source": "PUBTATOR", "charStart": 562, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "NSCLC"}, {"duid": "PU:PrZm", "entityType": "Gene", "charEnd": 950, "source": "PUBTATOR", "charStart": 946, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "BRCA1"}, {"duid": "PU:pyg4", "entityType": "Disease", "charEnd": 437, "source": "PUBTATOR", "charStart": 433, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:RWvs", "entityType": "Gene", "charEnd": 2117, "source": "PUBTATOR", "charStart": 2113, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "BRCA1"}, {"duid": "PU:Tehm", "entityType": "Gene", "charEnd": 1516, "source": "PUBTATOR", "charStart": 1512, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:hmnC", "entityType": "Gene", "charEnd": 671, "source": "PUBTATOR", "charStart": 668, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "RRM1"}, {"duid": "PU:oMUH", "entityType": "Gene", "charEnd": 1243, "source": "PUBTATOR", "charStart": 1240, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM2"}, {"duid": "PU:rRei", "entityType": "Gene", "charEnd": 1876, "source": "PUBTATOR", "charStart": 1873, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "RRM1"}, {"duid": "PU:Q8CW", "entityType": "Chemical", "charEnd": 349, "source": "PUBTATOR", "charStart": 336, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "ribonucleotide"}, {"duid": "PU:yUQ9", "entityType": "Chemical", "charEnd": 2024, "source": "PUBTATOR", "charStart": 2017, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 10, "entityText": "platinum"}, {"duid": "PU:g4km", "entityType": "Gene", "charEnd": 38, "source": "PUBTATOR", "charStart": 34, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:FHAG", "entityType": "Chemical", "charEnd": 460, "source": "PUBTATOR", "charStart": 453, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:H8z9", "entityType": "Gene", "charEnd": 2130, "source": "PUBTATOR", "charStart": 2127, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "RRM1"}, {"duid": "PU:ypUd", "entityType": "Gene", "charEnd": 1925, "source": "PUBTATOR", "charStart": 1921, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "BRCA1"}, {"duid": "PU:k6eK", "entityType": "Gene", "charEnd": 44, "source": "PUBTATOR", "charStart": 41, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "RRM1"}, {"duid": "PU:Z3Ty", "entityType": "Gene", "charEnd": 1420, "source": "PUBTATOR", "charStart": 1416, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}]}
{"text": "Prognostic significance of BRCA1, ERCC1, RRM1, and RRM2 in patients with advanced non-small cell lung cancer receiving chemotherapy. The aim of this study was to examine the prognostic value of breast cancer susceptibility gene 1 (BRCA1), excision repair cross-complementation 1 (ERCC1), ribonucleotide reductase subunit M1 (RRM1), and ribonucleotide reductase subunit M2 (RRM2) in patients with advanced non-small cell lung cancer (NSCLC) who received platinum-based chemotherapy. A total of 214 patients with histologically or cytologically confirmed advanced NSCLC were enrolled in this study. The relative complementary DNA (cDNA) quantification for BRCA1, ERCC1, RRM1, and RRM2 was conducted using a fluorescence-based, real-time detection method, and \u03b2-actin was used as a reference gene. A strong correlation was observed between ERCC1 and RRM1 messenger RNA (mRNA) levels (P\u2009=\u20090.0385). There were inverse significant correlations between BRCA1 and ERCC1 (P\u2009<\u20090.0001) or RRM1 (P\u2009<\u20090.0001) mRNA levels. As BRCA1 levels increased, the probability of response increased (odds ratio [OR]\u2009=\u20090.49; P\u2009<\u20090.001) and the risk of progression (hazard ratio [HR]\u2009=\u20091.52; P\u2009=\u20090.034) and death (HR\u2009=\u20091.45; P\u2009=\u20090.024) decreased. As ERCC1, RRM1, and RRM2 levels increased, the probability of response decreased (ERCC1, OR\u2009=\u20090.42, P\u2009<\u20090.001; RRM1, OR\u2009=\u20090.85, P\u2009=\u20090.083; RRM2, OR\u2009=\u20090.42, P\u2009=\u20090.005) and the risk of progression (ERCC1, HR\u2009=\u20091.59, P\u2009=\u20090.002; RRM1, HR\u2009=\u20091.48, P\u2009=\u20090.039; RRM2, HR\u2009=\u20091.49, P\u2009=\u20090.041) and death (ERCC1, HR\u2009=\u20091.62, P\u2009=\u20090.008; RRM1, HR\u2009=\u20091.52, P\u2009=\u20090.023; RRM2, HR\u2009=\u20091.48, P\u2009=\u20090.017) increased. At multivariate analysis, low expression of ERCC1 was shown to be an independent predictive factor for response to chemotherapy (P\u2009=\u20090.018), time to progression (P\u2009=\u20090.025), and overall survival (P\u2009=\u20090.038). Furthermore, concomitant low expression levels of ERCC1, RRM1, and RRM2 and the high expression level of BRCA1 were predictive of a better outcome (P\u2009=\u20090.014). This study suggests that the efficacy of platinum-based chemotherapy can be improved when customized according to the mRNA expression of BRCA1, ERCC1, RRM1, and RRM2.", "title": {"charStart": 0, "charEnd": 131}, "docId": "25227663", "entity": [{"duid": "PU:quzr", "entityType": "Gene", "charEnd": 1572, "source": "PUBTATOR", "charStart": 1569, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM2"}, {"duid": "PU:TdrS", "entityType": "Disease", "charEnd": 206, "source": "PUBTATOR", "charStart": 194, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast cancer"}, {"duid": "PU:ebDK", "entityType": "Species", "charEnd": 66, "source": "PUBTATOR", "charStart": 59, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:kFkX", "entityType": "Disease", "charEnd": 1509, "source": "PUBTATOR", "charStart": 1505, "entityId": [{"idString": "D003643", "source": "MESH"}], "sentenceIndex": 7, "entityText": "death"}, {"duid": "PU:M2yk", "entityType": "Gene", "charEnd": 1227, "source": "PUBTATOR", "charStart": 1223, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:3XHi", "entityType": "Gene", "charEnd": 981, "source": "PUBTATOR", "charStart": 978, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "RRM1"}, {"duid": "PU:PgKE", "entityType": "Gene", "charEnd": 681, "source": "PUBTATOR", "charStart": 678, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "RRM2"}, {"duid": "PU:n8Yq", "entityType": "Gene", "charEnd": 31, "source": "PUBTATOR", "charStart": 27, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "BRCA1"}, {"duid": "PU:Jgfr", "entityType": "Gene", "charEnd": 54, "source": "PUBTATOR", "charStart": 51, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "RRM2"}, {"duid": "PU:bLAq", "entityType": "Gene", "charEnd": 658, "source": "PUBTATOR", "charStart": 654, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "BRCA1"}, {"duid": "PU:vdau", "entityType": "Disease", "charEnd": 1184, "source": "PUBTATOR", "charStart": 1180, "entityId": [{"idString": "D003643", "source": "MESH"}], "sentenceIndex": 6, "entityText": "death"}, {"duid": "PU:LcMG", "entityType": "Gene", "charEnd": 1656, "source": "PUBTATOR", "charStart": 1652, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:b7mM", "entityType": "Gene", "charEnd": 284, "source": "PUBTATOR", "charStart": 280, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:AB8F", "entityType": "Gene", "charEnd": 850, "source": "PUBTATOR", "charStart": 847, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RRM1"}, {"duid": "PU:8GRY", "entityType": "Gene", "charEnd": 1870, "source": "PUBTATOR", "charStart": 1866, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:KpWM", "entityType": "Gene", "charEnd": 1362, "source": "PUBTATOR", "charStart": 1359, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM2"}, {"duid": "PU:myYo", "entityType": "Disease", "charEnd": 107, "source": "PUBTATOR", "charStart": 82, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:ZJm4", "entityType": "Gene", "charEnd": 2140, "source": "PUBTATOR", "charStart": 2137, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "RRM2"}, {"duid": "PU:5PfU", "entityType": "Gene", "charEnd": 2124, "source": "PUBTATOR", "charStart": 2120, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:sxnQ", "entityType": "Gene", "charEnd": 376, "source": "PUBTATOR", "charStart": 373, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "RRM2"}, {"duid": "PU:xGSR", "entityType": "Species", "charEnd": 389, "source": "PUBTATOR", "charStart": 382, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:3kJr", "entityType": "Gene", "charEnd": 1476, "source": "PUBTATOR", "charStart": 1473, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM2"}, {"duid": "PU:EUWt", "entityType": "Species", "charEnd": 504, "source": "PUBTATOR", "charStart": 497, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:d2Mi", "entityType": "Gene", "charEnd": 1886, "source": "PUBTATOR", "charStart": 1883, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "RRM2"}, {"duid": "PU:ikLf", "entityType": "Gene", "charEnd": 1448, "source": "PUBTATOR", "charStart": 1445, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM1"}, {"duid": "PU:th4L", "entityType": "Gene", "charEnd": 665, "source": "PUBTATOR", "charStart": 661, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:vxXS", "entityType": "Chemical", "charEnd": 301, "source": "PUBTATOR", "charStart": 288, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "ribonucleotide"}, {"duid": "PU:LkQY", "entityType": "Gene", "charEnd": 841, "source": "PUBTATOR", "charStart": 837, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:YLbB", "entityType": "Gene", "charEnd": 960, "source": "PUBTATOR", "charStart": 956, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:RcwX", "entityType": "Gene", "charEnd": 328, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "RRM1"}, {"duid": "PU:RYdm", "entityType": "Gene", "charEnd": 1544, "source": "PUBTATOR", "charStart": 1541, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM1"}, {"duid": "PU:BtKP", "entityType": "Disease", "charEnd": 430, "source": "PUBTATOR", "charStart": 405, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small cell lung cancer"}, {"duid": "PU:PASp", "entityType": "Gene", "charEnd": 1233, "source": "PUBTATOR", "charStart": 1230, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM1"}, {"duid": "PU:B4j8", "entityType": "Gene", "charEnd": 1334, "source": "PUBTATOR", "charStart": 1331, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM1"}, {"duid": "PU:KEF7", "entityType": "Gene", "charEnd": 1016, "source": "PUBTATOR", "charStart": 1012, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "BRCA1"}, {"duid": "PU:z6H6", "entityType": "Gene", "charEnd": 1306, "source": "PUBTATOR", "charStart": 1302, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:x3Zf", "entityType": "Gene", "charEnd": 235, "source": "PUBTATOR", "charStart": 231, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "BRCA1"}, {"duid": "PU:Wn3H", "entityType": "Disease", "charEnd": 566, "source": "PUBTATOR", "charStart": 562, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "NSCLC"}, {"duid": "PU:PrZm", "entityType": "Gene", "charEnd": 950, "source": "PUBTATOR", "charStart": 946, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "BRCA1"}, {"duid": "PU:pyg4", "entityType": "Disease", "charEnd": 437, "source": "PUBTATOR", "charStart": 433, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:RWvs", "entityType": "Gene", "charEnd": 2117, "source": "PUBTATOR", "charStart": 2113, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "BRCA1"}, {"duid": "PU:Tehm", "entityType": "Gene", "charEnd": 1516, "source": "PUBTATOR", "charStart": 1512, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:hmnC", "entityType": "Gene", "charEnd": 671, "source": "PUBTATOR", "charStart": 668, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "RRM1"}, {"duid": "PU:oMUH", "entityType": "Gene", "charEnd": 1243, "source": "PUBTATOR", "charStart": 1240, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM2"}, {"duid": "PU:rRei", "entityType": "Gene", "charEnd": 1876, "source": "PUBTATOR", "charStart": 1873, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "RRM1"}, {"duid": "PU:Q8CW", "entityType": "Chemical", "charEnd": 349, "source": "PUBTATOR", "charStart": 336, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "ribonucleotide"}, {"duid": "PU:yUQ9", "entityType": "Chemical", "charEnd": 2024, "source": "PUBTATOR", "charStart": 2017, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 10, "entityText": "platinum"}, {"duid": "PU:g4km", "entityType": "Gene", "charEnd": 38, "source": "PUBTATOR", "charStart": 34, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:FHAG", "entityType": "Chemical", "charEnd": 460, "source": "PUBTATOR", "charStart": 453, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:H8z9", "entityType": "Gene", "charEnd": 2130, "source": "PUBTATOR", "charStart": 2127, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "RRM1"}, {"duid": "PU:ypUd", "entityType": "Gene", "charEnd": 1925, "source": "PUBTATOR", "charStart": 1921, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "BRCA1"}, {"duid": "PU:k6eK", "entityType": "Gene", "charEnd": 44, "source": "PUBTATOR", "charStart": 41, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "RRM1"}, {"duid": "PU:Z3Ty", "entityType": "Gene", "charEnd": 1420, "source": "PUBTATOR", "charStart": 1416, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}]}
{"text": "O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma. Expression of the O(6)-methylguanine-DNA methyltransferase (MGMT) gene has been shown to correlate with clinical outcomes in patients with glioblastoma multiforme treated with alkylating agents. We evaluated MGMT protein expression in 53 primary glioblastomas by the immunohistochemistry (IHC) and analyzed the correlation between results of immunostaining and patient outcomes. There were 28 MGMT-immunopositive and 25 negative glioblastomas. Patients with MGMT-immunonegative glioblastomas showed significantly longer progression-free survival (PFS) (P = 0.0032), but no statistically significant benefits on overall survival (OS) (P = 0.0825) were shown. In 41 glioblastomas treated with temozolomide (TMZ) therapy (MGMT-immunopositive: n = 22, negative: n = 19), both PFS and OS were significantly better in MGMT-immunonegative glioblastomas. (PFS: P = 0.0015, OS: P = 0.0384). We conclude that MGMT expression on immunohistochemistry (IHC) correlates with outcomes in patients with primary glioblastoma receiving TMZ and suggest the use of MGMT-IHC as a surrogate marker for predicting tumor chemosensitivity.", "title": {"charStart": 0, "charEnd": 186}, "docId": "21331613", "entity": [{"duid": "PU:KBJw", "entityType": "Gene", "charEnd": 649, "source": "PUBTATOR", "charStart": 646, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MGMT"}, {"duid": "PU:7SVf", "entityType": "Gene", "charEnd": 37, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "O6-methylguanine DNA methyltransferase"}, {"duid": "PU:8dvn", "entityType": "Chemical", "charEnd": 15, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 0, "entityText": "O6-methylguanine"}, {"duid": "PU:JABF", "entityType": "Disease", "charEnd": 818, "source": "PUBTATOR", "charStart": 817, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 4, "entityText": "OS"}, {"duid": "PU:kfxh", "entityType": "Chemical", "charEnd": 1208, "source": "PUBTATOR", "charStart": 1206, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 7, "entityText": "TMZ"}, {"duid": "PU:r3Kr", "entityType": "Gene", "charEnd": 251, "source": "PUBTATOR", "charStart": 248, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "MGMT"}, {"duid": "PU:JbXY", "entityType": "Disease", "charEnd": 1283, "source": "PUBTATOR", "charStart": 1279, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumor"}, {"duid": "PU:Cy6o", "entityType": "Disease", "charEnd": 338, "source": "PUBTATOR", "charStart": 327, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 1, "entityText": "glioblastoma"}, {"duid": "PU:Kfqj", "entityType": "Disease", "charEnd": 1054, "source": "PUBTATOR", "charStart": 1053, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 6, "entityText": "OS"}, {"duid": "PU:QMLn", "entityType": "Gene", "charEnd": 1236, "source": "PUBTATOR", "charStart": 1233, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MGMT"}, {"duid": "PU:TeLB", "entityType": "Species", "charEnd": 639, "source": "PUBTATOR", "charStart": 632, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "Patients"}, {"duid": "PU:NbVg", "entityType": "Disease", "charEnd": 864, "source": "PUBTATOR", "charStart": 852, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 5, "entityText": "glioblastomas"}, {"duid": "PU:tCKs", "entityType": "Chemical", "charEnd": 890, "source": "PUBTATOR", "charStart": 879, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 5, "entityText": "temozolomide"}, {"duid": "PU:NXRj", "entityType": "Gene", "charEnd": 245, "source": "PUBTATOR", "charStart": 206, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "O(6)-methylguanine-DNA methyltransferase"}, {"duid": "PU:eq9w", "entityType": "Disease", "charEnd": 57, "source": "PUBTATOR", "charStart": 53, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 0, "entityText": "tumor"}, {"duid": "PU:9w7r", "entityType": "Gene", "charEnd": 910, "source": "PUBTATOR", "charStart": 907, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "MGMT"}, {"duid": "PU:knFV", "entityType": "Chemical", "charEnd": 895, "source": "PUBTATOR", "charStart": 893, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 5, "entityText": "TMZ"}, {"duid": "PU:q6RV", "entityType": "Species", "charEnd": 159, "source": "PUBTATOR", "charStart": 152, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:cdYX", "entityType": "Disease", "charEnd": 969, "source": "PUBTATOR", "charStart": 968, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 5, "entityText": "OS"}, {"duid": "PU:EuYW", "entityType": "Chemical", "charEnd": 223, "source": "PUBTATOR", "charStart": 206, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 1, "entityText": "O(6)-methylguanine"}, {"duid": "PU:R95c", "entityType": "Disease", "charEnd": 185, "source": "PUBTATOR", "charStart": 166, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 0, "entityText": "primary glioblastoma"}, {"duid": "PU:qEFm", "entityType": "Disease", "charEnd": 1194, "source": "PUBTATOR", "charStart": 1175, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 7, "entityText": "primary glioblastoma"}, {"duid": "PU:dZtt", "entityType": "Disease", "charEnd": 446, "source": "PUBTATOR", "charStart": 434, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 2, "entityText": "glioblastomas"}, {"duid": "PU:oCnm", "entityType": "Species", "charEnd": 320, "source": "PUBTATOR", "charStart": 313, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:pCk5", "entityType": "Disease", "charEnd": 814, "source": "PUBTATOR", "charStart": 799, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 4, "entityText": "overall survival"}, {"duid": "PU:NFKH", "entityType": "Gene", "charEnd": 1003, "source": "PUBTATOR", "charStart": 1000, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "MGMT"}, {"duid": "PU:jr6b", "entityType": "Chemical", "charEnd": 479, "source": "PUBTATOR", "charStart": 477, "entityId": [], "sentenceIndex": 2, "entityText": "IHC"}, {"duid": "PU:dzNM", "entityType": "Disease", "charEnd": 1032, "source": "PUBTATOR", "charStart": 1000, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 5, "entityText": "MGMT-immunonegative glioblastomas"}, {"duid": "PU:R4m2", "entityType": "Chemical", "charEnd": 139, "source": "PUBTATOR", "charStart": 128, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "temozolomide"}, {"duid": "PU:3XCR", "entityType": "Disease", "charEnd": 629, "source": "PUBTATOR", "charStart": 617, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 3, "entityText": "glioblastomas"}, {"duid": "PU:aNun", "entityType": "Gene", "charEnd": 584, "source": "PUBTATOR", "charStart": 581, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MGMT"}, {"duid": "PU:NPd6", "entityType": "Gene", "charEnd": 399, "source": "PUBTATOR", "charStart": 396, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "MGMT"}, {"duid": "PU:8BGv", "entityType": "Disease", "charEnd": 678, "source": "PUBTATOR", "charStart": 646, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 4, "entityText": "MGMT-immunonegative glioblastomas"}, {"duid": "PU:f5uR", "entityType": "Gene", "charEnd": 1090, "source": "PUBTATOR", "charStart": 1087, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MGMT"}, {"duid": "PU:oUec", "entityType": "Species", "charEnd": 555, "source": "PUBTATOR", "charStart": 549, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patient"}, {"duid": "PU:MK96", "entityType": "Species", "charEnd": 1168, "source": "PUBTATOR", "charStart": 1161, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}]}
{"text": "ERCC1 and RRM1 in the international adjuvant lung trial by automated quantitative in situ analysis. The excision repair cross completing group 1 gene product (ERCC1) and the regulatory subunit of ribonucleotide reductase (RRM1) have been reported as being prognostic of outcome and predictive of therapeutic efficacy in patients with non-small cell lung cancer. Routinely processed surgical specimens from 784 patients from the International Adjuvant Lung Trial were arrayed as tissue microarrays. In situ protein levels were scored with an automated, quantitative analysis system, dichotomized into high and low marker categories, and analyzed for associations with patients' characteristics, survival, and benefit from adjuvant chemotherapy. Scores for both markers were significantly associated with contributing center (P < 0.001) and skewed, with the bulk of scores being low. High scores were more frequent in women for ERCC1 and RRM1 and in older patients and those with adenocarcinoma for RRM1. Low ERCC1 scores indicated significant benefit from adjuvant chemotherapy [hazard ratio (HR) = 0.73 for chemotherapy versus control, P = 0.02]. Although all other survival associations were not statistically significant, low RRM1 scores trended to indicate benefit from adjuvant chemotherapy (HR = 0.84, P = 0.25), and ERCC1 scores were marginally prognostic of survival (HR = 0.77 for high versus low scores, P = 0.10). We conclude that contributing center and specimen quality substantially affect the levels of both markers. Future trials should incorporate the collection and processing of tumor specimens prospectively on standardized protocols to better reveal the impact of biomarkers on clinically relevant outcomes.", "title": {"charStart": 0, "charEnd": 98}, "docId": "21224045", "entity": [{"duid": "PU:aAW7", "entityType": "Gene", "charEnd": 1326, "source": "PUBTATOR", "charStart": 1322, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:9uG5", "entityType": "Species", "charEnd": 417, "source": "PUBTATOR", "charStart": 410, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:jHvY", "entityType": "Gene", "charEnd": 930, "source": "PUBTATOR", "charStart": 926, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:S5XN", "entityType": "Chemical", "charEnd": 209, "source": "PUBTATOR", "charStart": 196, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "ribonucleotide"}, {"duid": "PU:Krgi", "entityType": "Gene", "charEnd": 939, "source": "PUBTATOR", "charStart": 936, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "RRM1"}, {"duid": "PU:xQyg", "entityType": "Disease", "charEnd": 1601, "source": "PUBTATOR", "charStart": 1597, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumor"}, {"duid": "PU:8EFj", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:SMyQ", "entityType": "Species", "charEnd": 674, "source": "PUBTATOR", "charStart": 667, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:33A3", "entityType": "Disease", "charEnd": 991, "source": "PUBTATOR", "charStart": 978, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 5, "entityText": "adenocarcinoma"}, {"duid": "PU:VZsd", "entityType": "Gene", "charEnd": 13, "source": "PUBTATOR", "charStart": 10, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "RRM1"}, {"duid": "PU:yFGb", "entityType": "Gene", "charEnd": 163, "source": "PUBTATOR", "charStart": 159, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:CqVy", "entityType": "Gene", "charEnd": 225, "source": "PUBTATOR", "charStart": 222, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "RRM1"}, {"duid": "PU:r7jm", "entityType": "Gene", "charEnd": 1231, "source": "PUBTATOR", "charStart": 1228, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM1"}, {"duid": "PU:scHG", "entityType": "Gene", "charEnd": 1000, "source": "PUBTATOR", "charStart": 997, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "RRM1"}, {"duid": "PU:yf8s", "entityType": "Species", "charEnd": 327, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:owZC", "entityType": "Species", "charEnd": 961, "source": "PUBTATOR", "charStart": 954, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:vW8i", "entityType": "Disease", "charEnd": 359, "source": "PUBTATOR", "charStart": 334, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small cell lung cancer"}, {"duid": "PU:Sa9z", "entityType": "Gene", "charEnd": 1011, "source": "PUBTATOR", "charStart": 1007, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:NrQN", "entityType": "Species", "charEnd": 920, "source": "PUBTATOR", "charStart": 916, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "women"}]}
{"text": "ERCC1 and RRM1 in the international adjuvant lung trial by automated quantitative in situ analysis. The excision repair cross completing group 1 gene product (ERCC1) and the regulatory subunit of ribonucleotide reductase (RRM1) have been reported as being prognostic of outcome and predictive of therapeutic efficacy in patients with non-small cell lung cancer. Routinely processed surgical specimens from 784 patients from the International Adjuvant Lung Trial were arrayed as tissue microarrays. In situ protein levels were scored with an automated, quantitative analysis system, dichotomized into high and low marker categories, and analyzed for associations with patients' characteristics, survival, and benefit from adjuvant chemotherapy. Scores for both markers were significantly associated with contributing center (P < 0.001) and skewed, with the bulk of scores being low. High scores were more frequent in women for ERCC1 and RRM1 and in older patients and those with adenocarcinoma for RRM1. Low ERCC1 scores indicated significant benefit from adjuvant chemotherapy [hazard ratio (HR) = 0.73 for chemotherapy versus control, P = 0.02]. Although all other survival associations were not statistically significant, low RRM1 scores trended to indicate benefit from adjuvant chemotherapy (HR = 0.84, P = 0.25), and ERCC1 scores were marginally prognostic of survival (HR = 0.77 for high versus low scores, P = 0.10). We conclude that contributing center and specimen quality substantially affect the levels of both markers. Future trials should incorporate the collection and processing of tumor specimens prospectively on standardized protocols to better reveal the impact of biomarkers on clinically relevant outcomes.", "title": {"charStart": 0, "charEnd": 98}, "docId": "21224045", "entity": [{"duid": "PU:aAW7", "entityType": "Gene", "charEnd": 1326, "source": "PUBTATOR", "charStart": 1322, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:9uG5", "entityType": "Species", "charEnd": 417, "source": "PUBTATOR", "charStart": 410, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:jHvY", "entityType": "Gene", "charEnd": 930, "source": "PUBTATOR", "charStart": 926, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:S5XN", "entityType": "Chemical", "charEnd": 209, "source": "PUBTATOR", "charStart": 196, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "ribonucleotide"}, {"duid": "PU:Krgi", "entityType": "Gene", "charEnd": 939, "source": "PUBTATOR", "charStart": 936, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "RRM1"}, {"duid": "PU:xQyg", "entityType": "Disease", "charEnd": 1601, "source": "PUBTATOR", "charStart": 1597, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumor"}, {"duid": "PU:8EFj", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:SMyQ", "entityType": "Species", "charEnd": 674, "source": "PUBTATOR", "charStart": 667, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:33A3", "entityType": "Disease", "charEnd": 991, "source": "PUBTATOR", "charStart": 978, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 5, "entityText": "adenocarcinoma"}, {"duid": "PU:VZsd", "entityType": "Gene", "charEnd": 13, "source": "PUBTATOR", "charStart": 10, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "RRM1"}, {"duid": "PU:yFGb", "entityType": "Gene", "charEnd": 163, "source": "PUBTATOR", "charStart": 159, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:CqVy", "entityType": "Gene", "charEnd": 225, "source": "PUBTATOR", "charStart": 222, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "RRM1"}, {"duid": "PU:r7jm", "entityType": "Gene", "charEnd": 1231, "source": "PUBTATOR", "charStart": 1228, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM1"}, {"duid": "PU:scHG", "entityType": "Gene", "charEnd": 1000, "source": "PUBTATOR", "charStart": 997, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "RRM1"}, {"duid": "PU:yf8s", "entityType": "Species", "charEnd": 327, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:owZC", "entityType": "Species", "charEnd": 961, "source": "PUBTATOR", "charStart": 954, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:vW8i", "entityType": "Disease", "charEnd": 359, "source": "PUBTATOR", "charStart": 334, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small cell lung cancer"}, {"duid": "PU:Sa9z", "entityType": "Gene", "charEnd": 1011, "source": "PUBTATOR", "charStart": 1007, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:NrQN", "entityType": "Species", "charEnd": 920, "source": "PUBTATOR", "charStart": 916, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "women"}]}
{"text": "Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients. PURPOSE: The aim of this study is to evaluate the effect of excision repair cross-complementation group 1 (ERCC1) expression on treatment outcomes in advanced biliary tract adenocarcinoma (ABTA) patients treated with platinum-based chemotherapy. METHODS: One hundred and six patients with histologically confirmed adenocarcinoma of biliary tract were enrolled at 5 institutions in South Korea between January 2002 and September 2008. Of 106 patients, 93 were assessed by immunohistochemistry from tissue specimens. Sixty-five patients were treated with cisplatin-based regimens and the other 28 treated with oxaliplatin-based ones. RESULTS: For total study population, no significant differences were noted in progression-free survival (PFS) and overall survival (OS) between ERCC1-negative and ERCC1-positive patients, respectively (4.2 vs. 2.9\u00a0months, p\u00a0=\u00a00.116; 7.0 vs. 7.8\u00a0months, p\u00a0=\u00a00.143). In patients treated with cisplatin-based regimens, median PFS and OS were significantly longer in ERCC1-negative group than in ERCC1-positive group, respectively (4.6 vs. 1.9\u00a0months, p\u00a0=\u00a00.014; 9.1 vs. 7.9\u00a0months, p\u00a0=\u00a00.017). Disease control rate (DCR) was better in patients with ERCC1 negative than in patients with ERCC1 positive (p\u00a0=\u00a00.048). On the other hand, in patients treated with oxaliplatin-containing regimens, median PFS and OS tended to be longer in ERCC1-positive group, but these did not reach statistical significances. Response rate was better in patients with ERCC1 positive (p\u00a0=\u00a00.005). CONCLUSIONS: ERCC1 shows a significant prognostic value in ABTA patients treated with cisplatin. A survival benefit was observed in ERCC1-negative patients from cisplatin-containing chemotherapy but not from oxaliplatin-containing ones. The action mechanism of ERCC1 on cisplatin may be different from that on oxaliplatin.", "title": {"charStart": 0, "charEnd": 143}, "docId": "21298384", "entity": [{"duid": "PU:HFx4", "entityType": "Chemical", "charEnd": 369, "source": "PUBTATOR", "charStart": 362, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:EEoM", "entityType": "Gene", "charEnd": 1364, "source": "PUBTATOR", "charStart": 1360, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:UQkw", "entityType": "Disease", "charEnd": 133, "source": "PUBTATOR", "charStart": 97, "entityId": [{"idString": "D001661", "source": "MESH"}], "sentenceIndex": 0, "entityText": "advanced biliary tract adenocarcinoma"}, {"duid": "PU:5mCJ", "entityType": "Chemical", "charEnd": 1867, "source": "PUBTATOR", "charStart": 1857, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 11, "entityText": "oxaliplatin"}, {"duid": "PU:9pKD", "entityType": "Chemical", "charEnd": 1442, "source": "PUBTATOR", "charStart": 1432, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 8, "entityText": "oxaliplatin"}, {"duid": "PU:GpWP", "entityType": "Species", "charEnd": 593, "source": "PUBTATOR", "charStart": 586, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:ysKs", "entityType": "Chemical", "charEnd": 1075, "source": "PUBTATOR", "charStart": 1067, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 6, "entityText": "cisplatin"}, {"duid": "PU:r2Vs", "entityType": "Species", "charEnd": 1614, "source": "PUBTATOR", "charStart": 1607, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:k87d", "entityType": "Disease", "charEnd": 906, "source": "PUBTATOR", "charStart": 891, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 5, "entityText": "overall survival"}, {"duid": "PU:QHCP", "entityType": "Gene", "charEnd": 1914, "source": "PUBTATOR", "charStart": 1910, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "ERCC1"}, {"duid": "PU:K3ee", "entityType": "Chemical", "charEnd": 1927, "source": "PUBTATOR", "charStart": 1919, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 12, "entityText": "cisplatin"}, {"duid": "PU:DBPF", "entityType": "Gene", "charEnd": 256, "source": "PUBTATOR", "charStart": 252, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:WXf5", "entityType": "Species", "charEnd": 1803, "source": "PUBTATOR", "charStart": 1796, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:6pZk", "entityType": "Disease", "charEnd": 331, "source": "PUBTATOR", "charStart": 295, "entityId": [{"idString": "D001661", "source": "MESH"}], "sentenceIndex": 1, "entityText": "advanced biliary tract adenocarcinoma"}, {"duid": "PU:Hwj7", "entityType": "Gene", "charEnd": 1173, "source": "PUBTATOR", "charStart": 1169, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:Xwv2", "entityType": "Gene", "charEnd": 31, "source": "PUBTATOR", "charStart": 27, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:7RY8", "entityType": "Chemical", "charEnd": 706, "source": "PUBTATOR", "charStart": 698, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 4, "entityText": "cisplatin"}, {"duid": "PU:ptsB", "entityType": "Gene", "charEnd": 1666, "source": "PUBTATOR", "charStart": 1662, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:7ECT", "entityType": "Species", "charEnd": 1052, "source": "PUBTATOR", "charStart": 1045, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:eHnC", "entityType": "Species", "charEnd": 962, "source": "PUBTATOR", "charStart": 955, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:yY63", "entityType": "Chemical", "charEnd": 1969, "source": "PUBTATOR", "charStart": 1959, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 12, "entityText": "oxaliplatin"}, {"duid": "PU:i6gC", "entityType": "Disease", "charEnd": 472, "source": "PUBTATOR", "charStart": 459, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 2, "entityText": "adenocarcinoma"}, {"duid": "PU:mFNe", "entityType": "Species", "charEnd": 347, "source": "PUBTATOR", "charStart": 340, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:dc3U", "entityType": "Chemical", "charEnd": 1743, "source": "PUBTATOR", "charStart": 1735, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 10, "entityText": "cisplatin"}, {"duid": "PU:tnC3", "entityType": "Species", "charEnd": 1353, "source": "PUBTATOR", "charStart": 1346, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:yd7x", "entityType": "Gene", "charEnd": 925, "source": "PUBTATOR", "charStart": 921, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:u28r", "entityType": "Disease", "charEnd": 1109, "source": "PUBTATOR", "charStart": 1108, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 6, "entityText": "OS"}, {"duid": "PU:QpMe", "entityType": "Species", "charEnd": 1417, "source": "PUBTATOR", "charStart": 1410, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:tzZc", "entityType": "Gene", "charEnd": 1510, "source": "PUBTATOR", "charStart": 1506, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:FVEZ", "entityType": "Disease", "charEnd": 337, "source": "PUBTATOR", "charStart": 334, "entityId": [{"idString": "D001661", "source": "MESH"}], "sentenceIndex": 1, "entityText": "ABTA"}, {"duid": "PU:HYEX", "entityType": "Species", "charEnd": 678, "source": "PUBTATOR", "charStart": 671, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:RYZW", "entityType": "Species", "charEnd": 427, "source": "PUBTATOR", "charStart": 420, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:VSwx", "entityType": "Species", "charEnd": 142, "source": "PUBTATOR", "charStart": 135, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:7kKi", "entityType": "Gene", "charEnd": 1785, "source": "PUBTATOR", "charStart": 1781, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ERCC1"}, {"duid": "PU:FmJV", "entityType": "Disease", "charEnd": 1711, "source": "PUBTATOR", "charStart": 1708, "entityId": [{"idString": "D001661", "source": "MESH"}], "sentenceIndex": 10, "entityText": "ABTA"}, {"duid": "PU:zfC3", "entityType": "Species", "charEnd": 1316, "source": "PUBTATOR", "charStart": 1309, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:Q39T", "entityType": "Chemical", "charEnd": 85, "source": "PUBTATOR", "charStart": 78, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 0, "entityText": "platinum"}, {"duid": "PU:vQqZ", "entityType": "Gene", "charEnd": 1144, "source": "PUBTATOR", "charStart": 1140, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:sb2E", "entityType": "Gene", "charEnd": 249, "source": "PUBTATOR", "charStart": 205, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementation group 1"}, {"duid": "PU:NkQE", "entityType": "Gene", "charEnd": 944, "source": "PUBTATOR", "charStart": 940, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:pEyy", "entityType": "Chemical", "charEnd": 763, "source": "PUBTATOR", "charStart": 753, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 4, "entityText": "oxaliplatin"}, {"duid": "PU:ECaD", "entityType": "Species", "charEnd": 1720, "source": "PUBTATOR", "charStart": 1713, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:kANY", "entityType": "Gene", "charEnd": 1327, "source": "PUBTATOR", "charStart": 1323, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:qpMw", "entityType": "Disease", "charEnd": 910, "source": "PUBTATOR", "charStart": 909, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 5, "entityText": "OS"}, {"duid": "PU:vJCm", "entityType": "Chemical", "charEnd": 1818, "source": "PUBTATOR", "charStart": 1810, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 11, "entityText": "cisplatin"}, {"duid": "PU:krnv", "entityType": "Disease", "charEnd": 1481, "source": "PUBTATOR", "charStart": 1480, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 8, "entityText": "OS"}, {"duid": "PU:zVkY", "entityType": "Gene", "charEnd": 1625, "source": "PUBTATOR", "charStart": 1621, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}]}
{"text": "Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients. PURPOSE: The aim of this study is to evaluate the effect of excision repair cross-complementation group 1 (ERCC1) expression on treatment outcomes in advanced biliary tract adenocarcinoma (ABTA) patients treated with platinum-based chemotherapy. METHODS: One hundred and six patients with histologically confirmed adenocarcinoma of biliary tract were enrolled at 5 institutions in South Korea between January 2002 and September 2008. Of 106 patients, 93 were assessed by immunohistochemistry from tissue specimens. Sixty-five patients were treated with cisplatin-based regimens and the other 28 treated with oxaliplatin-based ones. RESULTS: For total study population, no significant differences were noted in progression-free survival (PFS) and overall survival (OS) between ERCC1-negative and ERCC1-positive patients, respectively (4.2 vs. 2.9\u00a0months, p\u00a0=\u00a00.116; 7.0 vs. 7.8\u00a0months, p\u00a0=\u00a00.143). In patients treated with cisplatin-based regimens, median PFS and OS were significantly longer in ERCC1-negative group than in ERCC1-positive group, respectively (4.6 vs. 1.9\u00a0months, p\u00a0=\u00a00.014; 9.1 vs. 7.9\u00a0months, p\u00a0=\u00a00.017). Disease control rate (DCR) was better in patients with ERCC1 negative than in patients with ERCC1 positive (p\u00a0=\u00a00.048). On the other hand, in patients treated with oxaliplatin-containing regimens, median PFS and OS tended to be longer in ERCC1-positive group, but these did not reach statistical significances. Response rate was better in patients with ERCC1 positive (p\u00a0=\u00a00.005). CONCLUSIONS: ERCC1 shows a significant prognostic value in ABTA patients treated with cisplatin. A survival benefit was observed in ERCC1-negative patients from cisplatin-containing chemotherapy but not from oxaliplatin-containing ones. The action mechanism of ERCC1 on cisplatin may be different from that on oxaliplatin.", "title": {"charStart": 0, "charEnd": 143}, "docId": "21298384", "entity": [{"duid": "PU:HFx4", "entityType": "Chemical", "charEnd": 369, "source": "PUBTATOR", "charStart": 362, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:EEoM", "entityType": "Gene", "charEnd": 1364, "source": "PUBTATOR", "charStart": 1360, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:UQkw", "entityType": "Disease", "charEnd": 133, "source": "PUBTATOR", "charStart": 97, "entityId": [{"idString": "D001661", "source": "MESH"}], "sentenceIndex": 0, "entityText": "advanced biliary tract adenocarcinoma"}, {"duid": "PU:5mCJ", "entityType": "Chemical", "charEnd": 1867, "source": "PUBTATOR", "charStart": 1857, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 11, "entityText": "oxaliplatin"}, {"duid": "PU:9pKD", "entityType": "Chemical", "charEnd": 1442, "source": "PUBTATOR", "charStart": 1432, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 8, "entityText": "oxaliplatin"}, {"duid": "PU:GpWP", "entityType": "Species", "charEnd": 593, "source": "PUBTATOR", "charStart": 586, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:ysKs", "entityType": "Chemical", "charEnd": 1075, "source": "PUBTATOR", "charStart": 1067, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 6, "entityText": "cisplatin"}, {"duid": "PU:r2Vs", "entityType": "Species", "charEnd": 1614, "source": "PUBTATOR", "charStart": 1607, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:k87d", "entityType": "Disease", "charEnd": 906, "source": "PUBTATOR", "charStart": 891, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 5, "entityText": "overall survival"}, {"duid": "PU:QHCP", "entityType": "Gene", "charEnd": 1914, "source": "PUBTATOR", "charStart": 1910, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "ERCC1"}, {"duid": "PU:K3ee", "entityType": "Chemical", "charEnd": 1927, "source": "PUBTATOR", "charStart": 1919, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 12, "entityText": "cisplatin"}, {"duid": "PU:DBPF", "entityType": "Gene", "charEnd": 256, "source": "PUBTATOR", "charStart": 252, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:WXf5", "entityType": "Species", "charEnd": 1803, "source": "PUBTATOR", "charStart": 1796, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:6pZk", "entityType": "Disease", "charEnd": 331, "source": "PUBTATOR", "charStart": 295, "entityId": [{"idString": "D001661", "source": "MESH"}], "sentenceIndex": 1, "entityText": "advanced biliary tract adenocarcinoma"}, {"duid": "PU:Hwj7", "entityType": "Gene", "charEnd": 1173, "source": "PUBTATOR", "charStart": 1169, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:Xwv2", "entityType": "Gene", "charEnd": 31, "source": "PUBTATOR", "charStart": 27, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:7RY8", "entityType": "Chemical", "charEnd": 706, "source": "PUBTATOR", "charStart": 698, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 4, "entityText": "cisplatin"}, {"duid": "PU:ptsB", "entityType": "Gene", "charEnd": 1666, "source": "PUBTATOR", "charStart": 1662, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:7ECT", "entityType": "Species", "charEnd": 1052, "source": "PUBTATOR", "charStart": 1045, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:eHnC", "entityType": "Species", "charEnd": 962, "source": "PUBTATOR", "charStart": 955, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:yY63", "entityType": "Chemical", "charEnd": 1969, "source": "PUBTATOR", "charStart": 1959, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 12, "entityText": "oxaliplatin"}, {"duid": "PU:i6gC", "entityType": "Disease", "charEnd": 472, "source": "PUBTATOR", "charStart": 459, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 2, "entityText": "adenocarcinoma"}, {"duid": "PU:mFNe", "entityType": "Species", "charEnd": 347, "source": "PUBTATOR", "charStart": 340, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:dc3U", "entityType": "Chemical", "charEnd": 1743, "source": "PUBTATOR", "charStart": 1735, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 10, "entityText": "cisplatin"}, {"duid": "PU:tnC3", "entityType": "Species", "charEnd": 1353, "source": "PUBTATOR", "charStart": 1346, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:yd7x", "entityType": "Gene", "charEnd": 925, "source": "PUBTATOR", "charStart": 921, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:u28r", "entityType": "Disease", "charEnd": 1109, "source": "PUBTATOR", "charStart": 1108, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 6, "entityText": "OS"}, {"duid": "PU:QpMe", "entityType": "Species", "charEnd": 1417, "source": "PUBTATOR", "charStart": 1410, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:tzZc", "entityType": "Gene", "charEnd": 1510, "source": "PUBTATOR", "charStart": 1506, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:FVEZ", "entityType": "Disease", "charEnd": 337, "source": "PUBTATOR", "charStart": 334, "entityId": [{"idString": "D001661", "source": "MESH"}], "sentenceIndex": 1, "entityText": "ABTA"}, {"duid": "PU:HYEX", "entityType": "Species", "charEnd": 678, "source": "PUBTATOR", "charStart": 671, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:RYZW", "entityType": "Species", "charEnd": 427, "source": "PUBTATOR", "charStart": 420, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:VSwx", "entityType": "Species", "charEnd": 142, "source": "PUBTATOR", "charStart": 135, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:7kKi", "entityType": "Gene", "charEnd": 1785, "source": "PUBTATOR", "charStart": 1781, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ERCC1"}, {"duid": "PU:FmJV", "entityType": "Disease", "charEnd": 1711, "source": "PUBTATOR", "charStart": 1708, "entityId": [{"idString": "D001661", "source": "MESH"}], "sentenceIndex": 10, "entityText": "ABTA"}, {"duid": "PU:zfC3", "entityType": "Species", "charEnd": 1316, "source": "PUBTATOR", "charStart": 1309, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:Q39T", "entityType": "Chemical", "charEnd": 85, "source": "PUBTATOR", "charStart": 78, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 0, "entityText": "platinum"}, {"duid": "PU:vQqZ", "entityType": "Gene", "charEnd": 1144, "source": "PUBTATOR", "charStart": 1140, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:sb2E", "entityType": "Gene", "charEnd": 249, "source": "PUBTATOR", "charStart": 205, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementation group 1"}, {"duid": "PU:NkQE", "entityType": "Gene", "charEnd": 944, "source": "PUBTATOR", "charStart": 940, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:pEyy", "entityType": "Chemical", "charEnd": 763, "source": "PUBTATOR", "charStart": 753, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 4, "entityText": "oxaliplatin"}, {"duid": "PU:ECaD", "entityType": "Species", "charEnd": 1720, "source": "PUBTATOR", "charStart": 1713, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:kANY", "entityType": "Gene", "charEnd": 1327, "source": "PUBTATOR", "charStart": 1323, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:qpMw", "entityType": "Disease", "charEnd": 910, "source": "PUBTATOR", "charStart": 909, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 5, "entityText": "OS"}, {"duid": "PU:vJCm", "entityType": "Chemical", "charEnd": 1818, "source": "PUBTATOR", "charStart": 1810, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 11, "entityText": "cisplatin"}, {"duid": "PU:krnv", "entityType": "Disease", "charEnd": 1481, "source": "PUBTATOR", "charStart": 1480, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 8, "entityText": "OS"}, {"duid": "PU:zVkY", "entityType": "Gene", "charEnd": 1625, "source": "PUBTATOR", "charStart": 1621, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}]}
{"text": "ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer. BACKGROUND: Platinum-based therapy is pivotal to the treatment of advanced non-small cell lung Cancer (NSCLC). Excision repair cross-complementation group 1 (ERCC1) is a key component of the platinum-DNA repair machinery responsible for nucleotide excision repair. We sought to determine the influence of ERCC1 mRNA expression in advanced NSCLC on chemotherapy response, toxicity, and survival after platinum-based chemotherapy. METHODS: Patients randomized to a phase III trial of platinum-based chemotherapy were eligible for inclusion. Formalin-fixed paraffin-embedded tumor biopsies were retrieved for mRNA extraction and purification before quantitative real-time polymerase chain reaction analysis using Taqman technology. Expression data were correlated with treatment response, toxicity, and overall survival. RESULTS: Sixty-six patients were enrolled. No statistically significant relationship existed between ERCC1 mRNA expression and response to chemotherapy (p = 0.794) or hematological toxicity. No statistically significant difference in median survival was demonstrated according to ERCC1 expression (high expression, 415 days, 95% confidence interval [95%CI]: 197-633 days; low expression, 327 days [95%CI: 211-433 days]; p = 0.801). High ERCC1 mRNA expression was associated with a hazard ratio for death of 0.96 (95% CI 0.919-1.004; p = 0.08). CONCLUSION: In contrast to recent publications, ERCC1 mRNA expression in our study did not favor a prognostically better outcome after platinum-based chemotherapy in advanced NSCLC. We explore potential reasons for this, including the need for cautious interpretation of mRNA expression data from archival materials and highlight the need for additional translational research linking gene expression with a promising ERCC1 polymorphism.", "title": {"charStart": 0, "charEnd": 148}, "docId": "17909351", "entity": [{"duid": "PU:pWdX", "entityType": "Gene", "charEnd": 1934, "source": "PUBTATOR", "charStart": 1930, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "ERCC1"}, {"duid": "PU:EuZa", "entityType": "Chemical", "charEnd": 169, "source": "PUBTATOR", "charStart": 162, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Platinum"}, {"duid": "PU:wGTT", "entityType": "Disease", "charEnd": 528, "source": "PUBTATOR", "charStart": 521, "entityId": [{"idString": "D064420", "source": "MESH"}], "sentenceIndex": 3, "entityText": "toxicity"}, {"duid": "PU:4oC6", "entityType": "Chemical", "charEnd": 348, "source": "PUBTATOR", "charStart": 341, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 2, "entityText": "platinum"}, {"duid": "PU:EZ5r", "entityType": "Gene", "charEnd": 1564, "source": "PUBTATOR", "charStart": 1560, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ERCC1"}, {"duid": "PU:YKuL", "entityType": "Disease", "charEnd": 257, "source": "PUBTATOR", "charStart": 253, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:yiRz", "entityType": "Species", "charEnd": 994, "source": "PUBTATOR", "charStart": 987, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:Lq2D", "entityType": "Disease", "charEnd": 147, "source": "PUBTATOR", "charStart": 122, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:z6UX", "entityType": "Disease", "charEnd": 250, "source": "PUBTATOR", "charStart": 225, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small cell lung Cancer"}, {"duid": "PU:nj8u", "entityType": "Chemical", "charEnd": 1654, "source": "PUBTATOR", "charStart": 1647, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 11, "entityText": "platinum"}, {"duid": "PU:bn5q", "entityType": "Gene", "charEnd": 1409, "source": "PUBTATOR", "charStart": 1405, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:iNTf", "entityType": "Chemical", "charEnd": 639, "source": "PUBTATOR", "charStart": 632, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 4, "entityText": "platinum"}, {"duid": "PU:Awew", "entityType": "Gene", "charEnd": 305, "source": "PUBTATOR", "charStart": 261, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "Excision repair cross-complementation group 1"}, {"duid": "PU:gizt", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:Ke7j", "entityType": "Chemical", "charEnd": 557, "source": "PUBTATOR", "charStart": 550, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 3, "entityText": "platinum"}, {"duid": "PU:CNfV", "entityType": "Gene", "charEnd": 1073, "source": "PUBTATOR", "charStart": 1069, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:WsaM", "entityType": "Disease", "charEnd": 493, "source": "PUBTATOR", "charStart": 489, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "NSCLC"}, {"duid": "PU:dExE", "entityType": "Disease", "charEnd": 726, "source": "PUBTATOR", "charStart": 722, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumor"}, {"duid": "PU:q37j", "entityType": "Gene", "charEnd": 459, "source": "PUBTATOR", "charStart": 455, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:TVSY", "entityType": "Species", "charEnd": 595, "source": "PUBTATOR", "charStart": 588, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "Patients"}, {"duid": "PU:N4af", "entityType": "Disease", "charEnd": 943, "source": "PUBTATOR", "charStart": 936, "entityId": [{"idString": "D064420", "source": "MESH"}], "sentenceIndex": 6, "entityText": "toxicity"}, {"duid": "PU:nLoQ", "entityType": "Gene", "charEnd": 312, "source": "PUBTATOR", "charStart": 308, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:ohsD", "entityType": "Chemical", "charEnd": 396, "source": "PUBTATOR", "charStart": 387, "entityId": [{"idString": "36976", "source": "CHEBI"}], "sentenceIndex": 2, "entityText": "nucleotide"}, {"duid": "PU:YN8W", "entityType": "Chemical", "charEnd": 80, "source": "PUBTATOR", "charStart": 73, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 0, "entityText": "platinum"}, {"duid": "PU:cbzx", "entityType": "Disease", "charEnd": 1156, "source": "PUBTATOR", "charStart": 1149, "entityId": [{"idString": "D064420", "source": "MESH"}], "sentenceIndex": 8, "entityText": "toxicity"}, {"duid": "PU:j85s", "entityType": "Disease", "charEnd": 1691, "source": "PUBTATOR", "charStart": 1687, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 11, "entityText": "NSCLC"}, {"duid": "PU:NDLf", "entityType": "Gene", "charEnd": 1252, "source": "PUBTATOR", "charStart": 1248, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}]}
{"text": "Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line. PURPOSE: The chemoresistance of human hepatocellular carcinoma (HCC) to cytotoxic drugs, especially intrinsic or acquired multidrug resistance (MDR), still remains a major challenge in the management of HCC. In the present study, possible mechanisms involved in MDR of HCC were identified using a 5-fluorouracil (5-FU) -resistant human HCC cell line. METHODS: BEL-7402/5-FU cells were established through continuous culturing parental BEL-7402 cells, imitating the pattern of chemotherapy clinically. Growth curves and chemosensitivity to cytotoxic drugs were determined by MTT assay. Doubling times, colony formation and adherence rates were calculated after cell counting. Morphological alteration, karyotype morphology, and untrastructure were assessed under optical and electron microscopes. The distribution in the cell cycle and drug efflux pump activity were measured by flow cytometry. Furthermore, expression of potential genes involved in MDR of BEL-7402/5-FU cells were detected by immunocytochemistry. RESULTS: Compared to its parental cells, BEL-7402/5-FU cells had a prolonged doubling time, a lower mitotic index, colony efficiency and adhesive ability, and a decreased drug efflux pump activity. The resistant cells tended to grow in clusters and apparent changes of ultrastructures occurred. BEL-7402/5-FU cells presented with an increased proportion in S and G2/M phases with a concomitant decrease in G0/G1 phase. The MDR phenotype of BEL-7402/5-FU might be partly attributed to increased drug efflux pump activity via multidrug resistance protein 1 (MRP1), overexpression of thymidylate synthase (TS), resistance to apoptosis by augmentation of the Bcl-xl/Bax ratio, and intracellular adhesion medicated by E-cadherin (E-cad). P-glycoprotein (P-gp) might play a limited role in the MDR of BEL-7402/5-FU. CONCLUSION: Increased activity or expression of MRP1, Bcl-xl, TS, and E-cad appear to be involved in the MDR mechanism of BEL-7402/5-FU.", "title": {"charStart": 0, "charEnd": 108}, "docId": "23167424", "entity": [{"duid": "PU:Fqhu", "entityType": "Gene", "charEnd": 1788, "source": "PUBTATOR", "charStart": 1786, "entityId": [{"idString": "581", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "Bax"}, {"duid": "PU:bQ46", "entityType": "Gene", "charEnd": 1846, "source": "PUBTATOR", "charStart": 1837, "entityId": [{"idString": "999", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "E-cadherin"}, {"duid": "PU:TgwL", "entityType": "Disease", "charEnd": 1728, "source": "PUBTATOR", "charStart": 1727, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 12, "entityText": "TS"}, {"duid": "PU:iygB", "entityType": "Disease", "charEnd": 176, "source": "PUBTATOR", "charStart": 174, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 1, "entityText": "HCC"}, {"duid": "PU:TWt5", "entityType": "Disease", "charEnd": 315, "source": "PUBTATOR", "charStart": 313, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 1, "entityText": "HCC"}, {"duid": "PU:m4af", "entityType": "Chemical", "charEnd": 426, "source": "PUBTATOR", "charStart": 423, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-FU"}, {"duid": "PU:azHd", "entityType": "Gene", "charEnd": 1724, "source": "PUBTATOR", "charStart": 1705, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "thymidylate synthase"}, {"duid": "PU:Bw69", "entityType": "Chemical", "charEnd": 1177, "source": "PUBTATOR", "charStart": 1174, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 9, "entityText": "5-FU"}, {"duid": "PU:iuEF", "entityType": "Chemical", "charEnd": 61, "source": "PUBTATOR", "charStart": 48, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-fluorouracil"}, {"duid": "PU:6Km9", "entityType": "Gene", "charEnd": 1784, "source": "PUBTATOR", "charStart": 1779, "entityId": [{"idString": "598", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "Bcl-xl"}, {"duid": "PU:FjNL", "entityType": "Species", "charEnd": 146, "source": "PUBTATOR", "charStart": 142, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "human"}, {"duid": "PU:uuqg", "entityType": "Chemical", "charEnd": 686, "source": "PUBTATOR", "charStart": 684, "entityId": [{"idString": "53233", "source": "CHEBI"}], "sentenceIndex": 4, "entityText": "MTT"}, {"duid": "PU:UWdc", "entityType": "Gene", "charEnd": 1876, "source": "PUBTATOR", "charStart": 1873, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "P-gp"}, {"duid": "PU:FmjS", "entityType": "Gene", "charEnd": 1985, "source": "PUBTATOR", "charStart": 1982, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "MRP1"}, {"duid": "PU:KzFe", "entityType": "Disease", "charEnd": 448, "source": "PUBTATOR", "charStart": 446, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 2, "entityText": "HCC"}, {"duid": "PU:zzYW", "entityType": "Disease", "charEnd": 171, "source": "PUBTATOR", "charStart": 148, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 1, "entityText": "hepatocellular carcinoma"}, {"duid": "PU:w9yJ", "entityType": "Disease", "charEnd": 381, "source": "PUBTATOR", "charStart": 379, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 2, "entityText": "HCC"}, {"duid": "PU:BLar", "entityType": "Chemical", "charEnd": 482, "source": "PUBTATOR", "charStart": 479, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 3, "entityText": "5-FU"}, {"duid": "PU:pzNa", "entityType": "Gene", "charEnd": 1870, "source": "PUBTATOR", "charStart": 1857, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "P-glycoprotein"}, {"duid": "PU:zVtp", "entityType": "Chemical", "charEnd": 1576, "source": "PUBTATOR", "charStart": 1573, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 12, "entityText": "5-FU"}, {"duid": "PU:R3ZY", "entityType": "Disease", "charEnd": 1997, "source": "PUBTATOR", "charStart": 1996, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 14, "entityText": "TS"}, {"duid": "PU:ECor", "entityType": "Chemical", "charEnd": 1078, "source": "PUBTATOR", "charStart": 1075, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 8, "entityText": "5-FU"}, {"duid": "PU:yS9f", "entityType": "Species", "charEnd": 444, "source": "PUBTATOR", "charStart": 440, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "human"}, {"duid": "PU:Wzp4", "entityType": "Gene", "charEnd": 1677, "source": "PUBTATOR", "charStart": 1648, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "multidrug resistance protein 1"}, {"duid": "PU:yVUZ", "entityType": "Chemical", "charEnd": 420, "source": "PUBTATOR", "charStart": 407, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-fluorouracil"}, {"duid": "PU:NG2z", "entityType": "Chemical", "charEnd": 2068, "source": "PUBTATOR", "charStart": 2065, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 14, "entityText": "5-FU"}, {"duid": "PU:z7Ru", "entityType": "Chemical", "charEnd": 1931, "source": "PUBTATOR", "charStart": 1928, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 13, "entityText": "5-FU"}, {"duid": "PU:r8cc", "entityType": "Chemical", "charEnd": 1431, "source": "PUBTATOR", "charStart": 1428, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 11, "entityText": "5-FU"}, {"duid": "PU:awNe", "entityType": "Gene", "charEnd": 1993, "source": "PUBTATOR", "charStart": 1988, "entityId": [{"idString": "598", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "Bcl-xl"}, {"duid": "PU:j82c", "entityType": "Disease", "charEnd": 97, "source": "PUBTATOR", "charStart": 74, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 0, "entityText": "hepatocellular carcinoma"}, {"duid": "PU:6Vbf", "entityType": "Gene", "charEnd": 2008, "source": "PUBTATOR", "charStart": 2004, "entityId": [{"idString": "999", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "E-cad"}, {"duid": "PU:ZDDy", "entityType": "Gene", "charEnd": 1853, "source": "PUBTATOR", "charStart": 1849, "entityId": [{"idString": "999", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "E-cad"}, {"duid": "PU:LrdV", "entityType": "Gene", "charEnd": 1683, "source": "PUBTATOR", "charStart": 1680, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "MRP1"}]}
{"text": "Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line. PURPOSE: The chemoresistance of human hepatocellular carcinoma (HCC) to cytotoxic drugs, especially intrinsic or acquired multidrug resistance (MDR), still remains a major challenge in the management of HCC. In the present study, possible mechanisms involved in MDR of HCC were identified using a 5-fluorouracil (5-FU) -resistant human HCC cell line. METHODS: BEL-7402/5-FU cells were established through continuous culturing parental BEL-7402 cells, imitating the pattern of chemotherapy clinically. Growth curves and chemosensitivity to cytotoxic drugs were determined by MTT assay. Doubling times, colony formation and adherence rates were calculated after cell counting. Morphological alteration, karyotype morphology, and untrastructure were assessed under optical and electron microscopes. The distribution in the cell cycle and drug efflux pump activity were measured by flow cytometry. Furthermore, expression of potential genes involved in MDR of BEL-7402/5-FU cells were detected by immunocytochemistry. RESULTS: Compared to its parental cells, BEL-7402/5-FU cells had a prolonged doubling time, a lower mitotic index, colony efficiency and adhesive ability, and a decreased drug efflux pump activity. The resistant cells tended to grow in clusters and apparent changes of ultrastructures occurred. BEL-7402/5-FU cells presented with an increased proportion in S and G2/M phases with a concomitant decrease in G0/G1 phase. The MDR phenotype of BEL-7402/5-FU might be partly attributed to increased drug efflux pump activity via multidrug resistance protein 1 (MRP1), overexpression of thymidylate synthase (TS), resistance to apoptosis by augmentation of the Bcl-xl/Bax ratio, and intracellular adhesion medicated by E-cadherin (E-cad). P-glycoprotein (P-gp) might play a limited role in the MDR of BEL-7402/5-FU. CONCLUSION: Increased activity or expression of MRP1, Bcl-xl, TS, and E-cad appear to be involved in the MDR mechanism of BEL-7402/5-FU.", "title": {"charStart": 0, "charEnd": 108}, "docId": "23167424", "entity": [{"duid": "PU:Fqhu", "entityType": "Gene", "charEnd": 1788, "source": "PUBTATOR", "charStart": 1786, "entityId": [{"idString": "581", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "Bax"}, {"duid": "PU:bQ46", "entityType": "Gene", "charEnd": 1846, "source": "PUBTATOR", "charStart": 1837, "entityId": [{"idString": "999", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "E-cadherin"}, {"duid": "PU:TgwL", "entityType": "Disease", "charEnd": 1728, "source": "PUBTATOR", "charStart": 1727, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 12, "entityText": "TS"}, {"duid": "PU:iygB", "entityType": "Disease", "charEnd": 176, "source": "PUBTATOR", "charStart": 174, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 1, "entityText": "HCC"}, {"duid": "PU:TWt5", "entityType": "Disease", "charEnd": 315, "source": "PUBTATOR", "charStart": 313, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 1, "entityText": "HCC"}, {"duid": "PU:m4af", "entityType": "Chemical", "charEnd": 426, "source": "PUBTATOR", "charStart": 423, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-FU"}, {"duid": "PU:azHd", "entityType": "Gene", "charEnd": 1724, "source": "PUBTATOR", "charStart": 1705, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "thymidylate synthase"}, {"duid": "PU:Bw69", "entityType": "Chemical", "charEnd": 1177, "source": "PUBTATOR", "charStart": 1174, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 9, "entityText": "5-FU"}, {"duid": "PU:iuEF", "entityType": "Chemical", "charEnd": 61, "source": "PUBTATOR", "charStart": 48, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-fluorouracil"}, {"duid": "PU:6Km9", "entityType": "Gene", "charEnd": 1784, "source": "PUBTATOR", "charStart": 1779, "entityId": [{"idString": "598", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "Bcl-xl"}, {"duid": "PU:FjNL", "entityType": "Species", "charEnd": 146, "source": "PUBTATOR", "charStart": 142, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "human"}, {"duid": "PU:uuqg", "entityType": "Chemical", "charEnd": 686, "source": "PUBTATOR", "charStart": 684, "entityId": [{"idString": "53233", "source": "CHEBI"}], "sentenceIndex": 4, "entityText": "MTT"}, {"duid": "PU:UWdc", "entityType": "Gene", "charEnd": 1876, "source": "PUBTATOR", "charStart": 1873, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "P-gp"}, {"duid": "PU:FmjS", "entityType": "Gene", "charEnd": 1985, "source": "PUBTATOR", "charStart": 1982, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "MRP1"}, {"duid": "PU:KzFe", "entityType": "Disease", "charEnd": 448, "source": "PUBTATOR", "charStart": 446, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 2, "entityText": "HCC"}, {"duid": "PU:zzYW", "entityType": "Disease", "charEnd": 171, "source": "PUBTATOR", "charStart": 148, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 1, "entityText": "hepatocellular carcinoma"}, {"duid": "PU:w9yJ", "entityType": "Disease", "charEnd": 381, "source": "PUBTATOR", "charStart": 379, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 2, "entityText": "HCC"}, {"duid": "PU:BLar", "entityType": "Chemical", "charEnd": 482, "source": "PUBTATOR", "charStart": 479, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 3, "entityText": "5-FU"}, {"duid": "PU:pzNa", "entityType": "Gene", "charEnd": 1870, "source": "PUBTATOR", "charStart": 1857, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "P-glycoprotein"}, {"duid": "PU:zVtp", "entityType": "Chemical", "charEnd": 1576, "source": "PUBTATOR", "charStart": 1573, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 12, "entityText": "5-FU"}, {"duid": "PU:R3ZY", "entityType": "Disease", "charEnd": 1997, "source": "PUBTATOR", "charStart": 1996, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 14, "entityText": "TS"}, {"duid": "PU:ECor", "entityType": "Chemical", "charEnd": 1078, "source": "PUBTATOR", "charStart": 1075, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 8, "entityText": "5-FU"}, {"duid": "PU:yS9f", "entityType": "Species", "charEnd": 444, "source": "PUBTATOR", "charStart": 440, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "human"}, {"duid": "PU:Wzp4", "entityType": "Gene", "charEnd": 1677, "source": "PUBTATOR", "charStart": 1648, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "multidrug resistance protein 1"}, {"duid": "PU:yVUZ", "entityType": "Chemical", "charEnd": 420, "source": "PUBTATOR", "charStart": 407, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-fluorouracil"}, {"duid": "PU:NG2z", "entityType": "Chemical", "charEnd": 2068, "source": "PUBTATOR", "charStart": 2065, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 14, "entityText": "5-FU"}, {"duid": "PU:z7Ru", "entityType": "Chemical", "charEnd": 1931, "source": "PUBTATOR", "charStart": 1928, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 13, "entityText": "5-FU"}, {"duid": "PU:r8cc", "entityType": "Chemical", "charEnd": 1431, "source": "PUBTATOR", "charStart": 1428, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 11, "entityText": "5-FU"}, {"duid": "PU:awNe", "entityType": "Gene", "charEnd": 1993, "source": "PUBTATOR", "charStart": 1988, "entityId": [{"idString": "598", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "Bcl-xl"}, {"duid": "PU:j82c", "entityType": "Disease", "charEnd": 97, "source": "PUBTATOR", "charStart": 74, "entityId": [{"idString": "D006528", "source": "MESH"}], "sentenceIndex": 0, "entityText": "hepatocellular carcinoma"}, {"duid": "PU:6Vbf", "entityType": "Gene", "charEnd": 2008, "source": "PUBTATOR", "charStart": 2004, "entityId": [{"idString": "999", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "E-cad"}, {"duid": "PU:ZDDy", "entityType": "Gene", "charEnd": 1853, "source": "PUBTATOR", "charStart": 1849, "entityId": [{"idString": "999", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "E-cad"}, {"duid": "PU:LrdV", "entityType": "Gene", "charEnd": 1683, "source": "PUBTATOR", "charStart": 1680, "entityId": [{"idString": "5243", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "MRP1"}]}
{"text": "High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway. We assessed the prognostic and predictive value of \u03b2-tubulin III (TUBB3) expression, as determined by immunohistochemistry, in 412 non-small cell lung cancer (NSCLC) specimens from early-stage patients who received neoadjuvant chemotherapy (paclitaxel- or gemcitabine-based) in a phase III trial (IFCT-0002). We also correlated TUBB3 expression with K-Ras and EGF receptor (EGFR) mutations in a subset of 208 cryopreserved specimens. High TUBB3 protein expression was associated with nonsquamous cell carcinomas (P < 0.001) and K-Ras mutation (P < 0.001). The 127 (30.8%) TUBB3-negative patients derived more than 1 year of overall survival advantage, with more than 84 months median overall survival versus 71.7 months for TUBB3-positive patients [HR, 1.58; 95% confidence interval (CI), 1.11-2.25)]. This prognostic value was confirmed in multivariate analysis (adjusted HR for death, 1.51; 95% CI, 1.04-2.21; P = 0.031) with a bootstrapping validation procedure. TUBB3 expression was associated with nonresponse to chemotherapy (adjusted HR, 1.31; 95% CI, 1.01-1.70; P = 0.044) but had no predictive value (taxane vs. gemcitabine). Taking account of these clinical findings, we further investigated TUBB3 expression in isogenic human bronchial cell lines only differing by K-Ras gene status and assessed the effect of K-Ras short interfering RNA (siRNA) mediated depletion, cell hypoxia, or pharmacologic inhibitors of K-Ras downstream effectors, on TUBB3 protein cell content. siRNA K-Ras knockdown, inhibition of RAF/MEK (MAP-ERK kinase) and phosphoinositide 3-kinase (PI3K)/AKT signaling, and hypoxia were shown to downregulate TUBB3 expression in bronchial cells. This study is the first one to identify K-Ras mutations as determinant of TUBB3 expression, a chemoresistance marker. Our in vitro data deserve studies combining standard chemotherapy with anti-MEK or anti-PI3K drugs in patients with TUBB3-overexpressing tumors.", "title": {"charStart": 0, "charEnd": 183}, "docId": "22411898", "entity": [{"duid": "PU:qDAf", "entityType": "Species", "charEnd": 1420, "source": "PUBTATOR", "charStart": 1416, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "human"}, {"duid": "PU:HhPc", "entityType": "Gene", "charEnd": 628, "source": "PUBTATOR", "charStart": 624, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "TUBB3"}, {"duid": "PU:vpBL", "entityType": "Gene", "charEnd": 1465, "source": "PUBTATOR", "charStart": 1461, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "K-Ras"}, {"duid": "PU:Qxro", "entityType": "Gene", "charEnd": 556, "source": "PUBTATOR", "charStart": 545, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGF receptor"}, {"duid": "PU:AV8t", "entityType": "Gene", "charEnd": 1762, "source": "PUBTATOR", "charStart": 1759, "entityId": [{"idString": "5293", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "PI3K"}, {"duid": "PU:22GC", "entityType": "Gene", "charEnd": 1611, "source": "PUBTATOR", "charStart": 1607, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "K-Ras"}, {"duid": "PU:c23T", "entityType": "Disease", "charEnd": 695, "source": "PUBTATOR", "charStart": 669, "entityId": [{"idString": "D002292", "source": "MESH"}], "sentenceIndex": 3, "entityText": "nonsquamous cell carcinomas"}, {"duid": "PU:xewa", "entityType": "Species", "charEnd": 66, "source": "PUBTATOR", "charStart": 59, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:iphj", "entityType": "Gene", "charEnd": 2094, "source": "PUBTATOR", "charStart": 2090, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "TUBB3"}, {"duid": "PU:LVPh", "entityType": "Disease", "charEnd": 1790, "source": "PUBTATOR", "charStart": 1784, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 8, "entityText": "hypoxia"}, {"duid": "PU:UQC6", "entityType": "Disease", "charEnd": 1573, "source": "PUBTATOR", "charStart": 1567, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 7, "entityText": "hypoxia"}, {"duid": "PU:7gSH", "entityType": "Disease", "charEnd": 2116, "source": "PUBTATOR", "charStart": 2111, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}, {"duid": "PU:ENNm", "entityType": "Species", "charEnd": 2083, "source": "PUBTATOR", "charStart": 2076, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:efvV", "entityType": "Disease", "charEnd": 104, "source": "PUBTATOR", "charStart": 79, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:9HnD", "entityType": "Gene", "charEnd": 562, "source": "PUBTATOR", "charStart": 559, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:vvHN", "entityType": "Gene", "charEnd": 913, "source": "PUBTATOR", "charStart": 909, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TUBB3"}, {"duid": "PU:WbyJ", "entityType": "Gene", "charEnd": 164, "source": "PUBTATOR", "charStart": 160, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "K-Ras"}, {"duid": "PU:X4P9", "entityType": "Gene", "charEnd": 517, "source": "PUBTATOR", "charStart": 513, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TUBB3"}, {"duid": "PU:fDDL", "entityType": "Gene", "charEnd": 1642, "source": "PUBTATOR", "charStart": 1638, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TUBB3"}, {"duid": "PU:Fgr7", "entityType": "Gene", "charEnd": 1934, "source": "PUBTATOR", "charStart": 1930, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TUBB3"}, {"duid": "PU:jYEQ", "entityType": "Chemical", "charEnd": 1300, "source": "PUBTATOR", "charStart": 1295, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 6, "entityText": "taxane"}, {"duid": "PU:sh3t", "entityType": "Chemical", "charEnd": 435, "source": "PUBTATOR", "charStart": 426, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 1, "entityText": "paclitaxel"}, {"duid": "PU:rsag", "entityType": "Chemical", "charEnd": 1316, "source": "PUBTATOR", "charStart": 1306, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gemcitabine"}, {"duid": "PU:G2SP", "entityType": "Gene", "charEnd": 1823, "source": "PUBTATOR", "charStart": 1819, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TUBB3"}, {"duid": "PU:kf2p", "entityType": "Gene", "charEnd": 1709, "source": "PUBTATOR", "charStart": 1703, "entityId": [{"idString": "22882", "source": "Entrez"}, {"idString": "5609", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "RAF/MEK"}, {"duid": "PU:gKMN", "entityType": "Species", "charEnd": 779, "source": "PUBTATOR", "charStart": 772, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:za8V", "entityType": "Species", "charEnd": 385, "source": "PUBTATOR", "charStart": 378, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:DbS4", "entityType": "Gene", "charEnd": 1391, "source": "PUBTATOR", "charStart": 1387, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TUBB3"}, {"duid": "PU:BZqs", "entityType": "Gene", "charEnd": 1155, "source": "PUBTATOR", "charStart": 1151, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:WZB2", "entityType": "Gene", "charEnd": 255, "source": "PUBTATOR", "charStart": 251, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TUBB3"}, {"duid": "PU:ADHJ", "entityType": "Gene", "charEnd": 717, "source": "PUBTATOR", "charStart": 713, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "K-Ras"}, {"duid": "PU:6pnV", "entityType": "Gene", "charEnd": 1756, "source": "PUBTATOR", "charStart": 1732, "entityId": [{"idString": "5293", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "phosphoinositide 3-kinase"}, {"duid": "PU:fFyB", "entityType": "Gene", "charEnd": 9, "source": "PUBTATOR", "charStart": 5, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "TUBB3"}, {"duid": "PU:vYij", "entityType": "Species", "charEnd": 931, "source": "PUBTATOR", "charStart": 924, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:XnEZ", "entityType": "Gene", "charEnd": 1510, "source": "PUBTATOR", "charStart": 1506, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "K-Ras"}, {"duid": "PU:u5D3", "entityType": "Chemical", "charEnd": 451, "source": "PUBTATOR", "charStart": 441, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gemcitabine"}, {"duid": "PU:cP4J", "entityType": "Gene", "charEnd": 761, "source": "PUBTATOR", "charStart": 757, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TUBB3"}, {"duid": "PU:9wXJ", "entityType": "Gene", "charEnd": 539, "source": "PUBTATOR", "charStart": 535, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "K-Ras"}, {"duid": "PU:VKc2", "entityType": "Disease", "charEnd": 1069, "source": "PUBTATOR", "charStart": 1065, "entityId": [{"idString": "D003643", "source": "MESH"}], "sentenceIndex": 5, "entityText": "death"}, {"duid": "PU:75M4", "entityType": "Disease", "charEnd": 348, "source": "PUBTATOR", "charStart": 344, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:p8Jj", "entityType": "Gene", "charEnd": 1900, "source": "PUBTATOR", "charStart": 1896, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "K-Ras"}, {"duid": "PU:Wwpk", "entityType": "Disease", "charEnd": 341, "source": "PUBTATOR", "charStart": 316, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small cell lung cancer"}, {"duid": "PU:wRXi", "entityType": "Gene", "charEnd": 1676, "source": "PUBTATOR", "charStart": 1672, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "K-Ras"}, {"duid": "PU:wwBi", "entityType": "Gene", "charEnd": 2065, "source": "PUBTATOR", "charStart": 2062, "entityId": [{"idString": "5293", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "PI3K"}, {"duid": "PU:BoNj", "entityType": "Gene", "charEnd": 2052, "source": "PUBTATOR", "charStart": 2050, "entityId": [{"idString": "5609", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "MEK"}]}
{"text": "Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker. PURPOSE: This phase II study was conducted to assess the efficacy of temozolomide in patients with relapsed small cell lung cancer (SCLC). EXPERIMENTAL DESIGN: Patients with disease progression after one or two prior chemotherapy regimens received temozolomide at 75 mg/m(2)/d for 21 days of a 28-day cycle. The primary endpoint was the overall response rate [ORR; complete response (CR) plus partial response (PR)], which was evaluated separately in sensitive and refractory cohorts. In the available tissue, we assessed O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation status by PCR and MGMT expression by immunohistochemistry. RESULTS: Sixty-four patients were accrued: 48 patients in the sensitive cohort and 16 in the refractory group. One CR and 10 PRs were noted in sensitive patients [ORR, 23%; 95% confidence interval (CI), 12%-37%]. Two PRs were seen in the refractory cohort (ORR, 13%; 95% CI, 2%-38%). As second- and third-line treatment, the ORR was 22% (95% CI, 9%-40%) and 19% (95% CI, 7%-36%), respectively. Among patients with target brain lesions, 38% had a CR or PR (95% CI, 14%-68%). Grade \u22653 thrombocytopenia and neutropenia were observed in nine patients (14%). A greater number of cases with methylated MGMT had a response compared to those with unmethylated MGMT (38% vs. 7%; P = 0.08). CONCLUSION: Temozolomide has activity in relapsed SCLC, particularly for brain metastases. Response to temozolomide may correlate with MGMT methylation in SCLC.", "title": {"charStart": 0, "charEnd": 184}, "docId": "22228633", "entity": [{"duid": "PU:WWJR", "entityType": "Species", "charEnd": 1381, "source": "PUBTATOR", "charStart": 1374, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:U5vM", "entityType": "Gene", "charEnd": 798, "source": "PUBTATOR", "charStart": 795, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MGMT"}, {"duid": "PU:rwNw", "entityType": "Disease", "charEnd": 1334, "source": "PUBTATOR", "charStart": 1319, "entityId": [{"idString": "D013921", "source": "MESH"}], "sentenceIndex": 10, "entityText": "thrombocytopenia"}, {"duid": "PU:UFjN", "entityType": "Disease", "charEnd": 315, "source": "PUBTATOR", "charStart": 285, "entityId": [{"idString": "D055752", "source": "MESH"}], "sentenceIndex": 1, "entityText": "relapsed small cell lung cancer"}, {"duid": "PU:LTRH", "entityType": "Species", "charEnd": 1243, "source": "PUBTATOR", "charStart": 1236, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:LnHW", "entityType": "Species", "charEnd": 353, "source": "PUBTATOR", "charStart": 346, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "Patients"}, {"duid": "PU:Bp9Z", "entityType": "Chemical", "charEnd": 725, "source": "PUBTATOR", "charStart": 708, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 4, "entityText": "O(6)-methylguanine"}, {"duid": "PU:q4rX", "entityType": "Chemical", "charEnd": 136, "source": "PUBTATOR", "charStart": 124, "entityId": [{"idString": "25305", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "methylguanine"}, {"duid": "PU:Q4BE", "entityType": "Disease", "charEnd": 1269, "source": "PUBTATOR", "charStart": 1257, "entityId": [{"idString": "D001927", "source": "MESH"}], "sentenceIndex": 9, "entityText": "brain lesions"}, {"duid": "PU:95Dx", "entityType": "Chemical", "charEnd": 29, "source": "PUBTATOR", "charStart": 18, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "temozolomide"}, {"duid": "PU:zxEJ", "entityType": "Chemical", "charEnd": 266, "source": "PUBTATOR", "charStart": 255, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "temozolomide"}, {"duid": "PU:3qtT", "entityType": "Disease", "charEnd": 321, "source": "PUBTATOR", "charStart": 318, "entityId": [{"idString": "D055752", "source": "MESH"}], "sentenceIndex": 1, "entityText": "SCLC"}, {"duid": "PU:C5xC", "entityType": "Disease", "charEnd": 1350, "source": "PUBTATOR", "charStart": 1340, "entityId": [{"idString": "D009503", "source": "MESH"}], "sentenceIndex": 10, "entityText": "neutropenia"}, {"duid": "PU:zLpZ", "entityType": "Gene", "charEnd": 753, "source": "PUBTATOR", "charStart": 750, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "MGMT"}, {"duid": "PU:WGqa", "entityType": "Disease", "charEnd": 1675, "source": "PUBTATOR", "charStart": 1672, "entityId": [{"idString": "D055752", "source": "MESH"}], "sentenceIndex": 13, "entityText": "SCLC"}, {"duid": "PU:5eES", "entityType": "Disease", "charEnd": 1570, "source": "PUBTATOR", "charStart": 1567, "entityId": [{"idString": "D055752", "source": "MESH"}], "sentenceIndex": 12, "entityText": "SCLC"}, {"duid": "PU:LBdS", "entityType": "Species", "charEnd": 863, "source": "PUBTATOR", "charStart": 856, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:Dwev", "entityType": "Species", "charEnd": 41, "source": "PUBTATOR", "charStart": 34, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:gUBm", "entityType": "Chemical", "charEnd": 1540, "source": "PUBTATOR", "charStart": 1529, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 12, "entityText": "Temozolomide"}, {"duid": "PU:Eu9f", "entityType": "Disease", "charEnd": 102, "source": "PUBTATOR", "charStart": 81, "entityId": [{"idString": "D055752", "source": "MESH"}], "sentenceIndex": 0, "entityText": "small cell lung cancer"}, {"duid": "PU:N7Jo", "entityType": "Gene", "charEnd": 158, "source": "PUBTATOR", "charStart": 124, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "methylguanine-DNA methyltransferase"}, {"duid": "PU:5ynY", "entityType": "Chemical", "charEnd": 1631, "source": "PUBTATOR", "charStart": 1620, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 13, "entityText": "temozolomide"}, {"duid": "PU:CLPr", "entityType": "Gene", "charEnd": 1655, "source": "PUBTATOR", "charStart": 1652, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "MGMT"}, {"duid": "PU:NZP8", "entityType": "Gene", "charEnd": 1491, "source": "PUBTATOR", "charStart": 1488, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "MGMT"}, {"duid": "PU:SRsK", "entityType": "Species", "charEnd": 996, "source": "PUBTATOR", "charStart": 989, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:rG6w", "entityType": "Gene", "charEnd": 747, "source": "PUBTATOR", "charStart": 708, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "O(6)-methylguanine-DNA methyltransferase"}, {"duid": "PU:xf9P", "entityType": "Gene", "charEnd": 1435, "source": "PUBTATOR", "charStart": 1432, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "MGMT"}, {"duid": "PU:cSHj", "entityType": "Species", "charEnd": 278, "source": "PUBTATOR", "charStart": 271, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:FhH8", "entityType": "Chemical", "charEnd": 445, "source": "PUBTATOR", "charStart": 434, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 2, "entityText": "temozolomide"}, {"duid": "PU:WHYb", "entityType": "Species", "charEnd": 889, "source": "PUBTATOR", "charStart": 882, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}]}
{"text": "Cell-cycle distribution and Thymidilate Synthatase (TS) expression correlate with 5-FU resistance in head and neck carcinoma cells. BACKGROUND: Acquired chemoresistance to 5-fluorouracil (5-FU) remains one of the obstacles for the success of 5-FU-based cancer chemotherapy, and some molecular mechanisms of acquired 5-FU resistance are still unknown. The main action of 5-FU is the suppression of DNA replication by inhibiting Thymidylate Synthase (TS). MATERIALS AND METHODS: We analyzed 5-FU resistance mechanisms using the head and neck squamous cell carcinoma cell lines, UM-SCC-23, and two different resistant cell lines, UM-SCC-23/WR and UM-SCC-23/MR, which were procured from UM-SCC-23 cells. To acquire resistance, the two cells underwent repeated treatment of 5-FU with different durations and frequency. We determined differences in the cell-cycle distribution and the expression of TS proteins in the three cell lines. Moreover, cell-cycle distribution in cells which acquired resistance after 5-FU treatment, was compared to that of parental cells, using flow cytometric analysis. RESULTS: There was a remarkable increase in TS protein expression levels in UM-SCC-23/WR following 5-FU treatment. S-phase cells of UM-SCC-23 and UM-SCC-23/WR cells were immediately increased after treatment with 5-FU, whereas UM-SCC-23/MR were accumulated to the S-phase slightly later. CONCLUSION: The cell-cycle perturbation or elevation of TS protein expression may be involved in acquired 5-FU resistance and identifies 5-FU resistance mechanisms in the two different 5-FU treatment regimens.", "title": {"charStart": 0, "charEnd": 130}, "docId": "24922653", "entity": [{"duid": "PU:Fvh8", "entityType": "Chemical", "charEnd": 1195, "source": "PUBTATOR", "charStart": 1192, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 7, "entityText": "5-FU"}, {"duid": "PU:E3eU", "entityType": "Chemical", "charEnd": 1521, "source": "PUBTATOR", "charStart": 1518, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 9, "entityText": "5-FU"}, {"duid": "PU:B8Qt", "entityType": "Chemical", "charEnd": 85, "source": "PUBTATOR", "charStart": 82, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-FU"}, {"duid": "PU:qqBw", "entityType": "Gene", "charEnd": 1138, "source": "PUBTATOR", "charStart": 1137, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TS"}, {"duid": "PU:48jh", "entityType": "Chemical", "charEnd": 373, "source": "PUBTATOR", "charStart": 370, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-FU"}, {"duid": "PU:6zLH", "entityType": "Chemical", "charEnd": 492, "source": "PUBTATOR", "charStart": 489, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 3, "entityText": "5-FU"}, {"duid": "PU:FscT", "entityType": "Gene", "charEnd": 1438, "source": "PUBTATOR", "charStart": 1437, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:ensf", "entityType": "Chemical", "charEnd": 319, "source": "PUBTATOR", "charStart": 316, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:kpNQ", "entityType": "Gene", "charEnd": 894, "source": "PUBTATOR", "charStart": 893, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:u5Hs", "entityType": "Chemical", "charEnd": 1309, "source": "PUBTATOR", "charStart": 1306, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 8, "entityText": "5-FU"}, {"duid": "PU:vDtL", "entityType": "Chemical", "charEnd": 1008, "source": "PUBTATOR", "charStart": 1005, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 6, "entityText": "5-FU"}, {"duid": "PU:KQuB", "entityType": "Disease", "charEnd": 123, "source": "PUBTATOR", "charStart": 101, "entityId": [{"idString": "D006258", "source": "MESH"}], "sentenceIndex": 0, "entityText": "head and neck carcinoma"}, {"duid": "PU:aLKj", "entityType": "Chemical", "charEnd": 1490, "source": "PUBTATOR", "charStart": 1487, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 9, "entityText": "5-FU"}, {"duid": "PU:4MvT", "entityType": "Disease", "charEnd": 258, "source": "PUBTATOR", "charStart": 253, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cancer"}, {"duid": "PU:tK5a", "entityType": "Gene", "charEnd": 446, "source": "PUBTATOR", "charStart": 427, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "Thymidylate Synthase"}, {"duid": "PU:UQDQ", "entityType": "Chemical", "charEnd": 191, "source": "PUBTATOR", "charStart": 188, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:z2xs", "entityType": "Gene", "charEnd": 450, "source": "PUBTATOR", "charStart": 449, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:BJsP", "entityType": "Chemical", "charEnd": 245, "source": "PUBTATOR", "charStart": 242, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:NTNs", "entityType": "Chemical", "charEnd": 1569, "source": "PUBTATOR", "charStart": 1566, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 9, "entityText": "5-FU"}, {"duid": "PU:eq2X", "entityType": "Chemical", "charEnd": 772, "source": "PUBTATOR", "charStart": 769, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 4, "entityText": "5-FU"}, {"duid": "PU:fB63", "entityType": "Chemical", "charEnd": 185, "source": "PUBTATOR", "charStart": 172, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-fluorouracil"}, {"duid": "PU:2wYH", "entityType": "Disease", "charEnd": 562, "source": "PUBTATOR", "charStart": 535, "entityId": [{"idString": "C535575", "source": "MESH"}], "sentenceIndex": 3, "entityText": "neck squamous cell carcinoma"}, {"duid": "PU:KY5W", "entityType": "Gene", "charEnd": 53, "source": "PUBTATOR", "charStart": 52, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "TS"}]}
{"text": "The role of \u03b2III-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy. BACKGROUND: The aim of this study is to evaluate whether class III \u03b2-tubulin (TUBB3) expression could predict progression-free survival or overall survival in relapsed non-small cell lung cancer (NSCLC) patients treated with taxene-based chemotherapy. METHODS: Immunohistochemistal staining was used to examine the expression of TUBB3 in resected lung tumor specimens obtained from 56 patients treated with platinum-based chemotherapy against recurrent tumors after curative resections. Excision repair cross-complementation group 1, breast cancer susceptibility gene 1, vascular endothelial growth factor, Ki-67, CD34, and p53 were also correlated with clinical features and outcome after treatment. RESULTS: Of the 56 patients enrolled in the study, 29 were treated by carboplatin plus paclitaxel as first-line treatment, and 24 patients received docetaxel monotherapy as second- or third-line treatment. A positive TUBB3 expression is closely associated with a poor response to taxane-based chemotherapy. TUBB3 expression was an independent prognostic factor for predicting poor progression-free survival after docetaxel administration. However, TUBB3 expression could not predict outcome after carboplatin plus paclitaxel treatment. The other biomarkers tested were not independent prognostic factors for predicting outcome after taxane-based chemotherapy. CONCLUSION: TUBB3 expression is associated with resistance to taxane-based chemotherapy and is an independent prognostic factor for predicting poor progression-free survival after docetaxel treatment alone. TUBB3 expression may be a predictive marker for chemoresistance to docetaxel in NSCLC with postoperative recurrent disease.", "title": {"charStart": 0, "charEnd": 100}, "docId": "22358390", "entity": [{"duid": "PU:4ZTa", "entityType": "Disease", "charEnd": 560, "source": "PUBTATOR", "charStart": 555, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumors"}, {"duid": "PU:EVGF", "entityType": "Species", "charEnd": 62, "source": "PUBTATOR", "charStart": 55, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:LBw8", "entityType": "Chemical", "charEnd": 1310, "source": "PUBTATOR", "charStart": 1300, "entityId": [{"idString": "D016190", "source": "MESH"}], "sentenceIndex": 7, "entityText": "carboplatin"}, {"duid": "PU:fBxx", "entityType": "Species", "charEnd": 494, "source": "PUBTATOR", "charStart": 487, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:88xm", "entityType": "Chemical", "charEnd": 883, "source": "PUBTATOR", "charStart": 873, "entityId": [{"idString": "D016190", "source": "MESH"}], "sentenceIndex": 4, "entityText": "carboplatin"}, {"duid": "PU:RdrL", "entityType": "Chemical", "charEnd": 959, "source": "PUBTATOR", "charStart": 951, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 4, "entityText": "docetaxel"}, {"duid": "PU:8xGY", "entityType": "Disease", "charEnd": 648, "source": "PUBTATOR", "charStart": 636, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 3, "entityText": "breast cancer"}, {"duid": "PU:HfFJ", "entityType": "Disease", "charEnd": 1754, "source": "PUBTATOR", "charStart": 1750, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 10, "entityText": "NSCLC"}, {"duid": "PU:myWH", "entityType": "Chemical", "charEnd": 1530, "source": "PUBTATOR", "charStart": 1525, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 9, "entityText": "taxane"}, {"duid": "PU:rwUF", "entityType": "Chemical", "charEnd": 1088, "source": "PUBTATOR", "charStart": 1083, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 5, "entityText": "taxane"}, {"duid": "PU:j4gz", "entityType": "Gene", "charEnd": 719, "source": "PUBTATOR", "charStart": 716, "entityId": [{"idString": "947", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "CD34"}, {"duid": "PU:FqMG", "entityType": "Disease", "charEnd": 458, "source": "PUBTATOR", "charStart": 449, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 2, "entityText": "lung tumor"}, {"duid": "PU:UPvN", "entityType": "Gene", "charEnd": 1674, "source": "PUBTATOR", "charStart": 1670, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "TUBB3"}, {"duid": "PU:j4wE", "entityType": "Gene", "charEnd": 1024, "source": "PUBTATOR", "charStart": 1020, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TUBB3"}, {"duid": "PU:mB6x", "entityType": "Chemical", "charEnd": 80, "source": "PUBTATOR", "charStart": 75, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 0, "entityText": "taxane"}, {"duid": "PU:Z9YQ", "entityType": "Gene", "charEnd": 1479, "source": "PUBTATOR", "charStart": 1475, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TUBB3"}, {"duid": "PU:2bxj", "entityType": "Chemical", "charEnd": 899, "source": "PUBTATOR", "charStart": 890, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 4, "entityText": "paclitaxel"}, {"duid": "PU:RY6t", "entityType": "Disease", "charEnd": 295, "source": "PUBTATOR", "charStart": 270, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small cell lung cancer"}, {"duid": "PU:RFCV", "entityType": "Chemical", "charEnd": 1745, "source": "PUBTATOR", "charStart": 1737, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 10, "entityText": "docetaxel"}, {"duid": "PU:jGJw", "entityType": "Gene", "charEnd": 728, "source": "PUBTATOR", "charStart": 726, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "p53"}, {"duid": "PU:TeEb", "entityType": "Chemical", "charEnd": 332, "source": "PUBTATOR", "charStart": 327, "entityId": [], "sentenceIndex": 1, "entityText": "taxene"}, {"duid": "PU:Cwcf", "entityType": "Chemical", "charEnd": 1441, "source": "PUBTATOR", "charStart": 1436, "entityId": [{"idString": "C080625", "source": "MESH"}], "sentenceIndex": 8, "entityText": "taxane"}, {"duid": "PU:JXtD", "entityType": "Species", "charEnd": 940, "source": "PUBTATOR", "charStart": 933, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:Q7B9", "entityType": "Gene", "charEnd": 435, "source": "PUBTATOR", "charStart": 431, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TUBB3"}, {"duid": "PU:HUK4", "entityType": "Species", "charEnd": 312, "source": "PUBTATOR", "charStart": 305, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:JbAB", "entityType": "Gene", "charEnd": 184, "source": "PUBTATOR", "charStart": 180, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TUBB3"}, {"duid": "PU:W2W4", "entityType": "Chemical", "charEnd": 516, "source": "PUBTATOR", "charStart": 509, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 2, "entityText": "platinum"}, {"duid": "PU:nCFo", "entityType": "Disease", "charEnd": 53, "source": "PUBTATOR", "charStart": 28, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:42Un", "entityType": "Gene", "charEnd": 1114, "source": "PUBTATOR", "charStart": 1110, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TUBB3"}, {"duid": "PU:UR5i", "entityType": "Disease", "charEnd": 1791, "source": "PUBTATOR", "charStart": 1761, "entityId": [{"idString": "D019106", "source": "MESH"}], "sentenceIndex": 10, "entityText": "postoperative recurrent disease"}, {"duid": "PU:W7PB", "entityType": "Gene", "charEnd": 1255, "source": "PUBTATOR", "charStart": 1251, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TUBB3"}, {"duid": "PU:esKF", "entityType": "Species", "charEnd": 829, "source": "PUBTATOR", "charStart": 822, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:w9hQ", "entityType": "Disease", "charEnd": 302, "source": "PUBTATOR", "charStart": 298, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:8L6K", "entityType": "Chemical", "charEnd": 1651, "source": "PUBTATOR", "charStart": 1643, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 9, "entityText": "docetaxel"}, {"duid": "PU:zz7U", "entityType": "Chemical", "charEnd": 1326, "source": "PUBTATOR", "charStart": 1317, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 7, "entityText": "paclitaxel"}, {"duid": "PU:Xqc5", "entityType": "Chemical", "charEnd": 1224, "source": "PUBTATOR", "charStart": 1216, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 6, "entityText": "docetaxel"}]}
{"text": "Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy. PURPOSE: Drug resistance is not only one of the major obstacles to treatment but also a poor prognosis in advanced non-small cell lung cancer (NSCLC) patients. The aim of this study was to evaluate the predictive value of APE1, BRCA1, ERCC1 and TUBB3 in advanced NSCLC patients who received platinum-paclitaxel treatment. METHODS: One hundred and thirty-six advanced NSCLC patients, who were treated with first-line platinum-paclitaxel chemotherapy, were enrolled in this study. The protein expression levels of APE1, BRCA1, ERCC1 and TUBB3 were assessed by immunohistochemistry and analyzed for the association with response to chemotherapy and progression-free survival (PFS) and overall survival (OS). RESULTS: Patients with negative expression of APE1, ERCC1 or TUBB3 benefited from platinum plus paclitaxel regimen chemotherapy. ERCC1-negative patients had better PFS (P = 0.016) and OS (P = 0.030) compared with positive patients. Similarly, the APE1-negative patients showed better PFS (P = 0.004) and longer OS though statistically insignificant. Multivariate analysis showed that APE1 and ERCC1 were independent predictor for PFS (HR 2.07; P = 0.004 and HR 1.66; P = 0.016) and OS (HR 1.99; P = 0.008 and HR 1.64; P = 0.040). Moreover, patients with both APE1- and ERCC1-negative or both APE1- and TUBB3-negative tumors had significantly higher response rate, longer median PFS and OS following treatment with platinum and paclitaxel (P < 0.05). CONCLUSION: The data indicate that APE1, ERCC1 and TUBB3 could be a useful biomarker to predict clinical outcome in patients with advanced NSCLC receiving first-line platinum-paclitaxel chemotherapy.", "title": {"charStart": 0, "charEnd": 174}, "docId": "25107571", "entity": [{"duid": "PU:msye", "entityType": "Chemical", "charEnd": 485, "source": "PUBTATOR", "charStart": 476, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 2, "entityText": "paclitaxel"}, {"duid": "PU:HDSW", "entityType": "Gene", "charEnd": 1278, "source": "PUBTATOR", "charStart": 1274, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:Bg7P", "entityType": "Chemical", "charEnd": 1815, "source": "PUBTATOR", "charStart": 1806, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 10, "entityText": "paclitaxel"}, {"duid": "PU:CNUu", "entityType": "Chemical", "charEnd": 1804, "source": "PUBTATOR", "charStart": 1797, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 10, "entityText": "platinum"}, {"duid": "PU:t4Gj", "entityType": "Species", "charEnd": 1149, "source": "PUBTATOR", "charStart": 1142, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:Hi5r", "entityType": "Gene", "charEnd": 30, "source": "PUBTATOR", "charStart": 26, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "BRCA1"}, {"duid": "PU:AFyk", "entityType": "Chemical", "charEnd": 599, "source": "PUBTATOR", "charStart": 592, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 3, "entityText": "platinum"}, {"duid": "PU:bTCT", "entityType": "Disease", "charEnd": 1568, "source": "PUBTATOR", "charStart": 1567, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 9, "entityText": "OS"}, {"duid": "PU:ev7w", "entityType": "Species", "charEnd": 1428, "source": "PUBTATOR", "charStart": 1421, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:WbTY", "entityType": "Gene", "charEnd": 1454, "source": "PUBTATOR", "charStart": 1450, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:PKRV", "entityType": "Species", "charEnd": 1032, "source": "PUBTATOR", "charStart": 1025, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:g5eb", "entityType": "Chemical", "charEnd": 160, "source": "PUBTATOR", "charStart": 151, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "paclitaxel"}, {"duid": "PU:qYNW", "entityType": "Gene", "charEnd": 1487, "source": "PUBTATOR", "charStart": 1483, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TUBB3"}, {"duid": "PU:ZYeD", "entityType": "Chemical", "charEnd": 1167, "source": "PUBTATOR", "charStart": 1165, "entityId": [], "sentenceIndex": 7, "entityText": "PFS"}, {"duid": "PU:ynrL", "entityType": "Disease", "charEnd": 1364, "source": "PUBTATOR", "charStart": 1363, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 8, "entityText": "OS"}, {"duid": "PU:kpA2", "entityType": "Gene", "charEnd": 930, "source": "PUBTATOR", "charStart": 927, "entityId": [{"idString": "328", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "APE1"}, {"duid": "PU:CPKn", "entityType": "Chemical", "charEnd": 1047, "source": "PUBTATOR", "charStart": 1045, "entityId": [], "sentenceIndex": 6, "entityText": "PFS"}, {"duid": "PU:WAxd", "entityType": "Gene", "charEnd": 937, "source": "PUBTATOR", "charStart": 933, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:LdR7", "entityType": "Gene", "charEnd": 408, "source": "PUBTATOR", "charStart": 404, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "BRCA1"}, {"duid": "PU:uRV2", "entityType": "Species", "charEnd": 333, "source": "PUBTATOR", "charStart": 326, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:QkUf", "entityType": "Gene", "charEnd": 1443, "source": "PUBTATOR", "charStart": 1440, "entityId": [{"idString": "328", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "APE1"}, {"duid": "PU:JMK6", "entityType": "Chemical", "charEnd": 1313, "source": "PUBTATOR", "charStart": 1311, "entityId": [], "sentenceIndex": 8, "entityText": "PFS"}, {"duid": "PU:ES6c", "entityType": "Gene", "charEnd": 401, "source": "PUBTATOR", "charStart": 398, "entityId": [{"idString": "328", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "APE1"}, {"duid": "PU:49Kg", "entityType": "Chemical", "charEnd": 970, "source": "PUBTATOR", "charStart": 963, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 5, "entityText": "platinum"}, {"duid": "PU:jZUE", "entityType": "Gene", "charEnd": 23, "source": "PUBTATOR", "charStart": 20, "entityId": [{"idString": "328", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "APE1"}, {"duid": "PU:9BSC", "entityType": "Chemical", "charEnd": 1561, "source": "PUBTATOR", "charStart": 1559, "entityId": [], "sentenceIndex": 9, "entityText": "PFS"}, {"duid": "PU:tWGF", "entityType": "Gene", "charEnd": 37, "source": "PUBTATOR", "charStart": 33, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:M5WL", "entityType": "Gene", "charEnd": 1686, "source": "PUBTATOR", "charStart": 1682, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "TUBB3"}, {"duid": "PU:3xvR", "entityType": "Gene", "charEnd": 1676, "source": "PUBTATOR", "charStart": 1672, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:eeBx", "entityType": "Chemical", "charEnd": 851, "source": "PUBTATOR", "charStart": 849, "entityId": [], "sentenceIndex": 4, "entityText": "PFS"}, {"duid": "PU:GVwX", "entityType": "Chemical", "charEnd": 149, "source": "PUBTATOR", "charStart": 142, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 0, "entityText": "platinum"}, {"duid": "PU:8rmu", "entityType": "Disease", "charEnd": 1503, "source": "PUBTATOR", "charStart": 1498, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:yhFA", "entityType": "Gene", "charEnd": 1476, "source": "PUBTATOR", "charStart": 1473, "entityId": [{"idString": "328", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "APE1"}, {"duid": "PU:Uesb", "entityType": "Disease", "charEnd": 316, "source": "PUBTATOR", "charStart": 291, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small cell lung cancer"}, {"duid": "PU:NnGS", "entityType": "Disease", "charEnd": 443, "source": "PUBTATOR", "charStart": 439, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "NSCLC"}, {"duid": "PU:yyPq", "entityType": "Chemical", "charEnd": 610, "source": "PUBTATOR", "charStart": 601, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 3, "entityText": "paclitaxel"}, {"duid": "PU:cFJ5", "entityType": "Disease", "charEnd": 877, "source": "PUBTATOR", "charStart": 876, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 4, "entityText": "OS"}, {"duid": "PU:tDGx", "entityType": "Gene", "charEnd": 1014, "source": "PUBTATOR", "charStart": 1010, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:3GsB", "entityType": "Gene", "charEnd": 715, "source": "PUBTATOR", "charStart": 711, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TUBB3"}, {"duid": "PU:TiNi", "entityType": "Gene", "charEnd": 698, "source": "PUBTATOR", "charStart": 694, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "BRCA1"}, {"duid": "PU:E2VN", "entityType": "Species", "charEnd": 897, "source": "PUBTATOR", "charStart": 890, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "Patients"}, {"duid": "PU:Exbu", "entityType": "Gene", "charEnd": 705, "source": "PUBTATOR", "charStart": 701, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:uAmt", "entityType": "Species", "charEnd": 1110, "source": "PUBTATOR", "charStart": 1103, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:oKYk", "entityType": "Species", "charEnd": 70, "source": "PUBTATOR", "charStart": 63, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:BoiW", "entityType": "Gene", "charEnd": 691, "source": "PUBTATOR", "charStart": 688, "entityId": [{"idString": "328", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "APE1"}, {"duid": "PU:Bk79", "entityType": "Disease", "charEnd": 111, "source": "PUBTATOR", "charStart": 86, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:fx7T", "entityType": "Chemical", "charEnd": 986, "source": "PUBTATOR", "charStart": 977, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 5, "entityText": "paclitaxel"}, {"duid": "PU:nCQK", "entityType": "Disease", "charEnd": 1774, "source": "PUBTATOR", "charStart": 1770, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 10, "entityText": "NSCLC"}, {"duid": "PU:5Ned", "entityType": "Disease", "charEnd": 1066, "source": "PUBTATOR", "charStart": 1065, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 6, "entityText": "OS"}, {"duid": "PU:GtgC", "entityType": "Disease", "charEnd": 1193, "source": "PUBTATOR", "charStart": 1192, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 7, "entityText": "OS"}, {"duid": "PU:TdjW", "entityType": "Disease", "charEnd": 547, "source": "PUBTATOR", "charStart": 543, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "NSCLC"}, {"duid": "PU:JMPU", "entityType": "Species", "charEnd": 452, "source": "PUBTATOR", "charStart": 445, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:neNB", "entityType": "Gene", "charEnd": 47, "source": "PUBTATOR", "charStart": 43, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "TUBB3"}, {"duid": "PU:3Vf4", "entityType": "Gene", "charEnd": 415, "source": "PUBTATOR", "charStart": 411, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:3zsT", "entityType": "Chemical", "charEnd": 1617, "source": "PUBTATOR", "charStart": 1608, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 9, "entityText": "paclitaxel"}, {"duid": "PU:tSSb", "entityType": "Disease", "charEnd": 873, "source": "PUBTATOR", "charStart": 858, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 4, "entityText": "overall survival"}, {"duid": "PU:ApPA", "entityType": "Species", "charEnd": 1754, "source": "PUBTATOR", "charStart": 1747, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:ozfB", "entityType": "Gene", "charEnd": 1669, "source": "PUBTATOR", "charStart": 1666, "entityId": [{"idString": "328", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "APE1"}, {"duid": "PU:kkAv", "entityType": "Chemical", "charEnd": 1602, "source": "PUBTATOR", "charStart": 1595, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 9, "entityText": "platinum"}, {"duid": "PU:MU2e", "entityType": "Disease", "charEnd": 323, "source": "PUBTATOR", "charStart": 319, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:2o7A", "entityType": "Species", "charEnd": 556, "source": "PUBTATOR", "charStart": 549, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:HKH9", "entityType": "Chemical", "charEnd": 474, "source": "PUBTATOR", "charStart": 467, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 2, "entityText": "platinum"}, {"duid": "PU:7cKS", "entityType": "Gene", "charEnd": 1268, "source": "PUBTATOR", "charStart": 1265, "entityId": [{"idString": "328", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "APE1"}, {"duid": "PU:GFdv", "entityType": "Disease", "charEnd": 118, "source": "PUBTATOR", "charStart": 114, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "NSCLC"}, {"duid": "PU:uZDu", "entityType": "Gene", "charEnd": 946, "source": "PUBTATOR", "charStart": 942, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TUBB3"}, {"duid": "PU:JFjx", "entityType": "Gene", "charEnd": 1131, "source": "PUBTATOR", "charStart": 1128, "entityId": [{"idString": "328", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "APE1"}, {"duid": "PU:ucq8", "entityType": "Gene", "charEnd": 425, "source": "PUBTATOR", "charStart": 421, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TUBB3"}]}
{"text": "Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy. Expression of excision repair cross-complementation group 1 (ERCC1), p53, or thioredoxin (TRX) is reported to be correlated with resistance to platinum-based drugs. The authors evaluated whether ERCC1, p53, or TRX expression could predict progression-free and/or overall survival in relapsed non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy. Immunohistochemistry was used to examine the expression of these three proteins in resected lung tumor samples obtained from 67 patients treated with platinum-based chemotherapy against recurrent tumors after curative resection. Immunostaining for ERCC1, p53, and TRX was positive in 29, 35, and 24 patients, respectively. Patients negative for ERCC1 had a significantly longer median progression-free (44 vs 26 weeks, P = 0.0075) and overall (73 vs 44 weeks, P = 0.0006) survival than those positive for ERCC1. Patients negative for p53 expression had a significantly longer median overall (70 vs 62 weeks, P = 0.0289), but not progression-free (37.5 vs 36 weeks, P = 0.2465), survival than those positive for p53 expression. From multivariate analysis, negative ERCC1 expression (hazard ratio [HR] = 1.3740, P = 0.0147) was a significantly favorable factor for progression-free survival, and negative ERCC1 expression (HR = 1.6533, P = 0.0018) and better performance status (HR = 1.9117, P = 0.0017) were significantly favorable factors for overall survival. This retrospective study indicates that immunostaining for ERCC1 may be useful for predicting survival in NSCLC patients receiving platinum-based chemotherapy against recurrent tumors after curative resection and can provide critical information for planning personalized chemotherapy.", "title": {"charStart": 0, "charEnd": 172}, "docId": "17640298", "entity": [{"duid": "PU:SoqV", "entityType": "Disease", "charEnd": 653, "source": "PUBTATOR", "charStart": 644, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 3, "entityText": "lung tumor"}, {"duid": "PU:w4nn", "entityType": "Disease", "charEnd": 1723, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 8, "entityText": "NSCLC"}, {"duid": "PU:zUCn", "entityType": "Chemical", "charEnd": 152, "source": "PUBTATOR", "charStart": 145, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 0, "entityText": "platinum"}, {"duid": "PU:VRNH", "entityType": "Gene", "charEnd": 818, "source": "PUBTATOR", "charStart": 816, "entityId": [{"idString": "7295", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TRX"}, {"duid": "PU:TLQ4", "entityType": "Gene", "charEnd": 245, "source": "PUBTATOR", "charStart": 243, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "p53"}, {"duid": "PU:bTTB", "entityType": "Species", "charEnd": 882, "source": "PUBTATOR", "charStart": 875, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "Patients"}, {"duid": "PU:6hNZ", "entityType": "Disease", "charEnd": 753, "source": "PUBTATOR", "charStart": 748, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:sCpR", "entityType": "Chemical", "charEnd": 1751, "source": "PUBTATOR", "charStart": 1744, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 8, "entityText": "platinum"}, {"duid": "PU:pSMg", "entityType": "Gene", "charEnd": 1676, "source": "PUBTATOR", "charStart": 1672, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:H74c", "entityType": "Gene", "charEnd": 386, "source": "PUBTATOR", "charStart": 384, "entityId": [{"idString": "7295", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TRX"}, {"duid": "PU:b25o", "entityType": "Gene", "charEnd": 1061, "source": "PUBTATOR", "charStart": 1057, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:ngcr", "entityType": "Gene", "charEnd": 373, "source": "PUBTATOR", "charStart": 369, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:fwqd", "entityType": "Species", "charEnd": 130, "source": "PUBTATOR", "charStart": 123, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:PDNW", "entityType": "Gene", "charEnd": 809, "source": "PUBTATOR", "charStart": 807, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "p53"}, {"duid": "PU:PFCU", "entityType": "Species", "charEnd": 1071, "source": "PUBTATOR", "charStart": 1064, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "Patients"}, {"duid": "PU:obcM", "entityType": "Disease", "charEnd": 491, "source": "PUBTATOR", "charStart": 466, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "non-small cell lung cancer"}, {"duid": "PU:ugRm", "entityType": "Gene", "charEnd": 1088, "source": "PUBTATOR", "charStart": 1086, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "p53"}, {"duid": "PU:VBhJ", "entityType": "Gene", "charEnd": 266, "source": "PUBTATOR", "charStart": 264, "entityId": [{"idString": "7295", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TRX"}, {"duid": "PU:wAp3", "entityType": "Species", "charEnd": 508, "source": "PUBTATOR", "charStart": 501, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:WmAu", "entityType": "Chemical", "charEnd": 324, "source": "PUBTATOR", "charStart": 317, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:an9d", "entityType": "Disease", "charEnd": 498, "source": "PUBTATOR", "charStart": 494, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "NSCLC"}, {"duid": "PU:7kDZ", "entityType": "Gene", "charEnd": 261, "source": "PUBTATOR", "charStart": 251, "entityId": [{"idString": "7295", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thioredoxin"}, {"duid": "PU:fFrt", "entityType": "Gene", "charEnd": 378, "source": "PUBTATOR", "charStart": 376, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "p53"}, {"duid": "PU:qBsu", "entityType": "Species", "charEnd": 687, "source": "PUBTATOR", "charStart": 680, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:BZWb", "entityType": "Disease", "charEnd": 1795, "source": "PUBTATOR", "charStart": 1790, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "tumors"}, {"duid": "PU:gvoo", "entityType": "Chemical", "charEnd": 530, "source": "PUBTATOR", "charStart": 523, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 2, "entityText": "platinum"}, {"duid": "PU:VpyW", "entityType": "Gene", "charEnd": 239, "source": "PUBTATOR", "charStart": 235, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:RGGK", "entityType": "Gene", "charEnd": 1320, "source": "PUBTATOR", "charStart": 1316, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:U8e9", "entityType": "Gene", "charEnd": 1265, "source": "PUBTATOR", "charStart": 1263, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "p53"}, {"duid": "PU:eHUN", "entityType": "Gene", "charEnd": 804, "source": "PUBTATOR", "charStart": 800, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:DqN2", "entityType": "Species", "charEnd": 858, "source": "PUBTATOR", "charStart": 851, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:E6pG", "entityType": "Disease", "charEnd": 121, "source": "PUBTATOR", "charStart": 96, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:5Jji", "entityType": "Chemical", "charEnd": 709, "source": "PUBTATOR", "charStart": 702, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 3, "entityText": "platinum"}, {"duid": "PU:qdt5", "entityType": "Gene", "charEnd": 1459, "source": "PUBTATOR", "charStart": 1455, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:dTSj", "entityType": "Species", "charEnd": 1732, "source": "PUBTATOR", "charStart": 1725, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:M6AZ", "entityType": "Gene", "charEnd": 901, "source": "PUBTATOR", "charStart": 897, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}]}
{"text": "Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy. Expression of excision repair cross-complementation group 1 (ERCC1), p53, or thioredoxin (TRX) is reported to be correlated with resistance to platinum-based drugs. The authors evaluated whether ERCC1, p53, or TRX expression could predict progression-free and/or overall survival in relapsed non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy. Immunohistochemistry was used to examine the expression of these three proteins in resected lung tumor samples obtained from 67 patients treated with platinum-based chemotherapy against recurrent tumors after curative resection. Immunostaining for ERCC1, p53, and TRX was positive in 29, 35, and 24 patients, respectively. Patients negative for ERCC1 had a significantly longer median progression-free (44 vs 26 weeks, P = 0.0075) and overall (73 vs 44 weeks, P = 0.0006) survival than those positive for ERCC1. Patients negative for p53 expression had a significantly longer median overall (70 vs 62 weeks, P = 0.0289), but not progression-free (37.5 vs 36 weeks, P = 0.2465), survival than those positive for p53 expression. From multivariate analysis, negative ERCC1 expression (hazard ratio [HR] = 1.3740, P = 0.0147) was a significantly favorable factor for progression-free survival, and negative ERCC1 expression (HR = 1.6533, P = 0.0018) and better performance status (HR = 1.9117, P = 0.0017) were significantly favorable factors for overall survival. This retrospective study indicates that immunostaining for ERCC1 may be useful for predicting survival in NSCLC patients receiving platinum-based chemotherapy against recurrent tumors after curative resection and can provide critical information for planning personalized chemotherapy.", "title": {"charStart": 0, "charEnd": 172}, "docId": "17640298", "entity": [{"duid": "PU:SoqV", "entityType": "Disease", "charEnd": 653, "source": "PUBTATOR", "charStart": 644, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 3, "entityText": "lung tumor"}, {"duid": "PU:w4nn", "entityType": "Disease", "charEnd": 1723, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 8, "entityText": "NSCLC"}, {"duid": "PU:zUCn", "entityType": "Chemical", "charEnd": 152, "source": "PUBTATOR", "charStart": 145, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 0, "entityText": "platinum"}, {"duid": "PU:VRNH", "entityType": "Gene", "charEnd": 818, "source": "PUBTATOR", "charStart": 816, "entityId": [{"idString": "7295", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TRX"}, {"duid": "PU:TLQ4", "entityType": "Gene", "charEnd": 245, "source": "PUBTATOR", "charStart": 243, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "p53"}, {"duid": "PU:bTTB", "entityType": "Species", "charEnd": 882, "source": "PUBTATOR", "charStart": 875, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "Patients"}, {"duid": "PU:6hNZ", "entityType": "Disease", "charEnd": 753, "source": "PUBTATOR", "charStart": 748, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:sCpR", "entityType": "Chemical", "charEnd": 1751, "source": "PUBTATOR", "charStart": 1744, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 8, "entityText": "platinum"}, {"duid": "PU:pSMg", "entityType": "Gene", "charEnd": 1676, "source": "PUBTATOR", "charStart": 1672, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:H74c", "entityType": "Gene", "charEnd": 386, "source": "PUBTATOR", "charStart": 384, "entityId": [{"idString": "7295", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TRX"}, {"duid": "PU:b25o", "entityType": "Gene", "charEnd": 1061, "source": "PUBTATOR", "charStart": 1057, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:ngcr", "entityType": "Gene", "charEnd": 373, "source": "PUBTATOR", "charStart": 369, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:fwqd", "entityType": "Species", "charEnd": 130, "source": "PUBTATOR", "charStart": 123, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:PDNW", "entityType": "Gene", "charEnd": 809, "source": "PUBTATOR", "charStart": 807, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "p53"}, {"duid": "PU:PFCU", "entityType": "Species", "charEnd": 1071, "source": "PUBTATOR", "charStart": 1064, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "Patients"}, {"duid": "PU:obcM", "entityType": "Disease", "charEnd": 491, "source": "PUBTATOR", "charStart": 466, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "non-small cell lung cancer"}, {"duid": "PU:ugRm", "entityType": "Gene", "charEnd": 1088, "source": "PUBTATOR", "charStart": 1086, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "p53"}, {"duid": "PU:VBhJ", "entityType": "Gene", "charEnd": 266, "source": "PUBTATOR", "charStart": 264, "entityId": [{"idString": "7295", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TRX"}, {"duid": "PU:wAp3", "entityType": "Species", "charEnd": 508, "source": "PUBTATOR", "charStart": 501, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:WmAu", "entityType": "Chemical", "charEnd": 324, "source": "PUBTATOR", "charStart": 317, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:an9d", "entityType": "Disease", "charEnd": 498, "source": "PUBTATOR", "charStart": 494, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "NSCLC"}, {"duid": "PU:7kDZ", "entityType": "Gene", "charEnd": 261, "source": "PUBTATOR", "charStart": 251, "entityId": [{"idString": "7295", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thioredoxin"}, {"duid": "PU:fFrt", "entityType": "Gene", "charEnd": 378, "source": "PUBTATOR", "charStart": 376, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "p53"}, {"duid": "PU:qBsu", "entityType": "Species", "charEnd": 687, "source": "PUBTATOR", "charStart": 680, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:BZWb", "entityType": "Disease", "charEnd": 1795, "source": "PUBTATOR", "charStart": 1790, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "tumors"}, {"duid": "PU:gvoo", "entityType": "Chemical", "charEnd": 530, "source": "PUBTATOR", "charStart": 523, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 2, "entityText": "platinum"}, {"duid": "PU:VpyW", "entityType": "Gene", "charEnd": 239, "source": "PUBTATOR", "charStart": 235, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:RGGK", "entityType": "Gene", "charEnd": 1320, "source": "PUBTATOR", "charStart": 1316, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:U8e9", "entityType": "Gene", "charEnd": 1265, "source": "PUBTATOR", "charStart": 1263, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "p53"}, {"duid": "PU:eHUN", "entityType": "Gene", "charEnd": 804, "source": "PUBTATOR", "charStart": 800, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:DqN2", "entityType": "Species", "charEnd": 858, "source": "PUBTATOR", "charStart": 851, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:E6pG", "entityType": "Disease", "charEnd": 121, "source": "PUBTATOR", "charStart": 96, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:5Jji", "entityType": "Chemical", "charEnd": 709, "source": "PUBTATOR", "charStart": 702, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 3, "entityText": "platinum"}, {"duid": "PU:qdt5", "entityType": "Gene", "charEnd": 1459, "source": "PUBTATOR", "charStart": 1455, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:dTSj", "entityType": "Species", "charEnd": 1732, "source": "PUBTATOR", "charStart": 1725, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:M6AZ", "entityType": "Gene", "charEnd": 901, "source": "PUBTATOR", "charStart": 897, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}]}
{"text": "Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer. BACKGROUND: The aim of this study was to determine a predictive indicator of gemcitabine (GEM) efficacy in unresectable pancreatic cancer using tissue obtained by endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA). METHODS: mRNAs extracted from 35 pancreatic tubular adenocarcinoma tissues obtained by EUS-FNA before GEM-treatment were studied. mRNAs were amplified and applied to a Focused DNA Array, which was restricted to well-known genes, including GEM sensitivity-related genes, deoxycytidine kinase (dCK), human equilibrative nucleoside transporter 1 (hENT1), hENT2, dCMP deaminase, cytidine deaminase, 5'-nucleotidase, ribonucleotide reductase 1 (RRM1) and RRM2. mRNA levels were classified into high and low expression based on a cut-off value defined as the average expression of 35 samples. These 35 patients were divided into the following two groups. Patients with partial response and those with stable disease whose tumor markers decreased by 50% or more were classified as the effective group. The rest of patients were classified as the non-effective group. The relationship between GEM efficacy and mRNA expression was then examined by chi-squared test. RESULTS: Among these GEM sensitivity-related genes, dCK alone showed a significant correlation with GEM efficacy. Eight of 12 patients in the effective group had high dCK expression, whereas 16 of 23 patients in non-effective group had low dCK expressions (P = 0.0398). CONCLUSION: dCK mRNA expression is a candidate indicator for GEM efficacy in unresectable pancreatic cancer. Quantitative mRNA measurements of dCK using EUS-FNA samples are necessary for definitive conclusions.", "title": {"charStart": 0, "charEnd": 143}, "docId": "19531250", "entity": [{"duid": "PU:eTr3", "entityType": "Gene", "charEnd": 770, "source": "PUBTATOR", "charStart": 753, "entityId": [{"idString": "978", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "cytidine deaminase"}, {"duid": "PU:dX3x", "entityType": "Gene", "charEnd": 1750, "source": "PUBTATOR", "charStart": 1748, "entityId": [{"idString": "43828", "source": "Entrez"}, {"idString": "7227", "source": "Tax"}], "sentenceIndex": 12, "entityText": "dCK"}, {"duid": "PU:97DV", "entityType": "Gene", "charEnd": 672, "source": "PUBTATOR", "charStart": 670, "entityId": [{"idString": "43828", "source": "Entrez"}, {"idString": "7227", "source": "Tax"}], "sentenceIndex": 3, "entityText": "dCK"}, {"duid": "PU:4vDW", "entityType": "Gene", "charEnd": 1504, "source": "PUBTATOR", "charStart": 1502, "entityId": [{"idString": "43828", "source": "Entrez"}, {"idString": "7227", "source": "Tax"}], "sentenceIndex": 10, "entityText": "dCK"}, {"duid": "PU:CThA", "entityType": "Species", "charEnd": 981, "source": "PUBTATOR", "charStart": 974, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:9PZ2", "entityType": "Gene", "charEnd": 1389, "source": "PUBTATOR", "charStart": 1387, "entityId": [{"idString": "43828", "source": "Entrez"}, {"idString": "7227", "source": "Tax"}], "sentenceIndex": 9, "entityText": "dCK"}, {"duid": "PU:ZZiA", "entityType": "Chemical", "charEnd": 760, "source": "PUBTATOR", "charStart": 753, "entityId": [{"idString": "D003562", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cytidine"}, {"duid": "PU:oxrA", "entityType": "Disease", "charEnd": 142, "source": "PUBTATOR", "charStart": 126, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 0, "entityText": "pancreatic cancer"}, {"duid": "PU:cy4j", "entityType": "Disease", "charEnd": 1711, "source": "PUBTATOR", "charStart": 1695, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 11, "entityText": "pancreatic cancer"}, {"duid": "PU:nD5M", "entityType": "Species", "charEnd": 1192, "source": "PUBTATOR", "charStart": 1185, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:j2cu", "entityType": "Chemical", "charEnd": 803, "source": "PUBTATOR", "charStart": 790, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 3, "entityText": "ribonucleotide"}, {"duid": "PU:8uJy", "entityType": "Gene", "charEnd": 1577, "source": "PUBTATOR", "charStart": 1575, "entityId": [{"idString": "43828", "source": "Entrez"}, {"idString": "7227", "source": "Tax"}], "sentenceIndex": 10, "entityText": "dCK"}, {"duid": "PU:2jqD", "entityType": "Disease", "charEnd": 443, "source": "PUBTATOR", "charStart": 411, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 2, "entityText": "pancreatic tubular adenocarcinoma"}, {"duid": "PU:9BjN", "entityType": "Chemical", "charEnd": 232, "source": "PUBTATOR", "charStart": 222, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gemcitabine"}, {"duid": "PU:W33y", "entityType": "Gene", "charEnd": 831, "source": "PUBTATOR", "charStart": 828, "entityId": [{"idString": "6241", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "RRM2"}, {"duid": "PU:T8U7", "entityType": "Gene", "charEnd": 719, "source": "PUBTATOR", "charStart": 682, "entityId": [{"idString": "2030", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "equilibrative nucleoside transporter 1"}, {"duid": "PU:QLwg", "entityType": "Gene", "charEnd": 821, "source": "PUBTATOR", "charStart": 818, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "RRM1"}, {"duid": "PU:8Uin", "entityType": "Chemical", "charEnd": 10, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Gemcitabine"}, {"duid": "PU:PSjC", "entityType": "Gene", "charEnd": 787, "source": "PUBTATOR", "charStart": 773, "entityId": [{"idString": "4907", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "5'-nucleotidase"}, {"duid": "PU:DmTP", "entityType": "Gene", "charEnd": 1619, "source": "PUBTATOR", "charStart": 1617, "entityId": [{"idString": "43828", "source": "Entrez"}, {"idString": "7227", "source": "Tax"}], "sentenceIndex": 11, "entityText": "dCK"}, {"duid": "PU:mMtQ", "entityType": "Species", "charEnd": 680, "source": "PUBTATOR", "charStart": 676, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "human"}, {"duid": "PU:Rht6", "entityType": "Species", "charEnd": 1542, "source": "PUBTATOR", "charStart": 1535, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:Lo5Y", "entityType": "Disease", "charEnd": 281, "source": "PUBTATOR", "charStart": 265, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 1, "entityText": "pancreatic cancer"}, {"duid": "PU:QaBQ", "entityType": "Species", "charEnd": 1468, "source": "PUBTATOR", "charStart": 1461, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:Vxy5", "entityType": "Species", "charEnd": 1034, "source": "PUBTATOR", "charStart": 1027, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "Patients"}, {"duid": "PU:F8tH", "entityType": "Chemical", "charEnd": 237, "source": "PUBTATOR", "charStart": 235, "entityId": [], "sentenceIndex": 1, "entityText": "GEM"}, {"duid": "PU:ttKp", "entityType": "Chemical", "charEnd": 660, "source": "PUBTATOR", "charStart": 648, "entityId": [{"idString": "D003841", "source": "MESH"}], "sentenceIndex": 3, "entityText": "deoxycytidine"}, {"duid": "PU:3q2M", "entityType": "Gene", "charEnd": 726, "source": "PUBTATOR", "charStart": 722, "entityId": [{"idString": "2030", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "hENT1"}, {"duid": "PU:dDFc", "entityType": "Chemical", "charEnd": 705, "source": "PUBTATOR", "charStart": 696, "entityId": [{"idString": "33838", "source": "CHEBI"}], "sentenceIndex": 3, "entityText": "nucleoside"}, {"duid": "PU:76P9", "entityType": "Gene", "charEnd": 734, "source": "PUBTATOR", "charStart": 730, "entityId": [{"idString": "3177", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "hENT2"}, {"duid": "PU:dZM7", "entityType": "Disease", "charEnd": 1098, "source": "PUBTATOR", "charStart": 1094, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumor"}, {"duid": "PU:SQjD", "entityType": "Gene", "charEnd": 667, "source": "PUBTATOR", "charStart": 648, "entityId": [{"idString": "1633", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "deoxycytidine kinase"}]}
{"text": "Tumour topoisomerase II alpha protein expression and outcome after adjuvant dose-dense anthracycline-based chemotherapy. There is a need for the selection of those breast cancers where benefit may be attained from the addition of an anthracycline to the adjuvant chemotherapy. The expression of topoisomerase II alpha (TOP2A) protein in 3 cohorts of breast cancers treated with adjuvant dose-dense anthracycline-based chemotherapy was determined retrospectively. The TOP2A status was analysed in relation with the other standard tumour features and the outcome. TOP2A IHC results were assessable in 106 patients: with a cut-off value of 15%, 48% of the tumours were classified as TOP2A-positive. The expression of TOP2A correlated with that of Ki67 (R\u2009=\u20090.532, p\u2009<\u20090.001) and a high grade (p\u2009=\u20090.04), but did not correlate with the proportion of ER- or PR-positive cells in the tumour. More tumors were TOP2A-negative among the ER- or PR-positive cancers than among the ER/PR-negative cancers (p\u2009=\u20090.021 and p\u2009=\u20090.002, respectively). After a median follow-up time of 64.5\u00a0months, 31 relapses (23.5%) and 23 deaths (17.4%) had occurred in 131 patients. The overall survival was longer in the TOP2A-positive cases than in the TOP2A-negative cases. The recurrence-free survival and the overall survival were significantly more favourable in the ER/PR-negative and TOP2A-positive tumours than in other subgroups. In a Cox proportional hazards model, the grade and TOP2A remained significant determinants in the ER/PR-negative subgroup. TOP2A positivity and grade 3 indicated a decrease in the risk of death with HR\u2009=\u20090.211 (95% CI: 0.042-1.05, p\u2009=\u20090.056) and HR\u2009=\u20090.216 (95% CI: 0.047-0.990, p\u2009=\u20090.048), respectively. A higher sensitivity to anthracycline-containing regimens is suggested in ER/PR-negative and TOP2A-positive cancers.", "title": {"charStart": 0, "charEnd": 119}, "docId": "21681601", "entity": [{"duid": "PU:ybLQ", "entityType": "Chemical", "charEnd": 99, "source": "PUBTATOR", "charStart": 87, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "anthracycline"}, {"duid": "PU:7JWa", "entityType": "Gene", "charEnd": 566, "source": "PUBTATOR", "charStart": 562, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TOP2A"}, {"duid": "PU:oNEm", "entityType": "Gene", "charEnd": 471, "source": "PUBTATOR", "charStart": 467, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "TOP2A"}, {"duid": "PU:yHpp", "entityType": "Gene", "charEnd": 1536, "source": "PUBTATOR", "charStart": 1532, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "TOP2A"}, {"duid": "PU:nMw3", "entityType": "Chemical", "charEnd": 245, "source": "PUBTATOR", "charStart": 233, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "anthracycline"}, {"duid": "PU:MxW2", "entityType": "Disease", "charEnd": 991, "source": "PUBTATOR", "charStart": 985, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "cancers"}, {"duid": "PU:364V", "entityType": "Chemical", "charEnd": 1750, "source": "PUBTATOR", "charStart": 1738, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 12, "entityText": "anthracycline"}, {"duid": "PU:XBUM", "entityType": "Species", "charEnd": 610, "source": "PUBTATOR", "charStart": 603, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:Ch9E", "entityType": "Disease", "charEnd": 1382, "source": "PUBTATOR", "charStart": 1376, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumours"}, {"duid": "PU:Qd6Q", "entityType": "Gene", "charEnd": 1365, "source": "PUBTATOR", "charStart": 1361, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TOP2A"}, {"duid": "PU:PZMz", "entityType": "Gene", "charEnd": 718, "source": "PUBTATOR", "charStart": 714, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TOP2A"}, {"duid": "PU:ndkk", "entityType": "Disease", "charEnd": 1828, "source": "PUBTATOR", "charStart": 1822, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 12, "entityText": "cancers"}, {"duid": "PU:jCXd", "entityType": "Disease", "charEnd": 534, "source": "PUBTATOR", "charStart": 529, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumour"}, {"duid": "PU:Vfzv", "entityType": "Gene", "charEnd": 1195, "source": "PUBTATOR", "charStart": 1191, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TOP2A"}, {"duid": "PU:2ViP", "entityType": "Gene", "charEnd": 684, "source": "PUBTATOR", "charStart": 680, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TOP2A"}, {"duid": "PU:5nJ7", "entityType": "Gene", "charEnd": 907, "source": "PUBTATOR", "charStart": 903, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TOP2A"}, {"duid": "PU:6Tpo", "entityType": "Gene", "charEnd": 1811, "source": "PUBTATOR", "charStart": 1807, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "TOP2A"}, {"duid": "PU:u5z6", "entityType": "Disease", "charEnd": 5, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Tumour"}, {"duid": "PU:Be2F", "entityType": "Disease", "charEnd": 659, "source": "PUBTATOR", "charStart": 653, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumours"}, {"duid": "PU:YBiX", "entityType": "Disease", "charEnd": 896, "source": "PUBTATOR", "charStart": 891, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumors"}, {"duid": "PU:9yhX", "entityType": "Disease", "charEnd": 883, "source": "PUBTATOR", "charStart": 878, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumour"}, {"duid": "PU:d52G", "entityType": "Gene", "charEnd": 1464, "source": "PUBTATOR", "charStart": 1460, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "TOP2A"}, {"duid": "PU:CpkV", "entityType": "Disease", "charEnd": 177, "source": "PUBTATOR", "charStart": 164, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast cancers"}, {"duid": "PU:vo2j", "entityType": "Disease", "charEnd": 1601, "source": "PUBTATOR", "charStart": 1597, "entityId": [{"idString": "D003643", "source": "MESH"}], "sentenceIndex": 11, "entityText": "death"}, {"duid": "PU:rpnm", "entityType": "Chemical", "charEnd": 410, "source": "PUBTATOR", "charStart": 398, "entityId": [{"idString": "48120", "source": "CHEBI"}], "sentenceIndex": 2, "entityText": "anthracycline"}, {"duid": "PU:a5rU", "entityType": "Species", "charEnd": 1149, "source": "PUBTATOR", "charStart": 1142, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:MnZe", "entityType": "Gene", "charEnd": 323, "source": "PUBTATOR", "charStart": 319, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TOP2A"}, {"duid": "PU:vmcq", "entityType": "Disease", "charEnd": 363, "source": "PUBTATOR", "charStart": 350, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 2, "entityText": "breast cancers"}, {"duid": "PU:86KW", "entityType": "Gene", "charEnd": 1228, "source": "PUBTATOR", "charStart": 1224, "entityId": [{"idString": "7153", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TOP2A"}, {"duid": "PU:xFz7", "entityType": "Disease", "charEnd": 953, "source": "PUBTATOR", "charStart": 947, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "cancers"}]}
{"text": "ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. The excision repair cross-complementation group 1 (ERCC1) enzyme plays a rate-limiting role in the nucleotide excision repair pathway and is associated with resistance to platinum-based chemotherapy. The purpose of this study was to evaluate the role of ERCC1 expression as a predictive marker of survival in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) treated with cisplatin-based concurrent chemoradiotherapy (CCRT). ERCC1 expression was assessed by immunohistochemical staining. The median age of the 45 patients analysed was 56 years (range 27-75 years), and 82% were men; 73% of all specimens showed high expression of ERCC1. The overall tumour response rate after CCRT was 89%. The median follow-up was 53.6 months (95% CI, 34.5-72.7 months). The 3-year progression-free survival (PFS) and overall survival (OS) rates were 58.7 and 61.3%, respectively. Univariate analyses showed that patients with low expression of ERCC1 had a significantly higher 3-year PFS (83.3 vs 49.4%, P=0.036) and OS (91.7 vs 45.5%, P=0.013) rates. Multivariate analysis showed that low expression of ERCC1 was an independent predictor for prolonged survival (HR, 0.120; 95% CI, 0.016-0.934, P=0.043). These results suggest that ERCC1 expression might be a useful predictive marker of locally advanced SCCHN in patients treated with cisplatin-based CCRT.", "title": {"charStart": 0, "charEnd": 142}, "docId": "18594541", "entity": [{"duid": "PU:65b9", "entityType": "Disease", "charEnd": 995, "source": "PUBTATOR", "charStart": 980, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 7, "entityText": "overall survival"}, {"duid": "PU:558f", "entityType": "Gene", "charEnd": 607, "source": "PUBTATOR", "charStart": 603, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:T7eE", "entityType": "Chemical", "charEnd": 558, "source": "PUBTATOR", "charStart": 550, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cisplatin"}, {"duid": "PU:EiPQ", "entityType": "Disease", "charEnd": 534, "source": "PUBTATOR", "charStart": 530, "entityId": [{"idString": "C535575", "source": "MESH"}], "sentenceIndex": 2, "entityText": "SCCHN"}, {"duid": "PU:Cs67", "entityType": "Gene", "charEnd": 1111, "source": "PUBTATOR", "charStart": 1107, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:LNib", "entityType": "Chemical", "charEnd": 1507, "source": "PUBTATOR", "charStart": 1499, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 10, "entityText": "cisplatin"}, {"duid": "PU:JTQ3", "entityType": "Gene", "charEnd": 199, "source": "PUBTATOR", "charStart": 195, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:T2ZS", "entityType": "Gene", "charEnd": 402, "source": "PUBTATOR", "charStart": 398, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:3j9L", "entityType": "Chemical", "charEnd": 322, "source": "PUBTATOR", "charStart": 315, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:TVCf", "entityType": "Gene", "charEnd": 192, "source": "PUBTATOR", "charStart": 148, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementation group 1"}, {"duid": "PU:TARH", "entityType": "Chemical", "charEnd": 109, "source": "PUBTATOR", "charStart": 101, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "cisplatin"}, {"duid": "PU:k8XA", "entityType": "Species", "charEnd": 758, "source": "PUBTATOR", "charStart": 756, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "men"}, {"duid": "PU:rQVf", "entityType": "Species", "charEnd": 1484, "source": "PUBTATOR", "charStart": 1477, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:YCHU", "entityType": "Gene", "charEnd": 1271, "source": "PUBTATOR", "charStart": 1267, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:ngEk", "entityType": "Gene", "charEnd": 812, "source": "PUBTATOR", "charStart": 808, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:zRhs", "entityType": "Disease", "charEnd": 1472, "source": "PUBTATOR", "charStart": 1468, "entityId": [{"idString": "C535575", "source": "MESH"}], "sentenceIndex": 10, "entityText": "SCCHN"}, {"duid": "PU:37Np", "entityType": "Species", "charEnd": 1082, "source": "PUBTATOR", "charStart": 1075, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:Hzuk", "entityType": "Disease", "charEnd": 527, "source": "PUBTATOR", "charStart": 484, "entityId": [{"idString": "C535575", "source": "MESH"}], "sentenceIndex": 2, "entityText": "squamous cell carcinoma of the head and neck"}, {"duid": "PU:4fDc", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:w4uL", "entityType": "Disease", "charEnd": 86, "source": "PUBTATOR", "charStart": 43, "entityId": [{"idString": "C535575", "source": "MESH"}], "sentenceIndex": 0, "entityText": "squamous cell carcinoma of the head and neck"}, {"duid": "PU:xv5w", "entityType": "Disease", "charEnd": 1181, "source": "PUBTATOR", "charStart": 1180, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 8, "entityText": "OS"}, {"duid": "PU:YuQV", "entityType": "Species", "charEnd": 460, "source": "PUBTATOR", "charStart": 453, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:ZTUJ", "entityType": "Gene", "charEnd": 1399, "source": "PUBTATOR", "charStart": 1395, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:vW9B", "entityType": "Chemical", "charEnd": 252, "source": "PUBTATOR", "charStart": 243, "entityId": [{"idString": "36976", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "nucleotide"}, {"duid": "PU:rCRJ", "entityType": "Species", "charEnd": 698, "source": "PUBTATOR", "charStart": 691, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:bGmB", "entityType": "Disease", "charEnd": 832, "source": "PUBTATOR", "charStart": 827, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumour"}, {"duid": "PU:yUB9", "entityType": "Disease", "charEnd": 999, "source": "PUBTATOR", "charStart": 998, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 7, "entityText": "OS"}]}
{"text": "ERCC1 mRNA expression is associated with the clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy. We conducted a prospective study to analyze the expression of the excision repair cross-complementing group 1 (ERCC1) and ribonucleotide reductase subunit M1 (RRM1) genes in 297 Chinese patients with advanced non-small cell lung cancer (NSCLC). The goal of this study was to evaluate these genes as potential biomarkers for prediction of tumor response and clinical outcome. Patients with unresectable, locally advanced or metastatic NSCLC were enrolled between September 2007 and September 2009, and they were followed up until September 2012. A fluorescence-based real-time detection method was used to quantify relative levels of ERCC1 and RRM1 cDNA. Relative amounts of ERCC1 and RRM1 cDNA were calculated by comparing to actin. By the end of follow-up, 132 patients had died and 165 patients experienced progression. The median overall survival time was 18.7 months (range, 1-60 months). The median levels of ERCC1 and RRM1 were 2.46 x 10(-2) and 0.97 x 10(-2), respectively. Patients with low ERCC1 expression had a significantly higher rate of complete response to chemotherapy, with an OR (95%CI) of 1.56 (1.03-2.47). Moreover, individuals with low levels of ERCC1 had longer overall survival than patients with high expression, with an adjusted hazard ratio (95%CI) of 0.57 (0.35-0.93). In summary, low ERCC1 mRNA expression was associated with better response to chemotherapy and correlated with longer survival in advanced NSCLC patients treated with platinum-based chemotherapy.", "title": {"charStart": 0, "charEnd": 132}, "docId": "25501233", "entity": [{"duid": "PU:CTTZ", "entityType": "Disease", "charEnd": 368, "source": "PUBTATOR", "charStart": 343, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small cell lung cancer"}, {"duid": "PU:7tct", "entityType": "Gene", "charEnd": 771, "source": "PUBTATOR", "charStart": 767, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:hoFh", "entityType": "Chemical", "charEnd": 269, "source": "PUBTATOR", "charStart": 256, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "ribonucleotide"}, {"duid": "PU:yBsF", "entityType": "Species", "charEnd": 1347, "source": "PUBTATOR", "charStart": 1340, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:BvFF", "entityType": "Species", "charEnd": 1122, "source": "PUBTATOR", "charStart": 1115, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "Patients"}, {"duid": "PU:xEgP", "entityType": "Gene", "charEnd": 812, "source": "PUBTATOR", "charStart": 808, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:dKyg", "entityType": "Species", "charEnd": 929, "source": "PUBTATOR", "charStart": 922, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:7DWi", "entityType": "Species", "charEnd": 327, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:S3yx", "entityType": "Gene", "charEnd": 296, "source": "PUBTATOR", "charStart": 293, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "RRM1"}, {"duid": "PU:gXb9", "entityType": "Species", "charEnd": 1581, "source": "PUBTATOR", "charStart": 1574, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:Uuhn", "entityType": "Gene", "charEnd": 242, "source": "PUBTATOR", "charStart": 200, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementing group 1"}, {"duid": "PU:EAdD", "entityType": "Disease", "charEnd": 572, "source": "PUBTATOR", "charStart": 568, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "NSCLC"}, {"duid": "PU:UDuh", "entityType": "Disease", "charEnd": 476, "source": "PUBTATOR", "charStart": 472, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:nPFK", "entityType": "Disease", "charEnd": 90, "source": "PUBTATOR", "charStart": 65, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:qgrz", "entityType": "Gene", "charEnd": 249, "source": "PUBTATOR", "charStart": 245, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:ASKR", "entityType": "Gene", "charEnd": 780, "source": "PUBTATOR", "charStart": 777, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RRM1"}, {"duid": "PU:Wuuy", "entityType": "Disease", "charEnd": 1572, "source": "PUBTATOR", "charStart": 1568, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 11, "entityText": "NSCLC"}, {"duid": "PU:AyZu", "entityType": "Species", "charEnd": 516, "source": "PUBTATOR", "charStart": 509, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "Patients"}, {"duid": "PU:MfTG", "entityType": "Gene", "charEnd": 1137, "source": "PUBTATOR", "charStart": 1133, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:k2kT", "entityType": "Disease", "charEnd": 375, "source": "PUBTATOR", "charStart": 371, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:WPzU", "entityType": "Gene", "charEnd": 290, "source": "PUBTATOR", "charStart": 256, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ribonucleotide reductase subunit M1"}, {"duid": "PU:jh69", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:Rfdx", "entityType": "Gene", "charEnd": 1061, "source": "PUBTATOR", "charStart": 1058, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "RRM1"}, {"duid": "PU:aZut", "entityType": "Chemical", "charEnd": 1603, "source": "PUBTATOR", "charStart": 1596, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 11, "entityText": "platinum"}, {"duid": "PU:9VuB", "entityType": "Gene", "charEnd": 1052, "source": "PUBTATOR", "charStart": 1048, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:bdVX", "entityType": "Gene", "charEnd": 1450, "source": "PUBTATOR", "charStart": 1446, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ERCC1"}, {"duid": "PU:PyJQ", "entityType": "Chemical", "charEnd": 112, "source": "PUBTATOR", "charStart": 105, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 0, "entityText": "platinum"}, {"duid": "PU:JQ3u", "entityType": "Gene", "charEnd": 821, "source": "PUBTATOR", "charStart": 818, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "RRM1"}, {"duid": "PU:xNBB", "entityType": "Species", "charEnd": 903, "source": "PUBTATOR", "charStart": 896, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:XD89", "entityType": "Gene", "charEnd": 1305, "source": "PUBTATOR", "charStart": 1301, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}]}
{"text": "Blockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in gastric cancer cells. PURPOSE: Hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) increases transcription of the vascular endothelial growth factor (VEGF) gene. Inhibition of VEGF abolishes VEGF mediated induction of HIF-1\u03b1. Recent reports suggested that HIF-1\u03b1 also mediated the induction of class III \u03b2-tubulin (TUBB3) in hypoxia. TUBB3 confers resistance to taxanes. Inhibition of VEGF may decrease the expression of HIF-1\u03b1 and TUBB3. This study was undertaken to investigate the roles of vascular endothelial growth factor receptor (VEGFR) in gastric cancer cell behavior and to identify methods to overcome paclitaxel resistance in vitro. MATERIALS AND METHODS: The protein expression levels of HIF-1\u03b1 and TUBB3 were measured in human gastric cancer cell lines (AGS) under normoxic and hypoxic conditions. The relationship between TUBB3 and paclitaxel resistance was assessed with small interfering TUBB3 RNA. AGS cells were treated with anti-VEGFR-1, anti-VEGFR-2, placental growth factor (PlGF), bevacizuamb, and paclitaxel. RESULTS: Hypoxia induced paclitaxel resistance was decreased by knockdown of TUBB3. Induction of HIF-1\u03b1 and TUBB3 in AGS is VEGFR-1 mediated and PlGF dependent. Hypoxia-dependent upregulation of HIF-1\u03b1 and TUBB3 was reduced in response to paclitaxel treatment. Expressions of HIF-1\u03b1 and TUBB3 were most decreased when AGS cells were treated with a combination of paclitaxel and anti-VEGFR-1. AGS cell cytotoxicity was most increased in response to paclitaxel, anti-VEGFR-1, and anti-VEGFR-2. CONCLUSION: We suggest that blockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in TUBB3-expressing gastric cancer cells.", "title": {"charStart": 0, "charEnd": 87}, "docId": "23364970", "entity": [{"duid": "PU:4yZp", "entityType": "Disease", "charEnd": 1479, "source": "PUBTATOR", "charStart": 1477, "entityId": [{"idString": "C535607", "source": "MESH"}], "sentenceIndex": 14, "entityText": "AGS"}, {"duid": "PU:tv4V", "entityType": "Disease", "charEnd": 1204, "source": "PUBTATOR", "charStart": 1202, "entityId": [{"idString": "C535607", "source": "MESH"}], "sentenceIndex": 11, "entityText": "AGS"}, {"duid": "PU:xuYo", "entityType": "Gene", "charEnd": 1007, "source": "PUBTATOR", "charStart": 1001, "entityId": [{"idString": "2321", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "VEGFR-1"}, {"duid": "PU:ymmr", "entityType": "Gene", "charEnd": 313, "source": "PUBTATOR", "charStart": 308, "entityId": [{"idString": "3091", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "HIF-1\u03b1"}, {"duid": "PU:cT3V", "entityType": "Gene", "charEnd": 1046, "source": "PUBTATOR", "charStart": 1024, "entityId": [{"idString": "5228", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "placental growth factor"}, {"duid": "PU:Ng4v", "entityType": "Gene", "charEnd": 488, "source": "PUBTATOR", "charStart": 484, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TUBB3"}, {"duid": "PU:XQRm", "entityType": "Chemical", "charEnd": 1082, "source": "PUBTATOR", "charStart": 1073, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 9, "entityText": "paclitaxel"}, {"duid": "PU:JVNi", "entityType": "Disease", "charEnd": 80, "source": "PUBTATOR", "charStart": 67, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric cancer"}, {"duid": "PU:RT68", "entityType": "Gene", "charEnd": 1021, "source": "PUBTATOR", "charStart": 1015, "entityId": [{"idString": "3791", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "VEGFR-2"}, {"duid": "PU:87MR", "entityType": "Gene", "charEnd": 231, "source": "PUBTATOR", "charStart": 228, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "VEGF"}, {"duid": "PU:8gWR", "entityType": "Gene", "charEnd": 1366, "source": "PUBTATOR", "charStart": 1361, "entityId": [{"idString": "3091", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "HIF-1\u03b1"}, {"duid": "PU:4H69", "entityType": "Gene", "charEnd": 594, "source": "PUBTATOR", "charStart": 590, "entityId": [{"idString": "3791", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "VEGFR"}, {"duid": "PU:9nBy", "entityType": "Gene", "charEnd": 1376, "source": "PUBTATOR", "charStart": 1372, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "TUBB3"}, {"duid": "PU:6i3v", "entityType": "Gene", "charEnd": 1635, "source": "PUBTATOR", "charStart": 1629, "entityId": [{"idString": "3791", "source": "Entrez"}], "sentenceIndex": 15, "entityText": "VEGFR-2"}, {"duid": "PU:mkAd", "entityType": "Species", "charEnd": 791, "source": "PUBTATOR", "charStart": 787, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "human"}, {"duid": "PU:sK6T", "entityType": "Disease", "charEnd": 1252, "source": "PUBTATOR", "charStart": 1246, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 12, "entityText": "Hypoxia"}, {"duid": "PU:kfkK", "entityType": "Gene", "charEnd": 132, "source": "PUBTATOR", "charStart": 127, "entityId": [{"idString": "3091", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "HIF-1\u03b1"}, {"duid": "PU:pECR", "entityType": "Disease", "charEnd": 383, "source": "PUBTATOR", "charStart": 377, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 3, "entityText": "hypoxia"}, {"duid": "PU:yTvN", "entityType": "Chemical", "charEnd": 1457, "source": "PUBTATOR", "charStart": 1448, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 13, "entityText": "paclitaxel"}, {"duid": "PU:u5NB", "entityType": "Disease", "charEnd": 104, "source": "PUBTATOR", "charStart": 98, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Hypoxia"}, {"duid": "PU:8Dje", "entityType": "Chemical", "charEnd": 1655, "source": "PUBTATOR", "charStart": 1646, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 15, "entityText": "paclitaxel"}, {"duid": "PU:sAwd", "entityType": "Gene", "charEnd": 1187, "source": "PUBTATOR", "charStart": 1182, "entityId": [{"idString": "3091", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "HIF-1\u03b1"}, {"duid": "PU:aSEp", "entityType": "Gene", "charEnd": 768, "source": "PUBTATOR", "charStart": 764, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TUBB3"}, {"duid": "PU:fee9", "entityType": "Gene", "charEnd": 1285, "source": "PUBTATOR", "charStart": 1280, "entityId": [{"idString": "3091", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "HIF-1\u03b1"}, {"duid": "PU:8Awx", "entityType": "Disease", "charEnd": 1405, "source": "PUBTATOR", "charStart": 1403, "entityId": [{"idString": "C535607", "source": "MESH"}], "sentenceIndex": 13, "entityText": "AGS"}, {"duid": "PU:GqR4", "entityType": "Gene", "charEnd": 1052, "source": "PUBTATOR", "charStart": 1049, "entityId": [{"idString": "5228", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "PlGF"}, {"duid": "PU:BjmP", "entityType": "Gene", "charEnd": 1474, "source": "PUBTATOR", "charStart": 1468, "entityId": [{"idString": "2321", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "VEGFR-1"}, {"duid": "PU:X4pd", "entityType": "Gene", "charEnd": 1233, "source": "PUBTATOR", "charStart": 1230, "entityId": [{"idString": "5228", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "PlGF"}, {"duid": "PU:sHZf", "entityType": "Gene", "charEnd": 478, "source": "PUBTATOR", "charStart": 473, "entityId": [{"idString": "3091", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "HIF-1\u03b1"}, {"duid": "PU:yCsz", "entityType": "Gene", "charEnd": 1295, "source": "PUBTATOR", "charStart": 1291, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "TUBB3"}, {"duid": "PU:XX9H", "entityType": "Gene", "charEnd": 1676, "source": "PUBTATOR", "charStart": 1672, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 15, "entityText": "TUBB3"}, {"duid": "PU:zBSi", "entityType": "Disease", "charEnd": 1702, "source": "PUBTATOR", "charStart": 1689, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 15, "entityText": "gastric cancer"}, {"duid": "PU:MW5f", "entityType": "Disease", "charEnd": 1497, "source": "PUBTATOR", "charStart": 1486, "entityId": [{"idString": "D064420", "source": "MESH"}], "sentenceIndex": 14, "entityText": "cytotoxicity"}, {"duid": "PU:jBKv", "entityType": "Disease", "charEnd": 806, "source": "PUBTATOR", "charStart": 793, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 7, "entityText": "gastric cancer"}, {"duid": "PU:V598", "entityType": "Gene", "charEnd": 124, "source": "PUBTATOR", "charStart": 98, "entityId": [{"idString": "3091", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "Hypoxia-inducible factor-1\u03b1"}, {"duid": "PU:bkcE", "entityType": "Gene", "charEnd": 275, "source": "PUBTATOR", "charStart": 270, "entityId": [{"idString": "3091", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "HIF-1\u03b1"}, {"duid": "PU:DX8e", "entityType": "Gene", "charEnd": 205, "source": "PUBTATOR", "charStart": 202, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "VEGF"}, {"duid": "PU:ymPK", "entityType": "Gene", "charEnd": 440, "source": "PUBTATOR", "charStart": 437, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "VEGF"}, {"duid": "PU:n4Dz", "entityType": "Gene", "charEnd": 246, "source": "PUBTATOR", "charStart": 243, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "VEGF"}, {"duid": "PU:XQpt", "entityType": "Gene", "charEnd": 199, "source": "PUBTATOR", "charStart": 166, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "vascular endothelial growth factor"}, {"duid": "PU:eQUg", "entityType": "Gene", "charEnd": 1215, "source": "PUBTATOR", "charStart": 1209, "entityId": [{"idString": "2321", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "VEGFR-1"}, {"duid": "PU:272R", "entityType": "Chemical", "charEnd": 1542, "source": "PUBTATOR", "charStart": 1533, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 14, "entityText": "paclitaxel"}, {"duid": "PU:iU7F", "entityType": "Chemical", "charEnd": 1119, "source": "PUBTATOR", "charStart": 1110, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 10, "entityText": "paclitaxel"}, {"duid": "PU:zEFW", "entityType": "Gene", "charEnd": 893, "source": "PUBTATOR", "charStart": 889, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TUBB3"}, {"duid": "PU:CTDr", "entityType": "Gene", "charEnd": 961, "source": "PUBTATOR", "charStart": 957, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TUBB3"}, {"duid": "PU:mEEH", "entityType": "Gene", "charEnd": 371, "source": "PUBTATOR", "charStart": 367, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "TUBB3"}, {"duid": "PU:b9qk", "entityType": "Gene", "charEnd": 30, "source": "PUBTATOR", "charStart": 24, "entityId": [{"idString": "3791", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "VEGFR-2"}, {"duid": "PU:CLnK", "entityType": "Gene", "charEnd": 1197, "source": "PUBTATOR", "charStart": 1193, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "TUBB3"}, {"duid": "PU:i78m", "entityType": "Disease", "charEnd": 1100, "source": "PUBTATOR", "charStart": 1094, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 10, "entityText": "Hypoxia"}, {"duid": "PU:w4bm", "entityType": "Gene", "charEnd": 390, "source": "PUBTATOR", "charStart": 386, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TUBB3"}, {"duid": "PU:ynte", "entityType": "Disease", "charEnd": 822, "source": "PUBTATOR", "charStart": 820, "entityId": [{"idString": "C535607", "source": "MESH"}], "sentenceIndex": 7, "entityText": "AGS"}, {"duid": "PU:Bgsm", "entityType": "Chemical", "charEnd": 50, "source": "PUBTATOR", "charStart": 41, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "paclitaxel"}, {"duid": "PU:Dnab", "entityType": "Chemical", "charEnd": 908, "source": "PUBTATOR", "charStart": 899, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 8, "entityText": "paclitaxel"}, {"duid": "PU:gWVN", "entityType": "Chemical", "charEnd": 1333, "source": "PUBTATOR", "charStart": 1324, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 12, "entityText": "paclitaxel"}, {"duid": "PU:xt7S", "entityType": "Disease", "charEnd": 970, "source": "PUBTATOR", "charStart": 968, "entityId": [{"idString": "C535607", "source": "MESH"}], "sentenceIndex": 9, "entityText": "AGS"}, {"duid": "PU:woHg", "entityType": "Chemical", "charEnd": 674, "source": "PUBTATOR", "charStart": 665, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 6, "entityText": "paclitaxel"}, {"duid": "PU:DzDF", "entityType": "Gene", "charEnd": 1556, "source": "PUBTATOR", "charStart": 1550, "entityId": [{"idString": "2321", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "VEGFR-1"}, {"duid": "PU:C3yr", "entityType": "Gene", "charEnd": 758, "source": "PUBTATOR", "charStart": 753, "entityId": [{"idString": "3091", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "HIF-1\u03b1"}, {"duid": "PU:XH7u", "entityType": "Gene", "charEnd": 587, "source": "PUBTATOR", "charStart": 545, "entityId": [{"idString": "3791", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "vascular endothelial growth factor receptor"}, {"duid": "PU:HZ6U", "entityType": "Chemical", "charEnd": 420, "source": "PUBTATOR", "charStart": 414, "entityId": [{"idString": "D043823", "source": "MESH"}], "sentenceIndex": 4, "entityText": "taxanes"}, {"duid": "PU:NcCK", "entityType": "Disease", "charEnd": 613, "source": "PUBTATOR", "charStart": 600, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gastric cancer"}, {"duid": "PU:qdZa", "entityType": "Gene", "charEnd": 1623, "source": "PUBTATOR", "charStart": 1617, "entityId": [{"idString": "2321", "source": "Entrez"}], "sentenceIndex": 15, "entityText": "VEGFR-1"}, {"duid": "PU:ugYE", "entityType": "Disease", "charEnd": 850, "source": "PUBTATOR", "charStart": 844, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 7, "entityText": "hypoxic"}, {"duid": "PU:obDj", "entityType": "Gene", "charEnd": 1574, "source": "PUBTATOR", "charStart": 1568, "entityId": [{"idString": "3791", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "VEGFR-2"}, {"duid": "PU:JMgJ", "entityType": "Gene", "charEnd": 18, "source": "PUBTATOR", "charStart": 12, "entityId": [{"idString": "2321", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "VEGFR-1"}, {"duid": "PU:6oMj", "entityType": "Gene", "charEnd": 1166, "source": "PUBTATOR", "charStart": 1162, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "TUBB3"}]}
{"text": "ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. PURPOSE: To test the hypotheses of whether the relative mRNA expression of the thymidylate synthase (TS) gene and the excision cross-complementing (ERCC1) gene are associated with response to and survival of fluorouracil (5-FU)/oxaliplatin chemotherapy in metastatic colorectal cancer. PATIENTS AND METHODS: Patients had progressive stage IV disease after unsuccessful 5-FU and irinotecan chemotherapy. All patients were evaluated for eligibility for a compassionate 5-FU/oxaliplatin protocol. cDNA was derived from paraffin-embedded tumor specimens to determine TS and ERCC1 mRNA expression relative to the internal reference gene beta-actin using fluorescence-based, real-time reverse transcriptase polymerase chain reaction. RESULTS: The median TS gene expression level from 50 metastasized tumors was 3.4 x 10(-3) (minimum expression, 0.18 x 10(-3);maximum expression, 11.5 x 10(-3)), and the median ERCC1 gene expression level was 2.53 x 10(-3) (minimum, 0.0; maximum, 14.61 x 10(-3)). The gene expression cutoff values for chemotherapy nonresponse were 7.5 x 10(-3) for TS and 4.9 x 10(-3) for ERCC1. The median survival time for patients with TS <or= 7.5 x 10(-3) (43 of 50 patients) was 10.2 months, compared with 1.5 months for patients with TS greater than 7.5 x 10(-3) (P < .001). Patients with ERCC1 expression <or= 4.9 x 10(-3) (40 of 50 patients) had a median survival time of 10.2 months, compared with 1.9 months for patients with ERCC1 expression greater than 4.9 x 10(-3) (P < .001). A TS of 7.5 x 10(-3) segregated significantly into response, stable disease, and progression (P = .02), whereas the association between ERCC1 and response did not reach statistical significance (P = .29). CONCLUSION: These data suggest that intratumoral ERCC1 mRNA and TS mRNA expression levels are independent predictive markers of survival for 5-FU and oxaliplatin combination chemotherapy in 5-FU-resistant metastatic colorectal cancer. Precise definition of the best TS cut point will require further analysis in a large, prospective study.", "title": {"charStart": 0, "charEnd": 154}, "docId": "11731512", "entity": [{"duid": "PU:2GXm", "entityType": "Chemical", "charEnd": 140, "source": "PUBTATOR", "charStart": 129, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "fluorouracil"}, {"duid": "PU:cjjr", "entityType": "Gene", "charEnd": 1607, "source": "PUBTATOR", "charStart": 1603, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:6jie", "entityType": "Gene", "charEnd": 720, "source": "PUBTATOR", "charStart": 719, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:uQeP", "entityType": "Gene", "charEnd": 258, "source": "PUBTATOR", "charStart": 257, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:66pw", "entityType": "Disease", "charEnd": 1408, "source": "PUBTATOR", "charStart": 1407, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 7, "entityText": "TS"}, {"duid": "PU:77NW", "entityType": "Disease", "charEnd": 1307, "source": "PUBTATOR", "charStart": 1306, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 7, "entityText": "TS"}, {"duid": "PU:Gs4q", "entityType": "Gene", "charEnd": 1260, "source": "PUBTATOR", "charStart": 1256, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:SCkf", "entityType": "Disease", "charEnd": 2130, "source": "PUBTATOR", "charStart": 2129, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 11, "entityText": "TS"}, {"duid": "PU:4XNH", "entityType": "Chemical", "charEnd": 2056, "source": "PUBTATOR", "charStart": 2053, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 10, "entityText": "5-FU"}, {"duid": "PU:uz6k", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:UW39", "entityType": "Gene", "charEnd": 308, "source": "PUBTATOR", "charStart": 304, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:cP5K", "entityType": "Chemical", "charEnd": 528, "source": "PUBTATOR", "charStart": 525, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-FU"}, {"duid": "PU:34Et", "entityType": "Chemical", "charEnd": 394, "source": "PUBTATOR", "charStart": 384, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 1, "entityText": "oxaliplatin"}, {"duid": "PU:2RSL", "entityType": "Chemical", "charEnd": 381, "source": "PUBTATOR", "charStart": 378, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:ncEP", "entityType": "Chemical", "charEnd": 2007, "source": "PUBTATOR", "charStart": 2004, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 10, "entityText": "5-FU"}, {"duid": "PU:7E5S", "entityType": "Disease", "charEnd": 1661, "source": "PUBTATOR", "charStart": 1660, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:3X7y", "entityType": "Gene", "charEnd": 1798, "source": "PUBTATOR", "charStart": 1794, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:gXge", "entityType": "Gene", "charEnd": 1064, "source": "PUBTATOR", "charStart": 1060, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:sk9z", "entityType": "Gene", "charEnd": 905, "source": "PUBTATOR", "charStart": 904, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:XX3S", "entityType": "Chemical", "charEnd": 123, "source": "PUBTATOR", "charStart": 113, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 0, "entityText": "oxaliplatin"}, {"duid": "PU:GUBU", "entityType": "Gene", "charEnd": 254, "source": "PUBTATOR", "charStart": 235, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:cV6X", "entityType": "Disease", "charEnd": 2095, "source": "PUBTATOR", "charStart": 2079, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 10, "entityText": "colorectal cancer"}, {"duid": "PU:gfui", "entityType": "Chemical", "charEnd": 638, "source": "PUBTATOR", "charStart": 628, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 3, "entityText": "oxaliplatin"}, {"duid": "PU:LKKe", "entityType": "Gene", "charEnd": 730, "source": "PUBTATOR", "charStart": 726, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:hW9s", "entityType": "Disease", "charEnd": 439, "source": "PUBTATOR", "charStart": 423, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 1, "entityText": "colorectal cancer"}, {"duid": "PU:hbRo", "entityType": "Disease", "charEnd": 1233, "source": "PUBTATOR", "charStart": 1232, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:rjR9", "entityType": "Gene", "charEnd": 797, "source": "PUBTATOR", "charStart": 788, "entityId": [{"idString": "728378", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "beta-actin"}, {"duid": "PU:c5Mo", "entityType": "Gene", "charEnd": 29, "source": "PUBTATOR", "charStart": 10, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidylate synthase"}, {"duid": "PU:A6oE", "entityType": "Chemical", "charEnd": 626, "source": "PUBTATOR", "charStart": 623, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 3, "entityText": "5-FU"}, {"duid": "PU:f5qB", "entityType": "Chemical", "charEnd": 543, "source": "PUBTATOR", "charStart": 534, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 2, "entityText": "irinotecan"}, {"duid": "PU:Qkgc", "entityType": "Chemical", "charEnd": 2023, "source": "PUBTATOR", "charStart": 2013, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 10, "entityText": "oxaliplatin"}, {"duid": "PU:CLMC", "entityType": "Chemical", "charEnd": 20, "source": "PUBTATOR", "charStart": 10, "entityId": [{"idString": "17013", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "thymidylate"}, {"duid": "PU:Y7P6", "entityType": "Disease", "charEnd": 955, "source": "PUBTATOR", "charStart": 950, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumors"}, {"duid": "PU:arxj", "entityType": "Disease", "charEnd": 1928, "source": "PUBTATOR", "charStart": 1927, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 10, "entityText": "TS"}, {"duid": "PU:UcAp", "entityType": "Disease", "charEnd": 694, "source": "PUBTATOR", "charStart": 690, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumor"}, {"duid": "PU:RB2G", "entityType": "Disease", "charEnd": 80, "source": "PUBTATOR", "charStart": 64, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 0, "entityText": "colorectal cancer"}, {"duid": "PU:3eyS", "entityType": "Gene", "charEnd": 1466, "source": "PUBTATOR", "charStart": 1462, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:ngoB", "entityType": "Chemical", "charEnd": 375, "source": "PUBTATOR", "charStart": 364, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "fluorouracil"}, {"duid": "PU:Dn3r", "entityType": "Gene", "charEnd": 1916, "source": "PUBTATOR", "charStart": 1912, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}]}
{"text": "ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. PURPOSE: To test the hypotheses of whether the relative mRNA expression of the thymidylate synthase (TS) gene and the excision cross-complementing (ERCC1) gene are associated with response to and survival of fluorouracil (5-FU)/oxaliplatin chemotherapy in metastatic colorectal cancer. PATIENTS AND METHODS: Patients had progressive stage IV disease after unsuccessful 5-FU and irinotecan chemotherapy. All patients were evaluated for eligibility for a compassionate 5-FU/oxaliplatin protocol. cDNA was derived from paraffin-embedded tumor specimens to determine TS and ERCC1 mRNA expression relative to the internal reference gene beta-actin using fluorescence-based, real-time reverse transcriptase polymerase chain reaction. RESULTS: The median TS gene expression level from 50 metastasized tumors was 3.4 x 10(-3) (minimum expression, 0.18 x 10(-3);maximum expression, 11.5 x 10(-3)), and the median ERCC1 gene expression level was 2.53 x 10(-3) (minimum, 0.0; maximum, 14.61 x 10(-3)). The gene expression cutoff values for chemotherapy nonresponse were 7.5 x 10(-3) for TS and 4.9 x 10(-3) for ERCC1. The median survival time for patients with TS <or= 7.5 x 10(-3) (43 of 50 patients) was 10.2 months, compared with 1.5 months for patients with TS greater than 7.5 x 10(-3) (P < .001). Patients with ERCC1 expression <or= 4.9 x 10(-3) (40 of 50 patients) had a median survival time of 10.2 months, compared with 1.9 months for patients with ERCC1 expression greater than 4.9 x 10(-3) (P < .001). A TS of 7.5 x 10(-3) segregated significantly into response, stable disease, and progression (P = .02), whereas the association between ERCC1 and response did not reach statistical significance (P = .29). CONCLUSION: These data suggest that intratumoral ERCC1 mRNA and TS mRNA expression levels are independent predictive markers of survival for 5-FU and oxaliplatin combination chemotherapy in 5-FU-resistant metastatic colorectal cancer. Precise definition of the best TS cut point will require further analysis in a large, prospective study.", "title": {"charStart": 0, "charEnd": 154}, "docId": "11731512", "entity": [{"duid": "PU:2GXm", "entityType": "Chemical", "charEnd": 140, "source": "PUBTATOR", "charStart": 129, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "fluorouracil"}, {"duid": "PU:cjjr", "entityType": "Gene", "charEnd": 1607, "source": "PUBTATOR", "charStart": 1603, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:6jie", "entityType": "Gene", "charEnd": 720, "source": "PUBTATOR", "charStart": 719, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:uQeP", "entityType": "Gene", "charEnd": 258, "source": "PUBTATOR", "charStart": 257, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:66pw", "entityType": "Disease", "charEnd": 1408, "source": "PUBTATOR", "charStart": 1407, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 7, "entityText": "TS"}, {"duid": "PU:77NW", "entityType": "Disease", "charEnd": 1307, "source": "PUBTATOR", "charStart": 1306, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 7, "entityText": "TS"}, {"duid": "PU:Gs4q", "entityType": "Gene", "charEnd": 1260, "source": "PUBTATOR", "charStart": 1256, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:SCkf", "entityType": "Disease", "charEnd": 2130, "source": "PUBTATOR", "charStart": 2129, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 11, "entityText": "TS"}, {"duid": "PU:4XNH", "entityType": "Chemical", "charEnd": 2056, "source": "PUBTATOR", "charStart": 2053, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 10, "entityText": "5-FU"}, {"duid": "PU:uz6k", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:UW39", "entityType": "Gene", "charEnd": 308, "source": "PUBTATOR", "charStart": 304, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:cP5K", "entityType": "Chemical", "charEnd": 528, "source": "PUBTATOR", "charStart": 525, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-FU"}, {"duid": "PU:34Et", "entityType": "Chemical", "charEnd": 394, "source": "PUBTATOR", "charStart": 384, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 1, "entityText": "oxaliplatin"}, {"duid": "PU:2RSL", "entityType": "Chemical", "charEnd": 381, "source": "PUBTATOR", "charStart": 378, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:ncEP", "entityType": "Chemical", "charEnd": 2007, "source": "PUBTATOR", "charStart": 2004, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 10, "entityText": "5-FU"}, {"duid": "PU:7E5S", "entityType": "Disease", "charEnd": 1661, "source": "PUBTATOR", "charStart": 1660, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:3X7y", "entityType": "Gene", "charEnd": 1798, "source": "PUBTATOR", "charStart": 1794, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:gXge", "entityType": "Gene", "charEnd": 1064, "source": "PUBTATOR", "charStart": 1060, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:sk9z", "entityType": "Gene", "charEnd": 905, "source": "PUBTATOR", "charStart": 904, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TS"}, {"duid": "PU:XX3S", "entityType": "Chemical", "charEnd": 123, "source": "PUBTATOR", "charStart": 113, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 0, "entityText": "oxaliplatin"}, {"duid": "PU:GUBU", "entityType": "Gene", "charEnd": 254, "source": "PUBTATOR", "charStart": 235, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:cV6X", "entityType": "Disease", "charEnd": 2095, "source": "PUBTATOR", "charStart": 2079, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 10, "entityText": "colorectal cancer"}, {"duid": "PU:gfui", "entityType": "Chemical", "charEnd": 638, "source": "PUBTATOR", "charStart": 628, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 3, "entityText": "oxaliplatin"}, {"duid": "PU:LKKe", "entityType": "Gene", "charEnd": 730, "source": "PUBTATOR", "charStart": 726, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:hW9s", "entityType": "Disease", "charEnd": 439, "source": "PUBTATOR", "charStart": 423, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 1, "entityText": "colorectal cancer"}, {"duid": "PU:hbRo", "entityType": "Disease", "charEnd": 1233, "source": "PUBTATOR", "charStart": 1232, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:rjR9", "entityType": "Gene", "charEnd": 797, "source": "PUBTATOR", "charStart": 788, "entityId": [{"idString": "728378", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "beta-actin"}, {"duid": "PU:c5Mo", "entityType": "Gene", "charEnd": 29, "source": "PUBTATOR", "charStart": 10, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidylate synthase"}, {"duid": "PU:A6oE", "entityType": "Chemical", "charEnd": 626, "source": "PUBTATOR", "charStart": 623, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 3, "entityText": "5-FU"}, {"duid": "PU:f5qB", "entityType": "Chemical", "charEnd": 543, "source": "PUBTATOR", "charStart": 534, "entityId": [{"idString": "C051890", "source": "MESH"}], "sentenceIndex": 2, "entityText": "irinotecan"}, {"duid": "PU:Qkgc", "entityType": "Chemical", "charEnd": 2023, "source": "PUBTATOR", "charStart": 2013, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 10, "entityText": "oxaliplatin"}, {"duid": "PU:CLMC", "entityType": "Chemical", "charEnd": 20, "source": "PUBTATOR", "charStart": 10, "entityId": [{"idString": "17013", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "thymidylate"}, {"duid": "PU:Y7P6", "entityType": "Disease", "charEnd": 955, "source": "PUBTATOR", "charStart": 950, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumors"}, {"duid": "PU:arxj", "entityType": "Disease", "charEnd": 1928, "source": "PUBTATOR", "charStart": 1927, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 10, "entityText": "TS"}, {"duid": "PU:UcAp", "entityType": "Disease", "charEnd": 694, "source": "PUBTATOR", "charStart": 690, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumor"}, {"duid": "PU:RB2G", "entityType": "Disease", "charEnd": 80, "source": "PUBTATOR", "charStart": 64, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 0, "entityText": "colorectal cancer"}, {"duid": "PU:3eyS", "entityType": "Gene", "charEnd": 1466, "source": "PUBTATOR", "charStart": 1462, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:ngoB", "entityType": "Chemical", "charEnd": 375, "source": "PUBTATOR", "charStart": 364, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "fluorouracil"}, {"duid": "PU:Dn3r", "entityType": "Gene", "charEnd": 1916, "source": "PUBTATOR", "charStart": 1912, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}]}
{"text": "Predictive value of expression of ERCC 1 and GST-p for 5-fluorouracil/oxaliplatin chemotherapy in advanced colorectal cancer. BACKGROUND/AIMS: The aim of this study was to determine whether expression of the excision repair cross complementing protein (ERCC1), glutathione S-transferase pi (GST-p) and thymidylate synthase (TS) predict response in patients with advanced colorectal cancer treated with 5-fluorouracil/oxaliplatin chemotherapy. METHODOLOGY: The study population consisted of 39 patients with advanced colorectal cancer (median age, 65 years). Patients were treated with the modified FOLFOX 6 regimen. The expression of ERCC-1, GST-p and TS of primary tumors were examined by immunohistochemistry. RESULTS: The response rate of modified FOLFOX 6 chemotherapy was 51.3%. The positive rates of ERCC-1, GST-p and TS were 43.6%, 33.3% and 66.7%, respectively. The patients without ERCC-1 (p=0.0248) or GST-p? (p=0.0019) expression were more likely to respond to chemotherapy. TS expression did not correlate with chemotherapeutic response. CONCLUSIONS: Immunohistochemical studies for ERCC-1 and GST-p may be useful in prediction of the response to 5-fluorouracil/oxaliplatin chemotherapy in advanced colorectal cancer patients.", "title": {"charStart": 0, "charEnd": 124}, "docId": "21940361", "entity": [{"duid": "PU:Beg6", "entityType": "Gene", "charEnd": 39, "source": "PUBTATOR", "charStart": 34, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC 1"}, {"duid": "PU:gkgj", "entityType": "Disease", "charEnd": 671, "source": "PUBTATOR", "charStart": 658, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "primary tumors"}, {"duid": "PU:3d7i", "entityType": "Chemical", "charEnd": 273, "source": "PUBTATOR", "charStart": 261, "entityId": [], "sentenceIndex": 1, "entityText": "glutathione S"}, {"duid": "PU:w6oj", "entityType": "Species", "charEnd": 355, "source": "PUBTATOR", "charStart": 348, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:xnSo", "entityType": "Species", "charEnd": 500, "source": "PUBTATOR", "charStart": 493, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:gs5f", "entityType": "Gene", "charEnd": 811, "source": "PUBTATOR", "charStart": 806, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC-1"}, {"duid": "PU:yeDu", "entityType": "Chemical", "charEnd": 1172, "source": "PUBTATOR", "charStart": 1159, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 10, "entityText": "5-fluorouracil"}, {"duid": "PU:ZBSi", "entityType": "Disease", "charEnd": 325, "source": "PUBTATOR", "charStart": 324, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:cJei", "entityType": "Species", "charEnd": 881, "source": "PUBTATOR", "charStart": 874, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:GfX2", "entityType": "Disease", "charEnd": 653, "source": "PUBTATOR", "charStart": 652, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:hX2N", "entityType": "Chemical", "charEnd": 415, "source": "PUBTATOR", "charStart": 402, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-fluorouracil"}, {"duid": "PU:cys3", "entityType": "Gene", "charEnd": 646, "source": "PUBTATOR", "charStart": 642, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "GST-p"}, {"duid": "PU:MogN", "entityType": "Gene", "charEnd": 49, "source": "PUBTATOR", "charStart": 45, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "GST-p"}, {"duid": "PU:sgPb", "entityType": "Chemical", "charEnd": 68, "source": "PUBTATOR", "charStart": 55, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-fluorouracil"}, {"duid": "PU:Ec4H", "entityType": "Disease", "charEnd": 532, "source": "PUBTATOR", "charStart": 516, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 2, "entityText": "colorectal cancer"}, {"duid": "PU:eZiL", "entityType": "Gene", "charEnd": 1110, "source": "PUBTATOR", "charStart": 1106, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "GST-p"}, {"duid": "PU:SV9j", "entityType": "Gene", "charEnd": 896, "source": "PUBTATOR", "charStart": 891, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC-1"}, {"duid": "PU:gdCQ", "entityType": "Gene", "charEnd": 295, "source": "PUBTATOR", "charStart": 291, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "GST-p"}, {"duid": "PU:cgUj", "entityType": "Gene", "charEnd": 1100, "source": "PUBTATOR", "charStart": 1095, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC-1"}, {"duid": "PU:oy7N", "entityType": "Gene", "charEnd": 321, "source": "PUBTATOR", "charStart": 302, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:oPKU", "entityType": "Species", "charEnd": 1236, "source": "PUBTATOR", "charStart": 1229, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:ZrUY", "entityType": "Disease", "charEnd": 987, "source": "PUBTATOR", "charStart": 986, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:xskU", "entityType": "Gene", "charEnd": 916, "source": "PUBTATOR", "charStart": 912, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "GST-p"}, {"duid": "PU:2rpq", "entityType": "Chemical", "charEnd": 427, "source": "PUBTATOR", "charStart": 417, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 1, "entityText": "oxaliplatin"}, {"duid": "PU:Unwv", "entityType": "Disease", "charEnd": 387, "source": "PUBTATOR", "charStart": 371, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 1, "entityText": "colorectal cancer"}, {"duid": "PU:nFvZ", "entityType": "Species", "charEnd": 565, "source": "PUBTATOR", "charStart": 558, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "Patients"}, {"duid": "PU:kQYw", "entityType": "Disease", "charEnd": 825, "source": "PUBTATOR", "charStart": 824, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:8i5h", "entityType": "Chemical", "charEnd": 80, "source": "PUBTATOR", "charStart": 70, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 0, "entityText": "oxaliplatin"}, {"duid": "PU:LuQV", "entityType": "Disease", "charEnd": 123, "source": "PUBTATOR", "charStart": 107, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 0, "entityText": "colorectal cancer"}, {"duid": "PU:QzTd", "entityType": "Gene", "charEnd": 818, "source": "PUBTATOR", "charStart": 814, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "GST-p"}, {"duid": "PU:dwyW", "entityType": "Disease", "charEnd": 1227, "source": "PUBTATOR", "charStart": 1211, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 10, "entityText": "colorectal cancer"}, {"duid": "PU:RxV2", "entityType": "Gene", "charEnd": 639, "source": "PUBTATOR", "charStart": 634, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC-1"}, {"duid": "PU:KSsh", "entityType": "Gene", "charEnd": 288, "source": "PUBTATOR", "charStart": 261, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "glutathione S-transferase pi"}, {"duid": "PU:KY3D", "entityType": "Gene", "charEnd": 257, "source": "PUBTATOR", "charStart": 253, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:Jpf8", "entityType": "Chemical", "charEnd": 1184, "source": "PUBTATOR", "charStart": 1174, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 10, "entityText": "oxaliplatin"}]}
{"text": "Predictive value of expression of ERCC 1 and GST-p for 5-fluorouracil/oxaliplatin chemotherapy in advanced colorectal cancer. BACKGROUND/AIMS: The aim of this study was to determine whether expression of the excision repair cross complementing protein (ERCC1), glutathione S-transferase pi (GST-p) and thymidylate synthase (TS) predict response in patients with advanced colorectal cancer treated with 5-fluorouracil/oxaliplatin chemotherapy. METHODOLOGY: The study population consisted of 39 patients with advanced colorectal cancer (median age, 65 years). Patients were treated with the modified FOLFOX 6 regimen. The expression of ERCC-1, GST-p and TS of primary tumors were examined by immunohistochemistry. RESULTS: The response rate of modified FOLFOX 6 chemotherapy was 51.3%. The positive rates of ERCC-1, GST-p and TS were 43.6%, 33.3% and 66.7%, respectively. The patients without ERCC-1 (p=0.0248) or GST-p? (p=0.0019) expression were more likely to respond to chemotherapy. TS expression did not correlate with chemotherapeutic response. CONCLUSIONS: Immunohistochemical studies for ERCC-1 and GST-p may be useful in prediction of the response to 5-fluorouracil/oxaliplatin chemotherapy in advanced colorectal cancer patients.", "title": {"charStart": 0, "charEnd": 124}, "docId": "21940361", "entity": [{"duid": "PU:Beg6", "entityType": "Gene", "charEnd": 39, "source": "PUBTATOR", "charStart": 34, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC 1"}, {"duid": "PU:gkgj", "entityType": "Disease", "charEnd": 671, "source": "PUBTATOR", "charStart": 658, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "primary tumors"}, {"duid": "PU:3d7i", "entityType": "Chemical", "charEnd": 273, "source": "PUBTATOR", "charStart": 261, "entityId": [], "sentenceIndex": 1, "entityText": "glutathione S"}, {"duid": "PU:w6oj", "entityType": "Species", "charEnd": 355, "source": "PUBTATOR", "charStart": 348, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:xnSo", "entityType": "Species", "charEnd": 500, "source": "PUBTATOR", "charStart": 493, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:gs5f", "entityType": "Gene", "charEnd": 811, "source": "PUBTATOR", "charStart": 806, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC-1"}, {"duid": "PU:yeDu", "entityType": "Chemical", "charEnd": 1172, "source": "PUBTATOR", "charStart": 1159, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 10, "entityText": "5-fluorouracil"}, {"duid": "PU:ZBSi", "entityType": "Disease", "charEnd": 325, "source": "PUBTATOR", "charStart": 324, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:cJei", "entityType": "Species", "charEnd": 881, "source": "PUBTATOR", "charStart": 874, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:GfX2", "entityType": "Disease", "charEnd": 653, "source": "PUBTATOR", "charStart": 652, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:hX2N", "entityType": "Chemical", "charEnd": 415, "source": "PUBTATOR", "charStart": 402, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-fluorouracil"}, {"duid": "PU:cys3", "entityType": "Gene", "charEnd": 646, "source": "PUBTATOR", "charStart": 642, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "GST-p"}, {"duid": "PU:MogN", "entityType": "Gene", "charEnd": 49, "source": "PUBTATOR", "charStart": 45, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "GST-p"}, {"duid": "PU:sgPb", "entityType": "Chemical", "charEnd": 68, "source": "PUBTATOR", "charStart": 55, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 0, "entityText": "5-fluorouracil"}, {"duid": "PU:Ec4H", "entityType": "Disease", "charEnd": 532, "source": "PUBTATOR", "charStart": 516, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 2, "entityText": "colorectal cancer"}, {"duid": "PU:eZiL", "entityType": "Gene", "charEnd": 1110, "source": "PUBTATOR", "charStart": 1106, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "GST-p"}, {"duid": "PU:SV9j", "entityType": "Gene", "charEnd": 896, "source": "PUBTATOR", "charStart": 891, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC-1"}, {"duid": "PU:gdCQ", "entityType": "Gene", "charEnd": 295, "source": "PUBTATOR", "charStart": 291, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "GST-p"}, {"duid": "PU:cgUj", "entityType": "Gene", "charEnd": 1100, "source": "PUBTATOR", "charStart": 1095, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC-1"}, {"duid": "PU:oy7N", "entityType": "Gene", "charEnd": 321, "source": "PUBTATOR", "charStart": 302, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:oPKU", "entityType": "Species", "charEnd": 1236, "source": "PUBTATOR", "charStart": 1229, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:ZrUY", "entityType": "Disease", "charEnd": 987, "source": "PUBTATOR", "charStart": 986, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:xskU", "entityType": "Gene", "charEnd": 916, "source": "PUBTATOR", "charStart": 912, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "GST-p"}, {"duid": "PU:2rpq", "entityType": "Chemical", "charEnd": 427, "source": "PUBTATOR", "charStart": 417, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 1, "entityText": "oxaliplatin"}, {"duid": "PU:Unwv", "entityType": "Disease", "charEnd": 387, "source": "PUBTATOR", "charStart": 371, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 1, "entityText": "colorectal cancer"}, {"duid": "PU:nFvZ", "entityType": "Species", "charEnd": 565, "source": "PUBTATOR", "charStart": 558, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "Patients"}, {"duid": "PU:kQYw", "entityType": "Disease", "charEnd": 825, "source": "PUBTATOR", "charStart": 824, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:8i5h", "entityType": "Chemical", "charEnd": 80, "source": "PUBTATOR", "charStart": 70, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 0, "entityText": "oxaliplatin"}, {"duid": "PU:LuQV", "entityType": "Disease", "charEnd": 123, "source": "PUBTATOR", "charStart": 107, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 0, "entityText": "colorectal cancer"}, {"duid": "PU:QzTd", "entityType": "Gene", "charEnd": 818, "source": "PUBTATOR", "charStart": 814, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "GST-p"}, {"duid": "PU:dwyW", "entityType": "Disease", "charEnd": 1227, "source": "PUBTATOR", "charStart": 1211, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 10, "entityText": "colorectal cancer"}, {"duid": "PU:RxV2", "entityType": "Gene", "charEnd": 639, "source": "PUBTATOR", "charStart": 634, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC-1"}, {"duid": "PU:KSsh", "entityType": "Gene", "charEnd": 288, "source": "PUBTATOR", "charStart": 261, "entityId": [{"idString": "2950", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "glutathione S-transferase pi"}, {"duid": "PU:KY3D", "entityType": "Gene", "charEnd": 257, "source": "PUBTATOR", "charStart": 253, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:Jpf8", "entityType": "Chemical", "charEnd": 1184, "source": "PUBTATOR", "charStart": 1174, "entityId": [{"idString": "C030110", "source": "MESH"}], "sentenceIndex": 10, "entityText": "oxaliplatin"}]}
{"text": "Immunohistochemical expression of thymidylate synthase as predictor of response to capecitabine in patients with advanced colorectal adenocarcinoma. Capecitabine is an oral prodrug to 5-fluorouracil (5-FU). The primary target of 5-FU is thymidylate synthase (TS). A mainstay of colorectal adenocarcinoma chemotherapy is inhibition of TS, which may be one of many determinant factors when predicting the outcome of chemotherapies based on fluoropyrimidine treatment. This retrospective study included 39 patients with advanced colorectal adenocarcinoma treated with capecitabine. Response was assessed by measuring the amount of tumour in the course of treatment. TS expression was evaluated by scoring the immunohistochemical (IHC) reaction and assessing the predominant IHC reaction pattern. This study showed significant correlation between the predominant IHC reaction pattern and response, but no correlation between IHC score and response. The predominant IHC reaction pattern may be a useful parameter in prediction of clinical outcome in patients treated with capecitabine.", "title": {"charStart": 0, "charEnd": 147}, "docId": "16218935", "entity": [{"duid": "PU:6CUs", "entityType": "Chemical", "charEnd": 232, "source": "PUBTATOR", "charStart": 229, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 2, "entityText": "5-FU"}, {"duid": "PU:YtAz", "entityType": "Species", "charEnd": 510, "source": "PUBTATOR", "charStart": 503, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:W6cy", "entityType": "Disease", "charEnd": 664, "source": "PUBTATOR", "charStart": 663, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:ijVD", "entityType": "Disease", "charEnd": 146, "source": "PUBTATOR", "charStart": 122, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 0, "entityText": "colorectal adenocarcinoma"}, {"duid": "PU:dxiX", "entityType": "Disease", "charEnd": 550, "source": "PUBTATOR", "charStart": 526, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 4, "entityText": "colorectal adenocarcinoma"}, {"duid": "PU:jN7X", "entityType": "Chemical", "charEnd": 1078, "source": "PUBTATOR", "charStart": 1067, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 8, "entityText": "capecitabine"}, {"duid": "PU:9GpG", "entityType": "Chemical", "charEnd": 160, "source": "PUBTATOR", "charStart": 149, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Capecitabine"}, {"duid": "PU:QBoL", "entityType": "Disease", "charEnd": 633, "source": "PUBTATOR", "charStart": 628, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumour"}, {"duid": "PU:XRPg", "entityType": "Chemical", "charEnd": 197, "source": "PUBTATOR", "charStart": 184, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-fluorouracil"}, {"duid": "PU:VKEH", "entityType": "Gene", "charEnd": 53, "source": "PUBTATOR", "charStart": 34, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "thymidylate synthase"}, {"duid": "PU:d3Yi", "entityType": "Species", "charEnd": 106, "source": "PUBTATOR", "charStart": 99, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:WpuT", "entityType": "Gene", "charEnd": 256, "source": "PUBTATOR", "charStart": 237, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "thymidylate synthase"}, {"duid": "PU:vx5f", "entityType": "Disease", "charEnd": 335, "source": "PUBTATOR", "charStart": 334, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 3, "entityText": "TS"}, {"duid": "PU:3ByQ", "entityType": "Disease", "charEnd": 260, "source": "PUBTATOR", "charStart": 259, "entityId": [{"idString": "D020159", "source": "MESH"}], "sentenceIndex": 2, "entityText": "TS"}, {"duid": "PU:ZUC9", "entityType": "Chemical", "charEnd": 576, "source": "PUBTATOR", "charStart": 565, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 4, "entityText": "capecitabine"}, {"duid": "PU:j8a4", "entityType": "Chemical", "charEnd": 203, "source": "PUBTATOR", "charStart": 200, "entityId": [{"idString": "D005472", "source": "MESH"}], "sentenceIndex": 1, "entityText": "5-FU"}, {"duid": "PU:JgPS", "entityType": "Chemical", "charEnd": 453, "source": "PUBTATOR", "charStart": 438, "entityId": [], "sentenceIndex": 3, "entityText": "fluoropyrimidine"}, {"duid": "PU:kc3P", "entityType": "Chemical", "charEnd": 94, "source": "PUBTATOR", "charStart": 83, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 0, "entityText": "capecitabine"}, {"duid": "PU:PDob", "entityType": "Species", "charEnd": 1052, "source": "PUBTATOR", "charStart": 1045, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:mPJP", "entityType": "Disease", "charEnd": 302, "source": "PUBTATOR", "charStart": 278, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 3, "entityText": "colorectal adenocarcinoma"}]}
{"text": "Temozolomide chemoresistance heterogeneity in melanoma with different treatment regimens: DNA damage accumulation contribution. The efficacy of temozolomide in melanoma treatment is low (response rate <20%) and may depend on the activity of O-methylguanine DNA methyltransferase (MGMT) and mismatch repair. We identified melanoma cell lines with different sensitivities to single versus prolonged clinical dosing regimens of temozolomide treatment and assessed a variety of potential resistance mechanisms using this model. We measured mRNA expression and promoter methylation of MGMT and essential mismatch repair genes (MLH1, MSH2). Cell cycle distribution, apoptosis/necrosis induction, O-methylguanine-adduct formation, and ABCB1 gene expression were assessed. We found that three cell lines, MelA, MelB, and MelC, were more sensitive to a single dose regimen than to a prolonged regimen, which would be expected to exhibit higher cytotoxicity. KAII and LIBR cell sensitivity was higher with regard to the prolonged treatment regimen, as expected. Only MelC expressed MGMT. Gene expression correlated well with promoter methylation. Temozolomide exposure did not alter mRNA expression. Different sensitivities to temozolomide were caused neither by delayed apoptosis induction due to early cell cycle arrest nor by O-methylguanine-adduct formation or efflux transporter expression. MelC was the most resistant cell line with rapid elimination of O-methylguanine adducts. This was in good agreement with its MGMT expression. The sensitive cell lines KAII and LIBR accumulated O-methylguanine adducts after a second treatment cycle with temozolomide in contrast with the other three cell lines. We conclude that MGMT expression and DNA adduct accumulation are relevant factors in temozolomide chemosensitivity. Considering individualized temozolomide treatment regimens either by quantification of DNA adducts or by chemosensitivity testing seems worthwhile clinically.", "title": {"charStart": 0, "charEnd": 126}, "docId": "21460749", "entity": [{"duid": "PU:mUU3", "entityType": "Disease", "charEnd": 677, "source": "PUBTATOR", "charStart": 670, "entityId": [{"idString": "D009336", "source": "MESH"}], "sentenceIndex": 4, "entityText": "necrosis"}, {"duid": "PU:NCBS", "entityType": "Gene", "charEnd": 277, "source": "PUBTATOR", "charStart": 241, "entityId": [{"idString": "17314", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 1, "entityText": "O-methylguanine DNA methyltransferase"}, {"duid": "PU:uBRQ", "entityType": "Gene", "charEnd": 1514, "source": "PUBTATOR", "charStart": 1511, "entityId": [{"idString": "17314", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 12, "entityText": "MGMT"}, {"duid": "PU:o97P", "entityType": "Gene", "charEnd": 631, "source": "PUBTATOR", "charStart": 628, "entityId": [{"idString": "17685", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 3, "entityText": "MSH2"}, {"duid": "PU:N3RE", "entityType": "Disease", "charEnd": 946, "source": "PUBTATOR", "charStart": 935, "entityId": [{"idString": "D064420", "source": "MESH"}], "sentenceIndex": 5, "entityText": "cytotoxicity"}, {"duid": "PU:b9G7", "entityType": "Chemical", "charEnd": 155, "source": "PUBTATOR", "charStart": 144, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "temozolomide"}, {"duid": "PU:oFsW", "entityType": "Chemical", "charEnd": 1333, "source": "PUBTATOR", "charStart": 1319, "entityId": [], "sentenceIndex": 10, "entityText": "O-methylguanine"}, {"duid": "PU:QH6s", "entityType": "Chemical", "charEnd": 11, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Temozolomide"}, {"duid": "PU:4P7M", "entityType": "Chemical", "charEnd": 1793, "source": "PUBTATOR", "charStart": 1782, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 14, "entityText": "temozolomide"}, {"duid": "PU:Eeh7", "entityType": "Disease", "charEnd": 328, "source": "PUBTATOR", "charStart": 321, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 2, "entityText": "melanoma"}, {"duid": "PU:pafn", "entityType": "Chemical", "charEnd": 704, "source": "PUBTATOR", "charStart": 690, "entityId": [], "sentenceIndex": 4, "entityText": "O-methylguanine"}, {"duid": "PU:3Xkk", "entityType": "Species", "charEnd": 1389, "source": "PUBTATOR", "charStart": 1386, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "MelC"}, {"duid": "PU:8AiK", "entityType": "Chemical", "charEnd": 1851, "source": "PUBTATOR", "charStart": 1840, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 15, "entityText": "temozolomide"}, {"duid": "PU:L7ap", "entityType": "Chemical", "charEnd": 1228, "source": "PUBTATOR", "charStart": 1217, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 10, "entityText": "temozolomide"}, {"duid": "PU:zxbo", "entityType": "Gene", "charEnd": 1075, "source": "PUBTATOR", "charStart": 1072, "entityId": [{"idString": "17314", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 7, "entityText": "MGMT"}, {"duid": "PU:cZ7P", "entityType": "Chemical", "charEnd": 1593, "source": "PUBTATOR", "charStart": 1579, "entityId": [], "sentenceIndex": 13, "entityText": "O-methylguanine"}, {"duid": "PU:w4sk", "entityType": "Chemical", "charEnd": 1650, "source": "PUBTATOR", "charStart": 1639, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 13, "entityText": "temozolomide"}, {"duid": "PU:GBEx", "entityType": "Species", "charEnd": 625, "source": "PUBTATOR", "charStart": 622, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "MLH1"}, {"duid": "PU:KFdi", "entityType": "Gene", "charEnd": 283, "source": "PUBTATOR", "charStart": 280, "entityId": [{"idString": "17314", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 1, "entityText": "MGMT"}, {"duid": "PU:xH4w", "entityType": "Gene", "charEnd": 800, "source": "PUBTATOR", "charStart": 797, "entityId": [{"idString": "17276", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "MelA"}, {"duid": "PU:TUdT", "entityType": "Chemical", "charEnd": 436, "source": "PUBTATOR", "charStart": 425, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 2, "entityText": "temozolomide"}, {"duid": "PU:h5JW", "entityType": "Gene", "charEnd": 732, "source": "PUBTATOR", "charStart": 728, "entityId": [{"idString": "18669", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 4, "entityText": "ABCB1"}, {"duid": "PU:EHRx", "entityType": "Chemical", "charEnd": 1464, "source": "PUBTATOR", "charStart": 1450, "entityId": [], "sentenceIndex": 11, "entityText": "O-methylguanine"}, {"duid": "PU:HPHc", "entityType": "Disease", "charEnd": 167, "source": "PUBTATOR", "charStart": 160, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 1, "entityText": "melanoma"}, {"duid": "PU:icdp", "entityType": "Gene", "charEnd": 583, "source": "PUBTATOR", "charStart": 580, "entityId": [{"idString": "17314", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 3, "entityText": "MGMT"}, {"duid": "PU:iEdi", "entityType": "Gene", "charEnd": 1717, "source": "PUBTATOR", "charStart": 1714, "entityId": [{"idString": "17314", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 14, "entityText": "MGMT"}, {"duid": "PU:wFmS", "entityType": "Chemical", "charEnd": 1148, "source": "PUBTATOR", "charStart": 1137, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Temozolomide"}, {"duid": "PU:VF5w", "entityType": "Disease", "charEnd": 53, "source": "PUBTATOR", "charStart": 46, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 0, "entityText": "melanoma"}, {"duid": "PU:3ENx", "entityType": "Chemical", "charEnd": 255, "source": "PUBTATOR", "charStart": 241, "entityId": [], "sentenceIndex": 1, "entityText": "O-methylguanine"}]}
{"text": "Alterations of beta-tubulin isotypes in breast cancer cells resistant to docetaxel. Docetaxel is one of the most active drugs used to treat breast cancer. The cellular target of docetaxel is the microtubule, specifically the beta-tubulin subunit, that comprises a series of isotypes and that can modulate function. This study has examined the role of alteration in beta-tubulin isotypes in vitro and has sequenced the beta-tubulin gene to determine if there were mutations, both of which may represent important mechanisms of acquired resistance to docetaxel. Breast cancer cells, MCF-7 (oestrogen-receptor positive) and MDA-MB-231, (oestrogen-receptor negative) were made resistant to docetaxel in vitro. Expression of beta-tubulin isotypes (class I, II, III, IVa, IVb, and VI) was determined at the RNA and protein level using RT-PCR and western analysis, respectively. DNA sequencing evaluated the beta-tubulin gene. At the mRNA level, class I, II, III, and IVa beta-tubulin mRNA isotypes were over-expressed in docetaxel-resistant MCF-7 cells when compared with the docetaxel-sensitive parental cells. However, class VI beta-tubulin mRNA isotype expression was decreased in resistant cells. In MDA-MB-231 cells, there was a decrease in expression of the class I and class IVa beta-tubulin mRNA. However, there were increased expressions in class II, IVb, and VI beta-tubulin mRNA isotypes in resistant cells. Western analysis has confirmed corresponding increases in beta-tubulin protein levels in MCF-7 cells. However, in MDA-MB-231 cells, there were decreased protein levels for class II and class III beta-tubulin. This study demonstrates that altered expression of mRNA beta-tubulin isotypes and modulation of beta-tubulin protein levels are associated with acquired docetaxel resistance in breast cancer cells. This allows further understanding and elucidation of mechanisms involved in resistance to docetaxel.", "title": {"charStart": 0, "charEnd": 82}, "docId": "15946994", "entity": [{"duid": "PU:PxvX", "entityType": "Chemical", "charEnd": 1023, "source": "PUBTATOR", "charStart": 1015, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 7, "entityText": "docetaxel"}, {"duid": "PU:xY86", "entityType": "Chemical", "charEnd": 81, "source": "PUBTATOR", "charStart": 73, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 0, "entityText": "docetaxel"}, {"duid": "PU:GbYt", "entityType": "Chemical", "charEnd": 1078, "source": "PUBTATOR", "charStart": 1070, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 7, "entityText": "docetaxel"}, {"duid": "PU:WbJL", "entityType": "Chemical", "charEnd": 92, "source": "PUBTATOR", "charStart": 84, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Docetaxel"}, {"duid": "PU:SbQF", "entityType": "Disease", "charEnd": 572, "source": "PUBTATOR", "charStart": 560, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 4, "entityText": "Breast cancer"}, {"duid": "PU:dyd8", "entityType": "Chemical", "charEnd": 596, "source": "PUBTATOR", "charStart": 588, "entityId": [{"idString": "50114", "source": "CHEBI"}], "sentenceIndex": 4, "entityText": "oestrogen"}, {"duid": "PU:HWTD", "entityType": "Chemical", "charEnd": 1918, "source": "PUBTATOR", "charStart": 1910, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 14, "entityText": "docetaxel"}, {"duid": "PU:8E2N", "entityType": "Chemical", "charEnd": 642, "source": "PUBTATOR", "charStart": 634, "entityId": [{"idString": "50114", "source": "CHEBI"}], "sentenceIndex": 4, "entityText": "oestrogen"}, {"duid": "PU:SsCf", "entityType": "Chemical", "charEnd": 694, "source": "PUBTATOR", "charStart": 686, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 4, "entityText": "docetaxel"}, {"duid": "PU:znHu", "entityType": "Chemical", "charEnd": 1783, "source": "PUBTATOR", "charStart": 1775, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 13, "entityText": "docetaxel"}, {"duid": "PU:nHbG", "entityType": "Disease", "charEnd": 152, "source": "PUBTATOR", "charStart": 140, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast cancer"}, {"duid": "PU:oScC", "entityType": "Disease", "charEnd": 52, "source": "PUBTATOR", "charStart": 40, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast cancer"}, {"duid": "PU:QZTP", "entityType": "Chemical", "charEnd": 557, "source": "PUBTATOR", "charStart": 549, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 3, "entityText": "docetaxel"}, {"duid": "PU:Ltky", "entityType": "Disease", "charEnd": 1811, "source": "PUBTATOR", "charStart": 1799, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 13, "entityText": "breast cancer"}, {"duid": "PU:58VN", "entityType": "Chemical", "charEnd": 186, "source": "PUBTATOR", "charStart": 178, "entityId": [{"idString": "C067311", "source": "MESH"}], "sentenceIndex": 2, "entityText": "docetaxel"}]}
{"text": "A kinome screen identifies checkpoint kinase 1 (CHK1) as a sensitizer for RRM1-dependent gemcitabine efficacy. Gemcitabine is among the most efficacious and widely used antimetabolite agents. Its molecular targets are ribonucleotide reductase M1 (RRM1) and elongating DNA. Acquired and de novo resistance as a result of RRM1 overexpression are major obstacles to therapeutic efficacy. We deployed a synthetic lethality screen to investigate if knockdown of 87 selected protein kinases by siRNA could overcome RRM1-dependent gemcitabine resistance in high and low RRM1-expressing model systems. The models included genetically RRM1-modified lung and breast cancer cell lines, cell lines with gemcitabine-induced RRM1 overexpression, and a series of naturally gemcitabine-resistant cell lines. Lead molecular targets were validated by determination of differential gemcitabine activity using cell lines with and without target knock down, and by assessing synergistic activity between gemcitabine and an inhibitor of the lead target. CHK1 was identified has the kinase with the most significant and robust interaction, and it was validated using AZD7762, a small-molecule ATP-competitive inhibitor of CHK1 activation. Synergism between CHK1 inhibition and RRM1-dependent gemcitabine efficacy was observed in cells with high RRM1 levels, while antagonism was observed in cells with low RRM1 levels. In addition, four cell lines with natural gemcitabine resistance demonstrated improved gemcitabine efficacy after CHK1 inhibition. In tumor specimens from 187 patients with non-small-cell lung cancer, total CHK1 and RRM1 in situ protein levels were significantly (p = 0.003) and inversely correlated. We conclude that inhibition of CHK1 may have its greatest clinical utility in malignancies where gemcitabine resistance is a result of elevated RRM1 levels. We also conclude that CHK1 inhibition in tumors with low RRM1 levels may be detrimental to gemcitabine efficacy.", "title": {"charStart": 0, "charEnd": 109}, "docId": "23483975", "entity": [{"duid": "PU:m5Yn", "entityType": "Chemical", "charEnd": 1955, "source": "PUBTATOR", "charStart": 1945, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 12, "entityText": "gemcitabine"}, {"duid": "PU:GUyj", "entityType": "Chemical", "charEnd": 534, "source": "PUBTATOR", "charStart": 524, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 4, "entityText": "gemcitabine"}, {"duid": "PU:Q4cF", "entityType": "Gene", "charEnd": 51, "source": "PUBTATOR", "charStart": 48, "entityId": [{"idString": "1111", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "CHK1"}, {"duid": "PU:pmh4", "entityType": "Gene", "charEnd": 250, "source": "PUBTATOR", "charStart": 247, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "RRM1"}, {"duid": "PU:8zC4", "entityType": "Species", "charEnd": 1562, "source": "PUBTATOR", "charStart": 1555, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:pfbR", "entityType": "Gene", "charEnd": 1257, "source": "PUBTATOR", "charStart": 1254, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "RRM1"}, {"duid": "PU:EaUp", "entityType": "Chemical", "charEnd": 1172, "source": "PUBTATOR", "charStart": 1170, "entityId": [{"idString": "D000255", "source": "MESH"}], "sentenceIndex": 7, "entityText": "ATP"}, {"duid": "PU:ysx7", "entityType": "Chemical", "charEnd": 873, "source": "PUBTATOR", "charStart": 863, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gemcitabine"}, {"duid": "PU:sAjk", "entityType": "Gene", "charEnd": 1325, "source": "PUBTATOR", "charStart": 1322, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "RRM1"}, {"duid": "PU:7pEY", "entityType": "Gene", "charEnd": 629, "source": "PUBTATOR", "charStart": 626, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "RRM1"}, {"duid": "PU:3EgL", "entityType": "Gene", "charEnd": 1386, "source": "PUBTATOR", "charStart": 1383, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "RRM1"}, {"duid": "PU:J8SA", "entityType": "Gene", "charEnd": 1035, "source": "PUBTATOR", "charStart": 1032, "entityId": [{"idString": "1111", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "CHK1"}, {"duid": "PU:HdJk", "entityType": "Gene", "charEnd": 1513, "source": "PUBTATOR", "charStart": 1510, "entityId": [{"idString": "1111", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "CHK1"}, {"duid": "PU:7oTm", "entityType": "Gene", "charEnd": 1237, "source": "PUBTATOR", "charStart": 1234, "entityId": [{"idString": "1111", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "CHK1"}, {"duid": "PU:QTTS", "entityType": "Gene", "charEnd": 77, "source": "PUBTATOR", "charStart": 74, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "RRM1"}, {"duid": "PU:TigZ", "entityType": "Chemical", "charEnd": 1493, "source": "PUBTATOR", "charStart": 1483, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 9, "entityText": "gemcitabine"}, {"duid": "PU:KbYo", "entityType": "Gene", "charEnd": 1914, "source": "PUBTATOR", "charStart": 1911, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "RRM1"}, {"duid": "PU:fvNn", "entityType": "Gene", "charEnd": 512, "source": "PUBTATOR", "charStart": 509, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RRM1"}, {"duid": "PU:Z8an", "entityType": "Chemical", "charEnd": 701, "source": "PUBTATOR", "charStart": 691, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gemcitabine"}, {"duid": "PU:6cKf", "entityType": "Disease", "charEnd": 1594, "source": "PUBTATOR", "charStart": 1569, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 10, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:mRFp", "entityType": "Gene", "charEnd": 566, "source": "PUBTATOR", "charStart": 563, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RRM1"}, {"duid": "PU:ue7X", "entityType": "Gene", "charEnd": 45, "source": "PUBTATOR", "charStart": 27, "entityId": [{"idString": "1111", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "checkpoint kinase 1"}, {"duid": "PU:njYR", "entityType": "Gene", "charEnd": 1844, "source": "PUBTATOR", "charStart": 1841, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "RRM1"}, {"duid": "PU:yBHz", "entityType": "Gene", "charEnd": 1615, "source": "PUBTATOR", "charStart": 1612, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "RRM1"}, {"duid": "PU:8S4b", "entityType": "Chemical", "charEnd": 993, "source": "PUBTATOR", "charStart": 983, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gemcitabine"}, {"duid": "PU:dwCM", "entityType": "Chemical", "charEnd": 121, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Gemcitabine"}, {"duid": "PU:ncyB", "entityType": "Disease", "charEnd": 1786, "source": "PUBTATOR", "charStart": 1775, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 11, "entityText": "malignancies"}, {"duid": "PU:r7zy", "entityType": "Disease", "charEnd": 1534, "source": "PUBTATOR", "charStart": 1530, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumor"}, {"duid": "PU:TEQ4", "entityType": "Gene", "charEnd": 323, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "RRM1"}, {"duid": "PU:hSML", "entityType": "Chemical", "charEnd": 1279, "source": "PUBTATOR", "charStart": 1269, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gemcitabine"}, {"duid": "PU:CEU3", "entityType": "Chemical", "charEnd": 768, "source": "PUBTATOR", "charStart": 758, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gemcitabine"}, {"duid": "PU:4fVd", "entityType": "Gene", "charEnd": 714, "source": "PUBTATOR", "charStart": 711, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "RRM1"}, {"duid": "PU:Dpv3", "entityType": "Chemical", "charEnd": 1448, "source": "PUBTATOR", "charStart": 1438, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 9, "entityText": "gemcitabine"}, {"duid": "PU:MZMP", "entityType": "Chemical", "charEnd": 1804, "source": "PUBTATOR", "charStart": 1794, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gemcitabine"}, {"duid": "PU:iXzj", "entityType": "Gene", "charEnd": 1731, "source": "PUBTATOR", "charStart": 1728, "entityId": [{"idString": "1111", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "CHK1"}, {"duid": "PU:WWjA", "entityType": "Chemical", "charEnd": 99, "source": "PUBTATOR", "charStart": 89, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gemcitabine"}, {"duid": "PU:6XNf", "entityType": "Gene", "charEnd": 1202, "source": "PUBTATOR", "charStart": 1199, "entityId": [{"idString": "1111", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "CHK1"}, {"duid": "PU:m6Cx", "entityType": "Gene", "charEnd": 1606, "source": "PUBTATOR", "charStart": 1603, "entityId": [{"idString": "1111", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "CHK1"}, {"duid": "PU:FoPk", "entityType": "Chemical", "charEnd": 1150, "source": "PUBTATOR", "charStart": 1144, "entityId": [{"idString": "C532363", "source": "MESH"}], "sentenceIndex": 7, "entityText": "AZD7762"}, {"duid": "PU:tV4M", "entityType": "Gene", "charEnd": 1879, "source": "PUBTATOR", "charStart": 1876, "entityId": [{"idString": "1111", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "CHK1"}, {"duid": "PU:QMQ7", "entityType": "Chemical", "charEnd": 231, "source": "PUBTATOR", "charStart": 218, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 2, "entityText": "ribonucleotide"}, {"duid": "PU:UMmf", "entityType": "Disease", "charEnd": 661, "source": "PUBTATOR", "charStart": 649, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 5, "entityText": "breast cancer"}, {"duid": "PU:fpZx", "entityType": "Gene", "charEnd": 244, "source": "PUBTATOR", "charStart": 218, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ribonucleotide reductase M1"}, {"duid": "PU:QDTB", "entityType": "Disease", "charEnd": 1900, "source": "PUBTATOR", "charStart": 1895, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 12, "entityText": "tumors"}]}
{"text": "ERCC1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis. It is hypothesized that high expression of the excision repair cross-complementation group 1 (ERCC1) gene might be a positive prognostic factor, but predict decreased sensitivity to platinum-based chemotherapy. Results from the published data are inconsistent. To derive a more precise estimation of the relationship between ERCC1 and the prognosis and predictive response to chemotherapy of non-small cell lung cancer (NSCLC), a meta-analysis was performed. An electronic search of the PubMed and Embase database was performed. Hazard ratio (HR) for overall survival (OS) was pooled in early stage patients received surgery alone to analyze the prognosis of ERCC1 on NSCLC. HRs for OS in patients received surgery plus adjuvant chemotherapy and in patients received palliative chemotherapy and relative risk (RR) for overall response to chemotherapy were aggregated to analyze the prediction of ERCC1 on NSCLC. The pooled HR indicated that high ERCC1 levels were associated with longer survival in early stage patients received surgery alone (HR, 0.69; 95% confidence interval (CI), 0.58-0.83; P = 0.000). There was no difference in survival between high and low ERCC1 levels in patients received surgery plus adjuvant chemotherapy (HR, 1.41; 95% CI, 0.93-2.12; P = 0.106). However, high ERCC1 levels were associated with shorter survival and lower response to chemotherapy in advanced NSCLC patients received palliative chemotherapy (HR, 1.75; 95% CI, 1.39-2.22; P = 0.000; RR, 0.77; 95% CI, 0.64-0.93; P = 0.007; respectively). The meta-analysis indicated that high ERCC1 expression might be a favourable prognostic and a drug resistance predictive factor for NSCLC.", "title": {"charStart": 0, "charEnd": 115}, "docId": "22302397", "entity": [{"duid": "PU:MpT5", "entityType": "Disease", "charEnd": 1784, "source": "PUBTATOR", "charStart": 1780, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 10, "entityText": "NSCLC"}, {"duid": "PU:rYeX", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:uSmZ", "entityType": "Gene", "charEnd": 208, "source": "PUBTATOR", "charStart": 164, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementation group 1"}, {"duid": "PU:Y2dy", "entityType": "Disease", "charEnd": 541, "source": "PUBTATOR", "charStart": 537, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "NSCLC"}, {"duid": "PU:Scmj", "entityType": "Gene", "charEnd": 446, "source": "PUBTATOR", "charStart": 442, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:Q7iz", "entityType": "Gene", "charEnd": 215, "source": "PUBTATOR", "charStart": 211, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:QnEV", "entityType": "Disease", "charEnd": 1508, "source": "PUBTATOR", "charStart": 1504, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 9, "entityText": "NSCLC"}, {"duid": "PU:gTav", "entityType": "Gene", "charEnd": 1067, "source": "PUBTATOR", "charStart": 1063, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:pf6z", "entityType": "Gene", "charEnd": 1410, "source": "PUBTATOR", "charStart": 1406, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:9QM2", "entityType": "Disease", "charEnd": 1026, "source": "PUBTATOR", "charStart": 1022, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 6, "entityText": "NSCLC"}, {"duid": "PU:kHp8", "entityType": "Disease", "charEnd": 801, "source": "PUBTATOR", "charStart": 800, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 6, "entityText": "OS"}, {"duid": "PU:YX6a", "entityType": "Disease", "charEnd": 97, "source": "PUBTATOR", "charStart": 72, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:CAfm", "entityType": "Species", "charEnd": 813, "source": "PUBTATOR", "charStart": 806, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:qArY", "entityType": "Disease", "charEnd": 789, "source": "PUBTATOR", "charStart": 785, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 5, "entityText": "NSCLC"}, {"duid": "PU:2nNp", "entityType": "Disease", "charEnd": 683, "source": "PUBTATOR", "charStart": 668, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 5, "entityText": "overall survival"}, {"duid": "PU:zw7U", "entityType": "Disease", "charEnd": 687, "source": "PUBTATOR", "charStart": 686, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 5, "entityText": "OS"}, {"duid": "PU:XzsM", "entityType": "Species", "charEnd": 873, "source": "PUBTATOR", "charStart": 866, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:nMGf", "entityType": "Gene", "charEnd": 780, "source": "PUBTATOR", "charStart": 776, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERCC1"}, {"duid": "PU:Rca7", "entityType": "Gene", "charEnd": 1690, "source": "PUBTATOR", "charStart": 1686, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERCC1"}, {"duid": "PU:dtV5", "entityType": "Species", "charEnd": 723, "source": "PUBTATOR", "charStart": 716, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:cDPE", "entityType": "Species", "charEnd": 1135, "source": "PUBTATOR", "charStart": 1128, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:QzG9", "entityType": "Species", "charEnd": 1517, "source": "PUBTATOR", "charStart": 1510, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:pe4f", "entityType": "Chemical", "charEnd": 306, "source": "PUBTATOR", "charStart": 299, "entityId": [{"idString": "D010984", "source": "MESH"}], "sentenceIndex": 1, "entityText": "platinum"}, {"duid": "PU:62Pm", "entityType": "Gene", "charEnd": 1017, "source": "PUBTATOR", "charStart": 1013, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:kBNm", "entityType": "Species", "charEnd": 1304, "source": "PUBTATOR", "charStart": 1297, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:g4oa", "entityType": "Gene", "charEnd": 1285, "source": "PUBTATOR", "charStart": 1281, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}, {"duid": "PU:odnH", "entityType": "Disease", "charEnd": 534, "source": "PUBTATOR", "charStart": 509, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "non-small cell lung cancer"}, {"duid": "PU:XpUr", "entityType": "Species", "charEnd": 65, "source": "PUBTATOR", "charStart": 58, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}]}
{"text": "A single cycle of treatment with temozolomide, alone or combined with O(6)-benzylguanine, induces strong chemoresistance in melanoma cell clones in vitro: role of O(6)-methylguanine-DNA methyltransferase and the mismatch repair system. Clinically achievable concentrations of temozolomide (TMZ) produce cytotoxic effects only in mismatch repair (MMR)-proficient cells endowed with low O6-methylguanine-DNA methyltransferase (MGMT) activity. Aim of the present study was to investigate the molecular mechanisms underlying acquired resistance of melanoma cells to TMZ and the effect of O6-benzylguanine (BG), a specific MGMT inhibitor, on the development of a TMZ-resistant phenotype. Three MMR-proficient melanoma cell clones with low or no MGMT activity were treated daily for 5 days with 50 micromol/l TMZ, alone or in combination with 5 micromol/l BG. Parental clones and sublines established after one or four cycles of treatment were analyzed for sensitivity to TMZ or TMZ+BG and for other parameters. The sublines established after one cycle of TMZ or TMZ+BG exhibited a marked increase in MGMT activity and resistance to TMZ alone. BG only partially reversed acquired resistance to the drug. In some cases, alterations in the MMR system accounted for MGMT-independent resistance to TMZ. Up-regulation of MGMT activity was associated with either demethylation of the MGMT promoter or hypermethylation of the body of the gene, and partially reversed by 5-aza-2'-deoxycytidine. The sublines established after four cycles of TMZ or TMZ+BG did not show a further increase in resistance to TMZ alone. However, two out of three sublines established after TMZ+BG treatment exhibited increased resistance to TMZ+BG. In conclusion, our data demonstrate that a single cycle of TMZ is sufficient to induce high levels of drug resistance in melanoma clones, principally, but not exclusively, via up-regulation of MGMT expression. Exposure to TMZ+BG favors the development of MGMT-independent mechanisms of TMZ resistance.", "title": {"charStart": 0, "charEnd": 234}, "docId": "16964376", "entity": [{"duid": "PU:96hK", "entityType": "Chemical", "charEnd": 287, "source": "PUBTATOR", "charStart": 276, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "temozolomide"}, {"duid": "PU:CctU", "entityType": "Chemical", "charEnd": 1529, "source": "PUBTATOR", "charStart": 1527, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TMZ"}, {"duid": "PU:R9ks", "entityType": "Gene", "charEnd": 202, "source": "PUBTATOR", "charStart": 163, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "O(6)-methylguanine-DNA methyltransferase"}, {"duid": "PU:MSuc", "entityType": "Disease", "charEnd": 711, "source": "PUBTATOR", "charStart": 704, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 3, "entityText": "melanoma"}, {"duid": "PU:uHVp", "entityType": "Gene", "charEnd": 428, "source": "PUBTATOR", "charStart": 425, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "MGMT"}, {"duid": "PU:7eNc", "entityType": "Chemical", "charEnd": 805, "source": "PUBTATOR", "charStart": 803, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 3, "entityText": "TMZ"}, {"duid": "PU:NWHX", "entityType": "Chemical", "charEnd": 968, "source": "PUBTATOR", "charStart": 966, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 4, "entityText": "TMZ"}, {"duid": "PU:ubwY", "entityType": "Chemical", "charEnd": 660, "source": "PUBTATOR", "charStart": 658, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 2, "entityText": "TMZ"}, {"duid": "PU:VyUf", "entityType": "Chemical", "charEnd": 1129, "source": "PUBTATOR", "charStart": 1127, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 5, "entityText": "TMZ"}, {"duid": "PU:P7tP", "entityType": "Chemical", "charEnd": 975, "source": "PUBTATOR", "charStart": 973, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 4, "entityText": "TMZ"}, {"duid": "PU:hKoi", "entityType": "Chemical", "charEnd": 1937, "source": "PUBTATOR", "charStart": 1935, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 12, "entityText": "TMZ"}, {"duid": "PU:PTbX", "entityType": "Chemical", "charEnd": 564, "source": "PUBTATOR", "charStart": 562, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 2, "entityText": "TMZ"}, {"duid": "PU:kru2", "entityType": "Gene", "charEnd": 621, "source": "PUBTATOR", "charStart": 618, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "MGMT"}, {"duid": "PU:eTAF", "entityType": "Gene", "charEnd": 1909, "source": "PUBTATOR", "charStart": 1906, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "MGMT"}, {"duid": "PU:4dKe", "entityType": "Disease", "charEnd": 1841, "source": "PUBTATOR", "charStart": 1834, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 11, "entityText": "melanoma"}, {"duid": "PU:grwc", "entityType": "Chemical", "charEnd": 1774, "source": "PUBTATOR", "charStart": 1772, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 11, "entityText": "TMZ"}, {"duid": "PU:kD3i", "entityType": "Gene", "charEnd": 1971, "source": "PUBTATOR", "charStart": 1968, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "MGMT"}, {"duid": "PU:CUM2", "entityType": "Gene", "charEnd": 743, "source": "PUBTATOR", "charStart": 740, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MGMT"}, {"duid": "PU:tZRo", "entityType": "Chemical", "charEnd": 1478, "source": "PUBTATOR", "charStart": 1457, "entityId": [{"idString": "C014347", "source": "MESH"}], "sentenceIndex": 8, "entityText": "5-aza-2'-deoxycytidine"}, {"duid": "PU:PSvA", "entityType": "Chemical", "charEnd": 1059, "source": "PUBTATOR", "charStart": 1057, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 5, "entityText": "TMZ"}, {"duid": "PU:Mbdk", "entityType": "Disease", "charEnd": 131, "source": "PUBTATOR", "charStart": 124, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 0, "entityText": "melanoma"}, {"duid": "PU:nxAF", "entityType": "Disease", "charEnd": 551, "source": "PUBTATOR", "charStart": 544, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 2, "entityText": "melanoma"}, {"duid": "PU:6rWN", "entityType": "Gene", "charEnd": 422, "source": "PUBTATOR", "charStart": 385, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "O6-methylguanine-DNA methyltransferase"}, {"duid": "PU:QZFj", "entityType": "Chemical", "charEnd": 1536, "source": "PUBTATOR", "charStart": 1534, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TMZ"}, {"duid": "PU:pAgo", "entityType": "Chemical", "charEnd": 1707, "source": "PUBTATOR", "charStart": 1705, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 10, "entityText": "TMZ"}, {"duid": "PU:Qe9J", "entityType": "Chemical", "charEnd": 400, "source": "PUBTATOR", "charStart": 385, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 1, "entityText": "O6-methylguanine"}, {"duid": "PU:MU6c", "entityType": "Chemical", "charEnd": 1592, "source": "PUBTATOR", "charStart": 1590, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TMZ"}, {"duid": "PU:CNMy", "entityType": "Gene", "charEnd": 1260, "source": "PUBTATOR", "charStart": 1257, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MGMT"}, {"duid": "PU:moEu", "entityType": "Chemical", "charEnd": 2001, "source": "PUBTATOR", "charStart": 1999, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 12, "entityText": "TMZ"}, {"duid": "PU:T5EV", "entityType": "Chemical", "charEnd": 851, "source": "PUBTATOR", "charStart": 850, "entityId": [{"idString": "C028315", "source": "MESH"}], "sentenceIndex": 3, "entityText": "BG"}, {"duid": "PU:9pbW", "entityType": "Chemical", "charEnd": 1290, "source": "PUBTATOR", "charStart": 1288, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 7, "entityText": "TMZ"}, {"duid": "PU:pBMb", "entityType": "Gene", "charEnd": 1375, "source": "PUBTATOR", "charStart": 1372, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MGMT"}, {"duid": "PU:zpqG", "entityType": "Chemical", "charEnd": 1052, "source": "PUBTATOR", "charStart": 1050, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 5, "entityText": "TMZ"}, {"duid": "PU:abia", "entityType": "Gene", "charEnd": 1313, "source": "PUBTATOR", "charStart": 1310, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MGMT"}, {"duid": "PU:ky7H", "entityType": "Chemical", "charEnd": 1656, "source": "PUBTATOR", "charStart": 1654, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 10, "entityText": "TMZ"}, {"duid": "PU:DWBp", "entityType": "Gene", "charEnd": 1098, "source": "PUBTATOR", "charStart": 1095, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "MGMT"}, {"duid": "PU:9n8M", "entityType": "Chemical", "charEnd": 44, "source": "PUBTATOR", "charStart": 33, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "temozolomide"}, {"duid": "PU:tz8m", "entityType": "Chemical", "charEnd": 599, "source": "PUBTATOR", "charStart": 584, "entityId": [{"idString": "C064976", "source": "MESH"}], "sentenceIndex": 2, "entityText": "O6-benzylguanine"}, {"duid": "PU:zagw", "entityType": "Chemical", "charEnd": 180, "source": "PUBTATOR", "charStart": 163, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 0, "entityText": "O(6)-methylguanine"}, {"duid": "PU:3koy", "entityType": "Chemical", "charEnd": 292, "source": "PUBTATOR", "charStart": 290, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TMZ"}, {"duid": "PU:Yu8z", "entityType": "Chemical", "charEnd": 87, "source": "PUBTATOR", "charStart": 70, "entityId": [{"idString": "C064976", "source": "MESH"}], "sentenceIndex": 0, "entityText": "O(6)-benzylguanine"}, {"duid": "PU:pwXz", "entityType": "Chemical", "charEnd": 1659, "source": "PUBTATOR", "charStart": 1658, "entityId": [{"idString": "C028315", "source": "MESH"}], "sentenceIndex": 10, "entityText": "BG"}]}
{"text": "Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models. The antitumor activity of the methylating agent temozolomide has been evaluated against a panel of 17 xenografts derived from pediatric solid tumors. Temozolomide was administered p.o. daily for five consecutive days at a dose level of 66 mg/kg. Courses of treatment were repeated every 21 days for three cycles. Tumor lines were classified as having high, intermediate, or low sensitivity, determined by complete responses, partial responses, or stable disease, respectively. Overall, temozolomide induced complete responses in five lines and partial responses in three additional tumor lines, giving objective regressions in 47% of xenograft lines. Analysis of temozolomide plasma systemic exposure indicated that this dose level was relevant to exposure achieved in patients. Tumors were analyzed by immunoblotting for levels of O6-methylguanine-DNA methyltransferase (MGMT) and two mismatch repair proteins, MLH-1 and MSH-2. Tumors classified as having high or intermediate sensitivity had low or undetectable MGMT and expressed detectable MLH-1 and MSH-2 proteins. Tumors classified as having low sensitivity had either (a) high MGMT or (b) low or undetectable MGMT but were deficient in MLH-1. The relationship between p53 and response to temozolomide was also examined. In vitro temozolomide did not induce p21cip1 in p53-competent NB-1643 neuroblastoma cells. Suppression of p53 function in NB1643 clones through stable expression of a trans dominant negative p53 (NB1643p53TDN) did not confer temozolomide resistance. Similarly, tumor sensitivity to temozolomide did not segregate with p53 genotype or p53 functional status. These results indicate that MGMT is the primary mechanism for temozolomide resistance, but in the absence of MGMT, proficient mismatch repair determines sensitivity to this agent.", "title": {"charStart": 0, "charEnd": 92}, "docId": "10741727", "entity": [{"duid": "PU:dVs5", "entityType": "Disease", "charEnd": 680, "source": "PUBTATOR", "charStart": 676, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumor"}, {"duid": "PU:scUD", "entityType": "Disease", "charEnd": 241, "source": "PUBTATOR", "charStart": 236, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumors"}, {"duid": "PU:QcLd", "entityType": "Species", "charEnd": 870, "source": "PUBTATOR", "charStart": 863, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:uXzr", "entityType": "Chemical", "charEnd": 37, "source": "PUBTATOR", "charStart": 26, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "temozolomide"}, {"duid": "PU:jEbm", "entityType": "Gene", "charEnd": 1142, "source": "PUBTATOR", "charStart": 1138, "entityId": [{"idString": "4292", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MLH-1"}, {"duid": "PU:MZkz", "entityType": "Gene", "charEnd": 1152, "source": "PUBTATOR", "charStart": 1148, "entityId": [{"idString": "4436", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MSH-2"}, {"duid": "PU:mdGE", "entityType": "Gene", "charEnd": 1291, "source": "PUBTATOR", "charStart": 1287, "entityId": [{"idString": "4292", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "MLH-1"}, {"duid": "PU:YCTQ", "entityType": "Disease", "charEnd": 1453, "source": "PUBTATOR", "charStart": 1441, "entityId": [{"idString": "D009447", "source": "MESH"}], "sentenceIndex": 11, "entityText": "neuroblastoma"}, {"duid": "PU:peHc", "entityType": "Disease", "charEnd": 1028, "source": "PUBTATOR", "charStart": 1023, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "Tumors"}, {"duid": "PU:cEpY", "entityType": "Chemical", "charEnd": 1664, "source": "PUBTATOR", "charStart": 1653, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 13, "entityText": "temozolomide"}, {"duid": "PU:bRRJ", "entityType": "Chemical", "charEnd": 1150, "source": "PUBTATOR", "charStart": 1148, "entityId": [{"idString": "D009074", "source": "MESH"}], "sentenceIndex": 8, "entityText": "MSH"}, {"duid": "PU:BZFX", "entityType": "Gene", "charEnd": 1111, "source": "PUBTATOR", "charStart": 1108, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MGMT"}, {"duid": "PU:js8N", "entityType": "Gene", "charEnd": 1691, "source": "PUBTATOR", "charStart": 1689, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "p53"}, {"duid": "PU:SnjZ", "entityType": "Disease", "charEnd": 1169, "source": "PUBTATOR", "charStart": 1164, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Tumors"}, {"duid": "PU:Lx5g", "entityType": "Gene", "charEnd": 1564, "source": "PUBTATOR", "charStart": 1562, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "p53"}, {"duid": "PU:d9kZ", "entityType": "Gene", "charEnd": 1231, "source": "PUBTATOR", "charStart": 1228, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "MGMT"}, {"duid": "PU:6Toi", "entityType": "Gene", "charEnd": 1479, "source": "PUBTATOR", "charStart": 1477, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "p53"}, {"duid": "PU:WeLJ", "entityType": "Gene", "charEnd": 1414, "source": "PUBTATOR", "charStart": 1408, "entityId": [{"idString": "1026", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "p21cip1"}, {"duid": "PU:dKmD", "entityType": "Disease", "charEnd": 878, "source": "PUBTATOR", "charStart": 873, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "Tumors"}, {"duid": "PU:YsNL", "entityType": "Gene", "charEnd": 1321, "source": "PUBTATOR", "charStart": 1319, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "p53"}, {"duid": "PU:GCj2", "entityType": "Chemical", "charEnd": 1391, "source": "PUBTATOR", "charStart": 1380, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 11, "entityText": "temozolomide"}, {"duid": "PU:bpTz", "entityType": "Gene", "charEnd": 1421, "source": "PUBTATOR", "charStart": 1419, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "p53"}, {"duid": "PU:5xVQ", "entityType": "Gene", "charEnd": 969, "source": "PUBTATOR", "charStart": 966, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MGMT"}, {"duid": "PU:8yah", "entityType": "Chemical", "charEnd": 1578, "source": "PUBTATOR", "charStart": 1567, "entityId": [{"idString": "C569064", "source": "MESH"}], "sentenceIndex": 12, "entityText": "NB1643p53TDN"}, {"duid": "PU:3Tpd", "entityType": "Gene", "charEnd": 1707, "source": "PUBTATOR", "charStart": 1705, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "p53"}, {"duid": "PU:PoqG", "entityType": "Chemical", "charEnd": 1350, "source": "PUBTATOR", "charStart": 1339, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 10, "entityText": "temozolomide"}, {"duid": "PU:myPy", "entityType": "Gene", "charEnd": 1010, "source": "PUBTATOR", "charStart": 1006, "entityId": [{"idString": "4292", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MLH-1"}, {"duid": "PU:gUBs", "entityType": "Chemical", "charEnd": 1801, "source": "PUBTATOR", "charStart": 1790, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 14, "entityText": "temozolomide"}, {"duid": "PU:39yA", "entityType": "Gene", "charEnd": 1840, "source": "PUBTATOR", "charStart": 1837, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "MGMT"}, {"duid": "PU:3FJa", "entityType": "Chemical", "charEnd": 153, "source": "PUBTATOR", "charStart": 142, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "temozolomide"}, {"duid": "PU:QEa2", "entityType": "Disease", "charEnd": 1636, "source": "PUBTATOR", "charStart": 1632, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 13, "entityText": "tumor"}, {"duid": "PU:RWVg", "entityType": "Chemical", "charEnd": 768, "source": "PUBTATOR", "charStart": 757, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 6, "entityText": "temozolomide"}, {"duid": "PU:bQv7", "entityType": "Chemical", "charEnd": 941, "source": "PUBTATOR", "charStart": 926, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 7, "entityText": "O6-methylguanine"}, {"duid": "PU:HUJW", "entityType": "Gene", "charEnd": 1263, "source": "PUBTATOR", "charStart": 1260, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "MGMT"}, {"duid": "PU:hU5j", "entityType": "Chemical", "charEnd": 1018, "source": "PUBTATOR", "charStart": 1016, "entityId": [{"idString": "D009074", "source": "MESH"}], "sentenceIndex": 7, "entityText": "MSH"}, {"duid": "PU:QXSK", "entityType": "Chemical", "charEnd": 1607, "source": "PUBTATOR", "charStart": 1596, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 12, "entityText": "temozolomide"}, {"duid": "PU:V6Uu", "entityType": "Disease", "charEnd": 74, "source": "PUBTATOR", "charStart": 70, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 0, "entityText": "tumor"}, {"duid": "PU:taa5", "entityType": "Gene", "charEnd": 1020, "source": "PUBTATOR", "charStart": 1016, "entityId": [{"idString": "4436", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MSH-2"}, {"duid": "PU:u8bP", "entityType": "Chemical", "charEnd": 255, "source": "PUBTATOR", "charStart": 244, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 2, "entityText": "Temozolomide"}, {"duid": "PU:kjKp", "entityType": "Chemical", "charEnd": 591, "source": "PUBTATOR", "charStart": 580, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 5, "entityText": "temozolomide"}, {"duid": "PU:7Umk", "entityType": "Gene", "charEnd": 1759, "source": "PUBTATOR", "charStart": 1756, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "MGMT"}, {"duid": "PU:WYd8", "entityType": "Gene", "charEnd": 963, "source": "PUBTATOR", "charStart": 926, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "O6-methylguanine-DNA methyltransferase"}]}
{"text": "Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models. The antitumor activity of the methylating agent temozolomide has been evaluated against a panel of 17 xenografts derived from pediatric solid tumors. Temozolomide was administered p.o. daily for five consecutive days at a dose level of 66 mg/kg. Courses of treatment were repeated every 21 days for three cycles. Tumor lines were classified as having high, intermediate, or low sensitivity, determined by complete responses, partial responses, or stable disease, respectively. Overall, temozolomide induced complete responses in five lines and partial responses in three additional tumor lines, giving objective regressions in 47% of xenograft lines. Analysis of temozolomide plasma systemic exposure indicated that this dose level was relevant to exposure achieved in patients. Tumors were analyzed by immunoblotting for levels of O6-methylguanine-DNA methyltransferase (MGMT) and two mismatch repair proteins, MLH-1 and MSH-2. Tumors classified as having high or intermediate sensitivity had low or undetectable MGMT and expressed detectable MLH-1 and MSH-2 proteins. Tumors classified as having low sensitivity had either (a) high MGMT or (b) low or undetectable MGMT but were deficient in MLH-1. The relationship between p53 and response to temozolomide was also examined. In vitro temozolomide did not induce p21cip1 in p53-competent NB-1643 neuroblastoma cells. Suppression of p53 function in NB1643 clones through stable expression of a trans dominant negative p53 (NB1643p53TDN) did not confer temozolomide resistance. Similarly, tumor sensitivity to temozolomide did not segregate with p53 genotype or p53 functional status. These results indicate that MGMT is the primary mechanism for temozolomide resistance, but in the absence of MGMT, proficient mismatch repair determines sensitivity to this agent.", "title": {"charStart": 0, "charEnd": 92}, "docId": "10741727", "entity": [{"duid": "PU:dVs5", "entityType": "Disease", "charEnd": 680, "source": "PUBTATOR", "charStart": 676, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumor"}, {"duid": "PU:scUD", "entityType": "Disease", "charEnd": 241, "source": "PUBTATOR", "charStart": 236, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumors"}, {"duid": "PU:QcLd", "entityType": "Species", "charEnd": 870, "source": "PUBTATOR", "charStart": 863, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:uXzr", "entityType": "Chemical", "charEnd": 37, "source": "PUBTATOR", "charStart": 26, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "temozolomide"}, {"duid": "PU:jEbm", "entityType": "Gene", "charEnd": 1142, "source": "PUBTATOR", "charStart": 1138, "entityId": [{"idString": "4292", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MLH-1"}, {"duid": "PU:MZkz", "entityType": "Gene", "charEnd": 1152, "source": "PUBTATOR", "charStart": 1148, "entityId": [{"idString": "4436", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MSH-2"}, {"duid": "PU:mdGE", "entityType": "Gene", "charEnd": 1291, "source": "PUBTATOR", "charStart": 1287, "entityId": [{"idString": "4292", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "MLH-1"}, {"duid": "PU:YCTQ", "entityType": "Disease", "charEnd": 1453, "source": "PUBTATOR", "charStart": 1441, "entityId": [{"idString": "D009447", "source": "MESH"}], "sentenceIndex": 11, "entityText": "neuroblastoma"}, {"duid": "PU:peHc", "entityType": "Disease", "charEnd": 1028, "source": "PUBTATOR", "charStart": 1023, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "Tumors"}, {"duid": "PU:cEpY", "entityType": "Chemical", "charEnd": 1664, "source": "PUBTATOR", "charStart": 1653, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 13, "entityText": "temozolomide"}, {"duid": "PU:bRRJ", "entityType": "Chemical", "charEnd": 1150, "source": "PUBTATOR", "charStart": 1148, "entityId": [{"idString": "D009074", "source": "MESH"}], "sentenceIndex": 8, "entityText": "MSH"}, {"duid": "PU:BZFX", "entityType": "Gene", "charEnd": 1111, "source": "PUBTATOR", "charStart": 1108, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "MGMT"}, {"duid": "PU:js8N", "entityType": "Gene", "charEnd": 1691, "source": "PUBTATOR", "charStart": 1689, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "p53"}, {"duid": "PU:SnjZ", "entityType": "Disease", "charEnd": 1169, "source": "PUBTATOR", "charStart": 1164, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Tumors"}, {"duid": "PU:Lx5g", "entityType": "Gene", "charEnd": 1564, "source": "PUBTATOR", "charStart": 1562, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "p53"}, {"duid": "PU:d9kZ", "entityType": "Gene", "charEnd": 1231, "source": "PUBTATOR", "charStart": 1228, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "MGMT"}, {"duid": "PU:6Toi", "entityType": "Gene", "charEnd": 1479, "source": "PUBTATOR", "charStart": 1477, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "p53"}, {"duid": "PU:WeLJ", "entityType": "Gene", "charEnd": 1414, "source": "PUBTATOR", "charStart": 1408, "entityId": [{"idString": "1026", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "p21cip1"}, {"duid": "PU:dKmD", "entityType": "Disease", "charEnd": 878, "source": "PUBTATOR", "charStart": 873, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "Tumors"}, {"duid": "PU:YsNL", "entityType": "Gene", "charEnd": 1321, "source": "PUBTATOR", "charStart": 1319, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "p53"}, {"duid": "PU:GCj2", "entityType": "Chemical", "charEnd": 1391, "source": "PUBTATOR", "charStart": 1380, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 11, "entityText": "temozolomide"}, {"duid": "PU:bpTz", "entityType": "Gene", "charEnd": 1421, "source": "PUBTATOR", "charStart": 1419, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "p53"}, {"duid": "PU:5xVQ", "entityType": "Gene", "charEnd": 969, "source": "PUBTATOR", "charStart": 966, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MGMT"}, {"duid": "PU:8yah", "entityType": "Chemical", "charEnd": 1578, "source": "PUBTATOR", "charStart": 1567, "entityId": [{"idString": "C569064", "source": "MESH"}], "sentenceIndex": 12, "entityText": "NB1643p53TDN"}, {"duid": "PU:3Tpd", "entityType": "Gene", "charEnd": 1707, "source": "PUBTATOR", "charStart": 1705, "entityId": [{"idString": "7157", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "p53"}, {"duid": "PU:PoqG", "entityType": "Chemical", "charEnd": 1350, "source": "PUBTATOR", "charStart": 1339, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 10, "entityText": "temozolomide"}, {"duid": "PU:myPy", "entityType": "Gene", "charEnd": 1010, "source": "PUBTATOR", "charStart": 1006, "entityId": [{"idString": "4292", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MLH-1"}, {"duid": "PU:gUBs", "entityType": "Chemical", "charEnd": 1801, "source": "PUBTATOR", "charStart": 1790, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 14, "entityText": "temozolomide"}, {"duid": "PU:39yA", "entityType": "Gene", "charEnd": 1840, "source": "PUBTATOR", "charStart": 1837, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "MGMT"}, {"duid": "PU:3FJa", "entityType": "Chemical", "charEnd": 153, "source": "PUBTATOR", "charStart": 142, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "temozolomide"}, {"duid": "PU:QEa2", "entityType": "Disease", "charEnd": 1636, "source": "PUBTATOR", "charStart": 1632, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 13, "entityText": "tumor"}, {"duid": "PU:RWVg", "entityType": "Chemical", "charEnd": 768, "source": "PUBTATOR", "charStart": 757, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 6, "entityText": "temozolomide"}, {"duid": "PU:bQv7", "entityType": "Chemical", "charEnd": 941, "source": "PUBTATOR", "charStart": 926, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 7, "entityText": "O6-methylguanine"}, {"duid": "PU:HUJW", "entityType": "Gene", "charEnd": 1263, "source": "PUBTATOR", "charStart": 1260, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "MGMT"}, {"duid": "PU:hU5j", "entityType": "Chemical", "charEnd": 1018, "source": "PUBTATOR", "charStart": 1016, "entityId": [{"idString": "D009074", "source": "MESH"}], "sentenceIndex": 7, "entityText": "MSH"}, {"duid": "PU:QXSK", "entityType": "Chemical", "charEnd": 1607, "source": "PUBTATOR", "charStart": 1596, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 12, "entityText": "temozolomide"}, {"duid": "PU:V6Uu", "entityType": "Disease", "charEnd": 74, "source": "PUBTATOR", "charStart": 70, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 0, "entityText": "tumor"}, {"duid": "PU:taa5", "entityType": "Gene", "charEnd": 1020, "source": "PUBTATOR", "charStart": 1016, "entityId": [{"idString": "4436", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "MSH-2"}, {"duid": "PU:u8bP", "entityType": "Chemical", "charEnd": 255, "source": "PUBTATOR", "charStart": 244, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 2, "entityText": "Temozolomide"}, {"duid": "PU:kjKp", "entityType": "Chemical", "charEnd": 591, "source": "PUBTATOR", "charStart": 580, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 5, "entityText": "temozolomide"}, {"duid": "PU:7Umk", "entityType": "Gene", "charEnd": 1759, "source": "PUBTATOR", "charStart": 1756, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "MGMT"}, {"duid": "PU:WYd8", "entityType": "Gene", "charEnd": 963, "source": "PUBTATOR", "charStart": 926, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "O6-methylguanine-DNA methyltransferase"}]}
{"text": "Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O\u2076-methylguanine-DNA methyltransferase and mismatch repair proteins. PURPOSE: Temozolomide (TMZ) is an oral derivative of dacarbazine that induces DNA damage by methylating nucleotide bases. Resistance has been associated with high levels of O\u2076-methylguanine-DNA methyltransferase (MGMT). Malignant CD4(+) T cells of patients with mycosis fungoides/S\u00e9zary syndrome (MF/SS) have been shown to have low levels of MGMT and may be particularly sensitive to this methylator. EXPERIMENTAL DESIGN: The efficacy of TMZ was evaluated in a multicenter phase II trial of patients with advanced stages of MF/SS. TMZ was given orally at daily doses of 200 mg/m\u00b2 for 5 days every 28 days. MGMT and mismatch repair protein expression was assessed by quantitative immunofluorescence and immunohistochemistry in skin and blood samples. RESULTS: Twenty-six patients (stages IB-IVB) were evaluable for response. Patients had a median of four prior treatments. Median follow-up time was 19 months (range, 1-95). The overall response was 27% with two complete remissions (8%) and five partial remissions (19%). Median disease-free survival was 4 months. The median overall survival was 24 months. The most frequent toxicities included constitutional symptoms, gastrointestinal symptoms, and hematologic toxicities. Treatment was discontinued in three patients following grade 3 thrombocytopenia, lymphopenia, and skin reaction. The relationship between pretreatment MGMT and mutL homolog 1 (MLH1)/mutS homolog 2 (MSH2) mismatch repair protein expression levels in skin biopsies of cutaneous lesions and clinical response to TMZ were evaluated. CONCLUSIONS: Pretreatment levels of MGMT and MLH1/MSH2 protein levels are not predictive of response to TMZ in MF/SS, suggesting that other resistance mechanisms are important.", "title": {"charStart": 0, "charEnd": 165}, "docId": "21747120", "entity": [{"duid": "PU:Zu5v", "entityType": "Disease", "charEnd": 1470, "source": "PUBTATOR", "charStart": 1455, "entityId": [{"idString": "D013921", "source": "MESH"}], "sentenceIndex": 14, "entityText": "thrombocytopenia"}, {"duid": "PU:hQ7p", "entityType": "Disease", "charEnd": 1389, "source": "PUBTATOR", "charStart": 1380, "entityId": [{"idString": "D064420", "source": "MESH"}], "sentenceIndex": 13, "entityText": "toxicities"}, {"duid": "PU:gpXQ", "entityType": "Gene", "charEnd": 1593, "source": "PUBTATOR", "charStart": 1590, "entityId": [{"idString": "4436", "source": "Entrez"}], "sentenceIndex": 15, "entityText": "MSH2"}, {"duid": "PU:KvRV", "entityType": "Chemical", "charEnd": 280, "source": "PUBTATOR", "charStart": 271, "entityId": [{"idString": "36976", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "nucleotide"}, {"duid": "PU:Va9z", "entityType": "Species", "charEnd": 665, "source": "PUBTATOR", "charStart": 658, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:9YfH", "entityType": "Chemical", "charEnd": 1827, "source": "PUBTATOR", "charStart": 1825, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 16, "entityText": "TMZ"}, {"duid": "PU:ti6W", "entityType": "Gene", "charEnd": 135, "source": "PUBTATOR", "charStart": 101, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "methylguanine-DNA methyltransferase"}, {"duid": "PU:e4EY", "entityType": "Gene", "charEnd": 1546, "source": "PUBTATOR", "charStart": 1543, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 15, "entityText": "MGMT"}, {"duid": "PU:VXqk", "entityType": "Gene", "charEnd": 1769, "source": "PUBTATOR", "charStart": 1766, "entityId": [{"idString": "4292", "source": "Entrez"}], "sentenceIndex": 16, "entityText": "MLH1"}, {"duid": "PU:DBD5", "entityType": "Species", "charEnd": 944, "source": "PUBTATOR", "charStart": 937, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:QBBn", "entityType": "Disease", "charEnd": 78, "source": "PUBTATOR", "charStart": 46, "entityId": [{"idString": "D009182", "source": "MESH"}], "sentenceIndex": 0, "entityText": "mycosis fungoides/sezary syndrome"}, {"duid": "PU:HXvo", "entityType": "Chemical", "charEnd": 41, "source": "PUBTATOR", "charStart": 30, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "temozolomide"}, {"duid": "PU:WZBG", "entityType": "Gene", "charEnd": 1760, "source": "PUBTATOR", "charStart": 1757, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 16, "entityText": "MGMT"}, {"duid": "PU:iv4R", "entityType": "Species", "charEnd": 422, "source": "PUBTATOR", "charStart": 415, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:zvKV", "entityType": "Disease", "charEnd": 1361, "source": "PUBTATOR", "charStart": 1337, "entityId": [{"idString": "D005767", "source": "MESH"}], "sentenceIndex": 13, "entityText": "gastrointestinal symptoms"}, {"duid": "PU:TsKb", "entityType": "Gene", "charEnd": 1571, "source": "PUBTATOR", "charStart": 1568, "entityId": [{"idString": "4292", "source": "Entrez"}], "sentenceIndex": 15, "entityText": "MLH1"}, {"duid": "PU:WPzs", "entityType": "Species", "charEnd": 1435, "source": "PUBTATOR", "charStart": 1428, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 14, "entityText": "patients"}, {"duid": "PU:nfov", "entityType": "Chemical", "charEnd": 192, "source": "PUBTATOR", "charStart": 190, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "TMZ"}, {"duid": "PU:myhM", "entityType": "Gene", "charEnd": 1774, "source": "PUBTATOR", "charStart": 1771, "entityId": [{"idString": "4436", "source": "Entrez"}], "sentenceIndex": 16, "entityText": "MSH2"}, {"duid": "PU:X3NU", "entityType": "Gene", "charEnd": 1565, "source": "PUBTATOR", "charStart": 1552, "entityId": [{"idString": "4292", "source": "Entrez"}], "sentenceIndex": 15, "entityText": "mutL homolog 1"}, {"duid": "PU:rUGd", "entityType": "Gene", "charEnd": 1587, "source": "PUBTATOR", "charStart": 1574, "entityId": [{"idString": "4436", "source": "Entrez"}], "sentenceIndex": 15, "entityText": "mutS homolog 2"}, {"duid": "PU:Ke9G", "entityType": "Chemical", "charEnd": 607, "source": "PUBTATOR", "charStart": 605, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 4, "entityText": "TMZ"}, {"duid": "PU:GMd4", "entityType": "Chemical", "charEnd": 113, "source": "PUBTATOR", "charStart": 101, "entityId": [{"idString": "25305", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "methylguanine"}, {"duid": "PU:wmXD", "entityType": "Species", "charEnd": 998, "source": "PUBTATOR", "charStart": 991, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "Patients"}, {"duid": "PU:5CBo", "entityType": "Gene", "charEnd": 512, "source": "PUBTATOR", "charStart": 509, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "MGMT"}, {"duid": "PU:ZLLr", "entityType": "Chemical", "charEnd": 98, "source": "PUBTATOR", "charStart": 98, "entityId": [], "sentenceIndex": 0, "entityText": "O"}, {"duid": "PU:xEnC", "entityType": "Chemical", "charEnd": 230, "source": "PUBTATOR", "charStart": 220, "entityId": [{"idString": "D003606", "source": "MESH"}], "sentenceIndex": 1, "entityText": "dacarbazine"}, {"duid": "PU:sG7B", "entityType": "Disease", "charEnd": 1301, "source": "PUBTATOR", "charStart": 1292, "entityId": [{"idString": "D064420", "source": "MESH"}], "sentenceIndex": 13, "entityText": "toxicities"}, {"duid": "PU:H8d9", "entityType": "Chemical", "charEnd": 187, "source": "PUBTATOR", "charStart": 176, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Temozolomide"}, {"duid": "PU:7bq3", "entityType": "Gene", "charEnd": 377, "source": "PUBTATOR", "charStart": 343, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "methylguanine-DNA methyltransferase"}, {"duid": "PU:FCxk", "entityType": "Chemical", "charEnd": 700, "source": "PUBTATOR", "charStart": 698, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 5, "entityText": "TMZ"}, {"duid": "PU:kmFj", "entityType": "Gene", "charEnd": 383, "source": "PUBTATOR", "charStart": 380, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "MGMT"}, {"duid": "PU:fWP8", "entityType": "Chemical", "charEnd": 340, "source": "PUBTATOR", "charStart": 340, "entityId": [], "sentenceIndex": 2, "entityText": "O"}, {"duid": "PU:V6ac", "entityType": "Disease", "charEnd": 435, "source": "PUBTATOR", "charStart": 429, "entityId": [{"idString": "D015821", "source": "MESH"}], "sentenceIndex": 3, "entityText": "mycosis"}, {"duid": "PU:bo6k", "entityType": "Gene", "charEnd": 776, "source": "PUBTATOR", "charStart": 773, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "MGMT"}, {"duid": "PU:Akm8", "entityType": "Chemical", "charEnd": 355, "source": "PUBTATOR", "charStart": 343, "entityId": [{"idString": "25305", "source": "CHEBI"}], "sentenceIndex": 2, "entityText": "methylguanine"}, {"duid": "PU:KnRq", "entityType": "Chemical", "charEnd": 1703, "source": "PUBTATOR", "charStart": 1701, "entityId": [{"idString": "72564", "source": "CHEBI"}], "sentenceIndex": 15, "entityText": "TMZ"}, {"duid": "PU:JW4x", "entityType": "Disease", "charEnd": 1483, "source": "PUBTATOR", "charStart": 1473, "entityId": [{"idString": "D008231", "source": "MESH"}], "sentenceIndex": 14, "entityText": "lymphopenia"}]}
{"text": "[Enhanced cisplatin cytotoxicity by RNA interfering the excision repair cross-complementing gene 1 in lung cancer cell A549/DDP]. BACKGROUND AND OBJECTIVE: The excision repair cross-complementing gene 1 (ERCC1), which is important in the repair of cisplatin-DNA adducts, was reported to be related to cisplatin resistance in tumor cells. The aim of this study is to investigate the changes of cisplatin sensitivity by silencing ERCC1 gene in lung cancer cell. METHODS: The small interfering RNA (siRNA) targeting ERCC1 gene was designed and synthesized, and transfected to lung cancer cell A549/DDP. The mRNA and protein expression levels of ERCC1 were evaluated by RT-PCR and Western blot. The changes of cisplatin sensitivity after RNA interference were examined by methyl thiazolyl assay. RESULTS: In A549/DDP cell, the mRNA and protein levels of ERCC1 were decreased and the sensitivity to cisplatin was increased from 12.49 \u03bcg/mL to 9.27 \u03bcg/mL after transfection. CONCLUSIONS: The sensitivity to cisplatin of lung cancer cell A549/DDP could be enhanced by RNA interfering ERCC1 gene targeted code 346.", "title": {"charStart": 0, "charEnd": 128}, "docId": "20840811", "entity": [{"duid": "PU:o85D", "entityType": "Disease", "charEnd": 597, "source": "PUBTATOR", "charStart": 595, "entityId": [{"idString": "C535808", "source": "MESH"}], "sentenceIndex": 3, "entityText": "DDP"}, {"duid": "PU:JrU6", "entityType": "Chemical", "charEnd": 18, "source": "PUBTATOR", "charStart": 10, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 0, "entityText": "cisplatin"}, {"duid": "PU:SHxG", "entityType": "Disease", "charEnd": 452, "source": "PUBTATOR", "charStart": 442, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 2, "entityText": "lung cancer"}, {"duid": "PU:fUbz", "entityType": "Disease", "charEnd": 811, "source": "PUBTATOR", "charStart": 809, "entityId": [{"idString": "C535808", "source": "MESH"}], "sentenceIndex": 6, "entityText": "DDP"}, {"duid": "PU:8gF3", "entityType": "Gene", "charEnd": 208, "source": "PUBTATOR", "charStart": 204, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:KJ9j", "entityType": "Disease", "charEnd": 329, "source": "PUBTATOR", "charStart": 325, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumor"}, {"duid": "PU:mf8s", "entityType": "Chemical", "charEnd": 1009, "source": "PUBTATOR", "charStart": 1001, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 7, "entityText": "cisplatin"}, {"duid": "PU:DMpy", "entityType": "Chemical", "charEnd": 1038, "source": "PUBTATOR", "charStart": 1036, "entityId": [], "sentenceIndex": 7, "entityText": "DDP"}, {"duid": "PU:HnEW", "entityType": "Chemical", "charEnd": 309, "source": "PUBTATOR", "charStart": 301, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:siDS", "entityType": "Chemical", "charEnd": 714, "source": "PUBTATOR", "charStart": 706, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 5, "entityText": "cisplatin"}, {"duid": "PU:jn3x", "entityType": "Gene", "charEnd": 201, "source": "PUBTATOR", "charStart": 160, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross-complementing gene 1"}, {"duid": "PU:3rgj", "entityType": "Chemical", "charEnd": 401, "source": "PUBTATOR", "charStart": 393, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cisplatin"}, {"duid": "PU:nwng", "entityType": "Disease", "charEnd": 112, "source": "PUBTATOR", "charStart": 102, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 0, "entityText": "lung cancer"}, {"duid": "PU:AcEj", "entityType": "Gene", "charEnd": 97, "source": "PUBTATOR", "charStart": 56, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "excision repair cross-complementing gene 1"}, {"duid": "PU:E2PA", "entityType": "Disease", "charEnd": 31, "source": "PUBTATOR", "charStart": 20, "entityId": [{"idString": "D064420", "source": "MESH"}], "sentenceIndex": 0, "entityText": "cytotoxicity"}, {"duid": "PU:PQA3", "entityType": "Gene", "charEnd": 432, "source": "PUBTATOR", "charStart": 428, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERCC1"}, {"duid": "PU:4uBr", "entityType": "Disease", "charEnd": 126, "source": "PUBTATOR", "charStart": 124, "entityId": [{"idString": "C535808", "source": "MESH"}], "sentenceIndex": 0, "entityText": "DDP"}, {"duid": "PU:wpCo", "entityType": "Gene", "charEnd": 1081, "source": "PUBTATOR", "charStart": 1077, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERCC1"}, {"duid": "PU:YQFE", "entityType": "Gene", "charEnd": 646, "source": "PUBTATOR", "charStart": 642, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:YXBR", "entityType": "Gene", "charEnd": 854, "source": "PUBTATOR", "charStart": 850, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:CjQE", "entityType": "Gene", "charEnd": 517, "source": "PUBTATOR", "charStart": 513, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERCC1"}, {"duid": "PU:jREd", "entityType": "Chemical", "charEnd": 256, "source": "PUBTATOR", "charStart": 248, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cisplatin"}, {"duid": "PU:NJkK", "entityType": "Chemical", "charEnd": 783, "source": "PUBTATOR", "charStart": 768, "entityId": [], "sentenceIndex": 5, "entityText": "methyl thiazolyl"}, {"duid": "PU:SCLq", "entityType": "Disease", "charEnd": 583, "source": "PUBTATOR", "charStart": 573, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 3, "entityText": "lung cancer"}, {"duid": "PU:3UDq", "entityType": "Chemical", "charEnd": 902, "source": "PUBTATOR", "charStart": 894, "entityId": [{"idString": "D002945", "source": "MESH"}], "sentenceIndex": 6, "entityText": "cisplatin"}, {"duid": "PU:uxaG", "entityType": "Disease", "charEnd": 1024, "source": "PUBTATOR", "charStart": 1014, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 7, "entityText": "lung cancer"}]}
{"text": "Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinoma. Biliary tract carcinoma is a relatively rare tumor with a poor prognosis. Surgical resection is the only potential cure. However, the efficacy of chemotherapeutic agents is disappointing in advanced or recurrent cases. Gemcitabine (GEM) appears to be one of the most promising chemotherapeutic agents in biliary tract carcinoma, and ribonucleotide reductase subunit M1 (RRM1) plays an important role in GEM resistance. The aim of this study was to evaluate the correlation between the expression of RRM1 and the response to GEM in biliary tract carcinoma in vitro and in vivo. The drug sensitivity to GEM was assessed by MTT assay. The expression of RRM1 was evaluated by quantitative RT-PCR, a Western blot analysis and immunohistochemistry. RNAi assay was used to investigate the down-regulation of the expression of RRM1. After the RRM1-specific RNAi transfection, a cell growth assay was performed to evaluate the drug sensitivity to GEM, and flow cytometry and TUNEL assay were performed to evaluate apoptosis. The results showed that in 6 biliary tract carcinoma cell lines, a tendency for a positive correlation between the expression of RRM1 and IC50 for GEM exists (R=0.620, p=0.19). The transfection of the RRM1-specific RNAi suppressed the expression level of RRM1 in a dose-dependent manner. After the transfection of RRM1-specific RNAi into G-415, the drug sensitivity to GEM markedly increased (p<0.001), and apoptosis was highly induced according to flow cytometry and the TUNEL assay. In an analysis of cancer tissue specimens obtained from the 12 patients treated with GEM for biliary tract cancer, RRM1 immunostaining was strongly positive in all of the PD cases (3/3), while weakly positive in all of the PR cases except for one (4/5). In conclusion, RRM1 may be one of the key marker molecules for GEM chemotherapy that overcomes advanced and recurrent biliary tract carcinoma.", "title": {"charStart": 0, "charEnd": 114}, "docId": "18636187", "entity": [{"duid": "PU:746X", "entityType": "Disease", "charEnd": 1789, "source": "PUBTATOR", "charStart": 1788, "entityId": [{"idString": "168600", "source": "OMIM"}], "sentenceIndex": 13, "entityText": "PD"}, {"duid": "PU:N24H", "entityType": "Chemical", "charEnd": 1936, "source": "PUBTATOR", "charStart": 1934, "entityId": [], "sentenceIndex": 14, "entityText": "GEM"}, {"duid": "PU:Vi4J", "entityType": "Disease", "charEnd": 1640, "source": "PUBTATOR", "charStart": 1635, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 13, "entityText": "cancer"}, {"duid": "PU:NH7y", "entityType": "Gene", "charEnd": 34, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Ribonucleotide reductase subunit M1"}, {"duid": "PU:VEn6", "entityType": "Chemical", "charEnd": 350, "source": "PUBTATOR", "charStart": 348, "entityId": [], "sentenceIndex": 4, "entityText": "GEM"}, {"duid": "PU:7urW", "entityType": "Chemical", "charEnd": 521, "source": "PUBTATOR", "charStart": 519, "entityId": [], "sentenceIndex": 4, "entityText": "GEM"}, {"duid": "PU:bC74", "entityType": "Gene", "charEnd": 1264, "source": "PUBTATOR", "charStart": 1261, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "RRM1"}, {"duid": "PU:pJpf", "entityType": "Disease", "charEnd": 1183, "source": "PUBTATOR", "charStart": 1175, "entityId": [{"idString": "D002277", "source": "MESH"}], "sentenceIndex": 10, "entityText": "carcinoma"}, {"duid": "PU:9tco", "entityType": "Gene", "charEnd": 483, "source": "PUBTATOR", "charStart": 449, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ribonucleotide reductase subunit M1"}, {"duid": "PU:XLEP", "entityType": "Chemical", "charEnd": 1056, "source": "PUBTATOR", "charStart": 1054, "entityId": [], "sentenceIndex": 9, "entityText": "GEM"}, {"duid": "PU:we4P", "entityType": "Disease", "charEnd": 669, "source": "PUBTATOR", "charStart": 640, "entityId": [{"idString": "D001661", "source": "MESH"}], "sentenceIndex": 5, "entityText": "GEM in biliary tract carcinoma"}, {"duid": "PU:DiNN", "entityType": "Disease", "charEnd": 165, "source": "PUBTATOR", "charStart": 161, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumor"}, {"duid": "PU:ni6K", "entityType": "Chemical", "charEnd": 462, "source": "PUBTATOR", "charStart": 449, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 4, "entityText": "ribonucleotide"}, {"duid": "PU:adK2", "entityType": "Gene", "charEnd": 618, "source": "PUBTATOR", "charStart": 615, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "RRM1"}, {"duid": "PU:fD22", "entityType": "Gene", "charEnd": 489, "source": "PUBTATOR", "charStart": 486, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "RRM1"}, {"duid": "PU:TotS", "entityType": "Chemical", "charEnd": 642, "source": "PUBTATOR", "charStart": 640, "entityId": [], "sentenceIndex": 5, "entityText": "GEM"}, {"duid": "PU:dudo", "entityType": "Chemical", "charEnd": 1281, "source": "PUBTATOR", "charStart": 1279, "entityId": [], "sentenceIndex": 10, "entityText": "GEM"}, {"duid": "PU:zxtG", "entityType": "Gene", "charEnd": 1889, "source": "PUBTATOR", "charStart": 1886, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "RRM1"}, {"duid": "PU:xWm2", "entityType": "Chemical", "charEnd": 345, "source": "PUBTATOR", "charStart": 335, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 4, "entityText": "Gemcitabine"}, {"duid": "PU:Ckhd", "entityType": "Gene", "charEnd": 769, "source": "PUBTATOR", "charStart": 766, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "RRM1"}, {"duid": "PU:Ubkp", "entityType": "Gene", "charEnd": 1390, "source": "PUBTATOR", "charStart": 1387, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "RRM1"}, {"duid": "PU:HWJQ", "entityType": "Gene", "charEnd": 1735, "source": "PUBTATOR", "charStart": 1732, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "RRM1"}, {"duid": "PU:HSQY", "entityType": "Chemical", "charEnd": 1503, "source": "PUBTATOR", "charStart": 1501, "entityId": [], "sentenceIndex": 12, "entityText": "GEM"}, {"duid": "PU:3FbB", "entityType": "Species", "charEnd": 1687, "source": "PUBTATOR", "charStart": 1680, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 13, "entityText": "patients"}, {"duid": "PU:wYd8", "entityType": "Disease", "charEnd": 138, "source": "PUBTATOR", "charStart": 116, "entityId": [{"idString": "D001661", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Biliary tract carcinoma"}, {"duid": "PU:Y33Y", "entityType": "Chemical", "charEnd": 739, "source": "PUBTATOR", "charStart": 737, "entityId": [{"idString": "53233", "source": "CHEBI"}], "sentenceIndex": 6, "entityText": "MTT"}, {"duid": "PU:3hEk", "entityType": "Gene", "charEnd": 1336, "source": "PUBTATOR", "charStart": 1333, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "RRM1"}, {"duid": "PU:E5TP", "entityType": "Gene", "charEnd": 954, "source": "PUBTATOR", "charStart": 951, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "RRM1"}, {"duid": "PU:nJEW", "entityType": "Gene", "charEnd": 1449, "source": "PUBTATOR", "charStart": 1446, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "RRM1"}, {"duid": "PU:2wkM", "entityType": "Chemical", "charEnd": 719, "source": "PUBTATOR", "charStart": 717, "entityId": [], "sentenceIndex": 6, "entityText": "GEM"}, {"duid": "PU:LaiY", "entityType": "Disease", "charEnd": 442, "source": "PUBTATOR", "charStart": 434, "entityId": [{"idString": "D002277", "source": "MESH"}], "sentenceIndex": 4, "entityText": "carcinoma"}, {"duid": "PU:F8FY", "entityType": "Chemical", "charEnd": 1704, "source": "PUBTATOR", "charStart": 1702, "entityId": [], "sentenceIndex": 13, "entityText": "GEM"}, {"duid": "PU:VAWJ", "entityType": "Disease", "charEnd": 2011, "source": "PUBTATOR", "charStart": 2003, "entityId": [{"idString": "D002277", "source": "MESH"}], "sentenceIndex": 14, "entityText": "carcinoma"}, {"duid": "PU:7aNB", "entityType": "Disease", "charEnd": 1729, "source": "PUBTATOR", "charStart": 1710, "entityId": [{"idString": "D001661", "source": "MESH"}], "sentenceIndex": 13, "entityText": "biliary tract cancer"}, {"duid": "PU:YgGA", "entityType": "Gene", "charEnd": 938, "source": "PUBTATOR", "charStart": 935, "entityId": [{"idString": "6240", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "RRM1"}, {"duid": "PU:FfkT", "entityType": "Disease", "charEnd": 113, "source": "PUBTATOR", "charStart": 105, "entityId": [{"idString": "D002277", "source": "MESH"}], "sentenceIndex": 0, "entityText": "carcinoma"}, {"duid": "PU:Sra5", "entityType": "Chemical", "charEnd": 13, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "26561", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "Ribonucleotide"}, {"duid": "PU:rvAo", "entityType": "Chemical", "charEnd": 86, "source": "PUBTATOR", "charStart": 76, "entityId": [{"idString": "C056507", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gemcitabine"}]}
{"text": "[Effect of TUBB3, TS and ERCC1 mRNA expression on chemoresponse and clinical outcome of advanced gastric cancer by multiplex branched-DNA liquid chip technology]. OBJECTIVE: To analyze the impact of \u03b2-tubulin-III (TUBB3), thymidylate synthase (TS) and excision repair cross complementation group 1 (ERCC1) mRNA expression on chemoresponse and clinical outcome of patients with advanced gastric cancer treated with TXT/CDDP/FU (DCF) regimen chemotherapy. METHODS: The study population consisted of 48 patients with advanced gastric cancer. All patients were treated with DCF regimen palliative chemotherapy. The mRNA expressions of TUBB3, TS and ERCC1 of primary tumors were examined by multiplex branched-DNA liquid chip technology. RESULTS: The patients with low TUBB3 mRNA expression had higher response rate to chemotherapy than patients with high TUBB3 expression (P=0.011). There were no significant differences between response rate and TS or ERCC1 expression pattern. Median overall survival (OS) and median time to progression (TTP) were significantly longer in patients with low TUBB3 mRNA expression (P=0.002, P<0.001). TS or ERCC1 expression was not correlated with TTP and OS. In the combined analysis including TUBB3, TS and ERCC1, the patients with 0 or 1 high expression gene had better response rate, TTP and OS than the remaining patients (all P<0.001). Multivariate analysis revealed that ECOG (Eastern Cooperative Oncology Group)\u22652 (HR=2.42, P=0.009) and TUBB3 (HR=2.34, P=0.036) mRNA expression significantly impacted on OS. CONCLUSION: High TUBB3 mRNA expression is correlated with resistance to DCF regimen chemotherapy. TUBB3 might be a predictive and prognostic factor in patients with advanced gastric cancer treated with TXT-based chemotherapy. The combined evaluation of TUBB3, TS and ERCC1 expression can promote the individual treatment in advanced gastric cancer.", "title": {"charStart": 0, "charEnd": 161}, "docId": "23828702", "entity": [{"duid": "PU:Fhn3", "entityType": "Species", "charEnd": 1703, "source": "PUBTATOR", "charStart": 1696, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 12, "entityText": "patients"}, {"duid": "PU:KLPe", "entityType": "Gene", "charEnd": 245, "source": "PUBTATOR", "charStart": 244, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:U532", "entityType": "Disease", "charEnd": 399, "source": "PUBTATOR", "charStart": 386, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gastric cancer"}, {"duid": "PU:Jwky", "entityType": "Disease", "charEnd": 1542, "source": "PUBTATOR", "charStart": 1541, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 10, "entityText": "OS"}, {"duid": "PU:teBa", "entityType": "Gene", "charEnd": 241, "source": "PUBTATOR", "charStart": 222, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:rLAE", "entityType": "Gene", "charEnd": 1478, "source": "PUBTATOR", "charStart": 1474, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "TUBB3"}, {"duid": "PU:F9Vd", "entityType": "Gene", "charEnd": 1228, "source": "PUBTATOR", "charStart": 1224, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TUBB3"}, {"duid": "PU:ffyg", "entityType": "Gene", "charEnd": 649, "source": "PUBTATOR", "charStart": 645, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:dH22", "entityType": "Gene", "charEnd": 1802, "source": "PUBTATOR", "charStart": 1798, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "TUBB3"}, {"duid": "PU:uQNN", "entityType": "Gene", "charEnd": 19, "source": "PUBTATOR", "charStart": 18, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "TS"}, {"duid": "PU:pfjG", "entityType": "Gene", "charEnd": 15, "source": "PUBTATOR", "charStart": 11, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "TUBB3"}, {"duid": "PU:qpbg", "entityType": "Gene", "charEnd": 953, "source": "PUBTATOR", "charStart": 949, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:FUSZ", "entityType": "Gene", "charEnd": 218, "source": "PUBTATOR", "charStart": 214, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TUBB3"}, {"duid": "PU:xpQZ", "entityType": "Species", "charEnd": 1354, "source": "PUBTATOR", "charStart": 1347, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:hEjQ", "entityType": "Gene", "charEnd": 1232, "source": "PUBTATOR", "charStart": 1231, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:oHYz", "entityType": "Gene", "charEnd": 1131, "source": "PUBTATOR", "charStart": 1130, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:ycrT", "entityType": "Gene", "charEnd": 768, "source": "PUBTATOR", "charStart": 764, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TUBB3"}, {"duid": "PU:emmz", "entityType": "Species", "charEnd": 753, "source": "PUBTATOR", "charStart": 746, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:WcgV", "entityType": "Disease", "charEnd": 536, "source": "PUBTATOR", "charStart": 523, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:Ej8o", "entityType": "Gene", "charEnd": 635, "source": "PUBTATOR", "charStart": 631, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TUBB3"}, {"duid": "PU:VsYs", "entityType": "Disease", "charEnd": 667, "source": "PUBTATOR", "charStart": 654, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "primary tumors"}, {"duid": "PU:SnRx", "entityType": "Disease", "charEnd": 1179, "source": "PUBTATOR", "charStart": 1177, "entityId": [{"idString": "D000377", "source": "MESH"}], "sentenceIndex": 8, "entityText": "TTP"}, {"duid": "PU:hXxv", "entityType": "Disease", "charEnd": 110, "source": "PUBTATOR", "charStart": 97, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric cancer"}, {"duid": "PU:pdCq", "entityType": "Chemical", "charEnd": 1619, "source": "PUBTATOR", "charStart": 1617, "entityId": [], "sentenceIndex": 11, "entityText": "DCF"}, {"duid": "PU:F4BX", "entityType": "Species", "charEnd": 839, "source": "PUBTATOR", "charStart": 832, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:f9Yi", "entityType": "Gene", "charEnd": 855, "source": "PUBTATOR", "charStart": 851, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TUBB3"}, {"duid": "PU:Foui", "entityType": "Species", "charEnd": 370, "source": "PUBTATOR", "charStart": 363, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:FZ9q", "entityType": "Chemical", "charEnd": 1319, "source": "PUBTATOR", "charStart": 1317, "entityId": [{"idString": "C024157", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TTP"}, {"duid": "PU:eYQ5", "entityType": "Gene", "charEnd": 1566, "source": "PUBTATOR", "charStart": 1562, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "TUBB3"}, {"duid": "PU:M3eT", "entityType": "Gene", "charEnd": 1647, "source": "PUBTATOR", "charStart": 1643, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "TUBB3"}, {"duid": "PU:GhpG", "entityType": "Disease", "charEnd": 997, "source": "PUBTATOR", "charStart": 982, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 7, "entityText": "overall survival"}, {"duid": "PU:eANV", "entityType": "Gene", "charEnd": 1092, "source": "PUBTATOR", "charStart": 1088, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TUBB3"}, {"duid": "PU:RY8u", "entityType": "Gene", "charEnd": 303, "source": "PUBTATOR", "charStart": 299, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:Jr2M", "entityType": "Gene", "charEnd": 639, "source": "PUBTATOR", "charStart": 638, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:tJx4", "entityType": "Gene", "charEnd": 1816, "source": "PUBTATOR", "charStart": 1812, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "ERCC1"}, {"duid": "PU:yvrR", "entityType": "Gene", "charEnd": 1806, "source": "PUBTATOR", "charStart": 1805, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "TS"}, {"duid": "PU:vbep", "entityType": "Disease", "charEnd": 1033, "source": "PUBTATOR", "charStart": 1015, "entityId": [{"idString": "D000377", "source": "MESH"}], "sentenceIndex": 7, "entityText": "time to progression"}, {"duid": "PU:UR4t", "entityType": "Species", "charEnd": 550, "source": "PUBTATOR", "charStart": 543, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:cBBD", "entityType": "Disease", "charEnd": 1326, "source": "PUBTATOR", "charStart": 1325, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 9, "entityText": "OS"}, {"duid": "PU:oPcf", "entityType": "Gene", "charEnd": 1242, "source": "PUBTATOR", "charStart": 1238, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:ZCoz", "entityType": "Gene", "charEnd": 944, "source": "PUBTATOR", "charStart": 943, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:k9cn", "entityType": "Gene", "charEnd": 296, "source": "PUBTATOR", "charStart": 252, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross complementation group 1"}, {"duid": "PU:bBjW", "entityType": "Disease", "charEnd": 1001, "source": "PUBTATOR", "charStart": 1000, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 7, "entityText": "OS"}, {"duid": "PU:QBts", "entityType": "Disease", "charEnd": 1891, "source": "PUBTATOR", "charStart": 1878, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 13, "entityText": "gastric cancer"}, {"duid": "PU:oMpc", "entityType": "Gene", "charEnd": 29, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:LfV4", "entityType": "Species", "charEnd": 507, "source": "PUBTATOR", "charStart": 500, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:x3LM", "entityType": "Species", "charEnd": 1256, "source": "PUBTATOR", "charStart": 1249, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:SYvS", "entityType": "Disease", "charEnd": 1732, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 12, "entityText": "gastric cancer"}, {"duid": "PU:Mi9s", "entityType": "Species", "charEnd": 1077, "source": "PUBTATOR", "charStart": 1070, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:DBeL", "entityType": "Disease", "charEnd": 1186, "source": "PUBTATOR", "charStart": 1185, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 8, "entityText": "OS"}, {"duid": "PU:W64c", "entityType": "Disease", "charEnd": 1038, "source": "PUBTATOR", "charStart": 1036, "entityId": [{"idString": "D000377", "source": "MESH"}], "sentenceIndex": 7, "entityText": "TTP"}, {"duid": "PU:Lm2r", "entityType": "Gene", "charEnd": 1140, "source": "PUBTATOR", "charStart": 1136, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}]}
{"text": "[Effect of TUBB3, TS and ERCC1 mRNA expression on chemoresponse and clinical outcome of advanced gastric cancer by multiplex branched-DNA liquid chip technology]. OBJECTIVE: To analyze the impact of \u03b2-tubulin-III (TUBB3), thymidylate synthase (TS) and excision repair cross complementation group 1 (ERCC1) mRNA expression on chemoresponse and clinical outcome of patients with advanced gastric cancer treated with TXT/CDDP/FU (DCF) regimen chemotherapy. METHODS: The study population consisted of 48 patients with advanced gastric cancer. All patients were treated with DCF regimen palliative chemotherapy. The mRNA expressions of TUBB3, TS and ERCC1 of primary tumors were examined by multiplex branched-DNA liquid chip technology. RESULTS: The patients with low TUBB3 mRNA expression had higher response rate to chemotherapy than patients with high TUBB3 expression (P=0.011). There were no significant differences between response rate and TS or ERCC1 expression pattern. Median overall survival (OS) and median time to progression (TTP) were significantly longer in patients with low TUBB3 mRNA expression (P=0.002, P<0.001). TS or ERCC1 expression was not correlated with TTP and OS. In the combined analysis including TUBB3, TS and ERCC1, the patients with 0 or 1 high expression gene had better response rate, TTP and OS than the remaining patients (all P<0.001). Multivariate analysis revealed that ECOG (Eastern Cooperative Oncology Group)\u22652 (HR=2.42, P=0.009) and TUBB3 (HR=2.34, P=0.036) mRNA expression significantly impacted on OS. CONCLUSION: High TUBB3 mRNA expression is correlated with resistance to DCF regimen chemotherapy. TUBB3 might be a predictive and prognostic factor in patients with advanced gastric cancer treated with TXT-based chemotherapy. The combined evaluation of TUBB3, TS and ERCC1 expression can promote the individual treatment in advanced gastric cancer.", "title": {"charStart": 0, "charEnd": 161}, "docId": "23828702", "entity": [{"duid": "PU:Fhn3", "entityType": "Species", "charEnd": 1703, "source": "PUBTATOR", "charStart": 1696, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 12, "entityText": "patients"}, {"duid": "PU:KLPe", "entityType": "Gene", "charEnd": 245, "source": "PUBTATOR", "charStart": 244, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TS"}, {"duid": "PU:U532", "entityType": "Disease", "charEnd": 399, "source": "PUBTATOR", "charStart": 386, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gastric cancer"}, {"duid": "PU:Jwky", "entityType": "Disease", "charEnd": 1542, "source": "PUBTATOR", "charStart": 1541, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 10, "entityText": "OS"}, {"duid": "PU:teBa", "entityType": "Gene", "charEnd": 241, "source": "PUBTATOR", "charStart": 222, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "thymidylate synthase"}, {"duid": "PU:rLAE", "entityType": "Gene", "charEnd": 1478, "source": "PUBTATOR", "charStart": 1474, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "TUBB3"}, {"duid": "PU:F9Vd", "entityType": "Gene", "charEnd": 1228, "source": "PUBTATOR", "charStart": 1224, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TUBB3"}, {"duid": "PU:ffyg", "entityType": "Gene", "charEnd": 649, "source": "PUBTATOR", "charStart": 645, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERCC1"}, {"duid": "PU:dH22", "entityType": "Gene", "charEnd": 1802, "source": "PUBTATOR", "charStart": 1798, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "TUBB3"}, {"duid": "PU:uQNN", "entityType": "Gene", "charEnd": 19, "source": "PUBTATOR", "charStart": 18, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "TS"}, {"duid": "PU:pfjG", "entityType": "Gene", "charEnd": 15, "source": "PUBTATOR", "charStart": 11, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "TUBB3"}, {"duid": "PU:qpbg", "entityType": "Gene", "charEnd": 953, "source": "PUBTATOR", "charStart": 949, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERCC1"}, {"duid": "PU:FUSZ", "entityType": "Gene", "charEnd": 218, "source": "PUBTATOR", "charStart": 214, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TUBB3"}, {"duid": "PU:xpQZ", "entityType": "Species", "charEnd": 1354, "source": "PUBTATOR", "charStart": 1347, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:hEjQ", "entityType": "Gene", "charEnd": 1232, "source": "PUBTATOR", "charStart": 1231, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TS"}, {"duid": "PU:oHYz", "entityType": "Gene", "charEnd": 1131, "source": "PUBTATOR", "charStart": 1130, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TS"}, {"duid": "PU:ycrT", "entityType": "Gene", "charEnd": 768, "source": "PUBTATOR", "charStart": 764, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TUBB3"}, {"duid": "PU:emmz", "entityType": "Species", "charEnd": 753, "source": "PUBTATOR", "charStart": 746, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:WcgV", "entityType": "Disease", "charEnd": 536, "source": "PUBTATOR", "charStart": 523, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:Ej8o", "entityType": "Gene", "charEnd": 635, "source": "PUBTATOR", "charStart": 631, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TUBB3"}, {"duid": "PU:VsYs", "entityType": "Disease", "charEnd": 667, "source": "PUBTATOR", "charStart": 654, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "primary tumors"}, {"duid": "PU:SnRx", "entityType": "Disease", "charEnd": 1179, "source": "PUBTATOR", "charStart": 1177, "entityId": [{"idString": "D000377", "source": "MESH"}], "sentenceIndex": 8, "entityText": "TTP"}, {"duid": "PU:hXxv", "entityType": "Disease", "charEnd": 110, "source": "PUBTATOR", "charStart": 97, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric cancer"}, {"duid": "PU:pdCq", "entityType": "Chemical", "charEnd": 1619, "source": "PUBTATOR", "charStart": 1617, "entityId": [], "sentenceIndex": 11, "entityText": "DCF"}, {"duid": "PU:F4BX", "entityType": "Species", "charEnd": 839, "source": "PUBTATOR", "charStart": 832, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:f9Yi", "entityType": "Gene", "charEnd": 855, "source": "PUBTATOR", "charStart": 851, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TUBB3"}, {"duid": "PU:Foui", "entityType": "Species", "charEnd": 370, "source": "PUBTATOR", "charStart": 363, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:FZ9q", "entityType": "Chemical", "charEnd": 1319, "source": "PUBTATOR", "charStart": 1317, "entityId": [{"idString": "C024157", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TTP"}, {"duid": "PU:eYQ5", "entityType": "Gene", "charEnd": 1566, "source": "PUBTATOR", "charStart": 1562, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "TUBB3"}, {"duid": "PU:M3eT", "entityType": "Gene", "charEnd": 1647, "source": "PUBTATOR", "charStart": 1643, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "TUBB3"}, {"duid": "PU:GhpG", "entityType": "Disease", "charEnd": 997, "source": "PUBTATOR", "charStart": 982, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 7, "entityText": "overall survival"}, {"duid": "PU:eANV", "entityType": "Gene", "charEnd": 1092, "source": "PUBTATOR", "charStart": 1088, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TUBB3"}, {"duid": "PU:RY8u", "entityType": "Gene", "charEnd": 303, "source": "PUBTATOR", "charStart": 299, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERCC1"}, {"duid": "PU:Jr2M", "entityType": "Gene", "charEnd": 639, "source": "PUBTATOR", "charStart": 638, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "TS"}, {"duid": "PU:tJx4", "entityType": "Gene", "charEnd": 1816, "source": "PUBTATOR", "charStart": 1812, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "ERCC1"}, {"duid": "PU:yvrR", "entityType": "Gene", "charEnd": 1806, "source": "PUBTATOR", "charStart": 1805, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "TS"}, {"duid": "PU:vbep", "entityType": "Disease", "charEnd": 1033, "source": "PUBTATOR", "charStart": 1015, "entityId": [{"idString": "D000377", "source": "MESH"}], "sentenceIndex": 7, "entityText": "time to progression"}, {"duid": "PU:UR4t", "entityType": "Species", "charEnd": 550, "source": "PUBTATOR", "charStart": 543, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:cBBD", "entityType": "Disease", "charEnd": 1326, "source": "PUBTATOR", "charStart": 1325, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 9, "entityText": "OS"}, {"duid": "PU:oPcf", "entityType": "Gene", "charEnd": 1242, "source": "PUBTATOR", "charStart": 1238, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERCC1"}, {"duid": "PU:ZCoz", "entityType": "Gene", "charEnd": 944, "source": "PUBTATOR", "charStart": 943, "entityId": [{"idString": "7298", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "TS"}, {"duid": "PU:k9cn", "entityType": "Gene", "charEnd": 296, "source": "PUBTATOR", "charStart": 252, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "excision repair cross complementation group 1"}, {"duid": "PU:bBjW", "entityType": "Disease", "charEnd": 1001, "source": "PUBTATOR", "charStart": 1000, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 7, "entityText": "OS"}, {"duid": "PU:QBts", "entityType": "Disease", "charEnd": 1891, "source": "PUBTATOR", "charStart": 1878, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 13, "entityText": "gastric cancer"}, {"duid": "PU:oMpc", "entityType": "Gene", "charEnd": 29, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERCC1"}, {"duid": "PU:LfV4", "entityType": "Species", "charEnd": 507, "source": "PUBTATOR", "charStart": 500, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:x3LM", "entityType": "Species", "charEnd": 1256, "source": "PUBTATOR", "charStart": 1249, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:SYvS", "entityType": "Disease", "charEnd": 1732, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 12, "entityText": "gastric cancer"}, {"duid": "PU:Mi9s", "entityType": "Species", "charEnd": 1077, "source": "PUBTATOR", "charStart": 1070, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:DBeL", "entityType": "Disease", "charEnd": 1186, "source": "PUBTATOR", "charStart": 1185, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 8, "entityText": "OS"}, {"duid": "PU:W64c", "entityType": "Disease", "charEnd": 1038, "source": "PUBTATOR", "charStart": 1036, "entityId": [{"idString": "D000377", "source": "MESH"}], "sentenceIndex": 7, "entityText": "TTP"}, {"duid": "PU:Lm2r", "entityType": "Gene", "charEnd": 1140, "source": "PUBTATOR", "charStart": 1136, "entityId": [{"idString": "2067", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERCC1"}]}
{"text": "Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy. This phase II trial evaluated efficacy and safety of temozolomide (TMZ) in combination with irinotecan (CPT-11) before radiotherapy in patients with newly diagnosed glioblastoma multiforme (GBM). Prior to radiotherapy, patients were treated with a maximum of three 6-week cycles of TMZ and CPT-11. Patients received TMZ at a dose of 200 mg/m(2)/day on days 1-5 and CPT-11 on days 1, 8, 22, and 29, with a dose adjustment for enzyme-inducing antiepileptic drug use. The primary end point was objective response rate (ORR). Secondary end points included progression-free survival (PFS), overall survival (OS), safety, and tumor O(6)-methylguanine-DNA methyltransferase (MGMT) expression. Of the 42 patients treated, 8 (19%) patients achieved a partial response. Median PFS and median OS were 3.1 and 13.8 months, respectively. Grade 3 or 4 AEs were documented in 36% of patients, most of which were hematologic (29%). Twenty-four percent of patients had grade 3 or 4 non-hematologic AEs, with gastrointestinal AEs being the most common (12%) Two patients died, one of intracranial hemorrhage and one of treatment-related renal failure. Low MGMT expression, compared with high MGMT expression, showed no significant difference in ORR (25 vs. 8%), median PFS (14 vs. 5 months) or OS (21 vs. 15 months). Although TMZ plus CPT-11 is at least comparable in efficacy to TMZ alone, this combination appears more toxic and poorly tolerated. The lack of correlation of activity with MGMT expression is intriguing, but needs further evaluation in subsequent trials.", "title": {"charStart": 0, "charEnd": 136}, "docId": "19533023", "entity": [{"duid": "PU:ZZKz", "entityType": "Chemical", "charEnd": 1448, "source": "PUBTATOR", "charStart": 1446, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 11, "entityText": "TMZ"}, {"duid": "PU:psgs", "entityType": "Species", "charEnd": 443, "source": "PUBTATOR", "charStart": 436, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "Patients"}, {"duid": "PU:NZjR", "entityType": "Gene", "charEnd": 508, "source": "PUBTATOR", "charStart": 503, "entityId": [{"idString": "963084", "source": "Entrez"}, {"idString": "115711", "source": "Tax"}], "sentenceIndex": 3, "entityText": "CPT-11"}, {"duid": "PU:5HWu", "entityType": "Species", "charEnd": 364, "source": "PUBTATOR", "charStart": 357, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:2LMm", "entityType": "Species", "charEnd": 280, "source": "PUBTATOR", "charStart": 273, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:6Mcw", "entityType": "Chemical", "charEnd": 207, "source": "PUBTATOR", "charStart": 205, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "TMZ"}, {"duid": "PU:8iz9", "entityType": "Chemical", "charEnd": 422, "source": "PUBTATOR", "charStart": 420, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 2, "entityText": "TMZ"}, {"duid": "PU:8V2a", "entityType": "Disease", "charEnd": 325, "source": "PUBTATOR", "charStart": 303, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 1, "entityText": "glioblastoma multiforme"}, {"duid": "PU:53wN", "entityType": "Chemical", "charEnd": 202, "source": "PUBTATOR", "charStart": 191, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 1, "entityText": "temozolomide"}, {"duid": "PU:9TEX", "entityType": "Disease", "charEnd": 762, "source": "PUBTATOR", "charStart": 758, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumor"}, {"duid": "PU:yQx5", "entityType": "Gene", "charEnd": 433, "source": "PUBTATOR", "charStart": 428, "entityId": [{"idString": "963084", "source": "Entrez"}, {"idString": "115711", "source": "Tax"}], "sentenceIndex": 2, "entityText": "CPT-11"}, {"duid": "PU:nKbz", "entityType": "Species", "charEnd": 1013, "source": "PUBTATOR", "charStart": 1006, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:F4o7", "entityType": "Species", "charEnd": 1189, "source": "PUBTATOR", "charStart": 1182, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:dMwD", "entityType": "Chemical", "charEnd": 456, "source": "PUBTATOR", "charStart": 454, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 3, "entityText": "TMZ"}, {"duid": "PU:y8EF", "entityType": "Chemical", "charEnd": 34, "source": "PUBTATOR", "charStart": 32, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "TMZ"}, {"duid": "PU:ET87", "entityType": "Chemical", "charEnd": 1502, "source": "PUBTATOR", "charStart": 1500, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 11, "entityText": "TMZ"}, {"duid": "PU:pcqc", "entityType": "Species", "charEnd": 841, "source": "PUBTATOR", "charStart": 834, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:KRh9", "entityType": "Disease", "charEnd": 1269, "source": "PUBTATOR", "charStart": 1257, "entityId": [{"idString": "D051437", "source": "MESH"}], "sentenceIndex": 9, "entityText": "renal failure"}, {"duid": "PU:baSh", "entityType": "Gene", "charEnd": 59, "source": "PUBTATOR", "charStart": 54, "entityId": [{"idString": "963084", "source": "Entrez"}, {"idString": "115711", "source": "Tax"}], "sentenceIndex": 0, "entityText": "CPT-11"}, {"duid": "PU:5n6K", "entityType": "Disease", "charEnd": 1226, "source": "PUBTATOR", "charStart": 1204, "entityId": [{"idString": "D020300", "source": "MESH"}], "sentenceIndex": 9, "entityText": "intracranial hemorrhage"}, {"duid": "PU:zXpZ", "entityType": "Gene", "charEnd": 1613, "source": "PUBTATOR", "charStart": 1610, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "MGMT"}, {"duid": "PU:qzmU", "entityType": "Gene", "charEnd": 1315, "source": "PUBTATOR", "charStart": 1312, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "MGMT"}, {"duid": "PU:KmKG", "entityType": "Gene", "charEnd": 1460, "source": "PUBTATOR", "charStart": 1455, "entityId": [{"idString": "963084", "source": "Entrez"}, {"idString": "115711", "source": "Tax"}], "sentenceIndex": 11, "entityText": "CPT-11"}, {"duid": "PU:ZzTJ", "entityType": "Chemical", "charEnd": 781, "source": "PUBTATOR", "charStart": 764, "entityId": [{"idString": "C008449", "source": "MESH"}], "sentenceIndex": 5, "entityText": "O(6)-methylguanine"}, {"duid": "PU:2MXd", "entityType": "Gene", "charEnd": 1279, "source": "PUBTATOR", "charStart": 1276, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "MGMT"}, {"duid": "PU:VgaJ", "entityType": "Disease", "charEnd": 115, "source": "PUBTATOR", "charStart": 93, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 0, "entityText": "glioblastoma multiforme"}, {"duid": "PU:4G3g", "entityType": "Disease", "charEnd": 1148, "source": "PUBTATOR", "charStart": 1129, "entityId": [{"idString": "D005767", "source": "MESH"}], "sentenceIndex": 9, "entityText": "gastrointestinal AEs"}, {"duid": "PU:vGc6", "entityType": "Gene", "charEnd": 247, "source": "PUBTATOR", "charStart": 242, "entityId": [{"idString": "963084", "source": "Entrez"}, {"idString": "115711", "source": "Tax"}], "sentenceIndex": 1, "entityText": "CPT-11"}, {"duid": "PU:8Qre", "entityType": "Gene", "charEnd": 809, "source": "PUBTATOR", "charStart": 806, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "MGMT"}, {"duid": "PU:cMJn", "entityType": "Gene", "charEnd": 803, "source": "PUBTATOR", "charStart": 764, "entityId": [{"idString": "4255", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "O(6)-methylguanine-DNA methyltransferase"}, {"duid": "PU:mn7i", "entityType": "Chemical", "charEnd": 29, "source": "PUBTATOR", "charStart": 18, "entityId": [{"idString": "C047246", "source": "MESH"}], "sentenceIndex": 0, "entityText": "temozolomide"}, {"duid": "PU:n9hP", "entityType": "Species", "charEnd": 867, "source": "PUBTATOR", "charStart": 860, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:hPh9", "entityType": "Species", "charEnd": 1084, "source": "PUBTATOR", "charStart": 1077, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}]}
{"text": "Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with advanced gastric cancer receiving first-line paclitaxel plus capecitabine. The overexpression of \u03b2-tubulin III (TUBB3) in tumor tissues was reversely related with the efficacy of paclitaxel and clinical outcome in different cancers. In this study, we aimed to investigate the association between serum levels of TUBB3 and clinical outcome in advanced gastric cancer patients receiving first-line paclitaxel plus capecitabine. One hundred and twenty-eight advanced gastric cancer patients receiving first-line paclitaxel plus capecitabine in Peking University Cancer Hospital from December 2006 to October 2010 were enrolled in the study. Serum samples from 32 healthy individuals were used as controls. TUBB3 expression level in advanced gastric cancer was significantly higher than that in healthy control group (31.6 \u00b1 17.8 ng/mL vs. 16.9 \u00b1 3.8 ng/mL, p < 0.001). For all patients, the clinical benefit rate (CBR), median progression-free survival (PFS), and overall survival (OS) were 55.6 %, 179 and 306 days, respectively. The CBR, median PFS, and OS in patients with low (n = 27) and high levels (n = 101) of TUBB3 were 95.8 %/45.1 % (low vs. high, p < 0.001), 190 days/166 days (p = 0.064), and 360 days/297 days (p = 0.023), respectively. Cox multivariate regression analysis demonstrated that the serum levels of TUBB3 were an independent prognostic factor for advanced gastric cancer patients (HR = 1.950; 95 % CI, 1.242-3.062; p = 0.004). This study indicated that low levels of TUBB3 in serum could predict better response and survival for advanced gastric cancer patients receiving paclitaxel plus capecitabine, which could be used to select patients who would benefit from this regimen.", "title": {"charStart": 0, "charEnd": 152}, "docId": "22766748", "entity": [{"duid": "PU:DCp7", "entityType": "Chemical", "charEnd": 502, "source": "PUBTATOR", "charStart": 491, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 2, "entityText": "capecitabine"}, {"duid": "PU:7EyK", "entityType": "Species", "charEnd": 1741, "source": "PUBTATOR", "charStart": 1734, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:DRoW", "entityType": "Disease", "charEnd": 1133, "source": "PUBTATOR", "charStart": 1132, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 7, "entityText": "OS"}, {"duid": "PU:toe9", "entityType": "Disease", "charEnd": 556, "source": "PUBTATOR", "charStart": 543, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gastric cancer"}, {"duid": "PU:PnWg", "entityType": "Chemical", "charEnd": 484, "source": "PUBTATOR", "charStart": 475, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 2, "entityText": "paclitaxel"}, {"duid": "PU:jRsk", "entityType": "Disease", "charEnd": 101, "source": "PUBTATOR", "charStart": 88, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gastric cancer"}, {"duid": "PU:4ACL", "entityType": "Species", "charEnd": 960, "source": "PUBTATOR", "charStart": 953, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:nvHu", "entityType": "Disease", "charEnd": 830, "source": "PUBTATOR", "charStart": 817, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gastric cancer"}, {"duid": "PU:yChz", "entityType": "Chemical", "charEnd": 151, "source": "PUBTATOR", "charStart": 140, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 0, "entityText": "capecitabine"}, {"duid": "PU:gyfv", "entityType": "Species", "charEnd": 1145, "source": "PUBTATOR", "charStart": 1138, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:PXJw", "entityType": "Species", "charEnd": 452, "source": "PUBTATOR", "charStart": 445, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:CEpX", "entityType": "Gene", "charEnd": 786, "source": "PUBTATOR", "charStart": 782, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "TUBB3"}, {"duid": "PU:jtwy", "entityType": "Gene", "charEnd": 1198, "source": "PUBTATOR", "charStart": 1194, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "TUBB3"}, {"duid": "PU:GtyE", "entityType": "Chemical", "charEnd": 267, "source": "PUBTATOR", "charStart": 258, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 1, "entityText": "paclitaxel"}, {"duid": "PU:6PAn", "entityType": "Disease", "charEnd": 1059, "source": "PUBTATOR", "charStart": 1058, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 6, "entityText": "OS"}, {"duid": "PU:zJPV", "entityType": "Chemical", "charEnd": 1683, "source": "PUBTATOR", "charStart": 1674, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 9, "entityText": "paclitaxel"}, {"duid": "PU:K9Ew", "entityType": "Disease", "charEnd": 1653, "source": "PUBTATOR", "charStart": 1640, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 9, "entityText": "gastric cancer"}, {"duid": "PU:boRQ", "entityType": "Species", "charEnd": 1662, "source": "PUBTATOR", "charStart": 1655, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:C2HP", "entityType": "Chemical", "charEnd": 597, "source": "PUBTATOR", "charStart": 588, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 3, "entityText": "paclitaxel"}, {"duid": "PU:gwEu", "entityType": "Gene", "charEnd": 195, "source": "PUBTATOR", "charStart": 191, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "TUBB3"}, {"duid": "PU:SdUE", "entityType": "Species", "charEnd": 565, "source": "PUBTATOR", "charStart": 558, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:5XCU", "entityType": "Gene", "charEnd": 1573, "source": "PUBTATOR", "charStart": 1569, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "TUBB3"}, {"duid": "PU:Z7oP", "entityType": "Gene", "charEnd": 20, "source": "PUBTATOR", "charStart": 16, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "TUBB3"}, {"duid": "PU:AuZA", "entityType": "Disease", "charEnd": 309, "source": "PUBTATOR", "charStart": 303, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "cancers"}, {"duid": "PU:swHs", "entityType": "Disease", "charEnd": 443, "source": "PUBTATOR", "charStart": 430, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gastric cancer"}, {"duid": "PU:aSmM", "entityType": "Species", "charEnd": 72, "source": "PUBTATOR", "charStart": 65, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:qwvX", "entityType": "Disease", "charEnd": 1471, "source": "PUBTATOR", "charStart": 1458, "entityId": [{"idString": "D013274", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gastric cancer"}, {"duid": "PU:BHdg", "entityType": "Gene", "charEnd": 395, "source": "PUBTATOR", "charStart": 391, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "TUBB3"}, {"duid": "PU:wrwp", "entityType": "Gene", "charEnd": 1405, "source": "PUBTATOR", "charStart": 1401, "entityId": [{"idString": "10381", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "TUBB3"}, {"duid": "PU:2jAE", "entityType": "Disease", "charEnd": 1055, "source": "PUBTATOR", "charStart": 1040, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 6, "entityText": "overall survival"}, {"duid": "PU:eV2z", "entityType": "Species", "charEnd": 1480, "source": "PUBTATOR", "charStart": 1473, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:4h42", "entityType": "Chemical", "charEnd": 615, "source": "PUBTATOR", "charStart": 604, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 3, "entityText": "capecitabine"}, {"duid": "PU:hUJU", "entityType": "Chemical", "charEnd": 133, "source": "PUBTATOR", "charStart": 124, "entityId": [{"idString": "D017239", "source": "MESH"}], "sentenceIndex": 0, "entityText": "paclitaxel"}, {"duid": "PU:seYw", "entityType": "Chemical", "charEnd": 1701, "source": "PUBTATOR", "charStart": 1690, "entityId": [{"idString": "C110904", "source": "MESH"}], "sentenceIndex": 9, "entityText": "capecitabine"}, {"duid": "PU:Rrnb", "entityType": "Disease", "charEnd": 205, "source": "PUBTATOR", "charStart": 201, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumor"}]}
{"text": "Overexpression of miR-145 increases the sensitivity of vemurafenib in drug-resistant colo205 cell line. Vemurafenib is a selective and potent small molecule inhibitor of the V600 mutant form of the BRAF protein used in the treatment of melanoma and colorectal cancer. However, vemurafenib has less effect in BRAF mutant colorectal cancer due to the resistance of tumor cell to vemurafenib. To verify whether or not miR-145, a short RNA molecule of microRNA which has been supposed to be a tumor suppressor, is involved in this process, we established vemurafenib-resistant cell line colo205/V and found that the miR-145 expression was significantly downregulated in colo205/V cells compared to normal colo205 cells. Moreover, the overexpression of miR-145 could increase the sensitivity of colo205/V cells to vemurafenib both in vitro and in vivo. In conclusion, miR-145 might be used as a therapeutic target in the treatment of colorectal cancer patients with BRAF V600E mutation.", "title": {"charStart": 0, "charEnd": 102}, "docId": "24248543", "entity": [{"duid": "PU:f9VG", "entityType": "Gene", "charEnd": 24, "source": "PUBTATOR", "charStart": 18, "entityId": [{"idString": "406937", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "miR-145"}, {"duid": "PU:xFhr", "entityType": "ProteinMutation", "charEnd": 970, "source": "PUBTATOR", "charStart": 966, "entityId": [{"idString": "p|SUB|V|600|E", "source": "Unk"}], "sentenceIndex": 5, "entityText": "V600E"}, {"duid": "PU:2zhq", "entityType": "Gene", "charEnd": 754, "source": "PUBTATOR", "charStart": 748, "entityId": [{"idString": "406937", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "miR-145"}, {"duid": "PU:Vf9W", "entityType": "Gene", "charEnd": 869, "source": "PUBTATOR", "charStart": 863, "entityId": [{"idString": "406937", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "miR-145"}, {"duid": "PU:PJ9X", "entityType": "Gene", "charEnd": 201, "source": "PUBTATOR", "charStart": 198, "entityId": [{"idString": "673", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "BRAF"}, {"duid": "PU:Qafn", "entityType": "Species", "charEnd": 954, "source": "PUBTATOR", "charStart": 947, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:4HQQ", "entityType": "Disease", "charEnd": 243, "source": "PUBTATOR", "charStart": 236, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 1, "entityText": "melanoma"}, {"duid": "PU:kBCB", "entityType": "Disease", "charEnd": 367, "source": "PUBTATOR", "charStart": 363, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:vGAH", "entityType": "Chemical", "charEnd": 114, "source": "PUBTATOR", "charStart": 104, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Vemurafenib"}, {"duid": "PU:h7L8", "entityType": "Disease", "charEnd": 945, "source": "PUBTATOR", "charStart": 929, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 5, "entityText": "colorectal cancer"}, {"duid": "PU:9fRW", "entityType": "Chemical", "charEnd": 65, "source": "PUBTATOR", "charStart": 55, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 0, "entityText": "vemurafenib"}, {"duid": "PU:cAsf", "entityType": "Disease", "charEnd": 493, "source": "PUBTATOR", "charStart": 489, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:6gpE", "entityType": "Chemical", "charEnd": 819, "source": "PUBTATOR", "charStart": 809, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 4, "entityText": "vemurafenib"}, {"duid": "PU:LWGP", "entityType": "Disease", "charEnd": 336, "source": "PUBTATOR", "charStart": 320, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 2, "entityText": "colorectal cancer"}, {"duid": "PU:WRHq", "entityType": "Gene", "charEnd": 618, "source": "PUBTATOR", "charStart": 612, "entityId": [{"idString": "406937", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "miR-145"}, {"duid": "PU:Kuka", "entityType": "Gene", "charEnd": 421, "source": "PUBTATOR", "charStart": 415, "entityId": [{"idString": "406937", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "miR-145"}, {"duid": "PU:ZuXa", "entityType": "Chemical", "charEnd": 561, "source": "PUBTATOR", "charStart": 551, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 3, "entityText": "vemurafenib"}, {"duid": "PU:ixSS", "entityType": "Chemical", "charEnd": 387, "source": "PUBTATOR", "charStart": 377, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 2, "entityText": "vemurafenib"}, {"duid": "PU:P2Lp", "entityType": "Gene", "charEnd": 311, "source": "PUBTATOR", "charStart": 308, "entityId": [{"idString": "673", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "BRAF"}, {"duid": "PU:RBfT", "entityType": "Chemical", "charEnd": 287, "source": "PUBTATOR", "charStart": 277, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 2, "entityText": "vemurafenib"}, {"duid": "PU:fB5z", "entityType": "Disease", "charEnd": 265, "source": "PUBTATOR", "charStart": 249, "entityId": [{"idString": "D015179", "source": "MESH"}], "sentenceIndex": 1, "entityText": "colorectal cancer"}, {"duid": "PU:gEYA", "entityType": "Gene", "charEnd": 964, "source": "PUBTATOR", "charStart": 961, "entityId": [{"idString": "673", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "BRAF"}]}
{"text": "Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib. PURPOSE: Non-small cell lung cancers carrying activating mutations in the gene for the epidermal growth factor receptor (EGFR) are highly sensitive to EGFR-specific tyrosine kinase inhibitors. However, most patients who initially respond subsequently experience disease progression while still on treatment. Part of this \"acquired resistance\" is attributable to a secondary mutation resulting in threonine to methionine at codon 790 (T790M) of EGFR. EXPERIMENTAL DESIGN: We sequenced exons 18 to 21 of the EGFR gene to look for secondary mutations in tumors with acquired resistance to gefitinib in 14 patients with adenocarcinomas. Subcloning or cycleave PCR was used in addition to normal sequencing to increase the sensitivity of the assay. We also looked for T790M in pretreatment samples from 52 patients who were treated with gefitinib. We also looked for secondary KRAS gene mutations because tumors with KRAS mutations are generally resistant to tyrosine kinase inhibitors. RESULTS: Seven of 14 tumors had a secondary T790M mutation. There were no other novel secondary mutations. We detected no T790M mutations in pretreatment specimens from available five tumors among these seven tumors. Patients with T790M tended to be women, never smokers, and carrying deletion mutations, but the T790M was not associated with the duration of gefitinib administration. None of the tumors had an acquired mutation in the KRAS gene. CONCLUSIONS: A secondary T790M mutation of EGFR accounted for half the tumors with acquired resistance to gefitinib in Japanese patients. Other drug-resistant secondary mutations are uncommon in the EGFR gene.", "title": {"charStart": 0, "charEnd": 139}, "docId": "17020982", "entity": [{"duid": "PU:uovk", "entityType": "Chemical", "charEnd": 545, "source": "PUBTATOR", "charStart": 537, "entityId": [{"idString": "26986", "source": "CHEBI"}], "sentenceIndex": 3, "entityText": "threonine"}, {"duid": "PU:XdAG", "entityType": "Chemical", "charEnd": 1490, "source": "PUBTATOR", "charStart": 1482, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gefitinib"}, {"duid": "PU:rgrW", "entityType": "Gene", "charEnd": 1772, "source": "PUBTATOR", "charStart": 1769, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "EGFR"}, {"duid": "PU:7R4p", "entityType": "Chemical", "charEnd": 981, "source": "PUBTATOR", "charStart": 973, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gefitinib"}, {"duid": "PU:iqym", "entityType": "Gene", "charEnd": 588, "source": "PUBTATOR", "charStart": 585, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:8H6o", "entityType": "Disease", "charEnd": 771, "source": "PUBTATOR", "charStart": 757, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 4, "entityText": "adenocarcinomas"}, {"duid": "PU:uPah", "entityType": "Disease", "charEnd": 1525, "source": "PUBTATOR", "charStart": 1520, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 12, "entityText": "tumors"}, {"duid": "PU:dAKy", "entityType": "Species", "charEnd": 1705, "source": "PUBTATOR", "charStart": 1698, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 13, "entityText": "patients"}, {"duid": "PU:YxSx", "entityType": "Gene", "charEnd": 43, "source": "PUBTATOR", "charStart": 12, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:MXYL", "entityType": "Species", "charEnd": 1347, "source": "PUBTATOR", "charStart": 1340, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "Patients"}, {"duid": "PU:2ApT", "entityType": "Species", "charEnd": 69, "source": "PUBTATOR", "charStart": 62, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:8Tjj", "entityType": "Gene", "charEnd": 1056, "source": "PUBTATOR", "charStart": 1053, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "KRAS"}, {"duid": "PU:sVCb", "entityType": "ProteinMutation", "charEnd": 572, "source": "PUBTATOR", "charStart": 537, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 3, "entityText": "threonine to methionine at codon 790"}, {"duid": "PU:JTre", "entityType": "ProteinMutation", "charEnd": 1358, "source": "PUBTATOR", "charStart": 1354, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 11, "entityText": "T790M"}, {"duid": "PU:Vk4k", "entityType": "ProteinMutation", "charEnd": 1249, "source": "PUBTATOR", "charStart": 1245, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 10, "entityText": "T790M"}, {"duid": "PU:RayG", "entityType": "Gene", "charEnd": 1562, "source": "PUBTATOR", "charStart": 1559, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "KRAS"}, {"duid": "PU:RxvB", "entityType": "Species", "charEnd": 750, "source": "PUBTATOR", "charStart": 743, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:VYnz", "entityType": "Disease", "charEnd": 697, "source": "PUBTATOR", "charStart": 692, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumors"}, {"duid": "PU:cqeq", "entityType": "Gene", "charEnd": 1016, "source": "PUBTATOR", "charStart": 1013, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "KRAS"}, {"duid": "PU:XEYv", "entityType": "Chemical", "charEnd": 735, "source": "PUBTATOR", "charStart": 727, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 4, "entityText": "gefitinib"}, {"duid": "PU:MpST", "entityType": "Gene", "charEnd": 295, "source": "PUBTATOR", "charStart": 292, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:FgCD", "entityType": "ProteinMutation", "charEnd": 1171, "source": "PUBTATOR", "charStart": 1167, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 8, "entityText": "T790M"}, {"duid": "PU:JFJ9", "entityType": "Disease", "charEnd": 1337, "source": "PUBTATOR", "charStart": 1332, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}, {"duid": "PU:nr2U", "entityType": "ProteinMutation", "charEnd": 908, "source": "PUBTATOR", "charStart": 904, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 6, "entityText": "T790M"}, {"duid": "PU:ebc5", "entityType": "Gene", "charEnd": 650, "source": "PUBTATOR", "charStart": 647, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:jVcF", "entityType": "Disease", "charEnd": 1149, "source": "PUBTATOR", "charStart": 1144, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "tumors"}, {"duid": "PU:hqHp", "entityType": "Chemical", "charEnd": 1102, "source": "PUBTATOR", "charStart": 1095, "entityId": [{"idString": "18186", "source": "CHEBI"}], "sentenceIndex": 7, "entityText": "tyrosine"}, {"duid": "PU:Lwqg", "entityType": "Species", "charEnd": 355, "source": "PUBTATOR", "charStart": 348, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:6G3a", "entityType": "Disease", "charEnd": 1312, "source": "PUBTATOR", "charStart": 1307, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tumors"}, {"duid": "PU:ZU7B", "entityType": "Disease", "charEnd": 1646, "source": "PUBTATOR", "charStart": 1641, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 13, "entityText": "tumors"}, {"duid": "PU:H355", "entityType": "Chemical", "charEnd": 559, "source": "PUBTATOR", "charStart": 550, "entityId": [{"idString": "D008715", "source": "MESH"}], "sentenceIndex": 3, "entityText": "methionine"}, {"duid": "PU:8z9C", "entityType": "Chemical", "charEnd": 313, "source": "PUBTATOR", "charStart": 306, "entityId": [{"idString": "18186", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "tyrosine"}, {"duid": "PU:zxDs", "entityType": "Disease", "charEnd": 1046, "source": "PUBTATOR", "charStart": 1041, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumors"}, {"duid": "PU:iQq5", "entityType": "Gene", "charEnd": 1616, "source": "PUBTATOR", "charStart": 1613, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "EGFR"}, {"duid": "PU:kEDU", "entityType": "ProteinMutation", "charEnd": 1440, "source": "PUBTATOR", "charStart": 1436, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 11, "entityText": "T790M"}, {"duid": "PU:dU9x", "entityType": "Species", "charEnd": 1377, "source": "PUBTATOR", "charStart": 1373, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "women"}, {"duid": "PU:YDSw", "entityType": "Species", "charEnd": 949, "source": "PUBTATOR", "charStart": 942, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:aTHF", "entityType": "Gene", "charEnd": 259, "source": "PUBTATOR", "charStart": 228, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:Nw36", "entityType": "Chemical", "charEnd": 1684, "source": "PUBTATOR", "charStart": 1676, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 13, "entityText": "gefitinib"}, {"duid": "PU:Czbb", "entityType": "Chemical", "charEnd": 138, "source": "PUBTATOR", "charStart": 130, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gefitinib"}, {"duid": "PU:YpbY", "entityType": "ProteinMutation", "charEnd": 1599, "source": "PUBTATOR", "charStart": 1595, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 13, "entityText": "T790M"}, {"duid": "PU:bFxP", "entityType": "Disease", "charEnd": 176, "source": "PUBTATOR", "charStart": 150, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Non-small cell lung cancers"}, {"duid": "PU:FDTu", "entityType": "ProteinMutation", "charEnd": 579, "source": "PUBTATOR", "charStart": 575, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 3, "entityText": "T790M"}, {"duid": "PU:YNaB", "entityType": "Disease", "charEnd": 101, "source": "PUBTATOR", "charStart": 76, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:DeMi", "entityType": "Gene", "charEnd": 265, "source": "PUBTATOR", "charStart": 262, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}]}
{"text": "An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor. Mutations of the epidermal growth factor receptor (EGFR) gene have been identified in non-small cell lung cancer specimens from patients responding to anilinoquinazoline EGFR inhibitors. However, clinical resistance to EGFR inhibitor therapy is commonly observed. Previously, we showed that such resistance can be caused by a second mutation of the EGFR gene, leading to a T790M amino acid change in the EGFR tyrosine kinase domain and also found that CL-387,785, a specific and irreversible anilinoquinazoline EGFR inhibitor, was able to overcome this resistance on the biochemical level. Here, we present the successful establishment of a stable Ba/F3 cell line model system for the study of oncogenic EGFR signaling and the functional consequences of the EGFR T790M resistance mutation. We show the ability of gefitinib to induce growth arrest and apoptosis in cells transfected with wild-type or L858R EGFR, whereas the T790M mutation leads to high-level functional resistance against gefitinib and erlotinib. In addition, CL-387,785 is able to overcome resistance caused by the T790M mutation on a functional level, correlating with effective inhibition of downstream signaling pathways. Similar data was also obtained with the use of the gefitinib-resistant H1975 lung cancer cell line. The systems established by us should prove useful for the large-scale screening of alternative EGFR inhibitor compounds against the T790M or other EGFR mutations. These data also support the notion that clinical investigations of compounds similar to CL-387,785 may be useful as a treatment strategy for patients with resistance to EGFR inhibitor therapy caused by the T790M mutation.", "title": {"charStart": 0, "charEnd": 106}, "docId": "16103058", "entity": [{"duid": "PU:sKAa", "entityType": "Chemical", "charEnd": 496, "source": "PUBTATOR", "charStart": 487, "entityId": [{"idString": "33704", "source": "CHEBI"}], "sentenceIndex": 3, "entityText": "amino acid"}, {"duid": "PU:nUqM", "entityType": "Chemical", "charEnd": 929, "source": "PUBTATOR", "charStart": 921, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:8UCJ", "entityType": "Gene", "charEnd": 1017, "source": "PUBTATOR", "charStart": 1014, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}, {"duid": "PU:jcAs", "entityType": "Disease", "charEnd": 219, "source": "PUBTATOR", "charStart": 194, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small cell lung cancer"}, {"duid": "PU:BXgt", "entityType": "Species", "charEnd": 243, "source": "PUBTATOR", "charStart": 236, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:qH8R", "entityType": "ProteinMutation", "charEnd": 875, "source": "PUBTATOR", "charStart": 871, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 4, "entityText": "T790M"}, {"duid": "PU:bq5G", "entityType": "Gene", "charEnd": 622, "source": "PUBTATOR", "charStart": 619, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:2YL2", "entityType": "Gene", "charEnd": 1551, "source": "PUBTATOR", "charStart": 1548, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:n74u", "entityType": "Disease", "charEnd": 1388, "source": "PUBTATOR", "charStart": 1372, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 7, "entityText": "H1975 lung cancer"}, {"duid": "PU:xULC", "entityType": "Gene", "charEnd": 162, "source": "PUBTATOR", "charStart": 159, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:wpq8", "entityType": "Chemical", "charEnd": 524, "source": "PUBTATOR", "charStart": 517, "entityId": [{"idString": "18186", "source": "CHEBI"}], "sentenceIndex": 3, "entityText": "tyrosine"}, {"duid": "PU:FrCy", "entityType": "Species", "charEnd": 760, "source": "PUBTATOR", "charStart": 756, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "Ba/F3"}, {"duid": "PU:5zCb", "entityType": "Gene", "charEnd": 460, "source": "PUBTATOR", "charStart": 457, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:iDfq", "entityType": "ProteinMutation", "charEnd": 1012, "source": "PUBTATOR", "charStart": 1008, "entityId": [{"idString": "p|SUB|L|858|R;RS#:121434568", "source": "Unk"}], "sentenceIndex": 5, "entityText": "L858R"}, {"duid": "PU:PYDC", "entityType": "ProteinMutation", "charEnd": 485, "source": "PUBTATOR", "charStart": 481, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 3, "entityText": "T790M"}, {"duid": "PU:nkCW", "entityType": "ProteinMutation", "charEnd": 1195, "source": "PUBTATOR", "charStart": 1191, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 6, "entityText": "T790M"}, {"duid": "PU:TbUA", "entityType": "Disease", "charEnd": 953, "source": "PUBTATOR", "charStart": 941, "entityId": [{"idString": "D006130", "source": "MESH"}], "sentenceIndex": 5, "entityText": "growth arrest"}, {"duid": "PU:H2Dx", "entityType": "Gene", "charEnd": 869, "source": "PUBTATOR", "charStart": 866, "entityId": [{"idString": "13649", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:ohaC", "entityType": "Chemical", "charEnd": 1105, "source": "PUBTATOR", "charStart": 1097, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:t6EB", "entityType": "ProteinMutation", "charEnd": 1537, "source": "PUBTATOR", "charStart": 1533, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 8, "entityText": "T790M"}, {"duid": "PU:j3hd", "entityType": "Gene", "charEnd": 156, "source": "PUBTATOR", "charStart": 125, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:DSjh", "entityType": "Species", "charEnd": 1712, "source": "PUBTATOR", "charStart": 1705, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:ReEu", "entityType": "Gene", "charEnd": 330, "source": "PUBTATOR", "charStart": 327, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:YJeE", "entityType": "Gene", "charEnd": 1736, "source": "PUBTATOR", "charStart": 1733, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "EGFR"}, {"duid": "PU:enf3", "entityType": "Gene", "charEnd": 1499, "source": "PUBTATOR", "charStart": 1496, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:Znnh", "entityType": "Gene", "charEnd": 515, "source": "PUBTATOR", "charStart": 512, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:TRzr", "entityType": "Gene", "charEnd": 105, "source": "PUBTATOR", "charStart": 74, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:V5q8", "entityType": "Chemical", "charEnd": 1119, "source": "PUBTATOR", "charStart": 1111, "entityId": [{"idString": "C400278", "source": "MESH"}], "sentenceIndex": 5, "entityText": "erlotinib"}, {"duid": "PU:sNQz", "entityType": "ProteinMutation", "charEnd": 1774, "source": "PUBTATOR", "charStart": 1770, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 9, "entityText": "T790M"}, {"duid": "PU:9P4y", "entityType": "Chemical", "charEnd": 1360, "source": "PUBTATOR", "charStart": 1352, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 7, "entityText": "gefitinib"}, {"duid": "PU:nG75", "entityType": "ProteinMutation", "charEnd": 1036, "source": "PUBTATOR", "charStart": 1032, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 5, "entityText": "T790M"}, {"duid": "PU:5tYL", "entityType": "Gene", "charEnd": 281, "source": "PUBTATOR", "charStart": 278, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:xR74", "entityType": "Gene", "charEnd": 815, "source": "PUBTATOR", "charStart": 812, "entityId": [{"idString": "13649", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 4, "entityText": "EGFR"}]}
{"text": "An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor. Mutations of the epidermal growth factor receptor (EGFR) gene have been identified in non-small cell lung cancer specimens from patients responding to anilinoquinazoline EGFR inhibitors. However, clinical resistance to EGFR inhibitor therapy is commonly observed. Previously, we showed that such resistance can be caused by a second mutation of the EGFR gene, leading to a T790M amino acid change in the EGFR tyrosine kinase domain and also found that CL-387,785, a specific and irreversible anilinoquinazoline EGFR inhibitor, was able to overcome this resistance on the biochemical level. Here, we present the successful establishment of a stable Ba/F3 cell line model system for the study of oncogenic EGFR signaling and the functional consequences of the EGFR T790M resistance mutation. We show the ability of gefitinib to induce growth arrest and apoptosis in cells transfected with wild-type or L858R EGFR, whereas the T790M mutation leads to high-level functional resistance against gefitinib and erlotinib. In addition, CL-387,785 is able to overcome resistance caused by the T790M mutation on a functional level, correlating with effective inhibition of downstream signaling pathways. Similar data was also obtained with the use of the gefitinib-resistant H1975 lung cancer cell line. The systems established by us should prove useful for the large-scale screening of alternative EGFR inhibitor compounds against the T790M or other EGFR mutations. These data also support the notion that clinical investigations of compounds similar to CL-387,785 may be useful as a treatment strategy for patients with resistance to EGFR inhibitor therapy caused by the T790M mutation.", "title": {"charStart": 0, "charEnd": 106}, "docId": "16103058", "entity": [{"duid": "PU:sKAa", "entityType": "Chemical", "charEnd": 496, "source": "PUBTATOR", "charStart": 487, "entityId": [{"idString": "33704", "source": "CHEBI"}], "sentenceIndex": 3, "entityText": "amino acid"}, {"duid": "PU:nUqM", "entityType": "Chemical", "charEnd": 929, "source": "PUBTATOR", "charStart": 921, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:8UCJ", "entityType": "Gene", "charEnd": 1017, "source": "PUBTATOR", "charStart": 1014, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}, {"duid": "PU:jcAs", "entityType": "Disease", "charEnd": 219, "source": "PUBTATOR", "charStart": 194, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small cell lung cancer"}, {"duid": "PU:BXgt", "entityType": "Species", "charEnd": 243, "source": "PUBTATOR", "charStart": 236, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:qH8R", "entityType": "ProteinMutation", "charEnd": 875, "source": "PUBTATOR", "charStart": 871, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 4, "entityText": "T790M"}, {"duid": "PU:bq5G", "entityType": "Gene", "charEnd": 622, "source": "PUBTATOR", "charStart": 619, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:2YL2", "entityType": "Gene", "charEnd": 1551, "source": "PUBTATOR", "charStart": 1548, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:n74u", "entityType": "Disease", "charEnd": 1388, "source": "PUBTATOR", "charStart": 1372, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 7, "entityText": "H1975 lung cancer"}, {"duid": "PU:xULC", "entityType": "Gene", "charEnd": 162, "source": "PUBTATOR", "charStart": 159, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:wpq8", "entityType": "Chemical", "charEnd": 524, "source": "PUBTATOR", "charStart": 517, "entityId": [{"idString": "18186", "source": "CHEBI"}], "sentenceIndex": 3, "entityText": "tyrosine"}, {"duid": "PU:FrCy", "entityType": "Species", "charEnd": 760, "source": "PUBTATOR", "charStart": 756, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "Ba/F3"}, {"duid": "PU:5zCb", "entityType": "Gene", "charEnd": 460, "source": "PUBTATOR", "charStart": 457, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:iDfq", "entityType": "ProteinMutation", "charEnd": 1012, "source": "PUBTATOR", "charStart": 1008, "entityId": [{"idString": "p|SUB|L|858|R;RS#:121434568", "source": "Unk"}], "sentenceIndex": 5, "entityText": "L858R"}, {"duid": "PU:PYDC", "entityType": "ProteinMutation", "charEnd": 485, "source": "PUBTATOR", "charStart": 481, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 3, "entityText": "T790M"}, {"duid": "PU:nkCW", "entityType": "ProteinMutation", "charEnd": 1195, "source": "PUBTATOR", "charStart": 1191, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 6, "entityText": "T790M"}, {"duid": "PU:TbUA", "entityType": "Disease", "charEnd": 953, "source": "PUBTATOR", "charStart": 941, "entityId": [{"idString": "D006130", "source": "MESH"}], "sentenceIndex": 5, "entityText": "growth arrest"}, {"duid": "PU:H2Dx", "entityType": "Gene", "charEnd": 869, "source": "PUBTATOR", "charStart": 866, "entityId": [{"idString": "13649", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:ohaC", "entityType": "Chemical", "charEnd": 1105, "source": "PUBTATOR", "charStart": 1097, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:t6EB", "entityType": "ProteinMutation", "charEnd": 1537, "source": "PUBTATOR", "charStart": 1533, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 8, "entityText": "T790M"}, {"duid": "PU:j3hd", "entityType": "Gene", "charEnd": 156, "source": "PUBTATOR", "charStart": 125, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:DSjh", "entityType": "Species", "charEnd": 1712, "source": "PUBTATOR", "charStart": 1705, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:ReEu", "entityType": "Gene", "charEnd": 330, "source": "PUBTATOR", "charStart": 327, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:YJeE", "entityType": "Gene", "charEnd": 1736, "source": "PUBTATOR", "charStart": 1733, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "EGFR"}, {"duid": "PU:enf3", "entityType": "Gene", "charEnd": 1499, "source": "PUBTATOR", "charStart": 1496, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:Znnh", "entityType": "Gene", "charEnd": 515, "source": "PUBTATOR", "charStart": 512, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:TRzr", "entityType": "Gene", "charEnd": 105, "source": "PUBTATOR", "charStart": 74, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:V5q8", "entityType": "Chemical", "charEnd": 1119, "source": "PUBTATOR", "charStart": 1111, "entityId": [{"idString": "C400278", "source": "MESH"}], "sentenceIndex": 5, "entityText": "erlotinib"}, {"duid": "PU:sNQz", "entityType": "ProteinMutation", "charEnd": 1774, "source": "PUBTATOR", "charStart": 1770, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 9, "entityText": "T790M"}, {"duid": "PU:9P4y", "entityType": "Chemical", "charEnd": 1360, "source": "PUBTATOR", "charStart": 1352, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 7, "entityText": "gefitinib"}, {"duid": "PU:nG75", "entityType": "ProteinMutation", "charEnd": 1036, "source": "PUBTATOR", "charStart": 1032, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 5, "entityText": "T790M"}, {"duid": "PU:5tYL", "entityType": "Gene", "charEnd": 281, "source": "PUBTATOR", "charStart": 278, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:xR74", "entityType": "Gene", "charEnd": 815, "source": "PUBTATOR", "charStart": 812, "entityId": [{"idString": "13649", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 4, "entityText": "EGFR"}]}
{"text": "ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib. Abnormal expression and signaling of ErbB receptors has been implicated in multiple epithelial malignancies, including pancreatic cancer. Erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), has been recently approved for pancreatic cancer treatment, but there are no reliable predictors of patient response. Expression of additional ErbB receptors seems to influence tumor response to EGFR-targeted therapy. We analyzed the influence of ErbB3 expression on pancreatic cancer cell response to erlotinib treatment. Proliferation assays of five human pancreatic cancer cell lines were performed following treatment with erlotinib. Expression and phosphorylation profiles of ErbB receptors and downstream adaptor protein (Akt, ERK1/2, STAT3, mTOR) were evaluated following stimulation with EGF or neuregulin-beta. The formation of EGFR homodimers and EGFR-ErbB3 heterodimers, necessary to enable ErbB3 downstream signaling, was demonstrated by chemical cross-linking assays. The effects of RNA inhibition of ErbB3 on sensitivity to erlotinib treatment were evaluated in AsPC-1 pancreatic cancer cells. Erlotinib inhibited Akt phosphorylation and proliferation of all the ErbB3-expressing cell lines but did not affect mTOR activation. Cross-linking studies confirmed the presence of EGFR-ErbB3 heterodimers in pancreatic cancer cells. Only the ErbB3-deficient MIA PaCa-2 cells displayed persistent Akt activation and ongoing proliferation in spite of erlotinib treatment. siRNA-mediated inhibition of ErbB3 expression in AsPC-1 cells resulted in acquired resistance to erlotinib treatment. Pancreatic cancer cells which lack ErbB3 do not display activation of the ErbB3-PI3K-Akt cascade induced by EGFR/ErbB3 heterodimers and become less critically dependent on EGFR signaling and therefore resistant to erlotinib. Pancreatic cancer expression of ErbB3 may be useful for EGFR-targeted therapy patient selection.", "title": {"charStart": 0, "charEnd": 101}, "docId": "17457047", "entity": [{"duid": "PU:S37q", "entityType": "Chemical", "charEnd": 1709, "source": "PUBTATOR", "charStart": 1701, "entityId": [{"idString": "C400278", "source": "MESH"}], "sentenceIndex": 12, "entityText": "erlotinib"}, {"duid": "PU:bVAB", "entityType": "Disease", "charEnd": 700, "source": "PUBTATOR", "charStart": 684, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 5, "entityText": "pancreatic cancer"}, {"duid": "PU:NHCt", "entityType": "Disease", "charEnd": 70, "source": "PUBTATOR", "charStart": 54, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 0, "entityText": "pancreatic cancer"}, {"duid": "PU:Rvm4", "entityType": "Species", "charEnd": 1658, "source": "PUBTATOR", "charStart": 1653, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 12, "entityText": "AsPC-1"}, {"duid": "PU:RC5a", "entityType": "Gene", "charEnd": 577, "source": "PUBTATOR", "charStart": 573, "entityId": [{"idString": "2065", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ErbB3"}, {"duid": "PU:YhYo", "entityType": "Species", "charEnd": 1207, "source": "PUBTATOR", "charStart": 1202, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "AsPC-1"}, {"duid": "PU:ZeAt", "entityType": "Disease", "charEnd": 373, "source": "PUBTATOR", "charStart": 357, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 2, "entityText": "pancreatic cancer"}, {"duid": "PU:E7bi", "entityType": "Disease", "charEnd": 507, "source": "PUBTATOR", "charStart": 503, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:x3oJ", "entityType": "Chemical", "charEnd": 1944, "source": "PUBTATOR", "charStart": 1936, "entityId": [{"idString": "C400278", "source": "MESH"}], "sentenceIndex": 13, "entityText": "erlotinib"}, {"duid": "PU:mnFv", "entityType": "Gene", "charEnd": 966, "source": "PUBTATOR", "charStart": 963, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:nvQA", "entityType": "Gene", "charEnd": 524, "source": "PUBTATOR", "charStart": 521, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:2U8S", "entityType": "Gene", "charEnd": 871, "source": "PUBTATOR", "charStart": 867, "entityId": [{"idString": "6774", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "STAT3"}, {"duid": "PU:fFun", "entityType": "Gene", "charEnd": 1532, "source": "PUBTATOR", "charStart": 1530, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "Akt"}, {"duid": "PU:ampY", "entityType": "Gene", "charEnd": 992, "source": "PUBTATOR", "charStart": 988, "entityId": [{"idString": "2065", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ErbB3"}, {"duid": "PU:bLwQ", "entityType": "Gene", "charEnd": 1637, "source": "PUBTATOR", "charStart": 1633, "entityId": [{"idString": "2065", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "ErbB3"}, {"duid": "PU:7SNo", "entityType": "Chemical", "charEnd": 249, "source": "PUBTATOR", "charStart": 241, "entityId": [{"idString": "C400278", "source": "MESH"}], "sentenceIndex": 2, "entityText": "Erlotinib"}, {"duid": "PU:bx8p", "entityType": "Gene", "charEnd": 322, "source": "PUBTATOR", "charStart": 315, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR-TKI"}, {"duid": "PU:FbTA", "entityType": "Disease", "charEnd": 1225, "source": "PUBTATOR", "charStart": 1209, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 8, "entityText": "pancreatic cancer"}, {"duid": "PU:QYeL", "entityType": "Gene", "charEnd": 1307, "source": "PUBTATOR", "charStart": 1303, "entityId": [{"idString": "2065", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ErbB3"}, {"duid": "PU:fWKt", "entityType": "Gene", "charEnd": 1800, "source": "PUBTATOR", "charStart": 1796, "entityId": [{"idString": "2065", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "ErbB3"}, {"duid": "PU:Fwgn", "entityType": "Gene", "charEnd": 1353, "source": "PUBTATOR", "charStart": 1350, "entityId": [{"idString": "2475", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "mTOR"}, {"duid": "PU:8Tv3", "entityType": "Gene", "charEnd": 1144, "source": "PUBTATOR", "charStart": 1140, "entityId": [{"idString": "2065", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ErbB3"}, {"duid": "PU:xFYU", "entityType": "Disease", "charEnd": 1738, "source": "PUBTATOR", "charStart": 1722, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 13, "entityText": "Pancreatic cancer"}, {"duid": "PU:ngjr", "entityType": "Gene", "charEnd": 1897, "source": "PUBTATOR", "charStart": 1894, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "EGFR"}, {"duid": "PU:AxH3", "entityType": "Gene", "charEnd": 1480, "source": "PUBTATOR", "charStart": 1476, "entityId": [{"idString": "2065", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ErbB3"}, {"duid": "PU:iNyY", "entityType": "Gene", "charEnd": 1983, "source": "PUBTATOR", "charStart": 1979, "entityId": [{"idString": "2065", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "ErbB3"}, {"duid": "PU:oHSM", "entityType": "Chemical", "charEnd": 636, "source": "PUBTATOR", "charStart": 628, "entityId": [{"idString": "C400278", "source": "MESH"}], "sentenceIndex": 4, "entityText": "erlotinib"}, {"duid": "PU:xUrm", "entityType": "Disease", "charEnd": 609, "source": "PUBTATOR", "charStart": 593, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 4, "entityText": "pancreatic cancer"}, {"duid": "PU:atrR", "entityType": "Gene", "charEnd": 42, "source": "PUBTATOR", "charStart": 39, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "EGFR"}, {"duid": "PU:fVeS", "entityType": "Gene", "charEnd": 4, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "2065", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ErbB3"}, {"duid": "PU:QyZJ", "entityType": "Gene", "charEnd": 2006, "source": "PUBTATOR", "charStart": 2003, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "EGFR"}, {"duid": "PU:KtZg", "entityType": "Gene", "charEnd": 1809, "source": "PUBTATOR", "charStart": 1807, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "Akt"}, {"duid": "PU:EBhK", "entityType": "Disease", "charEnd": 1458, "source": "PUBTATOR", "charStart": 1442, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 10, "entityText": "pancreatic cancer"}, {"duid": "PU:RTuh", "entityType": "Disease", "charEnd": 238, "source": "PUBTATOR", "charStart": 222, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 1, "entityText": "pancreatic cancer"}, {"duid": "PU:SQ7S", "entityType": "Chemical", "charEnd": 1591, "source": "PUBTATOR", "charStart": 1583, "entityId": [{"idString": "C400278", "source": "MESH"}], "sentenceIndex": 11, "entityText": "erlotinib"}, {"duid": "PU:L8Bw", "entityType": "Gene", "charEnd": 1256, "source": "PUBTATOR", "charStart": 1254, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "Akt"}, {"duid": "PU:qKUp", "entityType": "Chemical", "charEnd": 100, "source": "PUBTATOR", "charStart": 92, "entityId": [{"idString": "C400278", "source": "MESH"}], "sentenceIndex": 0, "entityText": "erlotinib"}, {"duid": "PU:ympb", "entityType": "Gene", "charEnd": 1032, "source": "PUBTATOR", "charStart": 1028, "entityId": [{"idString": "2065", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ErbB3"}, {"duid": "PU:bHgp", "entityType": "Gene", "charEnd": 1833, "source": "PUBTATOR", "charStart": 1830, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "EGFR"}, {"duid": "PU:CbCQ", "entityType": "Gene", "charEnd": 986, "source": "PUBTATOR", "charStart": 983, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:ykMj", "entityType": "Chemical", "charEnd": 295, "source": "PUBTATOR", "charStart": 288, "entityId": [{"idString": "D014443", "source": "CTD"}], "sentenceIndex": 2, "entityText": "tyrosine"}, {"duid": "PU:PJhK", "entityType": "Gene", "charEnd": 864, "source": "PUBTATOR", "charStart": 859, "entityId": [{"idString": "5595", "source": "Entrez"}, {"idString": "5594", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERK1/2"}, {"duid": "PU:erF5", "entityType": "Chemical", "charEnd": 1242, "source": "PUBTATOR", "charStart": 1234, "entityId": [{"idString": "C400278", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Erlotinib"}, {"duid": "PU:oEbU", "entityType": "Gene", "charEnd": 1418, "source": "PUBTATOR", "charStart": 1415, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:UDaM", "entityType": "Gene", "charEnd": 856, "source": "PUBTATOR", "charStart": 854, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "Akt"}, {"duid": "PU:PiRZ", "entityType": "Gene", "charEnd": 1424, "source": "PUBTATOR", "charStart": 1420, "entityId": [{"idString": "2065", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ErbB3"}, {"duid": "PU:ha8y", "entityType": "Chemical", "charEnd": 1172, "source": "PUBTATOR", "charStart": 1164, "entityId": [{"idString": "C400278", "source": "MESH"}], "sentenceIndex": 8, "entityText": "erlotinib"}, {"duid": "PU:V48U", "entityType": "Gene", "charEnd": 877, "source": "PUBTATOR", "charStart": 874, "entityId": [{"idString": "2475", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "mTOR"}, {"duid": "PU:JDnT", "entityType": "Species", "charEnd": 432, "source": "PUBTATOR", "charStart": 426, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patient"}, {"duid": "PU:gWyZ", "entityType": "Species", "charEnd": 682, "source": "PUBTATOR", "charStart": 678, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "human"}, {"duid": "PU:o6xM", "entityType": "Chemical", "charEnd": 761, "source": "PUBTATOR", "charStart": 753, "entityId": [{"idString": "C400278", "source": "MESH"}], "sentenceIndex": 5, "entityText": "erlotinib"}, {"duid": "PU:HcNd", "entityType": "Gene", "charEnd": 1839, "source": "PUBTATOR", "charStart": 1835, "entityId": [{"idString": "2065", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "ErbB3"}, {"duid": "PU:RyWz", "entityType": "Gene", "charEnd": 1761, "source": "PUBTATOR", "charStart": 1757, "entityId": [{"idString": "2065", "source": "Entrez"}], "sentenceIndex": 13, "entityText": "ErbB3"}, {"duid": "PU:S7wv", "entityType": "Disease", "charEnd": 1963, "source": "PUBTATOR", "charStart": 1947, "entityId": [{"idString": "D010190", "source": "MESH"}], "sentenceIndex": 14, "entityText": "Pancreatic cancer"}, {"duid": "PU:98Mc", "entityType": "Species", "charEnd": 2031, "source": "PUBTATOR", "charStart": 2025, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 14, "entityText": "patient"}, {"duid": "PU:5S7b", "entityType": "Disease", "charEnd": 209, "source": "PUBTATOR", "charStart": 198, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "malignancies"}]}
{"text": "Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Not all breast cancers respond to tamoxifen, and many develop resistance despite initial benefit. We used an in vivo model of estrogen receptor (ER)-positive breast cancer (MCF-7 xenografts) to investigate mechanisms of this resistance and develop strategies to circumvent it. Epidermal growth factor receptor (EGFR) and HER2, which were barely detected in control estrogen-treated tumors, increased slightly with tamoxifen and were markedly increased when tumors became resistant. Gefitinib, which inhibits EGFR/HER2, improved the antitumor effect of tamoxifen and delayed acquired resistance, but had no effect on estrogen-stimulated growth. Phosphorylated levels of p42/44 and p38 mitogen-activated protein kinases (both downstream of EGFR/HER2) were increased in the tamoxifen-resistant tumors and were suppressed by gefitinib. There was no apparent increase in phosphorylated AKT (also downstream of EGFR/HER2) in resistant tumors, but it was nonetheless suppressed by gefitinib. Phosphorylated insulin-like growth factor-IR (IGF-IR), which can interact with both EGFR and membrane ER, was elevated in the tamoxifen-resistant tumors compared with the sensitive group. However, ER-regulated gene products, including total IGF-IR itself and progesterone receptor, remained suppressed even at the time of acquired resistance. Tamoxifen's antagonism of classic ER genomic function was retained in these resistant tumors and even in tumors that overexpress HER2 (MCF-7 HER2/18) and are de novo tamoxifen-resistant. In conclusion, EGFR/HER2 may mediate tamoxifen resistance in ER-positive breast cancer despite continued suppression of ER genomic function by tamoxifen. IGF-IR expression remains dependent on ER but is activated in the tamoxifen-resistant tumors. This study provides a rationale to combine HER inhibitors with tamoxifen in clinical studies, even in tumors that do not initially overexpress EGFR/HER2.", "title": {"charStart": 0, "charEnd": 145}, "docId": "18245484", "entity": [{"duid": "PU:akK8", "entityType": "Disease", "charEnd": 609, "source": "PUBTATOR", "charStart": 604, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:TpFy", "entityType": "Gene", "charEnd": 1219, "source": "PUBTATOR", "charStart": 1216, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:5GKE", "entityType": "Gene", "charEnd": 471, "source": "PUBTATOR", "charStart": 468, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "HER2"}, {"duid": "PU:WE4e", "entityType": "Gene", "charEnd": 1510, "source": "PUBTATOR", "charStart": 1509, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ER"}, {"duid": "PU:AvSd", "entityType": "Gene", "charEnd": 1235, "source": "PUBTATOR", "charStart": 1234, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ER"}, {"duid": "PU:6hUj", "entityType": "Chemical", "charEnd": 637, "source": "PUBTATOR", "charStart": 629, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 4, "entityText": "Gefitinib"}, {"duid": "PU:pBoj", "entityType": "Gene", "charEnd": 289, "source": "PUBTATOR", "charStart": 273, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "estrogen receptor"}, {"duid": "PU:RAwj", "entityType": "Chemical", "charEnd": 1402, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "D011374", "source": "MESH"}], "sentenceIndex": 8, "entityText": "progesterone"}, {"duid": "PU:QKwK", "entityType": "Chemical", "charEnd": 118, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 0, "entityText": "estrogen"}, {"duid": "PU:UrsS", "entityType": "Gene", "charEnd": 1783, "source": "PUBTATOR", "charStart": 1782, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ER"}, {"duid": "PU:2TkB", "entityType": "Gene", "charEnd": 893, "source": "PUBTATOR", "charStart": 890, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "HER2"}, {"duid": "PU:NSK2", "entityType": "Gene", "charEnd": 663, "source": "PUBTATOR", "charStart": 660, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "HER2"}, {"duid": "PU:ct2g", "entityType": "Chemical", "charEnd": 519, "source": "PUBTATOR", "charStart": 512, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 3, "entityText": "estrogen"}, {"duid": "PU:ELtf", "entityType": "Chemical", "charEnd": 1266, "source": "PUBTATOR", "charStart": 1258, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tamoxifen"}, {"duid": "PU:giJ8", "entityType": "Disease", "charEnd": 168, "source": "PUBTATOR", "charStart": 155, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast cancers"}, {"duid": "PU:Rzxq", "entityType": "Chemical", "charEnd": 1981, "source": "PUBTATOR", "charStart": 1973, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 12, "entityText": "tamoxifen"}, {"duid": "PU:EvXj", "entityType": "Gene", "charEnd": 2056, "source": "PUBTATOR", "charStart": 2053, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "EGFR"}, {"duid": "PU:Rqbg", "entityType": "Gene", "charEnd": 1183, "source": "PUBTATOR", "charStart": 1178, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "IGF-IR"}, {"duid": "PU:9mb8", "entityType": "Chemical", "charEnd": 1649, "source": "PUBTATOR", "charStart": 1641, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tamoxifen"}, {"duid": "PU:mN3u", "entityType": "Gene", "charEnd": 818, "source": "PUBTATOR", "charStart": 816, "entityId": [{"idString": "2038", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p42"}, {"duid": "PU:CZ8u", "entityType": "Gene", "charEnd": 1055, "source": "PUBTATOR", "charStart": 1052, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:Ljhs", "entityType": "Chemical", "charEnd": 8, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Tamoxifen"}, {"duid": "PU:Eeiw", "entityType": "Disease", "charEnd": 534, "source": "PUBTATOR", "charStart": 529, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:PmoC", "entityType": "Disease", "charEnd": 1747, "source": "PUBTATOR", "charStart": 1723, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 10, "entityText": "ER-positive breast cancer"}, {"duid": "PU:2fr8", "entityType": "Chemical", "charEnd": 1707, "source": "PUBTATOR", "charStart": 1699, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tamoxifen"}, {"duid": "PU:3gcW", "entityType": "Chemical", "charEnd": 1483, "source": "PUBTATOR", "charStart": 1475, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Tamoxifen"}, {"duid": "PU:Naus", "entityType": "Gene", "charEnd": 1856, "source": "PUBTATOR", "charStart": 1855, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ER"}, {"duid": "PU:NWrH", "entityType": "Chemical", "charEnd": 189, "source": "PUBTATOR", "charStart": 181, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tamoxifen"}, {"duid": "PU:cxzJ", "entityType": "Gene", "charEnd": 461, "source": "PUBTATOR", "charStart": 458, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:GgYc", "entityType": "Chemical", "charEnd": 926, "source": "PUBTATOR", "charStart": 918, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tamoxifen"}, {"duid": "PU:xJmn", "entityType": "Disease", "charEnd": 1283, "source": "PUBTATOR", "charStart": 1278, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumors"}, {"duid": "PU:wrFT", "entityType": "Chemical", "charEnd": 569, "source": "PUBTATOR", "charStart": 561, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tamoxifen"}, {"duid": "PU:3UFG", "entityType": "Disease", "charEnd": 1566, "source": "PUBTATOR", "charStart": 1561, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:k9nf", "entityType": "Disease", "charEnd": 1081, "source": "PUBTATOR", "charStart": 1076, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumors"}, {"duid": "PU:TmEG", "entityType": "Gene", "charEnd": 658, "source": "PUBTATOR", "charStart": 655, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:uDi6", "entityType": "Gene", "charEnd": 127, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "estrogen receptor"}, {"duid": "PU:aDbj", "entityType": "Gene", "charEnd": 2061, "source": "PUBTATOR", "charStart": 2058, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "HER2"}, {"duid": "PU:FfDe", "entityType": "Gene", "charEnd": 1622, "source": "PUBTATOR", "charStart": 1616, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2/18"}, {"duid": "PU:2Hvz", "entityType": "Chemical", "charEnd": 1129, "source": "PUBTATOR", "charStart": 1121, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gefitinib"}, {"duid": "PU:h5sL", "entityType": "Gene", "charEnd": 1680, "source": "PUBTATOR", "charStart": 1677, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:vG4j", "entityType": "Gene", "charEnd": 1378, "source": "PUBTATOR", "charStart": 1373, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "IGF-IR"}, {"duid": "PU:zrMd", "entityType": "Gene", "charEnd": 1330, "source": "PUBTATOR", "charStart": 1329, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ER"}, {"duid": "PU:Ht4B", "entityType": "Disease", "charEnd": 36, "source": "PUBTATOR", "charStart": 24, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast tumors"}, {"duid": "PU:aszU", "entityType": "Gene", "charEnd": 1607, "source": "PUBTATOR", "charStart": 1604, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2"}, {"duid": "PU:6Eau", "entityType": "Gene", "charEnd": 1411, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "5241", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "progesterone receptor"}, {"duid": "PU:KHZQ", "entityType": "Chemical", "charEnd": 1813, "source": "PUBTATOR", "charStart": 1805, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tamoxifen"}, {"duid": "PU:bTq5", "entityType": "Disease", "charEnd": 1585, "source": "PUBTATOR", "charStart": 1580, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:sTnf", "entityType": "Gene", "charEnd": 455, "source": "PUBTATOR", "charStart": 424, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "Epidermal growth factor receptor"}, {"duid": "PU:o936", "entityType": "Gene", "charEnd": 829, "source": "PUBTATOR", "charStart": 827, "entityId": [{"idString": "1432", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p38"}, {"duid": "PU:adSa", "entityType": "Disease", "charEnd": 2017, "source": "PUBTATOR", "charStart": 2012, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 12, "entityText": "tumors"}, {"duid": "PU:Nkrm", "entityType": "Disease", "charEnd": 943, "source": "PUBTATOR", "charStart": 938, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumors"}, {"duid": "PU:ZASj", "entityType": "Disease", "charEnd": 1907, "source": "PUBTATOR", "charStart": 1902, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 11, "entityText": "tumors"}, {"duid": "PU:mpnZ", "entityType": "Disease", "charEnd": 317, "source": "PUBTATOR", "charStart": 305, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 2, "entityText": "breast cancer"}, {"duid": "PU:XMZz", "entityType": "Gene", "charEnd": 293, "source": "PUBTATOR", "charStart": 292, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ER"}, {"duid": "PU:zWBu", "entityType": "Chemical", "charEnd": 280, "source": "PUBTATOR", "charStart": 273, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 2, "entityText": "estrogen"}, {"duid": "PU:DZMN", "entityType": "Gene", "charEnd": 1724, "source": "PUBTATOR", "charStart": 1723, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ER"}, {"duid": "PU:vvqJ", "entityType": "Gene", "charEnd": 1175, "source": "PUBTATOR", "charStart": 1147, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "insulin-like growth factor-IR"}, {"duid": "PU:j6JD", "entityType": "Chemical", "charEnd": 976, "source": "PUBTATOR", "charStart": 968, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:sEGC", "entityType": "Gene", "charEnd": 1685, "source": "PUBTATOR", "charStart": 1682, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "HER2"}, {"duid": "PU:i8A9", "entityType": "Gene", "charEnd": 1821, "source": "PUBTATOR", "charStart": 1816, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "IGF-IR"}, {"duid": "PU:oXAg", "entityType": "Disease", "charEnd": 1165, "source": "PUBTATOR", "charStart": 1132, "entityId": [{"idString": "D006130", "source": "MESH"}], "sentenceIndex": 7, "entityText": "Phosphorylated insulin-like growth"}, {"duid": "PU:fMXn", "entityType": "Chemical", "charEnd": 770, "source": "PUBTATOR", "charStart": 763, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 4, "entityText": "estrogen"}, {"duid": "PU:kX45", "entityType": "Gene", "charEnd": 1060, "source": "PUBTATOR", "charStart": 1057, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "HER2"}, {"duid": "PU:h7A9", "entityType": "Chemical", "charEnd": 1890, "source": "PUBTATOR", "charStart": 1882, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 11, "entityText": "tamoxifen"}, {"duid": "PU:gFEv", "entityType": "Chemical", "charEnd": 707, "source": "PUBTATOR", "charStart": 699, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tamoxifen"}, {"duid": "PU:BZB5", "entityType": "Gene", "charEnd": 888, "source": "PUBTATOR", "charStart": 885, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}]}
{"text": "Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Not all breast cancers respond to tamoxifen, and many develop resistance despite initial benefit. We used an in vivo model of estrogen receptor (ER)-positive breast cancer (MCF-7 xenografts) to investigate mechanisms of this resistance and develop strategies to circumvent it. Epidermal growth factor receptor (EGFR) and HER2, which were barely detected in control estrogen-treated tumors, increased slightly with tamoxifen and were markedly increased when tumors became resistant. Gefitinib, which inhibits EGFR/HER2, improved the antitumor effect of tamoxifen and delayed acquired resistance, but had no effect on estrogen-stimulated growth. Phosphorylated levels of p42/44 and p38 mitogen-activated protein kinases (both downstream of EGFR/HER2) were increased in the tamoxifen-resistant tumors and were suppressed by gefitinib. There was no apparent increase in phosphorylated AKT (also downstream of EGFR/HER2) in resistant tumors, but it was nonetheless suppressed by gefitinib. Phosphorylated insulin-like growth factor-IR (IGF-IR), which can interact with both EGFR and membrane ER, was elevated in the tamoxifen-resistant tumors compared with the sensitive group. However, ER-regulated gene products, including total IGF-IR itself and progesterone receptor, remained suppressed even at the time of acquired resistance. Tamoxifen's antagonism of classic ER genomic function was retained in these resistant tumors and even in tumors that overexpress HER2 (MCF-7 HER2/18) and are de novo tamoxifen-resistant. In conclusion, EGFR/HER2 may mediate tamoxifen resistance in ER-positive breast cancer despite continued suppression of ER genomic function by tamoxifen. IGF-IR expression remains dependent on ER but is activated in the tamoxifen-resistant tumors. This study provides a rationale to combine HER inhibitors with tamoxifen in clinical studies, even in tumors that do not initially overexpress EGFR/HER2.", "title": {"charStart": 0, "charEnd": 145}, "docId": "18245484", "entity": [{"duid": "PU:akK8", "entityType": "Disease", "charEnd": 609, "source": "PUBTATOR", "charStart": 604, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:TpFy", "entityType": "Gene", "charEnd": 1219, "source": "PUBTATOR", "charStart": 1216, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:5GKE", "entityType": "Gene", "charEnd": 471, "source": "PUBTATOR", "charStart": 468, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "HER2"}, {"duid": "PU:WE4e", "entityType": "Gene", "charEnd": 1510, "source": "PUBTATOR", "charStart": 1509, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ER"}, {"duid": "PU:AvSd", "entityType": "Gene", "charEnd": 1235, "source": "PUBTATOR", "charStart": 1234, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ER"}, {"duid": "PU:6hUj", "entityType": "Chemical", "charEnd": 637, "source": "PUBTATOR", "charStart": 629, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 4, "entityText": "Gefitinib"}, {"duid": "PU:pBoj", "entityType": "Gene", "charEnd": 289, "source": "PUBTATOR", "charStart": 273, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "estrogen receptor"}, {"duid": "PU:RAwj", "entityType": "Chemical", "charEnd": 1402, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "D011374", "source": "MESH"}], "sentenceIndex": 8, "entityText": "progesterone"}, {"duid": "PU:QKwK", "entityType": "Chemical", "charEnd": 118, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 0, "entityText": "estrogen"}, {"duid": "PU:UrsS", "entityType": "Gene", "charEnd": 1783, "source": "PUBTATOR", "charStart": 1782, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ER"}, {"duid": "PU:2TkB", "entityType": "Gene", "charEnd": 893, "source": "PUBTATOR", "charStart": 890, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "HER2"}, {"duid": "PU:NSK2", "entityType": "Gene", "charEnd": 663, "source": "PUBTATOR", "charStart": 660, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "HER2"}, {"duid": "PU:ct2g", "entityType": "Chemical", "charEnd": 519, "source": "PUBTATOR", "charStart": 512, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 3, "entityText": "estrogen"}, {"duid": "PU:ELtf", "entityType": "Chemical", "charEnd": 1266, "source": "PUBTATOR", "charStart": 1258, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tamoxifen"}, {"duid": "PU:giJ8", "entityType": "Disease", "charEnd": 168, "source": "PUBTATOR", "charStart": 155, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast cancers"}, {"duid": "PU:Rzxq", "entityType": "Chemical", "charEnd": 1981, "source": "PUBTATOR", "charStart": 1973, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 12, "entityText": "tamoxifen"}, {"duid": "PU:EvXj", "entityType": "Gene", "charEnd": 2056, "source": "PUBTATOR", "charStart": 2053, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "EGFR"}, {"duid": "PU:Rqbg", "entityType": "Gene", "charEnd": 1183, "source": "PUBTATOR", "charStart": 1178, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "IGF-IR"}, {"duid": "PU:9mb8", "entityType": "Chemical", "charEnd": 1649, "source": "PUBTATOR", "charStart": 1641, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tamoxifen"}, {"duid": "PU:mN3u", "entityType": "Gene", "charEnd": 818, "source": "PUBTATOR", "charStart": 816, "entityId": [{"idString": "2038", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p42"}, {"duid": "PU:CZ8u", "entityType": "Gene", "charEnd": 1055, "source": "PUBTATOR", "charStart": 1052, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:Ljhs", "entityType": "Chemical", "charEnd": 8, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Tamoxifen"}, {"duid": "PU:Eeiw", "entityType": "Disease", "charEnd": 534, "source": "PUBTATOR", "charStart": 529, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:PmoC", "entityType": "Disease", "charEnd": 1747, "source": "PUBTATOR", "charStart": 1723, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 10, "entityText": "ER-positive breast cancer"}, {"duid": "PU:2fr8", "entityType": "Chemical", "charEnd": 1707, "source": "PUBTATOR", "charStart": 1699, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tamoxifen"}, {"duid": "PU:3gcW", "entityType": "Chemical", "charEnd": 1483, "source": "PUBTATOR", "charStart": 1475, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Tamoxifen"}, {"duid": "PU:Naus", "entityType": "Gene", "charEnd": 1856, "source": "PUBTATOR", "charStart": 1855, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ER"}, {"duid": "PU:NWrH", "entityType": "Chemical", "charEnd": 189, "source": "PUBTATOR", "charStart": 181, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tamoxifen"}, {"duid": "PU:cxzJ", "entityType": "Gene", "charEnd": 461, "source": "PUBTATOR", "charStart": 458, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:GgYc", "entityType": "Chemical", "charEnd": 926, "source": "PUBTATOR", "charStart": 918, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tamoxifen"}, {"duid": "PU:xJmn", "entityType": "Disease", "charEnd": 1283, "source": "PUBTATOR", "charStart": 1278, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumors"}, {"duid": "PU:wrFT", "entityType": "Chemical", "charEnd": 569, "source": "PUBTATOR", "charStart": 561, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tamoxifen"}, {"duid": "PU:3UFG", "entityType": "Disease", "charEnd": 1566, "source": "PUBTATOR", "charStart": 1561, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:k9nf", "entityType": "Disease", "charEnd": 1081, "source": "PUBTATOR", "charStart": 1076, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumors"}, {"duid": "PU:TmEG", "entityType": "Gene", "charEnd": 658, "source": "PUBTATOR", "charStart": 655, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:uDi6", "entityType": "Gene", "charEnd": 127, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "estrogen receptor"}, {"duid": "PU:aDbj", "entityType": "Gene", "charEnd": 2061, "source": "PUBTATOR", "charStart": 2058, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "HER2"}, {"duid": "PU:FfDe", "entityType": "Gene", "charEnd": 1622, "source": "PUBTATOR", "charStart": 1616, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2/18"}, {"duid": "PU:2Hvz", "entityType": "Chemical", "charEnd": 1129, "source": "PUBTATOR", "charStart": 1121, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gefitinib"}, {"duid": "PU:h5sL", "entityType": "Gene", "charEnd": 1680, "source": "PUBTATOR", "charStart": 1677, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:vG4j", "entityType": "Gene", "charEnd": 1378, "source": "PUBTATOR", "charStart": 1373, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "IGF-IR"}, {"duid": "PU:zrMd", "entityType": "Gene", "charEnd": 1330, "source": "PUBTATOR", "charStart": 1329, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ER"}, {"duid": "PU:Ht4B", "entityType": "Disease", "charEnd": 36, "source": "PUBTATOR", "charStart": 24, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast tumors"}, {"duid": "PU:aszU", "entityType": "Gene", "charEnd": 1607, "source": "PUBTATOR", "charStart": 1604, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2"}, {"duid": "PU:6Eau", "entityType": "Gene", "charEnd": 1411, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "5241", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "progesterone receptor"}, {"duid": "PU:KHZQ", "entityType": "Chemical", "charEnd": 1813, "source": "PUBTATOR", "charStart": 1805, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tamoxifen"}, {"duid": "PU:bTq5", "entityType": "Disease", "charEnd": 1585, "source": "PUBTATOR", "charStart": 1580, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:sTnf", "entityType": "Gene", "charEnd": 455, "source": "PUBTATOR", "charStart": 424, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "Epidermal growth factor receptor"}, {"duid": "PU:o936", "entityType": "Gene", "charEnd": 829, "source": "PUBTATOR", "charStart": 827, "entityId": [{"idString": "1432", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p38"}, {"duid": "PU:adSa", "entityType": "Disease", "charEnd": 2017, "source": "PUBTATOR", "charStart": 2012, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 12, "entityText": "tumors"}, {"duid": "PU:Nkrm", "entityType": "Disease", "charEnd": 943, "source": "PUBTATOR", "charStart": 938, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumors"}, {"duid": "PU:ZASj", "entityType": "Disease", "charEnd": 1907, "source": "PUBTATOR", "charStart": 1902, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 11, "entityText": "tumors"}, {"duid": "PU:mpnZ", "entityType": "Disease", "charEnd": 317, "source": "PUBTATOR", "charStart": 305, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 2, "entityText": "breast cancer"}, {"duid": "PU:XMZz", "entityType": "Gene", "charEnd": 293, "source": "PUBTATOR", "charStart": 292, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ER"}, {"duid": "PU:zWBu", "entityType": "Chemical", "charEnd": 280, "source": "PUBTATOR", "charStart": 273, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 2, "entityText": "estrogen"}, {"duid": "PU:DZMN", "entityType": "Gene", "charEnd": 1724, "source": "PUBTATOR", "charStart": 1723, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ER"}, {"duid": "PU:vvqJ", "entityType": "Gene", "charEnd": 1175, "source": "PUBTATOR", "charStart": 1147, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "insulin-like growth factor-IR"}, {"duid": "PU:j6JD", "entityType": "Chemical", "charEnd": 976, "source": "PUBTATOR", "charStart": 968, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:sEGC", "entityType": "Gene", "charEnd": 1685, "source": "PUBTATOR", "charStart": 1682, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "HER2"}, {"duid": "PU:i8A9", "entityType": "Gene", "charEnd": 1821, "source": "PUBTATOR", "charStart": 1816, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "IGF-IR"}, {"duid": "PU:oXAg", "entityType": "Disease", "charEnd": 1165, "source": "PUBTATOR", "charStart": 1132, "entityId": [{"idString": "D006130", "source": "MESH"}], "sentenceIndex": 7, "entityText": "Phosphorylated insulin-like growth"}, {"duid": "PU:fMXn", "entityType": "Chemical", "charEnd": 770, "source": "PUBTATOR", "charStart": 763, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 4, "entityText": "estrogen"}, {"duid": "PU:kX45", "entityType": "Gene", "charEnd": 1060, "source": "PUBTATOR", "charStart": 1057, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "HER2"}, {"duid": "PU:h7A9", "entityType": "Chemical", "charEnd": 1890, "source": "PUBTATOR", "charStart": 1882, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 11, "entityText": "tamoxifen"}, {"duid": "PU:gFEv", "entityType": "Chemical", "charEnd": 707, "source": "PUBTATOR", "charStart": 699, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tamoxifen"}, {"duid": "PU:BZB5", "entityType": "Gene", "charEnd": 888, "source": "PUBTATOR", "charStart": 885, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}]}
{"text": "Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Not all breast cancers respond to tamoxifen, and many develop resistance despite initial benefit. We used an in vivo model of estrogen receptor (ER)-positive breast cancer (MCF-7 xenografts) to investigate mechanisms of this resistance and develop strategies to circumvent it. Epidermal growth factor receptor (EGFR) and HER2, which were barely detected in control estrogen-treated tumors, increased slightly with tamoxifen and were markedly increased when tumors became resistant. Gefitinib, which inhibits EGFR/HER2, improved the antitumor effect of tamoxifen and delayed acquired resistance, but had no effect on estrogen-stimulated growth. Phosphorylated levels of p42/44 and p38 mitogen-activated protein kinases (both downstream of EGFR/HER2) were increased in the tamoxifen-resistant tumors and were suppressed by gefitinib. There was no apparent increase in phosphorylated AKT (also downstream of EGFR/HER2) in resistant tumors, but it was nonetheless suppressed by gefitinib. Phosphorylated insulin-like growth factor-IR (IGF-IR), which can interact with both EGFR and membrane ER, was elevated in the tamoxifen-resistant tumors compared with the sensitive group. However, ER-regulated gene products, including total IGF-IR itself and progesterone receptor, remained suppressed even at the time of acquired resistance. Tamoxifen's antagonism of classic ER genomic function was retained in these resistant tumors and even in tumors that overexpress HER2 (MCF-7 HER2/18) and are de novo tamoxifen-resistant. In conclusion, EGFR/HER2 may mediate tamoxifen resistance in ER-positive breast cancer despite continued suppression of ER genomic function by tamoxifen. IGF-IR expression remains dependent on ER but is activated in the tamoxifen-resistant tumors. This study provides a rationale to combine HER inhibitors with tamoxifen in clinical studies, even in tumors that do not initially overexpress EGFR/HER2.", "title": {"charStart": 0, "charEnd": 145}, "docId": "18245484", "entity": [{"duid": "PU:akK8", "entityType": "Disease", "charEnd": 609, "source": "PUBTATOR", "charStart": 604, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:TpFy", "entityType": "Gene", "charEnd": 1219, "source": "PUBTATOR", "charStart": 1216, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:5GKE", "entityType": "Gene", "charEnd": 471, "source": "PUBTATOR", "charStart": 468, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "HER2"}, {"duid": "PU:WE4e", "entityType": "Gene", "charEnd": 1510, "source": "PUBTATOR", "charStart": 1509, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ER"}, {"duid": "PU:AvSd", "entityType": "Gene", "charEnd": 1235, "source": "PUBTATOR", "charStart": 1234, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ER"}, {"duid": "PU:6hUj", "entityType": "Chemical", "charEnd": 637, "source": "PUBTATOR", "charStart": 629, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 4, "entityText": "Gefitinib"}, {"duid": "PU:pBoj", "entityType": "Gene", "charEnd": 289, "source": "PUBTATOR", "charStart": 273, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "estrogen receptor"}, {"duid": "PU:RAwj", "entityType": "Chemical", "charEnd": 1402, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "D011374", "source": "MESH"}], "sentenceIndex": 8, "entityText": "progesterone"}, {"duid": "PU:QKwK", "entityType": "Chemical", "charEnd": 118, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 0, "entityText": "estrogen"}, {"duid": "PU:UrsS", "entityType": "Gene", "charEnd": 1783, "source": "PUBTATOR", "charStart": 1782, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ER"}, {"duid": "PU:2TkB", "entityType": "Gene", "charEnd": 893, "source": "PUBTATOR", "charStart": 890, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "HER2"}, {"duid": "PU:NSK2", "entityType": "Gene", "charEnd": 663, "source": "PUBTATOR", "charStart": 660, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "HER2"}, {"duid": "PU:ct2g", "entityType": "Chemical", "charEnd": 519, "source": "PUBTATOR", "charStart": 512, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 3, "entityText": "estrogen"}, {"duid": "PU:ELtf", "entityType": "Chemical", "charEnd": 1266, "source": "PUBTATOR", "charStart": 1258, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tamoxifen"}, {"duid": "PU:giJ8", "entityType": "Disease", "charEnd": 168, "source": "PUBTATOR", "charStart": 155, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast cancers"}, {"duid": "PU:Rzxq", "entityType": "Chemical", "charEnd": 1981, "source": "PUBTATOR", "charStart": 1973, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 12, "entityText": "tamoxifen"}, {"duid": "PU:EvXj", "entityType": "Gene", "charEnd": 2056, "source": "PUBTATOR", "charStart": 2053, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "EGFR"}, {"duid": "PU:Rqbg", "entityType": "Gene", "charEnd": 1183, "source": "PUBTATOR", "charStart": 1178, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "IGF-IR"}, {"duid": "PU:9mb8", "entityType": "Chemical", "charEnd": 1649, "source": "PUBTATOR", "charStart": 1641, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tamoxifen"}, {"duid": "PU:mN3u", "entityType": "Gene", "charEnd": 818, "source": "PUBTATOR", "charStart": 816, "entityId": [{"idString": "2038", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p42"}, {"duid": "PU:CZ8u", "entityType": "Gene", "charEnd": 1055, "source": "PUBTATOR", "charStart": 1052, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:Ljhs", "entityType": "Chemical", "charEnd": 8, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Tamoxifen"}, {"duid": "PU:Eeiw", "entityType": "Disease", "charEnd": 534, "source": "PUBTATOR", "charStart": 529, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:PmoC", "entityType": "Disease", "charEnd": 1747, "source": "PUBTATOR", "charStart": 1723, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 10, "entityText": "ER-positive breast cancer"}, {"duid": "PU:2fr8", "entityType": "Chemical", "charEnd": 1707, "source": "PUBTATOR", "charStart": 1699, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tamoxifen"}, {"duid": "PU:3gcW", "entityType": "Chemical", "charEnd": 1483, "source": "PUBTATOR", "charStart": 1475, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Tamoxifen"}, {"duid": "PU:Naus", "entityType": "Gene", "charEnd": 1856, "source": "PUBTATOR", "charStart": 1855, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ER"}, {"duid": "PU:NWrH", "entityType": "Chemical", "charEnd": 189, "source": "PUBTATOR", "charStart": 181, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tamoxifen"}, {"duid": "PU:cxzJ", "entityType": "Gene", "charEnd": 461, "source": "PUBTATOR", "charStart": 458, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:GgYc", "entityType": "Chemical", "charEnd": 926, "source": "PUBTATOR", "charStart": 918, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tamoxifen"}, {"duid": "PU:xJmn", "entityType": "Disease", "charEnd": 1283, "source": "PUBTATOR", "charStart": 1278, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumors"}, {"duid": "PU:wrFT", "entityType": "Chemical", "charEnd": 569, "source": "PUBTATOR", "charStart": 561, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tamoxifen"}, {"duid": "PU:3UFG", "entityType": "Disease", "charEnd": 1566, "source": "PUBTATOR", "charStart": 1561, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:k9nf", "entityType": "Disease", "charEnd": 1081, "source": "PUBTATOR", "charStart": 1076, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumors"}, {"duid": "PU:TmEG", "entityType": "Gene", "charEnd": 658, "source": "PUBTATOR", "charStart": 655, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:uDi6", "entityType": "Gene", "charEnd": 127, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "estrogen receptor"}, {"duid": "PU:aDbj", "entityType": "Gene", "charEnd": 2061, "source": "PUBTATOR", "charStart": 2058, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "HER2"}, {"duid": "PU:FfDe", "entityType": "Gene", "charEnd": 1622, "source": "PUBTATOR", "charStart": 1616, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2/18"}, {"duid": "PU:2Hvz", "entityType": "Chemical", "charEnd": 1129, "source": "PUBTATOR", "charStart": 1121, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gefitinib"}, {"duid": "PU:h5sL", "entityType": "Gene", "charEnd": 1680, "source": "PUBTATOR", "charStart": 1677, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:vG4j", "entityType": "Gene", "charEnd": 1378, "source": "PUBTATOR", "charStart": 1373, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "IGF-IR"}, {"duid": "PU:zrMd", "entityType": "Gene", "charEnd": 1330, "source": "PUBTATOR", "charStart": 1329, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ER"}, {"duid": "PU:Ht4B", "entityType": "Disease", "charEnd": 36, "source": "PUBTATOR", "charStart": 24, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast tumors"}, {"duid": "PU:aszU", "entityType": "Gene", "charEnd": 1607, "source": "PUBTATOR", "charStart": 1604, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2"}, {"duid": "PU:6Eau", "entityType": "Gene", "charEnd": 1411, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "5241", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "progesterone receptor"}, {"duid": "PU:KHZQ", "entityType": "Chemical", "charEnd": 1813, "source": "PUBTATOR", "charStart": 1805, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tamoxifen"}, {"duid": "PU:bTq5", "entityType": "Disease", "charEnd": 1585, "source": "PUBTATOR", "charStart": 1580, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:sTnf", "entityType": "Gene", "charEnd": 455, "source": "PUBTATOR", "charStart": 424, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "Epidermal growth factor receptor"}, {"duid": "PU:o936", "entityType": "Gene", "charEnd": 829, "source": "PUBTATOR", "charStart": 827, "entityId": [{"idString": "1432", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p38"}, {"duid": "PU:adSa", "entityType": "Disease", "charEnd": 2017, "source": "PUBTATOR", "charStart": 2012, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 12, "entityText": "tumors"}, {"duid": "PU:Nkrm", "entityType": "Disease", "charEnd": 943, "source": "PUBTATOR", "charStart": 938, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumors"}, {"duid": "PU:ZASj", "entityType": "Disease", "charEnd": 1907, "source": "PUBTATOR", "charStart": 1902, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 11, "entityText": "tumors"}, {"duid": "PU:mpnZ", "entityType": "Disease", "charEnd": 317, "source": "PUBTATOR", "charStart": 305, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 2, "entityText": "breast cancer"}, {"duid": "PU:XMZz", "entityType": "Gene", "charEnd": 293, "source": "PUBTATOR", "charStart": 292, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ER"}, {"duid": "PU:zWBu", "entityType": "Chemical", "charEnd": 280, "source": "PUBTATOR", "charStart": 273, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 2, "entityText": "estrogen"}, {"duid": "PU:DZMN", "entityType": "Gene", "charEnd": 1724, "source": "PUBTATOR", "charStart": 1723, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ER"}, {"duid": "PU:vvqJ", "entityType": "Gene", "charEnd": 1175, "source": "PUBTATOR", "charStart": 1147, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "insulin-like growth factor-IR"}, {"duid": "PU:j6JD", "entityType": "Chemical", "charEnd": 976, "source": "PUBTATOR", "charStart": 968, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:sEGC", "entityType": "Gene", "charEnd": 1685, "source": "PUBTATOR", "charStart": 1682, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "HER2"}, {"duid": "PU:i8A9", "entityType": "Gene", "charEnd": 1821, "source": "PUBTATOR", "charStart": 1816, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "IGF-IR"}, {"duid": "PU:oXAg", "entityType": "Disease", "charEnd": 1165, "source": "PUBTATOR", "charStart": 1132, "entityId": [{"idString": "D006130", "source": "MESH"}], "sentenceIndex": 7, "entityText": "Phosphorylated insulin-like growth"}, {"duid": "PU:fMXn", "entityType": "Chemical", "charEnd": 770, "source": "PUBTATOR", "charStart": 763, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 4, "entityText": "estrogen"}, {"duid": "PU:kX45", "entityType": "Gene", "charEnd": 1060, "source": "PUBTATOR", "charStart": 1057, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "HER2"}, {"duid": "PU:h7A9", "entityType": "Chemical", "charEnd": 1890, "source": "PUBTATOR", "charStart": 1882, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 11, "entityText": "tamoxifen"}, {"duid": "PU:gFEv", "entityType": "Chemical", "charEnd": 707, "source": "PUBTATOR", "charStart": 699, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tamoxifen"}, {"duid": "PU:BZB5", "entityType": "Gene", "charEnd": 888, "source": "PUBTATOR", "charStart": 885, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}]}
{"text": "Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Not all breast cancers respond to tamoxifen, and many develop resistance despite initial benefit. We used an in vivo model of estrogen receptor (ER)-positive breast cancer (MCF-7 xenografts) to investigate mechanisms of this resistance and develop strategies to circumvent it. Epidermal growth factor receptor (EGFR) and HER2, which were barely detected in control estrogen-treated tumors, increased slightly with tamoxifen and were markedly increased when tumors became resistant. Gefitinib, which inhibits EGFR/HER2, improved the antitumor effect of tamoxifen and delayed acquired resistance, but had no effect on estrogen-stimulated growth. Phosphorylated levels of p42/44 and p38 mitogen-activated protein kinases (both downstream of EGFR/HER2) were increased in the tamoxifen-resistant tumors and were suppressed by gefitinib. There was no apparent increase in phosphorylated AKT (also downstream of EGFR/HER2) in resistant tumors, but it was nonetheless suppressed by gefitinib. Phosphorylated insulin-like growth factor-IR (IGF-IR), which can interact with both EGFR and membrane ER, was elevated in the tamoxifen-resistant tumors compared with the sensitive group. However, ER-regulated gene products, including total IGF-IR itself and progesterone receptor, remained suppressed even at the time of acquired resistance. Tamoxifen's antagonism of classic ER genomic function was retained in these resistant tumors and even in tumors that overexpress HER2 (MCF-7 HER2/18) and are de novo tamoxifen-resistant. In conclusion, EGFR/HER2 may mediate tamoxifen resistance in ER-positive breast cancer despite continued suppression of ER genomic function by tamoxifen. IGF-IR expression remains dependent on ER but is activated in the tamoxifen-resistant tumors. This study provides a rationale to combine HER inhibitors with tamoxifen in clinical studies, even in tumors that do not initially overexpress EGFR/HER2.", "title": {"charStart": 0, "charEnd": 145}, "docId": "18245484", "entity": [{"duid": "PU:akK8", "entityType": "Disease", "charEnd": 609, "source": "PUBTATOR", "charStart": 604, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:TpFy", "entityType": "Gene", "charEnd": 1219, "source": "PUBTATOR", "charStart": 1216, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:5GKE", "entityType": "Gene", "charEnd": 471, "source": "PUBTATOR", "charStart": 468, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "HER2"}, {"duid": "PU:WE4e", "entityType": "Gene", "charEnd": 1510, "source": "PUBTATOR", "charStart": 1509, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ER"}, {"duid": "PU:AvSd", "entityType": "Gene", "charEnd": 1235, "source": "PUBTATOR", "charStart": 1234, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ER"}, {"duid": "PU:6hUj", "entityType": "Chemical", "charEnd": 637, "source": "PUBTATOR", "charStart": 629, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 4, "entityText": "Gefitinib"}, {"duid": "PU:pBoj", "entityType": "Gene", "charEnd": 289, "source": "PUBTATOR", "charStart": 273, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "estrogen receptor"}, {"duid": "PU:RAwj", "entityType": "Chemical", "charEnd": 1402, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "D011374", "source": "MESH"}], "sentenceIndex": 8, "entityText": "progesterone"}, {"duid": "PU:QKwK", "entityType": "Chemical", "charEnd": 118, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 0, "entityText": "estrogen"}, {"duid": "PU:UrsS", "entityType": "Gene", "charEnd": 1783, "source": "PUBTATOR", "charStart": 1782, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ER"}, {"duid": "PU:2TkB", "entityType": "Gene", "charEnd": 893, "source": "PUBTATOR", "charStart": 890, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "HER2"}, {"duid": "PU:NSK2", "entityType": "Gene", "charEnd": 663, "source": "PUBTATOR", "charStart": 660, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "HER2"}, {"duid": "PU:ct2g", "entityType": "Chemical", "charEnd": 519, "source": "PUBTATOR", "charStart": 512, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 3, "entityText": "estrogen"}, {"duid": "PU:ELtf", "entityType": "Chemical", "charEnd": 1266, "source": "PUBTATOR", "charStart": 1258, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tamoxifen"}, {"duid": "PU:giJ8", "entityType": "Disease", "charEnd": 168, "source": "PUBTATOR", "charStart": 155, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast cancers"}, {"duid": "PU:Rzxq", "entityType": "Chemical", "charEnd": 1981, "source": "PUBTATOR", "charStart": 1973, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 12, "entityText": "tamoxifen"}, {"duid": "PU:EvXj", "entityType": "Gene", "charEnd": 2056, "source": "PUBTATOR", "charStart": 2053, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "EGFR"}, {"duid": "PU:Rqbg", "entityType": "Gene", "charEnd": 1183, "source": "PUBTATOR", "charStart": 1178, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "IGF-IR"}, {"duid": "PU:9mb8", "entityType": "Chemical", "charEnd": 1649, "source": "PUBTATOR", "charStart": 1641, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tamoxifen"}, {"duid": "PU:mN3u", "entityType": "Gene", "charEnd": 818, "source": "PUBTATOR", "charStart": 816, "entityId": [{"idString": "2038", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p42"}, {"duid": "PU:CZ8u", "entityType": "Gene", "charEnd": 1055, "source": "PUBTATOR", "charStart": 1052, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:Ljhs", "entityType": "Chemical", "charEnd": 8, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Tamoxifen"}, {"duid": "PU:Eeiw", "entityType": "Disease", "charEnd": 534, "source": "PUBTATOR", "charStart": 529, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:PmoC", "entityType": "Disease", "charEnd": 1747, "source": "PUBTATOR", "charStart": 1723, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 10, "entityText": "ER-positive breast cancer"}, {"duid": "PU:2fr8", "entityType": "Chemical", "charEnd": 1707, "source": "PUBTATOR", "charStart": 1699, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tamoxifen"}, {"duid": "PU:3gcW", "entityType": "Chemical", "charEnd": 1483, "source": "PUBTATOR", "charStart": 1475, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Tamoxifen"}, {"duid": "PU:Naus", "entityType": "Gene", "charEnd": 1856, "source": "PUBTATOR", "charStart": 1855, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ER"}, {"duid": "PU:NWrH", "entityType": "Chemical", "charEnd": 189, "source": "PUBTATOR", "charStart": 181, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tamoxifen"}, {"duid": "PU:cxzJ", "entityType": "Gene", "charEnd": 461, "source": "PUBTATOR", "charStart": 458, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:GgYc", "entityType": "Chemical", "charEnd": 926, "source": "PUBTATOR", "charStart": 918, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tamoxifen"}, {"duid": "PU:xJmn", "entityType": "Disease", "charEnd": 1283, "source": "PUBTATOR", "charStart": 1278, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumors"}, {"duid": "PU:wrFT", "entityType": "Chemical", "charEnd": 569, "source": "PUBTATOR", "charStart": 561, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tamoxifen"}, {"duid": "PU:3UFG", "entityType": "Disease", "charEnd": 1566, "source": "PUBTATOR", "charStart": 1561, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:k9nf", "entityType": "Disease", "charEnd": 1081, "source": "PUBTATOR", "charStart": 1076, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumors"}, {"duid": "PU:TmEG", "entityType": "Gene", "charEnd": 658, "source": "PUBTATOR", "charStart": 655, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:uDi6", "entityType": "Gene", "charEnd": 127, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "estrogen receptor"}, {"duid": "PU:aDbj", "entityType": "Gene", "charEnd": 2061, "source": "PUBTATOR", "charStart": 2058, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "HER2"}, {"duid": "PU:FfDe", "entityType": "Gene", "charEnd": 1622, "source": "PUBTATOR", "charStart": 1616, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2/18"}, {"duid": "PU:2Hvz", "entityType": "Chemical", "charEnd": 1129, "source": "PUBTATOR", "charStart": 1121, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gefitinib"}, {"duid": "PU:h5sL", "entityType": "Gene", "charEnd": 1680, "source": "PUBTATOR", "charStart": 1677, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:vG4j", "entityType": "Gene", "charEnd": 1378, "source": "PUBTATOR", "charStart": 1373, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "IGF-IR"}, {"duid": "PU:zrMd", "entityType": "Gene", "charEnd": 1330, "source": "PUBTATOR", "charStart": 1329, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ER"}, {"duid": "PU:Ht4B", "entityType": "Disease", "charEnd": 36, "source": "PUBTATOR", "charStart": 24, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast tumors"}, {"duid": "PU:aszU", "entityType": "Gene", "charEnd": 1607, "source": "PUBTATOR", "charStart": 1604, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2"}, {"duid": "PU:6Eau", "entityType": "Gene", "charEnd": 1411, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "5241", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "progesterone receptor"}, {"duid": "PU:KHZQ", "entityType": "Chemical", "charEnd": 1813, "source": "PUBTATOR", "charStart": 1805, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tamoxifen"}, {"duid": "PU:bTq5", "entityType": "Disease", "charEnd": 1585, "source": "PUBTATOR", "charStart": 1580, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:sTnf", "entityType": "Gene", "charEnd": 455, "source": "PUBTATOR", "charStart": 424, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "Epidermal growth factor receptor"}, {"duid": "PU:o936", "entityType": "Gene", "charEnd": 829, "source": "PUBTATOR", "charStart": 827, "entityId": [{"idString": "1432", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p38"}, {"duid": "PU:adSa", "entityType": "Disease", "charEnd": 2017, "source": "PUBTATOR", "charStart": 2012, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 12, "entityText": "tumors"}, {"duid": "PU:Nkrm", "entityType": "Disease", "charEnd": 943, "source": "PUBTATOR", "charStart": 938, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumors"}, {"duid": "PU:ZASj", "entityType": "Disease", "charEnd": 1907, "source": "PUBTATOR", "charStart": 1902, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 11, "entityText": "tumors"}, {"duid": "PU:mpnZ", "entityType": "Disease", "charEnd": 317, "source": "PUBTATOR", "charStart": 305, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 2, "entityText": "breast cancer"}, {"duid": "PU:XMZz", "entityType": "Gene", "charEnd": 293, "source": "PUBTATOR", "charStart": 292, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ER"}, {"duid": "PU:zWBu", "entityType": "Chemical", "charEnd": 280, "source": "PUBTATOR", "charStart": 273, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 2, "entityText": "estrogen"}, {"duid": "PU:DZMN", "entityType": "Gene", "charEnd": 1724, "source": "PUBTATOR", "charStart": 1723, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ER"}, {"duid": "PU:vvqJ", "entityType": "Gene", "charEnd": 1175, "source": "PUBTATOR", "charStart": 1147, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "insulin-like growth factor-IR"}, {"duid": "PU:j6JD", "entityType": "Chemical", "charEnd": 976, "source": "PUBTATOR", "charStart": 968, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:sEGC", "entityType": "Gene", "charEnd": 1685, "source": "PUBTATOR", "charStart": 1682, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "HER2"}, {"duid": "PU:i8A9", "entityType": "Gene", "charEnd": 1821, "source": "PUBTATOR", "charStart": 1816, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "IGF-IR"}, {"duid": "PU:oXAg", "entityType": "Disease", "charEnd": 1165, "source": "PUBTATOR", "charStart": 1132, "entityId": [{"idString": "D006130", "source": "MESH"}], "sentenceIndex": 7, "entityText": "Phosphorylated insulin-like growth"}, {"duid": "PU:fMXn", "entityType": "Chemical", "charEnd": 770, "source": "PUBTATOR", "charStart": 763, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 4, "entityText": "estrogen"}, {"duid": "PU:kX45", "entityType": "Gene", "charEnd": 1060, "source": "PUBTATOR", "charStart": 1057, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "HER2"}, {"duid": "PU:h7A9", "entityType": "Chemical", "charEnd": 1890, "source": "PUBTATOR", "charStart": 1882, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 11, "entityText": "tamoxifen"}, {"duid": "PU:gFEv", "entityType": "Chemical", "charEnd": 707, "source": "PUBTATOR", "charStart": 699, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tamoxifen"}, {"duid": "PU:BZB5", "entityType": "Gene", "charEnd": 888, "source": "PUBTATOR", "charStart": 885, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}]}
{"text": "Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China. BACKGROUND: Convincing data on epidermal growth factor receptor (EGFR) mutations in Chinese patients with non-small-cell lung cancer (NSCLC) remain limited. We investigated the relevance of demographic characteristics and EGFR mutations, correlations between the efficacy of gefitinib and EGFR mutations in NSCLC, and to identify individuals who would likely benefit from gefitinib. METHODS: We conducted a meta-analysis based on updated individual patient data from six medical centers in mainland China. Outcome measures included the EGFR mutation status, demographic characteristics, response, and survival. RESULTS: Among 506 patients with NSCLC who received EGFR mutation analysis, the EGFR mutation rate was 30.04%. Patients with adenocarcinoma had a higher mutation rate than those with non-adenocarcinoma (44.1% vs 9.2%; p < 0.00001). The EGFR mutation rate for smokers was 15.1%, lower than that for non-smokers (45.5%) (p < 0.00001). Male patients had a lower mutation rate than female patients (23.1% vs 42.9%; p < 0.0001). Multivariate analysis showed that \"adenocarcinoma\" and \"non-smoker\" were independent predictors of EGFR mutations. In a subgroup of 57 patients with complete treatment data, the response rate to gefitinib in the EGFR mutant group was 60.7%, significantly higher than that in the wild-type EGFR group (17.2%) (odds ratio, 5.78; 95% CI, 1.95-17.13; p = 0.002). \"EGFR mutation\", \"adenocarcinoma,\" and \"non-smoker\" were independent predictors of response. Overall survival in the EGFR mutant group and the wild-type group did not differ significantly (hazard ratio, 0.60; 95% CI, 0.32-1.12; p = 0.110). \"Adenocarcinoma status\" was an independent prognostic factor for survival. CONCLUSIONS: In mainland China, \"adenocarcinoma\" and \"non-smoker\" are independent predictors for EGFR mutations. Response to gefitinib favors patients with EGFR mutations. The clinical selected populations for gefitinib are non-smokers with adenocarcinoma.", "title": {"charStart": 0, "charEnd": 232}, "docId": "17473659", "entity": [{"duid": "PU:J2CJ", "entityType": "Disease", "charEnd": 882, "source": "PUBTATOR", "charStart": 878, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 5, "entityText": "NSCLC"}, {"duid": "PU:PZiG", "entityType": "Species", "charEnd": 98, "source": "PUBTATOR", "charStart": 91, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:Ah4D", "entityType": "Gene", "charEnd": 1561, "source": "PUBTATOR", "charStart": 1558, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:vkv3", "entityType": "Gene", "charEnd": 1484, "source": "PUBTATOR", "charStart": 1481, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:5bQo", "entityType": "Chemical", "charEnd": 78, "source": "PUBTATOR", "charStart": 70, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gefitinib"}, {"duid": "PU:LdSc", "entityType": "Species", "charEnd": 2092, "source": "PUBTATOR", "charStart": 2085, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 15, "entityText": "patients"}, {"duid": "PU:gUit", "entityType": "Disease", "charEnd": 365, "source": "PUBTATOR", "charStart": 340, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:noBN", "entityType": "Gene", "charEnd": 526, "source": "PUBTATOR", "charStart": 523, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:mibn", "entityType": "Gene", "charEnd": 31, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Epidermal growth factor receptor"}, {"duid": "PU:t7JF", "entityType": "Gene", "charEnd": 900, "source": "PUBTATOR", "charStart": 897, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}, {"duid": "PU:h6z3", "entityType": "Gene", "charEnd": 773, "source": "PUBTATOR", "charStart": 770, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:YDKc", "entityType": "Disease", "charEnd": 1882, "source": "PUBTATOR", "charStart": 1869, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 13, "entityText": "Adenocarcinoma"}, {"duid": "PU:Yjgk", "entityType": "Disease", "charEnd": 372, "source": "PUBTATOR", "charStart": 368, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:mpf8", "entityType": "Species", "charEnd": 1411, "source": "PUBTATOR", "charStart": 1404, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:xnvv", "entityType": "Chemical", "charEnd": 2076, "source": "PUBTATOR", "charStart": 2068, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 15, "entityText": "gefitinib"}, {"duid": "PU:cwkG", "entityType": "Disease", "charEnd": 1659, "source": "PUBTATOR", "charStart": 1646, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 11, "entityText": "adenocarcinoma"}, {"duid": "PU:d94E", "entityType": "Disease", "charEnd": 1317, "source": "PUBTATOR", "charStart": 1304, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 9, "entityText": "adenocarcinoma"}, {"duid": "PU:hCD4", "entityType": "Disease", "charEnd": 983, "source": "PUBTATOR", "charStart": 970, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 6, "entityText": "adenocarcinoma"}, {"duid": "PU:Drfc", "entityType": "Disease", "charEnd": 130, "source": "PUBTATOR", "charStart": 105, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:dpfb", "entityType": "Gene", "charEnd": 2102, "source": "PUBTATOR", "charStart": 2099, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 15, "entityText": "EGFR"}, {"duid": "PU:vNnY", "entityType": "Chemical", "charEnd": 517, "source": "PUBTATOR", "charStart": 509, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gefitinib"}, {"duid": "PU:8uTS", "entityType": "Species", "charEnd": 183, "source": "PUBTATOR", "charStart": 177, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patient"}, {"duid": "PU:ZCsQ", "entityType": "Species", "charEnd": 333, "source": "PUBTATOR", "charStart": 326, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:pPLB", "entityType": "Disease", "charEnd": 1989, "source": "PUBTATOR", "charStart": 1976, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 14, "entityText": "adenocarcinoma"}, {"duid": "PU:cTta", "entityType": "Disease", "charEnd": 2197, "source": "PUBTATOR", "charStart": 2184, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 16, "entityText": "adenocarcinoma"}, {"duid": "PU:5iTk", "entityType": "Chemical", "charEnd": 614, "source": "PUBTATOR", "charStart": 606, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gefitinib"}, {"duid": "PU:XQpU", "entityType": "Species", "charEnd": 871, "source": "PUBTATOR", "charStart": 864, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:bcTN", "entityType": "Gene", "charEnd": 928, "source": "PUBTATOR", "charStart": 925, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}, {"duid": "PU:ZzLo", "entityType": "Disease", "charEnd": 545, "source": "PUBTATOR", "charStart": 541, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "NSCLC"}, {"duid": "PU:MaF6", "entityType": "Chemical", "charEnd": 1472, "source": "PUBTATOR", "charStart": 1464, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 10, "entityText": "gefitinib"}, {"duid": "PU:WQCK", "entityType": "Chemical", "charEnd": 2161, "source": "PUBTATOR", "charStart": 2153, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 16, "entityText": "gefitinib"}, {"duid": "PU:PxqQ", "entityType": "Species", "charEnd": 689, "source": "PUBTATOR", "charStart": 683, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patient"}, {"duid": "PU:sjRr", "entityType": "Species", "charEnd": 1190, "source": "PUBTATOR", "charStart": 1183, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:HicC", "entityType": "Gene", "charEnd": 1084, "source": "PUBTATOR", "charStart": 1081, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:Vzvp", "entityType": "Gene", "charEnd": 2043, "source": "PUBTATOR", "charStart": 2040, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 14, "entityText": "EGFR"}, {"duid": "PU:QAU4", "entityType": "Species", "charEnd": 963, "source": "PUBTATOR", "charStart": 956, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "Patients"}, {"duid": "PU:ZjDV", "entityType": "Gene", "charEnd": 296, "source": "PUBTATOR", "charStart": 265, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:DhZE", "entityType": "Gene", "charEnd": 1748, "source": "PUBTATOR", "charStart": 1745, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "EGFR"}, {"duid": "PU:Hkh3", "entityType": "Species", "charEnd": 1237, "source": "PUBTATOR", "charStart": 1230, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:YbMG", "entityType": "Gene", "charEnd": 1371, "source": "PUBTATOR", "charStart": 1368, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "EGFR"}, {"duid": "PU:4JDp", "entityType": "Gene", "charEnd": 1632, "source": "PUBTATOR", "charStart": 1629, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}, {"duid": "PU:kNhD", "entityType": "Gene", "charEnd": 459, "source": "PUBTATOR", "charStart": 456, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:SHAT", "entityType": "Gene", "charEnd": 302, "source": "PUBTATOR", "charStart": 299, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:TsiD", "entityType": "Disease", "charEnd": 1045, "source": "PUBTATOR", "charStart": 1032, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 6, "entityText": "adenocarcinoma"}]}
{"text": "Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan. PURPOSE: The combination of a vascular endothelial growth factor (VEGF) -neutralizing antibody, bevacizumab, and irinotecan is associated with high radiographic response rates and improved survival outcomes in patients with recurrent malignant gliomas. The aim of these retrospective studies was to evaluate tumor vascularity and expression of components of the VEGF pathway and hypoxic responses as predictive markers for radiographic response and survival benefit from the bevacizumab and irinotecan therapy. PATIENTS AND METHODS: In a phase II trial, 60 patients with recurrent malignant astrocytomas were treated with bevacizumab and irinotecan. Tumor specimens collected at the time of diagnosis were available for further pathologic studies in 45 patients (75%). VEGF, VEGF receptor-2, CD31, hypoxia-inducible carbonic anhydrase 9 (CA9), and hypoxia-inducible factor-2alpha were semiquantitatively assessed by immunohistochemistry. Radiographic response and survival outcomes were correlated with these angiogenic and hypoxic markers. RESULTS: Of 45 patients, 27 patients had glioblastoma multiforme, and 18 patients had anaplastic astrocytoma. Twenty-six patients (58%) had at least partial radiographic response. High VEGF expression was associated with increased likelihood of radiographic response (P = .024) but not survival benefit. Survival analysis revealed that high CA9 expression was associated with poor survival outcome (P = .016). CONCLUSION: In this patient cohort, tumor expression levels of VEGF, the molecular target of bevacizumab, were associated with radiographic response, and the upstream promoter of angiogenesis, hypoxia, determined survival outcome, as measured from treatment initiation. Validation in a larger clinical trial is warranted.", "title": {"charStart": 0, "charEnd": 154}, "docId": "18182667", "entity": [{"duid": "PU:akbQ", "entityType": "Gene", "charEnd": 521, "source": "PUBTATOR", "charStart": 518, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "VEGF"}, {"duid": "PU:ho7U", "entityType": "Disease", "charEnd": 1010, "source": "PUBTATOR", "charStart": 1004, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 5, "entityText": "hypoxia"}, {"duid": "PU:xE9W", "entityType": "Disease", "charEnd": 104, "source": "PUBTATOR", "charStart": 84, "entityId": [{"idString": "D001254", "source": "MESH"}], "sentenceIndex": 0, "entityText": "malignant astrocytoma"}, {"duid": "PU:XXfv", "entityType": "Species", "charEnd": 1633, "source": "PUBTATOR", "charStart": 1627, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patient"}, {"duid": "PU:xzms", "entityType": "Disease", "charEnd": 1647, "source": "PUBTATOR", "charStart": 1643, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 11, "entityText": "tumor"}, {"duid": "PU:Yss8", "entityType": "Disease", "charEnd": 1260, "source": "PUBTATOR", "charStart": 1238, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 7, "entityText": "glioblastoma multiforme"}, {"duid": "PU:rZR6", "entityType": "Gene", "charEnd": 934, "source": "PUBTATOR", "charStart": 931, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "VEGF"}, {"duid": "PU:6ccD", "entityType": "Species", "charEnd": 113, "source": "PUBTATOR", "charStart": 106, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:Tyqo", "entityType": "Gene", "charEnd": 996, "source": "PUBTATOR", "charStart": 994, "entityId": [{"idString": "768", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "CA9"}, {"duid": "PU:Ybtn", "entityType": "Disease", "charEnd": 541, "source": "PUBTATOR", "charStart": 535, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 2, "entityText": "hypoxic"}, {"duid": "PU:y95p", "entityType": "Gene", "charEnd": 225, "source": "PUBTATOR", "charStart": 222, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "VEGF"}, {"duid": "PU:PWfS", "entityType": "Species", "charEnd": 373, "source": "PUBTATOR", "charStart": 366, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:noYM", "entityType": "Disease", "charEnd": 1806, "source": "PUBTATOR", "charStart": 1800, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 11, "entityText": "hypoxia"}, {"duid": "PU:VePw", "entityType": "Gene", "charEnd": 1385, "source": "PUBTATOR", "charStart": 1382, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "VEGF"}, {"duid": "PU:iWd9", "entityType": "Species", "charEnd": 1232, "source": "PUBTATOR", "charStart": 1225, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:meqA", "entityType": "Species", "charEnd": 1325, "source": "PUBTATOR", "charStart": 1318, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:V26J", "entityType": "Gene", "charEnd": 1034, "source": "PUBTATOR", "charStart": 1004, "entityId": [{"idString": "2034", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "hypoxia-inducible factor-2alpha"}, {"duid": "PU:Tdpe", "entityType": "Gene", "charEnd": 928, "source": "PUBTATOR", "charStart": 925, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "VEGF"}, {"duid": "PU:jsgN", "entityType": "Gene", "charEnd": 991, "source": "PUBTATOR", "charStart": 972, "entityId": [{"idString": "768", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "carbonic anhydrase 9"}, {"duid": "PU:ERmF", "entityType": "Disease", "charEnd": 758, "source": "PUBTATOR", "charStart": 737, "entityId": [{"idString": "D001254", "source": "MESH"}], "sentenceIndex": 3, "entityText": "malignant astrocytomas"}, {"duid": "PU:qUpn", "entityType": "Species", "charEnd": 720, "source": "PUBTATOR", "charStart": 713, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:swNr", "entityType": "Disease", "charEnd": 406, "source": "PUBTATOR", "charStart": 390, "entityId": [{"idString": "D005910", "source": "MESH"}], "sentenceIndex": 1, "entityText": "malignant gliomas"}, {"duid": "PU:KGkx", "entityType": "Gene", "charEnd": 219, "source": "PUBTATOR", "charStart": 186, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "vascular endothelial growth factor"}, {"duid": "PU:z7Ta", "entityType": "Disease", "charEnd": 1304, "source": "PUBTATOR", "charStart": 1294, "entityId": [{"idString": "D001254", "source": "MESH"}], "sentenceIndex": 7, "entityText": "astrocytoma"}, {"duid": "PU:7eGA", "entityType": "Gene", "charEnd": 1673, "source": "PUBTATOR", "charStart": 1670, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "VEGF"}, {"duid": "PU:xKAM", "entityType": "Species", "charEnd": 1277, "source": "PUBTATOR", "charStart": 1270, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:i68J", "entityType": "Species", "charEnd": 1219, "source": "PUBTATOR", "charStart": 1212, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:Pu3p", "entityType": "Gene", "charEnd": 951, "source": "PUBTATOR", "charStart": 948, "entityId": [{"idString": "5175", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "CD31"}, {"duid": "PU:3yt8", "entityType": "Species", "charEnd": 674, "source": "PUBTATOR", "charStart": 667, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "PATIENTS"}, {"duid": "PU:crA2", "entityType": "Disease", "charEnd": 468, "source": "PUBTATOR", "charStart": 464, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:nypp", "entityType": "Gene", "charEnd": 1540, "source": "PUBTATOR", "charStart": 1538, "entityId": [{"idString": "768", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "CA9"}, {"duid": "PU:btYg", "entityType": "Disease", "charEnd": 960, "source": "PUBTATOR", "charStart": 954, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 5, "entityText": "hypoxia"}, {"duid": "PU:S3cd", "entityType": "Species", "charEnd": 916, "source": "PUBTATOR", "charStart": 909, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}]}
{"text": "Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan. PURPOSE: The combination of a vascular endothelial growth factor (VEGF) -neutralizing antibody, bevacizumab, and irinotecan is associated with high radiographic response rates and improved survival outcomes in patients with recurrent malignant gliomas. The aim of these retrospective studies was to evaluate tumor vascularity and expression of components of the VEGF pathway and hypoxic responses as predictive markers for radiographic response and survival benefit from the bevacizumab and irinotecan therapy. PATIENTS AND METHODS: In a phase II trial, 60 patients with recurrent malignant astrocytomas were treated with bevacizumab and irinotecan. Tumor specimens collected at the time of diagnosis were available for further pathologic studies in 45 patients (75%). VEGF, VEGF receptor-2, CD31, hypoxia-inducible carbonic anhydrase 9 (CA9), and hypoxia-inducible factor-2alpha were semiquantitatively assessed by immunohistochemistry. Radiographic response and survival outcomes were correlated with these angiogenic and hypoxic markers. RESULTS: Of 45 patients, 27 patients had glioblastoma multiforme, and 18 patients had anaplastic astrocytoma. Twenty-six patients (58%) had at least partial radiographic response. High VEGF expression was associated with increased likelihood of radiographic response (P = .024) but not survival benefit. Survival analysis revealed that high CA9 expression was associated with poor survival outcome (P = .016). CONCLUSION: In this patient cohort, tumor expression levels of VEGF, the molecular target of bevacizumab, were associated with radiographic response, and the upstream promoter of angiogenesis, hypoxia, determined survival outcome, as measured from treatment initiation. Validation in a larger clinical trial is warranted.", "title": {"charStart": 0, "charEnd": 154}, "docId": "18182667", "entity": [{"duid": "PU:akbQ", "entityType": "Gene", "charEnd": 521, "source": "PUBTATOR", "charStart": 518, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "VEGF"}, {"duid": "PU:ho7U", "entityType": "Disease", "charEnd": 1010, "source": "PUBTATOR", "charStart": 1004, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 5, "entityText": "hypoxia"}, {"duid": "PU:xE9W", "entityType": "Disease", "charEnd": 104, "source": "PUBTATOR", "charStart": 84, "entityId": [{"idString": "D001254", "source": "MESH"}], "sentenceIndex": 0, "entityText": "malignant astrocytoma"}, {"duid": "PU:XXfv", "entityType": "Species", "charEnd": 1633, "source": "PUBTATOR", "charStart": 1627, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patient"}, {"duid": "PU:xzms", "entityType": "Disease", "charEnd": 1647, "source": "PUBTATOR", "charStart": 1643, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 11, "entityText": "tumor"}, {"duid": "PU:Yss8", "entityType": "Disease", "charEnd": 1260, "source": "PUBTATOR", "charStart": 1238, "entityId": [{"idString": "D005909", "source": "MESH"}], "sentenceIndex": 7, "entityText": "glioblastoma multiforme"}, {"duid": "PU:rZR6", "entityType": "Gene", "charEnd": 934, "source": "PUBTATOR", "charStart": 931, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "VEGF"}, {"duid": "PU:6ccD", "entityType": "Species", "charEnd": 113, "source": "PUBTATOR", "charStart": 106, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:Tyqo", "entityType": "Gene", "charEnd": 996, "source": "PUBTATOR", "charStart": 994, "entityId": [{"idString": "768", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "CA9"}, {"duid": "PU:Ybtn", "entityType": "Disease", "charEnd": 541, "source": "PUBTATOR", "charStart": 535, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 2, "entityText": "hypoxic"}, {"duid": "PU:y95p", "entityType": "Gene", "charEnd": 225, "source": "PUBTATOR", "charStart": 222, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "VEGF"}, {"duid": "PU:PWfS", "entityType": "Species", "charEnd": 373, "source": "PUBTATOR", "charStart": 366, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:noYM", "entityType": "Disease", "charEnd": 1806, "source": "PUBTATOR", "charStart": 1800, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 11, "entityText": "hypoxia"}, {"duid": "PU:VePw", "entityType": "Gene", "charEnd": 1385, "source": "PUBTATOR", "charStart": 1382, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "VEGF"}, {"duid": "PU:iWd9", "entityType": "Species", "charEnd": 1232, "source": "PUBTATOR", "charStart": 1225, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:meqA", "entityType": "Species", "charEnd": 1325, "source": "PUBTATOR", "charStart": 1318, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:V26J", "entityType": "Gene", "charEnd": 1034, "source": "PUBTATOR", "charStart": 1004, "entityId": [{"idString": "2034", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "hypoxia-inducible factor-2alpha"}, {"duid": "PU:Tdpe", "entityType": "Gene", "charEnd": 928, "source": "PUBTATOR", "charStart": 925, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "VEGF"}, {"duid": "PU:jsgN", "entityType": "Gene", "charEnd": 991, "source": "PUBTATOR", "charStart": 972, "entityId": [{"idString": "768", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "carbonic anhydrase 9"}, {"duid": "PU:ERmF", "entityType": "Disease", "charEnd": 758, "source": "PUBTATOR", "charStart": 737, "entityId": [{"idString": "D001254", "source": "MESH"}], "sentenceIndex": 3, "entityText": "malignant astrocytomas"}, {"duid": "PU:qUpn", "entityType": "Species", "charEnd": 720, "source": "PUBTATOR", "charStart": 713, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:swNr", "entityType": "Disease", "charEnd": 406, "source": "PUBTATOR", "charStart": 390, "entityId": [{"idString": "D005910", "source": "MESH"}], "sentenceIndex": 1, "entityText": "malignant gliomas"}, {"duid": "PU:KGkx", "entityType": "Gene", "charEnd": 219, "source": "PUBTATOR", "charStart": 186, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "vascular endothelial growth factor"}, {"duid": "PU:z7Ta", "entityType": "Disease", "charEnd": 1304, "source": "PUBTATOR", "charStart": 1294, "entityId": [{"idString": "D001254", "source": "MESH"}], "sentenceIndex": 7, "entityText": "astrocytoma"}, {"duid": "PU:7eGA", "entityType": "Gene", "charEnd": 1673, "source": "PUBTATOR", "charStart": 1670, "entityId": [{"idString": "7422", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "VEGF"}, {"duid": "PU:xKAM", "entityType": "Species", "charEnd": 1277, "source": "PUBTATOR", "charStart": 1270, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:i68J", "entityType": "Species", "charEnd": 1219, "source": "PUBTATOR", "charStart": 1212, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:Pu3p", "entityType": "Gene", "charEnd": 951, "source": "PUBTATOR", "charStart": 948, "entityId": [{"idString": "5175", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "CD31"}, {"duid": "PU:3yt8", "entityType": "Species", "charEnd": 674, "source": "PUBTATOR", "charStart": 667, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "PATIENTS"}, {"duid": "PU:crA2", "entityType": "Disease", "charEnd": 468, "source": "PUBTATOR", "charStart": 464, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:nypp", "entityType": "Gene", "charEnd": 1540, "source": "PUBTATOR", "charStart": 1538, "entityId": [{"idString": "768", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "CA9"}, {"duid": "PU:btYg", "entityType": "Disease", "charEnd": 960, "source": "PUBTATOR", "charStart": 954, "entityId": [{"idString": "D000860", "source": "MESH"}], "sentenceIndex": 5, "entityText": "hypoxia"}, {"duid": "PU:S3cd", "entityType": "Species", "charEnd": 916, "source": "PUBTATOR", "charStart": 909, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}]}
{"text": "Resistance to vemurafenib resulting from a novel mutation in the BRAFV600E kinase domain. Resistance to the BRAF inhibitor vemurafenib poses a significant problem for the treatment of BRAFV600E-positive melanomas. It is therefore critical to prospectively identify all vemurafenib resistance mechanisms prior to their emergence in the clinic. The vemurafenib resistance mechanisms described to date do not result from secondary mutations within BRAFV600E. To search for possible mutations within BRAFV600E that can confer drug resistance, we developed a systematic experimental approach involving targeted saturation mutagenesis, selection of drug-resistant variants, and deep sequencing. We identified a single nucleotide substitution (T1514A, encoding L505H) that greatly increased drug resistance in cultured cells and mouse xenografts. The kinase activity of BRAFV600E/L505H was higher than that of BRAFV600E, resulting in cross-resistance to a MEK inhibitor. However, BRAFV600E/L505H was less resistant to several other BRAF inhibitors whose binding sites were further from L505 than that of PLX4720. Our results identify a novel vemurafenib-resistant mutant and provide insights into the treatment for melanomas bearing this mutation.", "title": {"charStart": 0, "charEnd": 88}, "docId": "24112705", "entity": [{"duid": "PU:JcKZ", "entityType": "Chemical", "charEnd": 357, "source": "PUBTATOR", "charStart": 347, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 3, "entityText": "vemurafenib"}, {"duid": "PU:3joH", "entityType": "Chemical", "charEnd": 1145, "source": "PUBTATOR", "charStart": 1135, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 8, "entityText": "vemurafenib"}, {"duid": "PU:wSVd", "entityType": "Disease", "charEnd": 211, "source": "PUBTATOR", "charStart": 203, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 1, "entityText": "melanomas"}, {"duid": "PU:Bce3", "entityType": "Disease", "charEnd": 1216, "source": "PUBTATOR", "charStart": 1208, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 8, "entityText": "melanomas"}, {"duid": "PU:YUXi", "entityType": "ProteinMutation", "charEnd": 987, "source": "PUBTATOR", "charStart": 983, "entityId": [{"idString": "p|SUB|L|505|H", "source": "Unk"}], "sentenceIndex": 7, "entityText": "L505H"}, {"duid": "PU:FkPB", "entityType": "ProteinMutation", "charEnd": 758, "source": "PUBTATOR", "charStart": 754, "entityId": [{"idString": "p|SUB|L|505|H", "source": "Unk"}], "sentenceIndex": 5, "entityText": "L505H"}, {"duid": "PU:y6LK", "entityType": "Chemical", "charEnd": 133, "source": "PUBTATOR", "charStart": 123, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 1, "entityText": "vemurafenib"}, {"duid": "PU:Raif", "entityType": "Chemical", "charEnd": 721, "source": "PUBTATOR", "charStart": 712, "entityId": [{"idString": "D009711", "source": "CTD"}], "sentenceIndex": 5, "entityText": "nucleotide"}, {"duid": "PU:RWGS", "entityType": "Chemical", "charEnd": 24, "source": "PUBTATOR", "charStart": 14, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 0, "entityText": "vemurafenib"}, {"duid": "PU:9MAF", "entityType": "Gene", "charEnd": 111, "source": "PUBTATOR", "charStart": 108, "entityId": [{"idString": "109880", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 1, "entityText": "BRAF"}, {"duid": "PU:DBaf", "entityType": "Chemical", "charEnd": 1103, "source": "PUBTATOR", "charStart": 1097, "entityId": [{"idString": "C528407", "source": "MESH"}], "sentenceIndex": 7, "entityText": "PLX4720"}, {"duid": "PU:B8t5", "entityType": "Species", "charEnd": 826, "source": "PUBTATOR", "charStart": 822, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "mouse"}, {"duid": "PU:uj3q", "entityType": "ProteinMutation", "charEnd": 877, "source": "PUBTATOR", "charStart": 873, "entityId": [{"idString": "p|SUB|L|505|H", "source": "Unk"}], "sentenceIndex": 6, "entityText": "L505H"}, {"duid": "PU:7Kz2", "entityType": "Gene", "charEnd": 1028, "source": "PUBTATOR", "charStart": 1025, "entityId": [{"idString": "109880", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 7, "entityText": "BRAF"}, {"duid": "PU:txMh", "entityType": "DNAMutation", "charEnd": 742, "source": "PUBTATOR", "charStart": 737, "entityId": [{"idString": "c|SUB|T|1514|A", "source": "Unk"}], "sentenceIndex": 5, "entityText": "T1514A"}, {"duid": "PU:4rVu", "entityType": "Chemical", "charEnd": 279, "source": "PUBTATOR", "charStart": 269, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 2, "entityText": "vemurafenib"}]}
{"text": "Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). PURPOSE: To determine the clinical efficacy of imatinib in patients with advanced aggressive fibromatosis (AF) and to identify the molecular basis of response/nonresponse to this agent. PATIENTS AND METHODS: Nineteen patients with AF were treated with imatinib (800 mg/d) as part of a phase II clinical study. Tumor specimens were analyzed for mutations of KIT, PDGFRA, PDGFRB, and CTNNB1 (beta-catenin). Tumor expression of total and activated KIT, PDGFRA, and PDGFRB were assessed using immunohistochemistry and immunoblotting techniques. We also measured plasma levels of PDGF-AA and PDGF-BB in patients and normal patient controls. RESULTS: Three of 19 patients (15.7%) had a partial response to treatment, with four additional patients having stable disease that lasted more than 1 year (overall 1 year tumor control rate of 36.8%). No mutations of KIT, PDGFRA, or PDGFRB were found. Sixteen of 19 patients (84%) had mutations involving the WNT pathway (APC or CTNNB1). However, there was no correlation between WNT pathway mutations and clinical response to imatinib. AF tumors expressed minimal to null levels of KIT and PDGFRA but expressed levels of PDGFRB that are comparable with normal fibroblasts. However, PDGFRB phosphorylation was not detected, suggesting that PDGFRB is only weakly activated. AF patients had elevated levels of PDGF-AA and PDGF-BB compared with normal patient controls. Notably, the plasma level of PDGF-BB was inversely correlated with time to treatment failure. CONCLUSION: Imatinib is an active agent in the treatment of advanced AF. Imatinib response in AF patients may be mediated by inhibition of PDGFRB kinase activity.", "title": {"charStart": 0, "charEnd": 108}, "docId": "16505440", "entity": [{"duid": "PU:bqWj", "entityType": "Species", "charEnd": 774, "source": "PUBTATOR", "charStart": 767, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:7HoY", "entityType": "Disease", "charEnd": 1678, "source": "PUBTATOR", "charStart": 1677, "entityId": [{"idString": "D001281", "source": "MESH"}], "sentenceIndex": 14, "entityText": "AF"}, {"duid": "PU:NxLd", "entityType": "Disease", "charEnd": 342, "source": "PUBTATOR", "charStart": 341, "entityId": [{"idString": "D001281", "source": "MESH"}], "sentenceIndex": 2, "entityText": "AF"}, {"duid": "PU:2Qmo", "entityType": "Species", "charEnd": 1502, "source": "PUBTATOR", "charStart": 1496, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 12, "entityText": "patient"}, {"duid": "PU:KWK3", "entityType": "Species", "charEnd": 849, "source": "PUBTATOR", "charStart": 842, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:ANP4", "entityType": "Chemical", "charEnd": 1627, "source": "PUBTATOR", "charStart": 1620, "entityId": [{"idString": "C097613", "source": "MESH"}], "sentenceIndex": 14, "entityText": "Imatinib"}, {"duid": "PU:C98J", "entityType": "Chemical", "charEnd": 1461, "source": "PUBTATOR", "charStart": 1460, "entityId": [{"idString": "C493772", "source": "MESH"}], "sentenceIndex": 12, "entityText": "AA"}, {"duid": "PU:ZE7M", "entityType": "Species", "charEnd": 176, "source": "PUBTATOR", "charStart": 169, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:C9PL", "entityType": "Gene", "charEnd": 1335, "source": "PUBTATOR", "charStart": 1330, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "PDGFRB"}, {"duid": "PU:Z3Yw", "entityType": "Disease", "charEnd": 91, "source": "PUBTATOR", "charStart": 69, "entityId": [{"idString": "D001523", "source": "MESH"}], "sentenceIndex": 0, "entityText": "aggressive fibromatosis"}, {"duid": "PU:QWMP", "entityType": "Disease", "charEnd": 1703, "source": "PUBTATOR", "charStart": 1702, "entityId": [{"idString": "D001281", "source": "MESH"}], "sentenceIndex": 15, "entityText": "AF"}, {"duid": "PU:9AtD", "entityType": "Gene", "charEnd": 565, "source": "PUBTATOR", "charStart": 560, "entityId": [{"idString": "5156", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "PDGFRA"}, {"duid": "PU:fgus", "entityType": "Species", "charEnd": 1712, "source": "PUBTATOR", "charStart": 1705, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 15, "entityText": "patients"}, {"duid": "PU:qYMW", "entityType": "Chemical", "charEnd": 369, "source": "PUBTATOR", "charStart": 362, "entityId": [{"idString": "C097613", "source": "MESH"}], "sentenceIndex": 2, "entityText": "imatinib"}, {"duid": "PU:riut", "entityType": "Gene", "charEnd": 511, "source": "PUBTATOR", "charStart": 500, "entityId": [{"idString": "1499", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "beta-catenin"}, {"duid": "PU:5dyr", "entityType": "Disease", "charEnd": 1421, "source": "PUBTATOR", "charStart": 1420, "entityId": [{"idString": "D001281", "source": "MESH"}], "sentenceIndex": 12, "entityText": "AF"}, {"duid": "PU:KoX3", "entityType": "Gene", "charEnd": 1243, "source": "PUBTATOR", "charStart": 1238, "entityId": [{"idString": "5156", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "PDGFRA"}, {"duid": "PU:5Dmn", "entityType": "Disease", "charEnd": 1192, "source": "PUBTATOR", "charStart": 1184, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "AF tumors"}, {"duid": "PU:r82j", "entityType": "Gene", "charEnd": 1274, "source": "PUBTATOR", "charStart": 1269, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "PDGFRB"}, {"duid": "PU:ABgn", "entityType": "Gene", "charEnd": 477, "source": "PUBTATOR", "charStart": 472, "entityId": [{"idString": "5156", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "PDGFRA"}, {"duid": "PU:XoaL", "entityType": "Disease", "charEnd": 1071, "source": "PUBTATOR", "charStart": 1069, "entityId": [{"idString": "D011125", "source": "MESH"}], "sentenceIndex": 8, "entityText": "APC"}, {"duid": "PU:sFBg", "entityType": "Disease", "charEnd": 922, "source": "PUBTATOR", "charStart": 918, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumor"}, {"duid": "PU:bZ45", "entityType": "Chemical", "charEnd": 1549, "source": "PUBTATOR", "charStart": 1543, "entityId": [{"idString": "C072194", "source": "MESH"}], "sentenceIndex": 13, "entityText": "PDGF-BB"}, {"duid": "PU:JtCM", "entityType": "Species", "charEnd": 334, "source": "PUBTATOR", "charStart": 327, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:Q5yD", "entityType": "Gene", "charEnd": 1081, "source": "PUBTATOR", "charStart": 1076, "entityId": [{"idString": "1499", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "CTNNB1"}, {"duid": "PU:QQty", "entityType": "Gene", "charEnd": 485, "source": "PUBTATOR", "charStart": 480, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "PDGFRB"}, {"duid": "PU:Q28a", "entityType": "Disease", "charEnd": 106, "source": "PUBTATOR", "charStart": 94, "entityId": [{"idString": "C535944", "source": "MESH"}], "sentenceIndex": 0, "entityText": "desmoid tumor"}, {"duid": "PU:RgTb", "entityType": "Gene", "charEnd": 974, "source": "PUBTATOR", "charStart": 969, "entityId": [{"idString": "5156", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "PDGFRA"}, {"duid": "PU:eNqM", "entityType": "Species", "charEnd": 1020, "source": "PUBTATOR", "charStart": 1013, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:wPyk", "entityType": "Disease", "charEnd": 214, "source": "PUBTATOR", "charStart": 192, "entityId": [{"idString": "D001523", "source": "MESH"}], "sentenceIndex": 1, "entityText": "aggressive fibromatosis"}, {"duid": "PU:zCDh", "entityType": "Chemical", "charEnd": 55, "source": "PUBTATOR", "charStart": 48, "entityId": [{"idString": "C097613", "source": "MESH"}], "sentenceIndex": 0, "entityText": "imatinib"}, {"duid": "PU:dmdk", "entityType": "Species", "charEnd": 734, "source": "PUBTATOR", "charStart": 728, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patient"}, {"duid": "PU:BM3p", "entityType": "Species", "charEnd": 303, "source": "PUBTATOR", "charStart": 296, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "PATIENTS"}, {"duid": "PU:h34T", "entityType": "Disease", "charEnd": 218, "source": "PUBTATOR", "charStart": 217, "entityId": [{"idString": "D001281", "source": "MESH"}], "sentenceIndex": 1, "entityText": "AF"}, {"duid": "PU:jZXH", "entityType": "Gene", "charEnd": 1392, "source": "PUBTATOR", "charStart": 1387, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "PDGFRB"}, {"duid": "PU:BPtc", "entityType": "Gene", "charEnd": 1752, "source": "PUBTATOR", "charStart": 1747, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 15, "entityText": "PDGFRB"}, {"duid": "PU:pLbu", "entityType": "Gene", "charEnd": 497, "source": "PUBTATOR", "charStart": 492, "entityId": [{"idString": "1499", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "CTNNB1"}, {"duid": "PU:9PWG", "entityType": "Chemical", "charEnd": 691, "source": "PUBTATOR", "charStart": 690, "entityId": [{"idString": "C493772", "source": "MESH"}], "sentenceIndex": 5, "entityText": "AA"}, {"duid": "PU:bvea", "entityType": "Species", "charEnd": 1430, "source": "PUBTATOR", "charStart": 1423, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 12, "entityText": "patients"}, {"duid": "PU:cijh", "entityType": "Gene", "charEnd": 985, "source": "PUBTATOR", "charStart": 980, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "PDGFRB"}, {"duid": "PU:kUkN", "entityType": "Gene", "charEnd": 577, "source": "PUBTATOR", "charStart": 572, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "PDGFRB"}, {"duid": "PU:75TD", "entityType": "Species", "charEnd": 715, "source": "PUBTATOR", "charStart": 708, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}]}
{"text": "Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors. Inhibition of PARP is a promising therapeutic strategy for homologous recombination-deficient tumors, such as BRCA1-associated cancers. We previously reported that BRCA1-deficient mouse mammary tumors may acquire resistance to the clinical PARP inhibitor (PARPi) olaparib through activation of the P-glycoprotein drug efflux transporter. Here, we show that tumor-specific genetic inactivation of P-glycoprotein increases the long-term response of BRCA1-deficient mouse mammary tumors to olaparib, but these tumors eventually developed PARPi resistance. In a fraction of cases, this resistance is caused by partial restoration of homologous recombination due to somatic loss of 53BP1. Importantly, PARPi resistance was minimized by long-term treatment with the novel PARP inhibitor AZD2461, which is a poor P-glycoprotein substrate. Together, our data suggest that restoration of homologous recombination is an important mechanism for PARPi resistance in BRCA1-deficient mammary tumors and that the risk of relapse of BRCA1-deficient tumors can be effectively minimized by using optimized PARP inhibitors. SIGNIFICANCE: In this study, we show that loss of 53BP1 causes resistance to PARP inhibition in mouse mammary tumors that are deficient in BRCA1. We hypothesize that low expression or absence of 53BP1 also reduces the response of patients with BRCA1-deficient tumors to PARP inhibitors.", "title": {"charStart": 0, "charEnd": 84}, "docId": "23103855", "entity": [{"duid": "PU:Rokz", "entityType": "Disease", "charEnd": 1306, "source": "PUBTATOR", "charStart": 1293, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "mammary tumors"}, {"duid": "PU:YNpN", "entityType": "Gene", "charEnd": 1390, "source": "PUBTATOR", "charStart": 1386, "entityId": [{"idString": "7158", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "53BP1"}, {"duid": "PU:rxu7", "entityType": "Gene", "charEnd": 54, "source": "PUBTATOR", "charStart": 50, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 0, "entityText": "Brca1"}, {"duid": "PU:uyZf", "entityType": "Species", "charEnd": 270, "source": "PUBTATOR", "charStart": 266, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "mouse"}, {"duid": "PU:S4TF", "entityType": "Disease", "charEnd": 568, "source": "PUBTATOR", "charStart": 555, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "mammary tumors"}, {"duid": "PU:vGBK", "entityType": "Gene", "charEnd": 1464, "source": "PUBTATOR", "charStart": 1461, "entityId": [{"idString": "142", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "PARP"}, {"duid": "PU:sKdi", "entityType": "Disease", "charEnd": 1124, "source": "PUBTATOR", "charStart": 1103, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "BRCA1-deficient tumors"}, {"duid": "PU:rGun", "entityType": "Gene", "charEnd": 24, "source": "PUBTATOR", "charStart": 21, "entityId": [{"idString": "11545", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 0, "entityText": "PARP"}, {"duid": "PU:Y4MC", "entityType": "Disease", "charEnd": 219, "source": "PUBTATOR", "charStart": 196, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "BRCA1-associated cancers"}, {"duid": "PU:QqEA", "entityType": "Species", "charEnd": 1291, "source": "PUBTATOR", "charStart": 1287, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "mouse"}, {"duid": "PU:YaoS", "entityType": "Species", "charEnd": 1428, "source": "PUBTATOR", "charStart": 1421, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:2jNc", "entityType": "Disease", "charEnd": 1456, "source": "PUBTATOR", "charStart": 1435, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "BRCA1-deficient tumors"}, {"duid": "PU:hCUp", "entityType": "Disease", "charEnd": 264, "source": "PUBTATOR", "charStart": 250, "entityId": [{"idString": "D003677", "source": "MESH"}], "sentenceIndex": 2, "entityText": "BRCA1-deficient"}, {"duid": "PU:8ACY", "entityType": "Gene", "charEnd": 1044, "source": "PUBTATOR", "charStart": 1040, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 6, "entityText": "BRCA1"}, {"duid": "PU:CfGp", "entityType": "Gene", "charEnd": 1177, "source": "PUBTATOR", "charStart": 1174, "entityId": [{"idString": "11545", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 6, "entityText": "PARP"}, {"duid": "PU:UbiV", "entityType": "Disease", "charEnd": 447, "source": "PUBTATOR", "charStart": 443, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumor"}, {"duid": "PU:zeVX", "entityType": "Disease", "charEnd": 83, "source": "PUBTATOR", "charStart": 70, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 0, "entityText": "mammary tumors"}, {"duid": "PU:JWbE", "entityType": "Gene", "charEnd": 855, "source": "PUBTATOR", "charStart": 852, "entityId": [{"idString": "11545", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "PARP"}, {"duid": "PU:PydB", "entityType": "Disease", "charEnd": 547, "source": "PUBTATOR", "charStart": 533, "entityId": [{"idString": "D003677", "source": "MESH"}], "sentenceIndex": 3, "entityText": "BRCA1-deficient"}, {"duid": "PU:LMeb", "entityType": "Disease", "charEnd": 598, "source": "PUBTATOR", "charStart": 593, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:x8wf", "entityType": "Gene", "charEnd": 200, "source": "PUBTATOR", "charStart": 196, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 1, "entityText": "BRCA1"}, {"duid": "PU:rAKY", "entityType": "Gene", "charEnd": 767, "source": "PUBTATOR", "charStart": 763, "entityId": [{"idString": "27223", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 4, "entityText": "53BP1"}, {"duid": "PU:h2Hy", "entityType": "Gene", "charEnd": 254, "source": "PUBTATOR", "charStart": 250, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 2, "entityText": "BRCA1"}, {"duid": "PU:Q3dV", "entityType": "Gene", "charEnd": 537, "source": "PUBTATOR", "charStart": 533, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 3, "entityText": "BRCA1"}, {"duid": "PU:ZFcz", "entityType": "Gene", "charEnd": 1334, "source": "PUBTATOR", "charStart": 1330, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 7, "entityText": "BRCA1"}, {"duid": "PU:bZs5", "entityType": "Disease", "charEnd": 1069, "source": "PUBTATOR", "charStart": 1040, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "BRCA1-deficient mammary tumors"}, {"duid": "PU:apJo", "entityType": "Gene", "charEnd": 1271, "source": "PUBTATOR", "charStart": 1268, "entityId": [{"idString": "11545", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 7, "entityText": "PARP"}, {"duid": "PU:dyv9", "entityType": "Gene", "charEnd": 1107, "source": "PUBTATOR", "charStart": 1103, "entityId": [{"idString": "12189", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 6, "entityText": "BRCA1"}, {"duid": "PU:nymG", "entityType": "Gene", "charEnd": 329, "source": "PUBTATOR", "charStart": 326, "entityId": [{"idString": "11545", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 2, "entityText": "PARP"}, {"duid": "PU:KuGh", "entityType": "Gene", "charEnd": 12, "source": "PUBTATOR", "charStart": 8, "entityId": [{"idString": "27223", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 0, "entityText": "53BP1"}, {"duid": "PU:mLzZ", "entityType": "Gene", "charEnd": 103, "source": "PUBTATOR", "charStart": 100, "entityId": [{"idString": "11545", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 1, "entityText": "PARP"}, {"duid": "PU:f9Wa", "entityType": "Disease", "charEnd": 185, "source": "PUBTATOR", "charStart": 180, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumors"}, {"duid": "PU:98mV", "entityType": "Disease", "charEnd": 285, "source": "PUBTATOR", "charStart": 272, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "mammary tumors"}, {"duid": "PU:SCJ5", "entityType": "Species", "charEnd": 553, "source": "PUBTATOR", "charStart": 549, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "mouse"}, {"duid": "PU:yEZr", "entityType": "Gene", "charEnd": 1439, "source": "PUBTATOR", "charStart": 1435, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "BRCA1"}, {"duid": "PU:ZUfk", "entityType": "Species", "charEnd": 68, "source": "PUBTATOR", "charStart": 64, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "mouse"}, {"duid": "PU:MhJo", "entityType": "Gene", "charEnd": 1245, "source": "PUBTATOR", "charStart": 1241, "entityId": [{"idString": "27223", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 7, "entityText": "53BP1"}, {"duid": "PU:ZJec", "entityType": "Chemical", "charEnd": 873, "source": "PUBTATOR", "charStart": 867, "entityId": [], "sentenceIndex": 5, "entityText": "AZD2461"}]}
{"text": "Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation. PURPOSE: Mutations in epidermal growth factor receptor (EGFR) are strongly predictive of gefitinib efficacy in non-small-cell lung cancer. However, the presence of EGFR mutant nonresponses and nonmutant responses points out the need for more comprehensive analysis. PATIENTS AND METHODS: For 69 non-small-cell lung cancer patients treated with gefitinib, we have extended our analysis to EGFR gene copy number by fluorescence in situ hybridization, mutations in K-ras, HER2, and exon 20 of EGFR by direct sequencing, and phosphatase and tensin homologue expression by immunohistochemistry, in addition to EGFR exons 18, 19, and 21, and phosphorylations of Akt and extracellular signal-regulated kinase reported previously. RESULTS: EGFR mutation and high gene copy number were associated with better objective response in univariate analysis. However, only gefitinib-sensitive EGFR mutation was independently predictive of both response (P = 0.011) and survival (P = 0.002) in multivariate analysis. No patients with K-ras mutation, including two EGFR mutants, showed response. In EGFR nonmutants, patients with either K-ras mutation or p-Akt overexpression exhibited poor response and time-to-progression whereas patients with high gene copy number tended to have better outcomes in univariate analysis. In multivariate analysis of time-to-progression in EGFR nonmutants, K-ras mutation or p-Akt overexpression was associated with shorter time-to-progression (P = 0.017). No patient with HER2 mutation showed response to gefitinib. Reduced phosphatase and tensin homologue expression was not associated with gefitinib sensitivity. CONCLUSION: Gefitinib-sensitive EGFR mutation is the single most important predictor of gefitinib sensitivity. In addition to EGFR mutation, K-ras mutation and Akt phosphorylation aid in better prediction of gefitinib responsiveness in non-small-cell lung cancer.", "title": {"charStart": 0, "charEnd": 184}, "docId": "16638863", "entity": [{"duid": "PU:suqA", "entityType": "Gene", "charEnd": 353, "source": "PUBTATOR", "charStart": 350, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:P8mQ", "entityType": "Species", "charEnd": 515, "source": "PUBTATOR", "charStart": 508, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:n6MC", "entityType": "Gene", "charEnd": 1853, "source": "PUBTATOR", "charStart": 1850, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}, {"duid": "PU:7jk3", "entityType": "Species", "charEnd": 459, "source": "PUBTATOR", "charStart": 452, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "PATIENTS"}, {"duid": "PU:8UMd", "entityType": "Chemical", "charEnd": 283, "source": "PUBTATOR", "charStart": 275, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gefitinib"}, {"duid": "PU:pkKJ", "entityType": "Gene", "charEnd": 1270, "source": "PUBTATOR", "charStart": 1267, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:LQjV", "entityType": "Chemical", "charEnd": 1838, "source": "PUBTATOR", "charStart": 1830, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "Gefitinib"}, {"duid": "PU:ELAz", "entityType": "Gene", "charEnd": 1207, "source": "PUBTATOR", "charStart": 1203, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "K-ras"}, {"duid": "PU:xR6c", "entityType": "Gene", "charEnd": 1545, "source": "PUBTATOR", "charStart": 1542, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:VMJn", "entityType": "Gene", "charEnd": 149, "source": "PUBTATOR", "charStart": 145, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "K-ras"}, {"duid": "PU:XkW7", "entityType": "Gene", "charEnd": 844, "source": "PUBTATOR", "charStart": 842, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "Akt"}, {"duid": "PU:9kqP", "entityType": "Gene", "charEnd": 794, "source": "PUBTATOR", "charStart": 791, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:GJRD", "entityType": "Gene", "charEnd": 1980, "source": "PUBTATOR", "charStart": 1978, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "Akt"}, {"duid": "PU:Ej2d", "entityType": "Disease", "charEnd": 506, "source": "PUBTATOR", "charStart": 481, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:tY9V", "entityType": "Chemical", "charEnd": 2034, "source": "PUBTATOR", "charStart": 2026, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 12, "entityText": "gefitinib"}, {"duid": "PU:Tvx6", "entityType": "Chemical", "charEnd": 1051, "source": "PUBTATOR", "charStart": 1043, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:P5LL", "entityType": "Gene", "charEnd": 239, "source": "PUBTATOR", "charStart": 208, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:eZHs", "entityType": "Gene", "charEnd": 133, "source": "PUBTATOR", "charStart": 102, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:Pfrt", "entityType": "Gene", "charEnd": 1947, "source": "PUBTATOR", "charStart": 1944, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "EGFR"}, {"duid": "PU:sUqS", "entityType": "Gene", "charEnd": 1309, "source": "PUBTATOR", "charStart": 1305, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "K-ras"}, {"duid": "PU:T9JS", "entityType": "Gene", "charEnd": 1563, "source": "PUBTATOR", "charStart": 1559, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "K-ras"}, {"duid": "PU:7VDu", "entityType": "Species", "charEnd": 1291, "source": "PUBTATOR", "charStart": 1284, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:VXPs", "entityType": "Gene", "charEnd": 921, "source": "PUBTATOR", "charStart": 918, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:a3Jh", "entityType": "Chemical", "charEnd": 538, "source": "PUBTATOR", "charStart": 530, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gefitinib"}, {"duid": "PU:4fVC", "entityType": "Gene", "charEnd": 1678, "source": "PUBTATOR", "charStart": 1675, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2"}, {"duid": "PU:RwQJ", "entityType": "Species", "charEnd": 22, "source": "PUBTATOR", "charStart": 16, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patient"}, {"duid": "PU:5YaK", "entityType": "Gene", "charEnd": 652, "source": "PUBTATOR", "charStart": 648, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "K-ras"}, {"duid": "PU:K6Wk", "entityType": "Disease", "charEnd": 76, "source": "PUBTATOR", "charStart": 51, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:9W73", "entityType": "Chemical", "charEnd": 1803, "source": "PUBTATOR", "charStart": 1795, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 10, "entityText": "gefitinib"}, {"duid": "PU:TFty", "entityType": "Gene", "charEnd": 577, "source": "PUBTATOR", "charStart": 574, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:8Pox", "entityType": "Gene", "charEnd": 1066, "source": "PUBTATOR", "charStart": 1063, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}, {"duid": "PU:RrcS", "entityType": "Gene", "charEnd": 167, "source": "PUBTATOR", "charStart": 165, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Akt"}, {"duid": "PU:7cqW", "entityType": "Gene", "charEnd": 245, "source": "PUBTATOR", "charStart": 242, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:wQi3", "entityType": "Species", "charEnd": 1407, "source": "PUBTATOR", "charStart": 1400, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:itdJ", "entityType": "Gene", "charEnd": 1963, "source": "PUBTATOR", "charStart": 1959, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "K-ras"}, {"duid": "PU:Sfot", "entityType": "Species", "charEnd": 1196, "source": "PUBTATOR", "charStart": 1189, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:jjv5", "entityType": "Chemical", "charEnd": 1914, "source": "PUBTATOR", "charStart": 1906, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gefitinib"}, {"duid": "PU:3CHZ", "entityType": "Gene", "charEnd": 658, "source": "PUBTATOR", "charStart": 655, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "HER2"}, {"duid": "PU:X3bp", "entityType": "Species", "charEnd": 1668, "source": "PUBTATOR", "charStart": 1662, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patient"}, {"duid": "PU:AGbU", "entityType": "Gene", "charEnd": 1236, "source": "PUBTATOR", "charStart": 1233, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:hB4V", "entityType": "Disease", "charEnd": 322, "source": "PUBTATOR", "charStart": 297, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:NLPS", "entityType": "Gene", "charEnd": 1581, "source": "PUBTATOR", "charStart": 1579, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "Akt"}, {"duid": "PU:FSD7", "entityType": "Chemical", "charEnd": 46, "source": "PUBTATOR", "charStart": 38, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gefitinib"}, {"duid": "PU:SvwR", "entityType": "Gene", "charEnd": 679, "source": "PUBTATOR", "charStart": 676, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:sFzo", "entityType": "Disease", "charEnd": 2079, "source": "PUBTATOR", "charStart": 2054, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 12, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:Nrbv", "entityType": "Chemical", "charEnd": 1716, "source": "PUBTATOR", "charStart": 1708, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 9, "entityText": "gefitinib"}, {"duid": "PU:KxCu", "entityType": "Gene", "charEnd": 1327, "source": "PUBTATOR", "charStart": 1325, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "Akt"}]}
{"text": "Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation. PURPOSE: Mutations in epidermal growth factor receptor (EGFR) are strongly predictive of gefitinib efficacy in non-small-cell lung cancer. However, the presence of EGFR mutant nonresponses and nonmutant responses points out the need for more comprehensive analysis. PATIENTS AND METHODS: For 69 non-small-cell lung cancer patients treated with gefitinib, we have extended our analysis to EGFR gene copy number by fluorescence in situ hybridization, mutations in K-ras, HER2, and exon 20 of EGFR by direct sequencing, and phosphatase and tensin homologue expression by immunohistochemistry, in addition to EGFR exons 18, 19, and 21, and phosphorylations of Akt and extracellular signal-regulated kinase reported previously. RESULTS: EGFR mutation and high gene copy number were associated with better objective response in univariate analysis. However, only gefitinib-sensitive EGFR mutation was independently predictive of both response (P = 0.011) and survival (P = 0.002) in multivariate analysis. No patients with K-ras mutation, including two EGFR mutants, showed response. In EGFR nonmutants, patients with either K-ras mutation or p-Akt overexpression exhibited poor response and time-to-progression whereas patients with high gene copy number tended to have better outcomes in univariate analysis. In multivariate analysis of time-to-progression in EGFR nonmutants, K-ras mutation or p-Akt overexpression was associated with shorter time-to-progression (P = 0.017). No patient with HER2 mutation showed response to gefitinib. Reduced phosphatase and tensin homologue expression was not associated with gefitinib sensitivity. CONCLUSION: Gefitinib-sensitive EGFR mutation is the single most important predictor of gefitinib sensitivity. In addition to EGFR mutation, K-ras mutation and Akt phosphorylation aid in better prediction of gefitinib responsiveness in non-small-cell lung cancer.", "title": {"charStart": 0, "charEnd": 184}, "docId": "16638863", "entity": [{"duid": "PU:suqA", "entityType": "Gene", "charEnd": 353, "source": "PUBTATOR", "charStart": 350, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:P8mQ", "entityType": "Species", "charEnd": 515, "source": "PUBTATOR", "charStart": 508, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:n6MC", "entityType": "Gene", "charEnd": 1853, "source": "PUBTATOR", "charStart": 1850, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}, {"duid": "PU:7jk3", "entityType": "Species", "charEnd": 459, "source": "PUBTATOR", "charStart": 452, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "PATIENTS"}, {"duid": "PU:8UMd", "entityType": "Chemical", "charEnd": 283, "source": "PUBTATOR", "charStart": 275, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gefitinib"}, {"duid": "PU:pkKJ", "entityType": "Gene", "charEnd": 1270, "source": "PUBTATOR", "charStart": 1267, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:LQjV", "entityType": "Chemical", "charEnd": 1838, "source": "PUBTATOR", "charStart": 1830, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "Gefitinib"}, {"duid": "PU:ELAz", "entityType": "Gene", "charEnd": 1207, "source": "PUBTATOR", "charStart": 1203, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "K-ras"}, {"duid": "PU:xR6c", "entityType": "Gene", "charEnd": 1545, "source": "PUBTATOR", "charStart": 1542, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:VMJn", "entityType": "Gene", "charEnd": 149, "source": "PUBTATOR", "charStart": 145, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "K-ras"}, {"duid": "PU:XkW7", "entityType": "Gene", "charEnd": 844, "source": "PUBTATOR", "charStart": 842, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "Akt"}, {"duid": "PU:9kqP", "entityType": "Gene", "charEnd": 794, "source": "PUBTATOR", "charStart": 791, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:GJRD", "entityType": "Gene", "charEnd": 1980, "source": "PUBTATOR", "charStart": 1978, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "Akt"}, {"duid": "PU:Ej2d", "entityType": "Disease", "charEnd": 506, "source": "PUBTATOR", "charStart": 481, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:tY9V", "entityType": "Chemical", "charEnd": 2034, "source": "PUBTATOR", "charStart": 2026, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 12, "entityText": "gefitinib"}, {"duid": "PU:Tvx6", "entityType": "Chemical", "charEnd": 1051, "source": "PUBTATOR", "charStart": 1043, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:P5LL", "entityType": "Gene", "charEnd": 239, "source": "PUBTATOR", "charStart": 208, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:eZHs", "entityType": "Gene", "charEnd": 133, "source": "PUBTATOR", "charStart": 102, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:Pfrt", "entityType": "Gene", "charEnd": 1947, "source": "PUBTATOR", "charStart": 1944, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "EGFR"}, {"duid": "PU:sUqS", "entityType": "Gene", "charEnd": 1309, "source": "PUBTATOR", "charStart": 1305, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "K-ras"}, {"duid": "PU:T9JS", "entityType": "Gene", "charEnd": 1563, "source": "PUBTATOR", "charStart": 1559, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "K-ras"}, {"duid": "PU:7VDu", "entityType": "Species", "charEnd": 1291, "source": "PUBTATOR", "charStart": 1284, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:VXPs", "entityType": "Gene", "charEnd": 921, "source": "PUBTATOR", "charStart": 918, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:a3Jh", "entityType": "Chemical", "charEnd": 538, "source": "PUBTATOR", "charStart": 530, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gefitinib"}, {"duid": "PU:4fVC", "entityType": "Gene", "charEnd": 1678, "source": "PUBTATOR", "charStart": 1675, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2"}, {"duid": "PU:RwQJ", "entityType": "Species", "charEnd": 22, "source": "PUBTATOR", "charStart": 16, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patient"}, {"duid": "PU:5YaK", "entityType": "Gene", "charEnd": 652, "source": "PUBTATOR", "charStart": 648, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "K-ras"}, {"duid": "PU:K6Wk", "entityType": "Disease", "charEnd": 76, "source": "PUBTATOR", "charStart": 51, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:9W73", "entityType": "Chemical", "charEnd": 1803, "source": "PUBTATOR", "charStart": 1795, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 10, "entityText": "gefitinib"}, {"duid": "PU:TFty", "entityType": "Gene", "charEnd": 577, "source": "PUBTATOR", "charStart": 574, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:8Pox", "entityType": "Gene", "charEnd": 1066, "source": "PUBTATOR", "charStart": 1063, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}, {"duid": "PU:RrcS", "entityType": "Gene", "charEnd": 167, "source": "PUBTATOR", "charStart": 165, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Akt"}, {"duid": "PU:7cqW", "entityType": "Gene", "charEnd": 245, "source": "PUBTATOR", "charStart": 242, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:wQi3", "entityType": "Species", "charEnd": 1407, "source": "PUBTATOR", "charStart": 1400, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:itdJ", "entityType": "Gene", "charEnd": 1963, "source": "PUBTATOR", "charStart": 1959, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "K-ras"}, {"duid": "PU:Sfot", "entityType": "Species", "charEnd": 1196, "source": "PUBTATOR", "charStart": 1189, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:jjv5", "entityType": "Chemical", "charEnd": 1914, "source": "PUBTATOR", "charStart": 1906, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gefitinib"}, {"duid": "PU:3CHZ", "entityType": "Gene", "charEnd": 658, "source": "PUBTATOR", "charStart": 655, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "HER2"}, {"duid": "PU:X3bp", "entityType": "Species", "charEnd": 1668, "source": "PUBTATOR", "charStart": 1662, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patient"}, {"duid": "PU:AGbU", "entityType": "Gene", "charEnd": 1236, "source": "PUBTATOR", "charStart": 1233, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:hB4V", "entityType": "Disease", "charEnd": 322, "source": "PUBTATOR", "charStart": 297, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:NLPS", "entityType": "Gene", "charEnd": 1581, "source": "PUBTATOR", "charStart": 1579, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "Akt"}, {"duid": "PU:FSD7", "entityType": "Chemical", "charEnd": 46, "source": "PUBTATOR", "charStart": 38, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gefitinib"}, {"duid": "PU:SvwR", "entityType": "Gene", "charEnd": 679, "source": "PUBTATOR", "charStart": 676, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:sFzo", "entityType": "Disease", "charEnd": 2079, "source": "PUBTATOR", "charStart": 2054, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 12, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:Nrbv", "entityType": "Chemical", "charEnd": 1716, "source": "PUBTATOR", "charStart": 1708, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 9, "entityText": "gefitinib"}, {"duid": "PU:KxCu", "entityType": "Gene", "charEnd": 1327, "source": "PUBTATOR", "charStart": 1325, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "Akt"}]}
{"text": "Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation. PURPOSE: Mutations in epidermal growth factor receptor (EGFR) are strongly predictive of gefitinib efficacy in non-small-cell lung cancer. However, the presence of EGFR mutant nonresponses and nonmutant responses points out the need for more comprehensive analysis. PATIENTS AND METHODS: For 69 non-small-cell lung cancer patients treated with gefitinib, we have extended our analysis to EGFR gene copy number by fluorescence in situ hybridization, mutations in K-ras, HER2, and exon 20 of EGFR by direct sequencing, and phosphatase and tensin homologue expression by immunohistochemistry, in addition to EGFR exons 18, 19, and 21, and phosphorylations of Akt and extracellular signal-regulated kinase reported previously. RESULTS: EGFR mutation and high gene copy number were associated with better objective response in univariate analysis. However, only gefitinib-sensitive EGFR mutation was independently predictive of both response (P = 0.011) and survival (P = 0.002) in multivariate analysis. No patients with K-ras mutation, including two EGFR mutants, showed response. In EGFR nonmutants, patients with either K-ras mutation or p-Akt overexpression exhibited poor response and time-to-progression whereas patients with high gene copy number tended to have better outcomes in univariate analysis. In multivariate analysis of time-to-progression in EGFR nonmutants, K-ras mutation or p-Akt overexpression was associated with shorter time-to-progression (P = 0.017). No patient with HER2 mutation showed response to gefitinib. Reduced phosphatase and tensin homologue expression was not associated with gefitinib sensitivity. CONCLUSION: Gefitinib-sensitive EGFR mutation is the single most important predictor of gefitinib sensitivity. In addition to EGFR mutation, K-ras mutation and Akt phosphorylation aid in better prediction of gefitinib responsiveness in non-small-cell lung cancer.", "title": {"charStart": 0, "charEnd": 184}, "docId": "16638863", "entity": [{"duid": "PU:suqA", "entityType": "Gene", "charEnd": 353, "source": "PUBTATOR", "charStart": 350, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:P8mQ", "entityType": "Species", "charEnd": 515, "source": "PUBTATOR", "charStart": 508, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:n6MC", "entityType": "Gene", "charEnd": 1853, "source": "PUBTATOR", "charStart": 1850, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}, {"duid": "PU:7jk3", "entityType": "Species", "charEnd": 459, "source": "PUBTATOR", "charStart": 452, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "PATIENTS"}, {"duid": "PU:8UMd", "entityType": "Chemical", "charEnd": 283, "source": "PUBTATOR", "charStart": 275, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gefitinib"}, {"duid": "PU:pkKJ", "entityType": "Gene", "charEnd": 1270, "source": "PUBTATOR", "charStart": 1267, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:LQjV", "entityType": "Chemical", "charEnd": 1838, "source": "PUBTATOR", "charStart": 1830, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "Gefitinib"}, {"duid": "PU:ELAz", "entityType": "Gene", "charEnd": 1207, "source": "PUBTATOR", "charStart": 1203, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "K-ras"}, {"duid": "PU:xR6c", "entityType": "Gene", "charEnd": 1545, "source": "PUBTATOR", "charStart": 1542, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:VMJn", "entityType": "Gene", "charEnd": 149, "source": "PUBTATOR", "charStart": 145, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "K-ras"}, {"duid": "PU:XkW7", "entityType": "Gene", "charEnd": 844, "source": "PUBTATOR", "charStart": 842, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "Akt"}, {"duid": "PU:9kqP", "entityType": "Gene", "charEnd": 794, "source": "PUBTATOR", "charStart": 791, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:GJRD", "entityType": "Gene", "charEnd": 1980, "source": "PUBTATOR", "charStart": 1978, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "Akt"}, {"duid": "PU:Ej2d", "entityType": "Disease", "charEnd": 506, "source": "PUBTATOR", "charStart": 481, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:tY9V", "entityType": "Chemical", "charEnd": 2034, "source": "PUBTATOR", "charStart": 2026, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 12, "entityText": "gefitinib"}, {"duid": "PU:Tvx6", "entityType": "Chemical", "charEnd": 1051, "source": "PUBTATOR", "charStart": 1043, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:P5LL", "entityType": "Gene", "charEnd": 239, "source": "PUBTATOR", "charStart": 208, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:eZHs", "entityType": "Gene", "charEnd": 133, "source": "PUBTATOR", "charStart": 102, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:Pfrt", "entityType": "Gene", "charEnd": 1947, "source": "PUBTATOR", "charStart": 1944, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "EGFR"}, {"duid": "PU:sUqS", "entityType": "Gene", "charEnd": 1309, "source": "PUBTATOR", "charStart": 1305, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "K-ras"}, {"duid": "PU:T9JS", "entityType": "Gene", "charEnd": 1563, "source": "PUBTATOR", "charStart": 1559, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "K-ras"}, {"duid": "PU:7VDu", "entityType": "Species", "charEnd": 1291, "source": "PUBTATOR", "charStart": 1284, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:VXPs", "entityType": "Gene", "charEnd": 921, "source": "PUBTATOR", "charStart": 918, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:a3Jh", "entityType": "Chemical", "charEnd": 538, "source": "PUBTATOR", "charStart": 530, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gefitinib"}, {"duid": "PU:4fVC", "entityType": "Gene", "charEnd": 1678, "source": "PUBTATOR", "charStart": 1675, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2"}, {"duid": "PU:RwQJ", "entityType": "Species", "charEnd": 22, "source": "PUBTATOR", "charStart": 16, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patient"}, {"duid": "PU:5YaK", "entityType": "Gene", "charEnd": 652, "source": "PUBTATOR", "charStart": 648, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "K-ras"}, {"duid": "PU:K6Wk", "entityType": "Disease", "charEnd": 76, "source": "PUBTATOR", "charStart": 51, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:9W73", "entityType": "Chemical", "charEnd": 1803, "source": "PUBTATOR", "charStart": 1795, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 10, "entityText": "gefitinib"}, {"duid": "PU:TFty", "entityType": "Gene", "charEnd": 577, "source": "PUBTATOR", "charStart": 574, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:8Pox", "entityType": "Gene", "charEnd": 1066, "source": "PUBTATOR", "charStart": 1063, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}, {"duid": "PU:RrcS", "entityType": "Gene", "charEnd": 167, "source": "PUBTATOR", "charStart": 165, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Akt"}, {"duid": "PU:7cqW", "entityType": "Gene", "charEnd": 245, "source": "PUBTATOR", "charStart": 242, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:wQi3", "entityType": "Species", "charEnd": 1407, "source": "PUBTATOR", "charStart": 1400, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:itdJ", "entityType": "Gene", "charEnd": 1963, "source": "PUBTATOR", "charStart": 1959, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "K-ras"}, {"duid": "PU:Sfot", "entityType": "Species", "charEnd": 1196, "source": "PUBTATOR", "charStart": 1189, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:jjv5", "entityType": "Chemical", "charEnd": 1914, "source": "PUBTATOR", "charStart": 1906, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gefitinib"}, {"duid": "PU:3CHZ", "entityType": "Gene", "charEnd": 658, "source": "PUBTATOR", "charStart": 655, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "HER2"}, {"duid": "PU:X3bp", "entityType": "Species", "charEnd": 1668, "source": "PUBTATOR", "charStart": 1662, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patient"}, {"duid": "PU:AGbU", "entityType": "Gene", "charEnd": 1236, "source": "PUBTATOR", "charStart": 1233, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:hB4V", "entityType": "Disease", "charEnd": 322, "source": "PUBTATOR", "charStart": 297, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:NLPS", "entityType": "Gene", "charEnd": 1581, "source": "PUBTATOR", "charStart": 1579, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "Akt"}, {"duid": "PU:FSD7", "entityType": "Chemical", "charEnd": 46, "source": "PUBTATOR", "charStart": 38, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gefitinib"}, {"duid": "PU:SvwR", "entityType": "Gene", "charEnd": 679, "source": "PUBTATOR", "charStart": 676, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:sFzo", "entityType": "Disease", "charEnd": 2079, "source": "PUBTATOR", "charStart": 2054, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 12, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:Nrbv", "entityType": "Chemical", "charEnd": 1716, "source": "PUBTATOR", "charStart": 1708, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 9, "entityText": "gefitinib"}, {"duid": "PU:KxCu", "entityType": "Gene", "charEnd": 1327, "source": "PUBTATOR", "charStart": 1325, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "Akt"}]}
{"text": "Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation. PURPOSE: Mutations in epidermal growth factor receptor (EGFR) are strongly predictive of gefitinib efficacy in non-small-cell lung cancer. However, the presence of EGFR mutant nonresponses and nonmutant responses points out the need for more comprehensive analysis. PATIENTS AND METHODS: For 69 non-small-cell lung cancer patients treated with gefitinib, we have extended our analysis to EGFR gene copy number by fluorescence in situ hybridization, mutations in K-ras, HER2, and exon 20 of EGFR by direct sequencing, and phosphatase and tensin homologue expression by immunohistochemistry, in addition to EGFR exons 18, 19, and 21, and phosphorylations of Akt and extracellular signal-regulated kinase reported previously. RESULTS: EGFR mutation and high gene copy number were associated with better objective response in univariate analysis. However, only gefitinib-sensitive EGFR mutation was independently predictive of both response (P = 0.011) and survival (P = 0.002) in multivariate analysis. No patients with K-ras mutation, including two EGFR mutants, showed response. In EGFR nonmutants, patients with either K-ras mutation or p-Akt overexpression exhibited poor response and time-to-progression whereas patients with high gene copy number tended to have better outcomes in univariate analysis. In multivariate analysis of time-to-progression in EGFR nonmutants, K-ras mutation or p-Akt overexpression was associated with shorter time-to-progression (P = 0.017). No patient with HER2 mutation showed response to gefitinib. Reduced phosphatase and tensin homologue expression was not associated with gefitinib sensitivity. CONCLUSION: Gefitinib-sensitive EGFR mutation is the single most important predictor of gefitinib sensitivity. In addition to EGFR mutation, K-ras mutation and Akt phosphorylation aid in better prediction of gefitinib responsiveness in non-small-cell lung cancer.", "title": {"charStart": 0, "charEnd": 184}, "docId": "16638863", "entity": [{"duid": "PU:suqA", "entityType": "Gene", "charEnd": 353, "source": "PUBTATOR", "charStart": 350, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:P8mQ", "entityType": "Species", "charEnd": 515, "source": "PUBTATOR", "charStart": 508, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:n6MC", "entityType": "Gene", "charEnd": 1853, "source": "PUBTATOR", "charStart": 1850, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}, {"duid": "PU:7jk3", "entityType": "Species", "charEnd": 459, "source": "PUBTATOR", "charStart": 452, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "PATIENTS"}, {"duid": "PU:8UMd", "entityType": "Chemical", "charEnd": 283, "source": "PUBTATOR", "charStart": 275, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gefitinib"}, {"duid": "PU:pkKJ", "entityType": "Gene", "charEnd": 1270, "source": "PUBTATOR", "charStart": 1267, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:LQjV", "entityType": "Chemical", "charEnd": 1838, "source": "PUBTATOR", "charStart": 1830, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "Gefitinib"}, {"duid": "PU:ELAz", "entityType": "Gene", "charEnd": 1207, "source": "PUBTATOR", "charStart": 1203, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "K-ras"}, {"duid": "PU:xR6c", "entityType": "Gene", "charEnd": 1545, "source": "PUBTATOR", "charStart": 1542, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:VMJn", "entityType": "Gene", "charEnd": 149, "source": "PUBTATOR", "charStart": 145, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "K-ras"}, {"duid": "PU:XkW7", "entityType": "Gene", "charEnd": 844, "source": "PUBTATOR", "charStart": 842, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "Akt"}, {"duid": "PU:9kqP", "entityType": "Gene", "charEnd": 794, "source": "PUBTATOR", "charStart": 791, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:GJRD", "entityType": "Gene", "charEnd": 1980, "source": "PUBTATOR", "charStart": 1978, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "Akt"}, {"duid": "PU:Ej2d", "entityType": "Disease", "charEnd": 506, "source": "PUBTATOR", "charStart": 481, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 3, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:tY9V", "entityType": "Chemical", "charEnd": 2034, "source": "PUBTATOR", "charStart": 2026, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 12, "entityText": "gefitinib"}, {"duid": "PU:Tvx6", "entityType": "Chemical", "charEnd": 1051, "source": "PUBTATOR", "charStart": 1043, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:P5LL", "entityType": "Gene", "charEnd": 239, "source": "PUBTATOR", "charStart": 208, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:eZHs", "entityType": "Gene", "charEnd": 133, "source": "PUBTATOR", "charStart": 102, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:Pfrt", "entityType": "Gene", "charEnd": 1947, "source": "PUBTATOR", "charStart": 1944, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "EGFR"}, {"duid": "PU:sUqS", "entityType": "Gene", "charEnd": 1309, "source": "PUBTATOR", "charStart": 1305, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "K-ras"}, {"duid": "PU:T9JS", "entityType": "Gene", "charEnd": 1563, "source": "PUBTATOR", "charStart": 1559, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "K-ras"}, {"duid": "PU:7VDu", "entityType": "Species", "charEnd": 1291, "source": "PUBTATOR", "charStart": 1284, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:VXPs", "entityType": "Gene", "charEnd": 921, "source": "PUBTATOR", "charStart": 918, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:a3Jh", "entityType": "Chemical", "charEnd": 538, "source": "PUBTATOR", "charStart": 530, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gefitinib"}, {"duid": "PU:4fVC", "entityType": "Gene", "charEnd": 1678, "source": "PUBTATOR", "charStart": 1675, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2"}, {"duid": "PU:RwQJ", "entityType": "Species", "charEnd": 22, "source": "PUBTATOR", "charStart": 16, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patient"}, {"duid": "PU:5YaK", "entityType": "Gene", "charEnd": 652, "source": "PUBTATOR", "charStart": 648, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "K-ras"}, {"duid": "PU:K6Wk", "entityType": "Disease", "charEnd": 76, "source": "PUBTATOR", "charStart": 51, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small cell lung cancer"}, {"duid": "PU:9W73", "entityType": "Chemical", "charEnd": 1803, "source": "PUBTATOR", "charStart": 1795, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 10, "entityText": "gefitinib"}, {"duid": "PU:TFty", "entityType": "Gene", "charEnd": 577, "source": "PUBTATOR", "charStart": 574, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:8Pox", "entityType": "Gene", "charEnd": 1066, "source": "PUBTATOR", "charStart": 1063, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}, {"duid": "PU:RrcS", "entityType": "Gene", "charEnd": 167, "source": "PUBTATOR", "charStart": 165, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Akt"}, {"duid": "PU:7cqW", "entityType": "Gene", "charEnd": 245, "source": "PUBTATOR", "charStart": 242, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:wQi3", "entityType": "Species", "charEnd": 1407, "source": "PUBTATOR", "charStart": 1400, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:itdJ", "entityType": "Gene", "charEnd": 1963, "source": "PUBTATOR", "charStart": 1959, "entityId": [{"idString": "3845", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "K-ras"}, {"duid": "PU:Sfot", "entityType": "Species", "charEnd": 1196, "source": "PUBTATOR", "charStart": 1189, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:jjv5", "entityType": "Chemical", "charEnd": 1914, "source": "PUBTATOR", "charStart": 1906, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gefitinib"}, {"duid": "PU:3CHZ", "entityType": "Gene", "charEnd": 658, "source": "PUBTATOR", "charStart": 655, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "HER2"}, {"duid": "PU:X3bp", "entityType": "Species", "charEnd": 1668, "source": "PUBTATOR", "charStart": 1662, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patient"}, {"duid": "PU:AGbU", "entityType": "Gene", "charEnd": 1236, "source": "PUBTATOR", "charStart": 1233, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:hB4V", "entityType": "Disease", "charEnd": 322, "source": "PUBTATOR", "charStart": 297, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:NLPS", "entityType": "Gene", "charEnd": 1581, "source": "PUBTATOR", "charStart": 1579, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "Akt"}, {"duid": "PU:FSD7", "entityType": "Chemical", "charEnd": 46, "source": "PUBTATOR", "charStart": 38, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gefitinib"}, {"duid": "PU:SvwR", "entityType": "Gene", "charEnd": 679, "source": "PUBTATOR", "charStart": 676, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:sFzo", "entityType": "Disease", "charEnd": 2079, "source": "PUBTATOR", "charStart": 2054, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 12, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:Nrbv", "entityType": "Chemical", "charEnd": 1716, "source": "PUBTATOR", "charStart": 1708, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 9, "entityText": "gefitinib"}, {"duid": "PU:KxCu", "entityType": "Gene", "charEnd": 1327, "source": "PUBTATOR", "charStart": 1325, "entityId": [{"idString": "207", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "Akt"}]}
{"text": "EGFR mutation status in pleural fluid predicts tumor responsiveness and resistance to gefitinib. It has been reported that the threonine-to-methionine substitution at amino acid position 790 (T790M) of the epidermal growth factor receptor (EGFR) gene is correlated with acquired resistance to gefitinib. We previously reported that there was some population that harbored the EGFR T790M mutation as a minor clone of tumor cells prior to drug treatment, may be causing resistance to gefitinib during treatment. This fact also suggests that the detection of the EGFR T790M mutation prior to treatment may predict the development of resistance. We also showed that pleural fluid is a useful specimen for detection of EGFR mutation using sensitive assays. In this study, we reported a female patient who was treated with gefitinib because an EGFR L858R mutation was found in her pleural fluid. Our patient showed partial response to gefitinib, but she had progressive disease only 4 months after the start of treatment. Furthermore, the EGFR T790M mutation was detected in the pleural fluid before gefitinib treatment by the mutant-enriched PCR assay. Our findings confirmed that the EGFR T790M mutation was occasionally present as a minor population in tumor cells before treatment and caused resistance after gefitinib administration. The detection of a small fraction of T790M-positive alleles may be useful to predict the clinical course of the gefitinib-treated non-small-cell lung cancer patients.", "title": {"charStart": 0, "charEnd": 95}, "docId": "17335935", "entity": [{"duid": "PU:LMgW", "entityType": "Chemical", "charEnd": 301, "source": "PUBTATOR", "charStart": 293, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gefitinib"}, {"duid": "PU:NCkU", "entityType": "Chemical", "charEnd": 176, "source": "PUBTATOR", "charStart": 167, "entityId": [{"idString": "33704", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "amino acid"}, {"duid": "PU:MMVT", "entityType": "Species", "charEnd": 794, "source": "PUBTATOR", "charStart": 788, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patient"}, {"duid": "PU:mmDy", "entityType": "Gene", "charEnd": 1183, "source": "PUBTATOR", "charStart": 1180, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:6ZEX", "entityType": "Chemical", "charEnd": 490, "source": "PUBTATOR", "charStart": 482, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gefitinib"}, {"duid": "PU:U4qZ", "entityType": "Gene", "charEnd": 717, "source": "PUBTATOR", "charStart": 714, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:vYjQ", "entityType": "ProteinMutation", "charEnd": 189, "source": "PUBTATOR", "charStart": 127, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 1, "entityText": "threonine-to-methionine substitution at amino acid position 790"}, {"duid": "PU:3C4Q", "entityType": "Disease", "charEnd": 1254, "source": "PUBTATOR", "charStart": 1250, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "tumor"}, {"duid": "PU:zX4M", "entityType": "Chemical", "charEnd": 1102, "source": "PUBTATOR", "charStart": 1094, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 7, "entityText": "gefitinib"}, {"duid": "PU:dE2q", "entityType": "Chemical", "charEnd": 825, "source": "PUBTATOR", "charStart": 817, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:tann", "entityType": "Chemical", "charEnd": 937, "source": "PUBTATOR", "charStart": 929, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gefitinib"}, {"duid": "PU:pCMc", "entityType": "ProteinMutation", "charEnd": 1189, "source": "PUBTATOR", "charStart": 1185, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 8, "entityText": "T790M"}, {"duid": "PU:sToV", "entityType": "ProteinMutation", "charEnd": 569, "source": "PUBTATOR", "charStart": 565, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 3, "entityText": "T790M"}, {"duid": "PU:TwvT", "entityType": "Gene", "charEnd": 243, "source": "PUBTATOR", "charStart": 240, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:aVdv", "entityType": "Disease", "charEnd": 1488, "source": "PUBTATOR", "charStart": 1463, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 9, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:FyFe", "entityType": "Disease", "charEnd": 51, "source": "PUBTATOR", "charStart": 47, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 0, "entityText": "tumor"}, {"duid": "PU:tt5m", "entityType": "ProteinMutation", "charEnd": 385, "source": "PUBTATOR", "charStart": 381, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 2, "entityText": "T790M"}, {"duid": "PU:Mpw3", "entityType": "Chemical", "charEnd": 135, "source": "PUBTATOR", "charStart": 127, "entityId": [{"idString": "26986", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "threonine"}, {"duid": "PU:FR7T", "entityType": "Chemical", "charEnd": 1315, "source": "PUBTATOR", "charStart": 1307, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gefitinib"}, {"duid": "PU:Wcha", "entityType": "ProteinMutation", "charEnd": 1042, "source": "PUBTATOR", "charStart": 1038, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 7, "entityText": "T790M"}, {"duid": "PU:7yPP", "entityType": "ProteinMutation", "charEnd": 196, "source": "PUBTATOR", "charStart": 192, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 1, "entityText": "T790M"}, {"duid": "PU:y83m", "entityType": "Gene", "charEnd": 237, "source": "PUBTATOR", "charStart": 206, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:2xkv", "entityType": "Gene", "charEnd": 3, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "EGFR"}, {"duid": "PU:F3qx", "entityType": "Gene", "charEnd": 841, "source": "PUBTATOR", "charStart": 838, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}, {"duid": "PU:wt7G", "entityType": "Gene", "charEnd": 379, "source": "PUBTATOR", "charStart": 376, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:XJUe", "entityType": "Gene", "charEnd": 563, "source": "PUBTATOR", "charStart": 560, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:jbdA", "entityType": "Species", "charEnd": 1497, "source": "PUBTATOR", "charStart": 1490, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:QGfc", "entityType": "Chemical", "charEnd": 149, "source": "PUBTATOR", "charStart": 140, "entityId": [{"idString": "D008715", "source": "MESH"}], "sentenceIndex": 1, "entityText": "methionine"}, {"duid": "PU:fszV", "entityType": "ProteinMutation", "charEnd": 847, "source": "PUBTATOR", "charStart": 843, "entityId": [{"idString": "p|SUB|L|858|R;RS#:121434568", "source": "Unk"}], "sentenceIndex": 5, "entityText": "L858R"}, {"duid": "PU:JyY7", "entityType": "Gene", "charEnd": 1036, "source": "PUBTATOR", "charStart": 1033, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:3TYn", "entityType": "Disease", "charEnd": 420, "source": "PUBTATOR", "charStart": 416, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "tumor"}, {"duid": "PU:8uUk", "entityType": "ProteinMutation", "charEnd": 1374, "source": "PUBTATOR", "charStart": 1370, "entityId": [{"idString": "p|SUB|T|790|M;RS#:121434569", "source": "Unk"}], "sentenceIndex": 9, "entityText": "T790M"}, {"duid": "PU:wXny", "entityType": "Species", "charEnd": 900, "source": "PUBTATOR", "charStart": 894, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patient"}, {"duid": "PU:DCHe", "entityType": "Chemical", "charEnd": 1453, "source": "PUBTATOR", "charStart": 1445, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 9, "entityText": "gefitinib"}, {"duid": "PU:55Hf", "entityType": "Chemical", "charEnd": 94, "source": "PUBTATOR", "charStart": 86, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gefitinib"}]}
{"text": "ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors. Poly(ADP-ribose) polymerase-1 (PARP-1) inhibition is toxic to cells with mutations in the breast and ovarian cancer susceptibility genes BRCA1 or BRCA2, a concept termed synthetic lethality. However, whether this approach is applicable to other human cancers with defects in other DNA repair genes has yet to be determined. The ataxia telangiectasia mutated (ATM) gene is altered in several human cancers including mantle cell lymphoma (MCL). Here, we characterize a panel of MCL cell lines for ATM status and function and investigate the potential for synthetic lethality in MCL in the presence of small-molecule inhibitors of PARP-1. We show that Granta-519 and UPN2 cells have low levels of ATM protein, are defective in DNA damage-induced ATM-dependent signaling, are radiation sensitive, and have cell cycle checkpoint defects: all characteristics of defective ATM function. Significantly, Granta-519 and UPN2 cells were more sensitive to PARP-1 inhibition than were the ATM-proficient MCL cell lines examined. Furthermore, the PARP-1 inhibitor olaparib (known previously as AZD2281/KU-0059436) significantly decreased tumor growth and increased overall survival in mice bearing s.c. xenografts of ATM-deficient Granta-519 cells while producing only a modest effect on overall survival of mice bearing xenografts of the ATM-proficient cell line, Z138. Thus, PARP inhibitors have therapeutic potential in the treatment of MCL, and the concept of synthetic lethality extends to human cancers with ATM alterations.", "title": {"charStart": 0, "charEnd": 96}, "docId": "20124459", "entity": [{"duid": "PU:wpcV", "entityType": "Gene", "charEnd": 248, "source": "PUBTATOR", "charStart": 244, "entityId": [{"idString": "675", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "BRCA2"}, {"duid": "PU:XzG8", "entityType": "Species", "charEnd": 1395, "source": "PUBTATOR", "charStart": 1392, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "mice"}, {"duid": "PU:w8yg", "entityType": "Gene", "charEnd": 1464, "source": "PUBTATOR", "charStart": 1461, "entityId": [{"idString": "142", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "PARP"}, {"duid": "PU:uask", "entityType": "Chemical", "charEnd": 113, "source": "PUBTATOR", "charStart": 98, "entityId": [{"idString": "D011064", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Poly(ADP-ribose)"}, {"duid": "PU:nBEi", "entityType": "Disease", "charEnd": 1526, "source": "PUBTATOR", "charStart": 1524, "entityId": [{"idString": "D020522", "source": "MESH"}], "sentenceIndex": 8, "entityText": "MCL"}, {"duid": "PU:wBte", "entityType": "Disease", "charEnd": 576, "source": "PUBTATOR", "charStart": 574, "entityId": [{"idString": "D020522", "source": "MESH"}], "sentenceIndex": 4, "entityText": "MCL"}, {"duid": "PU:dNqd", "entityType": "Gene", "charEnd": 454, "source": "PUBTATOR", "charStart": 426, "entityId": [{"idString": "472", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ataxia telangiectasia mutated"}, {"duid": "PU:PtqP", "entityType": "Disease", "charEnd": 212, "source": "PUBTATOR", "charStart": 188, "entityId": [{"idString": "D061325", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast and ovarian cancer"}, {"duid": "PU:6F2H", "entityType": "Species", "charEnd": 1002, "source": "PUBTATOR", "charStart": 993, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "Granta-519"}, {"duid": "PU:giMo", "entityType": "Gene", "charEnd": 1047, "source": "PUBTATOR", "charStart": 1042, "entityId": [{"idString": "142", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "PARP-1"}, {"duid": "PU:azR6", "entityType": "Gene", "charEnd": 134, "source": "PUBTATOR", "charStart": 129, "entityId": [{"idString": "142", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "PARP-1"}, {"duid": "PU:6Nc9", "entityType": "Gene", "charEnd": 84, "source": "PUBTATOR", "charStart": 56, "entityId": [{"idString": "142", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "poly(ADP-ribose) polymerase-1"}, {"duid": "PU:QsQE", "entityType": "Gene", "charEnd": 731, "source": "PUBTATOR", "charStart": 726, "entityId": [{"idString": "142", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "PARP-1"}, {"duid": "PU:xsPL", "entityType": "Disease", "charEnd": 1591, "source": "PUBTATOR", "charStart": 1585, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 8, "entityText": "cancers"}, {"duid": "PU:fPyQ", "entityType": "Disease", "charEnd": 1091, "source": "PUBTATOR", "charStart": 1089, "entityId": [{"idString": "D020522", "source": "MESH"}], "sentenceIndex": 6, "entityText": "MCL"}, {"duid": "PU:D2nF", "entityType": "Disease", "charEnd": 537, "source": "PUBTATOR", "charStart": 535, "entityId": [{"idString": "D020522", "source": "MESH"}], "sentenceIndex": 3, "entityText": "MCL"}, {"duid": "PU:BedG", "entityType": "Species", "charEnd": 493, "source": "PUBTATOR", "charStart": 489, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "human"}, {"duid": "PU:ZU4n", "entityType": "Gene", "charEnd": 1425, "source": "PUBTATOR", "charStart": 1423, "entityId": [{"idString": "11920", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 7, "entityText": "ATM"}, {"duid": "PU:NsPT", "entityType": "Gene", "charEnd": 1303, "source": "PUBTATOR", "charStart": 1301, "entityId": [{"idString": "11920", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 7, "entityText": "ATM"}, {"duid": "PU:vq9V", "entityType": "Gene", "charEnd": 843, "source": "PUBTATOR", "charStart": 841, "entityId": [{"idString": "472", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ATM"}, {"duid": "PU:4WyP", "entityType": "Gene", "charEnd": 239, "source": "PUBTATOR", "charStart": 235, "entityId": [{"idString": "672", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "BRCA1"}, {"duid": "PU:tLCC", "entityType": "Chemical", "charEnd": 1184, "source": "PUBTATOR", "charStart": 1178, "entityId": [{"idString": "C531550", "source": "MESH"}], "sentenceIndex": 7, "entityText": "AZD2281"}, {"duid": "PU:m3fw", "entityType": "Disease", "charEnd": 532, "source": "PUBTATOR", "charStart": 513, "entityId": [{"idString": "D020522", "source": "MESH"}], "sentenceIndex": 3, "entityText": "mantle cell lymphoma"}, {"duid": "PU:MQ4h", "entityType": "Species", "charEnd": 1324, "source": "PUBTATOR", "charStart": 1315, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "Granta-519"}, {"duid": "PU:hLRR", "entityType": "Gene", "charEnd": 1076, "source": "PUBTATOR", "charStart": 1074, "entityId": [{"idString": "472", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ATM"}, {"duid": "PU:q9dD", "entityType": "Gene", "charEnd": 794, "source": "PUBTATOR", "charStart": 792, "entityId": [{"idString": "472", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ATM"}, {"duid": "PU:hq8s", "entityType": "Species", "charEnd": 1583, "source": "PUBTATOR", "charStart": 1579, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "human"}, {"duid": "PU:xj4f", "entityType": "Gene", "charEnd": 1600, "source": "PUBTATOR", "charStart": 1598, "entityId": [{"idString": "472", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ATM"}, {"duid": "PU:DBBs", "entityType": "Disease", "charEnd": 1226, "source": "PUBTATOR", "charStart": 1222, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumor"}, {"duid": "PU:7RKX", "entityType": "Gene", "charEnd": 2, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "472", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ATM"}, {"duid": "PU:FF2z", "entityType": "Chemical", "charEnd": 71, "source": "PUBTATOR", "charStart": 56, "entityId": [{"idString": "D011064", "source": "MESH"}], "sentenceIndex": 0, "entityText": "poly(ADP-ribose)"}, {"duid": "PU:iVAT", "entityType": "Disease", "charEnd": 45, "source": "PUBTATOR", "charStart": 26, "entityId": [{"idString": "D020522", "source": "MESH"}], "sentenceIndex": 0, "entityText": "mantle cell lymphoma"}, {"duid": "PU:AhNJ", "entityType": "Disease", "charEnd": 355, "source": "PUBTATOR", "charStart": 349, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 2, "entityText": "cancers"}, {"duid": "PU:CH7i", "entityType": "Disease", "charEnd": 446, "source": "PUBTATOR", "charStart": 426, "entityId": [{"idString": "D001260", "source": "MESH"}], "sentenceIndex": 3, "entityText": "ataxia telangiectasia"}, {"duid": "PU:ErWf", "entityType": "Species", "charEnd": 756, "source": "PUBTATOR", "charStart": 747, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "Granta-519"}, {"duid": "PU:3QV5", "entityType": "Disease", "charEnd": 676, "source": "PUBTATOR", "charStart": 674, "entityId": [{"idString": "D020522", "source": "MESH"}], "sentenceIndex": 4, "entityText": "MCL"}, {"duid": "PU:xL7X", "entityType": "Gene", "charEnd": 1136, "source": "PUBTATOR", "charStart": 1131, "entityId": [{"idString": "11545", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 7, "entityText": "PARP-1"}, {"duid": "PU:MY32", "entityType": "Disease", "charEnd": 501, "source": "PUBTATOR", "charStart": 495, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "cancers"}, {"duid": "PU:Pvuz", "entityType": "Gene", "charEnd": 459, "source": "PUBTATOR", "charStart": 457, "entityId": [{"idString": "472", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ATM"}, {"duid": "PU:pssN", "entityType": "Gene", "charEnd": 966, "source": "PUBTATOR", "charStart": 964, "entityId": [{"idString": "472", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ATM"}, {"duid": "PU:sKSt", "entityType": "Species", "charEnd": 1272, "source": "PUBTATOR", "charStart": 1269, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "mice"}, {"duid": "PU:gesc", "entityType": "Gene", "charEnd": 595, "source": "PUBTATOR", "charStart": 593, "entityId": [{"idString": "472", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ATM"}, {"duid": "PU:HWSr", "entityType": "Gene", "charEnd": 126, "source": "PUBTATOR", "charStart": 98, "entityId": [{"idString": "142", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "Poly(ADP-ribose) polymerase-1"}, {"duid": "PU:MqKZ", "entityType": "Species", "charEnd": 347, "source": "PUBTATOR", "charStart": 343, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "human"}]}
{"text": "EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib. Epidermal growth factor receptor (EGFR) mutations are strong determinants of tumour response to EGFR tyrosine kinase inhibitors in non-small-cell lung cancer (NSCLC). Pleural effusion is a common complication of lung cancer. In this study, we assessed the feasibility of detection of EGFR mutations in samples of pleural effusion fluid. We obtained 43 samples, which was the cell-free supernatant of pleural fluid, from Japanese NSCLC patients, and examined them for EGFR mutations. The epidermal growth factor receptor mutation status was determined by a direct sequencing method (exons 18-21 in EGFR). EGFR mutations were detected in 11 cases (E746_A750del in seven cases, E746_T751del insA in one case, L747_T751del in one case, and L858R in two cases). The EGFR mutations were observed more frequently in women and non-smokers. A comparison between the EGFR mutant status and the response to gefitinib in the 27 patients who received gefitinib revealed that all seven patients with partial response and one of the seven patients with stable disease had an EGFR mutation. No EGFR mutations were detected in the patients with progressive disease. The results suggest that DNA in pleural effusion fluid can be used to detect EGFR mutations and that the EGFR mutation status may be useful as a predictor of the response to gefitinib.", "title": {"charStart": 0, "charEnd": 132}, "docId": "17060940", "entity": [{"duid": "PU:QxcY", "entityType": "Disease", "charEnd": 290, "source": "PUBTATOR", "charStart": 265, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:5gy5", "entityType": "ProteinMutation", "charEnd": 874, "source": "PUBTATOR", "charStart": 870, "entityId": [{"idString": "p|SUB|L|858|R;RS#:121434568", "source": "Unk"}], "sentenceIndex": 6, "entityText": "L858R"}, {"duid": "PU:LB8j", "entityType": "Gene", "charEnd": 1197, "source": "PUBTATOR", "charStart": 1194, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:Exah", "entityType": "Gene", "charEnd": 604, "source": "PUBTATOR", "charStart": 601, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:UPNB", "entityType": "Gene", "charEnd": 1215, "source": "PUBTATOR", "charStart": 1212, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "EGFR"}, {"duid": "PU:gE7e", "entityType": "Species", "charEnd": 1057, "source": "PUBTATOR", "charStart": 1050, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:jHzY", "entityType": "ProteinMutation", "charEnd": 851, "source": "PUBTATOR", "charStart": 840, "entityId": [{"idString": "p|DEL|747,751|T", "source": "Unk"}], "sentenceIndex": 6, "entityText": "L747_T751del"}, {"duid": "PU:vGUS", "entityType": "Chemical", "charEnd": 1080, "source": "PUBTATOR", "charStart": 1072, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gefitinib"}, {"duid": "PU:8Mvd", "entityType": "Species", "charEnd": 947, "source": "PUBTATOR", "charStart": 943, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "women"}, {"duid": "PU:ufCY", "entityType": "Disease", "charEnd": 216, "source": "PUBTATOR", "charStart": 211, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tumour"}, {"duid": "PU:9XM8", "entityType": "Chemical", "charEnd": 131, "source": "PUBTATOR", "charStart": 123, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gefitinib"}, {"duid": "PU:Wrm4", "entityType": "Gene", "charEnd": 421, "source": "PUBTATOR", "charStart": 418, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:L8La", "entityType": "Disease", "charEnd": 297, "source": "PUBTATOR", "charStart": 293, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:oyRn", "entityType": "Disease", "charEnd": 1330, "source": "PUBTATOR", "charStart": 1315, "entityId": [{"idString": "D010996", "source": "MESH"}], "sentenceIndex": 10, "entityText": "pleural effusion"}, {"duid": "PU:bYva", "entityType": "Gene", "charEnd": 734, "source": "PUBTATOR", "charStart": 731, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}, {"duid": "PU:Kk4L", "entityType": "ProteinMutation", "charEnd": 825, "source": "PUBTATOR", "charStart": 809, "entityId": [{"idString": "p|INDEL|746,751|T,A", "source": "Unk"}], "sentenceIndex": 6, "entityText": "E746_T751del insA"}, {"duid": "PU:NLeS", "entityType": "Disease", "charEnd": 29, "source": "PUBTATOR", "charStart": 24, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 0, "entityText": "tumour"}, {"duid": "PU:LMce", "entityType": "Gene", "charEnd": 233, "source": "PUBTATOR", "charStart": 230, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:y8E6", "entityType": "Gene", "charEnd": 171, "source": "PUBTATOR", "charStart": 168, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:VMrt", "entityType": "Gene", "charEnd": 652, "source": "PUBTATOR", "charStart": 621, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:jed4", "entityType": "Disease", "charEnd": 63, "source": "PUBTATOR", "charStart": 48, "entityId": [{"idString": "D010996", "source": "MESH"}], "sentenceIndex": 0, "entityText": "pleural effusion"}, {"duid": "PU:XAKL", "entityType": "Disease", "charEnd": 316, "source": "PUBTATOR", "charStart": 301, "entityId": [{"idString": "D010996", "source": "MESH"}], "sentenceIndex": 2, "entityText": "Pleural effusion"}, {"duid": "PU:3Qex", "entityType": "Disease", "charEnd": 567, "source": "PUBTATOR", "charStart": 563, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 4, "entityText": "NSCLC"}, {"duid": "PU:DWrU", "entityType": "Disease", "charEnd": 356, "source": "PUBTATOR", "charStart": 346, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 2, "entityText": "lung cancer"}, {"duid": "PU:BqoS", "entityType": "Species", "charEnd": 1165, "source": "PUBTATOR", "charStart": 1158, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:QCpS", "entityType": "Species", "charEnd": 1255, "source": "PUBTATOR", "charStart": 1248, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:vqFy", "entityType": "Disease", "charEnd": 462, "source": "PUBTATOR", "charStart": 447, "entityId": [{"idString": "D010996", "source": "MESH"}], "sentenceIndex": 3, "entityText": "pleural effusion"}, {"duid": "PU:Zqpn", "entityType": "Species", "charEnd": 576, "source": "PUBTATOR", "charStart": 569, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:SBp9", "entityType": "Gene", "charEnd": 741, "source": "PUBTATOR", "charStart": 738, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:dUxA", "entityType": "Chemical", "charEnd": 1465, "source": "PUBTATOR", "charStart": 1457, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 10, "entityText": "gefitinib"}, {"duid": "PU:qxXQ", "entityType": "Gene", "charEnd": 165, "source": "PUBTATOR", "charStart": 134, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "Epidermal growth factor receptor"}, {"duid": "PU:YTBJ", "entityType": "ProteinMutation", "charEnd": 791, "source": "PUBTATOR", "charStart": 780, "entityId": [{"idString": "p|DEL|746,750|A", "source": "Unk"}], "sentenceIndex": 6, "entityText": "E746_A750del"}, {"duid": "PU:9ecv", "entityType": "Gene", "charEnd": 898, "source": "PUBTATOR", "charStart": 895, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:3Ywc", "entityType": "Gene", "charEnd": 3, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "EGFR"}, {"duid": "PU:ofQV", "entityType": "Species", "charEnd": 1113, "source": "PUBTATOR", "charStart": 1106, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:5mQs", "entityType": "Gene", "charEnd": 1363, "source": "PUBTATOR", "charStart": 1360, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:Yycs", "entityType": "Gene", "charEnd": 994, "source": "PUBTATOR", "charStart": 991, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:4Ve8", "entityType": "Gene", "charEnd": 1391, "source": "PUBTATOR", "charStart": 1388, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:HsTo", "entityType": "Chemical", "charEnd": 1038, "source": "PUBTATOR", "charStart": 1030, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 8, "entityText": "gefitinib"}, {"duid": "PU:G4dh", "entityType": "Chemical", "charEnd": 242, "source": "PUBTATOR", "charStart": 235, "entityId": [{"idString": "18186", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "tyrosine"}]}
{"text": "Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer. To evaluate the epidermal growth factor receptor (EGFR) protein expression, gene mutations and amplification as predictors of clinical outcome in patients with non-small-cell lung cancer (NSCLC) receiving gefitinib, we have performed fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC). We investigated the EGFR amplification and EGFR protein expression statuses in 27 surgically treated non-small-cell lung cancer (NSCLC) cases. These patients experienced relapse after surgery and received gefitinib 250 mg/day. The presence or absence of EGFR mutations of kinase domains was analyzed by genotyping analysis and sequences, and already reported. EGFR mutations were found from 15/27 lung cancer patients. EGFR mutation status was significantly correlated with better prognosis (log-rank test P=0.0023). Smoking status (never smoker vs. smoker, P=0.0032), and pathological subtypes (adenocarcinoma vs. non-adenocarcinoma, P=0.0011), but not EGFR amplification (P=0.1278), were correlated with survival of lung cancers. EGFR IHC results were correlated with FISH results (P=0.0125), but not correlated with prognosis (P=0.7921). Thus, the EGFR gene amplification or protein expression is not a predictor of gefitinib efficacy in Japanese patients with NSCLC. We have also evaluated the EGFR mutation status and clinico-pathological features for 27 NSCLC patients who had undergone surgery followed by treatment with gefitinib at the National Hospital Organization, Kinki-chuo Chest Medical Center. The EGFR mutation status, especially exon19 mutation was correlated with good response to gefitinib than exon 21 point mutation.", "title": {"charStart": 0, "charEnd": 116}, "docId": "17932690", "entity": [{"duid": "PU:6az9", "entityType": "Gene", "charEnd": 31, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Epidermal growth factor receptor"}, {"duid": "PU:DA99", "entityType": "Disease", "charEnd": 1058, "source": "PUBTATOR", "charStart": 1045, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 7, "entityText": "adenocarcinoma"}, {"duid": "PU:VZLM", "entityType": "Gene", "charEnd": 1083, "source": "PUBTATOR", "charStart": 1080, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:gRGT", "entityType": "Gene", "charEnd": 1280, "source": "PUBTATOR", "charStart": 1277, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "EGFR"}, {"duid": "PU:wyEx", "entityType": "Species", "charEnd": 1499, "source": "PUBTATOR", "charStart": 1492, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:Wzon", "entityType": "Disease", "charEnd": 1035, "source": "PUBTATOR", "charStart": 1022, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 7, "entityText": "adenocarcinoma"}, {"duid": "PU:EGVT", "entityType": "Species", "charEnd": 271, "source": "PUBTATOR", "charStart": 264, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:L6J6", "entityType": "Disease", "charEnd": 310, "source": "PUBTATOR", "charStart": 306, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:ppYH", "entityType": "Gene", "charEnd": 848, "source": "PUBTATOR", "charStart": 845, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:uTiD", "entityType": "Gene", "charEnd": 1427, "source": "PUBTATOR", "charStart": 1424, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:5g6w", "entityType": "Species", "charEnd": 842, "source": "PUBTATOR", "charStart": 835, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:P3MK", "entityType": "Gene", "charEnd": 165, "source": "PUBTATOR", "charStart": 134, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:iHW6", "entityType": "Disease", "charEnd": 115, "source": "PUBTATOR", "charStart": 105, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 0, "entityText": "lung cancer"}, {"duid": "PU:NU8R", "entityType": "Chemical", "charEnd": 639, "source": "PUBTATOR", "charStart": 631, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gefitinib"}, {"duid": "PU:zzJV", "entityType": "Disease", "charEnd": 1490, "source": "PUBTATOR", "charStart": 1486, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 10, "entityText": "NSCLC"}, {"duid": "PU:xViT", "entityType": "Gene", "charEnd": 472, "source": "PUBTATOR", "charStart": 469, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:RyHd", "entityType": "Chemical", "charEnd": 64, "source": "PUBTATOR", "charStart": 56, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gefitinib"}, {"duid": "PU:6p2f", "entityType": "Chemical", "charEnd": 1353, "source": "PUBTATOR", "charStart": 1345, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 9, "entityText": "gefitinib"}, {"duid": "PU:iLug", "entityType": "Disease", "charEnd": 552, "source": "PUBTATOR", "charStart": 527, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:ZYzz", "entityType": "Chemical", "charEnd": 331, "source": "PUBTATOR", "charStart": 323, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gefitinib"}, {"duid": "PU:FvE7", "entityType": "Gene", "charEnd": 171, "source": "PUBTATOR", "charStart": 168, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:oXKY", "entityType": "Disease", "charEnd": 15, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "D006130", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Epidermal growth"}, {"duid": "PU:zPNw", "entityType": "Gene", "charEnd": 1161, "source": "PUBTATOR", "charStart": 1158, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:hNEa", "entityType": "Species", "charEnd": 582, "source": "PUBTATOR", "charStart": 575, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:EBLh", "entityType": "Gene", "charEnd": 1643, "source": "PUBTATOR", "charStart": 1640, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}, {"duid": "PU:kfB2", "entityType": "Gene", "charEnd": 789, "source": "PUBTATOR", "charStart": 786, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}, {"duid": "PU:Ztxn", "entityType": "Disease", "charEnd": 1155, "source": "PUBTATOR", "charStart": 1132, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 7, "entityText": "survival of lung cancers"}, {"duid": "PU:oJTz", "entityType": "Disease", "charEnd": 559, "source": "PUBTATOR", "charStart": 555, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "NSCLC"}, {"duid": "PU:iAwj", "entityType": "Gene", "charEnd": 449, "source": "PUBTATOR", "charStart": 446, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:FFWo", "entityType": "Chemical", "charEnd": 1562, "source": "PUBTATOR", "charStart": 1554, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 10, "entityText": "gefitinib"}, {"duid": "PU:eMqt", "entityType": "Gene", "charEnd": 683, "source": "PUBTATOR", "charStart": 680, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:FrvJ", "entityType": "Species", "charEnd": 1383, "source": "PUBTATOR", "charStart": 1376, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:8ddE", "entityType": "Chemical", "charEnd": 1734, "source": "PUBTATOR", "charStart": 1726, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gefitinib"}, {"duid": "PU:SZqj", "entityType": "Species", "charEnd": 88, "source": "PUBTATOR", "charStart": 81, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:9dh7", "entityType": "Disease", "charEnd": 303, "source": "PUBTATOR", "charStart": 278, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:ng5u", "entityType": "Disease", "charEnd": 1394, "source": "PUBTATOR", "charStart": 1390, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 9, "entityText": "NSCLC"}, {"duid": "PU:8Kt7", "entityType": "Disease", "charEnd": 833, "source": "PUBTATOR", "charStart": 823, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 5, "entityText": "lung cancer"}]}
{"text": "Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer. To evaluate the epidermal growth factor receptor (EGFR) protein expression, gene mutations and amplification as predictors of clinical outcome in patients with non-small-cell lung cancer (NSCLC) receiving gefitinib, we have performed fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC). We investigated the EGFR amplification and EGFR protein expression statuses in 27 surgically treated non-small-cell lung cancer (NSCLC) cases. These patients experienced relapse after surgery and received gefitinib 250 mg/day. The presence or absence of EGFR mutations of kinase domains was analyzed by genotyping analysis and sequences, and already reported. EGFR mutations were found from 15/27 lung cancer patients. EGFR mutation status was significantly correlated with better prognosis (log-rank test P=0.0023). Smoking status (never smoker vs. smoker, P=0.0032), and pathological subtypes (adenocarcinoma vs. non-adenocarcinoma, P=0.0011), but not EGFR amplification (P=0.1278), were correlated with survival of lung cancers. EGFR IHC results were correlated with FISH results (P=0.0125), but not correlated with prognosis (P=0.7921). Thus, the EGFR gene amplification or protein expression is not a predictor of gefitinib efficacy in Japanese patients with NSCLC. We have also evaluated the EGFR mutation status and clinico-pathological features for 27 NSCLC patients who had undergone surgery followed by treatment with gefitinib at the National Hospital Organization, Kinki-chuo Chest Medical Center. The EGFR mutation status, especially exon19 mutation was correlated with good response to gefitinib than exon 21 point mutation.", "title": {"charStart": 0, "charEnd": 116}, "docId": "17932690", "entity": [{"duid": "PU:6az9", "entityType": "Gene", "charEnd": 31, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "Epidermal growth factor receptor"}, {"duid": "PU:DA99", "entityType": "Disease", "charEnd": 1058, "source": "PUBTATOR", "charStart": 1045, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 7, "entityText": "adenocarcinoma"}, {"duid": "PU:VZLM", "entityType": "Gene", "charEnd": 1083, "source": "PUBTATOR", "charStart": 1080, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:gRGT", "entityType": "Gene", "charEnd": 1280, "source": "PUBTATOR", "charStart": 1277, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "EGFR"}, {"duid": "PU:wyEx", "entityType": "Species", "charEnd": 1499, "source": "PUBTATOR", "charStart": 1492, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:Wzon", "entityType": "Disease", "charEnd": 1035, "source": "PUBTATOR", "charStart": 1022, "entityId": [{"idString": "D000230", "source": "MESH"}], "sentenceIndex": 7, "entityText": "adenocarcinoma"}, {"duid": "PU:EGVT", "entityType": "Species", "charEnd": 271, "source": "PUBTATOR", "charStart": 264, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:L6J6", "entityType": "Disease", "charEnd": 310, "source": "PUBTATOR", "charStart": 306, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:ppYH", "entityType": "Gene", "charEnd": 848, "source": "PUBTATOR", "charStart": 845, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:uTiD", "entityType": "Gene", "charEnd": 1427, "source": "PUBTATOR", "charStart": 1424, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:5g6w", "entityType": "Species", "charEnd": 842, "source": "PUBTATOR", "charStart": 835, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:P3MK", "entityType": "Gene", "charEnd": 165, "source": "PUBTATOR", "charStart": 134, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:iHW6", "entityType": "Disease", "charEnd": 115, "source": "PUBTATOR", "charStart": 105, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 0, "entityText": "lung cancer"}, {"duid": "PU:NU8R", "entityType": "Chemical", "charEnd": 639, "source": "PUBTATOR", "charStart": 631, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gefitinib"}, {"duid": "PU:zzJV", "entityType": "Disease", "charEnd": 1490, "source": "PUBTATOR", "charStart": 1486, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 10, "entityText": "NSCLC"}, {"duid": "PU:xViT", "entityType": "Gene", "charEnd": 472, "source": "PUBTATOR", "charStart": 469, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:RyHd", "entityType": "Chemical", "charEnd": 64, "source": "PUBTATOR", "charStart": 56, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gefitinib"}, {"duid": "PU:6p2f", "entityType": "Chemical", "charEnd": 1353, "source": "PUBTATOR", "charStart": 1345, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 9, "entityText": "gefitinib"}, {"duid": "PU:iLug", "entityType": "Disease", "charEnd": 552, "source": "PUBTATOR", "charStart": 527, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:ZYzz", "entityType": "Chemical", "charEnd": 331, "source": "PUBTATOR", "charStart": 323, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gefitinib"}, {"duid": "PU:FvE7", "entityType": "Gene", "charEnd": 171, "source": "PUBTATOR", "charStart": 168, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:oXKY", "entityType": "Disease", "charEnd": 15, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "D006130", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Epidermal growth"}, {"duid": "PU:zPNw", "entityType": "Gene", "charEnd": 1161, "source": "PUBTATOR", "charStart": 1158, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:hNEa", "entityType": "Species", "charEnd": 582, "source": "PUBTATOR", "charStart": 575, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:EBLh", "entityType": "Gene", "charEnd": 1643, "source": "PUBTATOR", "charStart": 1640, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}, {"duid": "PU:kfB2", "entityType": "Gene", "charEnd": 789, "source": "PUBTATOR", "charStart": 786, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}, {"duid": "PU:Ztxn", "entityType": "Disease", "charEnd": 1155, "source": "PUBTATOR", "charStart": 1132, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 7, "entityText": "survival of lung cancers"}, {"duid": "PU:oJTz", "entityType": "Disease", "charEnd": 559, "source": "PUBTATOR", "charStart": 555, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "NSCLC"}, {"duid": "PU:iAwj", "entityType": "Gene", "charEnd": 449, "source": "PUBTATOR", "charStart": 446, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:FFWo", "entityType": "Chemical", "charEnd": 1562, "source": "PUBTATOR", "charStart": 1554, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 10, "entityText": "gefitinib"}, {"duid": "PU:eMqt", "entityType": "Gene", "charEnd": 683, "source": "PUBTATOR", "charStart": 680, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:FrvJ", "entityType": "Species", "charEnd": 1383, "source": "PUBTATOR", "charStart": 1376, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:8ddE", "entityType": "Chemical", "charEnd": 1734, "source": "PUBTATOR", "charStart": 1726, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gefitinib"}, {"duid": "PU:SZqj", "entityType": "Species", "charEnd": 88, "source": "PUBTATOR", "charStart": 81, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:9dh7", "entityType": "Disease", "charEnd": 303, "source": "PUBTATOR", "charStart": 278, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:ng5u", "entityType": "Disease", "charEnd": 1394, "source": "PUBTATOR", "charStart": 1390, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 9, "entityText": "NSCLC"}, {"duid": "PU:8Kt7", "entityType": "Disease", "charEnd": 833, "source": "PUBTATOR", "charStart": 823, "entityId": [{"idString": "D008175", "source": "MESH"}], "sentenceIndex": 5, "entityText": "lung cancer"}]}
{"text": "Comparative analysis of epidermal growth factor receptor mutations and gene amplification as predictors of gefitinib efficacy in Japanese patients with nonsmall cell lung cancer. BACKGROUND: Because the investigation of epidermal growth factor receptor gene (EGFR) status as a predictor of gefitinib efficacy in Japanese patients has shown promise, the authors evaluated EGFR mutations and gene amplification in biopsy specimens from Japanese patients with nonsmall cell lung cancer (NSCLC) who received treatment with gefitinib to analyze the correlation between EGFR gene status and clinical outcome. METHODS: Fifty-nine patients were enrolled in this study. EGFR gene amplification was evaluated by fluorescence in situ hybridization (FISH), and EGFR mutations in exons 18, 19, and 21 were analyzed by polymerase chain reaction and direct sequencing. RESULTS: EGFR mutations were detected in 17 patients (28.8%). FISH-positive results were observed in 26 patients (48.1%). The response rate was significantly higher in the patients with EGFR mutations than in the patients without mutations (58.8% vs 14.3%; P=.0005). No significant difference in the response rate was observed between FISH-positive patients and FISH-negative patients (31.8% vs 21.4%; P=.4339). EGFR mutation was correlated with both a longer time to progression (TTP) (7.3 months vs 1.8 months; P=.0030) and longer overall survival (OS) (18.9 months vs 6.4 months; P=.0092). No significant differences in TTP or OS were observed between FISH-positive patients andFISH-negative patients. The results from a multivariate analysis indicated that EGFR mutations maintained a significant association with longer TTP and longer OS. CONCLUSIONS: The results of this study suggested that EGFR mutations may serve as predictors of response and survival and that the role of EGFR gene amplification is not a predictor of gefitinib efficacy in Japanese patients with NSCLC.", "title": {"charStart": 0, "charEnd": 177}, "docId": "17387741", "entity": [{"duid": "PU:Qeuo", "entityType": "Disease", "charEnd": 1859, "source": "PUBTATOR", "charStart": 1837, "entityId": [{"idString": "D030342", "source": "MESH"}], "sentenceIndex": 11, "entityText": "EGFR gene amplification"}, {"duid": "PU:2syJ", "entityType": "Disease", "charEnd": 176, "source": "PUBTATOR", "charStart": 152, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "nonsmall cell lung cancer"}, {"duid": "PU:hJAF", "entityType": "Gene", "charEnd": 1755, "source": "PUBTATOR", "charStart": 1752, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}, {"duid": "PU:KHWA", "entityType": "Gene", "charEnd": 1043, "source": "PUBTATOR", "charStart": 1040, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:4bZ4", "entityType": "Gene", "charEnd": 1618, "source": "PUBTATOR", "charStart": 1615, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:Nap9", "entityType": "Species", "charEnd": 450, "source": "PUBTATOR", "charStart": 443, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:utgA", "entityType": "Disease", "charEnd": 1406, "source": "PUBTATOR", "charStart": 1405, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 8, "entityText": "OS"}, {"duid": "PU:rgnB", "entityType": "Gene", "charEnd": 664, "source": "PUBTATOR", "charStart": 661, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:s5mM", "entityType": "Species", "charEnd": 905, "source": "PUBTATOR", "charStart": 898, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:538o", "entityType": "Gene", "charEnd": 55, "source": "PUBTATOR", "charStart": 24, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:zpp9", "entityType": "Disease", "charEnd": 1681, "source": "PUBTATOR", "charStart": 1679, "entityId": [{"idString": "D000377", "source": "MESH"}], "sentenceIndex": 10, "entityText": "TTP"}, {"duid": "PU:Z8Um", "entityType": "Disease", "charEnd": 1932, "source": "PUBTATOR", "charStart": 1928, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 11, "entityText": "NSCLC"}, {"duid": "PU:oTMx", "entityType": "Species", "charEnd": 328, "source": "PUBTATOR", "charStart": 321, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:bLqy", "entityType": "Species", "charEnd": 1210, "source": "PUBTATOR", "charStart": 1203, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:tHqy", "entityType": "Species", "charEnd": 965, "source": "PUBTATOR", "charStart": 958, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:yQnV", "entityType": "Species", "charEnd": 1237, "source": "PUBTATOR", "charStart": 1230, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:KDLn", "entityType": "Species", "charEnd": 630, "source": "PUBTATOR", "charStart": 623, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:ejGa", "entityType": "Species", "charEnd": 1921, "source": "PUBTATOR", "charStart": 1914, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:HwzH", "entityType": "Chemical", "charEnd": 527, "source": "PUBTATOR", "charStart": 519, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gefitinib"}, {"duid": "PU:9357", "entityType": "Species", "charEnd": 1074, "source": "PUBTATOR", "charStart": 1067, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:c3TW", "entityType": "Species", "charEnd": 1530, "source": "PUBTATOR", "charStart": 1523, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:x4TU", "entityType": "Disease", "charEnd": 683, "source": "PUBTATOR", "charStart": 661, "entityId": [{"idString": "D030342", "source": "MESH"}], "sentenceIndex": 3, "entityText": "EGFR gene amplification"}, {"duid": "PU:mmuR", "entityType": "Gene", "charEnd": 567, "source": "PUBTATOR", "charStart": 564, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:AfsN", "entityType": "Disease", "charEnd": 481, "source": "PUBTATOR", "charStart": 457, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "nonsmall cell lung cancer"}, {"duid": "PU:dMSg", "entityType": "Disease", "charEnd": 1695, "source": "PUBTATOR", "charStart": 1694, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 10, "entityText": "OS"}, {"duid": "PU:NvTG", "entityType": "Chemical", "charEnd": 1891, "source": "PUBTATOR", "charStart": 1883, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gefitinib"}, {"duid": "PU:WKcJ", "entityType": "Species", "charEnd": 1556, "source": "PUBTATOR", "charStart": 1549, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:GcwP", "entityType": "Disease", "charEnd": 1337, "source": "PUBTATOR", "charStart": 1335, "entityId": [{"idString": "D000377", "source": "MESH"}], "sentenceIndex": 8, "entityText": "TTP"}, {"duid": "PU:vyrm", "entityType": "Species", "charEnd": 145, "source": "PUBTATOR", "charStart": 138, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:9uiD", "entityType": "Gene", "charEnd": 262, "source": "PUBTATOR", "charStart": 259, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:K4Bp", "entityType": "Disease", "charEnd": 488, "source": "PUBTATOR", "charStart": 484, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:eJ22", "entityType": "Gene", "charEnd": 866, "source": "PUBTATOR", "charStart": 863, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:vLck", "entityType": "Species", "charEnd": 1033, "source": "PUBTATOR", "charStart": 1026, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:aHsk", "entityType": "Disease", "charEnd": 1485, "source": "PUBTATOR", "charStart": 1484, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 9, "entityText": "OS"}, {"duid": "PU:mawu", "entityType": "Chemical", "charEnd": 1479, "source": "PUBTATOR", "charStart": 1477, "entityId": [{"idString": "C024157", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TTP"}, {"duid": "PU:dFCr", "entityType": "Gene", "charEnd": 752, "source": "PUBTATOR", "charStart": 749, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:a6PW", "entityType": "Disease", "charEnd": 1332, "source": "PUBTATOR", "charStart": 1314, "entityId": [{"idString": "D000377", "source": "MESH"}], "sentenceIndex": 8, "entityText": "time to progression"}, {"duid": "PU:ubox", "entityType": "Gene", "charEnd": 1269, "source": "PUBTATOR", "charStart": 1266, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:GXqT", "entityType": "Chemical", "charEnd": 298, "source": "PUBTATOR", "charStart": 290, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gefitinib"}, {"duid": "PU:JxSD", "entityType": "Chemical", "charEnd": 115, "source": "PUBTATOR", "charStart": 107, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gefitinib"}, {"duid": "PU:aiFi", "entityType": "Disease", "charEnd": 1402, "source": "PUBTATOR", "charStart": 1387, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 8, "entityText": "overall survival"}, {"duid": "PU:AxLm", "entityType": "Gene", "charEnd": 251, "source": "PUBTATOR", "charStart": 220, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:V7qM", "entityType": "Gene", "charEnd": 374, "source": "PUBTATOR", "charStart": 371, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:vb9d", "entityType": "Gene", "charEnd": 1840, "source": "PUBTATOR", "charStart": 1837, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}]}
{"text": "Comparative analysis of epidermal growth factor receptor mutations and gene amplification as predictors of gefitinib efficacy in Japanese patients with nonsmall cell lung cancer. BACKGROUND: Because the investigation of epidermal growth factor receptor gene (EGFR) status as a predictor of gefitinib efficacy in Japanese patients has shown promise, the authors evaluated EGFR mutations and gene amplification in biopsy specimens from Japanese patients with nonsmall cell lung cancer (NSCLC) who received treatment with gefitinib to analyze the correlation between EGFR gene status and clinical outcome. METHODS: Fifty-nine patients were enrolled in this study. EGFR gene amplification was evaluated by fluorescence in situ hybridization (FISH), and EGFR mutations in exons 18, 19, and 21 were analyzed by polymerase chain reaction and direct sequencing. RESULTS: EGFR mutations were detected in 17 patients (28.8%). FISH-positive results were observed in 26 patients (48.1%). The response rate was significantly higher in the patients with EGFR mutations than in the patients without mutations (58.8% vs 14.3%; P=.0005). No significant difference in the response rate was observed between FISH-positive patients and FISH-negative patients (31.8% vs 21.4%; P=.4339). EGFR mutation was correlated with both a longer time to progression (TTP) (7.3 months vs 1.8 months; P=.0030) and longer overall survival (OS) (18.9 months vs 6.4 months; P=.0092). No significant differences in TTP or OS were observed between FISH-positive patients andFISH-negative patients. The results from a multivariate analysis indicated that EGFR mutations maintained a significant association with longer TTP and longer OS. CONCLUSIONS: The results of this study suggested that EGFR mutations may serve as predictors of response and survival and that the role of EGFR gene amplification is not a predictor of gefitinib efficacy in Japanese patients with NSCLC.", "title": {"charStart": 0, "charEnd": 177}, "docId": "17387741", "entity": [{"duid": "PU:Qeuo", "entityType": "Disease", "charEnd": 1859, "source": "PUBTATOR", "charStart": 1837, "entityId": [{"idString": "D030342", "source": "MESH"}], "sentenceIndex": 11, "entityText": "EGFR gene amplification"}, {"duid": "PU:2syJ", "entityType": "Disease", "charEnd": 176, "source": "PUBTATOR", "charStart": 152, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "nonsmall cell lung cancer"}, {"duid": "PU:hJAF", "entityType": "Gene", "charEnd": 1755, "source": "PUBTATOR", "charStart": 1752, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}, {"duid": "PU:KHWA", "entityType": "Gene", "charEnd": 1043, "source": "PUBTATOR", "charStart": 1040, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:4bZ4", "entityType": "Gene", "charEnd": 1618, "source": "PUBTATOR", "charStart": 1615, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:Nap9", "entityType": "Species", "charEnd": 450, "source": "PUBTATOR", "charStart": 443, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:utgA", "entityType": "Disease", "charEnd": 1406, "source": "PUBTATOR", "charStart": 1405, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 8, "entityText": "OS"}, {"duid": "PU:rgnB", "entityType": "Gene", "charEnd": 664, "source": "PUBTATOR", "charStart": 661, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:s5mM", "entityType": "Species", "charEnd": 905, "source": "PUBTATOR", "charStart": 898, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 4, "entityText": "patients"}, {"duid": "PU:538o", "entityType": "Gene", "charEnd": 55, "source": "PUBTATOR", "charStart": 24, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:zpp9", "entityType": "Disease", "charEnd": 1681, "source": "PUBTATOR", "charStart": 1679, "entityId": [{"idString": "D000377", "source": "MESH"}], "sentenceIndex": 10, "entityText": "TTP"}, {"duid": "PU:Z8Um", "entityType": "Disease", "charEnd": 1932, "source": "PUBTATOR", "charStart": 1928, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 11, "entityText": "NSCLC"}, {"duid": "PU:oTMx", "entityType": "Species", "charEnd": 328, "source": "PUBTATOR", "charStart": 321, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:bLqy", "entityType": "Species", "charEnd": 1210, "source": "PUBTATOR", "charStart": 1203, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:tHqy", "entityType": "Species", "charEnd": 965, "source": "PUBTATOR", "charStart": 958, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}, {"duid": "PU:yQnV", "entityType": "Species", "charEnd": 1237, "source": "PUBTATOR", "charStart": 1230, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:KDLn", "entityType": "Species", "charEnd": 630, "source": "PUBTATOR", "charStart": 623, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:ejGa", "entityType": "Species", "charEnd": 1921, "source": "PUBTATOR", "charStart": 1914, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:HwzH", "entityType": "Chemical", "charEnd": 527, "source": "PUBTATOR", "charStart": 519, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gefitinib"}, {"duid": "PU:9357", "entityType": "Species", "charEnd": 1074, "source": "PUBTATOR", "charStart": 1067, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:c3TW", "entityType": "Species", "charEnd": 1530, "source": "PUBTATOR", "charStart": 1523, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:x4TU", "entityType": "Disease", "charEnd": 683, "source": "PUBTATOR", "charStart": 661, "entityId": [{"idString": "D030342", "source": "MESH"}], "sentenceIndex": 3, "entityText": "EGFR gene amplification"}, {"duid": "PU:mmuR", "entityType": "Gene", "charEnd": 567, "source": "PUBTATOR", "charStart": 564, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:AfsN", "entityType": "Disease", "charEnd": 481, "source": "PUBTATOR", "charStart": 457, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "nonsmall cell lung cancer"}, {"duid": "PU:dMSg", "entityType": "Disease", "charEnd": 1695, "source": "PUBTATOR", "charStart": 1694, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 10, "entityText": "OS"}, {"duid": "PU:NvTG", "entityType": "Chemical", "charEnd": 1891, "source": "PUBTATOR", "charStart": 1883, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gefitinib"}, {"duid": "PU:WKcJ", "entityType": "Species", "charEnd": 1556, "source": "PUBTATOR", "charStart": 1549, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 9, "entityText": "patients"}, {"duid": "PU:GcwP", "entityType": "Disease", "charEnd": 1337, "source": "PUBTATOR", "charStart": 1335, "entityId": [{"idString": "D000377", "source": "MESH"}], "sentenceIndex": 8, "entityText": "TTP"}, {"duid": "PU:vyrm", "entityType": "Species", "charEnd": 145, "source": "PUBTATOR", "charStart": 138, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:9uiD", "entityType": "Gene", "charEnd": 262, "source": "PUBTATOR", "charStart": 259, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:K4Bp", "entityType": "Disease", "charEnd": 488, "source": "PUBTATOR", "charStart": 484, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "NSCLC"}, {"duid": "PU:eJ22", "entityType": "Gene", "charEnd": 866, "source": "PUBTATOR", "charStart": 863, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:vLck", "entityType": "Species", "charEnd": 1033, "source": "PUBTATOR", "charStart": 1026, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:aHsk", "entityType": "Disease", "charEnd": 1485, "source": "PUBTATOR", "charStart": 1484, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 9, "entityText": "OS"}, {"duid": "PU:mawu", "entityType": "Chemical", "charEnd": 1479, "source": "PUBTATOR", "charStart": 1477, "entityId": [{"idString": "C024157", "source": "MESH"}], "sentenceIndex": 9, "entityText": "TTP"}, {"duid": "PU:dFCr", "entityType": "Gene", "charEnd": 752, "source": "PUBTATOR", "charStart": 749, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:a6PW", "entityType": "Disease", "charEnd": 1332, "source": "PUBTATOR", "charStart": 1314, "entityId": [{"idString": "D000377", "source": "MESH"}], "sentenceIndex": 8, "entityText": "time to progression"}, {"duid": "PU:ubox", "entityType": "Gene", "charEnd": 1269, "source": "PUBTATOR", "charStart": 1266, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "EGFR"}, {"duid": "PU:GXqT", "entityType": "Chemical", "charEnd": 298, "source": "PUBTATOR", "charStart": 290, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 1, "entityText": "gefitinib"}, {"duid": "PU:JxSD", "entityType": "Chemical", "charEnd": 115, "source": "PUBTATOR", "charStart": 107, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gefitinib"}, {"duid": "PU:aiFi", "entityType": "Disease", "charEnd": 1402, "source": "PUBTATOR", "charStart": 1387, "entityId": [{"idString": "D011475", "source": "MESH"}], "sentenceIndex": 8, "entityText": "overall survival"}, {"duid": "PU:AxLm", "entityType": "Gene", "charEnd": 251, "source": "PUBTATOR", "charStart": 220, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:V7qM", "entityType": "Gene", "charEnd": 374, "source": "PUBTATOR", "charStart": 371, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:vb9d", "entityType": "Gene", "charEnd": 1840, "source": "PUBTATOR", "charStart": 1837, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}]}
{"text": "Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer. An anti-ERBB2 antibody, trastuzumab, has been shown to be highly efficient in the treatment of metastatic breast cancers overexpressing the ERBB2 gene. It has been suggested that overexpression and even amplification of ERBB2 may play a role in the development of prostate cancer. Here, we have analyzed gene copy number and expression of the ERBB2 gene in both androgen-dependent primary and metastatic tumors, as well as recurrent hormone-refractory tumors. The expression levels were compared to the expression of ERBB2 in breast cancers with or without ERBB2 gene amplification. Of 126 prostate tumors, chromogenic in situ hybridization (CISH) revealed only 1 case containing borderline (six to eight copies) amplifications of ERBB2. This hormone-refractory tumor, however, did not express ERBB2 protein. Immunohistochemical staining of ERBB2 protein was negative (0 or 1+ intensity) in all prostate samples (n = 124) analyzed. To quantitate the level of ERBB2 mRNA expression in prostate tumors (n = 34) and cell lines (n = 3), as well as in breast tumors (n = 30) and cell lines (n = 16), real-time reverse transcriptase-polymerase chain reaction (LightCycler) methodology was used. The expression level was similar in all prostate tumor types and corresponded to the level of expression in breast carcinomas without ERBB2 amplification. Breast tumors with ERBB2 amplification expressed, on average, approximately 20 times (P < 0.001) higher mRNA levels than prostate tumors or breast carcinomas without the gene amplification. In conclusion, the expression of ERBB2 in prostate cancer is relatively low, and is not altered during disease progression. Thus, it is unlikely that treatment modalities relying on the overexpression of ERBB2 gene will be useful in treating prostate cancer.", "title": {"charStart": 0, "charEnd": 77}, "docId": "11786427", "entity": [{"duid": "PU:mgyY", "entityType": "Disease", "charEnd": 1138, "source": "PUBTATOR", "charStart": 1126, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 8, "entityText": "breast tumors"}, {"duid": "PU:NMQe", "entityType": "Disease", "charEnd": 683, "source": "PUBTATOR", "charStart": 669, "entityId": [{"idString": "D011471", "source": "MESH"}], "sentenceIndex": 5, "entityText": "prostate tumors"}, {"duid": "PU:9Jv9", "entityType": "Gene", "charEnd": 600, "source": "PUBTATOR", "charStart": 596, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERBB2"}, {"duid": "PU:i3ot", "entityType": "Gene", "charEnd": 1406, "source": "PUBTATOR", "charStart": 1402, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ERBB2"}, {"duid": "PU:VMmd", "entityType": "Disease", "charEnd": 488, "source": "PUBTATOR", "charStart": 472, "entityId": [{"idString": "D009362", "source": "MESH"}], "sentenceIndex": 3, "entityText": "metastatic tumors"}, {"duid": "PU:iuho", "entityType": "Disease", "charEnd": 1435, "source": "PUBTATOR", "charStart": 1423, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 10, "entityText": "Breast tumors"}, {"duid": "PU:hgm2", "entityType": "Gene", "charEnd": 426, "source": "PUBTATOR", "charStart": 422, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "ERBB2"}, {"duid": "PU:L8Tx", "entityType": "Chemical", "charEnd": 768, "source": "PUBTATOR", "charStart": 759, "entityId": [], "sentenceIndex": 5, "entityText": "borderline"}, {"duid": "PU:pJ98", "entityType": "Gene", "charEnd": 877, "source": "PUBTATOR", "charStart": 873, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "ERBB2"}, {"duid": "PU:DGCx", "entityType": "Disease", "charEnd": 618, "source": "PUBTATOR", "charStart": 605, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 4, "entityText": "breast cancers"}, {"duid": "PU:GYcv", "entityType": "Disease", "charEnd": 536, "source": "PUBTATOR", "charStart": 531, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:AQVh", "entityType": "Gene", "charEnd": 924, "source": "PUBTATOR", "charStart": 920, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ERBB2"}, {"duid": "PU:RoRR", "entityType": "Gene", "charEnd": 1650, "source": "PUBTATOR", "charStart": 1646, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ERBB2"}, {"duid": "PU:ci5p", "entityType": "Disease", "charEnd": 1077, "source": "PUBTATOR", "charStart": 1063, "entityId": [{"idString": "D011471", "source": "MESH"}], "sentenceIndex": 8, "entityText": "prostate tumors"}, {"duid": "PU:K5yu", "entityType": "Disease", "charEnd": 845, "source": "PUBTATOR", "charStart": 841, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumor"}, {"duid": "PU:CYkw", "entityType": "Gene", "charEnd": 1446, "source": "PUBTATOR", "charStart": 1442, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ERBB2"}, {"duid": "PU:waag", "entityType": "Disease", "charEnd": 1321, "source": "PUBTATOR", "charStart": 1308, "entityId": [{"idString": "D011471", "source": "MESH"}], "sentenceIndex": 9, "entityText": "prostate tumor"}, {"duid": "PU:96Sz", "entityType": "Disease", "charEnd": 1392, "source": "PUBTATOR", "charStart": 1376, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 9, "entityText": "breast carcinomas"}, {"duid": "PU:Qhv3", "entityType": "Gene", "charEnd": 223, "source": "PUBTATOR", "charStart": 219, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERBB2"}, {"duid": "PU:CkmR", "entityType": "Disease", "charEnd": 357, "source": "PUBTATOR", "charStart": 343, "entityId": [{"idString": "D011471", "source": "MESH"}], "sentenceIndex": 2, "entityText": "prostate cancer"}, {"duid": "PU:XjqE", "entityType": "Disease", "charEnd": 1558, "source": "PUBTATOR", "charStart": 1544, "entityId": [{"idString": "D011471", "source": "MESH"}], "sentenceIndex": 10, "entityText": "prostate tumors"}, {"duid": "PU:Y6NF", "entityType": "Gene", "charEnd": 640, "source": "PUBTATOR", "charStart": 636, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "ERBB2"}, {"duid": "PU:BvKW", "entityType": "Gene", "charEnd": 1821, "source": "PUBTATOR", "charStart": 1817, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "ERBB2"}, {"duid": "PU:S4go", "entityType": "Disease", "charEnd": 1869, "source": "PUBTATOR", "charStart": 1855, "entityId": [{"idString": "D011471", "source": "MESH"}], "sentenceIndex": 12, "entityText": "prostate cancer"}, {"duid": "PU:YzBq", "entityType": "Gene", "charEnd": 91, "source": "PUBTATOR", "charStart": 87, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "ERBB2"}, {"duid": "PU:wota", "entityType": "Gene", "charEnd": 48, "source": "PUBTATOR", "charStart": 44, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "ERBB2"}, {"duid": "PU:TUQY", "entityType": "Disease", "charEnd": 1579, "source": "PUBTATOR", "charStart": 1563, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 10, "entityText": "breast carcinomas"}, {"duid": "PU:ZEwA", "entityType": "Gene", "charEnd": 814, "source": "PUBTATOR", "charStart": 810, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "ERBB2"}, {"duid": "PU:o8WH", "entityType": "Gene", "charEnd": 1042, "source": "PUBTATOR", "charStart": 1038, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ERBB2"}, {"duid": "PU:6AnA", "entityType": "Gene", "charEnd": 303, "source": "PUBTATOR", "charStart": 299, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ERBB2"}, {"duid": "PU:aGjR", "entityType": "Disease", "charEnd": 1669, "source": "PUBTATOR", "charStart": 1655, "entityId": [{"idString": "D011471", "source": "MESH"}], "sentenceIndex": 11, "entityText": "prostate cancer"}, {"duid": "PU:pgSR", "entityType": "Disease", "charEnd": 76, "source": "PUBTATOR", "charStart": 62, "entityId": [{"idString": "D011471", "source": "MESH"}], "sentenceIndex": 0, "entityText": "prostate cancer"}, {"duid": "PU:5hf3", "entityType": "Disease", "charEnd": 198, "source": "PUBTATOR", "charStart": 185, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast cancers"}, {"duid": "PU:n85D", "entityType": "Chemical", "charEnd": 448, "source": "PUBTATOR", "charStart": 441, "entityId": [{"idString": "50113", "source": "CHEBI"}], "sentenceIndex": 3, "entityText": "androgen"}]}
{"text": "Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer. The potential relevance of epidermal growth factor receptor (EGFR) mutations to non-small-cell lung cancer treatment has recently been identified. We have examined the presence of EGFR mutations in Japanese and Spanish gefitinib-treated non-small-cell lung cancer patients. A total of 34 gefitinib-treated patients were screened, 18 from Japan and 16 from Spain. Laser capture microdissection was performed for the accurate procurement of tumor cells. EGFR exons 18, 19 and 21 were amplified from genomic DNA by means of PCR, and the samples were then subjected to bi-directional automatic sequencing. EGFR somatic mutations in the tyrosine kinase domain were found in 8 of 34 patients (23.5%). Gefitinib response was observed in 7 of 8 patients (87.5%) with EGFR mutations and in 3 of 24 (12.5%) with wild-type EGFR (P=0.0003). Five deletion mutations were clustered in the region spanning codons 746 to 750 (ELREA) within exon 19. Three additional tumors had amino acid substitutions within exon 18, at codons 718 and 719. Logistic regression analysis showed that response was primarily linked to the presence of EGFR mutations and secondarily linked to female gender, non-smoker status and a greater number of prior chemotherapy regimens. The presence of EGFR mutations is a major determinant of gefitinib response, and EGFR tyrosine kinase inhibitors should be tested in clinical trials of first-line treatment of lung adenocarcinomas harboring EGFR mutations.", "title": {"charStart": 0, "charEnd": 121}, "docId": "16011858", "entity": [{"duid": "PU:P2fU", "entityType": "Chemical", "charEnd": 81, "source": "PUBTATOR", "charStart": 73, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 0, "entityText": "gefitinib"}, {"duid": "PU:6zyM", "entityType": "Disease", "charEnd": 1560, "source": "PUBTATOR", "charStart": 1541, "entityId": [{"idString": "C538231", "source": "MESH"}], "sentenceIndex": 11, "entityText": "lung adenocarcinomas"}, {"duid": "PU:LJYm", "entityType": "Gene", "charEnd": 306, "source": "PUBTATOR", "charStart": 303, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "EGFR"}, {"duid": "PU:risB", "entityType": "Gene", "charEnd": 50, "source": "PUBTATOR", "charStart": 47, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "EGFR"}, {"duid": "PU:o92n", "entityType": "Chemical", "charEnd": 24, "source": "PUBTATOR", "charStart": 17, "entityId": [{"idString": "18186", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "tyrosine"}, {"duid": "PU:9ZVy", "entityType": "Disease", "charEnd": 566, "source": "PUBTATOR", "charStart": 562, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tumor"}, {"duid": "PU:iQLN", "entityType": "Gene", "charEnd": 187, "source": "PUBTATOR", "charStart": 184, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "EGFR"}, {"duid": "PU:YKBf", "entityType": "Species", "charEnd": 436, "source": "PUBTATOR", "charStart": 429, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "patients"}, {"duid": "PU:a4GB", "entityType": "Chemical", "charEnd": 1458, "source": "PUBTATOR", "charStart": 1451, "entityId": [{"idString": "18186", "source": "CHEBI"}], "sentenceIndex": 11, "entityText": "tyrosine"}, {"duid": "PU:uB9c", "entityType": "Chemical", "charEnd": 419, "source": "PUBTATOR", "charStart": 411, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 3, "entityText": "gefitinib"}, {"duid": "PU:eTAM", "entityType": "Gene", "charEnd": 1575, "source": "PUBTATOR", "charStart": 1572, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}, {"duid": "PU:8LoD", "entityType": "Gene", "charEnd": 728, "source": "PUBTATOR", "charStart": 725, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:q59S", "entityType": "Species", "charEnd": 394, "source": "PUBTATOR", "charStart": 387, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:T87n", "entityType": "Disease", "charEnd": 1078, "source": "PUBTATOR", "charStart": 1073, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:5ah9", "entityType": "Disease", "charEnd": 385, "source": "PUBTATOR", "charStart": 360, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 2, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:6ejr", "entityType": "Gene", "charEnd": 1384, "source": "PUBTATOR", "charStart": 1381, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}, {"duid": "PU:pkra", "entityType": "Disease", "charEnd": 120, "source": "PUBTATOR", "charStart": 95, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 0, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:jfWT", "entityType": "Chemical", "charEnd": 1430, "source": "PUBTATOR", "charStart": 1422, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 11, "entityText": "gefitinib"}, {"duid": "PU:aLh5", "entityType": "Gene", "charEnd": 1449, "source": "PUBTATOR", "charStart": 1446, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "EGFR"}, {"duid": "PU:MeJq", "entityType": "Disease", "charEnd": 228, "source": "PUBTATOR", "charStart": 203, "entityId": [{"idString": "D002289", "source": "MESH"}], "sentenceIndex": 1, "entityText": "non-small-cell lung cancer"}, {"duid": "PU:SbCA", "entityType": "Species", "charEnd": 807, "source": "PUBTATOR", "charStart": 800, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:s9dH", "entityType": "Gene", "charEnd": 885, "source": "PUBTATOR", "charStart": 882, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:af8y", "entityType": "Species", "charEnd": 867, "source": "PUBTATOR", "charStart": 860, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:s7Ct", "entityType": "Gene", "charEnd": 938, "source": "PUBTATOR", "charStart": 935, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:MLqZ", "entityType": "Gene", "charEnd": 181, "source": "PUBTATOR", "charStart": 150, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:nsdC", "entityType": "Chemical", "charEnd": 826, "source": "PUBTATOR", "charStart": 818, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 7, "entityText": "Gefitinib"}, {"duid": "PU:fpbP", "entityType": "Gene", "charEnd": 1241, "source": "PUBTATOR", "charStart": 1238, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:69Vx", "entityType": "Chemical", "charEnd": 350, "source": "PUBTATOR", "charStart": 342, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 2, "entityText": "gefitinib"}, {"duid": "PU:yERs", "entityType": "Chemical", "charEnd": 762, "source": "PUBTATOR", "charStart": 755, "entityId": [{"idString": "18186", "source": "CHEBI"}], "sentenceIndex": 6, "entityText": "tyrosine"}, {"duid": "PU:WLmb", "entityType": "Gene", "charEnd": 578, "source": "PUBTATOR", "charStart": 575, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}, {"duid": "PU:Dm5p", "entityType": "Chemical", "charEnd": 1093, "source": "PUBTATOR", "charStart": 1084, "entityId": [{"idString": "33704", "source": "CHEBI"}], "sentenceIndex": 9, "entityText": "amino acid"}]}
{"text": "Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Not all breast cancers respond to tamoxifen, and many develop resistance despite initial benefit. We used an in vivo model of estrogen receptor (ER)-positive breast cancer (MCF-7 xenografts) to investigate mechanisms of this resistance and develop strategies to circumvent it. Epidermal growth factor receptor (EGFR) and HER2, which were barely detected in control estrogen-treated tumors, increased slightly with tamoxifen and were markedly increased when tumors became resistant. Gefitinib, which inhibits EGFR/HER2, improved the antitumor effect of tamoxifen and delayed acquired resistance, but had no effect on estrogen-stimulated growth. Phosphorylated levels of p42/44 and p38 mitogen-activated protein kinases (both downstream of EGFR/HER2) were increased in the tamoxifen-resistant tumors and were suppressed by gefitinib. There was no apparent increase in phosphorylated AKT (also downstream of EGFR/HER2) in resistant tumors, but it was nonetheless suppressed by gefitinib. Phosphorylated insulin-like growth factor-IR (IGF-IR), which can interact with both EGFR and membrane ER, was elevated in the tamoxifen-resistant tumors compared with the sensitive group. However, ER-regulated gene products, including total IGF-IR itself and progesterone receptor, remained suppressed even at the time of acquired resistance. Tamoxifen's antagonism of classic ER genomic function was retained in these resistant tumors and even in tumors that overexpress HER2 (MCF-7 HER2/18) and are de novo tamoxifen-resistant. In conclusion, EGFR/HER2 may mediate tamoxifen resistance in ER-positive breast cancer despite continued suppression of ER genomic function by tamoxifen. IGF-IR expression remains dependent on ER but is activated in the tamoxifen-resistant tumors. This study provides a rationale to combine HER inhibitors with tamoxifen in clinical studies, even in tumors that do not initially overexpress EGFR/HER2.", "title": {"charStart": 0, "charEnd": 145}, "docId": "18245484", "entity": [{"duid": "PU:akK8", "entityType": "Disease", "charEnd": 609, "source": "PUBTATOR", "charStart": 604, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:TpFy", "entityType": "Gene", "charEnd": 1219, "source": "PUBTATOR", "charStart": 1216, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "EGFR"}, {"duid": "PU:5GKE", "entityType": "Gene", "charEnd": 471, "source": "PUBTATOR", "charStart": 468, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "HER2"}, {"duid": "PU:WE4e", "entityType": "Gene", "charEnd": 1510, "source": "PUBTATOR", "charStart": 1509, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "ER"}, {"duid": "PU:AvSd", "entityType": "Gene", "charEnd": 1235, "source": "PUBTATOR", "charStart": 1234, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "ER"}, {"duid": "PU:6hUj", "entityType": "Chemical", "charEnd": 637, "source": "PUBTATOR", "charStart": 629, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 4, "entityText": "Gefitinib"}, {"duid": "PU:pBoj", "entityType": "Gene", "charEnd": 289, "source": "PUBTATOR", "charStart": 273, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "estrogen receptor"}, {"duid": "PU:RAwj", "entityType": "Chemical", "charEnd": 1402, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "D011374", "source": "MESH"}], "sentenceIndex": 8, "entityText": "progesterone"}, {"duid": "PU:QKwK", "entityType": "Chemical", "charEnd": 118, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 0, "entityText": "estrogen"}, {"duid": "PU:UrsS", "entityType": "Gene", "charEnd": 1783, "source": "PUBTATOR", "charStart": 1782, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ER"}, {"duid": "PU:2TkB", "entityType": "Gene", "charEnd": 893, "source": "PUBTATOR", "charStart": 890, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "HER2"}, {"duid": "PU:NSK2", "entityType": "Gene", "charEnd": 663, "source": "PUBTATOR", "charStart": 660, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "HER2"}, {"duid": "PU:ct2g", "entityType": "Chemical", "charEnd": 519, "source": "PUBTATOR", "charStart": 512, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 3, "entityText": "estrogen"}, {"duid": "PU:ELtf", "entityType": "Chemical", "charEnd": 1266, "source": "PUBTATOR", "charStart": 1258, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tamoxifen"}, {"duid": "PU:giJ8", "entityType": "Disease", "charEnd": 168, "source": "PUBTATOR", "charStart": 155, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 1, "entityText": "breast cancers"}, {"duid": "PU:Rzxq", "entityType": "Chemical", "charEnd": 1981, "source": "PUBTATOR", "charStart": 1973, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 12, "entityText": "tamoxifen"}, {"duid": "PU:EvXj", "entityType": "Gene", "charEnd": 2056, "source": "PUBTATOR", "charStart": 2053, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "EGFR"}, {"duid": "PU:Rqbg", "entityType": "Gene", "charEnd": 1183, "source": "PUBTATOR", "charStart": 1178, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "IGF-IR"}, {"duid": "PU:9mb8", "entityType": "Chemical", "charEnd": 1649, "source": "PUBTATOR", "charStart": 1641, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tamoxifen"}, {"duid": "PU:mN3u", "entityType": "Gene", "charEnd": 818, "source": "PUBTATOR", "charStart": 816, "entityId": [{"idString": "2038", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p42"}, {"duid": "PU:CZ8u", "entityType": "Gene", "charEnd": 1055, "source": "PUBTATOR", "charStart": 1052, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "EGFR"}, {"duid": "PU:Ljhs", "entityType": "Chemical", "charEnd": 8, "source": "PUBTATOR", "charStart": 0, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 0, "entityText": "Tamoxifen"}, {"duid": "PU:Eeiw", "entityType": "Disease", "charEnd": 534, "source": "PUBTATOR", "charStart": 529, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tumors"}, {"duid": "PU:PmoC", "entityType": "Disease", "charEnd": 1747, "source": "PUBTATOR", "charStart": 1723, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 10, "entityText": "ER-positive breast cancer"}, {"duid": "PU:2fr8", "entityType": "Chemical", "charEnd": 1707, "source": "PUBTATOR", "charStart": 1699, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tamoxifen"}, {"duid": "PU:3gcW", "entityType": "Chemical", "charEnd": 1483, "source": "PUBTATOR", "charStart": 1475, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Tamoxifen"}, {"duid": "PU:Naus", "entityType": "Gene", "charEnd": 1856, "source": "PUBTATOR", "charStart": 1855, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "ER"}, {"duid": "PU:NWrH", "entityType": "Chemical", "charEnd": 189, "source": "PUBTATOR", "charStart": 181, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 1, "entityText": "tamoxifen"}, {"duid": "PU:cxzJ", "entityType": "Gene", "charEnd": 461, "source": "PUBTATOR", "charStart": 458, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "EGFR"}, {"duid": "PU:GgYc", "entityType": "Chemical", "charEnd": 926, "source": "PUBTATOR", "charStart": 918, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tamoxifen"}, {"duid": "PU:xJmn", "entityType": "Disease", "charEnd": 1283, "source": "PUBTATOR", "charStart": 1278, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 7, "entityText": "tumors"}, {"duid": "PU:wrFT", "entityType": "Chemical", "charEnd": 569, "source": "PUBTATOR", "charStart": 561, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 3, "entityText": "tamoxifen"}, {"duid": "PU:3UFG", "entityType": "Disease", "charEnd": 1566, "source": "PUBTATOR", "charStart": 1561, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:k9nf", "entityType": "Disease", "charEnd": 1081, "source": "PUBTATOR", "charStart": 1076, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumors"}, {"duid": "PU:TmEG", "entityType": "Gene", "charEnd": 658, "source": "PUBTATOR", "charStart": 655, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "EGFR"}, {"duid": "PU:uDi6", "entityType": "Gene", "charEnd": 127, "source": "PUBTATOR", "charStart": 111, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 0, "entityText": "estrogen receptor"}, {"duid": "PU:aDbj", "entityType": "Gene", "charEnd": 2061, "source": "PUBTATOR", "charStart": 2058, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 12, "entityText": "HER2"}, {"duid": "PU:FfDe", "entityType": "Gene", "charEnd": 1622, "source": "PUBTATOR", "charStart": 1616, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2/18"}, {"duid": "PU:2Hvz", "entityType": "Chemical", "charEnd": 1129, "source": "PUBTATOR", "charStart": 1121, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 6, "entityText": "gefitinib"}, {"duid": "PU:h5sL", "entityType": "Gene", "charEnd": 1680, "source": "PUBTATOR", "charStart": 1677, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "EGFR"}, {"duid": "PU:vG4j", "entityType": "Gene", "charEnd": 1378, "source": "PUBTATOR", "charStart": 1373, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "IGF-IR"}, {"duid": "PU:zrMd", "entityType": "Gene", "charEnd": 1330, "source": "PUBTATOR", "charStart": 1329, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "ER"}, {"duid": "PU:Ht4B", "entityType": "Disease", "charEnd": 36, "source": "PUBTATOR", "charStart": 24, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast tumors"}, {"duid": "PU:aszU", "entityType": "Gene", "charEnd": 1607, "source": "PUBTATOR", "charStart": 1604, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 9, "entityText": "HER2"}, {"duid": "PU:6Eau", "entityType": "Gene", "charEnd": 1411, "source": "PUBTATOR", "charStart": 1391, "entityId": [{"idString": "5241", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "progesterone receptor"}, {"duid": "PU:KHZQ", "entityType": "Chemical", "charEnd": 1813, "source": "PUBTATOR", "charStart": 1805, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 10, "entityText": "tamoxifen"}, {"duid": "PU:bTq5", "entityType": "Disease", "charEnd": 1585, "source": "PUBTATOR", "charStart": 1580, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 9, "entityText": "tumors"}, {"duid": "PU:sTnf", "entityType": "Gene", "charEnd": 455, "source": "PUBTATOR", "charStart": 424, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "Epidermal growth factor receptor"}, {"duid": "PU:o936", "entityType": "Gene", "charEnd": 829, "source": "PUBTATOR", "charStart": 827, "entityId": [{"idString": "1432", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "p38"}, {"duid": "PU:adSa", "entityType": "Disease", "charEnd": 2017, "source": "PUBTATOR", "charStart": 2012, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 12, "entityText": "tumors"}, {"duid": "PU:Nkrm", "entityType": "Disease", "charEnd": 943, "source": "PUBTATOR", "charStart": 938, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 5, "entityText": "tumors"}, {"duid": "PU:ZASj", "entityType": "Disease", "charEnd": 1907, "source": "PUBTATOR", "charStart": 1902, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 11, "entityText": "tumors"}, {"duid": "PU:mpnZ", "entityType": "Disease", "charEnd": 317, "source": "PUBTATOR", "charStart": 305, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 2, "entityText": "breast cancer"}, {"duid": "PU:XMZz", "entityType": "Gene", "charEnd": 293, "source": "PUBTATOR", "charStart": 292, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 2, "entityText": "ER"}, {"duid": "PU:zWBu", "entityType": "Chemical", "charEnd": 280, "source": "PUBTATOR", "charStart": 273, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 2, "entityText": "estrogen"}, {"duid": "PU:DZMN", "entityType": "Gene", "charEnd": 1724, "source": "PUBTATOR", "charStart": 1723, "entityId": [{"idString": "2099", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "ER"}, {"duid": "PU:vvqJ", "entityType": "Gene", "charEnd": 1175, "source": "PUBTATOR", "charStart": 1147, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "insulin-like growth factor-IR"}, {"duid": "PU:j6JD", "entityType": "Chemical", "charEnd": 976, "source": "PUBTATOR", "charStart": 968, "entityId": [{"idString": "C419708", "source": "MESH"}], "sentenceIndex": 5, "entityText": "gefitinib"}, {"duid": "PU:sEGC", "entityType": "Gene", "charEnd": 1685, "source": "PUBTATOR", "charStart": 1682, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "HER2"}, {"duid": "PU:i8A9", "entityType": "Gene", "charEnd": 1821, "source": "PUBTATOR", "charStart": 1816, "entityId": [{"idString": "3480", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "IGF-IR"}, {"duid": "PU:oXAg", "entityType": "Disease", "charEnd": 1165, "source": "PUBTATOR", "charStart": 1132, "entityId": [{"idString": "D006130", "source": "MESH"}], "sentenceIndex": 7, "entityText": "Phosphorylated insulin-like growth"}, {"duid": "PU:fMXn", "entityType": "Chemical", "charEnd": 770, "source": "PUBTATOR", "charStart": 763, "entityId": [{"idString": "D004967", "source": "MESH"}], "sentenceIndex": 4, "entityText": "estrogen"}, {"duid": "PU:kX45", "entityType": "Gene", "charEnd": 1060, "source": "PUBTATOR", "charStart": 1057, "entityId": [{"idString": "2064", "source": "Entrez"}], "sentenceIndex": 6, "entityText": "HER2"}, {"duid": "PU:h7A9", "entityType": "Chemical", "charEnd": 1890, "source": "PUBTATOR", "charStart": 1882, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 11, "entityText": "tamoxifen"}, {"duid": "PU:gFEv", "entityType": "Chemical", "charEnd": 707, "source": "PUBTATOR", "charStart": 699, "entityId": [{"idString": "D013629", "source": "MESH"}], "sentenceIndex": 4, "entityText": "tamoxifen"}, {"duid": "PU:BZB5", "entityType": "Gene", "charEnd": 888, "source": "PUBTATOR", "charStart": 885, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "EGFR"}]}
{"text": "Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). PURPOSE: To determine the clinical efficacy of imatinib in patients with advanced aggressive fibromatosis (AF) and to identify the molecular basis of response/nonresponse to this agent. PATIENTS AND METHODS: Nineteen patients with AF were treated with imatinib (800 mg/d) as part of a phase II clinical study. Tumor specimens were analyzed for mutations of KIT, PDGFRA, PDGFRB, and CTNNB1 (beta-catenin). Tumor expression of total and activated KIT, PDGFRA, and PDGFRB were assessed using immunohistochemistry and immunoblotting techniques. We also measured plasma levels of PDGF-AA and PDGF-BB in patients and normal patient controls. RESULTS: Three of 19 patients (15.7%) had a partial response to treatment, with four additional patients having stable disease that lasted more than 1 year (overall 1 year tumor control rate of 36.8%). No mutations of KIT, PDGFRA, or PDGFRB were found. Sixteen of 19 patients (84%) had mutations involving the WNT pathway (APC or CTNNB1). However, there was no correlation between WNT pathway mutations and clinical response to imatinib. AF tumors expressed minimal to null levels of KIT and PDGFRA but expressed levels of PDGFRB that are comparable with normal fibroblasts. However, PDGFRB phosphorylation was not detected, suggesting that PDGFRB is only weakly activated. AF patients had elevated levels of PDGF-AA and PDGF-BB compared with normal patient controls. Notably, the plasma level of PDGF-BB was inversely correlated with time to treatment failure. CONCLUSION: Imatinib is an active agent in the treatment of advanced AF. Imatinib response in AF patients may be mediated by inhibition of PDGFRB kinase activity.", "title": {"charStart": 0, "charEnd": 108}, "docId": "16505440", "entity": [{"duid": "PU:bqWj", "entityType": "Species", "charEnd": 774, "source": "PUBTATOR", "charStart": 767, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:7HoY", "entityType": "Disease", "charEnd": 1678, "source": "PUBTATOR", "charStart": 1677, "entityId": [{"idString": "D001281", "source": "MESH"}], "sentenceIndex": 14, "entityText": "AF"}, {"duid": "PU:NxLd", "entityType": "Disease", "charEnd": 342, "source": "PUBTATOR", "charStart": 341, "entityId": [{"idString": "D001281", "source": "MESH"}], "sentenceIndex": 2, "entityText": "AF"}, {"duid": "PU:2Qmo", "entityType": "Species", "charEnd": 1502, "source": "PUBTATOR", "charStart": 1496, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 12, "entityText": "patient"}, {"duid": "PU:KWK3", "entityType": "Species", "charEnd": 849, "source": "PUBTATOR", "charStart": 842, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "patients"}, {"duid": "PU:ANP4", "entityType": "Chemical", "charEnd": 1627, "source": "PUBTATOR", "charStart": 1620, "entityId": [{"idString": "C097613", "source": "MESH"}], "sentenceIndex": 14, "entityText": "Imatinib"}, {"duid": "PU:C98J", "entityType": "Chemical", "charEnd": 1461, "source": "PUBTATOR", "charStart": 1460, "entityId": [{"idString": "C493772", "source": "MESH"}], "sentenceIndex": 12, "entityText": "AA"}, {"duid": "PU:ZE7M", "entityType": "Species", "charEnd": 176, "source": "PUBTATOR", "charStart": 169, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:C9PL", "entityType": "Gene", "charEnd": 1335, "source": "PUBTATOR", "charStart": 1330, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "PDGFRB"}, {"duid": "PU:Z3Yw", "entityType": "Disease", "charEnd": 91, "source": "PUBTATOR", "charStart": 69, "entityId": [{"idString": "D001523", "source": "MESH"}], "sentenceIndex": 0, "entityText": "aggressive fibromatosis"}, {"duid": "PU:QWMP", "entityType": "Disease", "charEnd": 1703, "source": "PUBTATOR", "charStart": 1702, "entityId": [{"idString": "D001281", "source": "MESH"}], "sentenceIndex": 15, "entityText": "AF"}, {"duid": "PU:9AtD", "entityType": "Gene", "charEnd": 565, "source": "PUBTATOR", "charStart": 560, "entityId": [{"idString": "5156", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "PDGFRA"}, {"duid": "PU:fgus", "entityType": "Species", "charEnd": 1712, "source": "PUBTATOR", "charStart": 1705, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 15, "entityText": "patients"}, {"duid": "PU:qYMW", "entityType": "Chemical", "charEnd": 369, "source": "PUBTATOR", "charStart": 362, "entityId": [{"idString": "C097613", "source": "MESH"}], "sentenceIndex": 2, "entityText": "imatinib"}, {"duid": "PU:riut", "entityType": "Gene", "charEnd": 511, "source": "PUBTATOR", "charStart": 500, "entityId": [{"idString": "1499", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "beta-catenin"}, {"duid": "PU:5dyr", "entityType": "Disease", "charEnd": 1421, "source": "PUBTATOR", "charStart": 1420, "entityId": [{"idString": "D001281", "source": "MESH"}], "sentenceIndex": 12, "entityText": "AF"}, {"duid": "PU:KoX3", "entityType": "Gene", "charEnd": 1243, "source": "PUBTATOR", "charStart": 1238, "entityId": [{"idString": "5156", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "PDGFRA"}, {"duid": "PU:5Dmn", "entityType": "Disease", "charEnd": 1192, "source": "PUBTATOR", "charStart": 1184, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 10, "entityText": "AF tumors"}, {"duid": "PU:r82j", "entityType": "Gene", "charEnd": 1274, "source": "PUBTATOR", "charStart": 1269, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 10, "entityText": "PDGFRB"}, {"duid": "PU:ABgn", "entityType": "Gene", "charEnd": 477, "source": "PUBTATOR", "charStart": 472, "entityId": [{"idString": "5156", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "PDGFRA"}, {"duid": "PU:XoaL", "entityType": "Disease", "charEnd": 1071, "source": "PUBTATOR", "charStart": 1069, "entityId": [{"idString": "D011125", "source": "MESH"}], "sentenceIndex": 8, "entityText": "APC"}, {"duid": "PU:sFBg", "entityType": "Disease", "charEnd": 922, "source": "PUBTATOR", "charStart": 918, "entityId": [{"idString": "D009369", "source": "MESH"}], "sentenceIndex": 6, "entityText": "tumor"}, {"duid": "PU:bZ45", "entityType": "Chemical", "charEnd": 1549, "source": "PUBTATOR", "charStart": 1543, "entityId": [{"idString": "C072194", "source": "MESH"}], "sentenceIndex": 13, "entityText": "PDGF-BB"}, {"duid": "PU:JtCM", "entityType": "Species", "charEnd": 334, "source": "PUBTATOR", "charStart": 327, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "patients"}, {"duid": "PU:Q5yD", "entityType": "Gene", "charEnd": 1081, "source": "PUBTATOR", "charStart": 1076, "entityId": [{"idString": "1499", "source": "Entrez"}], "sentenceIndex": 8, "entityText": "CTNNB1"}, {"duid": "PU:QQty", "entityType": "Gene", "charEnd": 485, "source": "PUBTATOR", "charStart": 480, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "PDGFRB"}, {"duid": "PU:Q28a", "entityType": "Disease", "charEnd": 106, "source": "PUBTATOR", "charStart": 94, "entityId": [{"idString": "C535944", "source": "MESH"}], "sentenceIndex": 0, "entityText": "desmoid tumor"}, {"duid": "PU:RgTb", "entityType": "Gene", "charEnd": 974, "source": "PUBTATOR", "charStart": 969, "entityId": [{"idString": "5156", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "PDGFRA"}, {"duid": "PU:eNqM", "entityType": "Species", "charEnd": 1020, "source": "PUBTATOR", "charStart": 1013, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 8, "entityText": "patients"}, {"duid": "PU:wPyk", "entityType": "Disease", "charEnd": 214, "source": "PUBTATOR", "charStart": 192, "entityId": [{"idString": "D001523", "source": "MESH"}], "sentenceIndex": 1, "entityText": "aggressive fibromatosis"}, {"duid": "PU:zCDh", "entityType": "Chemical", "charEnd": 55, "source": "PUBTATOR", "charStart": 48, "entityId": [{"idString": "C097613", "source": "MESH"}], "sentenceIndex": 0, "entityText": "imatinib"}, {"duid": "PU:dmdk", "entityType": "Species", "charEnd": 734, "source": "PUBTATOR", "charStart": 728, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patient"}, {"duid": "PU:BM3p", "entityType": "Species", "charEnd": 303, "source": "PUBTATOR", "charStart": 296, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 2, "entityText": "PATIENTS"}, {"duid": "PU:h34T", "entityType": "Disease", "charEnd": 218, "source": "PUBTATOR", "charStart": 217, "entityId": [{"idString": "D001281", "source": "MESH"}], "sentenceIndex": 1, "entityText": "AF"}, {"duid": "PU:jZXH", "entityType": "Gene", "charEnd": 1392, "source": "PUBTATOR", "charStart": 1387, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 11, "entityText": "PDGFRB"}, {"duid": "PU:BPtc", "entityType": "Gene", "charEnd": 1752, "source": "PUBTATOR", "charStart": 1747, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 15, "entityText": "PDGFRB"}, {"duid": "PU:pLbu", "entityType": "Gene", "charEnd": 497, "source": "PUBTATOR", "charStart": 492, "entityId": [{"idString": "1499", "source": "Entrez"}], "sentenceIndex": 3, "entityText": "CTNNB1"}, {"duid": "PU:9PWG", "entityType": "Chemical", "charEnd": 691, "source": "PUBTATOR", "charStart": 690, "entityId": [{"idString": "C493772", "source": "MESH"}], "sentenceIndex": 5, "entityText": "AA"}, {"duid": "PU:bvea", "entityType": "Species", "charEnd": 1430, "source": "PUBTATOR", "charStart": 1423, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 12, "entityText": "patients"}, {"duid": "PU:cijh", "entityType": "Gene", "charEnd": 985, "source": "PUBTATOR", "charStart": 980, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "PDGFRB"}, {"duid": "PU:kUkN", "entityType": "Gene", "charEnd": 577, "source": "PUBTATOR", "charStart": 572, "entityId": [{"idString": "5159", "source": "Entrez"}], "sentenceIndex": 4, "entityText": "PDGFRB"}, {"duid": "PU:75TD", "entityType": "Species", "charEnd": 715, "source": "PUBTATOR", "charStart": 708, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 5, "entityText": "patients"}]}
{"text": "Endocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancer. PURPOSE: The purpose of the study was to assess the endocrine effects of vandetanib, a multikinase inhibitor targeting RET, vascular endothelial growth factor receptor, and epidermal growth factor receptor, in 39 patients with progressive thyroid cancer included in two randomized placebo-controlled trials using vandetanib 300 mg/d. METHODS: Endocrine samplings were performed at baseline and then every 6 months. We compared differences in endocrine parameters between baseline and on vandetanib therapy or placebo. RESULTS: During vandetanib treatment, several changes were observed. 1) Calcium (P = 0.0004) and vitamin D (P = 0.001) mean replacement doses were increased; calcium level remained unchanged, but serum 25(OH) vitamin D level decreased (P = 0.001); and serum PTH (P = 0.01) and 1,25(OH)(2) vitamin D (P = 0.01) levels increased, suggesting a decreased intestinal absorption of vitamin D or lack of sun exposure as a result of photosensitization. 2) l-T(4) doses were increased (P < 0.0001) to maintain serum TSH within the normal range. 3) In male patients, total testosterone (P = 0.048), bioavailable testosterone (P = 0.03), and SHBG (P = 0.02) levels increased. Serum inhibin B decreased (P = 0.02) and stimulated FSH increased (P = 0.006), suggesting a Sertoli cells insufficiency. 4) Cortisol level increased (P = 0.007) as well as ACTH level (P = 0.03) and cortisol-binding globulin (P = 0.02), but free urinary cortisol levels remained in the normal range. None of these changes were observed in patients randomized to the placebo arm. CONCLUSION: In patients with locally advanced or metastatic thyroid cancer, the tyrosine kinase inhibitor vandetanib has several endocrine effects. Thyroid hormone, calcium, and vitamin D analog requirements increased, but consequences of the biological alterations on phosphocalcic metabolism and gonadotrope and adrenal functions are unknown.", "title": {"charStart": 0, "charEnd": 100}, "docId": "21715537", "entity": [{"duid": "PU:KSAA", "entityType": "Species", "charEnd": 72, "source": "PUBTATOR", "charStart": 65, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 0, "entityText": "patients"}, {"duid": "PU:jQNL", "entityType": "Chemical", "charEnd": 784, "source": "PUBTATOR", "charStart": 778, "entityId": [{"idString": "D002118", "source": "MESH"}], "sentenceIndex": 5, "entityText": "calcium"}, {"duid": "PU:PKm7", "entityType": "Chemical", "charEnd": 1834, "source": "PUBTATOR", "charStart": 1828, "entityId": [{"idString": "D002118", "source": "MESH"}], "sentenceIndex": 12, "entityText": "calcium"}, {"duid": "PU:FkLm", "entityType": "Species", "charEnd": 1630, "source": "PUBTATOR", "charStart": 1623, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 10, "entityText": "patients"}, {"duid": "PU:io3F", "entityType": "Chemical", "charEnd": 598, "source": "PUBTATOR", "charStart": 589, "entityId": [{"idString": "C452423", "source": "MESH"}], "sentenceIndex": 3, "entityText": "vandetanib"}, {"duid": "PU:hGfF", "entityType": "Chemical", "charEnd": 645, "source": "PUBTATOR", "charStart": 636, "entityId": [{"idString": "C452423", "source": "MESH"}], "sentenceIndex": 4, "entityText": "vandetanib"}, {"duid": "PU:FwNj", "entityType": "Chemical", "charEnd": 725, "source": "PUBTATOR", "charStart": 717, "entityId": [{"idString": "D014807", "source": "MESH"}], "sentenceIndex": 5, "entityText": "vitamin D"}, {"duid": "PU:AtHF", "entityType": "Chemical", "charEnd": 1490, "source": "PUBTATOR", "charStart": 1483, "entityId": [{"idString": "D006854", "source": "MESH"}], "sentenceIndex": 9, "entityText": "cortisol"}, {"duid": "PU:ypEB", "entityType": "Disease", "charEnd": 99, "source": "PUBTATOR", "charStart": 86, "entityId": [{"idString": "D013964", "source": "MESH"}], "sentenceIndex": 0, "entityText": "thyroid cancer"}, {"duid": "PU:8BmQ", "entityType": "Chemical", "charEnd": 1073, "source": "PUBTATOR", "charStart": 1068, "entityId": [{"idString": "18332", "source": "CHEBI"}], "sentenceIndex": 6, "entityText": "l-T(4)"}, {"duid": "PU:wmCZ", "entityType": "Chemical", "charEnd": 698, "source": "PUBTATOR", "charStart": 692, "entityId": [{"idString": "D002118", "source": "MESH"}], "sentenceIndex": 5, "entityText": "Calcium"}, {"duid": "PU:fC6q", "entityType": "Chemical", "charEnd": 60, "source": "PUBTATOR", "charStart": 51, "entityId": [{"idString": "C452423", "source": "MESH"}], "sentenceIndex": 0, "entityText": "vandetanib"}, {"duid": "PU:BeGW", "entityType": "Gene", "charEnd": 223, "source": "PUBTATOR", "charStart": 221, "entityId": [{"idString": "5979", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "RET"}, {"duid": "PU:zygM", "entityType": "Chemical", "charEnd": 1233, "source": "PUBTATOR", "charStart": 1222, "entityId": [{"idString": "D013739", "source": "MESH"}], "sentenceIndex": 7, "entityText": "testosterone"}, {"duid": "PU:HrjL", "entityType": "Gene", "charEnd": 1254, "source": "PUBTATOR", "charStart": 1251, "entityId": [{"idString": "6462", "source": "Entrez"}], "sentenceIndex": 7, "entityText": "SHBG"}, {"duid": "PU:ouYM", "entityType": "Chemical", "charEnd": 917, "source": "PUBTATOR", "charStart": 897, "entityId": [], "sentenceIndex": 5, "entityText": "1,25(OH)(2) vitamin D"}, {"duid": "PU:pYDC", "entityType": "Chemical", "charEnd": 1004, "source": "PUBTATOR", "charStart": 996, "entityId": [{"idString": "D014807", "source": "MESH"}], "sentenceIndex": 5, "entityText": "vitamin D"}, {"duid": "PU:MGpB", "entityType": "Species", "charEnd": 1685, "source": "PUBTATOR", "charStart": 1678, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 11, "entityText": "patients"}, {"duid": "PU:utqH", "entityType": "Chemical", "charEnd": 1849, "source": "PUBTATOR", "charStart": 1841, "entityId": [{"idString": "D014807", "source": "MESH"}], "sentenceIndex": 12, "entityText": "vitamin D"}, {"duid": "PU:Y2XB", "entityType": "Gene", "charEnd": 306, "source": "PUBTATOR", "charStart": 275, "entityId": [{"idString": "1956", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "epidermal growth factor receptor"}, {"duid": "PU:5dCT", "entityType": "Chemical", "charEnd": 184, "source": "PUBTATOR", "charStart": 175, "entityId": [{"idString": "C452423", "source": "MESH"}], "sentenceIndex": 1, "entityText": "vandetanib"}, {"duid": "PU:GxkC", "entityType": "Disease", "charEnd": 354, "source": "PUBTATOR", "charStart": 341, "entityId": [{"idString": "D013964", "source": "MESH"}], "sentenceIndex": 1, "entityText": "thyroid cancer"}, {"duid": "PU:DTCN", "entityType": "Gene", "charEnd": 880, "source": "PUBTATOR", "charStart": 878, "entityId": [{"idString": "5741", "source": "Entrez"}], "sentenceIndex": 5, "entityText": "PTH"}, {"duid": "PU:sSfT", "entityType": "Chemical", "charEnd": 1416, "source": "PUBTATOR", "charStart": 1409, "entityId": [{"idString": "D006854", "source": "MESH"}], "sentenceIndex": 9, "entityText": "Cortisol"}, {"duid": "PU:hVvH", "entityType": "Chemical", "charEnd": 424, "source": "PUBTATOR", "charStart": 415, "entityId": [{"idString": "C452423", "source": "MESH"}], "sentenceIndex": 1, "entityText": "vandetanib"}, {"duid": "PU:fTYm", "entityType": "Chemical", "charEnd": 1545, "source": "PUBTATOR", "charStart": 1538, "entityId": [{"idString": "D006854", "source": "MESH"}], "sentenceIndex": 9, "entityText": "cortisol"}, {"duid": "PU:J6AX", "entityType": "Chemical", "charEnd": 837, "source": "PUBTATOR", "charStart": 822, "entityId": [], "sentenceIndex": 5, "entityText": "25(OH) vitamin D"}, {"duid": "PU:5aV4", "entityType": "Chemical", "charEnd": 32, "source": "PUBTATOR", "charStart": 25, "entityId": [{"idString": "18186", "source": "CHEBI"}], "sentenceIndex": 0, "entityText": "tyrosine"}, {"duid": "PU:tJwQ", "entityType": "Chemical", "charEnd": 1750, "source": "PUBTATOR", "charStart": 1743, "entityId": [{"idString": "18186", "source": "CHEBI"}], "sentenceIndex": 11, "entityText": "tyrosine"}, {"duid": "PU:wxsH", "entityType": "Chemical", "charEnd": 1778, "source": "PUBTATOR", "charStart": 1769, "entityId": [{"idString": "C452423", "source": "MESH"}], "sentenceIndex": 11, "entityText": "vandetanib"}, {"duid": "PU:5NRY", "entityType": "Species", "charEnd": 1174, "source": "PUBTATOR", "charStart": 1167, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "patients"}, {"duid": "PU:w2ve", "entityType": "Chemical", "charEnd": 1194, "source": "PUBTATOR", "charStart": 1183, "entityId": [{"idString": "D013739", "source": "MESH"}], "sentenceIndex": 7, "entityText": "testosterone"}, {"duid": "PU:u2yL", "entityType": "Species", "charEnd": 322, "source": "PUBTATOR", "charStart": 315, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:9UvS", "entityType": "Disease", "charEnd": 1736, "source": "PUBTATOR", "charStart": 1723, "entityId": [{"idString": "D013964", "source": "MESH"}], "sentenceIndex": 11, "entityText": "thyroid cancer"}]}
{"text": "Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on the brain distribution of a novel BRAF inhibitor: vemurafenib (PLX4032). Vemurafenib [N-(3-{[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide(PLX4032)] is a novel small-molecule BRAF inhibitor, recently approved by the Food and Drug Administration for the treatment of patients with metastatic melanoma with a BRAF(V600E) mutation. The objective of this study was to investigate the role of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) in the distribution of vemurafenib to the central nervous system. In vitro studies conducted in transfected Madin-Darby canine kidney II cells show that the intracellular accumulation of vemurafenib is significantly restricted because of active efflux by P-gp and BCRP. Bidirectional flux studies indicated greater transport in the basolateral-to-apical direction than the apical-to-basolateral direction because of active efflux by P-gp and BCRP. The selective P-gp and BCRP inhibitors zosuquidar and (3S,6S,12aS)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino(1',2':1,6)pyrido(3,4-b)indole-3-propanoic acid-1,1-dimethylethyl ester (Ko143) were able to restore the intracellular accumulation and bidirectional net flux of vemurafenib. The in vivo studies revealed that the brain distribution coefficient (area under the concentration time profile of brain/area under the concentration time profile of plasma) of vemurafenib was 0.004 in wild-type mice. The steady-state brain-to-plasma ratio of vemurafenib was 0.035 \u00b1 0.009 in Mdr1a/b(-/-) mice, 0.009 \u00b1 0.006 in Bcrp1(-/-) mice, and 1.00 \u00b1 0.19 in Mdr1a/b(-/-)Bcrp1(-/-) mice compared with 0.012 \u00b1 0.004 in wild-type mice. These data indicate that the brain distribution of vemurafenib is severely restricted at the blood-brain barrier because of active efflux by both P-gp and BCRP. This finding has important clinical significance given the ongoing trials examining the efficacy of vemurafenib in brain metastases of melanoma.", "title": {"charStart": 0, "charEnd": 152}, "docId": "22454535", "entity": [{"duid": "PU:GNT5", "entityType": "ProteinMutation", "charEnd": 451, "source": "PUBTATOR", "charStart": 447, "entityId": [{"idString": "p|SUB|V|600|E;RS#:113488022", "source": "Unk"}], "sentenceIndex": 1, "entityText": "V600E"}, {"duid": "PU:PYb6", "entityType": "Disease", "charEnd": 49, "source": "PUBTATOR", "charStart": 37, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 0, "entityText": "breast cancer"}, {"duid": "PU:obsN", "entityType": "Gene", "charEnd": 1735, "source": "PUBTATOR", "charStart": 1731, "entityId": [{"idString": "26357", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 7, "entityText": "Bcrp1"}, {"duid": "PU:trra", "entityType": "Chemical", "charEnd": 1855, "source": "PUBTATOR", "charStart": 1845, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 8, "entityText": "vemurafenib"}, {"duid": "PU:2U5e", "entityType": "Chemical", "charEnd": 1541, "source": "PUBTATOR", "charStart": 1531, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 6, "entityText": "vemurafenib"}, {"duid": "PU:cmen", "entityType": "Gene", "charEnd": 1943, "source": "PUBTATOR", "charStart": 1940, "entityId": [{"idString": "67078", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 8, "entityText": "P-gp"}, {"duid": "PU:3Vuw", "entityType": "Species", "charEnd": 1663, "source": "PUBTATOR", "charStart": 1660, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "mice"}, {"duid": "PU:KA4r", "entityType": "Gene", "charEnd": 451, "source": "PUBTATOR", "charStart": 442, "entityId": [{"idString": "673", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "BRAF(V600E"}, {"duid": "PU:AFMq", "entityType": "Gene", "charEnd": 1054, "source": "PUBTATOR", "charStart": 1051, "entityId": [{"idString": "67078", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "P-gp"}, {"duid": "PU:dmaH", "entityType": "Species", "charEnd": 714, "source": "PUBTATOR", "charStart": 709, "entityId": [{"idString": "9615", "source": "NCBI"}], "sentenceIndex": 3, "entityText": "canine"}, {"duid": "PU:mhJT", "entityType": "Species", "charEnd": 1697, "source": "PUBTATOR", "charStart": 1694, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "mice"}, {"duid": "PU:wYdV", "entityType": "Species", "charEnd": 408, "source": "PUBTATOR", "charStart": 401, "entityId": [{"idString": "9606", "source": "NCBI"}], "sentenceIndex": 1, "entityText": "patients"}, {"duid": "PU:oQPB", "entityType": "Chemical", "charEnd": 280, "source": "PUBTATOR", "charStart": 274, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 1, "entityText": "PLX4032"}, {"duid": "PU:nw5F", "entityType": "Gene", "charEnd": 580, "source": "PUBTATOR", "charStart": 549, "entityId": [{"idString": "26357", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 2, "entityText": "breast cancer resistance protein"}, {"duid": "PU:cuQz", "entityType": "Chemical", "charEnd": 164, "source": "PUBTATOR", "charStart": 154, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 1, "entityText": "Vemurafenib"}, {"duid": "PU:7SjV", "entityType": "Chemical", "charEnd": 141, "source": "PUBTATOR", "charStart": 131, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 0, "entityText": "vemurafenib"}, {"duid": "PU:b5Sm", "entityType": "Chemical", "charEnd": 272, "source": "PUBTATOR", "charStart": 167, "entityId": [{"idString": "63637", "source": "CHEBI"}], "sentenceIndex": 1, "entityText": "N-(3-{[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide"}, {"duid": "PU:Mfab", "entityType": "Chemical", "charEnd": 1351, "source": "PUBTATOR", "charStart": 1341, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 5, "entityText": "vemurafenib"}, {"duid": "PU:jfgx", "entityType": "Gene", "charEnd": 847, "source": "PUBTATOR", "charStart": 844, "entityId": [{"idString": "610926", "source": "Entrez"}, {"idString": "9615", "source": "Tax"}], "sentenceIndex": 3, "entityText": "P-gp"}, {"duid": "PU:7NXt", "entityType": "Disease", "charEnd": 561, "source": "PUBTATOR", "charStart": 549, "entityId": [{"idString": "D001943", "source": "MESH"}], "sentenceIndex": 2, "entityText": "breast cancer"}, {"duid": "PU:niTw", "entityType": "Chemical", "charEnd": 1249, "source": "PUBTATOR", "charStart": 1091, "entityId": [], "sentenceIndex": 5, "entityText": "(3S,6S,12aS)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino(1',2':1,6)pyrido(3,4-b)indole-3-propanoic acid-1,1-dimethylethyl ester"}, {"duid": "PU:Wg38", "entityType": "Species", "charEnd": 1569, "source": "PUBTATOR", "charStart": 1566, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 6, "entityText": "mice"}, {"duid": "PU:yigE", "entityType": "Gene", "charEnd": 118, "source": "PUBTATOR", "charStart": 115, "entityId": [{"idString": "109880", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 0, "entityText": "BRAF"}, {"duid": "PU:xjZs", "entityType": "Gene", "charEnd": 313, "source": "PUBTATOR", "charStart": 310, "entityId": [{"idString": "673", "source": "Entrez"}], "sentenceIndex": 1, "entityText": "BRAF"}, {"duid": "PU:5LPv", "entityType": "Gene", "charEnd": 856, "source": "PUBTATOR", "charStart": 853, "entityId": [{"idString": "478472", "source": "Entrez"}, {"idString": "9615", "source": "Tax"}], "sentenceIndex": 3, "entityText": "BCRP"}, {"duid": "PU:rt4d", "entityType": "Gene", "charEnd": 1025, "source": "PUBTATOR", "charStart": 1022, "entityId": [{"idString": "67078", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 4, "entityText": "P-gp"}, {"duid": "PU:b2Xd", "entityType": "Disease", "charEnd": 433, "source": "PUBTATOR", "charStart": 415, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 1, "entityText": "metastatic melanoma"}, {"duid": "PU:wsvk", "entityType": "Chemical", "charEnd": 2065, "source": "PUBTATOR", "charStart": 2055, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 9, "entityText": "vemurafenib"}, {"duid": "PU:D5f5", "entityType": "Chemical", "charEnd": 622, "source": "PUBTATOR", "charStart": 612, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 2, "entityText": "vemurafenib"}, {"duid": "PU:UmnL", "entityType": "Gene", "charEnd": 542, "source": "PUBTATOR", "charStart": 539, "entityId": [{"idString": "67078", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 2, "entityText": "P-gp"}, {"duid": "PU:oYub", "entityType": "Gene", "charEnd": 1952, "source": "PUBTATOR", "charStart": 1949, "entityId": [{"idString": "26357", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 8, "entityText": "BCRP"}, {"duid": "PU:KDyG", "entityType": "Gene", "charEnd": 586, "source": "PUBTATOR", "charStart": 583, "entityId": [{"idString": "26357", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 2, "entityText": "BCRP"}, {"duid": "PU:7YTV", "entityType": "Gene", "charEnd": 1651, "source": "PUBTATOR", "charStart": 1647, "entityId": [{"idString": "18671", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 7, "entityText": "Mdr1a"}, {"duid": "PU:2L5U", "entityType": "Gene", "charEnd": 1063, "source": "PUBTATOR", "charStart": 1060, "entityId": [{"idString": "26357", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 5, "entityText": "BCRP"}, {"duid": "PU:Qw3P", "entityType": "Chemical", "charEnd": 150, "source": "PUBTATOR", "charStart": 144, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 0, "entityText": "PLX4032"}, {"duid": "PU:eL6K", "entityType": "Gene", "charEnd": 68, "source": "PUBTATOR", "charStart": 37, "entityId": [{"idString": "26357", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 0, "entityText": "breast cancer resistance protein"}, {"duid": "PU:f5p8", "entityType": "Gene", "charEnd": 23, "source": "PUBTATOR", "charStart": 10, "entityId": [{"idString": "67078", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 0, "entityText": "P-glycoprotein"}, {"duid": "PU:8J3d", "entityType": "Gene", "charEnd": 1687, "source": "PUBTATOR", "charStart": 1683, "entityId": [{"idString": "26357", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 7, "entityText": "Bcrp1"}, {"duid": "PU:dURA", "entityType": "Chemical", "charEnd": 786, "source": "PUBTATOR", "charStart": 776, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 3, "entityText": "vemurafenib"}, {"duid": "PU:EpYi", "entityType": "Chemical", "charEnd": 1624, "source": "PUBTATOR", "charStart": 1614, "entityId": [{"idString": "C551177", "source": "MESH"}], "sentenceIndex": 7, "entityText": "vemurafenib"}, {"duid": "PU:f2JL", "entityType": "Gene", "charEnd": 1034, "source": "PUBTATOR", "charStart": 1031, "entityId": [{"idString": "26357", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 4, "entityText": "BCRP"}, {"duid": "PU:K9hx", "entityType": "Species", "charEnd": 1791, "source": "PUBTATOR", "charStart": 1788, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "mice"}, {"duid": "PU:RnoF", "entityType": "Gene", "charEnd": 1723, "source": "PUBTATOR", "charStart": 1719, "entityId": [{"idString": "18671", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 7, "entityText": "Mdr1a"}, {"duid": "PU:sGmE", "entityType": "Species", "charEnd": 1745, "source": "PUBTATOR", "charStart": 1742, "entityId": [{"idString": "10090", "source": "NCBI"}], "sentenceIndex": 7, "entityText": "mice"}, {"duid": "PU:sY29", "entityType": "Chemical", "charEnd": 1085, "source": "PUBTATOR", "charStart": 1076, "entityId": [], "sentenceIndex": 5, "entityText": "zosuquidar"}, {"duid": "PU:2yt8", "entityType": "Chemical", "charEnd": 1256, "source": "PUBTATOR", "charStart": 1252, "entityId": [{"idString": "C541506", "source": "MESH"}], "sentenceIndex": 5, "entityText": "Ko143"}, {"duid": "PU:N749", "entityType": "Gene", "charEnd": 75, "source": "PUBTATOR", "charStart": 71, "entityId": [{"idString": "26357", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 0, "entityText": "ABCG2"}, {"duid": "PU:HJZu", "entityType": "Gene", "charEnd": 536, "source": "PUBTATOR", "charStart": 523, "entityId": [{"idString": "67078", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 2, "entityText": "P-glycoprotein"}, {"duid": "PU:EPtS", "entityType": "Disease", "charEnd": 2097, "source": "PUBTATOR", "charStart": 2090, "entityId": [{"idString": "D008545", "source": "MESH"}], "sentenceIndex": 9, "entityText": "melanoma"}, {"duid": "PU:Wftr", "entityType": "Gene", "charEnd": 30, "source": "PUBTATOR", "charStart": 26, "entityId": [{"idString": "18669", "source": "Entrez"}, {"idString": "10090", "source": "Tax"}], "sentenceIndex": 0, "entityText": "ABCB1"}]}
